data_1h7y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1h7y _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.542 ' CG ' HD21 ' A' ' 2' ' ' LEU . 4.6 ptp . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.287 0.565 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.542 HD21 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -67.09 147.16 53.5 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 2' ' ' LEU . 57.9 mt -118.41 126.65 52.53 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.429 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.543 ' CD1' ' HA ' ' A' ' 165' ' ' SER . 75.8 m-85 -114.15 121.58 44.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.482 ' C ' ' CD2' ' A' ' 13' ' ' LEU . 10.0 ptmt -126.37 160.79 29.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.616 -0.678 . . . . 0.0 109.228 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.409 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 25.6 t0 -98.86 154.08 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.329 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.36 -17.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.0 mt -75.43 -44.65 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 164.56 43.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.24 -41.94 3.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 57.1 99.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -1.19 . . . . 0.0 109.478 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 44.73 81.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.415 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.482 ' CD2' ' C ' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -86.15 -32.06 21.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 8.2 p -166.91 174.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.966 -1.083 . . . . 0.0 109.529 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 2' ' ' LEU . 28.2 t -146.17 168.34 21.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.987 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.49 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 20.4 t0 -93.11 -4.59 52.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 109.483 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.18 -20.71 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.151 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CD2' HD12 ' A' ' 68' ' ' LEU . 13.5 m-85 -99.08 -55.67 2.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.401 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 18' ' ' TYR . 3.3 m-20 155.44 130.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.523 ' CD1' ' CE2' ' A' ' 4' ' ' TYR . 76.7 mt -130.27 133.56 46.59 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.046 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -131.43 127.52 37.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 9.2 pt-20 -92.9 129.59 38.77 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.058 -1.026 . . . . 0.0 109.614 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' ASP . 4.1 t -78.32 152.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -43.79 -28.46 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.884 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.464 ' O ' HG21 ' A' ' 26' ' ' ILE . 3.0 m-20 -65.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.464 HG21 ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -162.98 49.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.987 -1.071 . . . . 0.0 109.203 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.536 HG22 ' CG2' ' A' ' 157' ' ' ILE . 6.7 m -140.57 151.42 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.654 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -100.6 157.63 16.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.081 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.2 tt0 -128.61 116.87 20.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.105 . . . . 0.0 109.629 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -107.24 112.82 25.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 108.958 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -73.89 146.64 43.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.979 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.04 148.54 48.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.828 . . . . 0.0 109.072 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.8 m120 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 71' ' ' SER . 19.7 p30 -85.45 -17.77 35.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.975 . . . . 0.0 109.57 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.574 HD12 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.09 -41.75 16.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 108.716 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 74' ' ' LEU . 45.2 t -72.35 -36.69 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.411 -0.805 . . . . 0.0 109.286 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -69.61 -43.18 73.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -74.22 -27.94 61.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.936 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.489 ' C ' ' CD ' ' A' ' 73' ' ' ARG . 26.3 m-85 -114.39 16.66 17.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.458 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER 37.84 44.06 0.55 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.729 -0.607 . . . . 0.0 110.596 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.534 ' HB2' ' CG2' ' A' ' 69' ' ' VAL . 6.6 mt -49.44 142.85 7.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.997 -1.065 . . . . 0.0 108.566 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.485 ' OG ' HG21 ' A' ' 132' ' ' ILE . 3.4 p -128.96 107.7 18.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.992 -1.067 . . . . 0.0 109.463 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 131' ' ' TYR . 35.8 Cg_endo -78.21 134.04 12.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.454 2.103 . . . . 0.0 110.247 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -124.26 159.69 29.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.729 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.75 164.36 24.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -150.24 179.98 7.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.778 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.59 153.62 36.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.105 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.55 67.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.703 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.66 -31.32 65.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 109.529 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.5 m -66.15 -29.96 70.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.462 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 10.3 t80 -65.75 -36.87 84.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.703 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.452 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 3.1 mtt -64.66 -38.03 89.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 110.011 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -71.11 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.918 . . . . 0.0 110.496 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -77.27 -38.98 49.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 92' ' ' MET . 6.7 tp -76.34 -26.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.843 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -76.77 -56.38 4.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 109.673 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.18 -23.0 73.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 91' ' ' TYR . 30.1 t80 -81.34 -40.7 23.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.022 -1.281 . . . . 0.0 108.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -63.47 -40.54 97.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.24 -38.53 90.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.94 -46.59 78.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.025 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 29.2 mm -64.74 -40.39 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -51.61 -38.09 53.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.133 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.61 -39.13 64.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 0.0 109.68 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -59.9 -32.11 70.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.365 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.551 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 50.6 mt -73.08 -47.35 45.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -55.34 -36.89 66.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.751 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.59 -31.5 41.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.2 t -105.08 -78.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.723 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 59.3 t30 -119.83 107.94 39.59 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.26 -19.78 19.42 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.385 2.057 . . . . 0.0 110.381 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -74.14 -11.43 60.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.214 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -94.1 0.71 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.489 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 53.6 t -71.95 -43.23 10.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 111.29 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.5 Cg_endo -76.45 -52.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.877 1.718 . . . . 0.0 111.085 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.445 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 2.3 m -59.72 -36.99 69.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.997 -1.064 . . . . 0.0 109.587 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.476 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 44.9 t80 -69.67 -37.34 76.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.276 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.432 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -68.53 -48.78 63.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.868 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -49.47 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.057 . . . . 0.0 110.807 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 109' ' ' VAL . 2.5 m120 -64.49 -48.91 73.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.439 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -62.72 -32.09 73.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.432 HD11 ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -68.27 -39.63 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.402 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.59 -47.82 73.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.47 ' CE2' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -61.22 -42.09 97.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.988 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 71.8 t -60.13 -35.53 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.847 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -68.18 -38.13 81.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.933 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -78.83 -17.56 55.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.94 . . . . 0.0 109.897 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.44 -37.87 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 109.678 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 15.7 mt -62.34 -31.63 72.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 109.659 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.487 ' O ' ' ND2' ' A' ' 124' ' ' ASN . . . -54.1 -26.29 26.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.636 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 123' ' ' ALA . 12.4 m-80 -154.76 54.53 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 2.2 p90 -59.8 -22.13 61.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.639 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.444 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -76.58 -43.42 38.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -65.11 -26.39 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 4.9 m-85 -85.11 -12.24 53.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.338 -0.851 . . . . 0.0 109.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 128' ' ' TYR . 4.1 m-20 50.88 177.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.667 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.559 ' CE1' ' O ' ' A' ' 131' ' ' TYR . 2.7 t80 -139.07 121.23 15.79 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.559 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 9.1 m-85 -103.36 170.69 7.8 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.056 -1.028 . . . . 0.0 110.669 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.485 HG21 ' OG ' ' A' ' 75' ' ' SER . 2.0 tt -156.54 142.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.65 -178.94 51.87 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.402 ' OE1' ' HG2' ' A' ' 73' ' ' ARG . 3.6 mp0 -64.36 -19.45 65.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 136' ' ' MET . 82.6 p -56.01 -33.58 65.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 135' ' ' SER . 13.7 mmt 64.7 53.86 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.572 -0.705 . . . . 0.0 109.494 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.459 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 6.4 t0 -128.96 120.12 20.2 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.323 -0.86 . . . . 0.0 109.176 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.98 2.67 6.37 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.286 1.99 . . . . 0.0 110.559 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.78 12.94 11.45 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.275 -0.891 . . . . 0.0 109.197 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 137' ' ' ASP . . . -98.39 -156.87 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.447 ' HE2' ' HB2' ' A' ' 159' ' ' PHE . 0.0 OUTLIER -64.5 121.53 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.449 HG11 ' CE1' ' A' ' 130' ' ' PHE . 94.4 t -106.35 120.27 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.549 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.577 HG23 ' CE2' ' A' ' 158' ' ' PHE . 7.2 t -109.46 141.52 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.485 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 129' ' ' ASP . 53.1 mt -114.65 141.42 47.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.31 -0.869 . . . . 0.0 108.965 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.1 ttm -104.8 119.68 39.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.018 . . . . 0.0 109.522 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.568 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 44.6 t30 -138.09 146.72 43.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.541 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.9 OUTLIER -87.3 146.2 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.885 . . . . 0.0 109.541 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -58.75 -171.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.29 -17.46 64.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -53.49 4.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.541 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 114.89 -24.72 10.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.426 ' O ' HG21 ' A' ' 152' ' ' ILE . 1.3 tp -85.18 3.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.291 -1.123 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 m -123.67 101.18 36.94 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.6 122.82 5.13 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.509 2.14 . . . . 0.0 109.924 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 155' ' ' TYR . 5.9 p90 -141.03 148.66 40.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.28 158.6 26.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 109.022 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.536 ' CG2' HG22 ' A' ' 27' ' ' VAL . 41.6 mt -116.64 141.93 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 110.02 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.577 ' CE2' HG23 ' A' ' 143' ' ' VAL . 4.5 m-85 -126.3 113.69 17.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.458 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 8.0 m-85 -42.93 119.31 1.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.06 -28.58 67.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.865 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.477 ' N ' ' HG3' ' A' ' 160' ' ' LYS . 3.3 p30 -57.63 -39.7 77.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.443 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -105.93 43.04 1.76 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.459 ' CD2' ' C ' ' A' ' 163' ' ' LEU . 3.6 tt -142.47 125.76 16.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.44 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -112.77 157.42 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.543 ' HA ' ' CD1' ' A' ' 4' ' ' TYR . 1.7 m -101.49 139.21 37.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.08 123.17 33.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -90.57 139.32 30.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 167' ' ' LYS . 12.2 mt -99.02 154.07 18.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.644 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.4 mt -113.56 138.16 50.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.765 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 13.2 m-85 -116.5 108.45 16.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.104 -0.998 . . . . 0.0 109.585 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.08 163.46 12.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.493 -0.754 . . . . 0.0 109.345 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.506 ' OD1' ' CE ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -81.01 157.12 25.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 109.303 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.435 ' CG2' HG11 ' A' ' 164' ' ' VAL . 68.5 t -106.52 -18.82 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.975 . . . . 0.0 109.601 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.425 ' O ' HG21 ' A' ' 8' ' ' ILE . 1.2 mt -85.9 -25.06 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 109.267 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.84 -58.62 1.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.498 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.21 74.42 0.91 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -161.98 160.53 27.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -1.153 . . . . 0.0 109.51 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.7 129.24 36.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.718 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.05 -76.76 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.09 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 6.0 p -131.78 167.21 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.467 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 1.9 p -136.35 148.91 48.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.87 -1.144 . . . . 0.0 110.408 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.486 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 36.3 t70 -82.23 5.61 19.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.491 -0.756 . . . . 0.0 109.284 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.46 -24.09 67.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.893 . . . . 0.0 108.884 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.524 ' CE1' ' OD1' ' A' ' 67' ' ' ASN . 30.2 m-85 -100.13 21.19 13.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.548 -0.72 . . . . 0.0 109.604 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER 58.3 112.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 108.89 -179.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.486 ' CD1' ' HA ' ' A' ' 16' ' ' ASP . 12.2 mt -103.48 147.1 27.56 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 110.343 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -129.75 122.85 29.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.803 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -80.86 128.64 33.89 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ASP . 2.5 t -86.79 92.36 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 0.0 110.116 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 23' ' ' VAL . 23.5 m-20 22.89 45.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 120.848 0.356 . . . . 0.0 111.673 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' VAL . 18.6 m-20 -161.25 -114.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.943 -1.098 . . . . 0.0 109.684 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 160' ' ' LYS . 1.0 OUTLIER -144.71 12.9 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.809 -1.182 . . . . 0.0 109.427 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.456 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 12.3 m -104.41 133.68 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -98.51 151.23 20.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.314 -0.866 . . . . 0.0 109.077 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 mt-10 -117.41 117.44 29.48 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.514 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.433 ' HA ' HD21 ' A' ' 20' ' ' LEU . . . -96.75 112.62 24.3 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 4.7 m-20 -68.93 150.78 47.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 110.042 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.59 144.24 36.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.27 -0.894 . . . . 0.0 109.188 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 0.0 109.586 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.447 ' CG ' ' HB ' ' A' ' 69' ' ' VAL . 1.5 p30 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.524 ' OD1' ' CE1' ' A' ' 18' ' ' TYR . 30.9 p30 -98.14 -15.01 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.87 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 48.9 tp -85.48 -41.57 15.23 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.148 -0.97 . . . . 0.0 108.989 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.478 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 66.6 t -72.77 -37.75 56.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.358 -0.839 . . . . 0.0 109.172 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -69.28 -48.89 60.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.453 -0.779 . . . . 0.0 110.295 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 t -69.4 -52.5 26.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.217 -0.927 . . . . 0.0 110.05 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 28.8 m-85 -75.19 -12.75 60.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.14 37.29 3.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 69' ' ' VAL . 9.3 mt -50.28 107.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.981 -1.074 . . . . 0.0 108.742 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.512 ' O ' ' CG2' ' A' ' 132' ' ' ILE . 0.6 OUTLIER -89.96 126.73 56.36 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.864 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.52 129.32 8.36 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.502 2.135 . . . . 0.0 110.16 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.12 135.81 37.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.088 -1.008 . . . . 0.0 109.656 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.5 m -64.54 -172.4 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.193 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -158.43 -176.94 6.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.082 -1.011 . . . . 0.0 109.592 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.537 ' CB ' ' HB2' ' A' ' 83' ' ' SER . 0.1 OUTLIER -114.69 142.09 46.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.454 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -44.97 95.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 110.153 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.61 -40.27 14.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.991 . . . . 0.0 110.427 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.537 ' HB2' ' CB ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -59.1 -29.48 67.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 109.59 -179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -56.9 -48.39 78.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.782 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mtt -64.05 -46.43 84.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.198 -0.939 . . . . 0.0 110.021 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 m -54.9 -37.05 65.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 109.97 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.57 ' CZ ' ' O ' ' A' ' 138' ' ' PRO . 24.1 t80 -76.47 -33.97 58.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 109.735 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' MET . 3.6 mm -71.42 -15.6 18.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.125 -0.984 . . . . 0.0 109.308 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -57.1 3.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.34 72.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -77.86 -36.8 49.51 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.282 -1.128 . . . . 0.0 108.395 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.524 ' CA ' ' HE1' ' A' ' 92' ' ' MET . 0.0 OUTLIER -62.44 -51.94 65.5 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -57.14 -38.82 74.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.487 -0.758 . . . . 0.0 109.293 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.76 -50.42 72.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.917 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.566 HG22 ' CZ ' ' A' ' 110' ' ' PHE . 30.3 mm -65.37 -28.97 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -44.78 93.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.192 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.468 ' HA ' ' HG2' ' A' ' 100' ' ' GLN . . . -69.3 -25.89 64.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -0.844 . . . . 0.0 109.102 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -71.27 -41.1 70.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.613 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.484 ' CD2' ' HB3' ' A' ' 106' ' ' ARG . 61.2 mt -72.79 -48.57 37.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.946 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -58.41 -31.77 68.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.741 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -79.24 -28.8 42.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.06 -1.025 . . . . 0.0 108.883 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.515 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 73.4 m -93.93 -79.02 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.4 -0.813 . . . . 0.0 109.015 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.95 140.36 26.64 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.832 . . . . 0.0 109.271 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -74.88 -17.25 20.03 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.654 2.236 . . . . 0.0 111.12 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -71.09 -8.95 56.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -0.967 . . . . 0.0 109.955 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.484 ' HB3' ' CD2' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -100.44 -5.06 27.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.117 -0.989 . . . . 0.0 109.793 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.588 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 3.1 t -69.18 -47.52 28.48 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.09 -1.006 . . . . 0.0 109.985 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 36.1 Cg_endo -78.54 -39.23 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.129 1.886 . . . . 0.0 110.876 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.09 -50.07 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.174 -0.953 . . . . 0.0 109.855 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.566 ' CZ ' HG22 ' A' ' 95' ' ' ILE . 60.2 t80 -68.81 -39.67 79.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.29 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 1.2 mm-40 -61.4 -43.47 98.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.119 -0.988 . . . . 0.0 110.406 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -70.39 -45.51 65.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.063 -1.023 . . . . 0.0 110.182 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 117' ' ' PHE . 3.8 t-20 -57.95 -38.7 76.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.159 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.515 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -71.02 -31.76 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 110.156 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.464 ' O ' ' HD2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -70.36 -48.89 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.134 -0.979 . . . . 0.0 109.747 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 120' ' ' LYS . . . -66.92 -49.31 55.41 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -58.14 -42.88 86.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.108 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 114' ' ' ALA . 53.3 t -57.28 -37.04 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.989 . . . . 0.0 110.023 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -71.01 -45.49 63.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.018 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 0.1 OUTLIER -56.67 -54.21 48.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.702 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.66 -53.68 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 0.0 109.347 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 42.9 mt -45.95 -48.05 16.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.729 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 120' ' ' LYS . . . -46.88 -45.86 20.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.43 ' HB3' ' OD1' ' A' ' 127' ' ' ASP . 7.1 m120 -139.42 66.14 1.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.524 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.85 -49.6 75.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -52.53 -28.6 21.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 109.776 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 124' ' ' ASN . 3.6 m-20 -77.75 -37.86 48.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 109.722 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 129' ' ' ASP . 27.4 m-85 -77.95 -14.65 59.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.648 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.4 OUTLIER 50.82 177.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.648 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 131' ' ' TYR . 2.0 t80 -136.78 121.3 18.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.828 . . . . 0.0 108.837 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.575 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 19.3 m-85 -107.75 175.78 5.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 110.871 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 75' ' ' SER . 18.6 tt -147.33 159.7 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.534 -0.729 . . . . 0.0 109.399 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -88.13 171.9 41.12 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -24.07 64.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -1.153 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.3 OUTLIER -59.68 -34.98 73.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.494 ' CB ' ' O ' ' A' ' 135' ' ' SER . 3.2 tpt 75.75 37.17 0.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.24 125.28 26.99 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.273 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.57 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 33.9 Cg_endo -75.44 -0.25 9.88 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.295 1.997 . . . . 0.0 110.35 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -105.65 -0.73 25.35 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.31 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 141' ' ' MET . . . -94.98 44.34 1.1 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.905 . . . . 0.0 109.617 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.506 ' CE ' ' OD1' ' A' ' 6' ' ' ASP . 2.3 mtp 67.42 140.84 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 109.688 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.566 ' CG1' ' CE1' ' A' ' 130' ' ' PHE . 19.0 m -112.73 141.32 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.267 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.57 HG13 ' CZ ' ' A' ' 158' ' ' PHE . 2.9 t -109.31 144.12 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 0.0 109.836 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.413 HD21 ' O ' ' A' ' 129' ' ' ASP . 25.0 mt -113.62 147.92 37.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.197 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.432 ' SD ' ' SD ' ' A' ' 156' ' ' MET . 5.2 tpp -116.71 123.0 46.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.866 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.54 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 13.9 t-20 -141.63 151.25 42.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.383 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -76.48 154.97 34.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.655 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -100.64 -172.66 2.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -28.62 63.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.27 -47.94 65.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.539 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 106.71 -34.66 5.56 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.503 HD11 ' N ' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -121.2 20.93 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -1.102 . . . . 0.0 109.191 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.3 m -117.01 101.5 53.34 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.339 -0.85 . . . . 0.0 109.361 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.68 129.06 8.99 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.5 2.133 . . . . 0.0 110.581 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 33.4 p90 -131.0 152.07 50.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 0.0 109.282 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.454 ' HB3' ' CG1' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -117.1 157.65 25.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.608 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.456 ' CG2' ' HB ' ' A' ' 27' ' ' VAL . 20.4 mt -115.39 137.12 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 109.616 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.57 ' CZ ' HG13 ' A' ' 143' ' ' VAL . 31.4 m-85 -129.22 141.71 51.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.087 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -75.24 117.57 17.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.896 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -68.44 -28.17 66.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 160' ' ' LYS . 0.8 OUTLIER -58.82 -18.92 36.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.748 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -125.72 39.88 1.96 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 158' ' ' PHE . 9.5 mt -137.57 149.5 46.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -1.221 . . . . 0.0 109.668 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.435 HG11 ' CG2' ' A' ' 7' ' ' VAL . 5.5 m -128.41 122.99 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.149 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.84 132.58 35.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.496 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -118.51 126.35 51.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.823 . . . . 0.0 109.221 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.439 ' HA ' ' CD2' ' A' ' 2' ' ' LEU . 0.9 OUTLIER -61.21 119.16 7.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.75 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.586 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 0.9 OUTLIER -68.82 149.44 48.96 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.23 -0.919 . . . . 0.0 109.852 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.0 mt -126.17 123.8 39.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.511 -0.743 . . . . 0.0 109.128 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.572 ' CE1' ' OG ' ' A' ' 165' ' ' SER . 30.3 m-85 -102.05 118.97 38.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 0.0 109.758 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 35.3 pttt -136.75 165.33 26.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.462 -0.774 . . . . 0.0 109.433 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 20.3 p30 -71.88 145.33 48.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 7' ' ' VAL . 14.9 p -107.81 43.22 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.474 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.431 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 1.1 tt -140.64 -38.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 27.1 t -104.89 -70.66 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.595 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 138.86 84.08 0.11 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 12' ' ' GLU . 19.2 t0 179.58 141.44 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -1.13 . . . . 0.0 109.336 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.545 ' HG3' ' CE2' ' A' ' 72' ' ' PHE . 1.2 pm0 -78.98 147.57 32.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.536 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 mt -130.9 -41.72 1.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.283 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.511 ' CG2' ' N ' ' A' ' 15' ' ' SER . 2.6 p -138.98 167.44 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.511 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -160.21 176.14 12.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.888 -1.132 . . . . 0.0 110.94 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.21 1.13 33.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.621 -0.674 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.52 -16.26 63.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.075 -1.016 . . . . 0.0 108.758 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.584 ' CE2' ' CD1' ' A' ' 68' ' ' LEU . 27.2 m-85 -122.56 19.31 10.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.463 -0.773 . . . . 0.0 109.081 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 18' ' ' TYR . 1.2 m-20 61.79 134.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 108.835 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.497 HD22 ' CG2' ' A' ' 14' ' ' VAL . 12.2 mt -126.44 155.04 42.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.199 -0.938 . . . . 0.0 110.119 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.508 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 12.6 mmtt -132.26 120.97 22.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.445 -0.784 . . . . 0.0 109.118 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -87.24 126.14 34.64 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.187 -0.946 . . . . 0.0 108.804 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 24' ' ' ASP . 3.4 t -76.63 158.43 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.591 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' VAL . 1.3 t0 -42.9 -33.17 0.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.418 -0.801 . . . . 0.0 109.313 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.486 ' HB3' ' ND2' ' A' ' 113' ' ' ASN . 5.4 m-20 -69.85 -140.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.069 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.484 ' CD1' ' OD1' ' A' ' 113' ' ' ASN . 1.5 pp -129.18 61.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.9 -1.125 . . . . 0.0 109.435 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 26' ' ' ILE . 11.6 m -146.12 147.61 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.773 . . . . 0.0 109.372 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.475 ' CE1' ' HB3' ' A' ' 22' ' ' GLU . 44.3 m-85 -103.89 158.52 16.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.508 ' CG ' ' HB2' ' A' ' 21' ' ' LYS . 11.2 pt-20 -130.2 129.4 43.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 109.57 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.503 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -111.77 134.4 53.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -0.929 . . . . 0.0 109.429 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -98.19 134.87 40.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.418 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 68' ' ' LEU . 63.1 m -110.36 155.86 21.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 109.731 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.346 -0.846 . . . . 0.0 109.462 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.456 ' CB ' ' HB ' ' A' ' 69' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.3 0.571 . . . . 0.0 109.578 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -89.25 -39.74 13.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.883 . . . . 0.0 109.634 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.584 ' CD1' ' CE2' ' A' ' 18' ' ' TYR . 25.4 tp -80.79 -34.76 33.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.082 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.49 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 94.5 t -67.45 -39.84 83.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.45 -0.781 . . . . 0.0 109.333 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -69.63 -52.22 27.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -28.55 70.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 0.0 110.545 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 68' ' ' LEU . 9.2 m-85 -102.97 -4.74 24.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.89 -1.131 . . . . 0.0 110.028 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.51 28.81 16.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.015 . . . . 0.0 109.852 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.491 ' N ' HD21 ' A' ' 74' ' ' LEU . 2.3 mm? -49.24 140.24 10.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.093 -1.005 . . . . 0.0 109.285 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.4 t -123.39 139.62 32.26 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 109.486 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.79 132.74 10.95 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.537 2.158 . . . . 0.0 110.145 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 p -128.18 165.76 19.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.417 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.28 129.73 3.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.517 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 17.0 t80 -141.6 160.38 40.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 109.452 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.57 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 40.3 m-20 -39.36 129.64 1.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.479 -0.763 . . . . 0.0 109.673 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.557 ' HG3' ' CE1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -61.63 -32.35 72.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.606 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -44.54 59.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 109.922 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 80' ' ' ASP . 10.8 t -62.91 -37.89 88.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.784 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.491 ' CE1' HG12 ' A' ' 88' ' ' ILE . 1.4 t80 -55.69 -35.83 66.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.235 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.461 ' O ' HG21 ' A' ' 88' ' ' ILE . 30.4 mtt -56.76 -48.26 78.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -0.954 . . . . 0.0 109.368 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.28 -45.38 91.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.18 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.438 ' O ' ' CD2' ' A' ' 91' ' ' TYR . 25.5 m-85 -68.04 -17.69 64.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.491 HG12 ' CE1' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -76.57 -30.2 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.491 ' N ' HG21 ' A' ' 88' ' ' ILE . 4.2 mmmm -79.17 -35.33 42.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.384 -0.822 . . . . 0.0 109.032 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.82 -36.58 87.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 87' ' ' TYR . 20.0 m-85 -78.48 -36.93 44.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.118 -1.225 . . . . 0.0 108.942 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.9 OUTLIER -62.38 -39.91 94.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 108.791 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -69.09 -34.33 74.93 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.1 73.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 109.164 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.483 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 47.1 mm -66.76 -36.12 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 109.23 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -35.49 75.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.161 -0.962 . . . . 0.0 109.255 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.52 -55.13 6.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.947 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.489 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -52.28 -33.1 40.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 109.936 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.489 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 83.6 mt -72.82 -45.11 60.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -56.55 -38.45 71.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -32.99 63.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 m -98.35 -72.49 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.823 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -140.7 119.06 8.21 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.52 -17.64 20.69 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.458 2.105 . . . . 0.0 110.745 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -68.99 -9.6 53.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.679 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.527 ' HA ' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -101.34 -5.78 24.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 109.603 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.623 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 51.9 t -71.34 -42.99 12.13 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 111.04 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.2 Cg_endo -76.97 -52.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.894 1.729 . . . . 0.0 110.984 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.527 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 15.6 m -55.87 -52.63 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.097 -1.002 . . . . 0.0 109.413 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.428 ' CD2' HG23 ' A' ' 95' ' ' ILE . 46.1 t80 -62.79 -37.04 85.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.116 -0.99 . . . . 0.0 109.177 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -54.13 -48.08 71.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 110.304 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 109' ' ' VAL . 1.0 OUTLIER -67.65 -36.12 80.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.05 -1.031 . . . . 0.0 110.179 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 25' ' ' ASP . 21.2 t-20 -67.5 -32.94 74.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.399 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -71.07 -29.82 65.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.157 -0.964 . . . . 0.0 109.889 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -40.21 73.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.231 -0.918 . . . . 0.0 108.985 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -67.56 -46.45 69.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.463 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -68.18 -30.74 69.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -1.154 . . . . 0.0 110.065 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 37.6 t -68.8 -50.59 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.095 -1.003 . . . . 0.0 109.509 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -65.97 -28.69 69.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 0.0 109.653 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.66 -60.75 2.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.147 -0.971 . . . . 0.0 109.609 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.564 ' HA ' ' CE2' ' A' ' 128' ' ' TYR . 1.2 mp -55.41 -37.65 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.441 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 45.5 mt -53.03 -42.29 65.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 109.603 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.88 -39.68 40.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 109.268 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.516 ' HB3' ' CB ' ' A' ' 127' ' ' ASP . 8.6 m120 -130.04 64.08 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.0 109.247 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.557 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 6.9 t80 -60.55 -38.98 86.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 109.856 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -77.23 -30.76 54.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 110.012 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.516 ' CB ' ' HB3' ' A' ' 124' ' ' ASN . 1.2 t70 -75.13 -23.83 57.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.986 . . . . 0.0 109.953 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.564 ' CE2' ' HA ' ' A' ' 121' ' ' ILE . 41.5 m-85 -94.03 -33.0 13.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.716 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.505 ' O ' ' CD2' ' A' ' 144' ' ' LEU . 92.1 m-20 53.87 -177.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -141.41 122.39 14.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 108.796 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -97.97 173.04 7.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.0 110.757 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 14.8 tt -156.59 138.21 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.651 -0.655 . . . . 0.0 109.268 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.06 170.88 8.04 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.29 -18.31 64.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -1.178 . . . . 0.0 109.355 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 136' ' ' MET . 4.8 t -60.54 -36.44 78.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 0.0 109.48 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.41 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 69.93 49.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.297 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.11 119.2 54.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.237 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.37 0.35 9.16 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.307 2.005 . . . . 0.0 110.239 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -100.55 -8.87 22.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.374 -0.829 . . . . 0.0 109.091 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.431 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -88.88 152.99 21.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -0.89 . . . . 0.0 109.286 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.489 ' CE ' ' HB2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -65.62 166.1 11.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.656 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.07 141.83 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.444 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.581 HG23 ' CE2' ' A' ' 158' ' ' PHE . 17.3 t -97.3 139.25 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.152 -0.968 . . . . 0.0 109.235 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.505 ' CD2' ' O ' ' A' ' 129' ' ' ASP . 17.6 mt -107.12 136.6 46.69 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.426 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.5 ' CE ' ' HE2' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.56 137.09 47.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.629 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.444 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 24.6 t-20 -152.16 164.34 37.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 109.534 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.42 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 2.6 m-85 -107.83 137.23 46.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.425 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.8 OUTLIER -65.56 167.06 9.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.284 -0.885 . . . . 0.0 109.387 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 148' ' ' ARG . 4.9 mt-10 -44.26 -28.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.444 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -50.43 70.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.516 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.42 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 101.18 -20.68 46.34 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.483 ' C ' ' CD1' ' A' ' 152' ' ' ILE . 2.0 pp -105.71 7.04 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -1.038 . . . . 0.0 109.366 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.2 m -114.08 101.34 53.92 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.236 -0.915 . . . . 0.0 109.26 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.2 119.24 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.443 2.095 . . . . 0.0 110.415 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 5.1 p90 -138.61 138.76 38.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.946 . . . . 0.0 109.465 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.508 ' N ' ' SD ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -116.92 149.59 39.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 109.174 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.492 ' C ' ' CD1' ' A' ' 158' ' ' PHE . 2.6 mt -105.89 149.12 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.617 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.581 ' CE2' HG23 ' A' ' 143' ' ' VAL . 6.0 m-85 -132.34 117.88 18.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 0.0 109.267 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.473 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 36.6 m-85 -53.67 121.65 8.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 109.375 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 8.1 tttt -66.84 -26.7 67.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.681 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 159' ' ' PHE . 0.4 OUTLIER -56.49 -43.99 80.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.331 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -108.41 27.93 12.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.526 HD23 ' N ' ' A' ' 164' ' ' VAL . 1.2 tm? -147.45 126.91 13.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.349 -1.089 . . . . 0.0 109.111 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.526 ' N ' HD23 ' A' ' 163' ' ' LEU . 10.8 m -135.72 155.95 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -88.85 150.45 22.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.449 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -142.57 122.59 13.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 109.313 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -90.46 146.03 24.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.39 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.501 ' CD2' ' HA ' ' A' ' 167' ' ' LYS . 12.7 mt -102.62 152.49 21.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 mt -107.54 146.49 31.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.84 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 8.3 m-85 -121.7 111.66 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 0.0 109.173 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.465 ' O ' HD22 ' A' ' 163' ' ' LEU . 15.8 mttm -114.48 156.68 24.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.68 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.0 155.9 21.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 p -92.07 -0.42 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.507 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 8' ' ' ILE . 47.6 mm -80.16 -58.68 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.686 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 10' ' ' GLY . 41.7 t -119.13 13.62 12.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' SER . . . 44.99 70.89 0.54 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.411 ' CG ' ' OG ' ' A' ' 135' ' ' SER . 15.0 t70 -137.85 138.35 39.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -1.07 . . . . 0.0 109.329 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' O ' HD21 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -44.83 143.82 1.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.47 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.476 HD13 ' CG2' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -134.32 -62.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.602 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 4.4 p -144.37 -178.85 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.91 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.7 m -149.45 165.38 32.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.723 -1.236 . . . . 0.0 110.602 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.42 ' CG ' HD13 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -86.19 7.98 22.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.498 -0.751 . . . . 0.0 109.503 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.82 -10.6 49.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.116 -0.99 . . . . 0.0 108.923 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.541 ' CE2' ' HG ' ' A' ' 68' ' ' LEU . 24.3 m-85 -121.03 21.54 11.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 0.0 109.147 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER 64.21 132.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 21.9 mt -126.14 142.79 51.38 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.216 -0.927 . . . . 0.0 110.052 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.04 140.14 50.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.465 -0.772 . . . . 0.0 109.42 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.14 112.92 24.94 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.259 -0.901 . . . . 0.0 108.903 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 24' ' ' ASP . 21.6 t -62.54 152.68 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.446 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.487 ' N ' HG11 ' A' ' 23' ' ' VAL . 67.4 m-20 -54.01 -19.6 5.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.668 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.514 ' O ' ' CG2' ' A' ' 26' ' ' ILE . 0.7 OUTLIER -75.46 -98.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.04 -1.038 . . . . 0.0 109.318 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.514 ' CG2' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -165.76 56.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.005 -1.06 . . . . 0.0 109.617 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 m -152.05 158.16 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.077 -1.014 . . . . 0.0 109.76 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.419 ' C ' ' HG2' ' A' ' 29' ' ' GLU . 6.0 m-85 -103.58 162.2 13.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 0.0 109.026 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.6 mm-40 -130.99 117.41 19.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.602 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -103.97 112.76 25.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 108.956 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 2.3 m-20 -77.92 150.47 34.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.824 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.441 ' SG ' ' HG2' ' A' ' 154' ' ' PRO . 1.7 p -125.46 175.72 7.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.871 . . . . 0.0 109.315 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 0.0 109.459 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 m120 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 71' ' ' SER . 10.0 p30 -74.19 -21.48 59.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 109.739 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.541 ' HG ' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -81.47 -36.94 28.72 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.099 -1.001 . . . . 0.0 108.771 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 73' ' ' ARG . 41.7 t -71.33 -54.32 17.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.419 -0.801 . . . . 0.0 109.706 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -61.76 -41.31 97.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 0.0 110.142 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 5.0 t -68.4 -33.19 73.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.152 -0.968 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 73' ' ' ARG . 22.9 m-85 -110.08 13.32 23.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.04 -1.037 . . . . 0.0 109.996 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 69' ' ' VAL . 55.0 mtt180 43.41 69.42 0.4 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.155 -0.966 . . . . 0.0 109.481 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.489 ' N ' HD21 ' A' ' 74' ' ' LEU . 1.7 mm? -89.81 137.96 31.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.399 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.03 117.83 62.63 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.152 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.71 123.59 5.37 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.551 2.168 . . . . 0.0 110.631 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.474 HG21 ' O ' ' A' ' 130' ' ' PHE . 2.4 t -132.69 174.2 10.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 108.988 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -142.57 9.22 1.79 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.222 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' A' ' 79' ' ' PHE . 16.7 p90 -86.91 123.04 31.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.045 -1.035 . . . . 0.0 109.599 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -174.23 21.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.943 . . . . 0.0 110.54 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -63.58 -53.46 51.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.945 -1.097 . . . . 0.0 109.347 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.06 -24.67 4.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -29.89 67.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.118 -0.989 . . . . 0.0 109.165 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.558 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -58.84 -46.27 88.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 109.356 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.412 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -64.84 -30.04 71.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.262 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -71.16 -55.4 8.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.017 -1.052 . . . . 0.0 110.691 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.547 ' CD1' ' HG2' ' A' ' 138' ' ' PRO . 39.7 m-85 -63.91 -41.45 97.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.088 -1.007 . . . . 0.0 109.897 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.497 HG22 HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -68.84 -22.33 26.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 109.469 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -55.2 5.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.344 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.12 -19.89 68.52 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -81.12 -39.02 26.26 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.157 -1.202 . . . . 0.0 108.326 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.65 -40.69 92.75 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.69 -43.99 95.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 0.0 109.125 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.56 -50.09 68.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 108.886 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.495 ' CG2' ' OD1' ' A' ' 161' ' ' ASP . 41.9 mm -60.02 -32.07 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.224 -0.923 . . . . 0.0 108.682 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HG2' HG12 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -56.2 -50.32 71.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 108.948 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.82 77.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.154 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 101' ' ' GLU . 3.8 tmt_? -58.63 -43.84 89.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.126 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 95' ' ' ILE . 24.7 mt -64.67 -48.47 74.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.378 -0.826 . . . . 0.0 109.033 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -52.72 -25.26 10.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.198 -0.939 . . . . 0.0 108.827 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -76.32 -43.28 41.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 108.966 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.8 t -88.85 -71.77 0.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.191 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -148.04 137.25 11.95 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.04 -16.73 19.95 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.604 2.203 . . . . 0.0 111.066 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.52 -14.08 62.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.008 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 110' ' ' PHE . 12.8 ttp-105 -93.09 -5.94 49.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.664 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 62.9 t -71.21 -43.09 12.55 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 111.344 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.4 Cg_endo -77.38 -54.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.883 1.722 . . . . 0.0 110.99 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.418 ' CG2' ' N ' ' A' ' 110' ' ' PHE . 35.7 m -56.52 -46.0 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.114 -0.992 . . . . 0.0 110.007 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 62.5 t80 -65.06 -45.87 83.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.822 . . . . 0.0 110.696 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 115' ' ' ILE . 67.7 tt0 -57.28 -47.77 80.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.008 -1.057 . . . . 0.0 110.536 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -68.38 -31.69 71.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.058 -1.026 . . . . 0.0 110.345 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -66.36 -54.24 26.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 109.913 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.57 -26.55 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.988 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 111' ' ' GLU . 4.1 mm -62.29 -49.08 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.127 -0.983 . . . . 0.0 109.162 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.96 -41.04 99.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -35.2 75.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.25 -1.147 . . . . 0.0 109.602 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.58 -38.06 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 109.561 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 115' ' ' ILE . 3.3 mmtt -64.34 -29.66 70.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 109.801 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -81.83 -46.9 13.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 109.893 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.2 OUTLIER -53.98 -37.86 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.16 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.02 -45.87 86.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.122 -0.986 . . . . 0.0 109.424 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -48.05 -39.66 20.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.868 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -136.43 45.65 2.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.146 -0.971 . . . . 0.0 109.735 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 10.1 p90 -63.02 -22.86 67.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.443 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.413 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -70.95 -47.02 61.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.547 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 2.0 m-20 -71.13 -23.57 62.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.342 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.53 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 6.3 m-85 -76.45 -10.72 59.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.513 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 50.94 -172.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.946 . . . . 0.0 109.451 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.474 ' O ' HG21 ' A' ' 77' ' ' THR . 0.3 OUTLIER -149.22 121.68 8.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -107.4 166.81 10.38 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.035 -1.041 . . . . 0.0 110.38 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' A' ' 136' ' ' MET . 7.6 tt -146.79 130.51 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.405 -0.809 . . . . 0.0 109.477 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.56 179.16 3.87 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.08 -23.27 67.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -1.127 . . . . 0.0 109.453 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 136' ' ' MET . 7.2 m -58.71 -34.58 71.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.511 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 76.81 20.4 1.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.308 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -114.62 119.58 39.37 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.242 -0.911 . . . . 0.0 109.276 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 87' ' ' TYR . 33.4 Cg_endo -75.4 -5.51 16.7 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.262 1.974 . . . . 0.0 110.303 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 8' ' ' ILE . 2.4 p30 -95.38 -4.88 44.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 0.0 109.143 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' A' ' 141' ' ' MET . . . -98.45 47.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.53 ' CB ' ' O ' ' A' ' 140' ' ' ALA . 27.3 ttm 79.66 115.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.759 -0.588 . . . . 0.0 109.606 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.15 130.59 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.351 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.586 HG23 ' CE2' ' A' ' 158' ' ' PHE . 3.0 t -99.84 138.82 23.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.271 -0.893 . . . . 0.0 109.069 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 128' ' ' TYR . 18.6 mt -115.0 146.49 41.19 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.229 -0.92 . . . . 0.0 109.622 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.413 ' HG2' ' HG2' ' A' ' 156' ' ' MET . 0.0 OUTLIER -109.3 124.79 51.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.329 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.53 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 24.3 t-20 -138.31 140.22 39.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.5 OUTLIER -77.8 147.04 35.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -0.845 . . . . 0.0 109.563 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -79.22 178.42 8.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.0 -25.36 8.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.45 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.426 ' OD2' HG13 ' A' ' 152' ' ' ILE . 31.9 t0 -72.17 -47.99 46.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 0.0 109.397 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 105.33 -28.61 13.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.469 ' C ' ' CD1' ' A' ' 152' ' ' ILE . 2.3 pp -99.78 11.51 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -1.153 . . . . 0.0 109.641 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.1 m -121.49 100.59 44.34 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.158 -0.964 . . . . 0.0 109.428 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.441 ' HG2' ' SG ' ' A' ' 32' ' ' CYS . 36.9 Cg_endo -81.22 131.02 7.49 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.554 2.169 . . . . 0.0 110.502 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 146' ' ' ASN . 32.9 p90 -135.18 144.49 47.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.377 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.483 ' HB3' ' CG1' ' A' ' 143' ' ' VAL . 2.0 mtt -107.93 163.91 12.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 109.888 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.46 ' O ' HG12 ' A' ' 143' ' ' VAL . 8.0 mt -124.15 139.36 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 109.384 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.586 ' CE2' HG23 ' A' ' 143' ' ' VAL . 52.7 m-85 -129.97 116.0 17.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.452 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 2.2 m-85 -43.15 116.81 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.263 -0.898 . . . . 0.0 109.746 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -68.65 -42.59 77.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.825 . . . . 0.0 109.979 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 95' ' ' ILE . 3.5 t70 -47.22 -35.79 8.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.467 ' O ' ' HE3' ' A' ' 141' ' ' MET . . . -110.74 50.26 0.78 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.465 HD22 ' O ' ' A' ' 5' ' ' LYS . 3.8 mt -134.16 154.96 50.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.237 . . . . 0.0 109.68 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.2 m -143.27 125.83 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 59.4 m -82.59 135.55 35.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -127.72 124.9 38.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.892 . . . . 0.0 109.574 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.501 ' HA ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -68.5 117.17 9.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.445 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.494 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttm . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 167' ' ' LYS . 12.6 mt -112.5 151.5 29.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 109.641 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 3' ' ' LEU . 32.4 mt -105.92 122.93 47.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 3.6 m-85 -103.92 117.88 35.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.942 . . . . 0.0 109.185 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -129.63 143.27 50.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.644 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.429 ' OD1' ' CD2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -74.35 156.77 36.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.529 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 7' ' ' VAL . 93.2 t -98.72 -6.45 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.356 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.522 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 3.1 mt -101.47 -61.31 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 109.651 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 8' ' ' ILE . 10.3 t -43.23 -47.39 6.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.57 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.96 -63.65 0.37 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.87 65.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -1.19 . . . . 0.0 109.52 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 179.37 141.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.429 ' CD2' ' OD1' ' A' ' 6' ' ' ASP . 23.9 tp -171.96 -75.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 0.0 109.62 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.507 HG23 ' CB ' ' A' ' 30' ' ' ALA . 3.2 p -153.18 -172.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 108.972 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.5 p -162.57 174.27 12.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.843 -1.161 . . . . 0.0 110.168 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.47 ' CA ' HD13 ' A' ' 20' ' ' LEU . 37.5 t70 -82.95 10.98 6.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.399 -0.813 . . . . 0.0 109.988 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.08 -9.67 33.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 109.227 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 39.4 m-85 -126.77 21.56 6.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.243 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 14.9 m-20 67.96 130.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 34.8 mt -126.31 147.89 49.64 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.178 -0.951 . . . . 0.0 110.371 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 136.8 44.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.504 -0.747 . . . . 0.0 109.381 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 1.1 tt0 -99.24 113.17 25.29 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.264 -0.898 . . . . 0.0 108.837 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.485 HG11 ' N ' ' A' ' 24' ' ' ASP . 33.2 t -62.36 157.69 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.222 -0.924 . . . . 0.0 109.574 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' N ' HG11 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -43.73 -28.37 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.247 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -75.24 -143.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 108.998 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 160' ' ' LYS . 1.0 OUTLIER -123.41 54.58 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.054 -1.029 . . . . 0.0 109.591 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.42 HG11 ' C ' ' A' ' 26' ' ' ILE . 5.2 m -136.86 153.84 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 109.473 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.407 ' CD2' ' HE2' ' A' ' 4' ' ' TYR . 4.3 m-85 -107.27 163.16 13.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.308 -0.87 . . . . 0.0 109.222 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 47.6 mt-10 -128.98 119.91 25.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.507 ' CB ' HG23 ' A' ' 14' ' ' VAL . . . -114.86 112.52 22.88 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 11.1 m-20 -75.01 145.62 42.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 t -104.21 125.89 50.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.415 -0.803 . . . . 0.0 108.944 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.104 -0.998 . . . . 0.0 109.969 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.458 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 32.8 m120 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.338 0.589 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 32.3 t-20 -92.71 -26.18 17.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.707 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.458 HD12 HG21 ' A' ' 14' ' ' VAL . 49.7 tp -87.78 -47.79 8.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 108.749 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 74' ' ' LEU . 50.7 t -60.42 -47.88 90.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -69.29 -47.59 64.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 110.139 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 t -49.4 -52.25 29.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.561 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.428 ' CD1' HD13 ' A' ' 68' ' ' LEU . 72.5 m-85 -102.12 8.48 40.71 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.046 -1.033 . . . . 0.0 110.178 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.24 95.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.023 . . . . 0.0 109.263 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.467 ' HB2' HG11 ' A' ' 69' ' ' VAL . 3.9 mm? -114.31 139.13 49.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.336 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 t -125.92 124.06 24.68 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 109.397 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.85 157.81 27.59 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.398 2.065 . . . . 0.0 110.263 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -93.87 -174.27 3.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 109.391 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.1 4.42 2.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.702 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 79' ' ' PHE . 14.1 t80 -160.34 124.26 3.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.481 ' HB2' ' CD2' ' A' ' 130' ' ' PHE . 0.3 OUTLIER -161.56 23.74 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.328 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -53.17 61.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -23.7 11.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.315 -0.866 . . . . 0.0 109.331 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.6 m -72.02 -31.45 66.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.457 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 3.9 t80 -58.83 -36.65 74.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.604 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.42 ' O ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -63.37 -53.04 58.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.73 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.3 m -61.62 -28.56 69.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.872 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 91' ' ' TYR . 10.9 m-85 -69.63 -46.3 66.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.092 -1.005 . . . . 0.0 109.749 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.469 HG21 ' N ' ' A' ' 89' ' ' LYS . 5.9 tp -65.12 -24.58 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.279 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.469 ' N ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -74.35 -46.85 38.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.766 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.94 -27.1 72.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 87' ' ' TYR . 21.1 m-85 -81.21 -36.75 29.67 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.083 -1.245 . . . . 0.0 109.307 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.483 ' CE ' ' O ' ' A' ' 92' ' ' MET . 0.0 OUTLIER -63.76 -41.32 98.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.89 . . . . 0.0 109.863 -179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -73.45 -40.9 63.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.958 . . . . 0.0 109.723 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -44.47 73.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.613 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.459 HD13 ' OD1' ' A' ' 161' ' ' ASP . 49.2 mm -62.15 -37.41 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.491 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -50.68 61.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.87 . . . . 0.0 109.29 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.89 -27.89 68.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.385 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.569 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.41 -36.49 82.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.316 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.569 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 33.3 mt -72.59 -50.45 25.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.127 -0.983 . . . . 0.0 109.616 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -51.51 -34.19 35.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.304 -0.872 . . . . 0.0 109.0 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.2 -37.09 72.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 109.056 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.5 m -96.95 -82.04 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.378 -0.826 . . . . 0.0 109.601 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.509 ' OD1' ' CG ' ' A' ' 105' ' ' GLU . 3.1 p30 -132.0 134.69 25.49 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.64 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.15 -19.01 17.95 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.503 2.135 . . . . 0.0 110.854 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.509 ' CG ' ' OD1' ' A' ' 103' ' ' ASN . 16.2 pt-20 -68.87 -8.76 46.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 0.0 109.861 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -93.92 -3.53 51.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.994 . . . . 0.0 109.782 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 25.8 t -72.4 -45.02 10.29 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 111.015 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.2 Cg_endo -77.41 -47.39 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.989 1.793 . . . . 0.0 111.156 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 110' ' ' PHE . 1.4 p -63.51 -44.68 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 109.598 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.532 ' N ' ' CG1' ' A' ' 109' ' ' VAL . 49.0 t80 -64.5 -41.0 96.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.501 -0.749 . . . . 0.0 110.34 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -40.37 94.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.015 -1.053 . . . . 0.0 110.338 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -48.98 45.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.045 -1.034 . . . . 0.0 110.783 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.41 -54.62 43.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.054 -1.029 . . . . 0.0 110.465 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -60.71 -26.71 67.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.001 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -49.15 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.086 -1.009 . . . . 0.0 109.286 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.37 -33.59 82.57 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.493 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.1 OUTLIER -63.6 -45.46 90.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -1.13 . . . . 0.0 109.969 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 114' ' ' ALA . 60.6 t -53.78 -38.62 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.326 -0.859 . . . . 0.0 110.657 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -71.19 -49.29 45.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 110.562 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 117' ' ' PHE . 0.1 OUTLIER -73.0 -11.18 60.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.028 -1.045 . . . . 0.0 110.27 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.5 HG21 ' N ' ' A' ' 122' ' ' LEU . 0.8 OUTLIER -83.2 -44.57 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.06 -1.025 . . . . 0.0 109.665 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.5 ' N ' HG21 ' A' ' 121' ' ' ILE . 40.0 mt -53.64 -36.4 62.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 109.964 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 122' ' ' LEU . . . -45.1 -39.39 5.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 109.719 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.564 ' O ' ' CE1' ' A' ' 128' ' ' TYR . 35.2 m-80 -113.0 50.71 0.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 109.939 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.64 ' HA ' ' CE1' ' A' ' 128' ' ' TYR . 53.7 t80 -64.02 -54.13 39.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.175 -0.953 . . . . 0.0 109.991 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.48 -5.46 58.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -0.904 . . . . 0.0 109.086 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 124' ' ' ASN . 15.8 m-20 -80.73 -41.53 23.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.84 . . . . 0.0 109.908 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.64 ' CE1' ' HA ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -102.03 10.78 39.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.086 . . . . 0.0 110.727 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 0.3 OUTLIER 43.86 -151.75 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.196 -0.94 . . . . 0.0 109.345 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.576 ' CE1' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -149.59 121.25 8.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 108.991 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.462 ' CE1' ' SD ' ' A' ' 145' ' ' MET . 13.2 m-85 -104.19 164.76 11.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.146 -0.971 . . . . 0.0 110.36 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.466 ' O ' HG21 ' A' ' 132' ' ' ILE . 12.8 tt -157.11 135.87 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.421 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -48.24 156.14 1.19 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -17.71 16.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.152 . . . . 0.0 109.522 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.1 OUTLIER -57.68 -38.92 75.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.214 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.491 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.1 OUTLIER 74.72 27.16 1.3 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 0.0 109.603 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.24 114.27 51.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 136' ' ' MET . 33.8 Cg_endo -74.49 1.69 7.16 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.336 2.024 . . . . 0.0 110.392 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 62.6 t0 -121.54 15.43 11.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.353 -0.842 . . . . 0.0 109.119 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.522 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -97.69 -94.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.867 . . . . 0.0 109.726 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 142' ' ' VAL . 9.1 tmm? -163.11 139.13 7.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 109.56 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.454 ' O ' ' SD ' ' A' ' 141' ' ' MET . 5.6 m -104.41 135.25 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.56 HG23 ' CE2' ' A' ' 158' ' ' PHE . 4.3 t -103.55 130.01 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.167 -0.958 . . . . 0.0 109.469 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.0 mt -88.99 152.41 21.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.846 . . . . 0.0 109.324 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.462 ' SD ' ' CE1' ' A' ' 131' ' ' TYR . 1.4 ttt -111.92 115.48 29.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 109.539 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 155' ' ' TYR . 1.5 m-20 -121.0 165.88 14.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' A' ' 151' ' ' GLY . 0.1 OUTLIER -107.64 135.52 48.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.464 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 153' ' ' THR . 3.3 ttp180 -60.32 173.22 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 109.453 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.38 -31.27 65.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.336 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.46 -46.8 68.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.855 . . . . 0.0 109.348 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.56 ' O ' ' CE1' ' A' ' 147' ' ' TYR . . . 102.09 -28.49 15.7 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 tp -87.45 -10.98 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -1.093 . . . . 0.0 109.24 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 148' ' ' ARG . 2.9 m -115.45 102.13 54.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.401 -0.812 . . . . 0.0 109.34 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.39 143.6 22.16 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.425 2.083 . . . . 0.0 110.3 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 146' ' ' ASN . 6.4 p90 -143.43 144.98 32.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.454 ' SD ' ' HE1' ' A' ' 145' ' ' MET . 1.5 mtm -110.21 166.96 10.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.346 -0.846 . . . . 0.0 109.177 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 157' ' ' ILE . 3.6 mt -131.55 139.37 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.56 ' CE2' HG23 ' A' ' 143' ' ' VAL . 29.9 m-85 -123.09 153.81 39.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.336 -0.853 . . . . 0.0 109.302 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -75.76 113.93 13.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 26' ' ' ILE . 1.7 tttt -60.35 -44.43 95.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 109.369 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.459 ' OD1' HD13 ' A' ' 95' ' ' ILE . 3.3 p30 -49.38 -38.89 30.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.188 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -104.64 47.55 1.06 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.9 tt -151.68 126.77 9.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.437 -1.037 . . . . 0.0 109.31 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.27 140.55 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.915 . . . . 0.0 109.575 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.99 134.38 47.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.464 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.83 126.78 53.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.893 . . . . 0.0 109.416 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.42 ' HA ' HD21 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -67.09 123.12 19.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.413 -0.804 . . . . 0.0 109.416 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.484 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.36 152.89 26.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.694 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.1 mt -114.98 143.44 45.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.493 -0.754 . . . . 0.0 109.078 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.45 ' HB2' HG11 ' A' ' 14' ' ' VAL . 53.0 m-85 -120.47 112.87 19.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.511 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 6' ' ' ASP . 10.5 ttpt -117.6 157.48 26.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.582 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.524 ' OD2' ' CE ' ' A' ' 141' ' ' MET . 2.0 t70 -92.67 155.27 17.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.343 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 8' ' ' ILE . 12.1 m -97.44 -38.87 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.473 ' N ' HG22 ' A' ' 7' ' ' VAL . 4.7 mt -46.65 -79.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.867 . . . . 0.0 109.301 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.24 31.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.919 . . . . 0.0 109.523 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.86 68.13 0.28 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 12' ' ' GLU . 10.1 p30 -52.3 143.81 14.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -1.166 . . . . 0.0 109.429 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 11' ' ' ASP . 44.0 mm-40 58.87 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 6' ' ' ASP . 0.4 OUTLIER -121.82 -74.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.303 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.584 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 7.9 p -149.66 175.4 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 108.95 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -138.21 165.83 25.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.862 -1.148 . . . . 0.0 110.754 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.486 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -85.2 8.88 16.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 0.0 109.77 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.94 -25.14 66.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.027 . . . . 0.0 108.961 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.544 ' CE2' HD11 ' A' ' 68' ' ' LEU . 47.2 m-85 -102.47 21.94 14.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.116 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER 60.31 122.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.5 -0.75 . . . . 0.0 109.161 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.51 ' CD2' ' CB ' ' A' ' 30' ' ' ALA . 22.9 mt -116.04 152.12 34.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.34 -0.85 . . . . 0.0 109.878 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HB2' ' OE2' ' A' ' 29' ' ' GLU . 1.7 mptp? -131.19 148.93 52.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -0.863 . . . . 0.0 109.746 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.38 125.36 36.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.834 . . . . 0.0 109.201 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 27' ' ' VAL . 15.8 t -78.09 148.48 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.729 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' VAL . 76.0 m-20 -44.13 -31.84 1.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.397 -0.815 . . . . 0.0 109.752 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 26' ' ' ILE . 6.5 m-20 -73.47 -101.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -164.66 59.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.041 -1.037 . . . . 0.0 109.382 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 23' ' ' VAL . 18.7 m -145.46 167.78 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.635 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -111.42 144.81 40.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.854 . . . . 0.0 109.353 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.7 pt-20 -117.06 125.11 50.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.014 -1.054 . . . . 0.0 109.317 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.584 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -113.6 112.73 24.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.441 -0.787 . . . . 0.0 108.944 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -67.18 149.62 50.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.35 -0.844 . . . . 0.0 109.893 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.424 ' SG ' ' SD ' ' A' ' 156' ' ' MET . 26.9 p -142.92 174.52 10.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.408 -0.808 . . . . 0.0 109.293 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.395 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.504 ' ND2' ' SD ' ' A' ' 145' ' ' MET . 11.9 m120 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -46.88 -24.47 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.694 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.544 HD11 ' CE2' ' A' ' 18' ' ' TYR . 31.4 tp -82.25 -42.73 18.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.039 -1.038 . . . . 0.0 108.49 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 74' ' ' LEU . 3.1 t -54.96 -56.1 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.473 -0.767 . . . . 0.0 108.954 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 70' ' ' TYR . 4.2 t80 -61.38 -41.34 96.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 109.92 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.94 -45.47 64.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.044 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.43 ' CD2' HD13 ' A' ' 68' ' ' LEU . 60.3 m-85 -111.74 19.83 17.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 109.882 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.63 82.58 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.938 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.515 ' HB2' HG12 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -95.22 169.76 9.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 108.824 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 132' ' ' ILE . 1.8 m -128.18 102.96 20.88 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.975 -1.078 . . . . 0.0 110.044 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.448 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 36.3 Cg_endo -80.0 118.37 3.71 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.489 2.126 . . . . 0.0 110.135 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.0 t -87.93 161.33 17.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.304 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 t -125.95 4.86 7.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 109.81 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 79' ' ' PHE . 6.5 t80 -138.62 128.35 24.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 109.711 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.529 ' OD2' ' CE1' ' A' ' 130' ' ' PHE . 4.4 p-10 169.96 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.766 . . . . 0.0 109.454 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -62.36 -42.97 99.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 109.237 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -113.76 -28.65 7.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.492 -0.755 . . . . 0.0 109.09 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -29.09 67.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.324 -0.86 . . . . 0.0 109.317 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.474 ' HB2' ' HB2' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -55.11 -48.96 72.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.488 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.42 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -64.26 -29.86 70.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 109.993 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -55.24 18.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 88' ' ' ILE . 21.6 m-85 -70.7 -58.25 3.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 109.845 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -42.74 -37.9 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 109.573 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 15.2 mmtp -63.07 -52.69 61.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.356 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.65 -20.26 56.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.602 ' CE2' ' CB ' ' A' ' 141' ' ' MET . 2.8 t80 -77.88 -36.45 49.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.212 -1.17 . . . . 0.0 108.484 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.479 ' O ' ' HE1' ' A' ' 92' ' ' MET . 0.0 OUTLIER -64.99 -42.14 94.79 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 4.5 mptt -67.1 -32.02 72.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.588 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.38 89.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.026 -1.046 . . . . 0.0 109.702 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.572 HG22 ' CZ ' ' A' ' 110' ' ' PHE . 34.8 mm -57.57 -45.44 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.172 -0.955 . . . . 0.0 109.749 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.542 ' HG3' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -48.09 -33.47 8.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 109.09 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.542 ' N ' ' HG3' ' A' ' 96' ' ' LYS . . . -73.04 -46.82 49.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 108.998 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.434 ' HD3' ' CD2' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -50.54 -38.05 42.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.143 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 95' ' ' ILE . 1.4 mt -69.92 -44.9 68.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.406 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -51.88 -30.27 23.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.331 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 97' ' ' ALA . 6.9 mt-10 -78.71 -39.26 37.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.156 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.54 -82.51 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.274 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -135.93 135.88 22.27 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 107' ' ' VAL . 33.8 Cg_endo -74.84 -14.84 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.593 2.195 . . . . 0.0 110.748 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.74 -13.54 61.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.854 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -89.56 -11.42 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.119 -0.988 . . . . 0.0 109.764 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 7.9 t -65.12 -44.39 70.02 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 111.203 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.4 Cg_endo -76.55 -58.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.933 1.756 . . . . 0.0 110.984 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.445 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 15.8 m -55.9 -43.93 76.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.067 -1.02 . . . . 0.0 109.592 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.572 ' CZ ' HG22 ' A' ' 95' ' ' ILE . 43.7 t80 -58.64 -49.63 76.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.734 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -57.25 -29.91 64.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.115 -0.991 . . . . 0.0 110.175 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -49.16 40.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.152 -0.968 . . . . 0.0 111.569 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.537 ' ND2' ' N ' ' A' ' 114' ' ' ALA . 1.7 p-10 -72.19 -46.73 55.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.847 -1.158 . . . . 0.0 110.733 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.537 ' N ' ' ND2' ' A' ' 113' ' ' ASN . . . -54.93 -46.82 74.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.066 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -53.36 -44.09 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.874 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.46 -41.21 96.47 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.472 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.72 -37.29 78.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -1.179 . . . . 0.0 110.028 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 47.8 t -63.89 -45.21 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.356 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.505 ' CD ' ' C ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -66.13 -28.87 69.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.984 . . . . 0.0 109.611 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -67.55 -49.13 64.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.983 . . . . 0.0 110.0 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.537 HG12 ' CD1' ' A' ' 144' ' ' LEU . 1.6 mp -70.18 -32.01 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 109.699 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 43.5 mt -57.16 -30.47 64.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.696 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.51 -48.32 62.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 109.773 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.448 ' HB3' ' OD2' ' A' ' 127' ' ' ASP . 1.5 m-80 -139.57 69.56 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -63.15 -21.59 66.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -62.93 -63.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.845 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 128' ' ' TYR . 18.7 p30 -65.63 -22.68 66.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.246 -0.909 . . . . 0.0 109.959 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.524 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 2.9 m-85 -76.08 -16.92 59.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 109.903 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.489 ' C ' ' CG ' ' A' ' 130' ' ' PHE . 3.0 m-20 44.8 -168.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.166 -0.959 . . . . 0.0 109.264 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.532 ' N ' ' CD1' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -154.06 121.14 5.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 108.681 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.52 ' CE2' ' HE1' ' A' ' 145' ' ' MET . 14.6 m-85 -105.16 164.42 11.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.178 -0.951 . . . . 0.0 110.692 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 75' ' ' SER . 1.1 tt -155.94 139.77 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.403 -0.81 . . . . 0.0 109.488 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.37 164.25 1.09 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 135' ' ' SER . 2.6 pt-20 -67.13 -21.07 65.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -1.177 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.2 OUTLIER -62.34 -35.3 78.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 77.48 50.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.869 . . . . 0.0 109.612 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.33 107.77 60.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.123 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.34 0.23 8.81 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.26 1.973 . . . . 0.0 110.486 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.77 -14.68 23.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.884 . . . . 0.0 109.115 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 141' ' ' MET . . . -79.7 -91.77 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.445 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.602 ' CB ' ' CE2' ' A' ' 91' ' ' TYR . 1.9 ptp 179.42 149.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 131' ' ' TYR . 70.3 t -97.76 138.15 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.183 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.564 HG23 ' CE2' ' A' ' 158' ' ' PHE . 3.6 t -93.25 111.35 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.134 -0.979 . . . . 0.0 109.043 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.537 ' CD1' HG12 ' A' ' 121' ' ' ILE . 2.5 mt -79.26 149.13 31.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.52 ' HE1' ' CE2' ' A' ' 131' ' ' TYR . 12.4 ttm -124.58 131.21 53.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.624 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.524 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 19.7 t30 -142.34 168.79 18.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 109.108 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.456 ' HB3' ' HA3' ' A' ' 151' ' ' GLY . 4.5 m-85 -77.06 159.39 29.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.058 -1.026 . . . . 0.0 109.385 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.589 ' HB2' ' CD1' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -151.59 -173.62 4.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 110.011 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 56.05 -97.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 109.655 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -106.94 -25.72 11.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.019 -1.051 . . . . 0.0 109.152 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 147' ' ' TYR . . . 123.17 17.43 3.31 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.65 -21.37 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.281 -1.129 . . . . 0.0 108.903 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 153' ' ' THR . 2.9 t -105.0 128.21 27.16 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.111 -0.993 . . . . 0.0 109.566 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -82.87 146.92 13.24 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.754 2.303 . . . . 0.0 110.696 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 148' ' ' ARG . 7.2 p90 -145.18 155.33 43.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 108.851 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.478 ' CE ' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -126.73 162.2 26.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 109.795 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.4 ' CG2' ' CG2' ' A' ' 27' ' ' VAL . 4.4 mt -124.26 145.3 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 109.507 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.564 ' CE2' HG23 ' A' ' 143' ' ' VAL . 9.7 m-85 -129.31 128.52 43.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.312 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -51.23 127.27 18.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -62.49 -53.69 51.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.405 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -47.52 -44.72 25.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -90.17 44.19 2.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.491 ' CD2' ' C ' ' A' ' 163' ' ' LEU . 2.2 tt -158.5 123.54 4.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.431 -1.041 . . . . 0.0 109.212 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.429 HG12 ' CG1' ' A' ' 7' ' ' VAL . 30.1 m -116.69 153.61 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.456 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.8 p -90.86 146.92 23.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.953 . . . . 0.0 109.639 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.53 120.64 15.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.471 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 168' ' ' PHE . 0.0 OUTLIER -70.21 108.27 4.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.404 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 168' ' ' PHE . 13.9 t80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.545 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 0.8 OUTLIER -68.48 146.74 52.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 110.126 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.529 HD12 ' CD2' ' A' ' 168' ' ' PHE . 6.8 mt -121.85 139.57 53.46 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.606 ' CE2' ' CD1' ' A' ' 20' ' ' LEU . 91.5 m-85 -121.43 108.89 14.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.977 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 1.8 mtmm -108.82 167.29 10.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.454 -0.778 . . . . 0.0 109.272 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -83.86 151.23 25.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.97 . . . . 0.0 109.362 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.496 ' CG2' HG12 ' A' ' 164' ' ' VAL . 5.3 t -108.31 35.6 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 109.486 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 139' ' ' ASP . 24.0 mm -117.07 -52.4 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.417 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.96 -34.96 2.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.5 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 106.62 2.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -176.28 136.54 0.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -1.145 . . . . 0.0 109.496 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.476 ' OE1' ' CG ' ' A' ' 72' ' ' PHE . 7.8 pt-20 -48.51 147.36 2.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.6 -80.58 0.49 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.154 -0.966 . . . . 0.0 109.532 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.573 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 2.6 p -132.37 166.77 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.853 . . . . 0.0 109.104 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.518 ' N ' HG23 ' A' ' 14' ' ' VAL . 3.9 p -142.0 161.93 36.75 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.017 -1.052 . . . . 0.0 110.098 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -83.02 1.27 40.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.381 -0.824 . . . . 0.0 109.598 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.86 -9.39 37.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.378 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.593 ' CE2' ' CD1' ' A' ' 68' ' ' LEU . 35.7 m-85 -119.52 20.69 12.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 65.38 130.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 109.006 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.606 ' CD1' ' CE2' ' A' ' 4' ' ' TYR . 49.4 mt -125.68 146.08 49.89 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -0.95 . . . . 0.0 110.015 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -123.43 134.26 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -0.807 . . . . 0.0 109.35 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.428 ' CD ' ' HA ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -90.93 122.4 33.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.181 -0.949 . . . . 0.0 108.789 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 2.3 t -114.55 120.44 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 4.0 t70 74.4 5.97 4.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 109.802 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 20.3 t0 59.12 68.89 0.77 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 109.513 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' A' ' 25' ' ' ASP . 5.8 tt 174.54 -29.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.129 -0.982 . . . . 0.0 109.905 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.539 HG23 ' CZ ' ' A' ' 117' ' ' PHE . 23.1 m -120.93 140.13 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.957 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -105.44 148.92 26.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.193 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -120.97 121.06 37.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.405 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.573 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -106.22 112.88 26.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.193 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -68.38 149.57 49.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.461 ' HB3' ' OD1' ' A' ' 66' ' ' ASN . 34.7 m -100.26 151.17 21.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 0.0 109.259 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.748 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 32' ' ' CYS . 1.5 m-20 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 71' ' ' SER . 33.7 t30 -89.7 -27.09 20.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.739 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.593 ' CD1' ' CE2' ' A' ' 18' ' ' TYR . 13.3 tp -83.48 -37.63 22.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 108.982 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 74' ' ' LEU . 53.3 t -72.61 -48.28 47.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.723 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -69.29 -36.04 76.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 110.93 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 70.3 m -79.49 -52.85 7.51 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.966 -1.084 . . . . 0.0 110.506 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CG ' ' OE1' ' A' ' 12' ' ' GLU . 7.2 m-30 -79.82 -3.6 48.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.128 -0.982 . . . . 0.0 109.968 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.425 ' C ' HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 62.81 88.04 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 109.571 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.502 ' CD1' ' HB3' ' A' ' 131' ' ' TYR . 1.4 mm? -111.85 139.05 47.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 108.719 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.67 122.99 18.1 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.066 -1.021 . . . . 0.0 109.871 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.14 126.28 7.7 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.374 2.049 . . . . 0.0 110.097 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 t -123.92 117.02 23.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -0.966 . . . . 0.0 109.645 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -59.34 151.46 23.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.242 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 17.9 t80 -151.93 155.3 37.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 109.703 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.637 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 1.4 m-20 -86.42 124.27 32.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -0.879 . . . . 0.0 109.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -34.61 68.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.147 -0.971 . . . . 0.0 110.033 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -56.25 -64.91 0.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.617 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.404 ' HB3' ' CE1' ' A' ' 79' ' ' PHE . 7.4 t -59.8 -28.74 67.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.788 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.32 -35.48 67.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.495 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.4 mtt -57.04 -49.42 75.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.141 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -48.81 79.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.489 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -62.7 -19.19 63.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.256 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.492 ' O ' ' HB2' ' A' ' 92' ' ' MET . 0.6 OUTLIER -79.22 -28.92 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -39.55 58.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.426 -0.796 . . . . 0.0 109.115 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.13 -38.79 88.48 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.568 ' CZ ' ' O ' ' A' ' 138' ' ' PRO . 14.7 m-30 -74.52 -36.5 63.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.101 -1.234 . . . . 0.0 108.816 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.536 ' CE ' ' O ' ' A' ' 92' ' ' MET . 0.0 OUTLIER -65.21 -38.99 92.15 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.624 0.726 . . . . 0.0 109.293 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.506 ' C ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.15 -36.91 82.86 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.571 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.58 -50.77 67.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.994 -1.066 . . . . 0.0 109.244 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.562 HG22 ' CZ ' ' A' ' 110' ' ' PHE . 29.5 mm -59.93 -43.0 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.235 -0.915 . . . . 0.0 108.969 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -47.38 -51.61 19.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.875 . . . . 0.0 109.364 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 100' ' ' GLN . . . -58.19 -36.53 73.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.015 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 101' ' ' GLU . 1.8 tmt_? -64.15 -32.85 74.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -0.916 . . . . 0.0 109.683 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.47 HD11 ' O ' ' A' ' 106' ' ' ARG . 22.4 mt -73.78 -50.21 21.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 110.213 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.52 ' HG3' ' N ' ' A' ' 101' ' ' GLU . 2.6 pt20 -55.83 -34.98 65.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.679 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 7.4 pt-20 -72.79 -35.52 67.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.103 -0.998 . . . . 0.0 109.191 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.513 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 10.2 t -88.28 -80.31 0.28 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.277 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -135.74 137.78 26.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 109.325 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.92 -25.97 11.53 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.547 2.165 . . . . 0.0 110.637 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -70.46 -6.83 38.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.676 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.47 ' O ' HD11 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -97.92 -4.8 35.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 109.819 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.607 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 32.7 t -70.18 -44.62 20.49 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.989 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.6 Cg_endo -77.7 -41.05 0.34 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.018 1.812 . . . . 0.0 111.096 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.34 -43.37 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 0.0 109.938 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.562 ' CZ ' HG22 ' A' ' 95' ' ' ILE . 87.1 t80 -69.72 -37.11 76.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 0.0 110.408 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -63.25 -53.78 47.64 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.09 -1.006 . . . . 0.0 110.719 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -47.19 61.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.016 -1.053 . . . . 0.0 110.675 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -55.73 -54.26 46.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.138 -0.976 . . . . 0.0 110.124 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.77 69.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 109.968 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.467 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -59.22 -35.51 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.126 -0.983 . . . . 0.0 109.559 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.48 -45.85 95.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.539 ' CZ ' HG23 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -68.14 -30.72 69.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -1.2 . . . . 0.0 110.081 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 54.4 t -68.02 -42.35 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.888 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 115' ' ' ILE . 40.2 mmtt -69.06 -42.05 76.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.075 -1.015 . . . . 0.0 109.78 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.495 ' HA ' ' CE ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -59.54 -60.5 3.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.797 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.3 mt -53.98 -47.69 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 25.6 mt -47.3 -49.6 23.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 109.762 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.78 -41.85 45.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.966 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.73 52.02 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.885 . . . . 0.0 109.435 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 8.9 p90 -63.43 -27.53 69.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.578 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.427 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 5.5 mttp -64.82 -39.77 94.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.404 -0.81 . . . . 0.0 109.704 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.67 -23.76 42.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 110.01 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 129' ' ' ASP . 7.1 m-85 -81.7 -25.92 35.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.874 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.521 ' C ' ' CD1' ' A' ' 130' ' ' PHE . 14.0 m-20 51.29 179.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.521 ' CD1' ' C ' ' A' ' 129' ' ' ASP . 36.3 m-85 -142.3 121.61 13.11 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.352 -0.843 . . . . 0.0 109.052 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.505 ' O ' ' CG1' ' A' ' 142' ' ' VAL . 10.9 m-85 -99.31 166.24 11.3 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.189 -0.944 . . . . 0.0 110.538 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.443 ' O ' HG21 ' A' ' 132' ' ' ILE . 7.8 tp -156.58 146.84 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.702 . . . . 0.0 109.278 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.03 162.38 52.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -58.24 -23.63 56.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -1.107 . . . . 0.0 109.427 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 136' ' ' MET . 11.4 p -68.59 -34.76 76.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 109.359 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.47 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 0.0 OUTLIER 70.6 63.63 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.521 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.37 105.73 38.2 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.341 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.568 ' O ' ' CZ ' ' A' ' 91' ' ' TYR . 34.0 Cg_endo -74.5 -20.85 17.7 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.274 1.982 . . . . 0.0 109.961 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.456 ' O ' HG22 ' A' ' 8' ' ' ILE . 7.7 t70 -75.43 -6.26 49.18 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.364 -0.835 . . . . 0.0 108.962 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.15 -175.71 2.88 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.266 -0.896 . . . . 0.0 109.35 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.2 ptm -92.31 167.47 11.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 109.475 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 131' ' ' TYR . 58.7 t -113.35 142.03 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 109.185 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.58 HG23 ' CE2' ' A' ' 158' ' ' PHE . 13.0 t -90.01 130.04 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.174 -0.954 . . . . 0.0 108.838 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 18.0 mt -92.55 134.4 35.02 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.492 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CE1' ' A' ' 131' ' ' TYR . 4.8 ttt -107.63 126.28 52.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.571 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 2.2 t30 -139.34 169.11 18.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 1.6 m-85 -110.23 144.81 38.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.65 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.48 170.67 7.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 109.608 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -47.67 -35.8 10.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 109.577 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -77.35 -44.63 28.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.298 -0.876 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.569 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 100.46 -30.2 10.71 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.6 tp -68.2 -6.57 5.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.47 -1.018 . . . . 0.0 109.661 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.7 m -122.81 101.73 39.08 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 109.665 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.14 121.8 5.02 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.57 2.18 . . . . 0.0 109.98 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 146' ' ' ASN . 31.7 p90 -126.37 148.35 49.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -0.983 . . . . 0.0 109.88 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.444 ' SD ' ' HG3' ' A' ' 145' ' ' MET . 0.2 OUTLIER -116.14 167.17 11.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.35 -0.844 . . . . 0.0 109.135 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.479 ' C ' ' CD1' ' A' ' 158' ' ' PHE . 11.6 mt -128.46 148.63 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 0.0 109.783 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.58 ' CE2' HG23 ' A' ' 143' ' ' VAL . 12.4 m-85 -136.55 125.73 24.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.472 ' HB3' ' OD1' ' A' ' 161' ' ' ASP . 2.5 m-85 -60.03 132.41 53.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 110.25 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 77.3 tttt -68.23 -41.85 80.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.487 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 159' ' ' PHE . 5.2 p-10 -50.56 -45.01 56.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.012 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -97.93 45.94 1.65 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.537 ' CD1' ' HB3' ' A' ' 4' ' ' TYR . 0.4 OUTLIER -161.34 129.23 4.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.464 -1.021 . . . . 0.0 108.919 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.496 HG12 ' CG2' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -115.46 149.16 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.624 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.89 121.64 38.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -118.42 142.98 47.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.671 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.49 113.6 25.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.529 ' CD2' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.489 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.419 ' O ' ' OG ' ' A' ' 15' ' ' SER . 10.3 mt -100.8 158.4 15.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.7 mt -112.41 134.47 53.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.479 -0.763 . . . . 0.0 109.427 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 10.5 m-85 -117.4 112.24 20.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.68 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.435 ' HG2' ' HA ' ' A' ' 12' ' ' GLU . 1.5 mtmt -123.15 162.39 22.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.415 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -97.04 158.21 15.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.416 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.491 ' CG2' HG12 ' A' ' 164' ' ' VAL . 16.8 t -115.86 54.32 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -0.984 . . . . 0.0 109.663 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -140.7 -50.1 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.034 -1.041 . . . . 0.0 109.595 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.578 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 1.5 t 176.47 45.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -141.87 -43.93 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 6.8 t0 74.96 -137.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -1.112 . . . . 0.0 109.275 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -42.33 121.37 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.047 -1.033 . . . . 0.0 109.677 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.402 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -125.1 -62.08 1.25 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.138 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.594 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 6.5 p -143.46 175.81 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.365 -0.834 . . . . 0.0 108.855 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 2' ' ' LEU . 22.6 t -147.49 169.59 19.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.846 -1.159 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.535 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 31.4 t70 -87.54 12.73 11.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.479 -0.763 . . . . 0.0 109.447 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.39 -15.28 63.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 108.996 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CE1' ' ND2' ' A' ' 67' ' ' ASN . 44.5 m-85 -115.92 21.38 13.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.471 -0.768 . . . . 0.0 109.207 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.2 t0 65.32 129.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 108.511 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.535 ' CD1' ' HA ' ' A' ' 16' ' ' ASP . 13.0 mt -124.28 143.2 50.69 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.144 -0.973 . . . . 0.0 110.252 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.32 136.7 52.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.34 117.74 34.45 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.252 -0.905 . . . . 0.0 108.767 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 t -68.46 147.81 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 109.49 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -46.31 -25.4 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 109.751 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.433 ' O ' HG21 ' A' ' 26' ' ' ILE . 2.2 m-20 -77.96 -110.39 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.433 HG21 ' O ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -154.82 64.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.811 -1.181 . . . . 0.0 109.305 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.458 ' O ' HG21 ' A' ' 27' ' ' VAL . 30.3 m -147.18 141.27 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 109.674 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.408 ' CE2' ' HE2' ' A' ' 4' ' ' TYR . 4.9 m-85 -98.65 148.39 23.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.152 -0.968 . . . . 0.0 109.066 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 19.4 mt-10 -125.15 121.11 33.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.116 -0.99 . . . . 0.0 110.12 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.594 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -106.39 112.71 25.83 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -71.52 146.48 48.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 110.509 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 28.3 p -126.74 115.18 19.01 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.412 ' HG2' ' ND2' ' A' ' 67' ' ' ASN . 14.6 pt20 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 110.056 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.462 ' ND2' ' CE1' ' A' ' 18' ' ' TYR . 38.5 p-10 -86.12 -19.57 29.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.671 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.47 ' CD1' ' CD2' ' A' ' 72' ' ' PHE . 18.1 tp -86.38 -47.56 9.23 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 108.957 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.505 HG21 ' CE ' ' A' ' 156' ' ' MET . 55.6 t -68.24 -37.33 77.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.322 -0.862 . . . . 0.0 109.171 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -69.84 -44.57 69.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 109.668 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 t -63.24 -36.93 85.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.315 -0.866 . . . . 0.0 110.121 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.47 ' CD2' ' CD1' ' A' ' 68' ' ' LEU . 25.9 m-85 -103.26 2.9 34.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 109.891 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER 56.82 29.66 16.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.154 -0.966 . . . . 0.0 109.789 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.493 ' N ' HD21 ' A' ' 74' ' ' LEU . 2.0 mm? -41.72 149.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.411 -0.806 . . . . 0.0 109.345 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.06 127.38 21.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.384 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.16 122.17 5.61 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.496 2.131 . . . . 0.0 110.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.4 127.26 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.37 -178.68 3.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.29 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 50.5 t80 -164.91 163.0 21.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.605 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 35.6 m-20 -77.38 120.48 22.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.458 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 2.1 tmtt? -59.14 -53.25 60.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.88 -45.33 86.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.76 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.483 ' CB ' ' HB2' ' A' ' 80' ' ' ASP . 1.3 t -61.75 -29.06 69.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.344 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 81' ' ' LYS . 41.6 t80 -58.41 -34.99 71.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.779 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -57.34 12.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.96 . . . . 0.0 109.778 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -59.87 -38.02 81.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.003 . . . . 0.0 109.273 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.509 ' CE2' ' CZ ' ' A' ' 91' ' ' TYR . 6.5 t80 -66.44 -23.1 66.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.385 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.481 HG22 HD11 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -78.72 -31.48 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 108.952 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -72.02 -47.28 52.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.41 -29.86 74.61 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.509 ' CZ ' ' CE2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -75.38 -35.79 61.02 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.129 -1.218 . . . . 0.0 108.41 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.504 ' CA ' ' HE1' ' A' ' 92' ' ' MET . 0.0 OUTLIER -65.87 -54.42 26.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.598 -0.689 . . . . 0.0 109.745 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -38.47 75.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.346 -0.846 . . . . 0.0 109.868 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.54 -45.34 73.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.113 -0.992 . . . . 0.0 109.297 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.463 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 34.8 mm -69.82 -36.67 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -47.19 63.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 109.202 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.72 81.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.127 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.95 -44.29 66.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.456 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.507 ' N ' HD21 ' A' ' 99' ' ' LEU . 2.0 mt -71.93 -44.06 64.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.295 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -25.16 9.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.199 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -86.98 -34.44 19.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 t -96.09 -89.02 0.26 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.326 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.439 ' OD1' ' NH2' ' A' ' 106' ' ' ARG . 27.8 p-10 -125.62 132.38 24.3 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.271 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.9 -19.44 18.09 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.641 2.227 . . . . 0.0 110.884 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.9 -6.82 29.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.202 -0.936 . . . . 0.0 109.905 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -95.81 -5.94 40.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.084 -1.01 . . . . 0.0 109.811 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 96.0 t -72.18 -43.25 9.99 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.137 -0.977 . . . . 0.0 111.229 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.6 Cg_endo -75.98 -56.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.762 1.641 . . . . 0.0 110.862 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.8 m -55.84 -40.95 64.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.036 -1.04 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 68.9 t80 -65.82 -37.1 85.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.817 . . . . 0.0 110.253 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.483 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -66.42 -49.87 65.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.964 -1.085 . . . . 0.0 110.562 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -66.14 -49.45 67.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.887 -1.133 . . . . 0.0 110.544 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -58.2 -46.42 85.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.985 . . . . 0.0 109.813 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.46 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -65.44 -27.56 68.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.373 -0.829 . . . . 0.0 109.751 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.483 HD11 ' O ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -67.13 -47.41 81.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.251 -0.905 . . . . 0.0 109.446 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.27 -50.51 44.53 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.469 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.78 -38.95 76.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.081 -1.247 . . . . 0.0 109.803 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 114' ' ' ALA . 53.1 t -68.4 -39.16 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -32.34 69.64 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.157 -0.964 . . . . 0.0 109.295 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -96.92 -10.07 27.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.661 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.534 ' CG2' ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.2 -53.68 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.629 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.534 ' N ' ' CG2' ' A' ' 121' ' ' ILE . 10.1 mt -48.77 -44.23 38.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.016 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.79 76.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 110.033 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.542 ' O ' ' CE2' ' A' ' 128' ' ' TYR . 19.6 m-20 -101.44 38.84 1.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.14 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.645 ' HA ' ' CE1' ' A' ' 128' ' ' TYR . 13.4 t80 -63.41 -53.69 48.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.082 -1.011 . . . . 0.0 109.061 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -78.9 -8.43 58.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 108.988 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 124' ' ' ASN . 0.8 OUTLIER -80.17 -39.53 29.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.341 -0.85 . . . . 0.0 109.937 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.645 ' CE1' ' HA ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -108.55 -10.43 15.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.969 -1.082 . . . . 0.0 110.041 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.8 m-20 52.27 173.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.726 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -114.71 122.23 45.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -103.27 177.63 4.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 110.558 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 137' ' ' ASP . 3.9 tp -143.02 149.03 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.541 -0.725 . . . . 0.0 109.545 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.433 ' N ' HG13 ' A' ' 132' ' ' ILE . . . -73.01 -178.77 35.41 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -18.06 63.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -1.187 . . . . 0.0 109.539 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -60.95 -41.69 96.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.217 -0.927 . . . . 0.0 109.39 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 75.56 48.88 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.672 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.444 ' O ' HD12 ' A' ' 132' ' ' ILE . 72.4 m-20 -118.84 134.02 23.6 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 109.373 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.41 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 34.1 Cg_endo -75.59 -5.48 16.58 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.317 2.011 . . . . 0.0 110.157 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' A' ' 9' ' ' SER . 11.4 t70 -101.48 -3.31 28.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 109.304 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 141' ' ' MET . . . -85.17 137.87 32.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 109.378 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 159' ' ' PHE . 1.4 ttp -43.42 152.99 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.742 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.9 m -100.67 141.44 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.365 -0.835 . . . . 0.0 109.279 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.552 HG13 ' CZ ' ' A' ' 158' ' ' PHE . 2.1 t -102.27 139.04 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.236 -0.915 . . . . 0.0 109.42 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.502 ' HB3' ' CG ' ' A' ' 128' ' ' TYR . 4.9 mt -107.13 146.16 31.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.31 -0.869 . . . . 0.0 109.206 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 128' ' ' TYR . 1.8 ttm -111.98 125.78 54.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.674 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -139.13 169.08 18.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 4.9 m-85 -102.66 145.91 28.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.597 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.573 ' HB2' ' CE2' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -142.85 -170.84 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.345 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 148' ' ' ARG . 0.8 OUTLIER 62.07 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.571 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.68 -22.17 11.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.586 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.591 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 124.27 -18.37 7.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.44 ' O ' HG22 ' A' ' 152' ' ' ILE . 2.4 tp -96.26 7.23 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.299 -1.118 . . . . 0.0 109.394 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.6 m -110.64 101.8 50.13 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.298 -0.876 . . . . 0.0 109.633 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.59 139.39 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.521 2.147 . . . . 0.0 110.18 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.573 ' CE2' ' HB2' ' A' ' 148' ' ' ARG . 52.0 p90 -145.14 158.64 43.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 109.655 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.505 ' CE ' HG21 ' A' ' 69' ' ' VAL . 7.1 mtm -107.44 156.14 19.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.301 -0.874 . . . . 0.0 109.295 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 143' ' ' VAL . 42.3 mt -122.6 132.61 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.08 -1.012 . . . . 0.0 110.011 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.552 ' CZ ' HG13 ' A' ' 143' ' ' VAL . 7.8 m-85 -126.22 115.11 19.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.469 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 3.8 m-85 -50.41 126.28 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.397 -0.814 . . . . 0.0 109.774 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 161' ' ' ASP . 4.9 tttm -68.49 -38.14 80.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.772 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 1.8 p30 -43.26 -41.45 3.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . -110.0 54.29 0.55 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.428 ' C ' HD21 ' A' ' 163' ' ' LEU . 8.7 tt -157.66 142.37 16.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -1.099 . . . . 0.0 109.556 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.491 HG12 ' CG2' ' A' ' 7' ' ' VAL . 19.8 m -127.65 152.65 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.4 m -104.31 121.34 43.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.099 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -115.93 127.56 55.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.616 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 146.53 25.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.875 . . . . 0.0 109.564 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.417 ' C ' HD22 ' A' ' 2' ' ' LEU . 2.4 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 167' ' ' LYS . 2.9 mt -105.44 165.04 11.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.897 . . . . 0.0 109.421 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.6 mt -127.27 129.63 48.08 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.432 -0.792 . . . . 0.0 109.584 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 64.2 m-85 -111.59 108.79 18.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.255 -0.903 . . . . 0.0 109.312 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.24 163.91 15.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.519 ' HB2' ' CD1' ' A' ' 13' ' ' LEU . 4.3 t0 -76.23 152.41 36.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.889 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.509 ' CG2' HG11 ' A' ' 164' ' ' VAL . 2.7 t -102.32 -5.97 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.81 . . . . 0.0 109.344 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 139' ' ' ASP . 4.7 mt -97.54 -79.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.415 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.435 ' N ' HG23 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -144.47 67.37 1.26 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 0.0 109.554 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -130.81 -65.83 0.1 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER 73.52 13.18 4.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.315 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 1.4 pt-20 170.67 107.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.039 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.519 ' CD1' ' HB2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -129.4 -64.98 0.87 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.834 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.545 HG22 ' CB ' ' A' ' 30' ' ' ALA . 11.3 p -157.31 170.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.299 -0.876 . . . . 0.0 108.968 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 p -155.06 -176.23 5.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.667 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.456 ' CA ' HD13 ' A' ' 20' ' ' LEU . 1.4 t0 -82.23 10.71 6.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.545 -0.722 . . . . 0.0 110.165 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.05 -10.25 38.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.056 -1.027 . . . . 0.0 109.19 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.564 ' CD2' HD13 ' A' ' 68' ' ' LEU . 8.1 m-85 -127.41 21.69 6.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.174 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.19 130.56 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 19.3 mt -126.86 148.46 49.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 110.484 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.96 133.14 53.77 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.7 122.47 38.5 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.179 -0.951 . . . . 0.0 108.839 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.39 158.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.095 -1.003 . . . . 0.0 109.168 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -64.1 -10.53 23.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.086 -1.009 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.543 ' O ' ' CG1' ' A' ' 26' ' ' ILE . 0.4 OUTLIER -76.87 1.45 17.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.779 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 75.22 25.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.2 m -119.3 156.57 21.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 110.186 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -107.64 157.01 18.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 0.0 109.07 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.5 mt-10 -130.47 117.63 19.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.946 -1.096 . . . . 0.0 109.342 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.545 ' CB ' HG22 ' A' ' 14' ' ' VAL . . . -110.25 114.15 27.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -57.46 143.13 41.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -102.84 174.1 6.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.244 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 3.0 tt0 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.912 . . . . 0.0 109.588 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 3.6 m-20 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 52.7 t-20 -90.98 -26.62 19.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.622 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.564 HD13 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -77.31 -42.5 36.56 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.497 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 44.6 t -73.19 -34.73 45.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.454 -0.779 . . . . 0.0 109.301 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 15.3 t80 -63.33 -48.79 76.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 110.384 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.54 -40.39 61.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.18 -0.95 . . . . 0.0 110.32 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -86.2 4.31 39.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 109.992 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.448 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 4.8 mtt85 52.82 35.66 19.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.569 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.497 ' HB2' ' HA ' ' A' ' 69' ' ' VAL . 1.8 mm? -57.59 167.58 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.879 -1.138 . . . . 0.0 108.715 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.23 117.03 17.8 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.996 -1.065 . . . . 0.0 109.73 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.86 123.29 5.71 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.488 2.125 . . . . 0.0 110.506 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 130' ' ' PHE . 14.8 t -105.91 128.35 53.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.354 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -100.46 2.08 41.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 109.847 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.51 ' C ' ' CD1' ' A' ' 79' ' ' PHE . 12.3 t80 -120.87 124.75 45.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.068 -1.02 . . . . 0.0 109.529 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 178.3 31.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.71 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -62.61 -46.78 86.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 109.349 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.13 -23.1 9.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.366 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 m -72.0 -32.65 67.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 0.0 109.656 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 2.2 t80 -60.14 -43.92 95.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.942 . . . . 0.0 109.808 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtt -60.18 -50.79 72.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.333 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -60.03 -36.54 77.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.042 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.632 ' CD1' ' CB ' ' A' ' 138' ' ' PRO . 8.9 m-85 -74.96 -23.84 58.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.102 -0.999 . . . . 0.0 109.686 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.3 -29.03 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.021 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.57 -36.91 25.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.233 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.98 -31.19 74.84 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.58 ' CZ ' ' HG3' ' A' ' 141' ' ' MET . 2.2 t80 -81.18 -39.32 25.66 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.16 -1.2 . . . . 0.0 109.077 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -47.46 84.4 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.113 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -39.34 93.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.312 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.52 -47.31 73.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.221 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.509 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 47.5 mm -66.33 -32.08 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.33 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.404 ' HE2' ' HG3' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -57.8 -36.06 71.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.889 -1.132 . . . . 0.0 108.577 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.72 -49.8 23.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.404 -0.81 . . . . 0.0 109.952 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.516 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -54.19 -34.69 61.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.064 -1.023 . . . . 0.0 109.708 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.516 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 61.3 mt -73.93 -35.52 64.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.102 -0.999 . . . . 0.0 109.12 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -22.23 65.05 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.147 -0.971 . . . . 0.0 109.287 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.01 -41.42 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 110.119 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 t -145.4 47.34 1.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.937 -1.102 . . . . 0.0 110.292 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 1.9 m-20 174.65 72.98 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.38 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.56 -43.31 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.7 2.267 . . . . 0.0 110.682 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.476 ' O ' HG23 ' A' ' 109' ' ' VAL . 4.9 mt-10 -72.27 -12.89 61.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.849 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -93.21 -7.57 44.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.139 -0.976 . . . . 0.0 109.799 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 71.0 t -67.16 -44.14 47.79 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 111.14 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.9 Cg_endo -76.54 -54.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.866 1.71 . . . . 0.0 110.979 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 105' ' ' GLU . 0.8 OUTLIER -59.78 -34.21 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.076 -1.015 . . . . 0.0 109.68 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.475 ' CB ' ' O ' ' A' ' 106' ' ' ARG . 93.4 t80 -68.95 -43.44 75.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.955 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.404 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -67.5 -31.17 71.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 109.814 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -71.82 -49.37 39.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.553 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -68.92 -51.36 40.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.17 -0.956 . . . . 0.0 110.391 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.458 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -54.4 -26.95 33.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.881 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.11 -39.0 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.454 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.74 -49.96 51.52 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -30.68 68.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -1.108 . . . . 0.0 109.582 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 78.5 t -63.69 -41.1 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.64 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.84 -37.23 79.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.118 -0.989 . . . . 0.0 109.798 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -61.79 -60.12 4.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.829 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.38 -48.32 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 109.766 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 52.8 mt -46.91 -35.17 6.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.129 -0.982 . . . . 0.0 109.695 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -45.74 -48.94 15.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.802 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.6 57.35 1.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 109.664 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 1.9 p90 -55.63 -20.53 14.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.628 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.438 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -71.35 -45.61 62.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.759 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -73.41 -26.34 60.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -78.03 -25.13 47.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.421 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 60.04 170.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.541 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.456 ' O ' HG21 ' A' ' 77' ' ' THR . 2.1 m-85 -133.16 122.02 23.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 108.872 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.497 ' CE2' HG23 ' A' ' 69' ' ' VAL . 14.7 m-85 -101.25 166.92 10.52 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.146 -0.971 . . . . 0.0 110.391 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 136' ' ' MET . 3.6 tt -152.06 135.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.636 -0.665 . . . . 0.0 109.516 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.1 173.61 0.36 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -66.18 -23.98 66.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -1.113 . . . . 0.0 109.499 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.2 OUTLIER -59.27 -35.2 73.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.177 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.457 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER 71.68 53.05 0.22 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 109.61 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.451 ' N ' HD12 ' A' ' 132' ' ' ILE . 1.9 t70 -130.6 134.01 25.52 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.363 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.632 ' CB ' ' CD1' ' A' ' 87' ' ' TYR . 34.4 Cg_endo -75.1 -0.21 9.73 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.345 2.03 . . . . 0.0 110.374 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -103.11 7.86 38.75 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 109.008 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 141' ' ' MET . . . -106.14 17.74 23.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.914 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.58 ' HG3' ' CZ ' ' A' ' 91' ' ' TYR . 7.9 ttm 74.45 148.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.037 -1.039 . . . . 0.0 110.274 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.5 t -114.38 139.3 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 109.226 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.557 HG23 ' CE2' ' A' ' 158' ' ' PHE . 2.7 t -105.73 125.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.062 -1.024 . . . . 0.0 109.602 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -106.21 149.4 26.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.921 . . . . 0.0 109.069 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.484 ' HE3' ' CE ' ' A' ' 156' ' ' MET . 12.9 ptp -146.1 147.34 31.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.0 . . . . 0.0 109.744 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -156.18 161.64 40.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.911 . . . . 0.0 109.424 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.4 139.29 58.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.947 . . . . 0.0 109.374 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.434 ' CD ' HG21 ' A' ' 153' ' ' THR . 15.4 ptm180 -70.38 -170.28 0.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 109.616 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -27.82 68.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.923 . . . . 0.0 109.672 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 152' ' ' ILE . 1.2 m-20 -75.79 -14.9 60.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 56.36 22.68 38.56 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.524 ' CD1' ' HB ' ' A' ' 153' ' ' THR . 2.7 pp -110.0 -29.26 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -1.136 . . . . 0.0 109.795 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.524 ' HB ' ' CD1' ' A' ' 152' ' ' ILE . 5.9 t -138.22 134.68 17.85 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.014 . . . . 0.0 109.812 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 153' ' ' THR . 36.7 Cg_endo -81.07 151.89 18.44 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.664 2.242 . . . . 0.0 110.332 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -145.17 133.66 21.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.448 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.591 ' HG3' ' CE1' ' A' ' 158' ' ' PHE . 0.0 OUTLIER -105.8 155.41 19.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.296 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mt -118.16 154.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.771 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.591 ' CE1' ' HG3' ' A' ' 156' ' ' MET . 49.9 m-85 -133.12 164.16 27.64 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.462 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 97.6 m-85 -107.88 121.12 44.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 0.0 109.426 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -59.19 -32.76 70.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 110.036 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 5.2 p30 -44.42 -28.26 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 109.683 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . -130.89 58.17 0.71 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 mt -153.92 138.14 16.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -1.198 . . . . 0.0 109.506 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.509 HG11 ' CG2' ' A' ' 7' ' ' VAL . 2.0 m -119.03 130.94 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 109.791 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.8 p -85.74 125.85 33.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.253 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.77 142.11 45.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.868 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 168' ' ' PHE . 4.6 tppt? -102.41 126.45 49.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 109.062 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 167' ' ' LYS . 7.4 p90 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.686 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.488 HD21 ' N ' ' A' ' 2' ' ' LEU . 0.3 OUTLIER -68.49 143.64 54.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.222 -0.924 . . . . 0.0 110.069 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 2' ' ' LEU . 21.8 mt -115.43 128.21 55.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.632 -0.668 . . . . 0.0 109.482 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.535 ' CD2' HD22 ' A' ' 163' ' ' LEU . 4.4 m-85 -104.27 132.08 50.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.325 -0.859 . . . . 0.0 109.419 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 9.6 pttt -146.89 164.63 32.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.735 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 162' ' ' GLY . 44.1 t0 -87.65 146.66 25.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.298 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.71 -12.38 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.586 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.478 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 29.4 mm -54.59 -69.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.507 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -99.37 -51.76 3.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.392 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 95.46 1.68 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 4.5 p30 -170.53 153.85 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.178 -1.19 . . . . 0.0 109.526 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 12' ' ' GLU . 3.7 mm-40 -71.29 118.57 14.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.252 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.84 -41.88 3.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 109.496 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.551 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 2.3 p -153.18 169.26 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.537 ' N ' HG23 ' A' ' 14' ' ' VAL . 51.8 p -153.64 177.7 10.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.975 -1.078 . . . . 0.0 110.419 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.1 6.77 17.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.419 -0.801 . . . . 0.0 109.783 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.04 -8.4 44.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.145 -0.972 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 19' ' ' ASP . 52.6 m-85 -126.54 19.14 7.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.432 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER 61.46 120.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 37.3 mt -111.82 138.73 48.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.168 -0.957 . . . . 0.0 110.45 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -119.58 136.61 54.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.602 -0.687 . . . . 0.0 109.462 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 1.4 tt0 -99.81 115.98 30.84 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.247 -0.908 . . . . 0.0 108.881 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' A' ' 24' ' ' ASP . 6.4 t -70.82 158.92 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 109.48 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' VAL . 21.9 t0 -39.22 -39.97 0.68 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.507 -0.745 . . . . 0.0 109.568 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.88 -143.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 108.834 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.525 HD11 ' N ' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -125.98 62.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.031 -1.043 . . . . 0.0 109.244 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.527 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 16.4 m -138.49 150.97 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.543 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -104.7 157.07 17.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 80.4 mt-10 -122.86 117.47 25.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.422 -0.799 . . . . 0.0 109.079 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.551 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -113.54 115.45 28.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.48 150.09 45.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.413 ' HB3' ' HE3' ' A' ' 156' ' ' MET . 25.9 p -143.55 158.37 43.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.394 -0.816 . . . . 0.0 109.207 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.427 ' HB2' ' CG2' ' A' ' 69' ' ' VAL . 34.9 m120 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.468 ' O ' ' OG ' ' A' ' 71' ' ' SER . 28.9 p-10 -56.18 -24.41 41.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.825 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.536 HD13 ' CD2' ' A' ' 72' ' ' PHE . 58.4 tp -82.06 -34.85 29.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 108.953 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.54 ' CG1' ' HB2' ' A' ' 74' ' ' LEU . 53.5 t -66.36 -55.33 19.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.487 -0.758 . . . . 0.0 109.751 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -66.46 -42.88 86.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 0.0 110.224 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 68.1 m -55.94 -46.03 78.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.044 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.536 ' CD2' HD13 ' A' ' 68' ' ' LEU . 16.4 m-30 -100.43 18.82 18.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.9 ttm105 49.3 89.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 109.479 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.54 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 1.9 mm? -117.4 143.06 46.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.326 -0.859 . . . . 0.0 109.049 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.459 ' O ' HG21 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -121.43 143.36 37.52 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 109.741 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 36.7 Cg_endo -79.89 139.91 14.09 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.677 2.252 . . . . 0.0 110.467 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.0 t -122.05 135.39 54.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.231 -0.918 . . . . 0.0 109.257 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 t -114.45 145.58 41.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.925 . . . . 0.0 109.717 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CZ ' ' CD2' ' A' ' 130' ' ' PHE . 5.1 p90 -172.29 -177.6 1.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 83' ' ' SER . 21.2 p-10 -101.07 169.13 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.023 . . . . 0.0 109.606 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -53.69 -47.78 70.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.0 109.913 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.451 ' HB2' ' OD2' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -50.37 -35.69 29.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.778 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.469 ' HB2' ' OD1' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -71.9 -36.94 70.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.772 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.456 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 1.6 t80 -63.51 -47.41 81.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.827 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -40.97 91.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.936 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.03 -28.57 66.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.977 . . . . 0.0 109.911 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 138' ' ' PRO . 3.2 m-85 -70.12 -47.25 62.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 109.625 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.449 ' O ' ' HB2' ' A' ' 92' ' ' MET . 6.3 tp -74.17 -15.98 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.398 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.17 -59.77 2.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.2 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.61 -26.57 72.92 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 91' ' ' TYR . 4.5 t80 -72.46 -36.1 68.4 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -63.44 -43.33 97.72 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -58.14 -45.36 87.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.36 -0.838 . . . . 0.0 109.001 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.52 71.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 108.768 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.511 HG23 ' CE2' ' A' ' 110' ' ' PHE . 27.0 mm -56.04 -30.44 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 0.0 109.026 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.446 ' HD2' HG11 ' A' ' 107' ' ' VAL . 0.3 OUTLIER -54.18 -47.29 72.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.57 -30.82 64.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.757 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.515 ' CZ ' ' O ' ' A' ' 161' ' ' ASP . 3.8 tmt_? -60.7 -44.92 95.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 109.898 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.475 ' CD1' ' O ' ' A' ' 106' ' ' ARG . 14.2 mt -72.33 -49.75 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.158 -0.964 . . . . 0.0 109.784 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.4 -26.17 40.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.955 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -79.76 -45.11 19.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 0.0 109.199 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p -95.86 -70.37 0.72 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.423 ' HB3' ' NH2' ' A' ' 106' ' ' ARG . 10.8 t30 -123.38 118.13 27.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.452 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.8 -29.03 9.02 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.403 2.069 . . . . 0.0 110.675 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.453 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 3.0 mt-10 -70.28 -6.64 36.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.64 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.475 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -88.71 -3.34 58.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 0.0 109.878 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 59.1 t -72.34 -43.79 9.85 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 111.171 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.4 Cg_endo -77.86 -50.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.824 1.683 . . . . 0.0 110.902 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 110' ' ' PHE . 3.9 p -60.59 -46.84 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.72 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.571 ' N ' ' CG1' ' A' ' 109' ' ' VAL . 73.3 t80 -67.66 -37.4 82.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -0.783 . . . . 0.0 110.401 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 6.2 tm-20 -59.47 -49.66 76.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.06 -1.025 . . . . 0.0 110.451 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -64.82 -44.05 91.12 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.11 -0.994 . . . . 0.0 110.281 -179.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -61.2 -32.5 72.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.937 -1.102 . . . . 0.0 110.007 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.22 -51.0 65.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 111.367 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.614 ' CD1' ' N ' ' A' ' 116' ' ' GLY . 1.7 pp -62.94 -45.79 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.769 -1.207 . . . . 0.0 110.576 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.614 ' N ' ' CD1' ' A' ' 115' ' ' ILE . . . -59.06 -40.14 95.21 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.422 ' O ' HD11 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -73.03 -30.24 63.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -1.16 . . . . 0.0 109.871 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 88' ' ' ILE . 69.2 t -65.65 -43.95 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.896 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.517 ' CD ' ' C ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -71.84 -32.06 67.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.627 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -28.65 61.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 109.999 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.432 HD11 ' N ' ' A' ' 121' ' ' ILE . 1.2 mp -79.55 -30.68 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.998 -1.064 . . . . 0.0 108.977 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 23.2 mt -58.93 -26.19 64.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.897 . . . . 0.0 109.621 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 122' ' ' LEU . . . -43.89 -39.61 4.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.843 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 128' ' ' TYR . 2.6 m-20 -143.82 58.67 1.37 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 109.804 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 4.6 p90 -62.59 -35.03 78.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.417 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.495 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -76.36 -26.37 55.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.71 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.468 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 2.8 t70 -77.52 -27.69 51.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 109.516 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 128' ' ' TYR . 1.6 m-30 -100.04 -1.57 36.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.07 -159.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 109.465 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 79' ' ' PHE . 68.5 m-85 -147.97 121.71 9.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.577 ' CE1' ' HE3' ' A' ' 145' ' ' MET . 11.9 m-85 -98.6 168.15 10.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.961 . . . . 0.0 110.296 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.459 HG21 ' O ' ' A' ' 75' ' ' SER . 2.1 tt -150.7 146.54 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.408 -0.807 . . . . 0.0 109.437 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.75 168.44 46.65 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 135' ' ' SER . 0.2 OUTLIER -57.45 -21.21 35.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -1.159 . . . . 0.0 109.368 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 136' ' ' MET . 49.9 m -62.58 -41.71 99.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 75.41 41.81 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 109.691 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.25 129.39 24.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.148 -0.97 . . . . 0.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.441 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 33.3 Cg_endo -75.13 -13.35 21.17 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.322 2.015 . . . . 0.0 110.306 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -97.25 8.29 44.85 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 108.953 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.478 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -92.26 -161.81 0.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.347 -0.846 . . . . 0.0 109.489 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.444 ' SD ' ' O ' ' A' ' 162' ' ' GLY . 2.6 ttp -88.82 145.68 25.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.676 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.96 141.05 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.285 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.553 HG23 ' CE2' ' A' ' 158' ' ' PHE . 2.1 t -109.79 136.46 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.87 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 121' ' ' ILE . 53.0 mt -107.7 151.24 25.94 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.813 . . . . 0.0 108.976 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.577 ' HE3' ' CE1' ' A' ' 131' ' ' TYR . 0.0 OUTLIER -108.82 134.98 50.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.632 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -155.03 143.3 20.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.38 -0.825 . . . . 0.0 109.292 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.433 ' CD1' ' HA3' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -65.41 160.41 22.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.313 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 153' ' ' THR . 0.0 OUTLIER -58.49 173.58 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.15 -17.28 39.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -107.36 -47.35 3.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -0.978 . . . . 0.0 109.364 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 147' ' ' TYR . . . 120.28 29.17 1.66 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.76 -38.87 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -1.075 . . . . 0.0 109.279 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 148' ' ' ARG . 14.8 t -137.43 142.11 36.18 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.069 -1.019 . . . . 0.0 109.713 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 153' ' ' THR . 36.5 Cg_endo -79.35 146.71 19.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.665 2.244 . . . . 0.0 110.447 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -145.13 160.24 41.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.387 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.478 ' HB2' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -122.17 159.06 28.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.336 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.527 ' CG2' ' HB ' ' A' ' 27' ' ' VAL . 36.8 mt -113.29 136.26 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.672 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.553 ' CE2' HG23 ' A' ' 143' ' ' VAL . 48.1 m-85 -123.74 118.22 26.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.03 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -50.07 119.5 3.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.096 -1.002 . . . . 0.0 109.565 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 161' ' ' ASP . 18.8 tptp -67.34 -42.09 84.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.341 -0.849 . . . . 0.0 109.526 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.555 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -44.11 -38.85 3.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.22 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.446 ' O ' ' OD1' ' A' ' 6' ' ' ASP . . . -108.8 52.73 0.63 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.535 HD22 ' CD2' ' A' ' 4' ' ' TYR . 7.9 tt -151.17 149.44 29.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -1.123 . . . . 0.0 109.405 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 165' ' ' SER . 0.6 OUTLIER -138.0 157.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.901 . . . . 0.0 109.61 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' A' ' 164' ' ' VAL . 0.7 OUTLIER -111.02 120.88 43.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.675 . . . . 0.0 109.458 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -108.11 147.2 31.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.428 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.07 116.02 28.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 0.0 109.329 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.447 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.42 ' O ' HD22 ' A' ' 2' ' ' LEU . 6.2 ptt? . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.479 HD21 ' HA ' ' A' ' 167' ' ' LYS . 11.9 mt -121.27 149.07 43.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.631 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 23.4 mt -101.4 122.91 44.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.555 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.472 ' CE2' HD11 ' A' ' 20' ' ' LEU . 6.2 m-85 -106.42 118.8 37.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.866 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 0.7 OUTLIER -129.67 141.13 50.97 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.474 ' O ' HD22 ' A' ' 13' ' ' LEU . 12.2 p-10 -167.36 110.14 0.66 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.074 -1.016 . . . . 0.0 110.183 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.9 t -147.77 48.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.539 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER 62.12 15.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.9 t -163.96 -34.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.571 -0.706 . . . . 0.0 109.596 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.46 100.29 2.61 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 12' ' ' GLU . 51.8 t0 -130.08 -78.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.763 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER 161.61 113.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 109.408 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.564 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -146.51 -31.31 0.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.136 -0.977 . . . . 0.0 110.817 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.509 HG22 ' CB ' ' A' ' 30' ' ' ALA . 9.3 p -134.97 174.12 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.723 -1.235 . . . . 0.0 109.06 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.46 ' HA ' ' HB2' ' A' ' 4' ' ' TYR . 36.2 m -164.49 -174.73 3.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.021 . . . . 0.0 110.404 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' HA ' HD13 ' A' ' 20' ' ' LEU . 12.3 t70 -85.05 12.89 6.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.568 -0.708 . . . . 0.0 109.711 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.04 -17.03 64.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.955 . . . . 0.0 109.053 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.483 ' CE2' HD12 ' A' ' 68' ' ' LEU . 56.7 m-85 -118.37 19.49 13.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.462 -0.774 . . . . 0.0 109.169 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 18' ' ' TYR . 8.6 t0 63.33 120.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.528 ' CD2' ' HB1' ' A' ' 30' ' ' ALA . 10.0 mt -113.71 153.11 29.53 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.2 -0.938 . . . . 0.0 110.359 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -129.41 141.21 51.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.496 -0.752 . . . . 0.0 109.177 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.487 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 1.5 mt-10 -93.97 128.55 40.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.938 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 t -80.07 153.44 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.841 . . . . 0.0 109.589 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.01 -17.14 6.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.761 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.48 ' O ' ' CG2' ' A' ' 26' ' ' ILE . 8.5 m-20 -81.61 -100.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.619 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.48 ' CG2' ' O ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -164.53 60.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 0.0 109.41 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 26' ' ' ILE . 14.7 m -152.28 164.02 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 110.179 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.487 ' CE1' ' HG3' ' A' ' 22' ' ' GLU . 7.2 m-85 -104.34 157.85 16.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.419 -0.8 . . . . 0.0 108.858 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 19.6 mt-10 -127.07 118.59 24.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.961 . . . . 0.0 109.314 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.528 ' HB1' ' CD2' ' A' ' 20' ' ' LEU . . . -114.71 112.44 22.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.009 -1.057 . . . . 0.0 109.062 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 13.9 t0 -79.87 150.24 30.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 p -129.26 -174.5 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.318 -179.955 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.426 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 22.9 m120 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -88.82 -28.1 20.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.694 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.483 HD12 ' CE2' ' A' ' 18' ' ' TYR . 12.1 tp -78.39 -45.07 23.3 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.054 -1.029 . . . . 0.0 108.407 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.517 ' CG1' ' HB2' ' A' ' 74' ' ' LEU . 33.4 t -63.82 -54.62 29.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.452 ' C ' ' CD1' ' A' ' 70' ' ' TYR . 15.8 t80 -55.57 -32.55 63.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.177 -0.952 . . . . 0.0 109.533 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m -70.09 -38.08 75.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.851 . . . . 0.0 110.061 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.564 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 43.2 m-85 -104.35 10.32 35.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.015 -1.053 . . . . 0.0 110.142 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 4.1 tpp180 60.24 25.25 14.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.062 -1.024 . . . . 0.0 109.984 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.517 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 0.6 OUTLIER -43.5 137.76 2.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.511 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.466 ' O ' HG21 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -107.58 119.11 51.58 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.68 134.52 12.26 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.343 2.029 . . . . 0.0 110.104 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.533 ' CG2' HG23 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -126.17 179.82 5.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.088 -1.008 . . . . 0.0 109.742 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.97 132.09 37.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.494 -0.754 . . . . 0.0 109.146 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 79' ' ' PHE . 30.5 p90 -124.81 161.54 26.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.682 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -89.43 150.32 22.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -53.27 -32.8 50.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.136 -0.978 . . . . 0.0 110.039 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -87.45 -25.74 23.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 110.138 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -71.11 -38.18 72.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.118 -0.988 . . . . 0.0 109.855 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 3.8 t80 -68.48 -35.38 77.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.562 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.458 ' O ' HG21 ' A' ' 88' ' ' ILE . 7.5 mtm -64.06 -56.03 17.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.9 p -58.87 -37.71 77.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -74.87 -19.5 60.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.52 HG21 ' N ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -75.16 -31.96 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.866 . . . . 0.0 108.845 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.52 ' N ' HG21 ' A' ' 88' ' ' ILE . 3.4 mttt -70.82 -53.97 13.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.462 -0.773 . . . . 0.0 109.345 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.16 -24.02 73.23 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -75.36 -36.84 60.91 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.153 -1.204 . . . . 0.0 108.235 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.432 ' O ' ' HE1' ' A' ' 92' ' ' MET . 0.2 OUTLIER -67.92 -48.36 66.17 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.549 -0.719 . . . . 0.0 109.148 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 89' ' ' LYS . 28.3 mmtm -55.2 -41.26 71.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.334 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.54 -42.58 71.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 109.137 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 28.3 mm -70.66 -26.6 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.319 -0.863 . . . . 0.0 109.26 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.46 -34.29 75.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.959 . . . . 0.0 108.684 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.27 -47.94 46.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.559 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.516 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -56.9 -32.94 66.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.989 . . . . 0.0 109.433 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.516 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 86.9 mt -73.0 -41.93 63.77 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.255 -0.903 . . . . 0.0 109.326 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -33.93 73.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.384 -0.823 . . . . 0.0 109.556 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -73.15 -39.25 65.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.557 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.6 p -90.97 -82.4 0.29 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.12 123.82 26.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.381 -0.824 . . . . 0.0 109.055 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.61 -26.45 11.73 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.401 2.067 . . . . 0.0 110.661 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.21 -7.11 39.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.614 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.442 ' HD2' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -92.29 1.74 57.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.618 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 14.3 t -69.83 -46.43 24.13 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 110.252 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.9 Cg_endo -78.26 -36.6 0.95 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.02 1.813 . . . . 0.0 110.673 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.69 -51.15 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.995 . . . . 0.0 109.592 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.469 ' CE1' HG23 ' A' ' 95' ' ' ILE . 6.5 t80 -65.31 -37.72 88.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.919 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.45 ' O ' HD11 ' A' ' 115' ' ' ILE . 1.2 mt-10 -64.56 -35.51 81.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 109.953 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -71.75 -41.02 68.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.497 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -69.52 -54.54 13.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.077 -1.014 . . . . 0.0 110.374 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -58.92 -27.17 65.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 109.972 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.481 HG21 ' N ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -60.17 -49.11 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.338 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.481 ' N ' HG21 ' A' ' 115' ' ' ILE . . . -67.26 -40.76 92.15 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.453 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -61.26 -30.76 70.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -1.128 . . . . 0.0 110.177 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 114' ' ' ALA . 69.4 t -67.14 -41.74 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 110.391 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -69.3 -44.13 72.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.047 -1.033 . . . . 0.0 110.027 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.1 OUTLIER -57.04 -52.28 65.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.172 -0.955 . . . . 0.0 110.039 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 121' ' ' ILE . 1.6 mp -58.18 -44.54 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.08 -1.012 . . . . 0.0 109.323 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.11 -30.42 64.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 120' ' ' LYS . . . -50.25 -46.32 54.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.729 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 124' ' ' ASN . 2.4 p-10 -143.5 57.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 109.698 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.43 ' CZ ' ' HG2' ' A' ' 126' ' ' LYS . 21.9 p90 -51.79 -25.61 7.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 109.815 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.43 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.2 mmtt -61.96 -44.84 95.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 109.676 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -79.06 -23.01 44.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.618 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.577 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 2.8 m-85 -76.05 -20.32 57.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 109.751 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.8 OUTLIER 49.6 -177.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 110.029 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.505 ' CE1' HG13 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -142.91 121.38 12.42 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -108.9 176.93 4.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.03 -1.044 . . . . 0.0 110.869 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.533 HG23 ' CG2' ' A' ' 77' ' ' THR . 1.6 tt -155.54 150.88 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.561 -0.712 . . . . 0.0 109.556 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.72 -176.68 43.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -18.85 63.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -1.205 . . . . 0.0 109.429 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 m -64.47 -37.06 86.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.259 -0.901 . . . . 0.0 109.461 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.435 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER 62.23 43.79 8.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.764 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -98.65 127.26 36.24 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.72 -1.55 11.5 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.291 1.994 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -115.03 10.95 16.34 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.344 -0.848 . . . . 0.0 109.003 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . . . -100.95 -177.38 3.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.266 -0.896 . . . . 0.0 109.6 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.425 ' HE1' ' HB2' ' A' ' 159' ' ' PHE . 10.7 tmm? -83.49 142.32 31.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.535 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.505 HG13 ' CE1' ' A' ' 130' ' ' PHE . 41.1 t -108.45 141.48 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 0.0 109.65 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.494 ' N ' HG11 ' A' ' 142' ' ' VAL . 21.8 t -92.04 122.97 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.313 -0.867 . . . . 0.0 108.932 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 128' ' ' TYR . 1.1 mt -90.24 124.53 34.95 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.288 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.584 ' CE ' ' CE ' ' A' ' 156' ' ' MET . 53.5 ttm -104.93 128.47 53.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.577 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 14.4 t-20 -147.01 165.24 30.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.54 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -84.47 157.78 21.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -87.77 176.12 7.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.187 -0.945 . . . . 0.0 109.214 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.18 -13.93 51.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.22 -0.925 . . . . 0.0 109.137 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.3 -60.8 3.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.326 -0.859 . . . . 0.0 109.096 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 131.61 -27.02 3.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -133.95 37.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -1.175 . . . . 0.0 109.421 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.2 m -129.03 100.58 20.48 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.368 -0.833 . . . . 0.0 109.358 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.74 127.16 6.2 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.534 2.156 . . . . 0.0 110.481 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -145.03 159.42 42.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.584 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -129.68 142.72 50.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.278 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.49 HG21 ' N ' ' A' ' 158' ' ' PHE . 64.5 mt -102.4 148.45 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.579 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.49 ' N ' HG21 ' A' ' 157' ' ' ILE . 54.9 m-85 -127.17 118.66 24.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 109.36 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.443 ' HB3' ' OD1' ' A' ' 161' ' ' ASP . 43.8 m-85 -53.51 119.52 4.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.653 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 26' ' ' ILE . 7.8 tptt -66.7 -38.06 85.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.74 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.444 ' OD2' HD13 ' A' ' 95' ' ' ILE . 1.4 p-10 -44.76 -48.81 10.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.642 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 6' ' ' ASP . . . -104.71 50.21 0.86 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 164' ' ' VAL . 6.9 tt -145.18 155.17 43.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -1.194 . . . . 0.0 109.3 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.515 ' N ' ' CD2' ' A' ' 163' ' ' LEU . 4.3 m -144.2 135.52 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.973 . . . . 0.0 109.818 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.0 m -99.02 137.96 36.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.079 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -127.12 139.09 53.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.782 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.479 ' HA ' HD21 ' A' ' 2' ' ' LEU . 5.5 ttmt -78.58 125.27 29.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 109.35 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.497 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.9 165.82 14.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.6 mt -120.99 135.31 55.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.62 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 68.6 m-85 -121.54 133.02 55.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.833 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -135.07 153.59 51.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.832 . . . . 0.0 109.366 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 41.9 t0 -61.78 148.11 44.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 164' ' ' VAL . 18.5 t -91.2 53.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.898 . . . . 0.0 109.434 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -163.76 -54.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.084 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 0.1 OUTLIER 177.81 64.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.496 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' A' ' 13' ' ' LEU . . . -111.1 -18.74 8.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.5 OUTLIER 45.98 87.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -1.187 . . . . 0.0 109.234 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 58.18 102.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.121 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.526 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -117.25 -55.78 2.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.556 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.528 HG21 ' CB ' ' A' ' 30' ' ' ALA . 7.9 p -140.19 164.25 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 108.942 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.486 ' N ' HG23 ' A' ' 14' ' ' VAL . 53.9 p -153.24 172.12 17.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.54 2.32 29.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.484 -0.76 . . . . 0.0 109.759 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.78 -10.24 45.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.102 -0.999 . . . . 0.0 109.035 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CD2' ' CD1' ' A' ' 68' ' ' LEU . 34.7 m-85 -123.42 19.47 9.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.366 -0.834 . . . . 0.0 109.157 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 0.6 OUTLIER 61.62 128.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.348 -0.845 . . . . 0.0 108.925 -179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 65.3 mt -118.91 151.17 38.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.129 -0.982 . . . . 0.0 110.139 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.66 122.86 24.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 109.492 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -80.97 121.24 25.78 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.271 -0.893 . . . . 0.0 108.733 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 24' ' ' ASP . 6.6 t -77.38 154.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.716 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' VAL . 6.9 m-20 -42.77 -32.0 0.55 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.818 . . . . 0.0 109.542 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -70.6 -116.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -153.77 63.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.734 -1.229 . . . . 0.0 109.483 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.6 m -152.36 144.21 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.127 -0.983 . . . . 0.0 109.757 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 3.7 m-85 -98.95 134.19 42.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 108.851 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -108.78 138.26 45.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.989 -1.069 . . . . 0.0 109.967 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.528 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -116.17 113.98 23.82 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -65.74 150.15 48.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 0.0 109.689 -179.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.6 t -102.94 146.82 27.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.147 -0.971 . . . . 0.0 109.642 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 32.8 m120 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.264 0.554 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 21.0 p30 -99.32 -21.77 15.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 109.333 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.574 ' CD1' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -82.86 -42.78 17.38 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.518 ' O ' ' CA ' ' A' ' 73' ' ' ARG . 87.8 t -72.37 -35.19 51.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.475 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 2.1 t80 -69.38 -58.25 4.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.906 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 t -56.93 -52.54 64.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.939 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 11.1 m-85 -83.17 -3.47 57.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 109.633 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.518 ' CA ' ' O ' ' A' ' 69' ' ' VAL . 11.4 tpt180 53.63 34.39 18.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 109.545 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 132' ' ' ILE . 11.8 mt -42.77 142.36 0.89 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.84 . . . . 0.0 109.251 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.46 135.6 26.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.682 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.38 140.98 15.65 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.526 2.151 . . . . 0.0 110.187 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 p -122.34 175.62 6.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.664 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.2 m -144.7 151.2 38.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.068 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.629 ' CE2' ' CD2' ' A' ' 130' ' ' PHE . 6.6 p90 -172.05 -177.54 1.91 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 0.0 109.819 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.08 166.71 10.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.364 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -57.86 -52.16 66.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.733 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -26.21 67.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.788 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.3 t -71.93 -41.06 68.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.967 . . . . 0.0 109.946 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 24.8 t80 -60.34 -39.06 85.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.796 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.5 mtm -63.44 -43.45 97.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.059 -1.026 . . . . 0.0 109.847 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -40.31 95.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.17 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -67.43 -58.2 5.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.161 -0.962 . . . . 0.0 109.895 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 84' ' ' TYR . 6.3 tp -52.2 -23.79 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.843 . . . . 0.0 109.862 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -74.18 -42.26 60.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.067 -1.02 . . . . 0.0 109.655 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.12 -30.72 76.13 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 141' ' ' MET . 31.2 t80 -80.82 -35.96 32.25 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.046 -1.267 . . . . 0.0 108.846 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -43.54 96.65 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.405 -0.809 . . . . 0.0 109.221 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -40.69 82.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.338 -0.851 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.23 82.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 39.7 mm -61.64 -44.3 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.159 -0.963 . . . . 0.0 109.555 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.438 ' HE2' HG11 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -47.02 -51.59 16.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.912 . . . . 0.0 109.194 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.84 80.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 102' ' ' SER . 1.2 tmt_? -57.46 -36.1 70.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 109.344 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.516 ' CD1' ' HD2' ' A' ' 106' ' ' ARG . 8.6 mt -72.59 -49.82 29.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -0.852 . . . . 0.0 109.601 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -23.99 52.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.719 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.48 -21.66 17.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 109.568 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 2.7 t -114.13 -89.0 0.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.56 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -120.74 99.64 47.14 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.382 -0.824 . . . . 0.0 109.535 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.479 ' HA ' HG22 ' A' ' 107' ' ' VAL . 32.8 Cg_endo -74.37 -13.19 22.98 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.433 2.088 . . . . 0.0 110.392 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -7.14 16.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.127 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.534 ' HA ' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -118.76 21.48 12.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.032 -1.043 . . . . 0.0 109.772 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 16.4 t -72.42 -46.34 10.24 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.494 -0.754 . . . . 0.0 110.868 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.5 Cg_endo -77.0 -48.89 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 121.976 1.784 . . . . 0.0 110.814 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 30.1 m -57.04 -44.86 83.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.104 -0.997 . . . . 0.0 109.589 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.545 ' CD2' ' OD2' ' A' ' 161' ' ' ASP . 29.0 t80 -67.0 -37.87 84.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.84 -54.28 47.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.1 -1.0 . . . . 0.0 110.308 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -60.63 -45.92 92.24 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.105 -0.997 . . . . 0.0 110.207 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -56.34 -40.42 74.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 109.909 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.23 -27.37 63.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.081 -1.012 . . . . 0.0 109.586 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.64 -48.53 71.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.221 -0.924 . . . . 0.0 109.138 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.66 -29.91 76.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -69.98 -42.65 72.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -1.217 . . . . 0.0 109.812 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.457 ' O ' HD13 ' A' ' 122' ' ' LEU . 97.4 t -69.68 -32.54 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -71.67 -34.51 69.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.127 -0.983 . . . . 0.0 109.624 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.52 ' N ' ' HD3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -84.53 -16.91 40.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.135 -0.978 . . . . 0.0 109.843 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -42.96 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.123 -0.986 . . . . 0.0 109.337 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 118' ' ' VAL . 6.6 mt -54.42 -28.2 42.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 109.465 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.24 -49.19 64.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 109.542 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -130.53 63.21 1.57 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -0.849 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.484 ' CE2' ' CD2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -62.02 -49.93 74.06 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.364 -0.835 . . . . 0.0 109.753 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -55.55 -29.02 58.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.585 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.526 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -81.2 -26.55 35.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 109.945 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 129' ' ' ASP . 11.8 m-85 -84.16 -21.25 31.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.932 . . . . 0.0 110.018 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 128' ' ' TYR . 38.6 m-20 54.79 168.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.045 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.629 ' CD2' ' CE2' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -128.01 121.14 29.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.136 -0.978 . . . . 0.0 108.963 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.509 ' CZ ' ' HE2' ' A' ' 145' ' ' MET . 17.2 m-85 -109.5 174.71 5.74 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.21 -0.931 . . . . 0.0 110.538 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.465 ' O ' HD21 ' A' ' 74' ' ' LEU . 3.6 tt -149.16 162.22 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.553 -0.717 . . . . 0.0 109.365 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.44 -176.93 50.54 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -68.5 -27.01 65.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -1.109 . . . . 0.0 109.398 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 136' ' ' MET . 1.0 OUTLIER -61.1 -34.15 74.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 65.16 39.77 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.385 -0.822 . . . . 0.0 109.371 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.35 139.91 27.46 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 109.198 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -73.8 -17.34 22.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.355 2.037 . . . . 0.0 109.982 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.76 -12.95 62.06 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.77 149.46 21.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.337 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -66.49 139.14 57.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.603 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.1 m -88.43 141.68 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.821 . . . . 0.0 109.469 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.585 HG23 ' CE2' ' A' ' 158' ' ' PHE . 16.5 t -97.05 140.82 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.193 -0.942 . . . . 0.0 109.053 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 129' ' ' ASP . 12.4 mt -110.94 134.55 52.48 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.514 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.509 ' HE2' ' CZ ' ' A' ' 131' ' ' TYR . 1.4 mtm -104.74 128.88 52.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 109.109 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.504 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 28.5 t-20 -150.24 159.15 44.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.958 . . . . 0.0 109.685 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -89.05 128.47 35.73 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.292 -0.88 . . . . 0.0 109.013 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -166.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 109.64 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -30.38 70.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 109.723 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -53.68 -59.3 4.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.698 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 111.39 -22.63 19.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.495 ' CD1' ' N ' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -116.51 8.67 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -1.123 . . . . 0.0 109.165 179.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.8 m -117.38 101.3 52.84 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.157 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.49 137.58 14.81 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.601 2.201 . . . . 0.0 110.378 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 14.9 p90 -145.25 139.64 27.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.162 -0.961 . . . . 0.0 109.733 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.508 ' HB2' ' CE1' ' A' ' 158' ' ' PHE . 3.3 mtt -101.89 165.06 11.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.532 ' O ' ' CG1' ' A' ' 143' ' ' VAL . 12.5 mt -125.8 141.07 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.984 -1.073 . . . . 0.0 110.23 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.585 ' CE2' HG23 ' A' ' 143' ' ' VAL . 11.3 m-85 -132.92 118.58 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.418 -0.801 . . . . 0.0 108.902 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -48.59 138.4 10.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 109.722 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -65.98 -51.98 53.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.898 . . . . 0.0 109.156 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 110' ' ' PHE . 3.9 m-20 -47.04 -48.46 22.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.009 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -86.76 50.53 4.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.452 ' O ' ' CD2' ' A' ' 163' ' ' LEU . 2.1 tt -158.96 116.51 2.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.465 -1.021 . . . . 0.0 109.222 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.414 ' CG1' HG23 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -114.29 148.73 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 4.9 p -96.64 120.58 37.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.32 -0.862 . . . . 0.0 109.372 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -127.3 129.04 46.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.16 128.62 37.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.194 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.408 ' OXT' ' CG ' ' A' ' 168' ' ' PHE . 15.6 p90 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.74 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.438 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.438 HD22 ' C ' ' A' ' 1' ' ' MET . 4.7 mt -114.05 166.26 11.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.026 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.1 mt -127.96 143.3 51.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 109.298 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 29.9 m-85 -121.59 112.35 18.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.885 . . . . 0.0 109.825 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -112.9 150.41 31.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.328 -0.858 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 141' ' ' MET . 0.4 OUTLIER -68.34 158.24 33.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.586 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.8 t -94.92 -15.68 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.389 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 139' ' ' ASP . 0.8 OUTLIER -89.47 -25.05 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.256 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.5 -46.02 2.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.13 58.35 2.34 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -134.24 179.96 5.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -1.144 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -78.65 89.45 4.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.962 . . . . 0.0 109.703 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.24 -62.8 1.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 109.029 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.553 ' CG2' ' HB1' ' A' ' 30' ' ' ALA . 13.8 p -143.19 171.03 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.418 ' C ' HD13 ' A' ' 20' ' ' LEU . 4.9 m -156.49 178.32 10.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.151 . . . . 0.0 110.804 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.48 ' CA ' HD13 ' A' ' 20' ' ' LEU . 23.9 t0 -84.12 12.5 6.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.517 -0.739 . . . . 0.0 109.889 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.416 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . . . -66.32 -9.23 31.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.004 . . . . 0.0 109.02 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.543 ' CD2' HD13 ' A' ' 68' ' ' LEU . 4.6 m-85 -128.7 21.13 5.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.424 -0.797 . . . . 0.0 109.264 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER 62.91 126.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.062 -1.024 . . . . 0.0 108.309 -178.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.52 ' CD2' ' HB1' ' A' ' 30' ' ' ALA . 12.9 mt -120.35 147.17 45.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 110.584 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.9 mmtp -123.23 140.59 52.87 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -100.75 114.41 28.14 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.11 -0.994 . . . . 0.0 108.828 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 24' ' ' ASP . 3.2 t -68.63 158.37 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.371 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' VAL . 1.5 t70 -41.15 -47.19 3.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.426 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' ASP . 16.2 m-20 -62.12 -148.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 108.957 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.425 ' C ' HG11 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -119.97 60.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.233 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.425 HG11 ' C ' ' A' ' 26' ' ' ILE . 11.9 m -134.19 150.62 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.882 . . . . 0.0 109.784 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.04 155.77 21.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -0.82 . . . . 0.0 109.134 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 2.4 pt-20 -133.29 120.71 21.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.043 -1.036 . . . . 0.0 109.661 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.553 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -100.14 127.05 46.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.441 -0.787 . . . . 0.0 109.087 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 64.9 m-20 -68.0 145.69 54.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.932 . . . . 0.0 109.77 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -125.52 152.97 44.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.248 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.435 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.557 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 56.1 p30 -80.4 -18.02 50.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.543 HD13 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.63 -35.41 22.7 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.21 -0.931 . . . . 0.0 108.976 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.409 HG22 ' HE3' ' A' ' 156' ' ' MET . 73.6 t -72.84 -45.2 56.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.395 -0.815 . . . . 0.0 109.277 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -69.31 -36.25 76.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.106 -0.996 . . . . 0.0 110.109 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.1 m -70.51 -49.74 45.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.19 -0.944 . . . . 0.0 110.437 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 14' ' ' VAL . 16.9 m-85 -92.24 -0.26 57.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.021 . . . . 0.0 110.132 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 57.27 64.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.956 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.417 ' CD1' ' SD ' ' A' ' 156' ' ' MET . 12.0 mt -77.78 164.38 25.27 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.101 -1.0 . . . . 0.0 108.941 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -131.45 106.16 14.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.269 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 35.4 Cg_endo -76.8 120.9 5.66 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.359 2.039 . . . . 0.0 110.503 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.0 t -88.95 157.55 18.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.9 . . . . 0.0 109.425 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.4 t -114.15 7.93 16.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.935 . . . . 0.0 109.509 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.516 ' C ' ' CD1' ' A' ' 79' ' ' PHE . 6.9 p90 -136.35 142.72 43.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.632 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 1.0 OUTLIER 172.68 30.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.883 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -52.98 60.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.037 -1.039 . . . . 0.0 109.428 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -118.41 -31.24 4.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.82 . . . . 0.0 109.297 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.459 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 4.1 m -59.67 -30.44 68.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.201 -0.937 . . . . 0.0 108.911 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 80' ' ' ASP . 5.0 t80 -66.61 -44.67 81.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 0.0 109.601 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.517 ' O ' ' CG2' ' A' ' 88' ' ' ILE . 7.6 mtt -60.93 -43.79 98.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.944 . . . . 0.0 109.92 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.1 m -66.87 -26.75 67.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.208 -0.932 . . . . 0.0 110.183 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CD2' ' O ' ' A' ' 83' ' ' SER . 12.4 m-85 -81.46 -29.34 33.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 109.945 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 85' ' ' MET . 3.0 tp -75.92 -28.16 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -49.2 16.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.374 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.01 -34.37 89.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -72.76 -36.2 67.62 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -61.0 -38.4 85.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -67.26 -39.48 86.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.382 -0.824 . . . . 0.0 109.182 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.11 72.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.113 -0.992 . . . . 0.0 108.761 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.495 ' CG2' ' OD2' ' A' ' 161' ' ' ASP . 33.2 mm -62.92 -43.43 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.307 -0.87 . . . . 0.0 109.253 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.08 -37.42 9.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.261 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.1 -47.1 47.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.424 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.489 ' CD ' HD22 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -48.97 -46.29 43.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 109.545 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 106' ' ' ARG . 6.1 mt -63.84 -46.46 84.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.204 -0.935 . . . . 0.0 109.17 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -23.74 7.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 108.881 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 98' ' ' ARG . 2.3 mt-10 -78.24 -48.15 16.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.441 -0.787 . . . . 0.0 109.223 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.0 -72.51 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.484 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.11 139.74 14.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.363 -0.836 . . . . 0.0 109.478 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.81 -13.97 21.74 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.662 2.241 . . . . 0.0 110.816 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 83.1 mt-10 -67.43 -23.52 65.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -0.972 . . . . 0.0 109.686 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.526 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -87.81 5.71 38.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 109.565 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.57 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 2.4 t -72.06 -50.02 9.49 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 109.532 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 36.8 Cg_endo -79.56 -33.39 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.226 1.951 . . . . 0.0 110.435 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 49.8 t -67.47 -53.93 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.37 -0.831 . . . . 0.0 109.885 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 161' ' ' ASP . 92.4 t80 -68.67 -37.53 79.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.895 . . . . 0.0 109.936 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -49.12 79.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.979 . . . . 0.0 110.229 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -70.88 -37.18 73.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.455 ' N ' ' HG3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -62.8 -35.07 78.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.879 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.42 -28.08 63.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 109.661 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -34.12 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.304 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.26 -44.95 84.41 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.5 -44.59 78.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -1.148 . . . . 0.0 109.811 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 85.1 t -53.56 -35.39 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.356 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -43.38 67.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 109.678 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -33.14 72.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.869 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.17 -35.15 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.106 -0.997 . . . . 0.0 109.377 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 44.9 mt -60.52 -28.65 68.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.652 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.31 -36.68 78.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -143.13 59.55 1.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.19 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -59.16 -28.88 67.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.937 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 4.7 mmtp -72.24 -36.2 69.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 109.796 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -80.08 -23.67 41.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.809 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 129' ' ' ASP . 46.7 m-85 -85.7 -25.0 26.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.122 -0.987 . . . . 0.0 109.712 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 126' ' ' LYS . 8.8 m-20 53.33 175.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.367 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.53 121.7 19.1 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.242 -0.911 . . . . 0.0 108.814 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.481 ' CE2' ' HB3' ' A' ' 76' ' ' PRO . 14.7 m-85 -101.7 166.91 10.43 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.201 -0.937 . . . . 0.0 110.308 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -156.42 142.97 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.528 -0.732 . . . . 0.0 109.497 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.45 179.57 1.86 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -67.74 -27.19 66.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -1.125 . . . . 0.0 109.248 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.544 ' O ' ' CG ' ' A' ' 136' ' ' MET . 1.0 OUTLIER -60.29 -35.07 74.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.301 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 79.92 20.01 0.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.501 -0.749 . . . . 0.0 109.471 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.47 123.62 35.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.029 -1.044 . . . . 0.0 109.798 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.41 ' HG3' ' CD1' ' A' ' 87' ' ' TYR . 32.3 Cg_endo -73.24 -13.5 25.67 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.145 1.897 . . . . 0.0 109.789 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.471 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.8 m-20 -62.86 -21.21 65.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 141' ' ' MET . . . -76.78 -69.82 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.85 . . . . 0.0 109.089 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 5.8 tmm? 173.4 137.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 109.352 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.449 HG11 ' O ' ' A' ' 131' ' ' TYR . 2.5 t -98.84 140.55 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.568 HG23 ' CE2' ' A' ' 158' ' ' PHE . 3.4 t -112.14 138.05 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -106.18 143.67 33.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.2 mtt -107.75 132.28 53.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.282 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 13.2 t30 -143.77 160.28 41.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 109.643 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.74 146.29 24.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.94 . . . . 0.0 109.444 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -77.81 -172.83 2.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.563 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -21.64 63.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.51 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -58.02 5.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.85 -13.0 9.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.462 HD11 ' O ' ' A' ' 152' ' ' ILE . 2.4 pp -124.47 5.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.267 -1.137 . . . . 0.0 109.586 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.2 m -111.88 100.28 48.19 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.242 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -81.59 132.27 7.73 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.622 2.215 . . . . 0.0 110.598 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 146' ' ' ASN . 38.4 p90 -133.78 142.59 47.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.106 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 9.6 mtt -100.79 161.15 13.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 110.207 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.509 ' C ' ' CD1' ' A' ' 158' ' ' PHE . 68.9 mt -124.46 145.78 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.215 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.576 ' N ' ' CD1' ' A' ' 158' ' ' PHE . 4.2 m-85 -137.3 141.82 41.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 109.483 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -58.83 120.31 8.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 109.356 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -67.58 -45.61 75.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 109.513 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.587 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . 4.6 t0 -54.53 -25.84 28.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.345 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -103.8 39.2 2.89 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 8.1 mt -149.75 140.19 22.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.388 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.0 123.01 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.521 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.56 119.57 23.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.468 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -117.18 138.03 51.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.571 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.35 146.48 31.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 168' ' ' PHE . 5.1 t80 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.373 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.291 0.567 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.616 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 1.3 mm? -75.11 156.56 35.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.282 -0.886 . . . . 0.0 109.683 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 mp -134.29 124.06 25.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 6.1 m-85 -96.12 109.58 21.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.429 -0.795 . . . . 0.0 109.81 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HG3' HG21 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -110.03 152.45 25.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.348 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.456 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 20.2 t0 -68.11 134.57 50.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.523 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 p -76.13 -36.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.433 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.463 HG23 ' OG ' ' A' ' 9' ' ' SER . 2.3 mp -66.47 -91.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.463 ' OG ' HG23 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -135.11 80.84 1.86 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.38 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 6' ' ' ASP . . . -145.31 -62.99 0.02 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.6 t0 68.21 11.01 8.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -1.099 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 173.1 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.693 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -122.7 -61.37 1.46 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 109.285 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.559 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 10.5 p -136.76 166.35 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 108.979 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.496 ' N ' HG23 ' A' ' 14' ' ' VAL . 1.4 p -145.47 164.34 31.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.009 -1.057 . . . . 0.0 110.543 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.488 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 1.5 t0 -82.96 8.1 13.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.461 -0.775 . . . . 0.0 109.745 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.23 -19.92 65.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 0.0 109.131 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.559 ' CG ' HD13 ' A' ' 68' ' ' LEU . 14.2 m-85 -110.87 21.26 16.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.272 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER 58.75 111.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 16.2 mt -105.53 144.8 31.79 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.14 -0.975 . . . . 0.0 110.609 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.83 133.03 56.51 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.914 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.13 120.94 38.42 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.298 -0.876 . . . . 0.0 108.703 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 24' ' ' ASP . 12.0 t -72.07 155.16 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' VAL . 22.2 t70 -43.4 -31.46 0.68 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.69 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.522 ' O ' ' CG2' ' A' ' 26' ' ' ILE . 1.0 OUTLIER -70.15 -103.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.473 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.522 ' CG2' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -166.95 63.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.959 -1.088 . . . . 0.0 109.442 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.41 ' CG2' HG22 ' A' ' 23' ' ' VAL . 3.6 m -142.83 142.27 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.965 . . . . 0.0 109.735 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -100.59 132.36 46.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.429 -0.794 . . . . 0.0 109.144 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 18.6 mt-10 -107.99 124.7 50.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.93 . . . . 0.0 109.268 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.559 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -105.59 116.09 31.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 109.27 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.95 147.05 49.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.727 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.452 ' HB2' ' HG2' ' A' ' 154' ' ' PRO . 3.9 m -115.56 167.8 10.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -0.912 . . . . 0.0 109.378 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.162 -0.961 . . . . 0.0 109.625 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.316 0.579 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' A' ' 71' ' ' SER . 31.9 t-20 -80.72 -21.65 40.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.551 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.559 HD13 ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.22 -40.0 18.62 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.17 -0.956 . . . . 0.0 108.566 179.574 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.467 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 41.4 t -67.07 -44.36 88.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.543 -0.723 . . . . 0.0 109.343 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -70.18 -40.46 74.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.869 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 1.3 t -63.26 -34.29 77.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 110.119 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.404 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 59.4 m-85 -111.32 6.75 20.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.03 -1.043 . . . . 0.0 109.904 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER 54.04 32.63 15.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 109.913 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.491 ' N ' HD21 ' A' ' 74' ' ' LEU . 1.3 mm? -43.13 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.269 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -127.92 141.69 41.96 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.149 -0.97 . . . . 0.0 109.48 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 36.3 Cg_endo -78.47 127.15 7.96 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.576 2.184 . . . . 0.0 110.456 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.471 HG22 ' HB ' ' A' ' 132' ' ' ILE . 1.0 OUTLIER -138.33 176.54 8.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.12 -0.988 . . . . 0.0 109.641 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.412 ' O ' ' CD2' ' A' ' 130' ' ' PHE . 13.1 m -120.66 -149.41 0.43 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.228 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.647 ' CG ' ' CE1' ' A' ' 125' ' ' PHE . 6.5 p90 -164.84 -178.75 5.41 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.173 -0.954 . . . . 0.0 109.405 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.543 ' CB ' ' CB ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -120.85 136.94 54.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.125 -0.984 . . . . 0.0 109.63 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.45 -38.18 88.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 109.851 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.82 -33.64 6.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 109.781 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.543 ' CB ' ' CB ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -71.08 -29.44 65.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.922 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.52 ' CE1' ' HB ' ' A' ' 88' ' ' ILE . 5.6 t80 -56.69 -35.95 69.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.006 -1.059 . . . . 0.0 109.812 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.8 mtm -53.66 -43.55 68.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.912 -1.118 . . . . 0.0 109.694 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 t -70.62 -41.07 72.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.064 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -56.67 -56.47 21.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 109.57 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.52 ' HB ' ' CE1' ' A' ' 84' ' ' TYR . 4.2 tp -59.33 -29.33 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.857 . . . . 0.0 109.459 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -57.45 11.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.136 -0.977 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.02 -19.91 70.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -70.64 -40.71 72.91 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.167 -1.196 . . . . 0.0 107.778 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -41.78 75.93 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -40.07 63.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.425 -0.797 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.07 73.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.21 -0.932 . . . . 0.0 109.189 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.493 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 13.5 mm -63.02 -38.21 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.185 -0.947 . . . . 0.0 109.127 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HD3' ' OE1' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -55.48 -35.1 65.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.068 . . . . 0.0 109.397 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.65 59.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.915 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.525 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -59.63 -31.74 69.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.015 . . . . 0.0 109.623 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.525 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 28.2 mt -72.56 -44.34 62.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.965 . . . . 0.0 109.6 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.447 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -58.56 -35.98 73.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.59 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -83.72 -18.29 38.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.442 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 t -115.83 -75.35 0.59 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -126.69 95.82 36.82 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.436 -0.79 . . . . 0.0 109.174 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.438 ' HB3' ' HA ' ' A' ' 100' ' ' GLN . 33.8 Cg_endo -74.42 -22.14 16.51 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.461 2.107 . . . . 0.0 110.489 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 -20.13 62.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.567 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.51 ' CD ' HD21 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -99.64 20.81 13.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.419 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 19.9 t -68.73 -45.59 33.49 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 110.638 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.8 Cg_endo -77.24 -25.1 8.84 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.952 1.768 . . . . 0.0 110.614 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.84 -52.77 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.262 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.46 ' CD1' HG23 ' A' ' 95' ' ' ILE . 24.7 t80 -67.31 -37.61 83.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.72 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -61.04 -37.39 82.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.033 -1.042 . . . . 0.0 109.978 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -71.28 -38.48 71.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.936 . . . . 0.0 110.224 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -67.33 -51.18 55.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.113 -0.992 . . . . 0.0 110.24 -179.323 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.89 -34.01 69.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.402 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.512 HG21 ' N ' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -58.1 -46.76 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.119 -0.988 . . . . 0.0 109.513 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.512 ' N ' HG21 ' A' ' 115' ' ' ILE . . . -67.51 -43.71 85.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.406 ' O ' HD11 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -58.1 -35.94 72.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.173 -1.192 . . . . 0.0 110.285 -179.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 39.6 t -63.15 -40.31 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.076 -1.015 . . . . 0.0 109.925 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.493 ' CD ' ' C ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -71.3 -28.78 64.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 109.202 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -56.33 10.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.885 . . . . 0.0 109.573 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.406 HD11 ' O ' ' A' ' 117' ' ' PHE . 1.3 mp -59.82 -42.95 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 0.0 109.528 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 59.6 mt -48.46 -26.91 2.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.66 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.14 67.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -136.7 55.61 1.83 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 109.392 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.647 ' CE1' ' CG ' ' A' ' 79' ' ' PHE . 20.3 t80 -58.55 -33.77 70.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.653 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -39.33 80.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 109.763 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -78.67 -24.82 44.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.939 . . . . 0.0 109.686 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 129' ' ' ASP . 10.6 m-85 -77.6 -9.64 59.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.549 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.9 m-20 48.1 -175.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.352 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.558 ' CE1' HG13 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -139.8 120.45 14.25 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.327 -0.858 . . . . 0.0 108.842 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 145' ' ' MET . 15.2 m-85 -111.72 171.89 7.22 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.095 -1.003 . . . . 0.0 110.467 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.471 ' HB ' HG22 ' A' ' 77' ' ' THR . 6.4 tt -149.23 140.55 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.474 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.11 160.24 22.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.405 ' HG3' ' CB ' ' A' ' 73' ' ' ARG . 2.3 tt0 -63.25 -21.82 66.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -1.086 . . . . 0.0 109.609 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 136' ' ' MET . 18.7 t -65.73 -34.84 79.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.469 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 135' ' ' SER . 3.2 ttm 74.86 59.78 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 0.0 109.464 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.416 ' OD2' ' HB3' ' A' ' 135' ' ' SER . 0.4 OUTLIER -129.45 109.63 17.63 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.356 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.13 -2.12 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.304 2.003 . . . . 0.0 110.32 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -104.41 -3.16 24.42 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.341 -0.85 . . . . 0.0 109.193 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.45 ' HA ' HG23 ' A' ' 8' ' ' ILE . . . -91.76 -72.89 0.57 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.161 -0.962 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.469 ' HE3' ' O ' ' A' ' 162' ' ' GLY . 3.6 ttp -177.78 141.43 0.28 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.779 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.558 HG13 ' CE1' ' A' ' 130' ' ' PHE . 74.6 t -102.76 141.53 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.114 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.477 HG12 ' CZ ' ' A' ' 158' ' ' PHE . 3.3 t -102.3 143.55 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.102 -0.999 . . . . 0.0 109.559 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.5 mt -106.63 134.58 49.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.326 -0.859 . . . . 0.0 109.195 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.493 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 12.1 ttm -113.28 124.49 52.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.337 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.575 ' O ' ' CD2' ' A' ' 155' ' ' TYR . 8.8 t30 -144.51 144.32 31.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -74.36 148.22 41.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -55.69 -172.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 109.586 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -79.99 -1.44 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.632 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -104.22 -35.04 8.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.327 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.25 38.22 6.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -127.71 -26.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -1.164 . . . . 0.0 109.763 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 t -136.58 132.39 18.65 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 0.0 109.351 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.452 ' HG2' ' HB2' ' A' ' 32' ' ' CYS . 36.6 Cg_endo -80.8 153.28 19.72 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.661 2.241 . . . . 0.0 110.602 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 146' ' ' ASN . 24.7 p90 -145.12 134.59 23.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 109.347 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.479 ' HE3' ' HE2' ' A' ' 145' ' ' MET . 0.2 OUTLIER -102.13 154.33 19.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.341 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.465 ' O ' HG11 ' A' ' 143' ' ' VAL . 6.4 mt -115.87 145.47 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.477 ' CZ ' HG12 ' A' ' 143' ' ' VAL . 58.1 m-85 -136.93 129.17 29.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.421 ' HB2' ' SD ' ' A' ' 141' ' ' MET . 3.4 m-85 -60.79 127.78 33.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 109.632 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.07 -54.42 18.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.781 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.449 ' OD1' ' HD2' ' A' ' 98' ' ' ARG . 12.7 t0 -43.62 -34.77 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.811 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.469 ' O ' ' HE3' ' A' ' 141' ' ' MET . . . -102.98 53.57 0.74 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.1 mt -161.96 130.23 4.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.44 HG21 ' HG3' ' A' ' 5' ' ' LYS . 5.4 m -114.1 139.15 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.3 p -83.24 142.71 30.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -133.79 123.16 24.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 109.523 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.419 ' CG ' HD12 ' A' ' 2' ' ' LEU . 0.2 OUTLIER -96.37 110.95 23.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.365 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.123 -0.985 . . . . 0.0 109.476 -179.83 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 168' ' ' PHE . 17.8 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 167' ' ' LYS . 14.7 mt -105.47 157.6 17.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.4 mt -104.51 123.52 47.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 0.0 109.288 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 4.2 m-85 -107.35 118.48 36.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.677 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -139.8 156.31 46.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.271 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.01 155.89 29.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.647 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.446 ' O ' HG21 ' A' ' 7' ' ' VAL . 8.5 p -97.58 -11.62 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.872 . . . . 0.0 109.418 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.42 ' O ' HG21 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -91.76 -23.87 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.179 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.5 m -124.37 -10.77 7.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.744 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.87 58.18 9.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.444 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 10.0 m-20 -127.51 134.53 49.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -1.134 . . . . 0.0 109.487 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.416 ' C ' HD22 ' A' ' 13' ' ' LEU . 43.3 mt-10 -63.17 116.64 5.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.87 . . . . 0.0 109.569 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 4.0 mt -116.72 -48.04 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.874 . . . . 0.0 109.377 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.594 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 6.1 p -136.58 175.1 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.002 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.441 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.1 p -159.57 173.22 16.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.87 -1.144 . . . . 0.0 110.594 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.453 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 10.9 t0 -84.1 2.86 37.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.529 -0.732 . . . . 0.0 109.7 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.74 -11.73 55.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.126 -0.984 . . . . 0.0 109.035 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.562 ' CE1' ' CD1' ' A' ' 68' ' ' LEU . 26.2 m-85 -120.62 21.08 11.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.453 -0.78 . . . . 0.0 109.267 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.31 133.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 69.1 mt -129.31 143.57 50.9 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.277 -0.889 . . . . 0.0 109.765 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -129.62 133.5 47.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 109.469 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -91.97 121.59 33.7 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.467 ' HB ' ' OD1' ' A' ' 25' ' ' ASP . 13.3 t -76.66 153.42 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -42.98 -36.93 1.71 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.579 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.576 ' OD2' ' CE1' ' A' ' 117' ' ' PHE . 6.1 p30 -63.73 -123.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.9 . . . . 0.0 109.311 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.519 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -146.14 63.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.746 -1.221 . . . . 0.0 109.35 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.465 HG23 ' OD1' ' A' ' 25' ' ' ASP . 13.3 m -151.94 163.47 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.746 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 4.8 m-85 -115.85 156.97 25.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.117 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 156' ' ' MET . 7.5 pt-20 -128.98 128.37 43.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.521 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.594 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -111.42 116.42 30.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.516 -0.74 . . . . 0.0 109.279 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 51.1 m-20 -63.32 142.55 58.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 109.581 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.458 ' SG ' HD21 ' A' ' 68' ' ' LEU . 58.6 m -133.45 152.66 51.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.902 . . . . 0.0 109.405 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.301 -0.874 . . . . 0.0 109.549 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -74.04 -24.28 59.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.729 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.562 ' CD1' ' CE1' ' A' ' 18' ' ' TYR . 27.7 tp -81.81 -45.03 16.14 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.083 -1.01 . . . . 0.0 108.552 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 74' ' ' LEU . 55.8 t -65.03 -38.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.397 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -69.59 -36.21 76.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.132 -0.98 . . . . 0.0 109.902 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.6 -50.69 62.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.868 . . . . 0.0 110.129 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 34.9 m-85 -82.71 -3.66 56.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.997 . . . . 0.0 110.128 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER 73.49 18.39 3.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.498 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.53 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 1.8 mm? -39.29 138.69 0.61 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.463 -0.773 . . . . 0.0 109.976 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.467 ' O ' HG21 ' A' ' 132' ' ' ILE . 2.2 p -118.05 113.97 37.28 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.34 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.21 149.23 21.93 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.418 2.078 . . . . 0.0 110.468 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.5 p -113.78 -175.42 2.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.347 -0.846 . . . . 0.0 108.974 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.38 -44.66 0.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.809 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 79' ' ' PHE . 6.6 p90 -78.57 132.11 37.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.586 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.538 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . 1.4 m-20 -175.97 27.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 109.825 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -45.0 95.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.069 -1.019 . . . . 0.0 109.354 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -122.49 -32.53 3.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.54 -32.4 72.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.293 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.573 ' CD2' ' CZ ' ' A' ' 125' ' ' PHE . 1.0 OUTLIER -58.71 -48.1 82.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.578 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.461 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.2 mtt -60.3 -33.79 72.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.974 . . . . 0.0 109.818 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 t -67.61 -39.2 84.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.74 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -67.9 -47.18 69.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.806 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 85' ' ' MET . 6.2 tp -61.46 -26.73 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.505 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -43.35 57.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 109.595 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.29 -26.52 73.48 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.536 ' CE2' ' HA ' ' A' ' 141' ' ' MET . 17.9 m-85 -81.64 -36.65 28.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -1.152 . . . . 0.0 109.03 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -41.86 86.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.305 -0.872 . . . . 0.0 109.55 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.526 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -70.72 -42.96 69.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.059 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.526 ' N ' ' HD2' ' A' ' 93' ' ' LYS . . . -55.31 -49.47 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.04 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.511 HG23 ' CE2' ' A' ' 110' ' ' PHE . 34.1 mm -57.28 -43.19 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.344 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.55 -47.61 39.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.276 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.19 -34.56 77.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.324 -0.86 . . . . 0.0 109.298 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.458 ' O ' ' OG ' ' A' ' 102' ' ' SER . 3.6 tmt_? -63.36 -34.01 76.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.512 ' CD1' ' HD2' ' A' ' 106' ' ' ARG . 9.9 mt -71.83 -45.53 61.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.161 -0.962 . . . . 0.0 109.295 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -54.76 -35.36 63.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.588 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.39 -40.31 62.14 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.0 109.085 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -89.83 -77.55 0.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.524 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' A' ' 106' ' ' ARG . 5.0 p30 -144.24 118.89 5.95 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.845 . . . . 0.0 109.398 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.69 -13.56 22.12 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.487 2.125 . . . . 0.0 110.609 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.28 -19.79 65.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.868 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.512 ' HD2' ' CD1' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -100.89 15.52 28.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 109.603 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.603 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 15.6 t -72.27 -45.41 10.7 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 110.894 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.0 Cg_endo -76.34 -49.29 0.12 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.953 1.769 . . . . 0.0 111.009 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 29.5 m -58.31 -44.35 88.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.043 -1.036 . . . . 0.0 109.679 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.511 ' CE2' HG23 ' A' ' 95' ' ' ILE . 52.6 t80 -65.5 -38.51 89.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.243 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 115' ' ' ILE . 1.1 mt-10 -63.71 -44.33 93.92 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.133 -0.98 . . . . 0.0 110.332 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -33.81 76.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.155 -0.965 . . . . 0.0 110.122 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -69.57 -46.96 65.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.986 . . . . 0.0 109.864 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.408 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -64.66 -27.25 68.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 109.688 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -72.48 -44.93 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.7 -48.4 72.91 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.576 ' CE1' ' OD2' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -60.12 -41.33 92.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -1.19 . . . . 0.0 109.869 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 56.9 t -64.32 -32.38 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.9 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -70.76 -33.28 70.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.029 . . . . 0.0 109.861 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -32.59 57.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.138 -0.976 . . . . 0.0 109.815 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 117' ' ' PHE . 1.5 mp -72.04 -31.21 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.923 . . . . 0.0 109.319 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 95.6 mt -64.86 -26.79 68.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.048 -1.033 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.6 -29.18 69.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.975 . . . . 0.0 109.928 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.61 55.53 1.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.156 -0.965 . . . . 0.0 109.436 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 130' ' ' PHE . 4.0 t80 -63.34 -20.88 65.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.731 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.433 ' CG ' ' N ' ' A' ' 127' ' ' ASP . 6.0 ptmm? -74.4 -47.11 35.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.058 -1.026 . . . . 0.0 109.71 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 126' ' ' LYS . 8.5 t70 -72.28 -23.72 61.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.616 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 1.1 m-85 -79.33 -24.28 42.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.112 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.531 ' C ' ' CD1' ' A' ' 130' ' ' PHE . 2.5 m-20 53.24 173.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 109.14 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.687 ' CE1' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -134.51 121.19 20.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 108.98 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.527 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 13.0 m-85 -105.66 164.63 11.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.102 -0.999 . . . . 0.0 110.661 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.468 ' O ' HG21 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -146.79 138.8 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.436 -0.79 . . . . 0.0 109.435 179.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.21 155.21 3.59 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -59.24 -23.9 62.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -1.143 . . . . 0.0 109.119 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 136' ' ' MET . 3.0 p -64.65 -35.22 80.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.408 -0.807 . . . . 0.0 109.285 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 72.67 40.82 0.59 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.293 -0.88 . . . . 0.0 109.365 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.84 134.14 32.63 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.867 . . . . 0.0 109.309 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.67 -5.74 16.83 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.385 2.057 . . . . 0.0 110.133 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -98.21 -4.32 35.66 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.287 -0.883 . . . . 0.0 109.208 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.05 134.99 39.68 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.536 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -64.49 152.17 42.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.6 m -88.64 141.89 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 109.369 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.562 HG23 ' CE2' ' A' ' 158' ' ' PHE . 2.6 t -92.23 130.01 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.236 -0.915 . . . . 0.0 108.967 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.462 HD21 ' O ' ' A' ' 129' ' ' ASP . 1.5 mt -103.42 135.43 45.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.527 ' HE3' ' CZ ' ' A' ' 131' ' ' TYR . 0.0 OUTLIER -108.54 142.73 38.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.569 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 1.8 t30 -145.97 166.37 26.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.717 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.72 125.93 35.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.566 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.472 ' HG3' ' CD2' ' A' ' 155' ' ' TYR . 0.9 OUTLIER -66.32 -169.31 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.24 -0.912 . . . . 0.0 109.404 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -16.09 60.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.465 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 148' ' ' ARG . 2.0 m-20 -57.89 -56.57 20.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 0.0 109.333 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 126.73 -23.19 5.68 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -140.45 37.07 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -1.127 . . . . 0.0 109.221 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.4 m -127.27 100.54 26.33 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.08 131.81 9.07 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.569 2.179 . . . . 0.0 109.814 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.472 ' CD2' ' HG3' ' A' ' 148' ' ' ARG . 40.3 p90 -135.96 142.64 44.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.097 -1.002 . . . . 0.0 109.718 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.545 ' HB2' ' CE1' ' A' ' 158' ' ' PHE . 6.5 mtp -99.02 149.16 23.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.208 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.451 ' O ' HG12 ' A' ' 143' ' ' VAL . 68.8 mt -117.15 141.38 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.562 ' CE2' HG23 ' A' ' 143' ' ' VAL . 5.7 m-85 -132.61 141.79 48.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 109.307 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 163' ' ' LEU . 72.6 m-85 -71.06 127.71 33.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 109.697 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.21 -40.83 86.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.343 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.62 -33.28 45.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.409 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -112.65 50.05 0.8 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 159' ' ' PHE . 0.6 OUTLIER -153.26 129.24 10.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -1.121 . . . . 0.0 109.525 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 m -118.81 144.84 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 109.307 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -106.08 129.64 54.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 109.862 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -120.65 122.43 40.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.249 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.473 ' HA ' HD21 ' A' ' 2' ' ' LEU . 2.1 tttp -55.75 123.24 13.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.736 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.403 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.542 ' CG ' HD21 ' A' ' 2' ' ' LEU . 4.6 ptp . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.287 0.565 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.542 HD21 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -67.09 147.16 53.5 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 2' ' ' LEU . 57.9 mt -118.41 126.65 52.53 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.429 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.543 ' CD1' ' HA ' ' A' ' 165' ' ' SER . 75.8 m-85 -114.15 121.58 44.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.482 ' C ' ' CD2' ' A' ' 13' ' ' LEU . 10.0 ptmt -126.37 160.79 29.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.616 -0.678 . . . . 0.0 109.228 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.409 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 25.6 t0 -98.86 154.08 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.329 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.36 -17.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.0 mt -75.43 -44.65 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 164.56 43.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.24 -41.94 3.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 57.1 99.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -1.19 . . . . 0.0 109.478 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 44.73 81.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.415 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.482 ' CD2' ' C ' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -86.15 -32.06 21.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 8.2 p -166.91 174.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.966 -1.083 . . . . 0.0 109.529 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 2' ' ' LEU . 28.2 t -146.17 168.34 21.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.987 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.49 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 20.4 t0 -93.11 -4.59 52.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 109.483 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.18 -20.71 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.151 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CD2' HD12 ' A' ' 68' ' ' LEU . 13.5 m-85 -99.08 -55.67 2.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.401 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 18' ' ' TYR . 3.3 m-20 155.44 130.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.523 ' CD1' ' CE2' ' A' ' 4' ' ' TYR . 76.7 mt -130.27 133.56 46.59 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.046 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -131.43 127.52 37.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 9.2 pt-20 -92.9 129.59 38.77 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.058 -1.026 . . . . 0.0 109.614 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' ASP . 4.1 t -78.32 152.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -43.79 -28.46 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.884 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.464 ' O ' HG21 ' A' ' 26' ' ' ILE . 3.0 m-20 -65.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.464 HG21 ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -162.98 49.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.987 -1.071 . . . . 0.0 109.203 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.536 HG22 ' CG2' ' A' ' 157' ' ' ILE . 6.7 m -140.57 151.42 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.654 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -100.6 157.63 16.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.081 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.2 tt0 -128.61 116.87 20.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.105 . . . . 0.0 109.629 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -107.24 112.82 25.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 108.958 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -73.89 146.64 43.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.979 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.04 148.54 48.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.828 . . . . 0.0 109.072 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.11 165.98 12.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.494 ' CG ' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -101.1 134.79 43.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.453 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 64' ' ' THR . 1.4 m -131.65 149.07 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.444 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.26 125.25 41.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.274 -0.891 . . . . 0.0 109.385 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.78 160.76 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.875 . . . . 0.0 109.385 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -93.8 98.19 10.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -104.89 137.54 42.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.375 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.76 43.4 1.71 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.96 154.7 8.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 43' ' ' VAL . 8.4 t70 -144.88 -53.19 0.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -1.17 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 42' ' ' ASP . 95.8 t 43.77 81.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.487 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.17 -172.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 2.5 mp -93.81 57.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.342 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 47' ' ' ALA . . . 121.52 118.81 2.58 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 46' ' ' GLY . . . 169.18 49.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -1.112 . . . . 0.0 109.585 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -146.51 141.96 16.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 109.482 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.49 -89.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.628 2.219 . . . . 0.0 110.424 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -134.17 141.53 47.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.394 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.97 178.01 8.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -121.78 -25.13 5.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.0 t0 63.87 37.36 9.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 109.487 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -109.8 -63.59 1.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.87 . . . . 0.0 109.356 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 10.4 mm-40 64.63 -91.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.598 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -123.57 172.91 8.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 109.706 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -113.81 18.07 17.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.326 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.33 17.19 7.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 179.56 123.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -72.52 -69.36 0.41 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.358 -0.839 . . . . 0.0 109.62 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 163.62 55.44 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.43 124.59 28.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -1.135 . . . . 0.0 109.391 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.55 129.82 43.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 109.501 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.494 ' OG1' ' CG ' ' A' ' 34' ' ' MET . 9.0 t -83.16 139.96 32.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.424 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.73 156.43 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -0.88 . . . . 0.0 109.48 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -60.68 152.41 26.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.305 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 71' ' ' SER . 19.7 p30 -85.45 -17.77 35.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.975 . . . . 0.0 109.57 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.574 HD12 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.09 -41.75 16.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 108.716 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 74' ' ' LEU . 45.2 t -72.35 -36.69 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.411 -0.805 . . . . 0.0 109.286 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -69.61 -43.18 73.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -74.22 -27.94 61.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.936 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' C ' ' CD ' ' A' ' 73' ' ' ARG . 26.3 m-85 -114.39 16.66 17.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.458 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER 37.84 44.06 0.55 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.729 -0.607 . . . . 0.0 110.596 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.534 ' HB2' ' CG2' ' A' ' 69' ' ' VAL . 6.6 mt -49.44 142.85 7.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.997 -1.065 . . . . 0.0 108.566 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.485 ' OG ' HG21 ' A' ' 132' ' ' ILE . 3.4 p -128.96 107.7 18.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.992 -1.067 . . . . 0.0 109.463 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 131' ' ' TYR . 35.8 Cg_endo -78.21 134.04 12.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.454 2.103 . . . . 0.0 110.247 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -124.26 159.69 29.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.729 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.75 164.36 24.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -150.24 179.98 7.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.778 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.59 153.62 36.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.105 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.55 67.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.703 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.66 -31.32 65.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 109.529 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.5 m -66.15 -29.96 70.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.462 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 10.3 t80 -65.75 -36.87 84.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.703 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.452 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 3.1 mtt -64.66 -38.03 89.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 110.011 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -71.11 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.918 . . . . 0.0 110.496 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -77.27 -38.98 49.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 92' ' ' MET . 6.7 tp -76.34 -26.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.843 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -76.77 -56.38 4.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 109.673 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.18 -23.0 73.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 91' ' ' TYR . 30.1 t80 -81.34 -40.7 23.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.022 -1.281 . . . . 0.0 108.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -63.47 -40.54 97.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.24 -38.53 90.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.94 -46.59 78.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.025 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 29.2 mm -64.74 -40.39 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -51.61 -38.09 53.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.133 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.61 -39.13 64.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 0.0 109.68 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -59.9 -32.11 70.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.365 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.551 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 50.6 mt -73.08 -47.35 45.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -55.34 -36.89 66.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.751 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.59 -31.5 41.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.2 t -105.08 -78.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.723 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 59.3 t30 -119.83 107.94 39.59 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.26 -19.78 19.42 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.385 2.057 . . . . 0.0 110.381 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -74.14 -11.43 60.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.214 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -94.1 0.71 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.489 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 53.6 t -71.95 -43.23 10.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 111.29 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.5 Cg_endo -76.45 -52.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.877 1.718 . . . . 0.0 111.085 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.445 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 2.3 m -59.72 -36.99 69.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.997 -1.064 . . . . 0.0 109.587 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.476 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 44.9 t80 -69.67 -37.34 76.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.276 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.432 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -68.53 -48.78 63.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.868 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -49.47 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.057 . . . . 0.0 110.807 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 109' ' ' VAL . 2.5 m120 -64.49 -48.91 73.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.439 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -62.72 -32.09 73.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.432 HD11 ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -68.27 -39.63 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.402 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.59 -47.82 73.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.47 ' CE2' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -61.22 -42.09 97.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.988 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 71.8 t -60.13 -35.53 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.847 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -68.18 -38.13 81.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.933 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -78.83 -17.56 55.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.94 . . . . 0.0 109.897 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.44 -37.87 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 109.678 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 15.7 mt -62.34 -31.63 72.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 109.659 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.487 ' O ' ' ND2' ' A' ' 124' ' ' ASN . . . -54.1 -26.29 26.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.636 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 123' ' ' ALA . 12.4 m-80 -154.76 54.53 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 2.2 p90 -59.8 -22.13 61.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.639 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.444 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -76.58 -43.42 38.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -65.11 -26.39 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 4.9 m-85 -85.11 -12.24 53.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.338 -0.851 . . . . 0.0 109.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 128' ' ' TYR . 4.1 m-20 50.88 177.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.667 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.559 ' CE1' ' O ' ' A' ' 131' ' ' TYR . 2.7 t80 -139.07 121.23 15.79 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.559 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 9.1 m-85 -103.36 170.69 7.8 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.056 -1.028 . . . . 0.0 110.669 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.485 HG21 ' OG ' ' A' ' 75' ' ' SER . 2.0 tt -156.54 142.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.65 -178.94 51.87 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.402 ' OE1' ' HG2' ' A' ' 73' ' ' ARG . 3.6 mp0 -64.36 -19.45 65.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 136' ' ' MET . 82.6 p -56.01 -33.58 65.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 135' ' ' SER . 13.7 mmt 64.7 53.86 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.572 -0.705 . . . . 0.0 109.494 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.459 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 6.4 t0 -128.96 120.12 20.2 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.323 -0.86 . . . . 0.0 109.176 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.98 2.67 6.37 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.286 1.99 . . . . 0.0 110.559 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.78 12.94 11.45 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.275 -0.891 . . . . 0.0 109.197 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 137' ' ' ASP . . . -98.39 -156.87 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.447 ' HE2' ' HB2' ' A' ' 159' ' ' PHE . 0.0 OUTLIER -64.5 121.53 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.449 HG11 ' CE1' ' A' ' 130' ' ' PHE . 94.4 t -106.35 120.27 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.549 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.577 HG23 ' CE2' ' A' ' 158' ' ' PHE . 7.2 t -109.46 141.52 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.485 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 129' ' ' ASP . 53.1 mt -114.65 141.42 47.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.31 -0.869 . . . . 0.0 108.965 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.1 ttm -104.8 119.68 39.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.018 . . . . 0.0 109.522 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.568 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 44.6 t30 -138.09 146.72 43.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.541 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.9 OUTLIER -87.3 146.2 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.885 . . . . 0.0 109.541 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -58.75 -171.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.29 -17.46 64.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -53.49 4.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.541 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 114.89 -24.72 10.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.426 ' O ' HG21 ' A' ' 152' ' ' ILE . 1.3 tp -85.18 3.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.291 -1.123 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 m -123.67 101.18 36.94 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.6 122.82 5.13 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.509 2.14 . . . . 0.0 109.924 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 155' ' ' TYR . 5.9 p90 -141.03 148.66 40.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.28 158.6 26.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 109.022 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.536 ' CG2' HG22 ' A' ' 27' ' ' VAL . 41.6 mt -116.64 141.93 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 110.02 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.577 ' CE2' HG23 ' A' ' 143' ' ' VAL . 4.5 m-85 -126.3 113.69 17.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.458 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 8.0 m-85 -42.93 119.31 1.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.06 -28.58 67.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.865 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.477 ' N ' ' HG3' ' A' ' 160' ' ' LYS . 3.3 p30 -57.63 -39.7 77.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.443 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -105.93 43.04 1.76 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.459 ' CD2' ' C ' ' A' ' 163' ' ' LEU . 3.6 tt -142.47 125.76 16.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.44 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -112.77 157.42 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.543 ' HA ' ' CD1' ' A' ' 4' ' ' TYR . 1.7 m -101.49 139.21 37.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.08 123.17 33.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -90.57 139.32 30.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 167' ' ' LYS . 12.2 mt -99.02 154.07 18.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.644 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.4 mt -113.56 138.16 50.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.765 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 13.2 m-85 -116.5 108.45 16.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.104 -0.998 . . . . 0.0 109.585 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.08 163.46 12.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.493 -0.754 . . . . 0.0 109.345 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.506 ' OD1' ' CE ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -81.01 157.12 25.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 109.303 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.435 ' CG2' HG11 ' A' ' 164' ' ' VAL . 68.5 t -106.52 -18.82 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.975 . . . . 0.0 109.601 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.425 ' O ' HG21 ' A' ' 8' ' ' ILE . 1.2 mt -85.9 -25.06 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 109.267 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.84 -58.62 1.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.498 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.21 74.42 0.91 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -161.98 160.53 27.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -1.153 . . . . 0.0 109.51 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.7 129.24 36.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.718 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.05 -76.76 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.09 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 6.0 p -131.78 167.21 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.467 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 1.9 p -136.35 148.91 48.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.87 -1.144 . . . . 0.0 110.408 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.486 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 36.3 t70 -82.23 5.61 19.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.491 -0.756 . . . . 0.0 109.284 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.46 -24.09 67.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.893 . . . . 0.0 108.884 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.524 ' CE1' ' OD1' ' A' ' 67' ' ' ASN . 30.2 m-85 -100.13 21.19 13.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.548 -0.72 . . . . 0.0 109.604 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER 58.3 112.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 108.89 -179.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.486 ' CD1' ' HA ' ' A' ' 16' ' ' ASP . 12.2 mt -103.48 147.1 27.56 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 110.343 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -129.75 122.85 29.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.803 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -80.86 128.64 33.89 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ASP . 2.5 t -86.79 92.36 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 0.0 110.116 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 23' ' ' VAL . 23.5 m-20 22.89 45.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 120.848 0.356 . . . . 0.0 111.673 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' VAL . 18.6 m-20 -161.25 -114.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.943 -1.098 . . . . 0.0 109.684 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 160' ' ' LYS . 1.0 OUTLIER -144.71 12.9 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.809 -1.182 . . . . 0.0 109.427 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.456 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 12.3 m -104.41 133.68 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -98.51 151.23 20.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.314 -0.866 . . . . 0.0 109.077 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 mt-10 -117.41 117.44 29.48 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.514 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.433 ' HA ' HD21 ' A' ' 20' ' ' LEU . . . -96.75 112.62 24.3 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 4.7 m-20 -68.93 150.78 47.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 110.042 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.59 144.24 36.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.27 -0.894 . . . . 0.0 109.188 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 137.67 51.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 0.0 109.586 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.9 mmt -82.06 129.69 34.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.3 m -114.51 135.17 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.366 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.75 110.93 17.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.954 . . . . 0.0 109.525 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.0 132.68 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 38' ' ' LYS . 1.1 ptmm? -67.44 106.49 2.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.407 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -93.99 146.06 24.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.543 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.74 83.16 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 42' ' ' ASP . . . -100.72 -125.34 5.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 2.8 m-20 58.41 45.05 17.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -1.172 . . . . 0.0 109.368 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -112.49 6.02 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.662 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.9 t70 56.18 64.74 1.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.661 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 mm -134.74 -85.08 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.77 -114.88 0.4 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.96 141.09 35.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.182 -1.187 . . . . 0.0 109.481 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -54.18 144.83 38.01 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.425 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.4 95.31 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.57 2.18 . . . . 0.0 110.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t -75.84 -27.45 57.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.416 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.19 54.74 0.23 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -133.15 40.69 3.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.236 -0.915 . . . . 0.0 109.405 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -166.19 -40.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.861 . . . . 0.0 109.284 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.86 179.38 8.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.191 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -161.7 90.01 0.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.661 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 4.3 mt-10 61.47 60.93 1.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.903 . . . . 0.0 109.759 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -102.54 -31.89 10.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.235 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.74 146.31 52.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.252 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.18 38.32 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.497 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -136.61 7.17 3.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.534 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.8 64.43 0.43 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.7 p -108.88 -174.42 2.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 109.535 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -140.39 132.72 28.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 109.414 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -72.89 127.6 33.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.205 -0.934 . . . . 0.0 109.463 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.66 136.06 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.447 ' CG ' ' HB ' ' A' ' 69' ' ' VAL . 1.5 p30 -56.7 151.92 13.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 108.954 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.524 ' OD1' ' CE1' ' A' ' 18' ' ' TYR . 30.9 p30 -98.14 -15.01 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.87 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 48.9 tp -85.48 -41.57 15.23 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.148 -0.97 . . . . 0.0 108.989 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.478 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 66.6 t -72.77 -37.75 56.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.358 -0.839 . . . . 0.0 109.172 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -69.28 -48.89 60.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.453 -0.779 . . . . 0.0 110.295 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 t -69.4 -52.5 26.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.217 -0.927 . . . . 0.0 110.05 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 28.8 m-85 -75.19 -12.75 60.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.14 37.29 3.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 69' ' ' VAL . 9.3 mt -50.28 107.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.981 -1.074 . . . . 0.0 108.742 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.512 ' O ' ' CG2' ' A' ' 132' ' ' ILE . 0.6 OUTLIER -89.96 126.73 56.36 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.864 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.52 129.32 8.36 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.502 2.135 . . . . 0.0 110.16 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.12 135.81 37.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.088 -1.008 . . . . 0.0 109.656 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.5 m -64.54 -172.4 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.193 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -158.43 -176.94 6.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.082 -1.011 . . . . 0.0 109.592 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.537 ' CB ' ' HB2' ' A' ' 83' ' ' SER . 0.1 OUTLIER -114.69 142.09 46.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.454 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -44.97 95.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 110.153 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.61 -40.27 14.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.991 . . . . 0.0 110.427 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.537 ' HB2' ' CB ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -59.1 -29.48 67.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 109.59 -179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -56.9 -48.39 78.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.782 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mtt -64.05 -46.43 84.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.198 -0.939 . . . . 0.0 110.021 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 m -54.9 -37.05 65.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 109.97 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.57 ' CZ ' ' O ' ' A' ' 138' ' ' PRO . 24.1 t80 -76.47 -33.97 58.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 109.735 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' MET . 3.6 mm -71.42 -15.6 18.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.125 -0.984 . . . . 0.0 109.308 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -57.1 3.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.34 72.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -77.86 -36.8 49.51 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.282 -1.128 . . . . 0.0 108.395 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.524 ' CA ' ' HE1' ' A' ' 92' ' ' MET . 0.0 OUTLIER -62.44 -51.94 65.5 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -57.14 -38.82 74.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.487 -0.758 . . . . 0.0 109.293 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.76 -50.42 72.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.917 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.566 HG22 ' CZ ' ' A' ' 110' ' ' PHE . 30.3 mm -65.37 -28.97 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -44.78 93.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.192 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.468 ' HA ' ' HG2' ' A' ' 100' ' ' GLN . . . -69.3 -25.89 64.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -0.844 . . . . 0.0 109.102 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -71.27 -41.1 70.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.613 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.484 ' CD2' ' HB3' ' A' ' 106' ' ' ARG . 61.2 mt -72.79 -48.57 37.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.946 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -58.41 -31.77 68.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.741 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -79.24 -28.8 42.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.06 -1.025 . . . . 0.0 108.883 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.515 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 73.4 m -93.93 -79.02 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.4 -0.813 . . . . 0.0 109.015 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.95 140.36 26.64 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.832 . . . . 0.0 109.271 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -74.88 -17.25 20.03 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.654 2.236 . . . . 0.0 111.12 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -71.09 -8.95 56.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -0.967 . . . . 0.0 109.955 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.484 ' HB3' ' CD2' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -100.44 -5.06 27.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.117 -0.989 . . . . 0.0 109.793 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.588 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 3.1 t -69.18 -47.52 28.48 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.09 -1.006 . . . . 0.0 109.985 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 36.1 Cg_endo -78.54 -39.23 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.129 1.886 . . . . 0.0 110.876 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.09 -50.07 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.174 -0.953 . . . . 0.0 109.855 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.566 ' CZ ' HG22 ' A' ' 95' ' ' ILE . 60.2 t80 -68.81 -39.67 79.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.29 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 1.2 mm-40 -61.4 -43.47 98.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.119 -0.988 . . . . 0.0 110.406 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -70.39 -45.51 65.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.063 -1.023 . . . . 0.0 110.182 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 117' ' ' PHE . 3.8 t-20 -57.95 -38.7 76.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.159 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.515 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -71.02 -31.76 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 110.156 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.464 ' O ' ' HD2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -70.36 -48.89 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.134 -0.979 . . . . 0.0 109.747 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 120' ' ' LYS . . . -66.92 -49.31 55.41 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -58.14 -42.88 86.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.108 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 114' ' ' ALA . 53.3 t -57.28 -37.04 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.989 . . . . 0.0 110.023 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -71.01 -45.49 63.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.018 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 0.1 OUTLIER -56.67 -54.21 48.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.702 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.66 -53.68 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 0.0 109.347 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 42.9 mt -45.95 -48.05 16.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.729 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 120' ' ' LYS . . . -46.88 -45.86 20.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.43 ' HB3' ' OD1' ' A' ' 127' ' ' ASP . 7.1 m120 -139.42 66.14 1.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.524 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.85 -49.6 75.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -52.53 -28.6 21.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 109.776 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 124' ' ' ASN . 3.6 m-20 -77.75 -37.86 48.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 109.722 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 129' ' ' ASP . 27.4 m-85 -77.95 -14.65 59.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.648 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.4 OUTLIER 50.82 177.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.648 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 131' ' ' TYR . 2.0 t80 -136.78 121.3 18.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.828 . . . . 0.0 108.837 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.575 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 19.3 m-85 -107.75 175.78 5.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 110.871 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 75' ' ' SER . 18.6 tt -147.33 159.7 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.534 -0.729 . . . . 0.0 109.399 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -88.13 171.9 41.12 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -24.07 64.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -1.153 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.3 OUTLIER -59.68 -34.98 73.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.494 ' CB ' ' O ' ' A' ' 135' ' ' SER . 3.2 tpt 75.75 37.17 0.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.24 125.28 26.99 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.273 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.57 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 33.9 Cg_endo -75.44 -0.25 9.88 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.295 1.997 . . . . 0.0 110.35 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -105.65 -0.73 25.35 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.31 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 141' ' ' MET . . . -94.98 44.34 1.1 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.905 . . . . 0.0 109.617 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.506 ' CE ' ' OD1' ' A' ' 6' ' ' ASP . 2.3 mtp 67.42 140.84 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 109.688 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.566 ' CG1' ' CE1' ' A' ' 130' ' ' PHE . 19.0 m -112.73 141.32 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.267 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.57 HG13 ' CZ ' ' A' ' 158' ' ' PHE . 2.9 t -109.31 144.12 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 0.0 109.836 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.413 HD21 ' O ' ' A' ' 129' ' ' ASP . 25.0 mt -113.62 147.92 37.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.197 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.432 ' SD ' ' SD ' ' A' ' 156' ' ' MET . 5.2 tpp -116.71 123.0 46.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.866 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.54 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 13.9 t-20 -141.63 151.25 42.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.383 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -76.48 154.97 34.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.655 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -100.64 -172.66 2.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -28.62 63.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.27 -47.94 65.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.539 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 106.71 -34.66 5.56 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.503 HD11 ' N ' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -121.2 20.93 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -1.102 . . . . 0.0 109.191 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.3 m -117.01 101.5 53.34 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.339 -0.85 . . . . 0.0 109.361 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.68 129.06 8.99 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.5 2.133 . . . . 0.0 110.581 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 33.4 p90 -131.0 152.07 50.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 0.0 109.282 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.454 ' HB3' ' CG1' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -117.1 157.65 25.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.608 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.456 ' CG2' ' HB ' ' A' ' 27' ' ' VAL . 20.4 mt -115.39 137.12 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 109.616 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.57 ' CZ ' HG13 ' A' ' 143' ' ' VAL . 31.4 m-85 -129.22 141.71 51.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.087 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -75.24 117.57 17.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.896 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -68.44 -28.17 66.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 160' ' ' LYS . 0.8 OUTLIER -58.82 -18.92 36.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.748 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -125.72 39.88 1.96 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 158' ' ' PHE . 9.5 mt -137.57 149.5 46.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -1.221 . . . . 0.0 109.668 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.435 HG11 ' CG2' ' A' ' 7' ' ' VAL . 5.5 m -128.41 122.99 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.149 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.84 132.58 35.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.496 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -118.51 126.35 51.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.823 . . . . 0.0 109.221 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.439 ' HA ' ' CD2' ' A' ' 2' ' ' LEU . 0.9 OUTLIER -61.21 119.16 7.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.75 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.586 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 0.9 OUTLIER -68.82 149.44 48.96 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.23 -0.919 . . . . 0.0 109.852 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.0 mt -126.17 123.8 39.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.511 -0.743 . . . . 0.0 109.128 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.572 ' CE1' ' OG ' ' A' ' 165' ' ' SER . 30.3 m-85 -102.05 118.97 38.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 0.0 109.758 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 35.3 pttt -136.75 165.33 26.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.462 -0.774 . . . . 0.0 109.433 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 20.3 p30 -71.88 145.33 48.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 7' ' ' VAL . 14.9 p -107.81 43.22 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.474 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.431 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 1.1 tt -140.64 -38.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 27.1 t -104.89 -70.66 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.595 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 138.86 84.08 0.11 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 12' ' ' GLU . 19.2 t0 179.58 141.44 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -1.13 . . . . 0.0 109.336 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.545 ' HG3' ' CE2' ' A' ' 72' ' ' PHE . 1.2 pm0 -78.98 147.57 32.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.536 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 mt -130.9 -41.72 1.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.283 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.511 ' CG2' ' N ' ' A' ' 15' ' ' SER . 2.6 p -138.98 167.44 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.511 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -160.21 176.14 12.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.888 -1.132 . . . . 0.0 110.94 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.21 1.13 33.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.621 -0.674 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.52 -16.26 63.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.075 -1.016 . . . . 0.0 108.758 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.584 ' CE2' ' CD1' ' A' ' 68' ' ' LEU . 27.2 m-85 -122.56 19.31 10.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.463 -0.773 . . . . 0.0 109.081 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 18' ' ' TYR . 1.2 m-20 61.79 134.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 108.835 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.497 HD22 ' CG2' ' A' ' 14' ' ' VAL . 12.2 mt -126.44 155.04 42.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.199 -0.938 . . . . 0.0 110.119 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.508 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 12.6 mmtt -132.26 120.97 22.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.445 -0.784 . . . . 0.0 109.118 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -87.24 126.14 34.64 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.187 -0.946 . . . . 0.0 108.804 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 24' ' ' ASP . 3.4 t -76.63 158.43 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.591 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' VAL . 1.3 t0 -42.9 -33.17 0.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.418 -0.801 . . . . 0.0 109.313 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.486 ' HB3' ' ND2' ' A' ' 113' ' ' ASN . 5.4 m-20 -69.85 -140.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.069 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.484 ' CD1' ' OD1' ' A' ' 113' ' ' ASN . 1.5 pp -129.18 61.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.9 -1.125 . . . . 0.0 109.435 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 26' ' ' ILE . 11.6 m -146.12 147.61 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.773 . . . . 0.0 109.372 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.475 ' CE1' ' HB3' ' A' ' 22' ' ' GLU . 44.3 m-85 -103.89 158.52 16.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.508 ' CG ' ' HB2' ' A' ' 21' ' ' LYS . 11.2 pt-20 -130.2 129.4 43.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 109.57 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.503 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -111.77 134.4 53.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -0.929 . . . . 0.0 109.429 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -98.19 134.87 40.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.418 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 68' ' ' LEU . 63.1 m -110.36 155.86 21.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 109.731 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.71 138.71 53.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -0.846 . . . . 0.0 109.462 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.44 118.7 21.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.137 -0.977 . . . . 0.0 109.386 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.3 m -123.48 167.53 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.948 . . . . 0.0 109.636 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.3 t -111.2 149.03 31.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.901 . . . . 0.0 109.547 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.59 147.47 26.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.192 -0.943 . . . . 0.0 109.632 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.5 97.76 6.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.52 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -98.63 115.83 29.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.83 68.48 1.59 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 42' ' ' ASP . . . -157.14 -91.43 0.08 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER 72.75 34.38 1.18 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -1.16 . . . . 0.0 109.656 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.5 67.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 109.349 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.46 170.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 109.6 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 48.8 mm -122.48 9.71 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.06 137.89 6.23 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 48' ' ' ASN . . . -62.64 -163.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -1.154 . . . . 0.0 109.323 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 27.2 m-20 63.3 149.09 0.1 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.562 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.99 95.52 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.587 2.191 . . . . 0.0 110.346 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.8 m -131.67 35.41 3.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.77 149.99 22.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' N ' ' OE1' ' A' ' 52' ' ' GLU . 17.9 mp0 -140.8 125.18 17.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.369 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.6 108.92 15.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.367 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 55' ' ' GLU . . . -48.53 -54.3 14.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.421 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HG3' ' HG2' ' A' ' 56' ' ' GLU . 5.1 pt-20 176.37 -33.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.481 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' HG2' ' HG3' ' A' ' 55' ' ' GLU . 3.0 pt-20 -161.13 105.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -151.74 174.13 13.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.45 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.17 150.26 24.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -118.03 -62.34 1.56 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.322 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 87.2 mt-10 60.87 85.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.888 . . . . 0.0 109.637 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 62' ' ' THR . . . 140.82 87.71 0.12 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 61' ' ' GLY . 1.2 p 61.87 141.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.324 -1.103 . . . . 0.0 109.579 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -151.85 147.8 27.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.367 -0.833 . . . . 0.0 109.523 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.36 136.31 39.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 109.371 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.03 160.44 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.606 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.456 ' CB ' ' HB ' ' A' ' 69' ' ' VAL . 0.8 OUTLIER -59.54 154.14 18.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -89.25 -39.74 13.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.883 . . . . 0.0 109.634 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.584 ' CD1' ' CE2' ' A' ' 18' ' ' TYR . 25.4 tp -80.79 -34.76 33.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.082 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.49 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 94.5 t -67.45 -39.84 83.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.45 -0.781 . . . . 0.0 109.333 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -69.63 -52.22 27.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -28.55 70.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 0.0 110.545 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 68' ' ' LEU . 9.2 m-85 -102.97 -4.74 24.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.89 -1.131 . . . . 0.0 110.028 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.51 28.81 16.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.015 . . . . 0.0 109.852 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.491 ' N ' HD21 ' A' ' 74' ' ' LEU . 2.3 mm? -49.24 140.24 10.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.093 -1.005 . . . . 0.0 109.285 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.4 t -123.39 139.62 32.26 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 109.486 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.79 132.74 10.95 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.537 2.158 . . . . 0.0 110.145 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 p -128.18 165.76 19.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.417 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.28 129.73 3.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.517 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 17.0 t80 -141.6 160.38 40.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 109.452 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.57 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 40.3 m-20 -39.36 129.64 1.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.479 -0.763 . . . . 0.0 109.673 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.557 ' HG3' ' CE1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -61.63 -32.35 72.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.606 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -44.54 59.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 109.922 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 80' ' ' ASP . 10.8 t -62.91 -37.89 88.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.784 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.491 ' CE1' HG12 ' A' ' 88' ' ' ILE . 1.4 t80 -55.69 -35.83 66.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.235 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.461 ' O ' HG21 ' A' ' 88' ' ' ILE . 30.4 mtt -56.76 -48.26 78.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -0.954 . . . . 0.0 109.368 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.28 -45.38 91.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.18 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.438 ' O ' ' CD2' ' A' ' 91' ' ' TYR . 25.5 m-85 -68.04 -17.69 64.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.491 HG12 ' CE1' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -76.57 -30.2 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.491 ' N ' HG21 ' A' ' 88' ' ' ILE . 4.2 mmmm -79.17 -35.33 42.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.384 -0.822 . . . . 0.0 109.032 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.82 -36.58 87.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 87' ' ' TYR . 20.0 m-85 -78.48 -36.93 44.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.118 -1.225 . . . . 0.0 108.942 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.9 OUTLIER -62.38 -39.91 94.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 108.791 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -69.09 -34.33 74.93 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.1 73.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 109.164 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.483 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 47.1 mm -66.76 -36.12 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 109.23 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -35.49 75.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.161 -0.962 . . . . 0.0 109.255 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.52 -55.13 6.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.947 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.489 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -52.28 -33.1 40.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 109.936 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.489 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 83.6 mt -72.82 -45.11 60.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -56.55 -38.45 71.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -32.99 63.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 m -98.35 -72.49 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.823 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -140.7 119.06 8.21 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.52 -17.64 20.69 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.458 2.105 . . . . 0.0 110.745 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -68.99 -9.6 53.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.679 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.527 ' HA ' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -101.34 -5.78 24.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 109.603 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.623 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 51.9 t -71.34 -42.99 12.13 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 111.04 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.2 Cg_endo -76.97 -52.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.894 1.729 . . . . 0.0 110.984 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.527 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 15.6 m -55.87 -52.63 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.097 -1.002 . . . . 0.0 109.413 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.428 ' CD2' HG23 ' A' ' 95' ' ' ILE . 46.1 t80 -62.79 -37.04 85.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.116 -0.99 . . . . 0.0 109.177 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -54.13 -48.08 71.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 110.304 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 109' ' ' VAL . 1.0 OUTLIER -67.65 -36.12 80.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.05 -1.031 . . . . 0.0 110.179 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 25' ' ' ASP . 21.2 t-20 -67.5 -32.94 74.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.399 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -71.07 -29.82 65.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.157 -0.964 . . . . 0.0 109.889 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -40.21 73.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.231 -0.918 . . . . 0.0 108.985 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -67.56 -46.45 69.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.463 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -68.18 -30.74 69.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -1.154 . . . . 0.0 110.065 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 37.6 t -68.8 -50.59 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.095 -1.003 . . . . 0.0 109.509 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -65.97 -28.69 69.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 0.0 109.653 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.66 -60.75 2.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.147 -0.971 . . . . 0.0 109.609 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.564 ' HA ' ' CE2' ' A' ' 128' ' ' TYR . 1.2 mp -55.41 -37.65 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.441 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 45.5 mt -53.03 -42.29 65.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 109.603 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.88 -39.68 40.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 109.268 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.516 ' HB3' ' CB ' ' A' ' 127' ' ' ASP . 8.6 m120 -130.04 64.08 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.0 109.247 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.557 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 6.9 t80 -60.55 -38.98 86.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 109.856 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -77.23 -30.76 54.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 110.012 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.516 ' CB ' ' HB3' ' A' ' 124' ' ' ASN . 1.2 t70 -75.13 -23.83 57.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.986 . . . . 0.0 109.953 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.564 ' CE2' ' HA ' ' A' ' 121' ' ' ILE . 41.5 m-85 -94.03 -33.0 13.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.716 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.505 ' O ' ' CD2' ' A' ' 144' ' ' LEU . 92.1 m-20 53.87 -177.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -141.41 122.39 14.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 108.796 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -97.97 173.04 7.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.0 110.757 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 14.8 tt -156.59 138.21 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.651 -0.655 . . . . 0.0 109.268 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.06 170.88 8.04 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.29 -18.31 64.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -1.178 . . . . 0.0 109.355 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 136' ' ' MET . 4.8 t -60.54 -36.44 78.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 0.0 109.48 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.41 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 69.93 49.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.297 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.11 119.2 54.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.237 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.37 0.35 9.16 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.307 2.005 . . . . 0.0 110.239 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -100.55 -8.87 22.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.374 -0.829 . . . . 0.0 109.091 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.431 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -88.88 152.99 21.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -0.89 . . . . 0.0 109.286 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.489 ' CE ' ' HB2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -65.62 166.1 11.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.656 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.07 141.83 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.444 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.581 HG23 ' CE2' ' A' ' 158' ' ' PHE . 17.3 t -97.3 139.25 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.152 -0.968 . . . . 0.0 109.235 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.505 ' CD2' ' O ' ' A' ' 129' ' ' ASP . 17.6 mt -107.12 136.6 46.69 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.426 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.5 ' CE ' ' HE2' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.56 137.09 47.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.629 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.444 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 24.6 t-20 -152.16 164.34 37.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 109.534 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.42 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 2.6 m-85 -107.83 137.23 46.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.425 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.8 OUTLIER -65.56 167.06 9.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.284 -0.885 . . . . 0.0 109.387 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 148' ' ' ARG . 4.9 mt-10 -44.26 -28.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.444 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -50.43 70.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.516 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.42 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 101.18 -20.68 46.34 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.483 ' C ' ' CD1' ' A' ' 152' ' ' ILE . 2.0 pp -105.71 7.04 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -1.038 . . . . 0.0 109.366 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.2 m -114.08 101.34 53.92 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.236 -0.915 . . . . 0.0 109.26 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.2 119.24 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.443 2.095 . . . . 0.0 110.415 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 5.1 p90 -138.61 138.76 38.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.946 . . . . 0.0 109.465 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.508 ' N ' ' SD ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -116.92 149.59 39.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 109.174 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.492 ' C ' ' CD1' ' A' ' 158' ' ' PHE . 2.6 mt -105.89 149.12 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.617 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.581 ' CE2' HG23 ' A' ' 143' ' ' VAL . 6.0 m-85 -132.34 117.88 18.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 0.0 109.267 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.473 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 36.6 m-85 -53.67 121.65 8.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 109.375 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 8.1 tttt -66.84 -26.7 67.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.681 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 159' ' ' PHE . 0.4 OUTLIER -56.49 -43.99 80.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.331 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -108.41 27.93 12.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.526 HD23 ' N ' ' A' ' 164' ' ' VAL . 1.2 tm? -147.45 126.91 13.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.349 -1.089 . . . . 0.0 109.111 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.526 ' N ' HD23 ' A' ' 163' ' ' LEU . 10.8 m -135.72 155.95 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -88.85 150.45 22.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.449 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -142.57 122.59 13.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 109.313 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -90.46 146.03 24.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.39 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.501 ' CD2' ' HA ' ' A' ' 167' ' ' LYS . 12.7 mt -102.62 152.49 21.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 mt -107.54 146.49 31.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.84 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 8.3 m-85 -121.7 111.66 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 0.0 109.173 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.465 ' O ' HD22 ' A' ' 163' ' ' LEU . 15.8 mttm -114.48 156.68 24.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.68 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.0 155.9 21.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 p -92.07 -0.42 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.507 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 8' ' ' ILE . 47.6 mm -80.16 -58.68 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.686 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 10' ' ' GLY . 41.7 t -119.13 13.62 12.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' SER . . . 44.99 70.89 0.54 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.411 ' CG ' ' OG ' ' A' ' 135' ' ' SER . 15.0 t70 -137.85 138.35 39.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -1.07 . . . . 0.0 109.329 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' O ' HD21 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -44.83 143.82 1.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.47 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.476 HD13 ' CG2' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -134.32 -62.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.602 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 4.4 p -144.37 -178.85 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.91 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.7 m -149.45 165.38 32.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.723 -1.236 . . . . 0.0 110.602 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.42 ' CG ' HD13 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -86.19 7.98 22.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.498 -0.751 . . . . 0.0 109.503 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.82 -10.6 49.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.116 -0.99 . . . . 0.0 108.923 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.541 ' CE2' ' HG ' ' A' ' 68' ' ' LEU . 24.3 m-85 -121.03 21.54 11.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 0.0 109.147 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER 64.21 132.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 21.9 mt -126.14 142.79 51.38 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.216 -0.927 . . . . 0.0 110.052 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.04 140.14 50.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.465 -0.772 . . . . 0.0 109.42 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.14 112.92 24.94 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.259 -0.901 . . . . 0.0 108.903 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 24' ' ' ASP . 21.6 t -62.54 152.68 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.446 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.487 ' N ' HG11 ' A' ' 23' ' ' VAL . 67.4 m-20 -54.01 -19.6 5.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.668 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' O ' ' CG2' ' A' ' 26' ' ' ILE . 0.7 OUTLIER -75.46 -98.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.04 -1.038 . . . . 0.0 109.318 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.514 ' CG2' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -165.76 56.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.005 -1.06 . . . . 0.0 109.617 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 m -152.05 158.16 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.077 -1.014 . . . . 0.0 109.76 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.419 ' C ' ' HG2' ' A' ' 29' ' ' GLU . 6.0 m-85 -103.58 162.2 13.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 0.0 109.026 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.6 mm-40 -130.99 117.41 19.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.602 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -103.97 112.76 25.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 108.956 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 2.3 m-20 -77.92 150.47 34.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.824 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.441 ' SG ' ' HG2' ' A' ' 154' ' ' PRO . 1.7 p -125.46 175.72 7.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.871 . . . . 0.0 109.315 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.33 164.65 27.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 0.0 109.459 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.5 126.19 48.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.465 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.8 m -115.14 131.22 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.855 . . . . 0.0 109.544 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.77 112.65 24.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 0.0 109.311 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 m -129.28 133.29 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.621 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -76.15 92.94 3.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.243 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.433 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -119.65 131.88 55.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.537 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.47 -58.17 4.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 42' ' ' ASP . . . 104.1 -109.09 3.3 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' GLY . 46.4 m-20 44.13 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -1.154 . . . . 0.0 109.379 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 60' ' ' GLU . 9.0 p -81.5 -27.35 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.68 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.464 ' OD2' HG21 ' A' ' 45' ' ' ILE . 23.0 t70 -126.7 -89.07 0.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.651 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -165.02 -39.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 109.407 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -171.78 139.97 5.6 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 57.41 70.23 0.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.113 -1.227 . . . . 0.0 109.306 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -60.62 126.51 85.14 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.164 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 50' ' ' SER . 36.3 Cg_endo -79.14 68.93 8.13 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.303 2.002 . . . . 0.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 49' ' ' PRO . 4.4 t 75.62 97.94 0.07 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.143 -0.973 . . . . 0.0 109.296 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' GLU . . . -56.38 -170.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' ALA . 3.9 mm-40 60.93 96.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 109.659 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 44.93 -97.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.699 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' GLU . . . 54.06 84.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 109.561 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 49.18 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.951 . . . . 0.0 109.514 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.55 117.95 22.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.85 . . . . 0.0 109.505 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -154.56 28.79 0.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.72 -167.15 1.47 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.368 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -75.37 164.73 26.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.406 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 2.1 mt-10 -87.69 -31.39 19.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.81 27.59 2.72 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.3 p -105.48 155.76 18.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.315 -1.109 . . . . 0.0 109.445 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.459 ' OE1' ' CG1' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -135.31 113.81 11.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 109.516 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.1 t -76.67 130.37 37.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.218 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' CG1' ' OE1' ' A' ' 63' ' ' GLU . 33.4 m -128.42 125.6 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.907 . . . . 0.0 109.682 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -51.09 142.02 13.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.18 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 71' ' ' SER . 10.0 p30 -74.19 -21.48 59.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 109.739 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.541 ' HG ' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -81.47 -36.94 28.72 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.099 -1.001 . . . . 0.0 108.771 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 73' ' ' ARG . 41.7 t -71.33 -54.32 17.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.419 -0.801 . . . . 0.0 109.706 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -61.76 -41.31 97.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 0.0 110.142 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 5.0 t -68.4 -33.19 73.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.152 -0.968 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 73' ' ' ARG . 22.9 m-85 -110.08 13.32 23.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.04 -1.037 . . . . 0.0 109.996 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 69' ' ' VAL . 55.0 mtt180 43.41 69.42 0.4 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.155 -0.966 . . . . 0.0 109.481 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.489 ' N ' HD21 ' A' ' 74' ' ' LEU . 1.7 mm? -89.81 137.96 31.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.399 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.03 117.83 62.63 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.152 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.71 123.59 5.37 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.551 2.168 . . . . 0.0 110.631 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.474 HG21 ' O ' ' A' ' 130' ' ' PHE . 2.4 t -132.69 174.2 10.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 108.988 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -142.57 9.22 1.79 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.222 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' A' ' 79' ' ' PHE . 16.7 p90 -86.91 123.04 31.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.045 -1.035 . . . . 0.0 109.599 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -174.23 21.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.943 . . . . 0.0 110.54 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -63.58 -53.46 51.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.945 -1.097 . . . . 0.0 109.347 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.06 -24.67 4.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -29.89 67.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.118 -0.989 . . . . 0.0 109.165 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.558 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -58.84 -46.27 88.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 109.356 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.412 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -64.84 -30.04 71.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.262 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -71.16 -55.4 8.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.017 -1.052 . . . . 0.0 110.691 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.547 ' CD1' ' HG2' ' A' ' 138' ' ' PRO . 39.7 m-85 -63.91 -41.45 97.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.088 -1.007 . . . . 0.0 109.897 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.497 HG22 HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -68.84 -22.33 26.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 109.469 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -55.2 5.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.344 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.12 -19.89 68.52 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -81.12 -39.02 26.26 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.157 -1.202 . . . . 0.0 108.326 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.65 -40.69 92.75 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.69 -43.99 95.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 0.0 109.125 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.56 -50.09 68.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 108.886 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.495 ' CG2' ' OD1' ' A' ' 161' ' ' ASP . 41.9 mm -60.02 -32.07 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.224 -0.923 . . . . 0.0 108.682 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HG2' HG12 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -56.2 -50.32 71.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 108.948 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.82 77.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.154 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 101' ' ' GLU . 3.8 tmt_? -58.63 -43.84 89.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.126 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 95' ' ' ILE . 24.7 mt -64.67 -48.47 74.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.378 -0.826 . . . . 0.0 109.033 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -52.72 -25.26 10.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.198 -0.939 . . . . 0.0 108.827 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -76.32 -43.28 41.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 108.966 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.8 t -88.85 -71.77 0.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.191 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -148.04 137.25 11.95 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.04 -16.73 19.95 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.604 2.203 . . . . 0.0 111.066 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.52 -14.08 62.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.008 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 110' ' ' PHE . 12.8 ttp-105 -93.09 -5.94 49.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.664 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 62.9 t -71.21 -43.09 12.55 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 111.344 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.4 Cg_endo -77.38 -54.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.883 1.722 . . . . 0.0 110.99 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.418 ' CG2' ' N ' ' A' ' 110' ' ' PHE . 35.7 m -56.52 -46.0 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.114 -0.992 . . . . 0.0 110.007 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 62.5 t80 -65.06 -45.87 83.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.822 . . . . 0.0 110.696 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 115' ' ' ILE . 67.7 tt0 -57.28 -47.77 80.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.008 -1.057 . . . . 0.0 110.536 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -68.38 -31.69 71.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.058 -1.026 . . . . 0.0 110.345 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -66.36 -54.24 26.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 109.913 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.57 -26.55 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.988 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 111' ' ' GLU . 4.1 mm -62.29 -49.08 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.127 -0.983 . . . . 0.0 109.162 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.96 -41.04 99.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -35.2 75.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.25 -1.147 . . . . 0.0 109.602 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.58 -38.06 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 109.561 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 115' ' ' ILE . 3.3 mmtt -64.34 -29.66 70.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 109.801 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -81.83 -46.9 13.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 109.893 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.2 OUTLIER -53.98 -37.86 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.16 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.02 -45.87 86.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.122 -0.986 . . . . 0.0 109.424 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -48.05 -39.66 20.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.868 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -136.43 45.65 2.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.146 -0.971 . . . . 0.0 109.735 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 10.1 p90 -63.02 -22.86 67.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.443 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.413 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -70.95 -47.02 61.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.547 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 2.0 m-20 -71.13 -23.57 62.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.342 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.53 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 6.3 m-85 -76.45 -10.72 59.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.513 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 50.94 -172.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.946 . . . . 0.0 109.451 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.474 ' O ' HG21 ' A' ' 77' ' ' THR . 0.3 OUTLIER -149.22 121.68 8.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -107.4 166.81 10.38 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.035 -1.041 . . . . 0.0 110.38 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' A' ' 136' ' ' MET . 7.6 tt -146.79 130.51 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.405 -0.809 . . . . 0.0 109.477 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.56 179.16 3.87 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.08 -23.27 67.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -1.127 . . . . 0.0 109.453 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 136' ' ' MET . 7.2 m -58.71 -34.58 71.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.511 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 76.81 20.4 1.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.308 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -114.62 119.58 39.37 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.242 -0.911 . . . . 0.0 109.276 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 87' ' ' TYR . 33.4 Cg_endo -75.4 -5.51 16.7 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.262 1.974 . . . . 0.0 110.303 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 8' ' ' ILE . 2.4 p30 -95.38 -4.88 44.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 0.0 109.143 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' A' ' 141' ' ' MET . . . -98.45 47.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.53 ' CB ' ' O ' ' A' ' 140' ' ' ALA . 27.3 ttm 79.66 115.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.759 -0.588 . . . . 0.0 109.606 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.15 130.59 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.351 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.586 HG23 ' CE2' ' A' ' 158' ' ' PHE . 3.0 t -99.84 138.82 23.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.271 -0.893 . . . . 0.0 109.069 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 128' ' ' TYR . 18.6 mt -115.0 146.49 41.19 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.229 -0.92 . . . . 0.0 109.622 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.413 ' HG2' ' HG2' ' A' ' 156' ' ' MET . 0.0 OUTLIER -109.3 124.79 51.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.329 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.53 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 24.3 t-20 -138.31 140.22 39.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.5 OUTLIER -77.8 147.04 35.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -0.845 . . . . 0.0 109.563 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -79.22 178.42 8.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.0 -25.36 8.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.45 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.426 ' OD2' HG13 ' A' ' 152' ' ' ILE . 31.9 t0 -72.17 -47.99 46.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 0.0 109.397 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 105.33 -28.61 13.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.469 ' C ' ' CD1' ' A' ' 152' ' ' ILE . 2.3 pp -99.78 11.51 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -1.153 . . . . 0.0 109.641 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.1 m -121.49 100.59 44.34 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.158 -0.964 . . . . 0.0 109.428 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.441 ' HG2' ' SG ' ' A' ' 32' ' ' CYS . 36.9 Cg_endo -81.22 131.02 7.49 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.554 2.169 . . . . 0.0 110.502 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 146' ' ' ASN . 32.9 p90 -135.18 144.49 47.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.377 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.483 ' HB3' ' CG1' ' A' ' 143' ' ' VAL . 2.0 mtt -107.93 163.91 12.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 109.888 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.46 ' O ' HG12 ' A' ' 143' ' ' VAL . 8.0 mt -124.15 139.36 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 109.384 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.586 ' CE2' HG23 ' A' ' 143' ' ' VAL . 52.7 m-85 -129.97 116.0 17.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.452 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 2.2 m-85 -43.15 116.81 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.263 -0.898 . . . . 0.0 109.746 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -68.65 -42.59 77.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.825 . . . . 0.0 109.979 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 95' ' ' ILE . 3.5 t70 -47.22 -35.79 8.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.467 ' O ' ' HE3' ' A' ' 141' ' ' MET . . . -110.74 50.26 0.78 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.465 HD22 ' O ' ' A' ' 5' ' ' LYS . 3.8 mt -134.16 154.96 50.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.237 . . . . 0.0 109.68 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.2 m -143.27 125.83 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 59.4 m -82.59 135.55 35.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -127.72 124.9 38.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.892 . . . . 0.0 109.574 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.501 ' HA ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -68.5 117.17 9.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.445 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.494 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttm . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 167' ' ' LYS . 12.6 mt -112.5 151.5 29.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 109.641 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 3' ' ' LEU . 32.4 mt -105.92 122.93 47.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 3.6 m-85 -103.92 117.88 35.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.942 . . . . 0.0 109.185 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -129.63 143.27 50.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.644 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' OD1' ' CD2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -74.35 156.77 36.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.529 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 7' ' ' VAL . 93.2 t -98.72 -6.45 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.356 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.522 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 3.1 mt -101.47 -61.31 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 109.651 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 8' ' ' ILE . 10.3 t -43.23 -47.39 6.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.57 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.96 -63.65 0.37 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.87 65.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -1.19 . . . . 0.0 109.52 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 179.37 141.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.429 ' CD2' ' OD1' ' A' ' 6' ' ' ASP . 23.9 tp -171.96 -75.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 0.0 109.62 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.507 HG23 ' CB ' ' A' ' 30' ' ' ALA . 3.2 p -153.18 -172.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 108.972 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.5 p -162.57 174.27 12.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.843 -1.161 . . . . 0.0 110.168 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.47 ' CA ' HD13 ' A' ' 20' ' ' LEU . 37.5 t70 -82.95 10.98 6.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.399 -0.813 . . . . 0.0 109.988 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.08 -9.67 33.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 109.227 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 39.4 m-85 -126.77 21.56 6.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.243 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 14.9 m-20 67.96 130.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 34.8 mt -126.31 147.89 49.64 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.178 -0.951 . . . . 0.0 110.371 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 136.8 44.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.504 -0.747 . . . . 0.0 109.381 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 1.1 tt0 -99.24 113.17 25.29 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.264 -0.898 . . . . 0.0 108.837 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.485 HG11 ' N ' ' A' ' 24' ' ' ASP . 33.2 t -62.36 157.69 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.222 -0.924 . . . . 0.0 109.574 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' N ' HG11 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -43.73 -28.37 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.247 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -75.24 -143.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 108.998 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 160' ' ' LYS . 1.0 OUTLIER -123.41 54.58 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.054 -1.029 . . . . 0.0 109.591 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.42 HG11 ' C ' ' A' ' 26' ' ' ILE . 5.2 m -136.86 153.84 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 109.473 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.407 ' CD2' ' HE2' ' A' ' 4' ' ' TYR . 4.3 m-85 -107.27 163.16 13.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.308 -0.87 . . . . 0.0 109.222 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 47.6 mt-10 -128.98 119.91 25.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.507 ' CB ' HG23 ' A' ' 14' ' ' VAL . . . -114.86 112.52 22.88 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 11.1 m-20 -75.01 145.62 42.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 t -104.21 125.89 50.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.415 -0.803 . . . . 0.0 108.944 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -106.63 154.64 20.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.104 -0.998 . . . . 0.0 109.969 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.3 mmm -103.5 135.12 45.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 108.808 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.54 174.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.067 -1.021 . . . . 0.0 109.802 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.525 HG23 ' CG2' ' A' ' 62' ' ' THR . 1.5 p -93.84 118.35 31.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.378 -0.826 . . . . 0.0 109.278 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 37' ' ' VAL . 15.5 m -123.71 125.95 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 99.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.341 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -81.75 115.95 21.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.915 . . . . 0.0 109.563 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.04 26.24 21.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.54 144.34 35.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -147.85 43.4 1.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -1.191 . . . . 0.0 109.496 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.27 -17.14 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.729 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.479 ' O ' HG21 ' A' ' 45' ' ' ILE . 31.1 m-20 -80.67 -16.94 52.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 109.392 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.491 ' O ' HG21 ' A' ' 45' ' ' ILE . 3.1 tp 38.64 60.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.619 -0.676 . . . . 0.0 110.287 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.83 144.07 35.33 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.95 109.63 10.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -1.225 . . . . 0.0 109.475 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.41 147.13 34.72 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.447 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 -86.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.612 2.208 . . . . 0.0 110.238 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 26.2 t -105.64 -64.46 1.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 109.445 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 50' ' ' SER . . . 174.53 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.833 . . . . 0.0 109.457 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -102.34 61.71 0.85 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.158 -0.964 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.76 173.08 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.582 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.96 154.81 29.28 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.905 . . . . 0.0 109.406 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 3.9 tt0 -50.02 -27.69 5.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.59 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.2 pt-20 179.52 177.35 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 109.689 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' GLU . 29.3 m120 43.73 79.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.866 . . . . 0.0 109.427 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -158.07 -161.42 1.01 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.95 . . . . 0.0 109.635 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -44.53 153.44 0.16 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 109.701 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 56.34 66.41 1.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 109.673 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 62' ' ' THR . . . 149.14 57.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.525 ' CG2' HG23 ' A' ' 36' ' ' THR . 5.8 t -56.43 -163.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -1.142 . . . . 0.0 109.284 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.56 140.78 26.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -0.955 . . . . 0.0 109.507 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.01 125.4 30.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.6 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.1 159.43 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 109.485 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.458 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 32.8 m120 -54.25 143.32 23.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.891 . . . . 0.0 109.525 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 32.3 t-20 -92.71 -26.18 17.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.707 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.458 HD12 HG21 ' A' ' 14' ' ' VAL . 49.7 tp -87.78 -47.79 8.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 108.749 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 74' ' ' LEU . 50.7 t -60.42 -47.88 90.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -69.29 -47.59 64.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 110.139 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 t -49.4 -52.25 29.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.561 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.428 ' CD1' HD13 ' A' ' 68' ' ' LEU . 72.5 m-85 -102.12 8.48 40.71 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.046 -1.033 . . . . 0.0 110.178 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.24 95.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.023 . . . . 0.0 109.263 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.467 ' HB2' HG11 ' A' ' 69' ' ' VAL . 3.9 mm? -114.31 139.13 49.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.336 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 t -125.92 124.06 24.68 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 109.397 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.85 157.81 27.59 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.398 2.065 . . . . 0.0 110.263 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -93.87 -174.27 3.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 109.391 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.1 4.42 2.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.702 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 79' ' ' PHE . 14.1 t80 -160.34 124.26 3.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.481 ' HB2' ' CD2' ' A' ' 130' ' ' PHE . 0.3 OUTLIER -161.56 23.74 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.328 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -53.17 61.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -23.7 11.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.315 -0.866 . . . . 0.0 109.331 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.6 m -72.02 -31.45 66.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.457 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 3.9 t80 -58.83 -36.65 74.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.604 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.42 ' O ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -63.37 -53.04 58.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.73 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.3 m -61.62 -28.56 69.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.872 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 91' ' ' TYR . 10.9 m-85 -69.63 -46.3 66.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.092 -1.005 . . . . 0.0 109.749 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.469 HG21 ' N ' ' A' ' 89' ' ' LYS . 5.9 tp -65.12 -24.58 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.279 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.469 ' N ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -74.35 -46.85 38.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.766 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.94 -27.1 72.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 87' ' ' TYR . 21.1 m-85 -81.21 -36.75 29.67 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.083 -1.245 . . . . 0.0 109.307 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.483 ' CE ' ' O ' ' A' ' 92' ' ' MET . 0.0 OUTLIER -63.76 -41.32 98.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.89 . . . . 0.0 109.863 -179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -73.45 -40.9 63.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.958 . . . . 0.0 109.723 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -44.47 73.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.613 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.459 HD13 ' OD1' ' A' ' 161' ' ' ASP . 49.2 mm -62.15 -37.41 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.491 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -50.68 61.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.87 . . . . 0.0 109.29 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.89 -27.89 68.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.385 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.569 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.41 -36.49 82.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.316 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.569 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 33.3 mt -72.59 -50.45 25.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.127 -0.983 . . . . 0.0 109.616 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -51.51 -34.19 35.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.304 -0.872 . . . . 0.0 109.0 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.2 -37.09 72.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 109.056 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.5 m -96.95 -82.04 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.378 -0.826 . . . . 0.0 109.601 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.509 ' OD1' ' CG ' ' A' ' 105' ' ' GLU . 3.1 p30 -132.0 134.69 25.49 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.64 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.15 -19.01 17.95 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.503 2.135 . . . . 0.0 110.854 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.509 ' CG ' ' OD1' ' A' ' 103' ' ' ASN . 16.2 pt-20 -68.87 -8.76 46.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 0.0 109.861 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -93.92 -3.53 51.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.994 . . . . 0.0 109.782 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 25.8 t -72.4 -45.02 10.29 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 111.015 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.2 Cg_endo -77.41 -47.39 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.989 1.793 . . . . 0.0 111.156 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 110' ' ' PHE . 1.4 p -63.51 -44.68 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 109.598 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.532 ' N ' ' CG1' ' A' ' 109' ' ' VAL . 49.0 t80 -64.5 -41.0 96.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.501 -0.749 . . . . 0.0 110.34 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -40.37 94.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.015 -1.053 . . . . 0.0 110.338 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -48.98 45.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.045 -1.034 . . . . 0.0 110.783 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.41 -54.62 43.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.054 -1.029 . . . . 0.0 110.465 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -60.71 -26.71 67.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.001 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -49.15 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.086 -1.009 . . . . 0.0 109.286 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.37 -33.59 82.57 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.493 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.1 OUTLIER -63.6 -45.46 90.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -1.13 . . . . 0.0 109.969 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 114' ' ' ALA . 60.6 t -53.78 -38.62 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.326 -0.859 . . . . 0.0 110.657 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -71.19 -49.29 45.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 110.562 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 117' ' ' PHE . 0.1 OUTLIER -73.0 -11.18 60.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.028 -1.045 . . . . 0.0 110.27 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.5 HG21 ' N ' ' A' ' 122' ' ' LEU . 0.8 OUTLIER -83.2 -44.57 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.06 -1.025 . . . . 0.0 109.665 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.5 ' N ' HG21 ' A' ' 121' ' ' ILE . 40.0 mt -53.64 -36.4 62.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 109.964 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 122' ' ' LEU . . . -45.1 -39.39 5.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 109.719 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.564 ' O ' ' CE1' ' A' ' 128' ' ' TYR . 35.2 m-80 -113.0 50.71 0.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 109.939 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.64 ' HA ' ' CE1' ' A' ' 128' ' ' TYR . 53.7 t80 -64.02 -54.13 39.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.175 -0.953 . . . . 0.0 109.991 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.48 -5.46 58.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -0.904 . . . . 0.0 109.086 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 124' ' ' ASN . 15.8 m-20 -80.73 -41.53 23.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.84 . . . . 0.0 109.908 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.64 ' CE1' ' HA ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -102.03 10.78 39.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.086 . . . . 0.0 110.727 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 0.3 OUTLIER 43.86 -151.75 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.196 -0.94 . . . . 0.0 109.345 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.576 ' CE1' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -149.59 121.25 8.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 108.991 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.462 ' CE1' ' SD ' ' A' ' 145' ' ' MET . 13.2 m-85 -104.19 164.76 11.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.146 -0.971 . . . . 0.0 110.36 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.466 ' O ' HG21 ' A' ' 132' ' ' ILE . 12.8 tt -157.11 135.87 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.421 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -48.24 156.14 1.19 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -17.71 16.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.152 . . . . 0.0 109.522 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.1 OUTLIER -57.68 -38.92 75.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.214 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.491 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.1 OUTLIER 74.72 27.16 1.3 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 0.0 109.603 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.24 114.27 51.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 136' ' ' MET . 33.8 Cg_endo -74.49 1.69 7.16 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.336 2.024 . . . . 0.0 110.392 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 62.6 t0 -121.54 15.43 11.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.353 -0.842 . . . . 0.0 109.119 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.522 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -97.69 -94.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.867 . . . . 0.0 109.726 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 142' ' ' VAL . 9.1 tmm? -163.11 139.13 7.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 109.56 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.454 ' O ' ' SD ' ' A' ' 141' ' ' MET . 5.6 m -104.41 135.25 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.56 HG23 ' CE2' ' A' ' 158' ' ' PHE . 4.3 t -103.55 130.01 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.167 -0.958 . . . . 0.0 109.469 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.0 mt -88.99 152.41 21.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.846 . . . . 0.0 109.324 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.462 ' SD ' ' CE1' ' A' ' 131' ' ' TYR . 1.4 ttt -111.92 115.48 29.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 109.539 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 155' ' ' TYR . 1.5 m-20 -121.0 165.88 14.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' A' ' 151' ' ' GLY . 0.1 OUTLIER -107.64 135.52 48.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.464 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 153' ' ' THR . 3.3 ttp180 -60.32 173.22 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 109.453 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.38 -31.27 65.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.336 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.46 -46.8 68.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.855 . . . . 0.0 109.348 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.56 ' O ' ' CE1' ' A' ' 147' ' ' TYR . . . 102.09 -28.49 15.7 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 tp -87.45 -10.98 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -1.093 . . . . 0.0 109.24 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 148' ' ' ARG . 2.9 m -115.45 102.13 54.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.401 -0.812 . . . . 0.0 109.34 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.39 143.6 22.16 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.425 2.083 . . . . 0.0 110.3 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 146' ' ' ASN . 6.4 p90 -143.43 144.98 32.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.454 ' SD ' ' HE1' ' A' ' 145' ' ' MET . 1.5 mtm -110.21 166.96 10.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.346 -0.846 . . . . 0.0 109.177 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 157' ' ' ILE . 3.6 mt -131.55 139.37 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.56 ' CE2' HG23 ' A' ' 143' ' ' VAL . 29.9 m-85 -123.09 153.81 39.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.336 -0.853 . . . . 0.0 109.302 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -75.76 113.93 13.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 26' ' ' ILE . 1.7 tttt -60.35 -44.43 95.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 109.369 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.459 ' OD1' HD13 ' A' ' 95' ' ' ILE . 3.3 p30 -49.38 -38.89 30.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.188 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -104.64 47.55 1.06 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.9 tt -151.68 126.77 9.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.437 -1.037 . . . . 0.0 109.31 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.27 140.55 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.915 . . . . 0.0 109.575 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.99 134.38 47.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.464 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.83 126.78 53.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.893 . . . . 0.0 109.416 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.42 ' HA ' HD21 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -67.09 123.12 19.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.413 -0.804 . . . . 0.0 109.416 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.484 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.36 152.89 26.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.694 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.1 mt -114.98 143.44 45.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.493 -0.754 . . . . 0.0 109.078 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.45 ' HB2' HG11 ' A' ' 14' ' ' VAL . 53.0 m-85 -120.47 112.87 19.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.511 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 6' ' ' ASP . 10.5 ttpt -117.6 157.48 26.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.582 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.524 ' OD2' ' CE ' ' A' ' 141' ' ' MET . 2.0 t70 -92.67 155.27 17.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.343 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 8' ' ' ILE . 12.1 m -97.44 -38.87 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.473 ' N ' HG22 ' A' ' 7' ' ' VAL . 4.7 mt -46.65 -79.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.867 . . . . 0.0 109.301 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.24 31.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.919 . . . . 0.0 109.523 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.86 68.13 0.28 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 12' ' ' GLU . 10.1 p30 -52.3 143.81 14.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -1.166 . . . . 0.0 109.429 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 11' ' ' ASP . 44.0 mm-40 58.87 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 6' ' ' ASP . 0.4 OUTLIER -121.82 -74.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.303 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.584 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 7.9 p -149.66 175.4 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 108.95 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -138.21 165.83 25.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.862 -1.148 . . . . 0.0 110.754 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.486 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -85.2 8.88 16.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 0.0 109.77 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.94 -25.14 66.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.027 . . . . 0.0 108.961 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.544 ' CE2' HD11 ' A' ' 68' ' ' LEU . 47.2 m-85 -102.47 21.94 14.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.116 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER 60.31 122.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.5 -0.75 . . . . 0.0 109.161 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.51 ' CD2' ' CB ' ' A' ' 30' ' ' ALA . 22.9 mt -116.04 152.12 34.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.34 -0.85 . . . . 0.0 109.878 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HB2' ' OE2' ' A' ' 29' ' ' GLU . 1.7 mptp? -131.19 148.93 52.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -0.863 . . . . 0.0 109.746 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.38 125.36 36.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.834 . . . . 0.0 109.201 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 27' ' ' VAL . 15.8 t -78.09 148.48 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.729 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' VAL . 76.0 m-20 -44.13 -31.84 1.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.397 -0.815 . . . . 0.0 109.752 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 26' ' ' ILE . 6.5 m-20 -73.47 -101.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -164.66 59.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.041 -1.037 . . . . 0.0 109.382 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 23' ' ' VAL . 18.7 m -145.46 167.78 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.635 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -111.42 144.81 40.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.854 . . . . 0.0 109.353 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.7 pt-20 -117.06 125.11 50.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.014 -1.054 . . . . 0.0 109.317 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.584 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -113.6 112.73 24.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.441 -0.787 . . . . 0.0 108.944 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -67.18 149.62 50.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.35 -0.844 . . . . 0.0 109.893 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.424 ' SG ' ' SD ' ' A' ' 156' ' ' MET . 26.9 p -142.92 174.52 10.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.408 -0.808 . . . . 0.0 109.293 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -115.56 163.32 15.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.74 120.56 38.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.319 -0.863 . . . . 0.0 109.291 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 65' ' ' VAL . 2.6 m -118.66 138.33 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.361 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.417 ' HA ' HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -88.43 134.72 33.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 m -137.31 155.59 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.341 -0.849 . . . . 0.0 109.28 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -115.48 109.93 18.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 109.518 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 40' ' ' GLY . 20.8 mt-30 -99.13 160.55 14.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.39 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 39' ' ' GLN . . . -44.22 -67.65 1.04 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.33 -81.49 0.13 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.05 99.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -1.153 . . . . 0.0 109.469 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -71.82 -33.98 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.589 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -89.74 102.14 14.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.737 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.476 ' CD1' ' OE2' ' A' ' 55' ' ' GLU . 19.5 tt -137.27 23.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 109.388 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.59 178.43 0.27 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 48' ' ' ASN . . . 59.48 -175.72 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -1.149 . . . . 0.0 109.474 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 4.4 m-20 64.31 146.54 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.433 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.18 173.65 13.59 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.573 2.182 . . . . 0.0 110.482 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.89 178.93 4.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.92 . . . . 0.0 109.396 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.44 179.91 7.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.22 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.8 -37.96 64.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -106.06 117.31 33.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 56.85 -179.91 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.875 . . . . 0.0 109.263 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.476 ' OE2' ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -85.87 -59.72 2.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.58 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.55 -171.54 2.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.86 -171.38 2.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.456 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 66.75 86.17 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.64 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.72 122.66 3.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.192 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -126.71 59.33 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.16 -0.963 . . . . 0.0 109.838 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.49 -105.3 2.22 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.1 p -69.5 167.51 16.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -1.184 . . . . 0.0 109.087 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 63' ' ' GLU . 1.6 pm0 -147.73 139.38 23.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.131 -0.98 . . . . 0.0 109.737 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.417 HG21 ' HA ' ' A' ' 36' ' ' THR . 0.9 OUTLIER -93.09 144.36 25.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 109.414 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.466 ' O ' HG21 ' A' ' 35' ' ' VAL . 32.7 m -126.25 131.7 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.504 ' ND2' ' SD ' ' A' ' 145' ' ' MET . 11.9 m120 -71.42 131.61 43.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.489 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -46.88 -24.47 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.694 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.544 HD11 ' CE2' ' A' ' 18' ' ' TYR . 31.4 tp -82.25 -42.73 18.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.039 -1.038 . . . . 0.0 108.49 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 74' ' ' LEU . 3.1 t -54.96 -56.1 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.473 -0.767 . . . . 0.0 108.954 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 70' ' ' TYR . 4.2 t80 -61.38 -41.34 96.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 109.92 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.94 -45.47 64.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.044 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.43 ' CD2' HD13 ' A' ' 68' ' ' LEU . 60.3 m-85 -111.74 19.83 17.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 109.882 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.63 82.58 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.938 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.515 ' HB2' HG12 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -95.22 169.76 9.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 108.824 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 132' ' ' ILE . 1.8 m -128.18 102.96 20.88 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.975 -1.078 . . . . 0.0 110.044 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.448 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 36.3 Cg_endo -80.0 118.37 3.71 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.489 2.126 . . . . 0.0 110.135 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.0 t -87.93 161.33 17.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.304 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 t -125.95 4.86 7.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 109.81 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 79' ' ' PHE . 6.5 t80 -138.62 128.35 24.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 109.711 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.529 ' OD2' ' CE1' ' A' ' 130' ' ' PHE . 4.4 p-10 169.96 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.766 . . . . 0.0 109.454 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -62.36 -42.97 99.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 109.237 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -113.76 -28.65 7.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.492 -0.755 . . . . 0.0 109.09 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -29.09 67.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.324 -0.86 . . . . 0.0 109.317 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.474 ' HB2' ' HB2' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -55.11 -48.96 72.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.488 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.42 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -64.26 -29.86 70.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 109.993 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -55.24 18.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 88' ' ' ILE . 21.6 m-85 -70.7 -58.25 3.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 109.845 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -42.74 -37.9 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 109.573 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 15.2 mmtp -63.07 -52.69 61.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.356 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.65 -20.26 56.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.602 ' CE2' ' CB ' ' A' ' 141' ' ' MET . 2.8 t80 -77.88 -36.45 49.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.212 -1.17 . . . . 0.0 108.484 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.479 ' O ' ' HE1' ' A' ' 92' ' ' MET . 0.0 OUTLIER -64.99 -42.14 94.79 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 4.5 mptt -67.1 -32.02 72.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.588 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.38 89.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.026 -1.046 . . . . 0.0 109.702 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.572 HG22 ' CZ ' ' A' ' 110' ' ' PHE . 34.8 mm -57.57 -45.44 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.172 -0.955 . . . . 0.0 109.749 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.542 ' HG3' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -48.09 -33.47 8.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 109.09 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.542 ' N ' ' HG3' ' A' ' 96' ' ' LYS . . . -73.04 -46.82 49.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 108.998 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.434 ' HD3' ' CD2' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -50.54 -38.05 42.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.143 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 95' ' ' ILE . 1.4 mt -69.92 -44.9 68.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.406 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -51.88 -30.27 23.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.331 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 97' ' ' ALA . 6.9 mt-10 -78.71 -39.26 37.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.156 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.54 -82.51 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.274 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -135.93 135.88 22.27 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 107' ' ' VAL . 33.8 Cg_endo -74.84 -14.84 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.593 2.195 . . . . 0.0 110.748 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.74 -13.54 61.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.854 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -89.56 -11.42 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.119 -0.988 . . . . 0.0 109.764 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 7.9 t -65.12 -44.39 70.02 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 111.203 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.4 Cg_endo -76.55 -58.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.933 1.756 . . . . 0.0 110.984 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.445 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 15.8 m -55.9 -43.93 76.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.067 -1.02 . . . . 0.0 109.592 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.572 ' CZ ' HG22 ' A' ' 95' ' ' ILE . 43.7 t80 -58.64 -49.63 76.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.734 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -57.25 -29.91 64.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.115 -0.991 . . . . 0.0 110.175 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -49.16 40.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.152 -0.968 . . . . 0.0 111.569 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.537 ' ND2' ' N ' ' A' ' 114' ' ' ALA . 1.7 p-10 -72.19 -46.73 55.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.847 -1.158 . . . . 0.0 110.733 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.537 ' N ' ' ND2' ' A' ' 113' ' ' ASN . . . -54.93 -46.82 74.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.066 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -53.36 -44.09 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.874 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.46 -41.21 96.47 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.472 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.72 -37.29 78.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -1.179 . . . . 0.0 110.028 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 47.8 t -63.89 -45.21 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.356 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.505 ' CD ' ' C ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -66.13 -28.87 69.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.984 . . . . 0.0 109.611 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -67.55 -49.13 64.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.983 . . . . 0.0 110.0 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.537 HG12 ' CD1' ' A' ' 144' ' ' LEU . 1.6 mp -70.18 -32.01 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 109.699 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 43.5 mt -57.16 -30.47 64.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.696 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.51 -48.32 62.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 109.773 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.448 ' HB3' ' OD2' ' A' ' 127' ' ' ASP . 1.5 m-80 -139.57 69.56 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -63.15 -21.59 66.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -62.93 -63.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.845 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 128' ' ' TYR . 18.7 p30 -65.63 -22.68 66.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.246 -0.909 . . . . 0.0 109.959 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.524 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 2.9 m-85 -76.08 -16.92 59.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 109.903 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.489 ' C ' ' CG ' ' A' ' 130' ' ' PHE . 3.0 m-20 44.8 -168.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.166 -0.959 . . . . 0.0 109.264 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.532 ' N ' ' CD1' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -154.06 121.14 5.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 108.681 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.52 ' CE2' ' HE1' ' A' ' 145' ' ' MET . 14.6 m-85 -105.16 164.42 11.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.178 -0.951 . . . . 0.0 110.692 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 75' ' ' SER . 1.1 tt -155.94 139.77 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.403 -0.81 . . . . 0.0 109.488 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.37 164.25 1.09 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 135' ' ' SER . 2.6 pt-20 -67.13 -21.07 65.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -1.177 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.2 OUTLIER -62.34 -35.3 78.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 77.48 50.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.869 . . . . 0.0 109.612 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.33 107.77 60.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.123 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.34 0.23 8.81 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.26 1.973 . . . . 0.0 110.486 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.77 -14.68 23.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.884 . . . . 0.0 109.115 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 141' ' ' MET . . . -79.7 -91.77 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.445 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.602 ' CB ' ' CE2' ' A' ' 91' ' ' TYR . 1.9 ptp 179.42 149.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 131' ' ' TYR . 70.3 t -97.76 138.15 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.183 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.564 HG23 ' CE2' ' A' ' 158' ' ' PHE . 3.6 t -93.25 111.35 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.134 -0.979 . . . . 0.0 109.043 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.537 ' CD1' HG12 ' A' ' 121' ' ' ILE . 2.5 mt -79.26 149.13 31.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.52 ' HE1' ' CE2' ' A' ' 131' ' ' TYR . 12.4 ttm -124.58 131.21 53.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.624 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.524 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 19.7 t30 -142.34 168.79 18.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 109.108 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.456 ' HB3' ' HA3' ' A' ' 151' ' ' GLY . 4.5 m-85 -77.06 159.39 29.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.058 -1.026 . . . . 0.0 109.385 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.589 ' HB2' ' CD1' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -151.59 -173.62 4.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 110.011 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 56.05 -97.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 109.655 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -106.94 -25.72 11.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.019 -1.051 . . . . 0.0 109.152 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 147' ' ' TYR . . . 123.17 17.43 3.31 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.65 -21.37 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.281 -1.129 . . . . 0.0 108.903 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 153' ' ' THR . 2.9 t -105.0 128.21 27.16 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.111 -0.993 . . . . 0.0 109.566 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -82.87 146.92 13.24 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.754 2.303 . . . . 0.0 110.696 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 148' ' ' ARG . 7.2 p90 -145.18 155.33 43.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 108.851 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.478 ' CE ' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -126.73 162.2 26.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 109.795 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.4 ' CG2' ' CG2' ' A' ' 27' ' ' VAL . 4.4 mt -124.26 145.3 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 109.507 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.564 ' CE2' HG23 ' A' ' 143' ' ' VAL . 9.7 m-85 -129.31 128.52 43.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.312 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -51.23 127.27 18.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -62.49 -53.69 51.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.405 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -47.52 -44.72 25.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -90.17 44.19 2.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.491 ' CD2' ' C ' ' A' ' 163' ' ' LEU . 2.2 tt -158.5 123.54 4.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.431 -1.041 . . . . 0.0 109.212 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.429 HG12 ' CG1' ' A' ' 7' ' ' VAL . 30.1 m -116.69 153.61 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.456 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.8 p -90.86 146.92 23.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.953 . . . . 0.0 109.639 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.53 120.64 15.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.471 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 168' ' ' PHE . 0.0 OUTLIER -70.21 108.27 4.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.404 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 168' ' ' PHE . 13.9 t80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.545 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 0.8 OUTLIER -68.48 146.74 52.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 110.126 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.529 HD12 ' CD2' ' A' ' 168' ' ' PHE . 6.8 mt -121.85 139.57 53.46 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.606 ' CE2' ' CD1' ' A' ' 20' ' ' LEU . 91.5 m-85 -121.43 108.89 14.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.977 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 1.8 mtmm -108.82 167.29 10.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.454 -0.778 . . . . 0.0 109.272 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -83.86 151.23 25.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.97 . . . . 0.0 109.362 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.496 ' CG2' HG12 ' A' ' 164' ' ' VAL . 5.3 t -108.31 35.6 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 109.486 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 139' ' ' ASP . 24.0 mm -117.07 -52.4 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.417 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.96 -34.96 2.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.5 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 106.62 2.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -176.28 136.54 0.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -1.145 . . . . 0.0 109.496 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' OE1' ' CG ' ' A' ' 72' ' ' PHE . 7.8 pt-20 -48.51 147.36 2.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.6 -80.58 0.49 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.154 -0.966 . . . . 0.0 109.532 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.573 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 2.6 p -132.37 166.77 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.853 . . . . 0.0 109.104 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.518 ' N ' HG23 ' A' ' 14' ' ' VAL . 3.9 p -142.0 161.93 36.75 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.017 -1.052 . . . . 0.0 110.098 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -83.02 1.27 40.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.381 -0.824 . . . . 0.0 109.598 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.86 -9.39 37.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.378 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.593 ' CE2' ' CD1' ' A' ' 68' ' ' LEU . 35.7 m-85 -119.52 20.69 12.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 65.38 130.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 109.006 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.606 ' CD1' ' CE2' ' A' ' 4' ' ' TYR . 49.4 mt -125.68 146.08 49.89 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -0.95 . . . . 0.0 110.015 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -123.43 134.26 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -0.807 . . . . 0.0 109.35 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.428 ' CD ' ' HA ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -90.93 122.4 33.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.181 -0.949 . . . . 0.0 108.789 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 2.3 t -114.55 120.44 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 4.0 t70 74.4 5.97 4.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 109.802 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 20.3 t0 59.12 68.89 0.77 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 109.513 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' A' ' 25' ' ' ASP . 5.8 tt 174.54 -29.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.129 -0.982 . . . . 0.0 109.905 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.539 HG23 ' CZ ' ' A' ' 117' ' ' PHE . 23.1 m -120.93 140.13 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.957 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -105.44 148.92 26.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.193 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -120.97 121.06 37.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.405 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.573 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -106.22 112.88 26.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.193 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -68.38 149.57 49.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.461 ' HB3' ' OD1' ' A' ' 66' ' ' ASN . 34.7 m -100.26 151.17 21.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 0.0 109.259 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.16 134.35 51.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.748 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.06 135.95 36.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -0.876 . . . . 0.0 109.059 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.457 ' O ' HG21 ' A' ' 35' ' ' VAL . 17.1 m -142.58 125.05 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.206 -0.934 . . . . 0.0 109.436 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.434 ' C ' HG11 ' A' ' 37' ' ' VAL . 1.4 t -86.07 142.72 28.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.434 HG11 ' C ' ' A' ' 36' ' ' THR . 2.9 m -129.01 137.25 57.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.226 -0.922 . . . . 0.0 109.601 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -90.77 102.7 15.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -108.28 131.12 55.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.512 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.59 2.72 53.25 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 -162.27 27.77 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -174.88 64.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -1.122 . . . . 0.0 109.697 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 3.2 t -114.49 -73.37 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.567 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.536 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 1.3 p30 170.22 -37.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.354 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER 40.52 30.95 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.523 -0.736 . . . . 0.0 109.729 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' ASP . . . 104.53 -131.19 10.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.22 64.79 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -1.183 . . . . 0.0 109.526 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -47.71 111.8 1.86 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.225 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 50' ' ' SER . 35.4 Cg_endo -77.47 6.29 4.53 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.469 2.113 . . . . 0.0 110.8 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 48.9 m 60.23 -89.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 109.518 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.498 ' C ' ' CG ' ' A' ' 52' ' ' GLU . . . -154.99 169.1 24.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.599 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.498 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 1.0 OUTLIER 39.63 -96.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 0.0 109.884 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 51' ' ' ALA . 17.1 p-10 -154.29 147.57 24.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -99.92 117.32 33.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.569 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -119.93 -16.67 8.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -96.31 175.7 6.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 109.37 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -133.97 38.92 3.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.579 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.78 76.16 1.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.441 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -115.69 128.02 55.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.435 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 60' ' ' GLU . 5.4 pt-20 -166.75 91.4 0.42 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.546 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.58 97.92 0.26 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p 49.65 -174.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -1.108 . . . . 0.0 109.716 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.429 ' HG2' HG23 ' A' ' 37' ' ' VAL . 2.2 pt-20 -155.31 146.11 22.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.682 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 138.07 32.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.865 . . . . 0.0 109.31 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.4 m -148.48 140.55 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 32' ' ' CYS . 1.5 m-20 -56.6 154.2 9.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.36 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 71' ' ' SER . 33.7 t30 -89.7 -27.09 20.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.739 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.593 ' CD1' ' CE2' ' A' ' 18' ' ' TYR . 13.3 tp -83.48 -37.63 22.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 108.982 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 74' ' ' LEU . 53.3 t -72.61 -48.28 47.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.723 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -69.29 -36.04 76.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 110.93 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 70.3 m -79.49 -52.85 7.51 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.966 -1.084 . . . . 0.0 110.506 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CG ' ' OE1' ' A' ' 12' ' ' GLU . 7.2 m-30 -79.82 -3.6 48.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.128 -0.982 . . . . 0.0 109.968 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.425 ' C ' HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 62.81 88.04 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 109.571 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.502 ' CD1' ' HB3' ' A' ' 131' ' ' TYR . 1.4 mm? -111.85 139.05 47.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 108.719 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.67 122.99 18.1 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.066 -1.021 . . . . 0.0 109.871 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.14 126.28 7.7 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.374 2.049 . . . . 0.0 110.097 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 t -123.92 117.02 23.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -0.966 . . . . 0.0 109.645 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -59.34 151.46 23.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.242 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 17.9 t80 -151.93 155.3 37.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 109.703 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.637 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 1.4 m-20 -86.42 124.27 32.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -0.879 . . . . 0.0 109.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -34.61 68.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.147 -0.971 . . . . 0.0 110.033 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -56.25 -64.91 0.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.617 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.404 ' HB3' ' CE1' ' A' ' 79' ' ' PHE . 7.4 t -59.8 -28.74 67.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.788 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.32 -35.48 67.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.495 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.4 mtt -57.04 -49.42 75.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.141 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -48.81 79.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.489 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -62.7 -19.19 63.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.256 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.492 ' O ' ' HB2' ' A' ' 92' ' ' MET . 0.6 OUTLIER -79.22 -28.92 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -39.55 58.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.426 -0.796 . . . . 0.0 109.115 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.13 -38.79 88.48 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.568 ' CZ ' ' O ' ' A' ' 138' ' ' PRO . 14.7 m-30 -74.52 -36.5 63.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.101 -1.234 . . . . 0.0 108.816 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.536 ' CE ' ' O ' ' A' ' 92' ' ' MET . 0.0 OUTLIER -65.21 -38.99 92.15 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.624 0.726 . . . . 0.0 109.293 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.506 ' C ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.15 -36.91 82.86 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.571 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.58 -50.77 67.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.994 -1.066 . . . . 0.0 109.244 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.562 HG22 ' CZ ' ' A' ' 110' ' ' PHE . 29.5 mm -59.93 -43.0 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.235 -0.915 . . . . 0.0 108.969 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -47.38 -51.61 19.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.875 . . . . 0.0 109.364 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 100' ' ' GLN . . . -58.19 -36.53 73.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.015 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 101' ' ' GLU . 1.8 tmt_? -64.15 -32.85 74.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -0.916 . . . . 0.0 109.683 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.47 HD11 ' O ' ' A' ' 106' ' ' ARG . 22.4 mt -73.78 -50.21 21.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 110.213 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.52 ' HG3' ' N ' ' A' ' 101' ' ' GLU . 2.6 pt20 -55.83 -34.98 65.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.679 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 7.4 pt-20 -72.79 -35.52 67.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.103 -0.998 . . . . 0.0 109.191 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.513 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 10.2 t -88.28 -80.31 0.28 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.277 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -135.74 137.78 26.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 109.325 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.92 -25.97 11.53 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.547 2.165 . . . . 0.0 110.637 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -70.46 -6.83 38.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.676 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.47 ' O ' HD11 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -97.92 -4.8 35.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 109.819 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.607 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 32.7 t -70.18 -44.62 20.49 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.989 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.6 Cg_endo -77.7 -41.05 0.34 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.018 1.812 . . . . 0.0 111.096 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.34 -43.37 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 0.0 109.938 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.562 ' CZ ' HG22 ' A' ' 95' ' ' ILE . 87.1 t80 -69.72 -37.11 76.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 0.0 110.408 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -63.25 -53.78 47.64 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.09 -1.006 . . . . 0.0 110.719 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -47.19 61.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.016 -1.053 . . . . 0.0 110.675 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -55.73 -54.26 46.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.138 -0.976 . . . . 0.0 110.124 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.77 69.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 109.968 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.467 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -59.22 -35.51 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.126 -0.983 . . . . 0.0 109.559 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.48 -45.85 95.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.539 ' CZ ' HG23 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -68.14 -30.72 69.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -1.2 . . . . 0.0 110.081 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 54.4 t -68.02 -42.35 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.888 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 115' ' ' ILE . 40.2 mmtt -69.06 -42.05 76.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.075 -1.015 . . . . 0.0 109.78 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.495 ' HA ' ' CE ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -59.54 -60.5 3.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.797 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.3 mt -53.98 -47.69 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 25.6 mt -47.3 -49.6 23.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 109.762 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.78 -41.85 45.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.966 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.73 52.02 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.885 . . . . 0.0 109.435 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 8.9 p90 -63.43 -27.53 69.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.578 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.427 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 5.5 mttp -64.82 -39.77 94.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.404 -0.81 . . . . 0.0 109.704 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.67 -23.76 42.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 110.01 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 129' ' ' ASP . 7.1 m-85 -81.7 -25.92 35.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.874 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.521 ' C ' ' CD1' ' A' ' 130' ' ' PHE . 14.0 m-20 51.29 179.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.521 ' CD1' ' C ' ' A' ' 129' ' ' ASP . 36.3 m-85 -142.3 121.61 13.11 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.352 -0.843 . . . . 0.0 109.052 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.505 ' O ' ' CG1' ' A' ' 142' ' ' VAL . 10.9 m-85 -99.31 166.24 11.3 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.189 -0.944 . . . . 0.0 110.538 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.443 ' O ' HG21 ' A' ' 132' ' ' ILE . 7.8 tp -156.58 146.84 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.702 . . . . 0.0 109.278 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.03 162.38 52.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -58.24 -23.63 56.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -1.107 . . . . 0.0 109.427 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 136' ' ' MET . 11.4 p -68.59 -34.76 76.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 109.359 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.47 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 0.0 OUTLIER 70.6 63.63 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.521 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.37 105.73 38.2 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.341 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.568 ' O ' ' CZ ' ' A' ' 91' ' ' TYR . 34.0 Cg_endo -74.5 -20.85 17.7 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.274 1.982 . . . . 0.0 109.961 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.456 ' O ' HG22 ' A' ' 8' ' ' ILE . 7.7 t70 -75.43 -6.26 49.18 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.364 -0.835 . . . . 0.0 108.962 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.15 -175.71 2.88 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.266 -0.896 . . . . 0.0 109.35 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.2 ptm -92.31 167.47 11.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 109.475 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 131' ' ' TYR . 58.7 t -113.35 142.03 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 109.185 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.58 HG23 ' CE2' ' A' ' 158' ' ' PHE . 13.0 t -90.01 130.04 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.174 -0.954 . . . . 0.0 108.838 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 18.0 mt -92.55 134.4 35.02 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.492 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CE1' ' A' ' 131' ' ' TYR . 4.8 ttt -107.63 126.28 52.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.571 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 2.2 t30 -139.34 169.11 18.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 1.6 m-85 -110.23 144.81 38.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.65 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.48 170.67 7.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 109.608 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -47.67 -35.8 10.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 109.577 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -77.35 -44.63 28.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.298 -0.876 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.569 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 100.46 -30.2 10.71 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.6 tp -68.2 -6.57 5.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.47 -1.018 . . . . 0.0 109.661 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.7 m -122.81 101.73 39.08 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 109.665 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.14 121.8 5.02 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.57 2.18 . . . . 0.0 109.98 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 146' ' ' ASN . 31.7 p90 -126.37 148.35 49.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -0.983 . . . . 0.0 109.88 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.444 ' SD ' ' HG3' ' A' ' 145' ' ' MET . 0.2 OUTLIER -116.14 167.17 11.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.35 -0.844 . . . . 0.0 109.135 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.479 ' C ' ' CD1' ' A' ' 158' ' ' PHE . 11.6 mt -128.46 148.63 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 0.0 109.783 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.58 ' CE2' HG23 ' A' ' 143' ' ' VAL . 12.4 m-85 -136.55 125.73 24.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.472 ' HB3' ' OD1' ' A' ' 161' ' ' ASP . 2.5 m-85 -60.03 132.41 53.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 110.25 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 77.3 tttt -68.23 -41.85 80.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.487 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 159' ' ' PHE . 5.2 p-10 -50.56 -45.01 56.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.012 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -97.93 45.94 1.65 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.537 ' CD1' ' HB3' ' A' ' 4' ' ' TYR . 0.4 OUTLIER -161.34 129.23 4.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.464 -1.021 . . . . 0.0 108.919 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.496 HG12 ' CG2' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -115.46 149.16 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.624 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.89 121.64 38.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -118.42 142.98 47.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.671 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.49 113.6 25.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.529 ' CD2' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.489 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.419 ' O ' ' OG ' ' A' ' 15' ' ' SER . 10.3 mt -100.8 158.4 15.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.7 mt -112.41 134.47 53.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.479 -0.763 . . . . 0.0 109.427 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 10.5 m-85 -117.4 112.24 20.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.68 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.435 ' HG2' ' HA ' ' A' ' 12' ' ' GLU . 1.5 mtmt -123.15 162.39 22.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.415 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -97.04 158.21 15.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.416 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.491 ' CG2' HG12 ' A' ' 164' ' ' VAL . 16.8 t -115.86 54.32 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -0.984 . . . . 0.0 109.663 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -140.7 -50.1 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.034 -1.041 . . . . 0.0 109.595 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.578 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 1.5 t 176.47 45.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -141.87 -43.93 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 6.8 t0 74.96 -137.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -1.112 . . . . 0.0 109.275 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -42.33 121.37 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.047 -1.033 . . . . 0.0 109.677 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.402 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -125.1 -62.08 1.25 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.138 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.594 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 6.5 p -143.46 175.81 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.365 -0.834 . . . . 0.0 108.855 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 2' ' ' LEU . 22.6 t -147.49 169.59 19.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.846 -1.159 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.535 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 31.4 t70 -87.54 12.73 11.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.479 -0.763 . . . . 0.0 109.447 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.39 -15.28 63.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 108.996 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CE1' ' ND2' ' A' ' 67' ' ' ASN . 44.5 m-85 -115.92 21.38 13.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.471 -0.768 . . . . 0.0 109.207 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.2 t0 65.32 129.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 108.511 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.535 ' CD1' ' HA ' ' A' ' 16' ' ' ASP . 13.0 mt -124.28 143.2 50.69 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.144 -0.973 . . . . 0.0 110.252 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.32 136.7 52.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.34 117.74 34.45 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.252 -0.905 . . . . 0.0 108.767 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 t -68.46 147.81 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 109.49 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -46.31 -25.4 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 109.751 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.433 ' O ' HG21 ' A' ' 26' ' ' ILE . 2.2 m-20 -77.96 -110.39 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.433 HG21 ' O ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -154.82 64.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.811 -1.181 . . . . 0.0 109.305 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.458 ' O ' HG21 ' A' ' 27' ' ' VAL . 30.3 m -147.18 141.27 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 109.674 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.408 ' CE2' ' HE2' ' A' ' 4' ' ' TYR . 4.9 m-85 -98.65 148.39 23.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.152 -0.968 . . . . 0.0 109.066 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 19.4 mt-10 -125.15 121.11 33.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.116 -0.99 . . . . 0.0 110.12 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.594 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -106.39 112.71 25.83 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -71.52 146.48 48.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 110.509 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 28.3 p -126.74 115.18 19.01 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.412 ' HG2' ' ND2' ' A' ' 67' ' ' ASN . 14.6 pt20 -92.69 157.22 16.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 110.056 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.5 mmm -92.25 133.28 35.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -0.815 . . . . 0.0 109.207 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.3 m -117.35 144.71 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.59 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -100.07 117.36 34.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.268 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 37' ' ' VAL . 3.3 m -85.18 123.01 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.893 . . . . 0.0 109.429 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -92.69 105.48 17.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.0 109.585 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -96.06 157.6 15.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.462 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.34 -44.63 65.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.55 -166.47 24.78 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.66 -38.8 1.87 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -1.107 . . . . 0.0 109.443 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 75.9 t -124.26 -92.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.315 -0.866 . . . . 0.0 109.322 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER 66.25 -88.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.739 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 46' ' ' GLY . 4.3 tt -135.38 -42.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.572 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' N ' HG22 ' A' ' 45' ' ' ILE . . . 152.36 155.26 6.98 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.23 74.25 1.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.386 -1.067 . . . . 0.0 109.58 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.48 146.24 0.11 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 109.734 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.57 -176.92 3.52 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.59 2.193 . . . . 0.0 110.335 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m 59.34 37.46 23.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 109.578 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 47.15 -168.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.491 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.462 ' N ' ' OE1' ' A' ' 52' ' ' GLU . 13.5 mp0 -119.09 -71.62 0.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.528 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 6.4 t70 179.39 160.35 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.535 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.33 177.68 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.321 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 -87.22 -172.31 3.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 6.0 pt-20 -125.99 134.0 51.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.496 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER 177.77 60.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.543 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.426 ' C ' ' HG3' ' A' ' 59' ' ' GLU . . . -141.77 122.53 14.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HG3' ' C ' ' A' ' 58' ' ' ALA . 42.0 mt-10 -149.67 -159.25 1.01 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.37 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER 68.96 8.66 6.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.923 . . . . 0.0 109.619 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 62' ' ' THR . . . 67.6 99.07 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 61' ' ' GLY . 1.3 p 57.97 159.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -1.145 . . . . 0.0 109.319 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -123.91 144.77 49.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 109.624 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.56 133.03 41.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.275 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.2 137.86 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 0.0 109.616 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -60.37 141.38 56.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.427 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.462 ' ND2' ' CE1' ' A' ' 18' ' ' TYR . 38.5 p-10 -86.12 -19.57 29.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.671 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.47 ' CD1' ' CD2' ' A' ' 72' ' ' PHE . 18.1 tp -86.38 -47.56 9.23 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 108.957 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.505 HG21 ' CE ' ' A' ' 156' ' ' MET . 55.6 t -68.24 -37.33 77.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.322 -0.862 . . . . 0.0 109.171 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -69.84 -44.57 69.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 109.668 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 t -63.24 -36.93 85.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.315 -0.866 . . . . 0.0 110.121 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.47 ' CD2' ' CD1' ' A' ' 68' ' ' LEU . 25.9 m-85 -103.26 2.9 34.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 109.891 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER 56.82 29.66 16.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.154 -0.966 . . . . 0.0 109.789 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.493 ' N ' HD21 ' A' ' 74' ' ' LEU . 2.0 mm? -41.72 149.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.411 -0.806 . . . . 0.0 109.345 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.06 127.38 21.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.384 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.16 122.17 5.61 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.496 2.131 . . . . 0.0 110.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.4 127.26 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.37 -178.68 3.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.29 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 50.5 t80 -164.91 163.0 21.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.605 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 35.6 m-20 -77.38 120.48 22.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.458 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 2.1 tmtt? -59.14 -53.25 60.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.88 -45.33 86.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.76 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.483 ' CB ' ' HB2' ' A' ' 80' ' ' ASP . 1.3 t -61.75 -29.06 69.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.344 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 81' ' ' LYS . 41.6 t80 -58.41 -34.99 71.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.779 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -57.34 12.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.96 . . . . 0.0 109.778 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -59.87 -38.02 81.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.003 . . . . 0.0 109.273 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.509 ' CE2' ' CZ ' ' A' ' 91' ' ' TYR . 6.5 t80 -66.44 -23.1 66.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.385 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.481 HG22 HD11 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -78.72 -31.48 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 108.952 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -72.02 -47.28 52.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.41 -29.86 74.61 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.509 ' CZ ' ' CE2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -75.38 -35.79 61.02 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.129 -1.218 . . . . 0.0 108.41 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.504 ' CA ' ' HE1' ' A' ' 92' ' ' MET . 0.0 OUTLIER -65.87 -54.42 26.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.598 -0.689 . . . . 0.0 109.745 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -38.47 75.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.346 -0.846 . . . . 0.0 109.868 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.54 -45.34 73.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.113 -0.992 . . . . 0.0 109.297 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.463 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 34.8 mm -69.82 -36.67 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -47.19 63.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 109.202 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.72 81.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.127 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.95 -44.29 66.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.456 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.507 ' N ' HD21 ' A' ' 99' ' ' LEU . 2.0 mt -71.93 -44.06 64.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.295 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -25.16 9.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.199 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -86.98 -34.44 19.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 t -96.09 -89.02 0.26 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.326 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.439 ' OD1' ' NH2' ' A' ' 106' ' ' ARG . 27.8 p-10 -125.62 132.38 24.3 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.271 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.9 -19.44 18.09 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.641 2.227 . . . . 0.0 110.884 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.9 -6.82 29.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.202 -0.936 . . . . 0.0 109.905 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -95.81 -5.94 40.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.084 -1.01 . . . . 0.0 109.811 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 96.0 t -72.18 -43.25 9.99 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.137 -0.977 . . . . 0.0 111.229 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.6 Cg_endo -75.98 -56.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.762 1.641 . . . . 0.0 110.862 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.8 m -55.84 -40.95 64.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.036 -1.04 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 68.9 t80 -65.82 -37.1 85.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.817 . . . . 0.0 110.253 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.483 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -66.42 -49.87 65.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.964 -1.085 . . . . 0.0 110.562 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -66.14 -49.45 67.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.887 -1.133 . . . . 0.0 110.544 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -58.2 -46.42 85.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.985 . . . . 0.0 109.813 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.46 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -65.44 -27.56 68.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.373 -0.829 . . . . 0.0 109.751 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.483 HD11 ' O ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -67.13 -47.41 81.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.251 -0.905 . . . . 0.0 109.446 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.27 -50.51 44.53 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.469 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.78 -38.95 76.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.081 -1.247 . . . . 0.0 109.803 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 114' ' ' ALA . 53.1 t -68.4 -39.16 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -32.34 69.64 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.157 -0.964 . . . . 0.0 109.295 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -96.92 -10.07 27.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.661 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.534 ' CG2' ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.2 -53.68 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.629 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.534 ' N ' ' CG2' ' A' ' 121' ' ' ILE . 10.1 mt -48.77 -44.23 38.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.016 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.79 76.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 110.033 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.542 ' O ' ' CE2' ' A' ' 128' ' ' TYR . 19.6 m-20 -101.44 38.84 1.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.14 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.645 ' HA ' ' CE1' ' A' ' 128' ' ' TYR . 13.4 t80 -63.41 -53.69 48.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.082 -1.011 . . . . 0.0 109.061 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -78.9 -8.43 58.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 108.988 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 124' ' ' ASN . 0.8 OUTLIER -80.17 -39.53 29.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.341 -0.85 . . . . 0.0 109.937 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.645 ' CE1' ' HA ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -108.55 -10.43 15.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.969 -1.082 . . . . 0.0 110.041 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.8 m-20 52.27 173.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.726 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -114.71 122.23 45.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -103.27 177.63 4.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 110.558 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 137' ' ' ASP . 3.9 tp -143.02 149.03 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.541 -0.725 . . . . 0.0 109.545 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.433 ' N ' HG13 ' A' ' 132' ' ' ILE . . . -73.01 -178.77 35.41 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -18.06 63.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -1.187 . . . . 0.0 109.539 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -60.95 -41.69 96.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.217 -0.927 . . . . 0.0 109.39 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 75.56 48.88 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.672 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.444 ' O ' HD12 ' A' ' 132' ' ' ILE . 72.4 m-20 -118.84 134.02 23.6 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 109.373 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.41 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 34.1 Cg_endo -75.59 -5.48 16.58 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.317 2.011 . . . . 0.0 110.157 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' A' ' 9' ' ' SER . 11.4 t70 -101.48 -3.31 28.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 109.304 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 141' ' ' MET . . . -85.17 137.87 32.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 109.378 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 159' ' ' PHE . 1.4 ttp -43.42 152.99 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.742 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.9 m -100.67 141.44 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.365 -0.835 . . . . 0.0 109.279 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.552 HG13 ' CZ ' ' A' ' 158' ' ' PHE . 2.1 t -102.27 139.04 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.236 -0.915 . . . . 0.0 109.42 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.502 ' HB3' ' CG ' ' A' ' 128' ' ' TYR . 4.9 mt -107.13 146.16 31.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.31 -0.869 . . . . 0.0 109.206 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 128' ' ' TYR . 1.8 ttm -111.98 125.78 54.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.674 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -139.13 169.08 18.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 4.9 m-85 -102.66 145.91 28.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.597 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.573 ' HB2' ' CE2' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -142.85 -170.84 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.345 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 148' ' ' ARG . 0.8 OUTLIER 62.07 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.571 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.68 -22.17 11.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.586 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.591 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 124.27 -18.37 7.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.44 ' O ' HG22 ' A' ' 152' ' ' ILE . 2.4 tp -96.26 7.23 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.299 -1.118 . . . . 0.0 109.394 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.6 m -110.64 101.8 50.13 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.298 -0.876 . . . . 0.0 109.633 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.59 139.39 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.521 2.147 . . . . 0.0 110.18 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.573 ' CE2' ' HB2' ' A' ' 148' ' ' ARG . 52.0 p90 -145.14 158.64 43.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 109.655 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.505 ' CE ' HG21 ' A' ' 69' ' ' VAL . 7.1 mtm -107.44 156.14 19.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.301 -0.874 . . . . 0.0 109.295 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 143' ' ' VAL . 42.3 mt -122.6 132.61 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.08 -1.012 . . . . 0.0 110.011 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.552 ' CZ ' HG13 ' A' ' 143' ' ' VAL . 7.8 m-85 -126.22 115.11 19.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.469 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 3.8 m-85 -50.41 126.28 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.397 -0.814 . . . . 0.0 109.774 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 161' ' ' ASP . 4.9 tttm -68.49 -38.14 80.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.772 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 1.8 p30 -43.26 -41.45 3.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . -110.0 54.29 0.55 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.428 ' C ' HD21 ' A' ' 163' ' ' LEU . 8.7 tt -157.66 142.37 16.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -1.099 . . . . 0.0 109.556 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.491 HG12 ' CG2' ' A' ' 7' ' ' VAL . 19.8 m -127.65 152.65 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.4 m -104.31 121.34 43.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.099 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -115.93 127.56 55.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.616 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 146.53 25.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.875 . . . . 0.0 109.564 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' C ' HD22 ' A' ' 2' ' ' LEU . 2.4 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 167' ' ' LYS . 2.9 mt -105.44 165.04 11.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.897 . . . . 0.0 109.421 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.6 mt -127.27 129.63 48.08 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.432 -0.792 . . . . 0.0 109.584 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 64.2 m-85 -111.59 108.79 18.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.255 -0.903 . . . . 0.0 109.312 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.24 163.91 15.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.519 ' HB2' ' CD1' ' A' ' 13' ' ' LEU . 4.3 t0 -76.23 152.41 36.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.889 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.509 ' CG2' HG11 ' A' ' 164' ' ' VAL . 2.7 t -102.32 -5.97 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.81 . . . . 0.0 109.344 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 139' ' ' ASP . 4.7 mt -97.54 -79.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.415 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.435 ' N ' HG23 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -144.47 67.37 1.26 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 0.0 109.554 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -130.81 -65.83 0.1 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER 73.52 13.18 4.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.315 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 1.4 pt-20 170.67 107.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.039 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.519 ' CD1' ' HB2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -129.4 -64.98 0.87 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.834 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.545 HG22 ' CB ' ' A' ' 30' ' ' ALA . 11.3 p -157.31 170.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.299 -0.876 . . . . 0.0 108.968 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 p -155.06 -176.23 5.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.667 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.456 ' CA ' HD13 ' A' ' 20' ' ' LEU . 1.4 t0 -82.23 10.71 6.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.545 -0.722 . . . . 0.0 110.165 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.05 -10.25 38.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.056 -1.027 . . . . 0.0 109.19 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.564 ' CD2' HD13 ' A' ' 68' ' ' LEU . 8.1 m-85 -127.41 21.69 6.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.174 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.19 130.56 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 19.3 mt -126.86 148.46 49.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 110.484 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.96 133.14 53.77 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.7 122.47 38.5 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.179 -0.951 . . . . 0.0 108.839 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.39 158.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.095 -1.003 . . . . 0.0 109.168 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -64.1 -10.53 23.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.086 -1.009 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.543 ' O ' ' CG1' ' A' ' 26' ' ' ILE . 0.4 OUTLIER -76.87 1.45 17.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.779 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 75.22 25.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.2 m -119.3 156.57 21.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 110.186 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -107.64 157.01 18.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 0.0 109.07 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.5 mt-10 -130.47 117.63 19.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.946 -1.096 . . . . 0.0 109.342 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.545 ' CB ' HG22 ' A' ' 14' ' ' VAL . . . -110.25 114.15 27.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -57.46 143.13 41.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -102.84 174.1 6.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.244 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 3.0 tt0 -138.48 150.85 46.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.912 . . . . 0.0 109.588 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.437 ' SD ' ' HG3' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -114.52 130.88 56.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.9 130.43 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.454 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.88 111.99 13.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.461 HG23 ' CG2' ' A' ' 65' ' ' VAL . 33.5 m -127.14 162.99 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.425 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -83.5 92.73 7.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.578 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -123.31 154.78 38.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.374 -0.829 . . . . 0.0 109.413 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.22 80.33 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.08 -33.24 0.42 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.45 14.76 5.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.13 -1.217 . . . . 0.0 109.642 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.445 ' CG1' HG23 ' A' ' 45' ' ' ILE . 13.0 t -94.15 -17.76 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.94 . . . . 0.0 109.448 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER 43.9 79.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.654 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.445 HG23 ' CG1' ' A' ' 43' ' ' VAL . 0.7 OUTLIER -172.93 66.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.185 -0.947 . . . . 0.0 109.612 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -46.25 130.47 11.0 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.5 -18.48 19.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -1.126 . . . . 0.0 109.556 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 4.5 p30 -139.25 92.54 10.57 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.32 153.94 31.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.692 2.261 . . . . 0.0 110.509 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t 58.12 31.68 21.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.845 . . . . 0.0 109.319 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.17 61.65 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 109.129 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' HB2' ' OD1' ' A' ' 57' ' ' ASN . 4.3 pt-20 -143.81 157.59 44.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 109.538 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 54' ' ' ALA . 17.1 t0 -149.15 92.12 1.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.306 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 53' ' ' ASP . . . 70.24 -168.66 0.16 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.263 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.48 -175.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.056 -1.027 . . . . 0.0 109.364 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.44 2.86 52.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 109.584 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.463 ' OD1' ' HB2' ' A' ' 52' ' ' GLU . 0.1 OUTLIER 60.18 -170.41 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 109.393 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 63.68 109.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.851 . . . . 0.0 109.52 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -138.9 64.52 1.48 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 0.0 109.504 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.02 59.1 0.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.596 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.472 ' O ' ' OG1' ' A' ' 62' ' ' THR . . . -168.56 -69.19 0.03 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 61' ' ' GLY . 3.5 p 59.8 145.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -1.111 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.422 ' O ' HG11 ' A' ' 65' ' ' VAL . 2.8 pt-20 -146.93 145.15 29.7 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.27 136.4 56.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.087 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.461 ' CG2' HG23 ' A' ' 37' ' ' VAL . 34.1 m -125.68 147.98 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 0.0 109.566 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 3.6 m-20 -69.88 152.92 43.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 52.7 t-20 -90.98 -26.62 19.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.622 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.564 HD13 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -77.31 -42.5 36.56 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.497 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 44.6 t -73.19 -34.73 45.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.454 -0.779 . . . . 0.0 109.301 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 15.3 t80 -63.33 -48.79 76.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 110.384 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.54 -40.39 61.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.18 -0.95 . . . . 0.0 110.32 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -86.2 4.31 39.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 109.992 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.448 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 4.8 mtt85 52.82 35.66 19.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.569 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.497 ' HB2' ' HA ' ' A' ' 69' ' ' VAL . 1.8 mm? -57.59 167.58 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.879 -1.138 . . . . 0.0 108.715 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.23 117.03 17.8 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.996 -1.065 . . . . 0.0 109.73 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.86 123.29 5.71 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.488 2.125 . . . . 0.0 110.506 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 130' ' ' PHE . 14.8 t -105.91 128.35 53.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.354 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -100.46 2.08 41.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 109.847 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' C ' ' CD1' ' A' ' 79' ' ' PHE . 12.3 t80 -120.87 124.75 45.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.068 -1.02 . . . . 0.0 109.529 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 178.3 31.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.71 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -62.61 -46.78 86.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 109.349 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.13 -23.1 9.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.366 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 m -72.0 -32.65 67.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 0.0 109.656 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 2.2 t80 -60.14 -43.92 95.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.942 . . . . 0.0 109.808 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtt -60.18 -50.79 72.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.333 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -60.03 -36.54 77.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.042 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.632 ' CD1' ' CB ' ' A' ' 138' ' ' PRO . 8.9 m-85 -74.96 -23.84 58.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.102 -0.999 . . . . 0.0 109.686 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.3 -29.03 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.021 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.57 -36.91 25.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.233 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.98 -31.19 74.84 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.58 ' CZ ' ' HG3' ' A' ' 141' ' ' MET . 2.2 t80 -81.18 -39.32 25.66 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.16 -1.2 . . . . 0.0 109.077 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -47.46 84.4 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.113 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -39.34 93.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.312 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.52 -47.31 73.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.221 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.509 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 47.5 mm -66.33 -32.08 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.33 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.404 ' HE2' ' HG3' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -57.8 -36.06 71.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.889 -1.132 . . . . 0.0 108.577 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.72 -49.8 23.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.404 -0.81 . . . . 0.0 109.952 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.516 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -54.19 -34.69 61.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.064 -1.023 . . . . 0.0 109.708 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.516 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 61.3 mt -73.93 -35.52 64.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.102 -0.999 . . . . 0.0 109.12 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -22.23 65.05 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.147 -0.971 . . . . 0.0 109.287 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.01 -41.42 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 110.119 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 t -145.4 47.34 1.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.937 -1.102 . . . . 0.0 110.292 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 1.9 m-20 174.65 72.98 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.38 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.56 -43.31 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.7 2.267 . . . . 0.0 110.682 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.476 ' O ' HG23 ' A' ' 109' ' ' VAL . 4.9 mt-10 -72.27 -12.89 61.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.849 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -93.21 -7.57 44.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.139 -0.976 . . . . 0.0 109.799 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 71.0 t -67.16 -44.14 47.79 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 111.14 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.9 Cg_endo -76.54 -54.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.866 1.71 . . . . 0.0 110.979 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 105' ' ' GLU . 0.8 OUTLIER -59.78 -34.21 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.076 -1.015 . . . . 0.0 109.68 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.475 ' CB ' ' O ' ' A' ' 106' ' ' ARG . 93.4 t80 -68.95 -43.44 75.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.955 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.404 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -67.5 -31.17 71.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 109.814 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -71.82 -49.37 39.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.553 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -68.92 -51.36 40.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.17 -0.956 . . . . 0.0 110.391 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.458 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -54.4 -26.95 33.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.881 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.11 -39.0 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.454 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.74 -49.96 51.52 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -30.68 68.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -1.108 . . . . 0.0 109.582 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 78.5 t -63.69 -41.1 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.64 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.84 -37.23 79.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.118 -0.989 . . . . 0.0 109.798 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -61.79 -60.12 4.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.829 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.38 -48.32 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 109.766 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 52.8 mt -46.91 -35.17 6.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.129 -0.982 . . . . 0.0 109.695 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -45.74 -48.94 15.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.802 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.6 57.35 1.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 109.664 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 1.9 p90 -55.63 -20.53 14.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.628 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.438 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -71.35 -45.61 62.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.759 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -73.41 -26.34 60.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -78.03 -25.13 47.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.421 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 60.04 170.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.541 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.456 ' O ' HG21 ' A' ' 77' ' ' THR . 2.1 m-85 -133.16 122.02 23.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 108.872 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.497 ' CE2' HG23 ' A' ' 69' ' ' VAL . 14.7 m-85 -101.25 166.92 10.52 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.146 -0.971 . . . . 0.0 110.391 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 136' ' ' MET . 3.6 tt -152.06 135.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.636 -0.665 . . . . 0.0 109.516 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.1 173.61 0.36 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -66.18 -23.98 66.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -1.113 . . . . 0.0 109.499 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.2 OUTLIER -59.27 -35.2 73.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.177 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.457 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER 71.68 53.05 0.22 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 109.61 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.451 ' N ' HD12 ' A' ' 132' ' ' ILE . 1.9 t70 -130.6 134.01 25.52 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.363 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.632 ' CB ' ' CD1' ' A' ' 87' ' ' TYR . 34.4 Cg_endo -75.1 -0.21 9.73 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.345 2.03 . . . . 0.0 110.374 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -103.11 7.86 38.75 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 109.008 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 141' ' ' MET . . . -106.14 17.74 23.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.914 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.58 ' HG3' ' CZ ' ' A' ' 91' ' ' TYR . 7.9 ttm 74.45 148.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.037 -1.039 . . . . 0.0 110.274 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.5 t -114.38 139.3 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 109.226 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.557 HG23 ' CE2' ' A' ' 158' ' ' PHE . 2.7 t -105.73 125.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.062 -1.024 . . . . 0.0 109.602 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -106.21 149.4 26.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.921 . . . . 0.0 109.069 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.484 ' HE3' ' CE ' ' A' ' 156' ' ' MET . 12.9 ptp -146.1 147.34 31.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.0 . . . . 0.0 109.744 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -156.18 161.64 40.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.911 . . . . 0.0 109.424 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.4 139.29 58.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.947 . . . . 0.0 109.374 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.434 ' CD ' HG21 ' A' ' 153' ' ' THR . 15.4 ptm180 -70.38 -170.28 0.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 109.616 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -27.82 68.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.923 . . . . 0.0 109.672 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 152' ' ' ILE . 1.2 m-20 -75.79 -14.9 60.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 56.36 22.68 38.56 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.524 ' CD1' ' HB ' ' A' ' 153' ' ' THR . 2.7 pp -110.0 -29.26 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -1.136 . . . . 0.0 109.795 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.524 ' HB ' ' CD1' ' A' ' 152' ' ' ILE . 5.9 t -138.22 134.68 17.85 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.014 . . . . 0.0 109.812 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.437 ' HG3' ' SD ' ' A' ' 34' ' ' MET . 36.7 Cg_endo -81.07 151.89 18.44 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.664 2.242 . . . . 0.0 110.332 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -145.17 133.66 21.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.448 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.591 ' HG3' ' CE1' ' A' ' 158' ' ' PHE . 0.0 OUTLIER -105.8 155.41 19.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.296 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mt -118.16 154.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.771 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.591 ' CE1' ' HG3' ' A' ' 156' ' ' MET . 49.9 m-85 -133.12 164.16 27.64 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.462 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 97.6 m-85 -107.88 121.12 44.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 0.0 109.426 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -59.19 -32.76 70.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 110.036 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 5.2 p30 -44.42 -28.26 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 109.683 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . -130.89 58.17 0.71 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 mt -153.92 138.14 16.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -1.198 . . . . 0.0 109.506 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.509 HG11 ' CG2' ' A' ' 7' ' ' VAL . 2.0 m -119.03 130.94 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 109.791 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.8 p -85.74 125.85 33.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.253 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.77 142.11 45.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.868 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 168' ' ' PHE . 4.6 tppt? -102.41 126.45 49.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 109.062 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 167' ' ' LYS . 7.4 p90 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.686 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.488 HD21 ' N ' ' A' ' 2' ' ' LEU . 0.3 OUTLIER -68.49 143.64 54.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.222 -0.924 . . . . 0.0 110.069 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 2' ' ' LEU . 21.8 mt -115.43 128.21 55.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.632 -0.668 . . . . 0.0 109.482 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.535 ' CD2' HD22 ' A' ' 163' ' ' LEU . 4.4 m-85 -104.27 132.08 50.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.325 -0.859 . . . . 0.0 109.419 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 9.6 pttt -146.89 164.63 32.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.735 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 162' ' ' GLY . 44.1 t0 -87.65 146.66 25.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.298 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.71 -12.38 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.586 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.478 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 29.4 mm -54.59 -69.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.507 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -99.37 -51.76 3.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.392 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 95.46 1.68 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 4.5 p30 -170.53 153.85 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.178 -1.19 . . . . 0.0 109.526 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 12' ' ' GLU . 3.7 mm-40 -71.29 118.57 14.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.252 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.84 -41.88 3.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 109.496 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.551 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 2.3 p -153.18 169.26 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.537 ' N ' HG23 ' A' ' 14' ' ' VAL . 51.8 p -153.64 177.7 10.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.975 -1.078 . . . . 0.0 110.419 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.1 6.77 17.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.419 -0.801 . . . . 0.0 109.783 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.04 -8.4 44.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.145 -0.972 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 19' ' ' ASP . 52.6 m-85 -126.54 19.14 7.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.432 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER 61.46 120.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 37.3 mt -111.82 138.73 48.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.168 -0.957 . . . . 0.0 110.45 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -119.58 136.61 54.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.602 -0.687 . . . . 0.0 109.462 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 1.4 tt0 -99.81 115.98 30.84 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.247 -0.908 . . . . 0.0 108.881 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' A' ' 24' ' ' ASP . 6.4 t -70.82 158.92 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 109.48 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' VAL . 21.9 t0 -39.22 -39.97 0.68 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.507 -0.745 . . . . 0.0 109.568 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.88 -143.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 108.834 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.525 HD11 ' N ' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -125.98 62.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.031 -1.043 . . . . 0.0 109.244 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.527 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 16.4 m -138.49 150.97 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.543 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -104.7 157.07 17.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 80.4 mt-10 -122.86 117.47 25.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.422 -0.799 . . . . 0.0 109.079 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.551 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -113.54 115.45 28.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.48 150.09 45.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.413 ' HB3' ' HE3' ' A' ' 156' ' ' MET . 25.9 p -143.55 158.37 43.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.394 -0.816 . . . . 0.0 109.207 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.43 157.78 17.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.484 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.427 ' HE1' ' HB ' ' A' ' 64' ' ' THR . 5.7 mtp -108.06 121.97 45.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.332 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.2 m -119.46 160.67 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 0.0 109.573 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.415 HG21 HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -102.6 138.53 39.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.92 . . . . 0.0 109.677 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 m -125.18 141.67 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.62 106.64 17.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.427 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -71.53 160.52 32.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.402 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 41' ' ' GLY . . . -122.27 74.21 0.37 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 40' ' ' GLY . . . -49.37 179.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.97 -12.65 54.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -1.161 . . . . 0.0 109.587 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 93.1 t -117.75 -66.56 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.942 . . . . 0.0 109.562 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 18.4 m-20 60.43 -100.39 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.431 -0.793 . . . . 0.0 109.616 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 44' ' ' ASP . 3.8 tp 177.95 43.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 0.0 109.415 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 45' ' ' ILE . . . -50.83 -99.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.27 -90.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -1.147 . . . . 0.0 109.392 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 46' ' ' GLY . 10.4 p30 -110.48 146.85 35.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.363 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.38 -2.69 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.623 2.215 . . . . 0.0 110.459 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.57 -161.89 1.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.542 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 62.96 -136.93 0.41 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.0 109.295 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 51' ' ' ALA . 12.3 mt-10 -41.92 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.085 -1.01 . . . . 0.0 109.883 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 51' ' ' ALA . 18.0 t0 -119.49 -26.55 5.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.302 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.562 ' O ' ' CB ' ' A' ' 55' ' ' GLU . . . 51.53 -90.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 109.619 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 83.89 -50.25 0.13 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.788 -0.57 . . . . 0.0 109.703 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -110.23 -177.97 3.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -0.945 . . . . 0.0 109.578 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 m120 62.0 104.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 109.724 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.25 129.19 17.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.203 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.81 29.52 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.512 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.4 -89.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.5 32.44 2.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 p -85.29 122.55 29.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.015 -1.285 . . . . 0.0 109.332 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.01 151.98 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.501 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.427 ' HB ' ' HE1' ' A' ' 34' ' ' MET . 0.0 OUTLIER -88.33 131.76 34.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.885 . . . . 0.0 109.726 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 m -117.03 134.74 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.9 . . . . 0.0 109.571 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.427 ' HB2' ' CG2' ' A' ' 69' ' ' VAL . 34.9 m120 -69.86 134.81 48.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.468 ' O ' ' OG ' ' A' ' 71' ' ' SER . 28.9 p-10 -56.18 -24.41 41.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.825 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.536 HD13 ' CD2' ' A' ' 72' ' ' PHE . 58.4 tp -82.06 -34.85 29.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 108.953 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.54 ' CG1' ' HB2' ' A' ' 74' ' ' LEU . 53.5 t -66.36 -55.33 19.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.487 -0.758 . . . . 0.0 109.751 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -66.46 -42.88 86.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 0.0 110.224 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 68.1 m -55.94 -46.03 78.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.044 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.536 ' CD2' HD13 ' A' ' 68' ' ' LEU . 16.4 m-30 -100.43 18.82 18.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.9 ttm105 49.3 89.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 109.479 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.54 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 1.9 mm? -117.4 143.06 46.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.326 -0.859 . . . . 0.0 109.049 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.459 ' O ' HG21 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -121.43 143.36 37.52 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 109.741 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 36.7 Cg_endo -79.89 139.91 14.09 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.677 2.252 . . . . 0.0 110.467 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.0 t -122.05 135.39 54.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.231 -0.918 . . . . 0.0 109.257 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 t -114.45 145.58 41.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.925 . . . . 0.0 109.717 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CZ ' ' CD2' ' A' ' 130' ' ' PHE . 5.1 p90 -172.29 -177.6 1.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 83' ' ' SER . 21.2 p-10 -101.07 169.13 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.023 . . . . 0.0 109.606 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -53.69 -47.78 70.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.0 109.913 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.451 ' HB2' ' OD2' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -50.37 -35.69 29.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.778 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.469 ' HB2' ' OD1' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -71.9 -36.94 70.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.772 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.456 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 1.6 t80 -63.51 -47.41 81.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.827 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -40.97 91.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.936 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.03 -28.57 66.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.977 . . . . 0.0 109.911 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 138' ' ' PRO . 3.2 m-85 -70.12 -47.25 62.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 109.625 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.449 ' O ' ' HB2' ' A' ' 92' ' ' MET . 6.3 tp -74.17 -15.98 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.398 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.17 -59.77 2.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.2 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.61 -26.57 72.92 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 91' ' ' TYR . 4.5 t80 -72.46 -36.1 68.4 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -63.44 -43.33 97.72 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -58.14 -45.36 87.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.36 -0.838 . . . . 0.0 109.001 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.52 71.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 108.768 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.511 HG23 ' CE2' ' A' ' 110' ' ' PHE . 27.0 mm -56.04 -30.44 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 0.0 109.026 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.446 ' HD2' HG11 ' A' ' 107' ' ' VAL . 0.3 OUTLIER -54.18 -47.29 72.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.57 -30.82 64.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.757 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.515 ' CZ ' ' O ' ' A' ' 161' ' ' ASP . 3.8 tmt_? -60.7 -44.92 95.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 109.898 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.475 ' CD1' ' O ' ' A' ' 106' ' ' ARG . 14.2 mt -72.33 -49.75 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.158 -0.964 . . . . 0.0 109.784 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.4 -26.17 40.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.955 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -79.76 -45.11 19.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 0.0 109.199 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p -95.86 -70.37 0.72 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.423 ' HB3' ' NH2' ' A' ' 106' ' ' ARG . 10.8 t30 -123.38 118.13 27.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.452 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.8 -29.03 9.02 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.403 2.069 . . . . 0.0 110.675 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.453 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 3.0 mt-10 -70.28 -6.64 36.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.64 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.475 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -88.71 -3.34 58.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 0.0 109.878 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 59.1 t -72.34 -43.79 9.85 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 111.171 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.4 Cg_endo -77.86 -50.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.824 1.683 . . . . 0.0 110.902 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 110' ' ' PHE . 3.9 p -60.59 -46.84 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.72 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.571 ' N ' ' CG1' ' A' ' 109' ' ' VAL . 73.3 t80 -67.66 -37.4 82.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -0.783 . . . . 0.0 110.401 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 6.2 tm-20 -59.47 -49.66 76.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.06 -1.025 . . . . 0.0 110.451 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -64.82 -44.05 91.12 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.11 -0.994 . . . . 0.0 110.281 -179.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -61.2 -32.5 72.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.937 -1.102 . . . . 0.0 110.007 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.22 -51.0 65.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 111.367 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.614 ' CD1' ' N ' ' A' ' 116' ' ' GLY . 1.7 pp -62.94 -45.79 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.769 -1.207 . . . . 0.0 110.576 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.614 ' N ' ' CD1' ' A' ' 115' ' ' ILE . . . -59.06 -40.14 95.21 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.422 ' O ' HD11 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -73.03 -30.24 63.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -1.16 . . . . 0.0 109.871 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 88' ' ' ILE . 69.2 t -65.65 -43.95 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.896 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.517 ' CD ' ' C ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -71.84 -32.06 67.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.627 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -28.65 61.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 109.999 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.432 HD11 ' N ' ' A' ' 121' ' ' ILE . 1.2 mp -79.55 -30.68 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.998 -1.064 . . . . 0.0 108.977 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 23.2 mt -58.93 -26.19 64.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.897 . . . . 0.0 109.621 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 122' ' ' LEU . . . -43.89 -39.61 4.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.843 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 128' ' ' TYR . 2.6 m-20 -143.82 58.67 1.37 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 109.804 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 4.6 p90 -62.59 -35.03 78.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.417 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.495 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -76.36 -26.37 55.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.71 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.468 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 2.8 t70 -77.52 -27.69 51.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 109.516 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 128' ' ' TYR . 1.6 m-30 -100.04 -1.57 36.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.07 -159.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 109.465 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 79' ' ' PHE . 68.5 m-85 -147.97 121.71 9.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.577 ' CE1' ' HE3' ' A' ' 145' ' ' MET . 11.9 m-85 -98.6 168.15 10.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.961 . . . . 0.0 110.296 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.459 HG21 ' O ' ' A' ' 75' ' ' SER . 2.1 tt -150.7 146.54 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.408 -0.807 . . . . 0.0 109.437 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.75 168.44 46.65 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 135' ' ' SER . 0.2 OUTLIER -57.45 -21.21 35.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -1.159 . . . . 0.0 109.368 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 136' ' ' MET . 49.9 m -62.58 -41.71 99.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 75.41 41.81 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 109.691 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.25 129.39 24.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.148 -0.97 . . . . 0.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.441 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 33.3 Cg_endo -75.13 -13.35 21.17 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.322 2.015 . . . . 0.0 110.306 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -97.25 8.29 44.85 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 108.953 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.478 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -92.26 -161.81 0.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.347 -0.846 . . . . 0.0 109.489 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.444 ' SD ' ' O ' ' A' ' 162' ' ' GLY . 2.6 ttp -88.82 145.68 25.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.676 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.96 141.05 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.285 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.553 HG23 ' CE2' ' A' ' 158' ' ' PHE . 2.1 t -109.79 136.46 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.87 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 121' ' ' ILE . 53.0 mt -107.7 151.24 25.94 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.813 . . . . 0.0 108.976 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.577 ' HE3' ' CE1' ' A' ' 131' ' ' TYR . 0.0 OUTLIER -108.82 134.98 50.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.632 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -155.03 143.3 20.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.38 -0.825 . . . . 0.0 109.292 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.433 ' CD1' ' HA3' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -65.41 160.41 22.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.313 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 153' ' ' THR . 0.0 OUTLIER -58.49 173.58 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.15 -17.28 39.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -107.36 -47.35 3.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -0.978 . . . . 0.0 109.364 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 147' ' ' TYR . . . 120.28 29.17 1.66 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.76 -38.87 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -1.075 . . . . 0.0 109.279 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 148' ' ' ARG . 14.8 t -137.43 142.11 36.18 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.069 -1.019 . . . . 0.0 109.713 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 153' ' ' THR . 36.5 Cg_endo -79.35 146.71 19.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.665 2.244 . . . . 0.0 110.447 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -145.13 160.24 41.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.387 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.478 ' HB2' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -122.17 159.06 28.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.336 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.527 ' CG2' ' HB ' ' A' ' 27' ' ' VAL . 36.8 mt -113.29 136.26 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.672 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.553 ' CE2' HG23 ' A' ' 143' ' ' VAL . 48.1 m-85 -123.74 118.22 26.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.03 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -50.07 119.5 3.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.096 -1.002 . . . . 0.0 109.565 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 161' ' ' ASP . 18.8 tptp -67.34 -42.09 84.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.341 -0.849 . . . . 0.0 109.526 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.555 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -44.11 -38.85 3.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.22 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.446 ' O ' ' OD1' ' A' ' 6' ' ' ASP . . . -108.8 52.73 0.63 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.535 HD22 ' CD2' ' A' ' 4' ' ' TYR . 7.9 tt -151.17 149.44 29.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -1.123 . . . . 0.0 109.405 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 165' ' ' SER . 0.6 OUTLIER -138.0 157.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.901 . . . . 0.0 109.61 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' A' ' 164' ' ' VAL . 0.7 OUTLIER -111.02 120.88 43.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.675 . . . . 0.0 109.458 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -108.11 147.2 31.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.428 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.07 116.02 28.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 0.0 109.329 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.447 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' O ' HD22 ' A' ' 2' ' ' LEU . 6.2 ptt? . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.479 HD21 ' HA ' ' A' ' 167' ' ' LYS . 11.9 mt -121.27 149.07 43.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.631 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 23.4 mt -101.4 122.91 44.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.555 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.472 ' CE2' HD11 ' A' ' 20' ' ' LEU . 6.2 m-85 -106.42 118.8 37.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.866 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 0.7 OUTLIER -129.67 141.13 50.97 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.474 ' O ' HD22 ' A' ' 13' ' ' LEU . 12.2 p-10 -167.36 110.14 0.66 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.074 -1.016 . . . . 0.0 110.183 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.9 t -147.77 48.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.539 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER 62.12 15.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.9 t -163.96 -34.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.571 -0.706 . . . . 0.0 109.596 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.46 100.29 2.61 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 12' ' ' GLU . 51.8 t0 -130.08 -78.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.763 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER 161.61 113.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 109.408 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.564 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -146.51 -31.31 0.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.136 -0.977 . . . . 0.0 110.817 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.509 HG22 ' CB ' ' A' ' 30' ' ' ALA . 9.3 p -134.97 174.12 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.723 -1.235 . . . . 0.0 109.06 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.46 ' HA ' ' HB2' ' A' ' 4' ' ' TYR . 36.2 m -164.49 -174.73 3.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.021 . . . . 0.0 110.404 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' HA ' HD13 ' A' ' 20' ' ' LEU . 12.3 t70 -85.05 12.89 6.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.568 -0.708 . . . . 0.0 109.711 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.04 -17.03 64.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.955 . . . . 0.0 109.053 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.483 ' CE2' HD12 ' A' ' 68' ' ' LEU . 56.7 m-85 -118.37 19.49 13.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.462 -0.774 . . . . 0.0 109.169 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 18' ' ' TYR . 8.6 t0 63.33 120.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.528 ' CD2' ' HB1' ' A' ' 30' ' ' ALA . 10.0 mt -113.71 153.11 29.53 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.2 -0.938 . . . . 0.0 110.359 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -129.41 141.21 51.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.496 -0.752 . . . . 0.0 109.177 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.487 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 1.5 mt-10 -93.97 128.55 40.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.938 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 t -80.07 153.44 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.841 . . . . 0.0 109.589 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.01 -17.14 6.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.761 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.48 ' O ' ' CG2' ' A' ' 26' ' ' ILE . 8.5 m-20 -81.61 -100.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.619 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.48 ' CG2' ' O ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -164.53 60.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 0.0 109.41 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 26' ' ' ILE . 14.7 m -152.28 164.02 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 110.179 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.487 ' CE1' ' HG3' ' A' ' 22' ' ' GLU . 7.2 m-85 -104.34 157.85 16.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.419 -0.8 . . . . 0.0 108.858 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 19.6 mt-10 -127.07 118.59 24.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.961 . . . . 0.0 109.314 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.528 ' HB1' ' CD2' ' A' ' 20' ' ' LEU . . . -114.71 112.44 22.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.009 -1.057 . . . . 0.0 109.062 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 13.9 t0 -79.87 150.24 30.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 p -129.26 -174.5 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -141.15 141.71 34.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.318 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.466 ' CG ' ' O ' ' A' ' 34' ' ' MET . 7.6 ptm -91.22 123.94 35.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.535 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.3 m -121.57 160.13 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.442 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.34 121.78 34.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.405 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.5 m -121.13 138.47 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.587 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -71.19 93.5 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -119.14 139.21 52.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.313 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.69 -54.35 0.05 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.77 -119.03 6.1 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -117.13 -9.37 11.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.219 -1.165 . . . . 0.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 44' ' ' ASP . 68.7 t -119.11 -92.98 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.488 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 43' ' ' VAL . 3.3 t70 44.75 52.78 7.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 109.282 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 45' ' ' ILE . 6.8 tp -123.2 14.11 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.691 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.56 52.54 0.17 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' A' ' 48' ' ' ASN . . . -132.02 151.39 51.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -1.151 . . . . 0.0 109.325 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.452 ' C ' ' O ' ' A' ' 47' ' ' ALA . 1.4 p-10 40.84 78.55 0.37 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.447 -0.783 . . . . 0.0 109.469 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.62 -7.75 15.79 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.744 2.296 . . . . 0.0 110.711 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 56.27 -167.05 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.537 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HB3' ' OE2' ' A' ' 52' ' ' GLU . . . -134.0 -73.15 0.49 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.883 . . . . 0.0 109.421 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.439 ' OE2' ' HB3' ' A' ' 51' ' ' ALA . 3.8 mp0 -109.79 18.61 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.341 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 t70 55.97 -177.44 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.344 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 55' ' ' GLU . . . -115.89 -8.16 11.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.463 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 14.5 tt0 72.03 48.14 0.28 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.298 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -147.7 -80.73 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.242 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -97.27 128.64 44.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.32 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.71 -98.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.312 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.48 ' C ' ' CG ' ' A' ' 60' ' ' GLU . 5.3 tp10 -172.62 -74.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 109.447 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' CG ' ' C ' ' A' ' 59' ' ' GLU . 1.4 pt-20 39.18 43.11 0.83 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.457 -0.777 . . . . 0.0 109.851 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.434 ' O ' HG21 ' A' ' 62' ' ' THR . . . 69.81 69.38 1.4 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.434 HG21 ' O ' ' A' ' 61' ' ' GLY . 20.5 p -142.65 126.99 17.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -1.096 . . . . 0.0 109.46 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -126.16 142.92 51.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.364 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.54 135.45 36.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.963 . . . . 0.0 109.451 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASN . 17.7 m -132.95 131.64 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.426 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 22.9 m120 -45.2 153.74 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.473 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -88.82 -28.1 20.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.694 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.483 HD12 ' CE2' ' A' ' 18' ' ' TYR . 12.1 tp -78.39 -45.07 23.3 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.054 -1.029 . . . . 0.0 108.407 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.517 ' CG1' ' HB2' ' A' ' 74' ' ' LEU . 33.4 t -63.82 -54.62 29.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.452 ' C ' ' CD1' ' A' ' 70' ' ' TYR . 15.8 t80 -55.57 -32.55 63.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.177 -0.952 . . . . 0.0 109.533 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m -70.09 -38.08 75.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.851 . . . . 0.0 110.061 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.564 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 43.2 m-85 -104.35 10.32 35.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.015 -1.053 . . . . 0.0 110.142 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 4.1 tpp180 60.24 25.25 14.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.062 -1.024 . . . . 0.0 109.984 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.517 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 0.6 OUTLIER -43.5 137.76 2.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.511 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.466 ' O ' HG21 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -107.58 119.11 51.58 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.68 134.52 12.26 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.343 2.029 . . . . 0.0 110.104 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.533 ' CG2' HG23 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -126.17 179.82 5.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.088 -1.008 . . . . 0.0 109.742 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.97 132.09 37.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.494 -0.754 . . . . 0.0 109.146 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 79' ' ' PHE . 30.5 p90 -124.81 161.54 26.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.682 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -89.43 150.32 22.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -53.27 -32.8 50.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.136 -0.978 . . . . 0.0 110.039 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -87.45 -25.74 23.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 110.138 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -71.11 -38.18 72.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.118 -0.988 . . . . 0.0 109.855 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 3.8 t80 -68.48 -35.38 77.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.562 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.458 ' O ' HG21 ' A' ' 88' ' ' ILE . 7.5 mtm -64.06 -56.03 17.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.9 p -58.87 -37.71 77.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -74.87 -19.5 60.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.52 HG21 ' N ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -75.16 -31.96 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.866 . . . . 0.0 108.845 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.52 ' N ' HG21 ' A' ' 88' ' ' ILE . 3.4 mttt -70.82 -53.97 13.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.462 -0.773 . . . . 0.0 109.345 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.16 -24.02 73.23 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -75.36 -36.84 60.91 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.153 -1.204 . . . . 0.0 108.235 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.432 ' O ' ' HE1' ' A' ' 92' ' ' MET . 0.2 OUTLIER -67.92 -48.36 66.17 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.549 -0.719 . . . . 0.0 109.148 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 89' ' ' LYS . 28.3 mmtm -55.2 -41.26 71.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.334 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.54 -42.58 71.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 109.137 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 28.3 mm -70.66 -26.6 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.319 -0.863 . . . . 0.0 109.26 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.46 -34.29 75.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.959 . . . . 0.0 108.684 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.27 -47.94 46.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.559 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.516 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -56.9 -32.94 66.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.989 . . . . 0.0 109.433 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.516 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 86.9 mt -73.0 -41.93 63.77 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.255 -0.903 . . . . 0.0 109.326 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -33.93 73.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.384 -0.823 . . . . 0.0 109.556 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -73.15 -39.25 65.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.557 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.6 p -90.97 -82.4 0.29 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.12 123.82 26.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.381 -0.824 . . . . 0.0 109.055 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.61 -26.45 11.73 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.401 2.067 . . . . 0.0 110.661 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.21 -7.11 39.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.614 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.442 ' HD2' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -92.29 1.74 57.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.618 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 14.3 t -69.83 -46.43 24.13 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 110.252 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.9 Cg_endo -78.26 -36.6 0.95 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.02 1.813 . . . . 0.0 110.673 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.69 -51.15 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.995 . . . . 0.0 109.592 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.469 ' CE1' HG23 ' A' ' 95' ' ' ILE . 6.5 t80 -65.31 -37.72 88.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.919 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.45 ' O ' HD11 ' A' ' 115' ' ' ILE . 1.2 mt-10 -64.56 -35.51 81.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 109.953 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -71.75 -41.02 68.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.497 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -69.52 -54.54 13.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.077 -1.014 . . . . 0.0 110.374 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -58.92 -27.17 65.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 109.972 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.481 HG21 ' N ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -60.17 -49.11 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.338 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.481 ' N ' HG21 ' A' ' 115' ' ' ILE . . . -67.26 -40.76 92.15 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.453 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -61.26 -30.76 70.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -1.128 . . . . 0.0 110.177 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 114' ' ' ALA . 69.4 t -67.14 -41.74 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 110.391 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -69.3 -44.13 72.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.047 -1.033 . . . . 0.0 110.027 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.1 OUTLIER -57.04 -52.28 65.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.172 -0.955 . . . . 0.0 110.039 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 121' ' ' ILE . 1.6 mp -58.18 -44.54 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.08 -1.012 . . . . 0.0 109.323 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.11 -30.42 64.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 120' ' ' LYS . . . -50.25 -46.32 54.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.729 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 124' ' ' ASN . 2.4 p-10 -143.5 57.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 109.698 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.43 ' CZ ' ' HG2' ' A' ' 126' ' ' LYS . 21.9 p90 -51.79 -25.61 7.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 109.815 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.43 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.2 mmtt -61.96 -44.84 95.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 109.676 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -79.06 -23.01 44.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.618 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.577 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 2.8 m-85 -76.05 -20.32 57.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 109.751 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.8 OUTLIER 49.6 -177.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 110.029 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.505 ' CE1' HG13 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -142.91 121.38 12.42 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -108.9 176.93 4.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.03 -1.044 . . . . 0.0 110.869 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.533 HG23 ' CG2' ' A' ' 77' ' ' THR . 1.6 tt -155.54 150.88 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.561 -0.712 . . . . 0.0 109.556 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.72 -176.68 43.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -18.85 63.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -1.205 . . . . 0.0 109.429 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 m -64.47 -37.06 86.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.259 -0.901 . . . . 0.0 109.461 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.435 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER 62.23 43.79 8.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.764 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -98.65 127.26 36.24 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.72 -1.55 11.5 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.291 1.994 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -115.03 10.95 16.34 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.344 -0.848 . . . . 0.0 109.003 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . . . -100.95 -177.38 3.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.266 -0.896 . . . . 0.0 109.6 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.425 ' HE1' ' HB2' ' A' ' 159' ' ' PHE . 10.7 tmm? -83.49 142.32 31.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.535 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.505 HG13 ' CE1' ' A' ' 130' ' ' PHE . 41.1 t -108.45 141.48 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 0.0 109.65 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.494 ' N ' HG11 ' A' ' 142' ' ' VAL . 21.8 t -92.04 122.97 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.313 -0.867 . . . . 0.0 108.932 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 128' ' ' TYR . 1.1 mt -90.24 124.53 34.95 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.288 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.584 ' CE ' ' CE ' ' A' ' 156' ' ' MET . 53.5 ttm -104.93 128.47 53.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.577 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 14.4 t-20 -147.01 165.24 30.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.54 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -84.47 157.78 21.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -87.77 176.12 7.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.187 -0.945 . . . . 0.0 109.214 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.18 -13.93 51.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.22 -0.925 . . . . 0.0 109.137 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.3 -60.8 3.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.326 -0.859 . . . . 0.0 109.096 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 131.61 -27.02 3.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -133.95 37.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -1.175 . . . . 0.0 109.421 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.2 m -129.03 100.58 20.48 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.368 -0.833 . . . . 0.0 109.358 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.74 127.16 6.2 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.534 2.156 . . . . 0.0 110.481 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -145.03 159.42 42.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.584 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -129.68 142.72 50.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.278 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.49 HG21 ' N ' ' A' ' 158' ' ' PHE . 64.5 mt -102.4 148.45 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.579 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.49 ' N ' HG21 ' A' ' 157' ' ' ILE . 54.9 m-85 -127.17 118.66 24.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 109.36 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.443 ' HB3' ' OD1' ' A' ' 161' ' ' ASP . 43.8 m-85 -53.51 119.52 4.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.653 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 26' ' ' ILE . 7.8 tptt -66.7 -38.06 85.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.74 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.444 ' OD2' HD13 ' A' ' 95' ' ' ILE . 1.4 p-10 -44.76 -48.81 10.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.642 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 6' ' ' ASP . . . -104.71 50.21 0.86 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 164' ' ' VAL . 6.9 tt -145.18 155.17 43.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -1.194 . . . . 0.0 109.3 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.515 ' N ' ' CD2' ' A' ' 163' ' ' LEU . 4.3 m -144.2 135.52 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.973 . . . . 0.0 109.818 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.0 m -99.02 137.96 36.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.079 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -127.12 139.09 53.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.782 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.479 ' HA ' HD21 ' A' ' 2' ' ' LEU . 5.5 ttmt -78.58 125.27 29.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 109.35 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.497 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.9 165.82 14.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.6 mt -120.99 135.31 55.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.62 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 68.6 m-85 -121.54 133.02 55.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.833 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -135.07 153.59 51.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.832 . . . . 0.0 109.366 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 41.9 t0 -61.78 148.11 44.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 164' ' ' VAL . 18.5 t -91.2 53.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.898 . . . . 0.0 109.434 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -163.76 -54.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.084 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 0.1 OUTLIER 177.81 64.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.496 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' A' ' 13' ' ' LEU . . . -111.1 -18.74 8.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.5 OUTLIER 45.98 87.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -1.187 . . . . 0.0 109.234 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 58.18 102.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.121 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.526 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -117.25 -55.78 2.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.556 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.528 HG21 ' CB ' ' A' ' 30' ' ' ALA . 7.9 p -140.19 164.25 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 108.942 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.486 ' N ' HG23 ' A' ' 14' ' ' VAL . 53.9 p -153.24 172.12 17.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.54 2.32 29.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.484 -0.76 . . . . 0.0 109.759 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.78 -10.24 45.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.102 -0.999 . . . . 0.0 109.035 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CD2' ' CD1' ' A' ' 68' ' ' LEU . 34.7 m-85 -123.42 19.47 9.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.366 -0.834 . . . . 0.0 109.157 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 0.6 OUTLIER 61.62 128.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.348 -0.845 . . . . 0.0 108.925 -179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 65.3 mt -118.91 151.17 38.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.129 -0.982 . . . . 0.0 110.139 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.66 122.86 24.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 109.492 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -80.97 121.24 25.78 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.271 -0.893 . . . . 0.0 108.733 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 24' ' ' ASP . 6.6 t -77.38 154.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.716 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' VAL . 6.9 m-20 -42.77 -32.0 0.55 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.818 . . . . 0.0 109.542 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -70.6 -116.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -153.77 63.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.734 -1.229 . . . . 0.0 109.483 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.6 m -152.36 144.21 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.127 -0.983 . . . . 0.0 109.757 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 3.7 m-85 -98.95 134.19 42.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 108.851 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -108.78 138.26 45.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.989 -1.069 . . . . 0.0 109.967 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.528 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -116.17 113.98 23.82 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -65.74 150.15 48.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 0.0 109.689 -179.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.6 t -102.94 146.82 27.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.0 150.75 50.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.147 -0.971 . . . . 0.0 109.642 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.506 ' HG2' ' CG2' ' A' ' 64' ' ' THR . 0.0 OUTLIER -89.52 133.09 34.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.402 ' O ' HG21 ' A' ' 35' ' ' VAL . 11.8 m -128.08 120.81 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.287 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.416 ' C ' HG11 ' A' ' 37' ' ' VAL . 3.4 t -76.74 151.16 36.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.94 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.416 HG11 ' C ' ' A' ' 36' ' ' THR . 3.9 m -137.03 131.65 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.312 -0.867 . . . . 0.0 109.44 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.45 ' HA ' HG23 ' A' ' 62' ' ' THR . 31.0 mttt -77.47 128.92 35.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.648 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -102.06 150.45 23.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 109.331 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.22 15.96 61.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.85 57.23 4.65 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -161.87 71.84 0.37 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -1.154 . . . . 0.0 109.459 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -51.88 -72.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.214 -0.929 . . . . 0.0 109.377 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -100.52 118.38 36.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.452 -0.78 . . . . 0.0 109.577 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.43 ' O ' HG21 ' A' ' 45' ' ' ILE . 6.9 tp -146.93 72.19 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.82 142.52 16.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 48' ' ' ASN . . . -160.29 127.23 4.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -1.167 . . . . 0.0 109.51 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.512 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 1.4 m-80 43.28 62.42 8.87 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 48' ' ' ASN . 35.8 Cg_endo -78.03 75.85 4.64 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.786 2.324 . . . . 0.0 110.424 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.8 42.02 1.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.482 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 59.65 52.14 5.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 53' ' ' ASP . 12.5 mt-10 -97.91 18.84 14.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.511 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 52' ' ' GLU . 11.5 t70 61.13 134.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 0.0 109.65 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.37 -170.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 109.82 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 1.6 pp20? -114.04 170.07 8.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.62 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 2.1 mt-10 164.66 166.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.548 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 56' ' ' GLU . 8.9 t30 62.18 130.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.333 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -171.59 -78.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -151.38 -60.77 0.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.506 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -77.36 -80.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 62' ' ' THR . . . 106.62 77.21 1.06 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 61' ' ' GLY . 17.8 p 43.73 -167.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.113 . . . . 0.0 109.683 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.419 ' HG2' ' C ' ' A' ' 62' ' ' THR . 65.3 mm-40 -145.56 146.22 31.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.506 ' CG2' ' HG2' ' A' ' 34' ' ' MET . 0.0 OUTLIER -99.89 134.26 43.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 109.446 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.54 146.62 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.406 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 32.8 m120 -54.46 148.56 11.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.57 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 21.0 p30 -99.32 -21.77 15.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 109.333 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.574 ' CD1' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -82.86 -42.78 17.38 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.518 ' O ' ' CA ' ' A' ' 73' ' ' ARG . 87.8 t -72.37 -35.19 51.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.475 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 2.1 t80 -69.38 -58.25 4.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.906 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 t -56.93 -52.54 64.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.939 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 11.1 m-85 -83.17 -3.47 57.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 109.633 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.518 ' CA ' ' O ' ' A' ' 69' ' ' VAL . 11.4 tpt180 53.63 34.39 18.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 109.545 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 132' ' ' ILE . 11.8 mt -42.77 142.36 0.89 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.84 . . . . 0.0 109.251 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.46 135.6 26.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.682 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.38 140.98 15.65 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.526 2.151 . . . . 0.0 110.187 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 p -122.34 175.62 6.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.664 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.2 m -144.7 151.2 38.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.068 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.629 ' CE2' ' CD2' ' A' ' 130' ' ' PHE . 6.6 p90 -172.05 -177.54 1.91 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 0.0 109.819 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.08 166.71 10.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.364 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -57.86 -52.16 66.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.733 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -26.21 67.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.788 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.3 t -71.93 -41.06 68.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.967 . . . . 0.0 109.946 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 24.8 t80 -60.34 -39.06 85.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.796 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.5 mtm -63.44 -43.45 97.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.059 -1.026 . . . . 0.0 109.847 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -40.31 95.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.17 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -67.43 -58.2 5.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.161 -0.962 . . . . 0.0 109.895 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 84' ' ' TYR . 6.3 tp -52.2 -23.79 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.843 . . . . 0.0 109.862 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -74.18 -42.26 60.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.067 -1.02 . . . . 0.0 109.655 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.12 -30.72 76.13 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 141' ' ' MET . 31.2 t80 -80.82 -35.96 32.25 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.046 -1.267 . . . . 0.0 108.846 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -43.54 96.65 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.405 -0.809 . . . . 0.0 109.221 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -40.69 82.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.338 -0.851 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.23 82.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 39.7 mm -61.64 -44.3 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.159 -0.963 . . . . 0.0 109.555 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.438 ' HE2' HG11 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -47.02 -51.59 16.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.912 . . . . 0.0 109.194 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.84 80.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 102' ' ' SER . 1.2 tmt_? -57.46 -36.1 70.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 109.344 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.516 ' CD1' ' HD2' ' A' ' 106' ' ' ARG . 8.6 mt -72.59 -49.82 29.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -0.852 . . . . 0.0 109.601 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -23.99 52.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.719 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.48 -21.66 17.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 109.568 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 2.7 t -114.13 -89.0 0.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.56 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -120.74 99.64 47.14 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.382 -0.824 . . . . 0.0 109.535 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.479 ' HA ' HG22 ' A' ' 107' ' ' VAL . 32.8 Cg_endo -74.37 -13.19 22.98 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.433 2.088 . . . . 0.0 110.392 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -7.14 16.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.127 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.534 ' HA ' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -118.76 21.48 12.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.032 -1.043 . . . . 0.0 109.772 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 16.4 t -72.42 -46.34 10.24 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.494 -0.754 . . . . 0.0 110.868 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.5 Cg_endo -77.0 -48.89 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 121.976 1.784 . . . . 0.0 110.814 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 30.1 m -57.04 -44.86 83.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.104 -0.997 . . . . 0.0 109.589 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.545 ' CD2' ' OD2' ' A' ' 161' ' ' ASP . 29.0 t80 -67.0 -37.87 84.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.84 -54.28 47.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.1 -1.0 . . . . 0.0 110.308 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -60.63 -45.92 92.24 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.105 -0.997 . . . . 0.0 110.207 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -56.34 -40.42 74.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 109.909 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.23 -27.37 63.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.081 -1.012 . . . . 0.0 109.586 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.64 -48.53 71.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.221 -0.924 . . . . 0.0 109.138 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.66 -29.91 76.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -69.98 -42.65 72.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -1.217 . . . . 0.0 109.812 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.457 ' O ' HD13 ' A' ' 122' ' ' LEU . 97.4 t -69.68 -32.54 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -71.67 -34.51 69.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.127 -0.983 . . . . 0.0 109.624 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.52 ' N ' ' HD3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -84.53 -16.91 40.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.135 -0.978 . . . . 0.0 109.843 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -42.96 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.123 -0.986 . . . . 0.0 109.337 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 118' ' ' VAL . 6.6 mt -54.42 -28.2 42.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 109.465 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.24 -49.19 64.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 109.542 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -130.53 63.21 1.57 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -0.849 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.484 ' CE2' ' CD2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -62.02 -49.93 74.06 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.364 -0.835 . . . . 0.0 109.753 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -55.55 -29.02 58.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.585 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.526 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -81.2 -26.55 35.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 109.945 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 129' ' ' ASP . 11.8 m-85 -84.16 -21.25 31.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.932 . . . . 0.0 110.018 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 128' ' ' TYR . 38.6 m-20 54.79 168.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.045 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.629 ' CD2' ' CE2' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -128.01 121.14 29.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.136 -0.978 . . . . 0.0 108.963 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.509 ' CZ ' ' HE2' ' A' ' 145' ' ' MET . 17.2 m-85 -109.5 174.71 5.74 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.21 -0.931 . . . . 0.0 110.538 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.465 ' O ' HD21 ' A' ' 74' ' ' LEU . 3.6 tt -149.16 162.22 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.553 -0.717 . . . . 0.0 109.365 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.44 -176.93 50.54 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -68.5 -27.01 65.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -1.109 . . . . 0.0 109.398 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 136' ' ' MET . 1.0 OUTLIER -61.1 -34.15 74.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 65.16 39.77 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.385 -0.822 . . . . 0.0 109.371 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.35 139.91 27.46 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 109.198 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -73.8 -17.34 22.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.355 2.037 . . . . 0.0 109.982 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.76 -12.95 62.06 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.77 149.46 21.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.337 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -66.49 139.14 57.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.603 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.1 m -88.43 141.68 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.821 . . . . 0.0 109.469 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.585 HG23 ' CE2' ' A' ' 158' ' ' PHE . 16.5 t -97.05 140.82 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.193 -0.942 . . . . 0.0 109.053 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 129' ' ' ASP . 12.4 mt -110.94 134.55 52.48 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.514 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.509 ' HE2' ' CZ ' ' A' ' 131' ' ' TYR . 1.4 mtm -104.74 128.88 52.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 109.109 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.504 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 28.5 t-20 -150.24 159.15 44.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.958 . . . . 0.0 109.685 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -89.05 128.47 35.73 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.292 -0.88 . . . . 0.0 109.013 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -166.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 109.64 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -30.38 70.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 109.723 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -53.68 -59.3 4.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.698 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 111.39 -22.63 19.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.495 ' CD1' ' N ' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -116.51 8.67 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -1.123 . . . . 0.0 109.165 179.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.8 m -117.38 101.3 52.84 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.157 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.49 137.58 14.81 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.601 2.201 . . . . 0.0 110.378 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 14.9 p90 -145.25 139.64 27.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.162 -0.961 . . . . 0.0 109.733 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.508 ' HB2' ' CE1' ' A' ' 158' ' ' PHE . 3.3 mtt -101.89 165.06 11.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.532 ' O ' ' CG1' ' A' ' 143' ' ' VAL . 12.5 mt -125.8 141.07 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.984 -1.073 . . . . 0.0 110.23 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.585 ' CE2' HG23 ' A' ' 143' ' ' VAL . 11.3 m-85 -132.92 118.58 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.418 -0.801 . . . . 0.0 108.902 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -48.59 138.4 10.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 109.722 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -65.98 -51.98 53.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.898 . . . . 0.0 109.156 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 110' ' ' PHE . 3.9 m-20 -47.04 -48.46 22.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.009 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -86.76 50.53 4.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.452 ' O ' ' CD2' ' A' ' 163' ' ' LEU . 2.1 tt -158.96 116.51 2.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.465 -1.021 . . . . 0.0 109.222 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.414 ' CG1' HG23 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -114.29 148.73 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 4.9 p -96.64 120.58 37.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.32 -0.862 . . . . 0.0 109.372 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -127.3 129.04 46.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.16 128.62 37.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.194 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.408 ' OXT' ' CG ' ' A' ' 168' ' ' PHE . 15.6 p90 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.74 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.438 HD22 ' C ' ' A' ' 1' ' ' MET . 4.7 mt -114.05 166.26 11.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.026 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.1 mt -127.96 143.3 51.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 109.298 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 29.9 m-85 -121.59 112.35 18.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.885 . . . . 0.0 109.825 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -112.9 150.41 31.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.328 -0.858 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 141' ' ' MET . 0.4 OUTLIER -68.34 158.24 33.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.586 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.8 t -94.92 -15.68 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.389 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 139' ' ' ASP . 0.8 OUTLIER -89.47 -25.05 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.256 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.5 -46.02 2.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.13 58.35 2.34 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -134.24 179.96 5.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -1.144 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -78.65 89.45 4.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.962 . . . . 0.0 109.703 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.24 -62.8 1.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 109.029 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.553 ' CG2' ' HB1' ' A' ' 30' ' ' ALA . 13.8 p -143.19 171.03 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.418 ' C ' HD13 ' A' ' 20' ' ' LEU . 4.9 m -156.49 178.32 10.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.151 . . . . 0.0 110.804 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' CA ' HD13 ' A' ' 20' ' ' LEU . 23.9 t0 -84.12 12.5 6.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.517 -0.739 . . . . 0.0 109.889 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.416 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . . . -66.32 -9.23 31.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.004 . . . . 0.0 109.02 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.543 ' CD2' HD13 ' A' ' 68' ' ' LEU . 4.6 m-85 -128.7 21.13 5.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.424 -0.797 . . . . 0.0 109.264 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER 62.91 126.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.062 -1.024 . . . . 0.0 108.309 -178.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.52 ' CD2' ' HB1' ' A' ' 30' ' ' ALA . 12.9 mt -120.35 147.17 45.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 110.584 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.9 mmtp -123.23 140.59 52.87 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -100.75 114.41 28.14 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.11 -0.994 . . . . 0.0 108.828 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 24' ' ' ASP . 3.2 t -68.63 158.37 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.371 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' VAL . 1.5 t70 -41.15 -47.19 3.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.426 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' ASP . 16.2 m-20 -62.12 -148.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 108.957 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.425 ' C ' HG11 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -119.97 60.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.233 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.425 HG11 ' C ' ' A' ' 26' ' ' ILE . 11.9 m -134.19 150.62 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.882 . . . . 0.0 109.784 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.04 155.77 21.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -0.82 . . . . 0.0 109.134 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 2.4 pt-20 -133.29 120.71 21.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.043 -1.036 . . . . 0.0 109.661 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.553 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -100.14 127.05 46.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.441 -0.787 . . . . 0.0 109.087 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 64.9 m-20 -68.0 145.69 54.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.932 . . . . 0.0 109.77 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -125.52 152.97 44.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.248 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.435 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -122.45 152.07 40.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.557 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.434 ' CG ' ' HB ' ' A' ' 64' ' ' THR . 2.9 ttm -96.53 135.63 38.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.41 -0.807 . . . . 0.0 109.401 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -123.5 174.15 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.182 -0.949 . . . . 0.0 109.637 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.29 120.58 41.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.92 162.89 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.355 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.526 ' CE ' HG23 ' A' ' 62' ' ' THR . 1.0 OUTLIER -123.19 112.49 17.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.396 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 40' ' ' GLY . 19.7 mt-30 -117.4 147.4 42.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.484 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 39' ' ' GLN . . . -45.19 -61.75 3.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.48 -58.19 0.55 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.44 46.48 2.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -1.153 . . . . 0.0 109.536 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.7 t -54.57 -29.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.6 170.61 11.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.514 ' O ' ' CG1' ' A' ' 45' ' ' ILE . 2.4 tt -164.91 26.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 109.588 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.0 12.08 77.59 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.81 132.29 54.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -1.168 . . . . 0.0 109.382 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 t30 58.22 86.93 0.15 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.407 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.17 117.24 4.07 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.64 2.227 . . . . 0.0 110.578 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.37 10.58 2.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.336 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -167.5 -66.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.915 . . . . 0.0 109.468 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 48.25 85.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 9.0 p-10 -118.99 45.32 2.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 109.297 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . 64.62 114.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.551 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -83.0 127.96 34.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.182 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -147.7 81.13 1.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.625 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -113.75 -169.27 1.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.316 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 60' ' ' GLU . . . -178.96 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.713 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 47.17 -92.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.633 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 58' ' ' ALA . 1.5 mt-10 49.12 23.16 0.71 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.533 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' O ' ' OG1' ' A' ' 62' ' ' THR . . . 65.03 91.6 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.526 HG23 ' CE ' ' A' ' 38' ' ' LYS . 4.8 p 57.26 -162.45 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.384 -1.068 . . . . 0.0 109.437 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.69 145.36 24.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.471 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.434 ' HB ' ' CG ' ' A' ' 34' ' ' MET . 1.2 p -88.45 147.01 24.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 109.405 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.7 m -135.89 147.99 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.563 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -70.71 154.06 42.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.291 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 56.1 p30 -80.4 -18.02 50.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.543 HD13 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.63 -35.41 22.7 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.21 -0.931 . . . . 0.0 108.976 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.409 HG22 ' HE3' ' A' ' 156' ' ' MET . 73.6 t -72.84 -45.2 56.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.395 -0.815 . . . . 0.0 109.277 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -69.31 -36.25 76.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.106 -0.996 . . . . 0.0 110.109 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.1 m -70.51 -49.74 45.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.19 -0.944 . . . . 0.0 110.437 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 14' ' ' VAL . 16.9 m-85 -92.24 -0.26 57.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.021 . . . . 0.0 110.132 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 57.27 64.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.956 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.417 ' CD1' ' SD ' ' A' ' 156' ' ' MET . 12.0 mt -77.78 164.38 25.27 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.101 -1.0 . . . . 0.0 108.941 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -131.45 106.16 14.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.269 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 35.4 Cg_endo -76.8 120.9 5.66 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.359 2.039 . . . . 0.0 110.503 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.0 t -88.95 157.55 18.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.9 . . . . 0.0 109.425 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.4 t -114.15 7.93 16.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.935 . . . . 0.0 109.509 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.516 ' C ' ' CD1' ' A' ' 79' ' ' PHE . 6.9 p90 -136.35 142.72 43.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.632 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 1.0 OUTLIER 172.68 30.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.883 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -52.98 60.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.037 -1.039 . . . . 0.0 109.428 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -118.41 -31.24 4.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.82 . . . . 0.0 109.297 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.459 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 4.1 m -59.67 -30.44 68.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.201 -0.937 . . . . 0.0 108.911 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 80' ' ' ASP . 5.0 t80 -66.61 -44.67 81.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 0.0 109.601 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.517 ' O ' ' CG2' ' A' ' 88' ' ' ILE . 7.6 mtt -60.93 -43.79 98.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.944 . . . . 0.0 109.92 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.1 m -66.87 -26.75 67.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.208 -0.932 . . . . 0.0 110.183 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CD2' ' O ' ' A' ' 83' ' ' SER . 12.4 m-85 -81.46 -29.34 33.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 109.945 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 85' ' ' MET . 3.0 tp -75.92 -28.16 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -49.2 16.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.374 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.01 -34.37 89.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -72.76 -36.2 67.62 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -61.0 -38.4 85.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -67.26 -39.48 86.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.382 -0.824 . . . . 0.0 109.182 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.11 72.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.113 -0.992 . . . . 0.0 108.761 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.495 ' CG2' ' OD2' ' A' ' 161' ' ' ASP . 33.2 mm -62.92 -43.43 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.307 -0.87 . . . . 0.0 109.253 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.08 -37.42 9.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.261 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.1 -47.1 47.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.424 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.489 ' CD ' HD22 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -48.97 -46.29 43.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 109.545 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 106' ' ' ARG . 6.1 mt -63.84 -46.46 84.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.204 -0.935 . . . . 0.0 109.17 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -23.74 7.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 108.881 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 98' ' ' ARG . 2.3 mt-10 -78.24 -48.15 16.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.441 -0.787 . . . . 0.0 109.223 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.0 -72.51 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.484 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.11 139.74 14.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.363 -0.836 . . . . 0.0 109.478 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.81 -13.97 21.74 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.662 2.241 . . . . 0.0 110.816 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 83.1 mt-10 -67.43 -23.52 65.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -0.972 . . . . 0.0 109.686 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.526 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -87.81 5.71 38.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 109.565 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.57 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 2.4 t -72.06 -50.02 9.49 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 109.532 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 36.8 Cg_endo -79.56 -33.39 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.226 1.951 . . . . 0.0 110.435 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 49.8 t -67.47 -53.93 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.37 -0.831 . . . . 0.0 109.885 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 161' ' ' ASP . 92.4 t80 -68.67 -37.53 79.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.895 . . . . 0.0 109.936 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -49.12 79.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.979 . . . . 0.0 110.229 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -70.88 -37.18 73.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.455 ' N ' ' HG3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -62.8 -35.07 78.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.879 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.42 -28.08 63.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 109.661 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -34.12 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.304 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.26 -44.95 84.41 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.5 -44.59 78.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -1.148 . . . . 0.0 109.811 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 85.1 t -53.56 -35.39 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.356 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -43.38 67.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 109.678 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -33.14 72.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.869 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.17 -35.15 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.106 -0.997 . . . . 0.0 109.377 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 44.9 mt -60.52 -28.65 68.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.652 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.31 -36.68 78.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -143.13 59.55 1.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.19 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -59.16 -28.88 67.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.937 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 4.7 mmtp -72.24 -36.2 69.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 109.796 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -80.08 -23.67 41.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.809 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 129' ' ' ASP . 46.7 m-85 -85.7 -25.0 26.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.122 -0.987 . . . . 0.0 109.712 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 126' ' ' LYS . 8.8 m-20 53.33 175.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.367 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.53 121.7 19.1 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.242 -0.911 . . . . 0.0 108.814 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.481 ' CE2' ' HB3' ' A' ' 76' ' ' PRO . 14.7 m-85 -101.7 166.91 10.43 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.201 -0.937 . . . . 0.0 110.308 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -156.42 142.97 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.528 -0.732 . . . . 0.0 109.497 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.45 179.57 1.86 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -67.74 -27.19 66.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -1.125 . . . . 0.0 109.248 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.544 ' O ' ' CG ' ' A' ' 136' ' ' MET . 1.0 OUTLIER -60.29 -35.07 74.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.301 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 79.92 20.01 0.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.501 -0.749 . . . . 0.0 109.471 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.47 123.62 35.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.029 -1.044 . . . . 0.0 109.798 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.41 ' HG3' ' CD1' ' A' ' 87' ' ' TYR . 32.3 Cg_endo -73.24 -13.5 25.67 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.145 1.897 . . . . 0.0 109.789 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.471 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.8 m-20 -62.86 -21.21 65.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 141' ' ' MET . . . -76.78 -69.82 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.85 . . . . 0.0 109.089 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 5.8 tmm? 173.4 137.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 109.352 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.449 HG11 ' O ' ' A' ' 131' ' ' TYR . 2.5 t -98.84 140.55 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.568 HG23 ' CE2' ' A' ' 158' ' ' PHE . 3.4 t -112.14 138.05 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -106.18 143.67 33.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.2 mtt -107.75 132.28 53.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.282 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 13.2 t30 -143.77 160.28 41.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 109.643 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.74 146.29 24.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.94 . . . . 0.0 109.444 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -77.81 -172.83 2.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.563 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -21.64 63.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.51 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -58.02 5.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.85 -13.0 9.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.462 HD11 ' O ' ' A' ' 152' ' ' ILE . 2.4 pp -124.47 5.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.267 -1.137 . . . . 0.0 109.586 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.2 m -111.88 100.28 48.19 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.242 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -81.59 132.27 7.73 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.622 2.215 . . . . 0.0 110.598 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 146' ' ' ASN . 38.4 p90 -133.78 142.59 47.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.106 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 9.6 mtt -100.79 161.15 13.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 110.207 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.509 ' C ' ' CD1' ' A' ' 158' ' ' PHE . 68.9 mt -124.46 145.78 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.215 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.576 ' N ' ' CD1' ' A' ' 158' ' ' PHE . 4.2 m-85 -137.3 141.82 41.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 109.483 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -58.83 120.31 8.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 109.356 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -67.58 -45.61 75.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 109.513 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.587 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . 4.6 t0 -54.53 -25.84 28.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.345 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -103.8 39.2 2.89 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 8.1 mt -149.75 140.19 22.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.388 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.0 123.01 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.521 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.56 119.57 23.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.468 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -117.18 138.03 51.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.571 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.35 146.48 31.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 168' ' ' PHE . 5.1 t80 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.373 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.291 0.567 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.616 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 1.3 mm? -75.11 156.56 35.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.282 -0.886 . . . . 0.0 109.683 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 mp -134.29 124.06 25.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 6.1 m-85 -96.12 109.58 21.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.429 -0.795 . . . . 0.0 109.81 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HG3' HG21 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -110.03 152.45 25.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.348 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.456 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 20.2 t0 -68.11 134.57 50.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.523 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 p -76.13 -36.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.433 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.463 HG23 ' OG ' ' A' ' 9' ' ' SER . 2.3 mp -66.47 -91.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.463 ' OG ' HG23 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -135.11 80.84 1.86 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.38 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 6' ' ' ASP . . . -145.31 -62.99 0.02 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.6 t0 68.21 11.01 8.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -1.099 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 173.1 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.693 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -122.7 -61.37 1.46 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 109.285 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.559 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 10.5 p -136.76 166.35 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 108.979 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.496 ' N ' HG23 ' A' ' 14' ' ' VAL . 1.4 p -145.47 164.34 31.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.009 -1.057 . . . . 0.0 110.543 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.488 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 1.5 t0 -82.96 8.1 13.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.461 -0.775 . . . . 0.0 109.745 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.23 -19.92 65.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 0.0 109.131 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.559 ' CG ' HD13 ' A' ' 68' ' ' LEU . 14.2 m-85 -110.87 21.26 16.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.272 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER 58.75 111.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 16.2 mt -105.53 144.8 31.79 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.14 -0.975 . . . . 0.0 110.609 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.83 133.03 56.51 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.914 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.13 120.94 38.42 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.298 -0.876 . . . . 0.0 108.703 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 24' ' ' ASP . 12.0 t -72.07 155.16 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' VAL . 22.2 t70 -43.4 -31.46 0.68 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.69 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.522 ' O ' ' CG2' ' A' ' 26' ' ' ILE . 1.0 OUTLIER -70.15 -103.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.473 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.522 ' CG2' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -166.95 63.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.959 -1.088 . . . . 0.0 109.442 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.41 ' CG2' HG22 ' A' ' 23' ' ' VAL . 3.6 m -142.83 142.27 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.965 . . . . 0.0 109.735 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -100.59 132.36 46.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.429 -0.794 . . . . 0.0 109.144 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 18.6 mt-10 -107.99 124.7 50.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.93 . . . . 0.0 109.268 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.559 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -105.59 116.09 31.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 109.27 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.95 147.05 49.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.727 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.452 ' HB2' ' HG2' ' A' ' 154' ' ' PRO . 3.9 m -115.56 167.8 10.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -0.912 . . . . 0.0 109.378 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.41 ' HG2' ' N ' ' A' ' 34' ' ' MET . 18.5 tt0 -131.84 148.6 52.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.162 -0.961 . . . . 0.0 109.625 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.444 ' CG ' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -99.08 121.06 40.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 109.635 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 m -119.83 144.79 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 0.0 109.353 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 p -78.74 128.91 34.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.401 ' O ' HG21 ' A' ' 37' ' ' VAL . 15.6 m -133.01 134.22 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.25 -0.906 . . . . 0.0 109.437 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 104.16 16.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.673 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.57 151.18 33.84 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -0.897 . . . . 0.0 109.453 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.48 -61.31 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 42' ' ' ASP . . . 170.0 -69.43 0.14 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER 39.33 34.24 0.12 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.52 -0.988 . . . . 0.0 109.761 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 44' ' ' ASP . 56.5 t -139.23 -38.29 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 43' ' ' VAL . 2.2 m-20 44.68 92.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.504 HD11 HG22 ' A' ' 45' ' ' ILE . 12.8 mt -68.15 -63.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.502 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.83 143.12 14.33 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.26 121.01 9.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -1.13 . . . . 0.0 109.533 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 179.02 90.49 0.17 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.54 103.76 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.725 2.283 . . . . 0.0 110.304 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -146.1 60.08 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 109.707 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 173.81 148.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 0.0 109.756 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 54.26 52.05 13.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.598 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.77 -38.12 82.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.169 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.56 126.89 29.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.232 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -52.14 108.6 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.828 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 9.2 tt0 73.49 130.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.972 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.05 -158.9 0.68 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.57 -59.25 1.75 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.149 -0.969 . . . . 0.0 109.454 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.17 162.17 0.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.676 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -112.73 -21.29 11.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.29 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.05 1.46 61.29 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.1 p -57.68 136.61 56.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -1.167 . . . . 0.0 109.481 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.29 142.86 28.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.444 ' HB ' ' CG ' ' A' ' 34' ' ' MET . 0.1 OUTLIER -86.19 147.57 26.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.69 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.02 139.15 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.852 . . . . 0.0 109.281 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -62.71 152.26 36.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.771 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' A' ' 71' ' ' SER . 31.9 t-20 -80.72 -21.65 40.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.551 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.559 HD13 ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.22 -40.0 18.62 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.17 -0.956 . . . . 0.0 108.566 179.574 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.467 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 41.4 t -67.07 -44.36 88.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.543 -0.723 . . . . 0.0 109.343 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -70.18 -40.46 74.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.869 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 1.3 t -63.26 -34.29 77.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 110.119 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.404 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 59.4 m-85 -111.32 6.75 20.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.03 -1.043 . . . . 0.0 109.904 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER 54.04 32.63 15.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 109.913 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.491 ' N ' HD21 ' A' ' 74' ' ' LEU . 1.3 mm? -43.13 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.269 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -127.92 141.69 41.96 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.149 -0.97 . . . . 0.0 109.48 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 36.3 Cg_endo -78.47 127.15 7.96 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.576 2.184 . . . . 0.0 110.456 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.471 HG22 ' HB ' ' A' ' 132' ' ' ILE . 1.0 OUTLIER -138.33 176.54 8.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.12 -0.988 . . . . 0.0 109.641 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.412 ' O ' ' CD2' ' A' ' 130' ' ' PHE . 13.1 m -120.66 -149.41 0.43 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.228 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.647 ' CG ' ' CE1' ' A' ' 125' ' ' PHE . 6.5 p90 -164.84 -178.75 5.41 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.173 -0.954 . . . . 0.0 109.405 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.543 ' CB ' ' CB ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -120.85 136.94 54.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.125 -0.984 . . . . 0.0 109.63 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.45 -38.18 88.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 109.851 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.82 -33.64 6.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 109.781 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.543 ' CB ' ' CB ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -71.08 -29.44 65.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.922 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.52 ' CE1' ' HB ' ' A' ' 88' ' ' ILE . 5.6 t80 -56.69 -35.95 69.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.006 -1.059 . . . . 0.0 109.812 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.8 mtm -53.66 -43.55 68.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.912 -1.118 . . . . 0.0 109.694 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 t -70.62 -41.07 72.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.064 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -56.67 -56.47 21.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 109.57 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.52 ' HB ' ' CE1' ' A' ' 84' ' ' TYR . 4.2 tp -59.33 -29.33 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.857 . . . . 0.0 109.459 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -57.45 11.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.136 -0.977 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.02 -19.91 70.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -70.64 -40.71 72.91 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.167 -1.196 . . . . 0.0 107.778 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -41.78 75.93 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -40.07 63.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.425 -0.797 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.07 73.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.21 -0.932 . . . . 0.0 109.189 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.493 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 13.5 mm -63.02 -38.21 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.185 -0.947 . . . . 0.0 109.127 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HD3' ' OE1' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -55.48 -35.1 65.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.068 . . . . 0.0 109.397 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.65 59.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.915 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.525 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -59.63 -31.74 69.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.015 . . . . 0.0 109.623 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.525 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 28.2 mt -72.56 -44.34 62.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.965 . . . . 0.0 109.6 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.447 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -58.56 -35.98 73.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.59 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -83.72 -18.29 38.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.442 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 t -115.83 -75.35 0.59 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -126.69 95.82 36.82 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.436 -0.79 . . . . 0.0 109.174 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.438 ' HB3' ' HA ' ' A' ' 100' ' ' GLN . 33.8 Cg_endo -74.42 -22.14 16.51 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.461 2.107 . . . . 0.0 110.489 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 -20.13 62.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.567 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.51 ' CD ' HD21 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -99.64 20.81 13.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.419 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 19.9 t -68.73 -45.59 33.49 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 110.638 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.8 Cg_endo -77.24 -25.1 8.84 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.952 1.768 . . . . 0.0 110.614 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.84 -52.77 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.262 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.46 ' CD1' HG23 ' A' ' 95' ' ' ILE . 24.7 t80 -67.31 -37.61 83.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.72 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -61.04 -37.39 82.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.033 -1.042 . . . . 0.0 109.978 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -71.28 -38.48 71.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.936 . . . . 0.0 110.224 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -67.33 -51.18 55.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.113 -0.992 . . . . 0.0 110.24 -179.323 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.89 -34.01 69.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.402 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.512 HG21 ' N ' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -58.1 -46.76 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.119 -0.988 . . . . 0.0 109.513 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.512 ' N ' HG21 ' A' ' 115' ' ' ILE . . . -67.51 -43.71 85.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.406 ' O ' HD11 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -58.1 -35.94 72.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.173 -1.192 . . . . 0.0 110.285 -179.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 39.6 t -63.15 -40.31 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.076 -1.015 . . . . 0.0 109.925 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.493 ' CD ' ' C ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -71.3 -28.78 64.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 109.202 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -56.33 10.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.885 . . . . 0.0 109.573 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.406 HD11 ' O ' ' A' ' 117' ' ' PHE . 1.3 mp -59.82 -42.95 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 0.0 109.528 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 59.6 mt -48.46 -26.91 2.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.66 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.14 67.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -136.7 55.61 1.83 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 109.392 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.647 ' CE1' ' CG ' ' A' ' 79' ' ' PHE . 20.3 t80 -58.55 -33.77 70.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.653 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -39.33 80.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 109.763 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -78.67 -24.82 44.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.939 . . . . 0.0 109.686 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 129' ' ' ASP . 10.6 m-85 -77.6 -9.64 59.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.549 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.9 m-20 48.1 -175.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.352 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.558 ' CE1' HG13 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -139.8 120.45 14.25 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.327 -0.858 . . . . 0.0 108.842 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 145' ' ' MET . 15.2 m-85 -111.72 171.89 7.22 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.095 -1.003 . . . . 0.0 110.467 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.471 ' HB ' HG22 ' A' ' 77' ' ' THR . 6.4 tt -149.23 140.55 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.474 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.11 160.24 22.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.405 ' HG3' ' CB ' ' A' ' 73' ' ' ARG . 2.3 tt0 -63.25 -21.82 66.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -1.086 . . . . 0.0 109.609 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 136' ' ' MET . 18.7 t -65.73 -34.84 79.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.469 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 135' ' ' SER . 3.2 ttm 74.86 59.78 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 0.0 109.464 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.416 ' OD2' ' HB3' ' A' ' 135' ' ' SER . 0.4 OUTLIER -129.45 109.63 17.63 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.356 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.13 -2.12 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.304 2.003 . . . . 0.0 110.32 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -104.41 -3.16 24.42 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.341 -0.85 . . . . 0.0 109.193 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.45 ' HA ' HG23 ' A' ' 8' ' ' ILE . . . -91.76 -72.89 0.57 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.161 -0.962 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.469 ' HE3' ' O ' ' A' ' 162' ' ' GLY . 3.6 ttp -177.78 141.43 0.28 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.779 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.558 HG13 ' CE1' ' A' ' 130' ' ' PHE . 74.6 t -102.76 141.53 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.114 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.477 HG12 ' CZ ' ' A' ' 158' ' ' PHE . 3.3 t -102.3 143.55 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.102 -0.999 . . . . 0.0 109.559 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.5 mt -106.63 134.58 49.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.326 -0.859 . . . . 0.0 109.195 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.493 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 12.1 ttm -113.28 124.49 52.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.337 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.575 ' O ' ' CD2' ' A' ' 155' ' ' TYR . 8.8 t30 -144.51 144.32 31.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -74.36 148.22 41.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -55.69 -172.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 109.586 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -79.99 -1.44 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.632 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -104.22 -35.04 8.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.327 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.25 38.22 6.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -127.71 -26.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -1.164 . . . . 0.0 109.763 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 t -136.58 132.39 18.65 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 0.0 109.351 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.452 ' HG2' ' HB2' ' A' ' 32' ' ' CYS . 36.6 Cg_endo -80.8 153.28 19.72 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.661 2.241 . . . . 0.0 110.602 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 146' ' ' ASN . 24.7 p90 -145.12 134.59 23.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 109.347 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.479 ' HE3' ' HE2' ' A' ' 145' ' ' MET . 0.2 OUTLIER -102.13 154.33 19.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.341 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.465 ' O ' HG11 ' A' ' 143' ' ' VAL . 6.4 mt -115.87 145.47 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.477 ' CZ ' HG12 ' A' ' 143' ' ' VAL . 58.1 m-85 -136.93 129.17 29.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.421 ' HB2' ' SD ' ' A' ' 141' ' ' MET . 3.4 m-85 -60.79 127.78 33.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 109.632 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.07 -54.42 18.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.781 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.449 ' OD1' ' HD2' ' A' ' 98' ' ' ARG . 12.7 t0 -43.62 -34.77 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.811 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.469 ' O ' ' HE3' ' A' ' 141' ' ' MET . . . -102.98 53.57 0.74 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.1 mt -161.96 130.23 4.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.44 HG21 ' HG3' ' A' ' 5' ' ' LYS . 5.4 m -114.1 139.15 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.3 p -83.24 142.71 30.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -133.79 123.16 24.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 109.523 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.419 ' CG ' HD12 ' A' ' 2' ' ' LEU . 0.2 OUTLIER -96.37 110.95 23.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.365 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.123 -0.985 . . . . 0.0 109.476 -179.83 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 168' ' ' PHE . 17.8 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 167' ' ' LYS . 14.7 mt -105.47 157.6 17.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.4 mt -104.51 123.52 47.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 0.0 109.288 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 4.2 m-85 -107.35 118.48 36.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.677 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -139.8 156.31 46.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.271 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.01 155.89 29.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.647 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.446 ' O ' HG21 ' A' ' 7' ' ' VAL . 8.5 p -97.58 -11.62 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.872 . . . . 0.0 109.418 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.42 ' O ' HG21 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -91.76 -23.87 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.179 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.5 m -124.37 -10.77 7.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.744 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.87 58.18 9.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 10.0 m-20 -127.51 134.53 49.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -1.134 . . . . 0.0 109.487 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.416 ' C ' HD22 ' A' ' 13' ' ' LEU . 43.3 mt-10 -63.17 116.64 5.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.87 . . . . 0.0 109.569 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 4.0 mt -116.72 -48.04 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.874 . . . . 0.0 109.377 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.594 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 6.1 p -136.58 175.1 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.002 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.441 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.1 p -159.57 173.22 16.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.87 -1.144 . . . . 0.0 110.594 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.453 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 10.9 t0 -84.1 2.86 37.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.529 -0.732 . . . . 0.0 109.7 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.74 -11.73 55.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.126 -0.984 . . . . 0.0 109.035 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.562 ' CE1' ' CD1' ' A' ' 68' ' ' LEU . 26.2 m-85 -120.62 21.08 11.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.453 -0.78 . . . . 0.0 109.267 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.31 133.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 69.1 mt -129.31 143.57 50.9 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.277 -0.889 . . . . 0.0 109.765 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -129.62 133.5 47.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 109.469 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -91.97 121.59 33.7 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.467 ' HB ' ' OD1' ' A' ' 25' ' ' ASP . 13.3 t -76.66 153.42 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -42.98 -36.93 1.71 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.579 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.576 ' OD2' ' CE1' ' A' ' 117' ' ' PHE . 6.1 p30 -63.73 -123.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.9 . . . . 0.0 109.311 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.519 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -146.14 63.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.746 -1.221 . . . . 0.0 109.35 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.465 HG23 ' OD1' ' A' ' 25' ' ' ASP . 13.3 m -151.94 163.47 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.746 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 4.8 m-85 -115.85 156.97 25.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.117 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 156' ' ' MET . 7.5 pt-20 -128.98 128.37 43.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.521 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.594 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -111.42 116.42 30.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.516 -0.74 . . . . 0.0 109.279 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 51.1 m-20 -63.32 142.55 58.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 109.581 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.458 ' SG ' HD21 ' A' ' 68' ' ' LEU . 58.6 m -133.45 152.66 51.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.902 . . . . 0.0 109.405 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -103.41 161.52 13.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.301 -0.874 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.7 mtt -105.0 131.71 52.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.468 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -136.84 128.02 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.898 . . . . 0.0 109.389 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.459 ' O ' HG21 ' A' ' 36' ' ' THR . 9.6 t -76.5 135.88 39.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 109.569 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.57 152.52 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 0.0 109.634 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.63 97.74 11.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.72 139.19 39.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.66 -106.11 2.79 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.04 150.56 19.6 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -128.82 -59.74 1.12 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -1.12 . . . . 0.0 109.361 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.02 69.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.936 . . . . 0.0 109.347 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.7 -172.82 4.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 109.581 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.4 mm -67.55 -23.39 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.494 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.33 54.7 0.12 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 51' ' ' ALA . . . -115.11 -88.06 0.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -1.135 . . . . 0.0 109.596 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.577 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -48.83 -51.59 53.1 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.992 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 48' ' ' ASN . 35.6 Cg_endo -78.72 -16.06 13.22 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.489 2.126 . . . . 0.0 110.906 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -143.72 57.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.064 -1.022 . . . . 0.0 109.717 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 50' ' ' SER . . . 179.22 -66.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.94 . . . . 0.0 109.668 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 48' ' ' ASN . 7.8 pt-20 -143.81 178.38 7.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -111.1 31.62 5.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.328 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' A' ' 48' ' ' ASN . . . -77.08 115.44 16.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 109.662 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -73.53 96.6 2.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.312 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.79 83.55 3.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.976 . . . . 0.0 109.698 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -124.92 -165.15 1.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -0.89 . . . . 0.0 109.451 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -176.51 45.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.313 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 67.18 23.17 9.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.347 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.29 13.53 8.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.873 . . . . 0.0 109.493 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.02 -27.78 11.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.7 p -65.64 123.37 19.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -1.142 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -133.75 148.75 51.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.57 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.94 117.87 23.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 109.272 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.94 143.6 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -74.02 154.38 39.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -74.04 -24.28 59.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.729 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.562 ' CD1' ' CE1' ' A' ' 18' ' ' TYR . 27.7 tp -81.81 -45.03 16.14 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.083 -1.01 . . . . 0.0 108.552 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 74' ' ' LEU . 55.8 t -65.03 -38.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.397 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -69.59 -36.21 76.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.132 -0.98 . . . . 0.0 109.902 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.6 -50.69 62.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.868 . . . . 0.0 110.129 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 34.9 m-85 -82.71 -3.66 56.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.997 . . . . 0.0 110.128 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER 73.49 18.39 3.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.498 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.53 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 1.8 mm? -39.29 138.69 0.61 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.463 -0.773 . . . . 0.0 109.976 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.467 ' O ' HG21 ' A' ' 132' ' ' ILE . 2.2 p -118.05 113.97 37.28 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.34 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.21 149.23 21.93 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.418 2.078 . . . . 0.0 110.468 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.5 p -113.78 -175.42 2.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.347 -0.846 . . . . 0.0 108.974 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.38 -44.66 0.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.809 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 79' ' ' PHE . 6.6 p90 -78.57 132.11 37.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.586 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.538 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . 1.4 m-20 -175.97 27.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 109.825 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -45.0 95.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.069 -1.019 . . . . 0.0 109.354 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -122.49 -32.53 3.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.54 -32.4 72.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.293 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.573 ' CD2' ' CZ ' ' A' ' 125' ' ' PHE . 1.0 OUTLIER -58.71 -48.1 82.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.578 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.461 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.2 mtt -60.3 -33.79 72.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.974 . . . . 0.0 109.818 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 t -67.61 -39.2 84.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.74 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -67.9 -47.18 69.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.806 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 85' ' ' MET . 6.2 tp -61.46 -26.73 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.505 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -43.35 57.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 109.595 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.29 -26.52 73.48 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.536 ' CE2' ' HA ' ' A' ' 141' ' ' MET . 17.9 m-85 -81.64 -36.65 28.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -1.152 . . . . 0.0 109.03 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -41.86 86.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.305 -0.872 . . . . 0.0 109.55 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.526 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -70.72 -42.96 69.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.059 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.526 ' N ' ' HD2' ' A' ' 93' ' ' LYS . . . -55.31 -49.47 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.04 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.511 HG23 ' CE2' ' A' ' 110' ' ' PHE . 34.1 mm -57.28 -43.19 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.344 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.55 -47.61 39.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.276 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.19 -34.56 77.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.324 -0.86 . . . . 0.0 109.298 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.458 ' O ' ' OG ' ' A' ' 102' ' ' SER . 3.6 tmt_? -63.36 -34.01 76.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.512 ' CD1' ' HD2' ' A' ' 106' ' ' ARG . 9.9 mt -71.83 -45.53 61.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.161 -0.962 . . . . 0.0 109.295 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -54.76 -35.36 63.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.588 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.39 -40.31 62.14 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.0 109.085 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -89.83 -77.55 0.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.524 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' A' ' 106' ' ' ARG . 5.0 p30 -144.24 118.89 5.95 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.845 . . . . 0.0 109.398 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.69 -13.56 22.12 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.487 2.125 . . . . 0.0 110.609 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.28 -19.79 65.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.868 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.512 ' HD2' ' CD1' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -100.89 15.52 28.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 109.603 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.603 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 15.6 t -72.27 -45.41 10.7 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 110.894 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.0 Cg_endo -76.34 -49.29 0.12 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.953 1.769 . . . . 0.0 111.009 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 29.5 m -58.31 -44.35 88.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.043 -1.036 . . . . 0.0 109.679 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.511 ' CE2' HG23 ' A' ' 95' ' ' ILE . 52.6 t80 -65.5 -38.51 89.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.243 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 115' ' ' ILE . 1.1 mt-10 -63.71 -44.33 93.92 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.133 -0.98 . . . . 0.0 110.332 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -33.81 76.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.155 -0.965 . . . . 0.0 110.122 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -69.57 -46.96 65.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.986 . . . . 0.0 109.864 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.408 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -64.66 -27.25 68.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 109.688 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -72.48 -44.93 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.7 -48.4 72.91 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.576 ' CE1' ' OD2' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -60.12 -41.33 92.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -1.19 . . . . 0.0 109.869 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 56.9 t -64.32 -32.38 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.9 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -70.76 -33.28 70.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.029 . . . . 0.0 109.861 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -32.59 57.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.138 -0.976 . . . . 0.0 109.815 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 117' ' ' PHE . 1.5 mp -72.04 -31.21 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.923 . . . . 0.0 109.319 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 95.6 mt -64.86 -26.79 68.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.048 -1.033 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.6 -29.18 69.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.975 . . . . 0.0 109.928 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.61 55.53 1.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.156 -0.965 . . . . 0.0 109.436 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 130' ' ' PHE . 4.0 t80 -63.34 -20.88 65.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.731 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.433 ' CG ' ' N ' ' A' ' 127' ' ' ASP . 6.0 ptmm? -74.4 -47.11 35.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.058 -1.026 . . . . 0.0 109.71 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 126' ' ' LYS . 8.5 t70 -72.28 -23.72 61.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.616 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 1.1 m-85 -79.33 -24.28 42.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.112 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.531 ' C ' ' CD1' ' A' ' 130' ' ' PHE . 2.5 m-20 53.24 173.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 109.14 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.687 ' CE1' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -134.51 121.19 20.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 108.98 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.527 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 13.0 m-85 -105.66 164.63 11.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.102 -0.999 . . . . 0.0 110.661 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.468 ' O ' HG21 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -146.79 138.8 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.436 -0.79 . . . . 0.0 109.435 179.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.21 155.21 3.59 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -59.24 -23.9 62.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -1.143 . . . . 0.0 109.119 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 136' ' ' MET . 3.0 p -64.65 -35.22 80.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.408 -0.807 . . . . 0.0 109.285 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 72.67 40.82 0.59 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.293 -0.88 . . . . 0.0 109.365 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.84 134.14 32.63 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.867 . . . . 0.0 109.309 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.67 -5.74 16.83 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.385 2.057 . . . . 0.0 110.133 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -98.21 -4.32 35.66 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.287 -0.883 . . . . 0.0 109.208 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.05 134.99 39.68 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.536 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -64.49 152.17 42.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.6 m -88.64 141.89 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 109.369 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.562 HG23 ' CE2' ' A' ' 158' ' ' PHE . 2.6 t -92.23 130.01 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.236 -0.915 . . . . 0.0 108.967 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.462 HD21 ' O ' ' A' ' 129' ' ' ASP . 1.5 mt -103.42 135.43 45.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.527 ' HE3' ' CZ ' ' A' ' 131' ' ' TYR . 0.0 OUTLIER -108.54 142.73 38.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.569 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 1.8 t30 -145.97 166.37 26.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.717 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.72 125.93 35.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.566 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.472 ' HG3' ' CD2' ' A' ' 155' ' ' TYR . 0.9 OUTLIER -66.32 -169.31 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.24 -0.912 . . . . 0.0 109.404 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -16.09 60.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.465 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 148' ' ' ARG . 2.0 m-20 -57.89 -56.57 20.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 0.0 109.333 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 126.73 -23.19 5.68 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -140.45 37.07 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -1.127 . . . . 0.0 109.221 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.4 m -127.27 100.54 26.33 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.08 131.81 9.07 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.569 2.179 . . . . 0.0 109.814 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.472 ' CD2' ' HG3' ' A' ' 148' ' ' ARG . 40.3 p90 -135.96 142.64 44.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.097 -1.002 . . . . 0.0 109.718 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.545 ' HB2' ' CE1' ' A' ' 158' ' ' PHE . 6.5 mtp -99.02 149.16 23.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.208 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.451 ' O ' HG12 ' A' ' 143' ' ' VAL . 68.8 mt -117.15 141.38 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.562 ' CE2' HG23 ' A' ' 143' ' ' VAL . 5.7 m-85 -132.61 141.79 48.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 109.307 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 163' ' ' LEU . 72.6 m-85 -71.06 127.71 33.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 109.697 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.21 -40.83 86.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.343 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.62 -33.28 45.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.409 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -112.65 50.05 0.8 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 159' ' ' PHE . 0.6 OUTLIER -153.26 129.24 10.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -1.121 . . . . 0.0 109.525 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 m -118.81 144.84 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 109.307 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -106.08 129.64 54.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 109.862 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -120.65 122.43 40.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.249 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.473 ' HA ' HD21 ' A' ' 2' ' ' LEU . 2.1 tttp -55.75 123.24 13.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.736 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.403 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.486 ' CG ' HD23 ' A' ' 2' ' ' LEU . 4.6 ptp . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.287 0.565 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.486 HD23 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -67.09 147.16 53.5 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 2' ' ' LEU . 57.9 mt -118.41 126.65 52.53 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.429 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 165' ' ' SER . 75.8 m-85 -114.15 121.58 44.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.725 ' HA ' HD23 ' A' ' 13' ' ' LEU . 10.0 ptmt -126.37 160.79 29.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.616 -0.678 . . . . 0.0 109.228 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.418 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 25.6 t0 -98.86 154.08 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.329 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.36 -17.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.0 mt -75.43 -44.65 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 164.56 43.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.24 -41.94 3.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 57.1 99.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -1.19 . . . . 0.0 109.478 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 44.73 81.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.415 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.068 HD11 HD12 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -86.15 -32.06 21.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.718 HG21 ' CB ' ' A' ' 30' ' ' ALA . 8.2 p -166.91 174.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.966 -1.083 . . . . 0.0 109.529 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.626 ' H ' HG22 ' A' ' 14' ' ' VAL . 28.2 t -146.17 168.34 21.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.987 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.51 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 20.4 t0 -93.11 -4.59 52.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 109.483 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.18 -20.71 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.151 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.631 ' CD2' HD11 ' A' ' 68' ' ' LEU . 13.5 m-85 -99.08 -55.67 2.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.401 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 18' ' ' TYR . 3.3 m-20 155.44 130.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 30' ' ' ALA . 76.7 mt -130.27 133.56 46.59 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.046 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -131.43 127.52 37.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 9.2 pt-20 -92.9 129.59 38.77 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.058 -1.026 . . . . 0.0 109.614 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' ASP . 4.1 t -78.32 152.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -43.79 -28.46 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.884 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.728 ' O ' HG23 ' A' ' 26' ' ' ILE . 3.0 m-20 -65.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -162.98 49.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.987 -1.071 . . . . 0.0 109.203 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 6.7 m -140.57 151.42 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.654 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -100.6 157.63 16.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.081 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.2 tt0 -128.61 116.87 20.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.105 . . . . 0.0 109.629 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.718 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -107.24 112.82 25.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 108.958 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -73.89 146.64 43.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.979 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.04 148.54 48.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.828 . . . . 0.0 109.072 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 71' ' ' SER . 19.7 p30 -85.45 -17.77 35.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.975 . . . . 0.0 109.57 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.631 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.09 -41.75 16.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 108.716 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.856 HG22 ' HB2' ' A' ' 74' ' ' LEU . 45.2 t -72.35 -36.69 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.411 -0.805 . . . . 0.0 109.286 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -69.61 -43.18 73.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -74.22 -27.94 61.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.936 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.489 ' C ' ' CD ' ' A' ' 73' ' ' ARG . 26.3 m-85 -114.39 16.66 17.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.458 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER 37.84 44.06 0.55 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.729 -0.607 . . . . 0.0 110.596 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.856 ' HB2' HG22 ' A' ' 69' ' ' VAL . 6.6 mt -49.44 142.85 7.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.997 -1.065 . . . . 0.0 108.566 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.693 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.4 p -128.96 107.7 18.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.992 -1.067 . . . . 0.0 109.463 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 131' ' ' TYR . 35.8 Cg_endo -78.21 134.04 12.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.454 2.103 . . . . 0.0 110.247 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -124.26 159.69 29.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.729 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.75 164.36 24.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -150.24 179.98 7.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.778 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.59 153.62 36.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.105 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.55 67.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.703 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.66 -31.32 65.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 109.529 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.5 m -66.15 -29.96 70.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 10.3 t80 -65.75 -36.87 84.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.703 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 3.1 mtt -64.66 -38.03 89.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 110.011 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -71.11 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.918 . . . . 0.0 110.496 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -77.27 -38.98 49.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.5 HG23 ' HE3' ' A' ' 89' ' ' LYS . 6.7 tp -76.34 -26.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.843 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.5 ' HE3' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -76.77 -56.38 4.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 109.673 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.18 -23.0 73.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 91' ' ' TYR . 30.1 t80 -81.34 -40.7 23.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.022 -1.281 . . . . 0.0 108.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -63.47 -40.54 97.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 89' ' ' LYS . 0.5 OUTLIER -65.24 -38.53 90.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.94 -46.59 78.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.025 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.515 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 29.2 mm -64.74 -40.39 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -51.61 -38.09 53.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.133 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.61 -39.13 64.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 0.0 109.68 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.547 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -59.9 -32.11 70.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.365 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.547 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 50.6 mt -73.08 -47.35 45.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -55.34 -36.89 66.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.751 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.59 -31.5 41.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.2 t -105.08 -78.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.723 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 9.9 t-20 -119.83 107.94 39.59 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.26 -19.78 19.42 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.385 2.057 . . . . 0.0 110.381 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -74.14 -11.43 60.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.214 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.544 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -94.1 0.71 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.489 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 53.6 t -71.95 -43.23 10.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 111.29 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.5 Cg_endo -76.45 -52.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.877 1.718 . . . . 0.0 111.085 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 2.3 m -59.72 -36.99 69.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.997 -1.064 . . . . 0.0 109.587 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 44.9 t80 -69.67 -37.34 76.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.276 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.784 ' O ' HD12 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -68.53 -48.78 63.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.868 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -49.47 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.057 . . . . 0.0 110.807 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 109' ' ' VAL . 2.5 m120 -64.49 -48.91 73.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.439 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -62.72 -32.09 73.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -68.27 -39.63 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.402 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.59 -47.82 73.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -42.09 97.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.988 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 114' ' ' ALA . 71.8 t -60.13 -35.53 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.847 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -68.18 -38.13 81.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.933 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -78.83 -17.56 55.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.94 . . . . 0.0 109.897 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.44 -37.87 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 109.678 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 15.7 mt -62.34 -31.63 72.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 109.659 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.1 -26.29 26.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.636 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -154.76 54.53 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 2.2 p90 -59.8 -22.13 61.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.639 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.444 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -76.58 -43.42 38.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -65.11 -26.39 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 4.9 m-85 -85.11 -12.24 53.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.338 -0.851 . . . . 0.0 109.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.486 ' O ' HD22 ' A' ' 144' ' ' LEU . 4.1 m-20 50.88 177.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.667 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.804 ' CE1' HG13 ' A' ' 142' ' ' VAL . 2.7 t80 -139.07 121.23 15.79 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.559 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 9.1 m-85 -103.36 170.69 7.8 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.056 -1.028 . . . . 0.0 110.669 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 75' ' ' SER . 2.0 tt -156.54 142.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.65 -178.94 51.87 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.421 ' OE1' ' HG2' ' A' ' 73' ' ' ARG . 3.6 mp0 -64.36 -19.45 65.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 136' ' ' MET . 82.6 p -56.01 -33.58 65.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 135' ' ' SER . 13.7 mmt 64.7 53.86 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.572 -0.705 . . . . 0.0 109.494 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.43 ' N ' HD11 ' A' ' 132' ' ' ILE . 6.4 t0 -128.96 120.12 20.2 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.323 -0.86 . . . . 0.0 109.176 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.98 2.67 6.37 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.286 1.99 . . . . 0.0 110.559 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.78 12.94 11.45 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.275 -0.891 . . . . 0.0 109.197 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.39 -156.87 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.452 ' HE3' ' HB2' ' A' ' 159' ' ' PHE . 0.0 OUTLIER -64.5 121.53 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.804 HG13 ' CE1' ' A' ' 130' ' ' PHE . 94.4 t -106.35 120.27 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.549 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.623 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 7.2 t -109.46 141.52 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.485 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 129' ' ' ASP . 53.1 mt -114.65 141.42 47.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.31 -0.869 . . . . 0.0 108.965 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.1 ttm -104.8 119.68 39.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.018 . . . . 0.0 109.522 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.586 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 44.6 t30 -138.09 146.72 43.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.541 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.9 OUTLIER -87.3 146.2 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.885 . . . . 0.0 109.541 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -58.75 -171.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.29 -17.46 64.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -53.49 4.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.541 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 114.89 -24.72 10.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 152' ' ' ILE . 1.3 tp -85.18 3.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.291 -1.123 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 m -123.67 101.18 36.94 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.6 122.82 5.13 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.509 2.14 . . . . 0.0 109.924 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 155' ' ' TYR . 5.9 p90 -141.03 148.66 40.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.28 158.6 26.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 109.022 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 143' ' ' VAL . 41.6 mt -116.64 141.93 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 110.02 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 4.5 m-85 -126.3 113.69 17.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.477 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 8.0 m-85 -42.93 119.31 1.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.06 -28.58 67.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.865 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 159' ' ' PHE . 3.3 p30 -57.63 -39.7 77.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.443 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -105.93 43.04 1.76 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 1.068 HD12 HD11 ' A' ' 13' ' ' LEU . 3.6 tt -142.47 125.76 16.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.44 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -112.77 157.42 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.552 ' HA ' ' CD1' ' A' ' 4' ' ' TYR . 1.7 m -101.49 139.21 37.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.08 123.17 33.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -90.57 139.32 30.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 167' ' ' LYS . 12.2 mt -99.02 154.07 18.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.644 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.4 mt -113.56 138.16 50.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.765 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.484 ' HB2' HG13 ' A' ' 14' ' ' VAL . 13.2 m-85 -116.5 108.45 16.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.104 -0.998 . . . . 0.0 109.585 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.526 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.6 OUTLIER -105.08 163.46 12.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.493 -0.754 . . . . 0.0 109.345 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.506 ' OD1' ' CE ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -81.01 157.12 25.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 109.303 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.475 ' CG2' HG13 ' A' ' 164' ' ' VAL . 68.5 t -106.52 -18.82 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.975 . . . . 0.0 109.601 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 mt -85.9 -25.06 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 109.267 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.84 -58.62 1.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.498 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.21 74.42 0.91 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -161.98 160.53 27.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -1.153 . . . . 0.0 109.51 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.7 129.24 36.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.718 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -118.05 -76.76 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.09 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 6.0 p -131.78 167.21 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.599 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.9 p -136.35 148.91 48.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.87 -1.144 . . . . 0.0 110.408 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.494 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 36.3 t70 -82.23 5.61 19.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.491 -0.756 . . . . 0.0 109.284 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.46 -24.09 67.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.893 . . . . 0.0 108.884 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.583 ' CE2' HD13 ' A' ' 68' ' ' LEU . 30.2 m-85 -100.13 21.19 13.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.548 -0.72 . . . . 0.0 109.604 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER 58.3 112.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 108.89 -179.328 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 30' ' ' ALA . 12.2 mt -103.48 147.1 27.56 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 110.343 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -129.75 122.85 29.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.803 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -80.86 128.64 33.89 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ASP . 2.5 t -86.79 92.36 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 0.0 110.116 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 23' ' ' VAL . 23.5 m-20 22.89 45.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 120.848 0.356 . . . . 0.0 111.673 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' VAL . 18.6 m-20 -161.25 -114.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.943 -1.098 . . . . 0.0 109.684 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 160' ' ' LYS . 1.0 OUTLIER -144.71 12.9 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.809 -1.182 . . . . 0.0 109.427 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 12.3 m -104.41 133.68 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 34.7 m-85 -98.51 151.23 20.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.314 -0.866 . . . . 0.0 109.077 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 mt-10 -117.41 117.44 29.48 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.514 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.82 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -96.75 112.62 24.3 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 4.7 m-20 -68.93 150.78 47.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 110.042 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.59 144.24 36.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.27 -0.894 . . . . 0.0 109.188 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 0.0 109.586 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.514 ' N ' ' ND2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.524 ' OD1' ' CE1' ' A' ' 18' ' ' TYR . 30.9 p30 -98.14 -15.01 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.87 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.964 HD23 ' HE2' ' A' ' 156' ' ' MET . 48.9 tp -85.48 -41.57 15.23 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.148 -0.97 . . . . 0.0 108.989 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.685 HG13 ' HB2' ' A' ' 74' ' ' LEU . 66.6 t -72.77 -37.75 56.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.358 -0.839 . . . . 0.0 109.172 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -69.28 -48.89 60.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.453 -0.779 . . . . 0.0 110.295 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 t -69.4 -52.5 26.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.217 -0.927 . . . . 0.0 110.05 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.698 ' CD1' HD12 ' A' ' 68' ' ' LEU . 28.8 m-85 -75.19 -12.75 60.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.14 37.29 3.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.685 ' HB2' HG13 ' A' ' 69' ' ' VAL . 9.3 mt -50.28 107.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.981 -1.074 . . . . 0.0 108.742 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.047 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -89.96 126.73 56.36 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.864 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.52 129.32 8.36 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.502 2.135 . . . . 0.0 110.16 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.12 135.81 37.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.088 -1.008 . . . . 0.0 109.656 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.5 m -64.54 -172.4 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.193 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -158.43 -176.94 6.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.082 -1.011 . . . . 0.0 109.592 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.568 ' CB ' ' HB2' ' A' ' 83' ' ' SER . 0.1 OUTLIER -114.69 142.09 46.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.454 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -44.97 95.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 110.153 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.61 -40.27 14.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.991 . . . . 0.0 110.427 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.568 ' HB2' ' CB ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -59.1 -29.48 67.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 109.59 -179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -56.9 -48.39 78.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.782 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mtt -64.05 -46.43 84.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.198 -0.939 . . . . 0.0 110.021 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 m -54.9 -37.05 65.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 109.97 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.57 ' CZ ' ' O ' ' A' ' 138' ' ' PRO . 24.1 t80 -76.47 -33.97 58.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 109.735 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' MET . 3.6 mm -71.42 -15.6 18.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.125 -0.984 . . . . 0.0 109.308 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -57.1 3.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.34 72.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -77.86 -36.8 49.51 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.282 -1.128 . . . . 0.0 108.395 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.456 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -62.44 -51.94 65.5 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -57.14 -38.82 74.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.487 -0.758 . . . . 0.0 109.293 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.76 -50.42 72.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.917 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.771 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 30.3 mm -65.37 -28.97 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -44.78 93.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.192 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 100' ' ' GLN . . . -69.3 -25.89 64.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -0.844 . . . . 0.0 109.102 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -71.27 -41.1 70.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.613 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 106' ' ' ARG . 61.2 mt -72.79 -48.57 37.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.946 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -58.41 -31.77 68.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.741 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -79.24 -28.8 42.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.06 -1.025 . . . . 0.0 108.883 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.502 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 73.4 m -93.93 -79.02 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.4 -0.813 . . . . 0.0 109.015 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.95 140.36 26.64 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.832 . . . . 0.0 109.271 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -74.88 -17.25 20.03 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.654 2.236 . . . . 0.0 111.12 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -71.09 -8.95 56.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -0.967 . . . . 0.0 109.955 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.903 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -100.44 -5.06 27.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.117 -0.989 . . . . 0.0 109.793 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.588 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 3.1 t -69.18 -47.52 28.48 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.09 -1.006 . . . . 0.0 109.985 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 36.1 Cg_endo -78.54 -39.23 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.129 1.886 . . . . 0.0 110.876 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.09 -50.07 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.174 -0.953 . . . . 0.0 109.855 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.771 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 60.2 t80 -68.81 -39.67 79.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.29 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 1.2 mm-40 -61.4 -43.47 98.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.119 -0.988 . . . . 0.0 110.406 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -70.39 -45.51 65.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.063 -1.023 . . . . 0.0 110.182 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 117' ' ' PHE . 3.8 t-20 -57.95 -38.7 76.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.159 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.794 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -71.02 -31.76 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 110.156 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.474 ' O ' ' HD2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -70.36 -48.89 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.134 -0.979 . . . . 0.0 109.747 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 120' ' ' LYS . . . -66.92 -49.31 55.41 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -58.14 -42.88 86.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.108 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 114' ' ' ALA . 53.3 t -57.28 -37.04 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.989 . . . . 0.0 110.023 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -71.01 -45.49 63.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.018 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 0.1 OUTLIER -56.67 -54.21 48.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.702 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.66 -53.68 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 0.0 109.347 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 119' ' ' LYS . 42.9 mt -45.95 -48.05 16.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.729 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -46.88 -45.86 20.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.42 ' HB3' ' OD1' ' A' ' 127' ' ' ASP . 7.1 m120 -139.42 66.14 1.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.524 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.85 -49.6 75.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -52.53 -28.6 21.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 109.776 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 124' ' ' ASN . 3.6 m-20 -77.75 -37.86 48.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 109.722 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 129' ' ' ASP . 27.4 m-85 -77.95 -14.65 59.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.648 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.4 OUTLIER 50.82 177.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.648 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 131' ' ' TYR . 2.0 t80 -136.78 121.3 18.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.828 . . . . 0.0 108.837 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.575 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 19.3 m-85 -107.75 175.78 5.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 110.871 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 1.047 HG22 ' O ' ' A' ' 75' ' ' SER . 18.6 tt -147.33 159.7 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.534 -0.729 . . . . 0.0 109.399 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -88.13 171.9 41.12 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -24.07 64.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -1.153 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.3 OUTLIER -59.68 -34.98 73.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.494 ' CB ' ' O ' ' A' ' 135' ' ' SER . 3.2 tpt 75.75 37.17 0.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.24 125.28 26.99 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.273 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.57 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 33.9 Cg_endo -75.44 -0.25 9.88 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.295 1.997 . . . . 0.0 110.35 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -105.65 -0.73 25.35 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.31 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 141' ' ' MET . . . -94.98 44.34 1.1 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.905 . . . . 0.0 109.617 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.506 ' CE ' ' OD1' ' A' ' 6' ' ' ASP . 2.3 mtp 67.42 140.84 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 109.688 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.566 ' CG1' ' CE1' ' A' ' 130' ' ' PHE . 19.0 m -112.73 141.32 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.267 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.784 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.9 t -109.31 144.12 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 0.0 109.836 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.0 mt -113.62 147.92 37.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.197 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.432 ' SD ' ' SD ' ' A' ' 156' ' ' MET . 5.2 tpp -116.71 123.0 46.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.866 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.54 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 13.9 t-20 -141.63 151.25 42.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.383 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -76.48 154.97 34.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.655 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -100.64 -172.66 2.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -28.62 63.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.27 -47.94 65.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.539 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 106.71 -34.66 5.56 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.744 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -121.2 20.93 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -1.102 . . . . 0.0 109.191 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.3 m -117.01 101.5 53.34 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.339 -0.85 . . . . 0.0 109.361 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.68 129.06 8.99 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.5 2.133 . . . . 0.0 110.581 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 33.4 p90 -131.0 152.07 50.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 0.0 109.282 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.964 ' HE2' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -117.1 157.65 25.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.608 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.525 ' O ' HG13 ' A' ' 143' ' ' VAL . 20.4 mt -115.39 137.12 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 109.616 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.784 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 31.4 m-85 -129.22 141.71 51.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.087 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -75.24 117.57 17.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.896 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -68.44 -28.17 66.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 160' ' ' LYS . 0.8 OUTLIER -58.82 -18.92 36.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.748 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -125.72 39.88 1.96 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.526 HD23 ' O ' ' A' ' 5' ' ' LYS . 9.5 mt -137.57 149.5 46.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -1.221 . . . . 0.0 109.668 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.475 HG13 ' CG2' ' A' ' 7' ' ' VAL . 5.5 m -128.41 122.99 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.149 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.84 132.58 35.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.496 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -118.51 126.35 51.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.823 . . . . 0.0 109.221 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.454 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.9 OUTLIER -61.21 119.16 7.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.75 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.586 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 0.9 OUTLIER -68.82 149.44 48.96 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.23 -0.919 . . . . 0.0 109.852 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.843 HD23 ' HB3' ' A' ' 15' ' ' SER . 13.0 mt -126.17 123.8 39.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.511 -0.743 . . . . 0.0 109.128 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.869 ' HD2' HD11 ' A' ' 163' ' ' LEU . 30.3 m-85 -102.05 118.97 38.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 0.0 109.758 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 35.3 pttt -136.75 165.33 26.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.462 -0.774 . . . . 0.0 109.433 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 20.3 p30 -71.88 145.33 48.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 7' ' ' VAL . 14.9 p -107.81 43.22 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.474 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.441 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 1.1 tt -140.64 -38.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 27.1 t -104.89 -70.66 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.595 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 138.86 84.08 0.11 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 12' ' ' GLU . 19.2 t0 179.58 141.44 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -1.13 . . . . 0.0 109.336 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.562 ' HG3' ' CE2' ' A' ' 72' ' ' PHE . 1.2 pm0 -78.98 147.57 32.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.536 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 mt -130.9 -41.72 1.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.283 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.858 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 2.6 p -138.98 167.44 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.843 ' HB3' HD23 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -160.21 176.14 12.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.888 -1.132 . . . . 0.0 110.94 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 8.5 t70 -81.21 1.13 33.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.621 -0.674 . . . . 0.0 109.804 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.52 -16.26 63.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.075 -1.016 . . . . 0.0 108.758 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.845 ' CE2' HD13 ' A' ' 68' ' ' LEU . 27.2 m-85 -122.56 19.31 10.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.463 -0.773 . . . . 0.0 109.081 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 18' ' ' TYR . 1.2 m-20 61.79 134.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 108.835 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.601 HD21 ' CG2' ' A' ' 14' ' ' VAL . 12.2 mt -126.44 155.04 42.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.199 -0.938 . . . . 0.0 110.119 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.517 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 12.6 mmtt -132.26 120.97 22.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.445 -0.784 . . . . 0.0 109.118 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -87.24 126.14 34.64 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.187 -0.946 . . . . 0.0 108.804 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 24' ' ' ASP . 3.4 t -76.63 158.43 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.591 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' VAL . 1.3 t0 -42.9 -33.17 0.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.418 -0.801 . . . . 0.0 109.313 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.491 ' HB3' ' ND2' ' A' ' 113' ' ' ASN . 5.4 m-20 -69.85 -140.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.069 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.842 HD11 ' OD1' ' A' ' 113' ' ' ASN . 1.5 pp -129.18 61.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.9 -1.125 . . . . 0.0 109.435 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 m -146.12 147.61 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.773 . . . . 0.0 109.372 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 22' ' ' GLU . 44.3 m-85 -103.89 158.52 16.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.517 ' CG ' ' HB2' ' A' ' 21' ' ' LYS . 11.2 pt-20 -130.2 129.4 43.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 109.57 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.858 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -111.77 134.4 53.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -0.929 . . . . 0.0 109.429 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -98.19 134.87 40.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.418 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 68' ' ' LEU . 63.1 m -110.36 155.86 21.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 109.731 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.346 -0.846 . . . . 0.0 109.462 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.464 ' CB ' ' HB ' ' A' ' 69' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.3 0.571 . . . . 0.0 109.578 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -89.25 -39.74 13.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.883 . . . . 0.0 109.634 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.845 HD13 ' CE2' ' A' ' 18' ' ' TYR . 25.4 tp -80.79 -34.76 33.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.082 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.692 HG13 ' HB2' ' A' ' 74' ' ' LEU . 94.5 t -67.45 -39.84 83.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.45 -0.781 . . . . 0.0 109.333 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -69.63 -52.22 27.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -28.55 70.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 0.0 110.545 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.562 ' CE2' ' HG3' ' A' ' 12' ' ' GLU . 9.2 m-85 -102.97 -4.74 24.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.89 -1.131 . . . . 0.0 110.028 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.51 28.81 16.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.015 . . . . 0.0 109.852 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.692 ' HB2' HG13 ' A' ' 69' ' ' VAL . 2.3 mm? -49.24 140.24 10.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.093 -1.005 . . . . 0.0 109.285 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.4 t -123.39 139.62 32.26 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 109.486 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.79 132.74 10.95 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.537 2.158 . . . . 0.0 110.145 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 p -128.18 165.76 19.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.417 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.28 129.73 3.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.517 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 17.0 t80 -141.6 160.38 40.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 109.452 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.57 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 40.3 m-20 -39.36 129.64 1.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.479 -0.763 . . . . 0.0 109.673 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HG3' ' CE1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -61.63 -32.35 72.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.606 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -44.54 59.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 109.922 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 80' ' ' ASP . 10.8 t -62.91 -37.89 88.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.784 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.502 ' CE1' HG12 ' A' ' 88' ' ' ILE . 1.4 t80 -55.69 -35.83 66.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.235 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.754 ' O ' HG22 ' A' ' 88' ' ' ILE . 30.4 mtt -56.76 -48.26 78.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -0.954 . . . . 0.0 109.368 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.28 -45.38 91.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.18 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.438 ' O ' ' CD2' ' A' ' 91' ' ' TYR . 25.5 m-85 -68.04 -17.69 64.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.754 HG22 ' O ' ' A' ' 85' ' ' MET . 0.3 OUTLIER -76.57 -30.2 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -79.17 -35.33 42.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.384 -0.822 . . . . 0.0 109.032 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.82 -36.58 87.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 87' ' ' TYR . 20.0 m-85 -78.48 -36.93 44.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.118 -1.225 . . . . 0.0 108.942 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.9 OUTLIER -62.38 -39.91 94.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 108.791 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -69.09 -34.33 74.93 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.1 73.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 109.164 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 47.1 mm -66.76 -36.12 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 109.23 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HD3' HG13 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -60.22 -35.49 75.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.161 -0.962 . . . . 0.0 109.255 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.52 -55.13 6.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.947 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -52.28 -33.1 40.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 109.936 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.959 HD22 ' HB3' ' A' ' 106' ' ' ARG . 83.6 mt -72.82 -45.11 60.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -56.55 -38.45 71.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -32.99 63.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 m -98.35 -72.49 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.823 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -140.7 119.06 8.21 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.52 -17.64 20.69 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.458 2.105 . . . . 0.0 110.745 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -68.99 -9.6 53.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.679 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.959 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -101.34 -5.78 24.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 109.603 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.623 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 51.9 t -71.34 -42.99 12.13 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 111.04 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.2 Cg_endo -76.97 -52.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.894 1.729 . . . . 0.0 110.984 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.579 HG23 ' H ' ' A' ' 110' ' ' PHE . 15.6 m -55.87 -52.63 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.097 -1.002 . . . . 0.0 109.413 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.579 ' H ' HG23 ' A' ' 109' ' ' VAL . 46.1 t80 -62.79 -37.04 85.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.116 -0.99 . . . . 0.0 109.177 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -54.13 -48.08 71.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 110.304 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 109' ' ' VAL . 1.0 OUTLIER -67.65 -36.12 80.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.05 -1.031 . . . . 0.0 110.179 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.842 ' OD1' HD11 ' A' ' 26' ' ' ILE . 21.2 t-20 -67.5 -32.94 74.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.399 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.693 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -71.07 -29.82 65.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.157 -0.964 . . . . 0.0 109.889 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -71.32 -40.21 73.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.231 -0.918 . . . . 0.0 108.985 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -67.56 -46.45 69.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.484 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -68.18 -30.74 69.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -1.154 . . . . 0.0 110.065 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 114' ' ' ALA . 37.6 t -68.8 -50.59 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.095 -1.003 . . . . 0.0 109.509 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.455 ' C ' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -65.97 -28.69 69.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 0.0 109.653 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.66 -60.75 2.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.147 -0.971 . . . . 0.0 109.609 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.579 HG12 HD13 ' A' ' 144' ' ' LEU . 1.2 mp -55.41 -37.65 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.441 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 45.5 mt -53.03 -42.29 65.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 109.603 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.88 -39.68 40.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 109.268 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.523 ' HB3' ' CB ' ' A' ' 127' ' ' ASP . 8.6 m120 -130.04 64.08 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.0 109.247 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.577 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 6.9 t80 -60.55 -38.98 86.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 109.856 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -77.23 -30.76 54.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 110.012 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.523 ' CB ' ' HB3' ' A' ' 124' ' ' ASN . 1.2 t70 -75.13 -23.83 57.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.986 . . . . 0.0 109.953 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.793 ' HB3' HD22 ' A' ' 144' ' ' LEU . 41.5 m-85 -94.03 -33.0 13.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.716 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.887 ' O ' HD23 ' A' ' 144' ' ' LEU . 92.1 m-20 53.87 -177.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -141.41 122.39 14.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 108.796 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.41 ' HB3' HD12 ' A' ' 74' ' ' LEU . 10.6 m-85 -97.97 173.04 7.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.0 110.757 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 14.8 tt -156.59 138.21 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.651 -0.655 . . . . 0.0 109.268 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.06 170.88 8.04 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.29 -18.31 64.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -1.178 . . . . 0.0 109.355 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 136' ' ' MET . 4.8 t -60.54 -36.44 78.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 0.0 109.48 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.41 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 69.93 49.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.297 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.11 119.2 54.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.237 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.37 0.35 9.16 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.307 2.005 . . . . 0.0 110.239 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -100.55 -8.87 22.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.374 -0.829 . . . . 0.0 109.091 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.441 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -88.88 152.99 21.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -0.89 . . . . 0.0 109.286 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.507 ' CE ' ' HB2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -65.62 166.1 11.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.656 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.07 141.83 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.444 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.49 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 17.3 t -97.3 139.25 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.152 -0.968 . . . . 0.0 109.235 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 129' ' ' ASP . 17.6 mt -107.12 136.6 46.69 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.426 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.56 137.09 47.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.629 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.444 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 24.6 t-20 -152.16 164.34 37.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 109.534 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.42 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 2.6 m-85 -107.83 137.23 46.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.425 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.8 OUTLIER -65.56 167.06 9.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.284 -0.885 . . . . 0.0 109.387 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 148' ' ' ARG . 4.9 mt-10 -44.26 -28.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.444 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -50.43 70.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.516 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.42 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 101.18 -20.68 46.34 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.82 ' O ' HD12 ' A' ' 152' ' ' ILE . 2.0 pp -105.71 7.04 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -1.038 . . . . 0.0 109.366 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.2 m -114.08 101.34 53.92 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.236 -0.915 . . . . 0.0 109.26 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.2 119.24 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.443 2.095 . . . . 0.0 110.415 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 5.1 p90 -138.61 138.76 38.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.946 . . . . 0.0 109.465 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.508 ' SD ' ' N ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -116.92 149.59 39.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 109.174 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.492 ' C ' ' CD1' ' A' ' 158' ' ' PHE . 2.6 mt -105.89 149.12 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.617 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 6.0 m-85 -132.34 117.88 18.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 0.0 109.267 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 163' ' ' LEU . 36.6 m-85 -53.67 121.65 8.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 109.375 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 8.1 tttt -66.84 -26.7 67.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.681 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 159' ' ' PHE . 0.4 OUTLIER -56.49 -43.99 80.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.331 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -108.41 27.93 12.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.869 HD11 ' HD2' ' A' ' 4' ' ' TYR . 1.2 tm? -147.45 126.91 13.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.349 -1.089 . . . . 0.0 109.111 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.783 ' N ' HD22 ' A' ' 163' ' ' LEU . 10.8 m -135.72 155.95 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.57 ' OG ' ' CE1' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -88.85 150.45 22.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.449 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -142.57 122.59 13.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 109.313 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -90.46 146.03 24.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.39 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.73 HD21 ' HE3' ' A' ' 167' ' ' LYS . 12.7 mt -102.62 152.49 21.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 2' ' ' LEU . 12.8 mt -107.54 146.49 31.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.84 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.51 ' HD2' HD13 ' A' ' 163' ' ' LEU . 8.3 m-85 -121.7 111.66 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 0.0 109.173 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.679 ' O ' HD23 ' A' ' 163' ' ' LEU . 15.8 mttm -114.48 156.68 24.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.68 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.0 155.9 21.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.546 ' O ' HG22 ' A' ' 7' ' ' VAL . 13.3 p -92.07 -0.42 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.507 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.483 HG21 ' O ' ' A' ' 139' ' ' ASP . 47.6 mm -80.16 -58.68 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.686 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 10' ' ' GLY . 41.7 t -119.13 13.62 12.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' SER . . . 44.99 70.89 0.54 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.411 ' CG ' ' OG ' ' A' ' 135' ' ' SER . 15.0 t70 -137.85 138.35 39.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -1.07 . . . . 0.0 109.329 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.447 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -44.83 143.82 1.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.47 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.65 HD12 ' CE2' ' A' ' 158' ' ' PHE . 0.2 OUTLIER -134.32 -62.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.831 HG21 ' CB ' ' A' ' 30' ' ' ALA . 4.4 p -144.37 -178.85 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.91 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.729 ' H ' HG22 ' A' ' 14' ' ' VAL . 72.7 m -149.45 165.38 32.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.723 -1.236 . . . . 0.0 110.602 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.19 7.98 22.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.498 -0.751 . . . . 0.0 109.503 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.82 -10.6 49.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.116 -0.99 . . . . 0.0 108.923 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.783 ' CD2' HD11 ' A' ' 68' ' ' LEU . 24.3 m-85 -121.03 21.54 11.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 0.0 109.147 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER 64.21 132.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD23 ' HA ' ' A' ' 30' ' ' ALA . 21.9 mt -126.14 142.79 51.38 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.216 -0.927 . . . . 0.0 110.052 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.04 140.14 50.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.465 -0.772 . . . . 0.0 109.42 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.14 112.92 24.94 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.259 -0.901 . . . . 0.0 108.903 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.54 152.68 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.446 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -54.01 -19.6 5.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.668 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -75.46 -98.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.04 -1.038 . . . . 0.0 109.318 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -165.76 56.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.005 -1.06 . . . . 0.0 109.617 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.411 HG13 ' C ' ' A' ' 26' ' ' ILE . 11.1 m -152.05 158.16 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.077 -1.014 . . . . 0.0 109.76 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.413 ' C ' ' HG2' ' A' ' 29' ' ' GLU . 6.0 m-85 -103.58 162.2 13.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 0.0 109.026 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.6 mm-40 -130.99 117.41 19.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.831 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -103.97 112.76 25.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 108.956 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 2.3 m-20 -77.92 150.47 34.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.824 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.434 ' SG ' ' HG2' ' A' ' 154' ' ' PRO . 1.7 p -125.46 175.72 7.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.871 . . . . 0.0 109.315 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 0.0 109.459 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 m120 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 71' ' ' SER . 10.0 p30 -74.19 -21.48 59.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 109.739 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.783 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -81.47 -36.94 28.72 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.099 -1.001 . . . . 0.0 108.771 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 73' ' ' ARG . 41.7 t -71.33 -54.32 17.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.419 -0.801 . . . . 0.0 109.706 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -61.76 -41.31 97.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 0.0 110.142 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 5.0 t -68.4 -33.19 73.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.152 -0.968 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.485 ' HB2' HD23 ' A' ' 74' ' ' LEU . 22.9 m-85 -110.08 13.32 23.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.04 -1.037 . . . . 0.0 109.996 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 69' ' ' VAL . 55.0 mtt180 43.41 69.42 0.4 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.155 -0.966 . . . . 0.0 109.481 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 72' ' ' PHE . 1.7 mm? -89.81 137.96 31.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.399 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.539 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -100.03 117.83 62.63 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.152 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.71 123.59 5.37 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.551 2.168 . . . . 0.0 110.631 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.47 ' HG1' ' HD2' ' A' ' 79' ' ' PHE . 2.4 t -132.69 174.2 10.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 108.988 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -142.57 9.22 1.79 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.222 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 16.7 p90 -86.91 123.04 31.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.045 -1.035 . . . . 0.0 109.599 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -174.23 21.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.943 . . . . 0.0 110.54 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -63.58 -53.46 51.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.945 -1.097 . . . . 0.0 109.347 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.06 -24.67 4.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -29.89 67.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.118 -0.989 . . . . 0.0 109.165 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.558 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -58.84 -46.27 88.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 109.356 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.447 ' HA ' HG22 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -64.84 -30.04 71.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.262 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -71.16 -55.4 8.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.017 -1.052 . . . . 0.0 110.691 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.554 ' CD1' ' HG2' ' A' ' 138' ' ' PRO . 39.7 m-85 -63.91 -41.45 97.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.088 -1.007 . . . . 0.0 109.897 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -68.84 -22.33 26.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 109.469 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -55.2 5.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.344 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.12 -19.89 68.52 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -81.12 -39.02 26.26 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.157 -1.202 . . . . 0.0 108.326 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.65 -40.69 92.75 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.69 -43.99 95.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 0.0 109.125 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.56 -50.09 68.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 108.886 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.633 HG23 ' OD1' ' A' ' 161' ' ' ASP . 41.9 mm -60.02 -32.07 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.224 -0.923 . . . . 0.0 108.682 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -50.32 71.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 108.948 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.82 77.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.154 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HD3' HD23 ' A' ' 99' ' ' LEU . 3.8 tmt_? -58.63 -43.84 89.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.126 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.504 HD13 ' HG2' ' A' ' 106' ' ' ARG . 24.7 mt -64.67 -48.47 74.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.378 -0.826 . . . . 0.0 109.033 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -52.72 -25.26 10.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.198 -0.939 . . . . 0.0 108.827 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -76.32 -43.28 41.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 108.966 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.8 t -88.85 -71.77 0.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.191 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -148.04 137.25 11.95 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.04 -16.73 19.95 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.604 2.203 . . . . 0.0 111.066 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.52 -14.08 62.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.008 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.504 ' HG2' HD13 ' A' ' 99' ' ' LEU . 12.8 ttp-105 -93.09 -5.94 49.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.664 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 62.9 t -71.21 -43.09 12.55 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 111.344 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.4 Cg_endo -77.38 -54.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.883 1.722 . . . . 0.0 110.99 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.606 HG23 ' N ' ' A' ' 110' ' ' PHE . 35.7 m -56.52 -46.0 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.114 -0.992 . . . . 0.0 110.007 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.606 ' N ' HG23 ' A' ' 109' ' ' VAL . 62.5 t80 -65.06 -45.87 83.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.822 . . . . 0.0 110.696 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 115' ' ' ILE . 67.7 tt0 -57.28 -47.77 80.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.008 -1.057 . . . . 0.0 110.536 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -68.38 -31.69 71.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.058 -1.026 . . . . 0.0 110.345 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -66.36 -54.24 26.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 109.913 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -69.57 -26.55 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.988 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 111' ' ' GLU . 4.1 mm -62.29 -49.08 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.127 -0.983 . . . . 0.0 109.162 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.96 -41.04 99.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -35.2 75.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.25 -1.147 . . . . 0.0 109.602 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 114' ' ' ALA . 70.4 t -70.58 -38.06 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 109.561 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 115' ' ' ILE . 3.3 mmtt -64.34 -29.66 70.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 109.801 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -81.83 -46.9 13.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 109.893 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.2 OUTLIER -53.98 -37.86 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.16 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.02 -45.87 86.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.122 -0.986 . . . . 0.0 109.424 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -48.05 -39.66 20.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.868 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -136.43 45.65 2.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.146 -0.971 . . . . 0.0 109.735 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 10.1 p90 -63.02 -22.86 67.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.443 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.413 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -70.95 -47.02 61.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.547 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 2.0 m-20 -71.13 -23.57 62.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.342 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.559 ' HB3' HD22 ' A' ' 144' ' ' LEU . 6.3 m-85 -76.45 -10.72 59.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.513 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 50.94 -172.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.946 . . . . 0.0 109.451 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 77' ' ' THR . 0.3 OUTLIER -149.22 121.68 8.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -107.4 166.81 10.38 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.035 -1.041 . . . . 0.0 110.38 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 75' ' ' SER . 7.6 tt -146.79 130.51 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.405 -0.809 . . . . 0.0 109.477 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.56 179.16 3.87 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.08 -23.27 67.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -1.127 . . . . 0.0 109.453 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 136' ' ' MET . 7.2 m -58.71 -34.58 71.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.511 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 76.81 20.4 1.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.308 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -114.62 119.58 39.37 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.242 -0.911 . . . . 0.0 109.276 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 87' ' ' TYR . 33.4 Cg_endo -75.4 -5.51 16.7 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.262 1.974 . . . . 0.0 110.303 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.483 ' O ' HG21 ' A' ' 8' ' ' ILE . 2.4 p30 -95.38 -4.88 44.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 0.0 109.143 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' A' ' 141' ' ' MET . . . -98.45 47.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.53 ' CB ' ' O ' ' A' ' 140' ' ' ALA . 27.3 ttm 79.66 115.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.759 -0.588 . . . . 0.0 109.606 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.15 130.59 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.351 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 157' ' ' ILE . 3.0 t -99.84 138.82 23.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.271 -0.893 . . . . 0.0 109.069 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 128' ' ' TYR . 18.6 mt -115.0 146.49 41.19 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.229 -0.92 . . . . 0.0 109.622 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.428 ' HG2' ' HG2' ' A' ' 156' ' ' MET . 0.0 OUTLIER -109.3 124.79 51.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.329 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.542 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 24.3 t-20 -138.31 140.22 39.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.5 OUTLIER -77.8 147.04 35.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -0.845 . . . . 0.0 109.563 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -79.22 178.42 8.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.0 -25.36 8.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.45 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.447 ' OD2' HG13 ' A' ' 152' ' ' ILE . 31.9 t0 -72.17 -47.99 46.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 0.0 109.397 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 105.33 -28.61 13.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.798 ' O ' HD12 ' A' ' 152' ' ' ILE . 2.3 pp -99.78 11.51 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -1.153 . . . . 0.0 109.641 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.1 m -121.49 100.59 44.34 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.158 -0.964 . . . . 0.0 109.428 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.434 ' HG2' ' SG ' ' A' ' 32' ' ' CYS . 36.9 Cg_endo -81.22 131.02 7.49 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.554 2.169 . . . . 0.0 110.502 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 146' ' ' ASN . 32.9 p90 -135.18 144.49 47.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.377 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.5 ' HB3' ' CG1' ' A' ' 143' ' ' VAL . 2.0 mtt -107.93 163.91 12.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 109.888 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.638 ' O ' HG13 ' A' ' 143' ' ' VAL . 8.0 mt -124.15 139.36 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 109.384 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.65 ' CE2' HD12 ' A' ' 13' ' ' LEU . 52.7 m-85 -129.97 116.0 17.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.491 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 2.2 m-85 -43.15 116.81 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.263 -0.898 . . . . 0.0 109.746 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -68.65 -42.59 77.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.825 . . . . 0.0 109.979 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.633 ' OD1' HG23 ' A' ' 95' ' ' ILE . 3.5 t70 -47.22 -35.79 8.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.465 ' O ' ' HE2' ' A' ' 141' ' ' MET . . . -110.74 50.26 0.78 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 5' ' ' LYS . 3.8 mt -134.16 154.96 50.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.237 . . . . 0.0 109.68 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 5' ' ' LYS . 7.2 m -143.27 125.83 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 59.4 m -82.59 135.55 35.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -127.72 124.9 38.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.892 . . . . 0.0 109.574 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.73 ' HE3' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -68.5 117.17 9.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.445 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.494 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttm . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 167' ' ' LYS . 12.6 mt -112.5 151.5 29.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 109.641 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 3' ' ' LEU . 32.4 mt -105.92 122.93 47.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.667 ' HD2' HD11 ' A' ' 163' ' ' LEU . 3.6 m-85 -103.92 117.88 35.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.942 . . . . 0.0 109.185 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -129.63 143.27 50.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.644 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.861 ' OD1' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -74.35 156.77 36.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.529 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 7' ' ' VAL . 93.2 t -98.72 -6.45 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.356 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 3.1 mt -101.47 -61.31 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 109.651 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 8' ' ' ILE . 10.3 t -43.23 -47.39 6.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.57 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.96 -63.65 0.37 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.87 65.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -1.19 . . . . 0.0 109.52 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 179.37 141.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.861 HD22 ' OD1' ' A' ' 6' ' ' ASP . 23.9 tp -171.96 -75.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 0.0 109.62 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.843 HG21 ' CB ' ' A' ' 30' ' ' ALA . 3.2 p -153.18 -172.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 108.972 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.743 ' H ' HG22 ' A' ' 14' ' ' VAL . 51.5 p -162.57 174.27 12.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.843 -1.161 . . . . 0.0 110.168 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.42 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 37.5 t70 -82.95 10.98 6.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.399 -0.813 . . . . 0.0 109.988 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.08 -9.67 33.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 109.227 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 39.4 m-85 -126.77 21.56 6.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.243 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 14.9 m-20 67.96 130.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 30' ' ' ALA . 34.8 mt -126.31 147.89 49.64 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.178 -0.951 . . . . 0.0 110.371 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 136.8 44.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.504 -0.747 . . . . 0.0 109.381 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 1.1 tt0 -99.24 113.17 25.29 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.264 -0.898 . . . . 0.0 108.837 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ASP . 33.2 t -62.36 157.69 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.222 -0.924 . . . . 0.0 109.574 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -43.73 -28.37 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.247 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -75.24 -143.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 108.998 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.446 ' O ' ' HB3' ' A' ' 160' ' ' LYS . 1.0 OUTLIER -123.41 54.58 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.054 -1.029 . . . . 0.0 109.591 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.2 m -136.86 153.84 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 109.473 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 4.3 m-85 -107.27 163.16 13.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.308 -0.87 . . . . 0.0 109.222 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 47.6 mt-10 -128.98 119.91 25.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.843 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -114.86 112.52 22.88 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 11.1 m-20 -75.01 145.62 42.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 t -104.21 125.89 50.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.415 -0.803 . . . . 0.0 108.944 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.104 -0.998 . . . . 0.0 109.969 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.492 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 32.8 m120 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.338 0.589 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 32.3 t-20 -92.71 -26.18 17.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.707 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.615 HD11 HG23 ' A' ' 14' ' ' VAL . 49.7 tp -87.78 -47.79 8.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 108.749 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 74' ' ' LEU . 50.7 t -60.42 -47.88 90.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -69.29 -47.59 64.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 110.139 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 t -49.4 -52.25 29.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.561 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 68' ' ' LEU . 72.5 m-85 -102.12 8.48 40.71 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.046 -1.033 . . . . 0.0 110.178 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.481 ' O ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 57.24 95.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.023 . . . . 0.0 109.263 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.726 ' HB2' HG13 ' A' ' 69' ' ' VAL . 3.9 mm? -114.31 139.13 49.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.336 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.523 ' O ' HG22 ' A' ' 132' ' ' ILE . 4.4 t -125.92 124.06 24.68 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 109.397 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.85 157.81 27.59 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.398 2.065 . . . . 0.0 110.263 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -93.87 -174.27 3.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 109.391 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.1 4.42 2.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.702 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 14.1 t80 -160.34 124.26 3.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.501 ' HB2' ' CD2' ' A' ' 130' ' ' PHE . 0.3 OUTLIER -161.56 23.74 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.328 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -53.17 61.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -23.7 11.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.315 -0.866 . . . . 0.0 109.331 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.6 m -72.02 -31.45 66.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 80' ' ' ASP . 3.9 t80 -58.83 -36.65 74.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.604 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.738 ' O ' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -63.37 -53.04 58.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.73 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.3 m -61.62 -28.56 69.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.872 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 91' ' ' TYR . 10.9 m-85 -69.63 -46.3 66.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.092 -1.005 . . . . 0.0 109.749 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 85' ' ' MET . 5.9 tp -65.12 -24.58 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.279 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -46.85 38.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.766 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.94 -27.1 72.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 87' ' ' TYR . 21.1 m-85 -81.21 -36.75 29.67 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.083 -1.245 . . . . 0.0 109.307 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.511 ' O ' ' HE3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -63.76 -41.32 98.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.89 . . . . 0.0 109.863 -179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -73.45 -40.9 63.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.958 . . . . 0.0 109.723 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -44.47 73.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.613 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.676 HD12 ' OD1' ' A' ' 161' ' ' ASP . 49.2 mm -62.15 -37.41 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.491 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -50.68 61.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.87 . . . . 0.0 109.29 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.89 -27.89 68.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.385 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.578 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.41 -36.49 82.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.316 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 106' ' ' ARG . 33.3 mt -72.59 -50.45 25.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.127 -0.983 . . . . 0.0 109.616 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -51.51 -34.19 35.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.304 -0.872 . . . . 0.0 109.0 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.2 -37.09 72.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 109.056 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.5 m -96.95 -82.04 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.378 -0.826 . . . . 0.0 109.601 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.509 ' OD1' ' CG ' ' A' ' 105' ' ' GLU . 3.1 p30 -132.0 134.69 25.49 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.64 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.15 -19.01 17.95 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.503 2.135 . . . . 0.0 110.854 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.509 ' CG ' ' OD1' ' A' ' 103' ' ' ASN . 16.2 pt-20 -68.87 -8.76 46.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 0.0 109.861 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.729 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -93.92 -3.53 51.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.994 . . . . 0.0 109.782 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 25.8 t -72.4 -45.02 10.29 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 111.015 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.2 Cg_endo -77.41 -47.39 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.989 1.793 . . . . 0.0 111.156 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 110' ' ' PHE . 1.4 p -63.51 -44.68 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 109.598 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.532 ' N ' ' CG1' ' A' ' 109' ' ' VAL . 49.0 t80 -64.5 -41.0 96.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.501 -0.749 . . . . 0.0 110.34 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -40.37 94.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.015 -1.053 . . . . 0.0 110.338 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -48.98 45.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.045 -1.034 . . . . 0.0 110.783 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.41 -54.62 43.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.054 -1.029 . . . . 0.0 110.465 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.716 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -60.71 -26.71 67.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.001 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 115' ' ' ILE . 0.9 OUTLIER -65.12 -49.15 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.086 -1.009 . . . . 0.0 109.286 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.37 -33.59 82.57 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.507 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.1 OUTLIER -63.6 -45.46 90.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -1.13 . . . . 0.0 109.969 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 114' ' ' ALA . 60.6 t -53.78 -38.62 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.326 -0.859 . . . . 0.0 110.657 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -71.19 -49.29 45.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 110.562 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 117' ' ' PHE . 0.1 OUTLIER -73.0 -11.18 60.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.028 -1.045 . . . . 0.0 110.27 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -83.2 -44.57 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.06 -1.025 . . . . 0.0 109.665 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.402 ' N ' HG22 ' A' ' 121' ' ' ILE . 40.0 mt -53.64 -36.4 62.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 109.964 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 122' ' ' LEU . . . -45.1 -39.39 5.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 109.719 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.564 ' O ' ' CE1' ' A' ' 128' ' ' TYR . 35.2 m-80 -113.0 50.71 0.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 109.939 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.651 ' HA ' ' CE1' ' A' ' 128' ' ' TYR . 53.7 t80 -64.02 -54.13 39.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.175 -0.953 . . . . 0.0 109.991 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.48 -5.46 58.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -0.904 . . . . 0.0 109.086 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.515 ' HB2' ' CB ' ' A' ' 124' ' ' ASN . 15.8 m-20 -80.73 -41.53 23.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.84 . . . . 0.0 109.908 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.651 ' CE1' ' HA ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -102.03 10.78 39.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.086 . . . . 0.0 110.727 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 0.3 OUTLIER 43.86 -151.75 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.196 -0.94 . . . . 0.0 109.345 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.576 ' CE1' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -149.59 121.25 8.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 108.991 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.462 ' CE1' ' SD ' ' A' ' 145' ' ' MET . 13.2 m-85 -104.19 164.76 11.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.146 -0.971 . . . . 0.0 110.36 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 75' ' ' SER . 12.8 tt -157.11 135.87 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.421 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -48.24 156.14 1.19 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -17.71 16.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.152 . . . . 0.0 109.522 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.1 OUTLIER -57.68 -38.92 75.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.214 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.491 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.1 OUTLIER 74.72 27.16 1.3 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 0.0 109.603 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.24 114.27 51.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 136' ' ' MET . 33.8 Cg_endo -74.49 1.69 7.16 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.336 2.024 . . . . 0.0 110.392 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 139' ' ' ASP . 62.6 t0 -121.54 15.43 11.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.353 -0.842 . . . . 0.0 109.119 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -97.69 -94.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.867 . . . . 0.0 109.726 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 142' ' ' VAL . 9.1 tmm? -163.11 139.13 7.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 109.56 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.454 ' O ' ' SD ' ' A' ' 141' ' ' MET . 5.6 m -104.41 135.25 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 157' ' ' ILE . 4.3 t -103.55 130.01 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.167 -0.958 . . . . 0.0 109.469 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.592 HD22 ' CD1' ' A' ' 128' ' ' TYR . 47.0 mt -88.99 152.41 21.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.846 . . . . 0.0 109.324 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.462 ' SD ' ' CE1' ' A' ' 131' ' ' TYR . 1.4 ttt -111.92 115.48 29.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 109.539 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 155' ' ' TYR . 1.5 m-20 -121.0 165.88 14.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' A' ' 151' ' ' GLY . 0.1 OUTLIER -107.64 135.52 48.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.464 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 153' ' ' THR . 3.3 ttp180 -60.32 173.22 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 109.453 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.38 -31.27 65.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.336 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.46 -46.8 68.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.855 . . . . 0.0 109.348 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.56 ' O ' ' CE1' ' A' ' 147' ' ' TYR . . . 102.09 -28.49 15.7 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 152' ' ' ILE . 1.2 tp -87.45 -10.98 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -1.093 . . . . 0.0 109.24 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 148' ' ' ARG . 2.9 m -115.45 102.13 54.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.401 -0.812 . . . . 0.0 109.34 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.39 143.6 22.16 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.425 2.083 . . . . 0.0 110.3 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 146' ' ' ASN . 6.4 p90 -143.43 144.98 32.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 mtm -110.21 166.96 10.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.346 -0.846 . . . . 0.0 109.177 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 143' ' ' VAL . 3.6 mt -131.55 139.37 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 29.9 m-85 -123.09 153.81 39.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.336 -0.853 . . . . 0.0 109.302 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -75.76 113.93 13.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 26' ' ' ILE . 1.7 tttt -60.35 -44.43 95.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 109.369 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.676 ' OD1' HD12 ' A' ' 95' ' ' ILE . 3.3 p30 -49.38 -38.89 30.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.188 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -104.64 47.55 1.06 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.667 HD11 ' HD2' ' A' ' 4' ' ' TYR . 4.9 tt -151.68 126.77 9.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.437 -1.037 . . . . 0.0 109.31 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.502 HG13 ' CG2' ' A' ' 7' ' ' VAL . 13.4 m -112.27 140.55 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.915 . . . . 0.0 109.575 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.99 134.38 47.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.464 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.83 126.78 53.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.893 . . . . 0.0 109.416 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.459 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -67.09 123.12 19.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.413 -0.804 . . . . 0.0 109.416 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.484 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 2' ' ' LEU . 6.8 mt -111.36 152.89 26.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.694 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.1 mt -114.98 143.44 45.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.493 -0.754 . . . . 0.0 109.078 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.673 ' HD2' HD21 ' A' ' 163' ' ' LEU . 53.0 m-85 -120.47 112.87 19.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.511 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 164' ' ' VAL . 10.5 ttpt -117.6 157.48 26.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.582 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.524 ' OD2' ' CE ' ' A' ' 141' ' ' MET . 2.0 t70 -92.67 155.27 17.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.343 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 8' ' ' ILE . 12.1 m -97.44 -38.87 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.481 ' N ' HG23 ' A' ' 7' ' ' VAL . 4.7 mt -46.65 -79.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.867 . . . . 0.0 109.301 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.24 31.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.919 . . . . 0.0 109.523 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.86 68.13 0.28 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 12' ' ' GLU . 10.1 p30 -52.3 143.81 14.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -1.166 . . . . 0.0 109.429 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 11' ' ' ASP . 44.0 mm-40 58.87 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.82 -74.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.303 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.033 HG23 HD21 ' A' ' 68' ' ' LEU . 7.9 p -149.66 175.4 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 108.95 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.628 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.2 p -138.21 165.83 25.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.862 -1.148 . . . . 0.0 110.754 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.503 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -85.2 8.88 16.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 0.0 109.77 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.94 -25.14 66.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.027 . . . . 0.0 108.961 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.755 ' CE2' HD13 ' A' ' 68' ' ' LEU . 47.2 m-85 -102.47 21.94 14.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.116 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER 60.31 122.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.5 -0.75 . . . . 0.0 109.161 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.813 HD23 ' HA ' ' A' ' 30' ' ' ALA . 22.9 mt -116.04 152.12 34.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.34 -0.85 . . . . 0.0 109.878 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' ' OE2' ' A' ' 29' ' ' GLU . 1.7 mptp? -131.19 148.93 52.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -0.863 . . . . 0.0 109.746 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.38 125.36 36.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.834 . . . . 0.0 109.201 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' ASP . 15.8 t -78.09 148.48 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.729 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' VAL . 76.0 m-20 -44.13 -31.84 1.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.397 -0.815 . . . . 0.0 109.752 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.773 ' O ' HG23 ' A' ' 26' ' ' ILE . 6.5 m-20 -73.47 -101.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.773 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -164.66 59.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.041 -1.037 . . . . 0.0 109.382 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.507 HG21 HG21 ' A' ' 157' ' ' ILE . 18.7 m -145.46 167.78 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.635 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -111.42 144.81 40.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.854 . . . . 0.0 109.353 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.7 pt-20 -117.06 125.11 50.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.014 -1.054 . . . . 0.0 109.317 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.913 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -113.6 112.73 24.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.441 -0.787 . . . . 0.0 108.944 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 31.5 m-20 -67.18 149.62 50.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.35 -0.844 . . . . 0.0 109.893 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.9 p -142.92 174.52 10.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.408 -0.808 . . . . 0.0 109.293 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.395 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.504 ' ND2' ' SD ' ' A' ' 145' ' ' MET . 11.9 m120 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -46.88 -24.47 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.694 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.033 HD21 HG23 ' A' ' 14' ' ' VAL . 31.4 tp -82.25 -42.73 18.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.039 -1.038 . . . . 0.0 108.49 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.578 HG13 ' HB2' ' A' ' 74' ' ' LEU . 3.1 t -54.96 -56.1 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.473 -0.767 . . . . 0.0 108.954 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 70' ' ' TYR . 4.2 t80 -61.38 -41.34 96.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 109.92 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.94 -45.47 64.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.044 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -111.74 19.83 17.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 109.882 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.63 82.58 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.938 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.578 ' HB2' HG13 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -95.22 169.76 9.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 108.824 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.61 ' O ' HG22 ' A' ' 132' ' ' ILE . 1.8 m -128.18 102.96 20.88 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.975 -1.078 . . . . 0.0 110.044 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.433 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 36.3 Cg_endo -80.0 118.37 3.71 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.489 2.126 . . . . 0.0 110.135 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 130' ' ' PHE . 6.0 t -87.93 161.33 17.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.304 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 t -125.95 4.86 7.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 109.81 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.55 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 6.5 t80 -138.62 128.35 24.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 109.711 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.529 ' OD2' ' CE1' ' A' ' 130' ' ' PHE . 4.4 p-10 169.96 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.766 . . . . 0.0 109.454 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -62.36 -42.97 99.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 109.237 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -113.76 -28.65 7.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.492 -0.755 . . . . 0.0 109.09 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -29.09 67.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.324 -0.86 . . . . 0.0 109.317 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.485 ' HB2' ' HB2' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -55.11 -48.96 72.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.488 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.474 ' HA ' HG22 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -64.26 -29.86 70.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 109.993 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -55.24 18.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 88' ' ' ILE . 21.6 m-85 -70.7 -58.25 3.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 109.845 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -42.74 -37.9 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 109.573 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 15.2 mmtp -63.07 -52.69 61.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.356 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.65 -20.26 56.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.602 ' CE2' ' CB ' ' A' ' 141' ' ' MET . 2.8 t80 -77.88 -36.45 49.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.212 -1.17 . . . . 0.0 108.484 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.448 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -64.99 -42.14 94.79 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 4.5 mptt -67.1 -32.02 72.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.588 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.38 89.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.026 -1.046 . . . . 0.0 109.702 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.775 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 34.8 mm -57.57 -45.44 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.172 -0.955 . . . . 0.0 109.749 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -48.09 -33.47 8.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 109.09 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.529 ' N ' ' HG3' ' A' ' 96' ' ' LYS . . . -73.04 -46.82 49.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 108.998 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.881 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -50.54 -38.05 42.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.143 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.881 HD23 ' HD3' ' A' ' 98' ' ' ARG . 1.4 mt -69.92 -44.9 68.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.406 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -51.88 -30.27 23.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.331 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 97' ' ' ALA . 6.9 mt-10 -78.71 -39.26 37.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.156 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.54 -82.51 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.274 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -135.93 135.88 22.27 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -74.84 -14.84 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.593 2.195 . . . . 0.0 110.748 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.74 -13.54 61.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.854 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.782 ' HB3' HD13 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -89.56 -11.42 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.119 -0.988 . . . . 0.0 109.764 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.704 ' HA ' HD12 ' A' ' 99' ' ' LEU . 7.9 t -65.12 -44.39 70.02 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 111.203 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.4 Cg_endo -76.55 -58.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.933 1.756 . . . . 0.0 110.984 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 110' ' ' PHE . 15.8 m -55.9 -43.93 76.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.067 -1.02 . . . . 0.0 109.592 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.775 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 43.7 t80 -58.64 -49.63 76.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.734 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -57.25 -29.91 64.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.115 -0.991 . . . . 0.0 110.175 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -49.16 40.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.152 -0.968 . . . . 0.0 111.569 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.596 ' ND2' ' HA ' ' A' ' 110' ' ' PHE . 10.8 p30 -72.19 -46.73 55.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.847 -1.158 . . . . 0.0 110.733 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -54.93 -46.82 74.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.066 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -53.36 -44.09 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.874 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.46 -41.21 96.47 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.561 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.72 -37.29 78.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -1.179 . . . . 0.0 110.028 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 47.8 t -63.89 -45.21 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.356 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.505 ' C ' ' CD ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -66.13 -28.87 69.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.984 . . . . 0.0 109.611 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -67.55 -49.13 64.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.983 . . . . 0.0 110.0 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.07 HG12 HD13 ' A' ' 144' ' ' LEU . 1.6 mp -70.18 -32.01 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 109.699 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 122' ' ' LEU . 43.5 mt -57.16 -30.47 64.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.696 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.51 -48.32 62.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 109.773 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 127' ' ' ASP . 1.5 m-80 -139.57 69.56 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -63.15 -21.59 66.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -62.93 -63.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.845 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 128' ' ' TYR . 18.7 p30 -65.63 -22.68 66.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.246 -0.909 . . . . 0.0 109.959 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 2.9 m-85 -76.08 -16.92 59.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 109.903 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.489 ' C ' ' CG ' ' A' ' 130' ' ' PHE . 3.0 m-20 44.8 -168.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.166 -0.959 . . . . 0.0 109.264 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.811 ' HB3' HG11 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -154.06 121.14 5.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 108.681 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.967 ' O ' HG13 ' A' ' 142' ' ' VAL . 14.6 m-85 -105.16 164.42 11.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.178 -0.951 . . . . 0.0 110.692 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 75' ' ' SER . 1.1 tt -155.94 139.77 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.403 -0.81 . . . . 0.0 109.488 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.37 164.25 1.09 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 135' ' ' SER . 2.6 pt-20 -67.13 -21.07 65.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -1.177 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.2 OUTLIER -62.34 -35.3 78.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 77.48 50.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.869 . . . . 0.0 109.612 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.33 107.77 60.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.123 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.34 0.23 8.81 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.26 1.973 . . . . 0.0 110.486 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.77 -14.68 23.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.884 . . . . 0.0 109.115 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 141' ' ' MET . . . -79.7 -91.77 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.445 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.602 ' CB ' ' CE2' ' A' ' 91' ' ' TYR . 1.9 ptp 179.42 149.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 131' ' ' TYR . 70.3 t -97.76 138.15 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.183 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.639 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 3.6 t -93.25 111.35 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.134 -0.979 . . . . 0.0 109.043 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 1.07 HD13 HG12 ' A' ' 121' ' ' ILE . 2.5 mt -79.26 149.13 31.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.778 ' HE3' ' CE2' ' A' ' 131' ' ' TYR . 12.4 ttm -124.58 131.21 53.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.624 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.545 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 25.8 t-20 -142.34 168.79 18.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 109.108 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.468 ' HB3' ' HA2' ' A' ' 151' ' ' GLY . 4.5 m-85 -77.06 159.39 29.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.058 -1.026 . . . . 0.0 109.385 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.59 ' HB2' ' CD1' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -151.59 -173.62 4.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 110.011 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 56.05 -97.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 109.655 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -106.94 -25.72 11.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.019 -1.051 . . . . 0.0 109.152 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 147' ' ' TYR . . . 123.17 17.43 3.31 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.65 -21.37 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.281 -1.129 . . . . 0.0 108.903 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 153' ' ' THR . 2.9 t -105.0 128.21 27.16 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.111 -0.993 . . . . 0.0 109.566 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -82.87 146.92 13.24 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.754 2.303 . . . . 0.0 110.696 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.59 ' CD1' ' HB2' ' A' ' 148' ' ' ARG . 7.2 p90 -145.18 155.33 43.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 108.851 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.461 ' SD ' ' N ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -126.73 162.2 26.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 109.795 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.507 HG21 HG21 ' A' ' 27' ' ' VAL . 4.4 mt -124.26 145.3 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 109.507 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.639 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 9.7 m-85 -129.31 128.52 43.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.312 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -51.23 127.27 18.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -62.49 -53.69 51.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.405 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -47.52 -44.72 25.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -90.17 44.19 2.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.806 ' O ' HD23 ' A' ' 163' ' ' LEU . 2.2 tt -158.5 123.54 4.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.431 -1.041 . . . . 0.0 109.212 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 5' ' ' LYS . 30.1 m -116.69 153.61 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.456 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.8 p -90.86 146.92 23.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.953 . . . . 0.0 109.639 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.53 120.64 15.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.471 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 168' ' ' PHE . 0.0 OUTLIER -70.21 108.27 4.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.404 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 168' ' ' PHE . 13.9 t80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.545 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.52 ' HG2' HD21 ' A' ' 3' ' ' LEU . 7.6 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.616 HD13 ' O ' ' A' ' 166' ' ' GLU . 0.8 OUTLIER -68.48 146.74 52.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 110.126 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.914 HD11 ' CG ' ' A' ' 168' ' ' PHE . 6.8 mt -121.85 139.57 53.46 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.633 ' HB2' HG13 ' A' ' 14' ' ' VAL . 91.5 m-85 -121.43 108.89 14.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.977 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 1.8 mtmm -108.82 167.29 10.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.454 -0.778 . . . . 0.0 109.272 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -83.86 151.23 25.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.97 . . . . 0.0 109.362 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.543 HG21 HG13 ' A' ' 164' ' ' VAL . 5.3 t -108.31 35.6 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 109.486 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.927 HG21 ' O ' ' A' ' 139' ' ' ASP . 24.0 mm -117.07 -52.4 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.417 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.96 -34.96 2.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.5 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 106.62 2.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -176.28 136.54 0.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -1.145 . . . . 0.0 109.496 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.476 ' OE1' ' CG ' ' A' ' 72' ' ' PHE . 7.8 pt-20 -48.51 147.36 2.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.642 HD22 ' HD2' ' A' ' 158' ' ' PHE . 3.7 mt -132.6 -80.58 0.49 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.154 -0.966 . . . . 0.0 109.532 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.862 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 2.6 p -132.37 166.77 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.853 . . . . 0.0 109.104 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.596 ' N ' HG22 ' A' ' 14' ' ' VAL . 3.9 p -142.0 161.93 36.75 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.017 -1.052 . . . . 0.0 110.098 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -83.02 1.27 40.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.381 -0.824 . . . . 0.0 109.598 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.86 -9.39 37.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.378 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.673 ' CE2' HD13 ' A' ' 68' ' ' LEU . 35.7 m-85 -119.52 20.69 12.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 65.38 130.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 109.006 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.734 HD23 ' HA ' ' A' ' 30' ' ' ALA . 49.4 mt -125.68 146.08 49.89 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -0.95 . . . . 0.0 110.015 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -123.43 134.26 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -0.807 . . . . 0.0 109.35 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.438 ' CD ' ' HA ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -90.93 122.4 33.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.181 -0.949 . . . . 0.0 108.789 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 2.3 t -114.55 120.44 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 4.0 t70 74.4 5.97 4.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 109.802 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 20.3 t0 59.12 68.89 0.77 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 109.513 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.656 HG23 HG13 ' A' ' 27' ' ' VAL . 5.8 tt 174.54 -29.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.129 -0.982 . . . . 0.0 109.905 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.656 HG13 HG23 ' A' ' 26' ' ' ILE . 23.1 m -120.93 140.13 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.957 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -105.44 148.92 26.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.193 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -120.97 121.06 37.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.405 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.862 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -106.22 112.88 26.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.193 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -68.38 149.57 49.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 66' ' ' ASN . 34.7 m -100.26 151.17 21.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 0.0 109.259 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.748 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.485 ' OD1' ' HB3' ' A' ' 32' ' ' CYS . 1.5 m-20 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 71' ' ' SER . 33.7 t30 -89.7 -27.09 20.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.739 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.673 HD13 ' CE2' ' A' ' 18' ' ' TYR . 13.3 tp -83.48 -37.63 22.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 108.982 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.573 HG13 ' HB2' ' A' ' 74' ' ' LEU . 53.3 t -72.61 -48.28 47.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.723 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -69.29 -36.04 76.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 110.93 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 70.3 m -79.49 -52.85 7.51 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.966 -1.084 . . . . 0.0 110.506 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CG ' ' OE1' ' A' ' 12' ' ' GLU . 7.2 m-30 -79.82 -3.6 48.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.128 -0.982 . . . . 0.0 109.968 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.81 88.04 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 109.571 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.573 ' HB2' HG13 ' A' ' 69' ' ' VAL . 1.4 mm? -111.85 139.05 47.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 108.719 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.67 122.99 18.1 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.066 -1.021 . . . . 0.0 109.871 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.14 126.28 7.7 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.374 2.049 . . . . 0.0 110.097 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 t -123.92 117.02 23.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -0.966 . . . . 0.0 109.645 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -59.34 151.46 23.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.242 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 17.9 t80 -151.93 155.3 37.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 109.703 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.637 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 1.4 m-20 -86.42 124.27 32.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -0.879 . . . . 0.0 109.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -34.61 68.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.147 -0.971 . . . . 0.0 110.033 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -56.25 -64.91 0.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.617 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 79' ' ' PHE . 7.4 t -59.8 -28.74 67.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.788 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.32 -35.48 67.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.495 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.4 mtt -57.04 -49.42 75.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.141 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -48.81 79.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.489 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -62.7 -19.19 63.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.256 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 92' ' ' MET . 0.6 OUTLIER -79.22 -28.92 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -39.55 58.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.426 -0.796 . . . . 0.0 109.115 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.13 -38.79 88.48 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.568 ' CZ ' ' O ' ' A' ' 138' ' ' PRO . 14.7 m-30 -74.52 -36.5 63.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.101 -1.234 . . . . 0.0 108.816 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.536 ' CE ' ' O ' ' A' ' 92' ' ' MET . 0.0 OUTLIER -65.21 -38.99 92.15 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.624 0.726 . . . . 0.0 109.293 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.506 ' C ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.15 -36.91 82.86 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.571 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.58 -50.77 67.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.994 -1.066 . . . . 0.0 109.244 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.837 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 29.5 mm -59.93 -43.0 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.235 -0.915 . . . . 0.0 108.969 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -47.38 -51.61 19.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.875 . . . . 0.0 109.364 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 100' ' ' GLN . . . -58.19 -36.53 73.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.015 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 101' ' ' GLU . 1.8 tmt_? -64.15 -32.85 74.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -0.916 . . . . 0.0 109.683 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.526 HD23 ' HD3' ' A' ' 98' ' ' ARG . 22.4 mt -73.78 -50.21 21.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 110.213 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.539 ' HG3' ' N ' ' A' ' 101' ' ' GLU . 2.6 pt20 -55.83 -34.98 65.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.679 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 7.4 pt-20 -72.79 -35.52 67.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.103 -0.998 . . . . 0.0 109.191 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.52 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 10.2 t -88.28 -80.31 0.28 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.277 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.74 137.78 26.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 109.325 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.92 -25.97 11.53 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.547 2.165 . . . . 0.0 110.637 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -70.46 -6.83 38.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.676 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.516 ' O ' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -97.92 -4.8 35.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 109.819 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.607 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 32.7 t -70.18 -44.62 20.49 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.989 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.6 Cg_endo -77.7 -41.05 0.34 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.018 1.812 . . . . 0.0 111.096 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.34 -43.37 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 0.0 109.938 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.837 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 87.1 t80 -69.72 -37.11 76.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 0.0 110.408 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -63.25 -53.78 47.64 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.09 -1.006 . . . . 0.0 110.719 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -47.19 61.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.016 -1.053 . . . . 0.0 110.675 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -55.73 -54.26 46.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.138 -0.976 . . . . 0.0 110.124 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.77 69.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 109.968 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -59.22 -35.51 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.126 -0.983 . . . . 0.0 109.559 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.48 -45.85 95.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.623 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -68.14 -30.72 69.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -1.2 . . . . 0.0 110.081 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 54.4 t -68.02 -42.35 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.888 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 115' ' ' ILE . 40.2 mmtt -69.06 -42.05 76.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.075 -1.015 . . . . 0.0 109.78 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.499 ' HA ' ' CE ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -59.54 -60.5 3.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.797 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 117' ' ' PHE . 1.3 mt -53.98 -47.69 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 122' ' ' LEU . 25.6 mt -47.3 -49.6 23.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 109.762 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.78 -41.85 45.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.966 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.73 52.02 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.885 . . . . 0.0 109.435 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 8.9 p90 -63.43 -27.53 69.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.578 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.427 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 5.5 mttp -64.82 -39.77 94.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.404 -0.81 . . . . 0.0 109.704 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.67 -23.76 42.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 110.01 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 129' ' ' ASP . 7.1 m-85 -81.7 -25.92 35.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.874 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.521 ' C ' ' CD1' ' A' ' 130' ' ' PHE . 14.0 m-20 51.29 179.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.59 ' HB3' HG11 ' A' ' 142' ' ' VAL . 36.3 m-85 -142.3 121.61 13.11 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.352 -0.843 . . . . 0.0 109.052 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.987 ' O ' HG13 ' A' ' 142' ' ' VAL . 10.9 m-85 -99.31 166.24 11.3 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.189 -0.944 . . . . 0.0 110.538 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 7.8 tp -156.58 146.84 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.702 . . . . 0.0 109.278 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.03 162.38 52.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -58.24 -23.63 56.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -1.107 . . . . 0.0 109.427 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 136' ' ' MET . 11.4 p -68.59 -34.76 76.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 109.359 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.486 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 0.0 OUTLIER 70.6 63.63 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.521 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.37 105.73 38.2 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.341 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.568 ' O ' ' CZ ' ' A' ' 91' ' ' TYR . 34.0 Cg_endo -74.5 -20.85 17.7 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.274 1.982 . . . . 0.0 109.961 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.927 ' O ' HG21 ' A' ' 8' ' ' ILE . 7.7 t70 -75.43 -6.26 49.18 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.364 -0.835 . . . . 0.0 108.962 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.15 -175.71 2.88 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.266 -0.896 . . . . 0.0 109.35 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.2 ptm -92.31 167.47 11.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 109.475 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.987 HG13 ' O ' ' A' ' 131' ' ' TYR . 58.7 t -113.35 142.03 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 109.185 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 157' ' ' ILE . 13.0 t -90.01 130.04 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.174 -0.954 . . . . 0.0 108.838 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.558 HD13 HG12 ' A' ' 121' ' ' ILE . 18.0 mt -92.55 134.4 35.02 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.492 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.471 ' HB2' ' CE1' ' A' ' 131' ' ' TYR . 4.8 ttt -107.63 126.28 52.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.571 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 2.2 t30 -139.34 169.11 18.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 1.6 m-85 -110.23 144.81 38.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.65 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.445 ' CZ ' HG21 ' A' ' 153' ' ' THR . 0.5 OUTLIER -67.48 170.67 7.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 109.608 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -47.67 -35.8 10.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 109.577 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -77.35 -44.63 28.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.298 -0.876 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.569 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 100.46 -30.2 10.71 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.6 tp -68.2 -6.57 5.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.47 -1.018 . . . . 0.0 109.661 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 153' ' ' THR . 1.7 m -122.81 101.73 39.08 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 109.665 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.14 121.8 5.02 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.57 2.18 . . . . 0.0 109.98 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 146' ' ' ASN . 31.7 p90 -126.37 148.35 49.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -0.983 . . . . 0.0 109.88 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.461 ' HG2' ' HG3' ' A' ' 145' ' ' MET . 0.2 OUTLIER -116.14 167.17 11.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.35 -0.844 . . . . 0.0 109.135 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.772 ' O ' HG13 ' A' ' 143' ' ' VAL . 11.6 mt -128.46 148.63 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 0.0 109.783 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.642 ' HD2' HD22 ' A' ' 13' ' ' LEU . 12.4 m-85 -136.55 125.73 24.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.471 ' HB3' ' OD1' ' A' ' 161' ' ' ASP . 2.5 m-85 -60.03 132.41 53.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 110.25 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 77.3 tttt -68.23 -41.85 80.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.487 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.471 ' OD1' ' HB3' ' A' ' 159' ' ' PHE . 5.2 p-10 -50.56 -45.01 56.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.012 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -97.93 45.94 1.65 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.845 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -161.34 129.23 4.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.464 -1.021 . . . . 0.0 108.919 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.543 HG13 HG21 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -115.46 149.16 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.624 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.89 121.64 38.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.616 ' O ' HD13 ' A' ' 2' ' ' LEU . 1.8 tp10 -118.42 142.98 47.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.671 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.49 113.6 25.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.914 ' CG ' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.489 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mt -100.8 158.4 15.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 3' ' ' LEU . 25.7 mt -112.41 134.47 53.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.479 -0.763 . . . . 0.0 109.427 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.599 ' CD2' HD21 ' A' ' 163' ' ' LEU . 10.5 m-85 -117.4 112.24 20.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.68 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 12' ' ' GLU . 1.5 mtmt -123.15 162.39 22.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.415 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -97.04 158.21 15.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.416 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.86 54.32 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -0.984 . . . . 0.0 109.663 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -140.7 -50.1 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.034 -1.041 . . . . 0.0 109.595 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.587 ' O ' ' HB2' ' A' ' 140' ' ' ALA . 1.5 t 176.47 45.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -141.87 -43.93 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 6.8 t0 74.96 -137.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -1.112 . . . . 0.0 109.275 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.447 ' HA ' ' HG2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -42.33 121.37 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.047 -1.033 . . . . 0.0 109.677 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.476 ' HA ' HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -125.1 -62.08 1.25 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.138 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.826 HG21 ' CB ' ' A' ' 30' ' ' ALA . 6.5 p -143.46 175.81 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.365 -0.834 . . . . 0.0 108.855 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.652 ' H ' HG22 ' A' ' 14' ' ' VAL . 22.6 t -147.49 169.59 19.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.846 -1.159 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.545 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 31.4 t70 -87.54 12.73 11.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.479 -0.763 . . . . 0.0 109.447 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.39 -15.28 63.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 108.996 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CE1' ' ND2' ' A' ' 67' ' ' ASN . 44.5 m-85 -115.92 21.38 13.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.471 -0.768 . . . . 0.0 109.207 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.2 t0 65.32 129.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 108.511 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 30' ' ' ALA . 13.0 mt -124.28 143.2 50.69 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.144 -0.973 . . . . 0.0 110.252 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.32 136.7 52.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.34 117.74 34.45 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.252 -0.905 . . . . 0.0 108.767 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 t -68.46 147.81 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 109.49 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -46.31 -25.4 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 109.751 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.467 ' O ' HG23 ' A' ' 26' ' ' ILE . 2.2 m-20 -77.96 -110.39 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -154.82 64.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.811 -1.181 . . . . 0.0 109.305 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.3 m -147.18 141.27 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 109.674 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.409 ' CE2' ' HE2' ' A' ' 4' ' ' TYR . 4.9 m-85 -98.65 148.39 23.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.152 -0.968 . . . . 0.0 109.066 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 19.4 mt-10 -125.15 121.11 33.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.116 -0.99 . . . . 0.0 110.12 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.89 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -106.39 112.71 25.83 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -71.52 146.48 48.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 110.509 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 28.3 p -126.74 115.18 19.01 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.425 ' HG2' ' ND2' ' A' ' 67' ' ' ASN . 14.6 pt20 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 110.056 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.462 ' ND2' ' CE1' ' A' ' 18' ' ' TYR . 38.5 p-10 -86.12 -19.57 29.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.671 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 18.1 tp -86.38 -47.56 9.23 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 108.957 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.773 HG13 ' HB2' ' A' ' 74' ' ' LEU . 55.6 t -68.24 -37.33 77.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.322 -0.862 . . . . 0.0 109.171 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -69.84 -44.57 69.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 109.668 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 t -63.24 -36.93 85.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.315 -0.866 . . . . 0.0 110.121 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.692 ' HB2' HD23 ' A' ' 74' ' ' LEU . 25.9 m-85 -103.26 2.9 34.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 109.891 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER 56.82 29.66 16.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.154 -0.966 . . . . 0.0 109.789 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.773 ' HB2' HG13 ' A' ' 69' ' ' VAL . 2.0 mm? -41.72 149.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.411 -0.806 . . . . 0.0 109.345 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.434 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -131.06 127.38 21.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.384 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.16 122.17 5.61 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.496 2.131 . . . . 0.0 110.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.4 127.26 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.37 -178.68 3.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.29 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 50.5 t80 -164.91 163.0 21.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.605 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 35.6 m-20 -77.38 120.48 22.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.458 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 2.1 tmtt? -59.14 -53.25 60.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.88 -45.33 86.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.76 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.505 ' CB ' ' HB2' ' A' ' 80' ' ' ASP . 1.3 t -61.75 -29.06 69.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.344 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 81' ' ' LYS . 41.6 t80 -58.41 -34.99 71.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.779 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -57.34 12.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.96 . . . . 0.0 109.778 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -59.87 -38.02 81.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.003 . . . . 0.0 109.273 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.509 ' CE2' ' CZ ' ' A' ' 91' ' ' TYR . 6.5 t80 -66.44 -23.1 66.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.385 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -78.72 -31.48 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 108.952 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -72.02 -47.28 52.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.41 -29.86 74.61 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.509 ' CZ ' ' CE2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -75.38 -35.79 61.02 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.129 -1.218 . . . . 0.0 108.41 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -54.42 26.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.598 -0.689 . . . . 0.0 109.745 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -38.47 75.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.346 -0.846 . . . . 0.0 109.868 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.54 -45.34 73.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.113 -0.992 . . . . 0.0 109.297 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.473 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 34.8 mm -69.82 -36.67 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -47.19 63.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 109.202 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.72 81.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.127 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.4 OUTLIER -52.95 -44.29 66.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.456 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.827 HD13 ' HB3' ' A' ' 106' ' ' ARG . 2.0 mt -71.93 -44.06 64.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.295 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -25.16 9.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.199 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -86.98 -34.44 19.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 t -96.09 -89.02 0.26 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.326 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.439 ' OD1' ' NH2' ' A' ' 106' ' ' ARG . 27.8 p-10 -125.62 132.38 24.3 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.271 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.9 -19.44 18.09 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.641 2.227 . . . . 0.0 110.884 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.9 -6.82 29.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.202 -0.936 . . . . 0.0 109.905 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.827 ' HB3' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -95.81 -5.94 40.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.084 -1.01 . . . . 0.0 109.811 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.625 ' HA ' HD12 ' A' ' 99' ' ' LEU . 96.0 t -72.18 -43.25 9.99 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.137 -0.977 . . . . 0.0 111.229 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.6 Cg_endo -75.98 -56.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.762 1.641 . . . . 0.0 110.862 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 110' ' ' PHE . 12.8 m -55.84 -40.95 64.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.036 -1.04 . . . . 0.0 109.471 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.511 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 68.9 t80 -65.82 -37.1 85.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.817 . . . . 0.0 110.253 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.775 ' O ' HD13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -66.42 -49.87 65.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.964 -1.085 . . . . 0.0 110.562 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -66.14 -49.45 67.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.887 -1.133 . . . . 0.0 110.544 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -58.2 -46.42 85.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.985 . . . . 0.0 109.813 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -65.44 -27.56 68.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.373 -0.829 . . . . 0.0 109.751 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.775 HD13 ' O ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -67.13 -47.41 81.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.251 -0.905 . . . . 0.0 109.446 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.27 -50.51 44.53 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.475 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.78 -38.95 76.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.081 -1.247 . . . . 0.0 109.803 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 114' ' ' ALA . 53.1 t -68.4 -39.16 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -32.34 69.64 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.157 -0.964 . . . . 0.0 109.295 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -96.92 -10.07 27.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.661 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.2 -53.68 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.629 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.537 ' N ' HG22 ' A' ' 121' ' ' ILE . 10.1 mt -48.77 -44.23 38.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.016 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.79 76.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 110.033 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.542 ' O ' ' CE2' ' A' ' 128' ' ' TYR . 19.6 m-20 -101.44 38.84 1.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.14 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.651 ' HA ' ' CE1' ' A' ' 128' ' ' TYR . 13.4 t80 -63.41 -53.69 48.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.082 -1.011 . . . . 0.0 109.061 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -78.9 -8.43 58.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 108.988 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 124' ' ' ASN . 0.8 OUTLIER -80.17 -39.53 29.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.341 -0.85 . . . . 0.0 109.937 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.651 ' CE1' ' HA ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -108.55 -10.43 15.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.969 -1.082 . . . . 0.0 110.041 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.8 m-20 52.27 173.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.726 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -114.71 122.23 45.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.599 ' HB3' HD12 ' A' ' 74' ' ' LEU . 11.2 m-85 -103.27 177.63 4.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 110.558 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.671 ' O ' HD13 ' A' ' 74' ' ' LEU . 3.9 tp -143.02 149.03 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.541 -0.725 . . . . 0.0 109.545 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 132' ' ' ILE . . . -73.01 -178.77 35.41 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -18.06 63.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -1.187 . . . . 0.0 109.539 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -60.95 -41.69 96.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.217 -0.927 . . . . 0.0 109.39 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 75.56 48.88 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.672 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.53 ' O ' HD11 ' A' ' 132' ' ' ILE . 72.4 m-20 -118.84 134.02 23.6 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 109.373 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.409 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 34.1 Cg_endo -75.59 -5.48 16.58 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.317 2.011 . . . . 0.0 110.157 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.425 ' HB3' ' CB ' ' A' ' 9' ' ' SER . 11.4 t70 -101.48 -3.31 28.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 109.304 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 9' ' ' SER . . . -85.17 137.87 32.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 109.378 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.471 ' SD ' ' HB2' ' A' ' 159' ' ' PHE . 1.4 ttp -43.42 152.99 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.742 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.9 m -100.67 141.44 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.365 -0.835 . . . . 0.0 109.279 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.611 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.1 t -102.27 139.04 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.236 -0.915 . . . . 0.0 109.42 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.515 ' HB3' ' CG ' ' A' ' 128' ' ' TYR . 4.9 mt -107.13 146.16 31.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.31 -0.869 . . . . 0.0 109.206 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 128' ' ' TYR . 1.8 ttm -111.98 125.78 54.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.674 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.41 ' HB3' ' OH ' ' A' ' 155' ' ' TYR . 2.4 t-20 -139.13 169.08 18.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 4.9 m-85 -102.66 145.91 28.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.597 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.574 ' HB2' ' CE2' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -142.85 -170.84 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.345 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' ARG . 0.8 OUTLIER 62.07 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.571 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.68 -22.17 11.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.586 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.591 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 124.27 -18.37 7.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 152' ' ' ILE . 2.4 tp -96.26 7.23 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.299 -1.118 . . . . 0.0 109.394 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.6 m -110.64 101.8 50.13 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.298 -0.876 . . . . 0.0 109.633 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.59 139.39 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.521 2.147 . . . . 0.0 110.18 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 148' ' ' ARG . 52.0 p90 -145.14 158.64 43.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 109.655 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 158' ' ' PHE . 7.1 mtm -107.44 156.14 19.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.301 -0.874 . . . . 0.0 109.295 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.497 ' O ' HG13 ' A' ' 143' ' ' VAL . 42.3 mt -122.6 132.61 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.08 -1.012 . . . . 0.0 110.011 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.611 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 7.8 m-85 -126.22 115.11 19.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.481 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 3.8 m-85 -50.41 126.28 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.397 -0.814 . . . . 0.0 109.774 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 161' ' ' ASP . 4.9 tttm -68.49 -38.14 80.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.772 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 1.8 p30 -43.26 -41.45 3.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . -110.0 54.29 0.55 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.608 ' C ' HD23 ' A' ' 163' ' ' LEU . 8.7 tt -157.66 142.37 16.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -1.099 . . . . 0.0 109.556 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.475 ' N ' HD23 ' A' ' 163' ' ' LEU . 19.8 m -127.65 152.65 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.4 m -104.31 121.34 43.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.099 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -115.93 127.56 55.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.616 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 146.53 25.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.875 . . . . 0.0 109.564 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.433 ' C ' HD23 ' A' ' 2' ' ' LEU . 2.4 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 167' ' ' LYS . 2.9 mt -105.44 165.04 11.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.897 . . . . 0.0 109.421 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 3' ' ' LEU . 79.6 mt -127.27 129.63 48.08 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.432 -0.792 . . . . 0.0 109.584 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HB3' HD22 ' A' ' 163' ' ' LEU . 64.2 m-85 -111.59 108.79 18.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.255 -0.903 . . . . 0.0 109.312 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.669 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -117.24 163.91 15.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.773 ' HB2' HD12 ' A' ' 13' ' ' LEU . 4.3 t0 -76.23 152.41 36.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.889 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.572 ' CG2' HG13 ' A' ' 164' ' ' VAL . 2.7 t -102.32 -5.97 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.81 . . . . 0.0 109.344 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.603 HG21 ' O ' ' A' ' 139' ' ' ASP . 4.7 mt -97.54 -79.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.415 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -144.47 67.37 1.26 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 0.0 109.554 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -130.81 -65.83 0.1 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER 73.52 13.18 4.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.315 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 1.4 pt-20 170.67 107.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.039 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.773 HD12 ' HB2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -129.4 -64.98 0.87 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.834 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.894 HG23 HD21 ' A' ' 68' ' ' LEU . 11.3 p -157.31 170.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.299 -0.876 . . . . 0.0 108.968 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.68 ' C ' HD11 ' A' ' 20' ' ' LEU . 3.7 p -155.06 -176.23 5.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.667 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.23 10.71 6.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.545 -0.722 . . . . 0.0 110.165 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.493 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . . . -66.05 -10.25 38.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.056 -1.027 . . . . 0.0 109.19 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.614 ' CG ' HD11 ' A' ' 68' ' ' LEU . 8.1 m-85 -127.41 21.69 6.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.174 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.19 130.56 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.768 HD23 ' HA ' ' A' ' 30' ' ' ALA . 19.3 mt -126.86 148.46 49.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 110.484 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.96 133.14 53.77 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.7 122.47 38.5 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.179 -0.951 . . . . 0.0 108.839 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.39 158.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.095 -1.003 . . . . 0.0 109.168 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -64.1 -10.53 23.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.086 -1.009 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.76 ' C ' HG23 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -76.87 1.45 17.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.779 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.76 HG23 ' C ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 75.22 25.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.428 ' HB ' HG22 ' A' ' 157' ' ' ILE . 20.2 m -119.3 156.57 21.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 110.186 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -107.64 157.01 18.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 0.0 109.07 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.5 mt-10 -130.47 117.63 19.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.946 -1.096 . . . . 0.0 109.342 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.768 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -110.25 114.15 27.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -57.46 143.13 41.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -102.84 174.1 6.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.244 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 3.0 tt0 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.912 . . . . 0.0 109.588 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 3.6 m-20 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 52.7 t-20 -90.98 -26.62 19.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.622 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.894 HD21 HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -77.31 -42.5 36.56 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.771 HG13 ' HB2' ' A' ' 74' ' ' LEU . 44.6 t -73.19 -34.73 45.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.454 -0.779 . . . . 0.0 109.301 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 15.3 t80 -63.33 -48.79 76.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 110.384 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.54 -40.39 61.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.18 -0.95 . . . . 0.0 110.32 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CB ' HD23 ' A' ' 74' ' ' LEU . 62.8 m-85 -86.2 4.31 39.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 109.992 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.468 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 4.8 mtt85 52.82 35.66 19.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.569 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.771 ' HB2' HG13 ' A' ' 69' ' ' VAL . 1.8 mm? -57.59 167.58 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.879 -1.138 . . . . 0.0 108.715 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.568 ' HB3' HG23 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -130.23 117.03 17.8 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.996 -1.065 . . . . 0.0 109.73 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.86 123.29 5.71 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.488 2.125 . . . . 0.0 110.506 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.863 HG22 ' O ' ' A' ' 130' ' ' PHE . 14.8 t -105.91 128.35 53.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.354 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -100.46 2.08 41.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 109.847 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 12.3 t80 -120.87 124.75 45.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.068 -1.02 . . . . 0.0 109.529 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 178.3 31.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.71 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -62.61 -46.78 86.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 109.349 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.13 -23.1 9.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.366 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 m -72.0 -32.65 67.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 0.0 109.656 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 2.2 t80 -60.14 -43.92 95.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.942 . . . . 0.0 109.808 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtt -60.18 -50.79 72.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.333 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -60.03 -36.54 77.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.042 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.632 ' CD1' ' CB ' ' A' ' 138' ' ' PRO . 8.9 m-85 -74.96 -23.84 58.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.102 -0.999 . . . . 0.0 109.686 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.3 -29.03 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.021 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.57 -36.91 25.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.233 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.98 -31.19 74.84 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.604 ' CZ ' ' HG3' ' A' ' 141' ' ' MET . 2.2 t80 -81.18 -39.32 25.66 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.16 -1.2 . . . . 0.0 109.077 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -47.46 84.4 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.113 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -39.34 93.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.312 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.52 -47.31 73.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.221 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.537 HD11 ' HE1' ' A' ' 91' ' ' TYR . 47.5 mm -66.33 -32.08 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.33 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -36.06 71.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.889 -1.132 . . . . 0.0 108.577 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.72 -49.8 23.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.404 -0.81 . . . . 0.0 109.952 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -54.19 -34.69 61.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.064 -1.023 . . . . 0.0 109.708 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.535 ' HB2' HG22 ' A' ' 107' ' ' VAL . 61.3 mt -73.93 -35.52 64.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.102 -0.999 . . . . 0.0 109.12 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -22.23 65.05 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.147 -0.971 . . . . 0.0 109.287 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.01 -41.42 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 110.119 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 t -145.4 47.34 1.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.937 -1.102 . . . . 0.0 110.292 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 1.9 m-20 174.65 72.98 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.38 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.56 -43.31 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.7 2.267 . . . . 0.0 110.682 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.408 ' O ' HG22 ' A' ' 109' ' ' VAL . 4.9 mt-10 -72.27 -12.89 61.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.849 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.501 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -93.21 -7.57 44.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.139 -0.976 . . . . 0.0 109.799 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 71.0 t -67.16 -44.14 47.79 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 111.14 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.9 Cg_endo -76.54 -54.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.866 1.71 . . . . 0.0 110.979 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 0.8 OUTLIER -59.78 -34.21 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.076 -1.015 . . . . 0.0 109.68 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.475 ' CB ' ' O ' ' A' ' 106' ' ' ARG . 93.4 t80 -68.95 -43.44 75.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.955 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -31.17 71.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 109.814 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -71.82 -49.37 39.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.553 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -68.92 -51.36 40.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.17 -0.956 . . . . 0.0 110.391 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.921 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -54.4 -26.95 33.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.881 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.11 -39.0 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.454 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.74 -49.96 51.52 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.413 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.44 -30.68 68.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -1.108 . . . . 0.0 109.582 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 114' ' ' ALA . 78.5 t -63.69 -41.1 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.64 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.84 -37.23 79.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.118 -0.989 . . . . 0.0 109.798 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -61.79 -60.12 4.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.829 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 117' ' ' PHE . 1.9 mp -56.38 -48.32 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 109.766 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 52.8 mt -46.91 -35.17 6.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.129 -0.982 . . . . 0.0 109.695 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -45.74 -48.94 15.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.802 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.6 57.35 1.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 109.664 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 1.9 p90 -55.63 -20.53 14.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.628 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.438 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -71.35 -45.61 62.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.759 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -73.41 -26.34 60.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -78.03 -25.13 47.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.421 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 60.04 170.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.541 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.863 ' O ' HG22 ' A' ' 77' ' ' THR . 2.1 m-85 -133.16 122.02 23.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 108.872 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.63 ' O ' HG13 ' A' ' 142' ' ' VAL . 14.7 m-85 -101.25 166.92 10.52 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.146 -0.971 . . . . 0.0 110.391 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.568 HG23 ' HB3' ' A' ' 75' ' ' SER . 3.6 tt -152.06 135.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.636 -0.665 . . . . 0.0 109.516 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.1 173.61 0.36 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -66.18 -23.98 66.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -1.113 . . . . 0.0 109.499 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.2 OUTLIER -59.27 -35.2 73.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.177 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.464 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER 71.68 53.05 0.22 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 109.61 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.531 ' N ' HD11 ' A' ' 132' ' ' ILE . 1.9 t70 -130.6 134.01 25.52 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.363 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.632 ' CB ' ' CD1' ' A' ' 87' ' ' TYR . 34.4 Cg_endo -75.1 -0.21 9.73 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.345 2.03 . . . . 0.0 110.374 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.603 ' O ' HG21 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -103.11 7.86 38.75 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 109.008 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 141' ' ' MET . . . -106.14 17.74 23.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.914 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.604 ' HG3' ' CZ ' ' A' ' 91' ' ' TYR . 7.9 ttm 74.45 148.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.037 -1.039 . . . . 0.0 110.274 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 131' ' ' TYR . 16.5 t -114.38 139.3 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 109.226 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.71 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.7 t -105.73 125.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.062 -1.024 . . . . 0.0 109.602 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -106.21 149.4 26.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.921 . . . . 0.0 109.069 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.502 ' HB3' ' HB3' ' A' ' 156' ' ' MET . 12.9 ptp -146.1 147.34 31.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.0 . . . . 0.0 109.744 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -156.18 161.64 40.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.911 . . . . 0.0 109.424 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.4 139.29 58.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.947 . . . . 0.0 109.374 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.441 ' CD ' HG22 ' A' ' 153' ' ' THR . 15.4 ptm180 -70.38 -170.28 0.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 109.616 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -27.82 68.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.923 . . . . 0.0 109.672 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 152' ' ' ILE . 1.2 m-20 -75.79 -14.9 60.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 56.36 22.68 38.56 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.804 HD12 ' HB ' ' A' ' 153' ' ' THR . 2.7 pp -110.0 -29.26 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -1.136 . . . . 0.0 109.795 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.804 ' HB ' HD12 ' A' ' 152' ' ' ILE . 5.9 t -138.22 134.68 17.85 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.014 . . . . 0.0 109.812 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 153' ' ' THR . 36.7 Cg_endo -81.07 151.89 18.44 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.664 2.242 . . . . 0.0 110.332 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -145.17 133.66 21.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.448 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.617 ' HG3' ' CE1' ' A' ' 158' ' ' PHE . 0.0 OUTLIER -105.8 155.41 19.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.296 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.428 HG22 ' HB ' ' A' ' 27' ' ' VAL . 2.5 mt -118.16 154.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.771 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.71 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 49.9 m-85 -133.12 164.16 27.64 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.483 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 97.6 m-85 -107.88 121.12 44.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 0.0 109.426 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -59.19 -32.76 70.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 110.036 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 5.2 p30 -44.42 -28.26 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 109.683 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . -130.89 58.17 0.71 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 5' ' ' LYS . 4.4 mt -153.92 138.14 16.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -1.198 . . . . 0.0 109.506 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.572 HG13 ' CG2' ' A' ' 7' ' ' VAL . 2.0 m -119.03 130.94 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 109.791 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.8 p -85.74 125.85 33.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.253 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.77 142.11 45.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.868 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.441 ' HA ' HD22 ' A' ' 2' ' ' LEU . 4.6 tppt? -102.41 126.45 49.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 109.062 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 167' ' ' LYS . 7.4 p90 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.686 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 166' ' ' GLU . 0.3 OUTLIER -68.49 143.64 54.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.222 -0.924 . . . . 0.0 110.069 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 2' ' ' LEU . 21.8 mt -115.43 128.21 55.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.632 -0.668 . . . . 0.0 109.482 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.742 ' CD2' HD21 ' A' ' 163' ' ' LEU . 4.4 m-85 -104.27 132.08 50.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.325 -0.859 . . . . 0.0 109.419 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 9.6 pttt -146.89 164.63 32.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.735 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 162' ' ' GLY . 44.1 t0 -87.65 146.66 25.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.298 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.71 -12.38 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.586 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.871 HG21 ' HA ' ' A' ' 140' ' ' ALA . 29.4 mm -54.59 -69.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.507 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -99.37 -51.76 3.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.392 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 95.46 1.68 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 4.5 p30 -170.53 153.85 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.178 -1.19 . . . . 0.0 109.526 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 3.7 mm-40 -71.29 118.57 14.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.252 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.84 -41.88 3.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 109.496 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.839 HG21 ' HB2' ' A' ' 30' ' ' ALA . 2.3 p -153.18 169.26 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.603 ' N ' HG22 ' A' ' 14' ' ' VAL . 51.8 p -153.64 177.7 10.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.975 -1.078 . . . . 0.0 110.419 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.1 6.77 17.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.419 -0.801 . . . . 0.0 109.783 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.04 -8.4 44.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.145 -0.972 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 19' ' ' ASP . 52.6 m-85 -126.54 19.14 7.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.432 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER 61.46 120.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 37.3 mt -111.82 138.73 48.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.168 -0.957 . . . . 0.0 110.45 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -119.58 136.61 54.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.602 -0.687 . . . . 0.0 109.462 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 1.4 tt0 -99.81 115.98 30.84 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.247 -0.908 . . . . 0.0 108.881 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.519 HG22 ' OE2' ' A' ' 29' ' ' GLU . 6.4 t -70.82 158.92 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 109.48 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' VAL . 21.9 t0 -39.22 -39.97 0.68 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.507 -0.745 . . . . 0.0 109.568 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.88 -143.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 108.834 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.564 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -125.98 62.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.031 -1.043 . . . . 0.0 109.244 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.535 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 16.4 m -138.49 150.97 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.543 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -104.7 157.07 17.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.519 ' OE2' HG22 ' A' ' 23' ' ' VAL . 80.4 mt-10 -122.86 117.47 25.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.422 -0.799 . . . . 0.0 109.079 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.839 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -113.54 115.45 28.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.48 150.09 45.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.9 p -143.55 158.37 43.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.394 -0.816 . . . . 0.0 109.207 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.545 ' HB2' HG23 ' A' ' 69' ' ' VAL . 34.9 m120 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 28.9 p-10 -56.18 -24.41 41.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.825 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' A' ' 72' ' ' PHE . 58.4 tp -82.06 -34.85 29.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 108.953 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.847 HG13 ' CB ' ' A' ' 74' ' ' LEU . 53.5 t -66.36 -55.33 19.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.487 -0.758 . . . . 0.0 109.751 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -66.46 -42.88 86.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 0.0 110.224 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.1 m -55.94 -46.03 78.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.044 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.565 ' CE2' HD11 ' A' ' 68' ' ' LEU . 16.4 m-30 -100.43 18.82 18.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.483 ' O ' HD22 ' A' ' 74' ' ' LEU . 18.9 ttm105 49.3 89.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 109.479 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.847 ' CB ' HG13 ' A' ' 69' ' ' VAL . 1.9 mm? -117.4 143.06 46.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.326 -0.859 . . . . 0.0 109.049 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.728 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -121.43 143.36 37.52 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 109.741 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 36.7 Cg_endo -79.89 139.91 14.09 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.677 2.252 . . . . 0.0 110.467 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.0 t -122.05 135.39 54.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.231 -0.918 . . . . 0.0 109.257 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 t -114.45 145.58 41.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.925 . . . . 0.0 109.717 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CZ ' ' CD2' ' A' ' 130' ' ' PHE . 5.1 p90 -172.29 -177.6 1.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 82' ' ' LYS . 21.2 p-10 -101.07 169.13 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.023 . . . . 0.0 109.606 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -53.69 -47.78 70.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.0 109.913 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.464 ' HB2' ' OD2' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -50.37 -35.69 29.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.778 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.461 ' HB2' ' OD1' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -71.9 -36.94 70.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.772 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 1.6 t80 -63.51 -47.41 81.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.827 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -40.97 91.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.936 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.03 -28.57 66.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.977 . . . . 0.0 109.911 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 138' ' ' PRO . 3.2 m-85 -70.12 -47.25 62.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 109.625 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 92' ' ' MET . 6.3 tp -74.17 -15.98 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.398 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.17 -59.77 2.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.2 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.61 -26.57 72.92 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.598 ' CE1' HD11 ' A' ' 95' ' ' ILE . 4.5 t80 -72.46 -36.1 68.4 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -63.44 -43.33 97.72 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -58.14 -45.36 87.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.36 -0.838 . . . . 0.0 109.001 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.52 71.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 108.768 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.697 HG21 ' CE2' ' A' ' 110' ' ' PHE . 27.0 mm -56.04 -30.44 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 0.0 109.026 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.584 ' HD2' HG13 ' A' ' 107' ' ' VAL . 0.3 OUTLIER -54.18 -47.29 72.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.57 -30.82 64.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.757 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.515 ' CZ ' ' O ' ' A' ' 161' ' ' ASP . 3.8 tmt_? -60.7 -44.92 95.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 109.898 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 106' ' ' ARG . 14.2 mt -72.33 -49.75 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.158 -0.964 . . . . 0.0 109.784 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.4 -26.17 40.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.955 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -79.76 -45.11 19.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 0.0 109.199 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p -95.86 -70.37 0.72 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.447 ' HB3' ' NH2' ' A' ' 106' ' ' ARG . 12.9 t-20 -123.38 118.13 27.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.452 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.8 -29.03 9.02 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.403 2.069 . . . . 0.0 110.675 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.448 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 3.0 mt-10 -70.28 -6.64 36.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.64 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HB3' HD13 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -88.71 -3.34 58.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 0.0 109.878 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 59.1 t -72.34 -43.79 9.85 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 111.171 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.4 Cg_endo -77.86 -50.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.824 1.683 . . . . 0.0 110.902 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 110' ' ' PHE . 3.9 p -60.59 -46.84 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.72 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.697 ' CE2' HG21 ' A' ' 95' ' ' ILE . 73.3 t80 -67.66 -37.4 82.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -0.783 . . . . 0.0 110.401 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 6.2 tm-20 -59.47 -49.66 76.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.06 -1.025 . . . . 0.0 110.451 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -64.82 -44.05 91.12 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.11 -0.994 . . . . 0.0 110.281 -179.273 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -61.2 -32.5 72.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.937 -1.102 . . . . 0.0 110.007 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.75 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -64.22 -51.0 65.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 111.367 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.88 HD12 ' N ' ' A' ' 116' ' ' GLY . 1.7 pp -62.94 -45.79 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.769 -1.207 . . . . 0.0 110.576 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.88 ' N ' HD12 ' A' ' 115' ' ' ILE . . . -59.06 -40.14 95.21 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.487 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -73.03 -30.24 63.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -1.16 . . . . 0.0 109.871 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 114' ' ' ALA . 69.2 t -65.65 -43.95 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.896 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.517 ' C ' ' CD ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -71.84 -32.06 67.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.627 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -28.65 61.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 109.999 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 117' ' ' PHE . 1.2 mp -79.55 -30.68 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.998 -1.064 . . . . 0.0 108.977 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 122' ' ' LEU . 23.2 mt -58.93 -26.19 64.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.897 . . . . 0.0 109.621 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 122' ' ' LEU . . . -43.89 -39.61 4.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.843 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 128' ' ' TYR . 2.6 m-20 -143.82 58.67 1.37 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 109.804 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 4.6 p90 -62.59 -35.03 78.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.417 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.495 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -76.36 -26.37 55.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.71 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 2.8 t70 -77.52 -27.69 51.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 109.516 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 128' ' ' TYR . 1.6 m-30 -100.04 -1.57 36.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.07 -159.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 109.465 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 79' ' ' PHE . 68.5 m-85 -147.97 121.71 9.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 69' ' ' VAL . 11.9 m-85 -98.6 168.15 10.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.961 . . . . 0.0 110.296 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.815 ' O ' HD13 ' A' ' 74' ' ' LEU . 2.1 tt -150.7 146.54 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.408 -0.807 . . . . 0.0 109.437 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.75 168.44 46.65 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 135' ' ' SER . 0.2 OUTLIER -57.45 -21.21 35.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -1.159 . . . . 0.0 109.368 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 136' ' ' MET . 49.9 m -62.58 -41.71 99.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 75.41 41.81 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 109.691 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.25 129.39 24.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.148 -0.97 . . . . 0.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 87' ' ' TYR . 33.3 Cg_endo -75.13 -13.35 21.17 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.322 2.015 . . . . 0.0 110.306 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -97.25 8.29 44.85 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 108.953 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.871 ' HA ' HG21 ' A' ' 8' ' ' ILE . . . -92.26 -161.81 0.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.347 -0.846 . . . . 0.0 109.489 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.444 ' SD ' ' O ' ' A' ' 162' ' ' GLY . 2.6 ttp -88.82 145.68 25.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.676 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.96 141.05 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.285 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.535 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.1 t -109.79 136.46 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.87 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 128' ' ' TYR . 53.0 mt -107.7 151.24 25.94 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.813 . . . . 0.0 108.976 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.82 134.98 50.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.632 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -155.03 143.3 20.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.38 -0.825 . . . . 0.0 109.292 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.433 ' CD1' ' HA2' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -65.41 160.41 22.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.313 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 153' ' ' THR . 0.0 OUTLIER -58.49 173.58 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.15 -17.28 39.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -107.36 -47.35 3.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -0.978 . . . . 0.0 109.364 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.433 ' HA2' ' CD1' ' A' ' 147' ' ' TYR . . . 120.28 29.17 1.66 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.76 -38.87 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -1.075 . . . . 0.0 109.279 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 148' ' ' ARG . 14.8 t -137.43 142.11 36.18 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.069 -1.019 . . . . 0.0 109.713 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 153' ' ' THR . 36.5 Cg_endo -79.35 146.71 19.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.665 2.244 . . . . 0.0 110.447 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -145.13 160.24 41.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.387 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.501 ' HB2' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -122.17 159.06 28.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.336 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 27' ' ' VAL . 36.8 mt -113.29 136.26 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.672 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.535 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 48.1 m-85 -123.74 118.22 26.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.03 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -50.07 119.5 3.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.096 -1.002 . . . . 0.0 109.565 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 161' ' ' ASP . 18.8 tptp -67.34 -42.09 84.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.341 -0.849 . . . . 0.0 109.526 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.562 ' OD2' HD21 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -44.11 -38.85 3.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.22 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.446 ' O ' ' OD1' ' A' ' 6' ' ' ASP . . . -108.8 52.73 0.63 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.742 HD21 ' CD2' ' A' ' 4' ' ' TYR . 7.9 tt -151.17 149.44 29.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -1.123 . . . . 0.0 109.405 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 165' ' ' SER . 0.6 OUTLIER -138.0 157.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.901 . . . . 0.0 109.61 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' A' ' 164' ' ' VAL . 0.7 OUTLIER -111.02 120.88 43.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.675 . . . . 0.0 109.458 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.579 ' O ' HD13 ' A' ' 2' ' ' LEU . 2.9 tt0 -108.11 147.2 31.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.428 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.07 116.02 28.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 0.0 109.329 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.447 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.488 ' O ' HD23 ' A' ' 2' ' ' LEU . 6.2 ptt? . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 167' ' ' LYS . 11.9 mt -121.27 149.07 43.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.631 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 3' ' ' LEU . 23.4 mt -101.4 122.91 44.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.555 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.585 ' CB ' HG13 ' A' ' 14' ' ' VAL . 6.2 m-85 -106.42 118.8 37.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.866 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 0.7 OUTLIER -129.67 141.13 50.97 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.8 ' OD1' HD11 ' A' ' 13' ' ' LEU . 12.2 p-10 -167.36 110.14 0.66 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.074 -1.016 . . . . 0.0 110.183 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.515 HG12 ' HB1' ' A' ' 140' ' ' ALA . 20.9 t -147.77 48.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER 62.12 15.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.9 t -163.96 -34.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.571 -0.706 . . . . 0.0 109.596 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.46 100.29 2.61 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 12' ' ' GLU . 51.8 t0 -130.08 -78.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.763 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.546 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER 161.61 113.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 109.408 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.978 HD12 ' N ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -146.51 -31.31 0.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.136 -0.977 . . . . 0.0 110.817 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.978 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.3 p -134.97 174.12 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.723 -1.235 . . . . 0.0 109.06 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.624 ' C ' HD11 ' A' ' 20' ' ' LEU . 36.2 m -164.49 -174.73 3.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.021 . . . . 0.0 110.404 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.05 12.89 6.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.568 -0.708 . . . . 0.0 109.711 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.04 -17.03 64.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.955 . . . . 0.0 109.053 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.561 ' CE2' HD13 ' A' ' 68' ' ' LEU . 56.7 m-85 -118.37 19.49 13.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.462 -0.774 . . . . 0.0 109.169 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 18' ' ' TYR . 8.6 t0 63.33 120.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 30' ' ' ALA . 10.0 mt -113.71 153.11 29.53 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.2 -0.938 . . . . 0.0 110.359 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -129.41 141.21 51.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.496 -0.752 . . . . 0.0 109.177 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.512 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 1.5 mt-10 -93.97 128.55 40.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.938 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 t -80.07 153.44 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.841 . . . . 0.0 109.589 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.01 -17.14 6.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.761 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 26' ' ' ILE . 8.5 m-20 -81.61 -100.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.619 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -164.53 60.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 0.0 109.41 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 159' ' ' PHE . 14.7 m -152.28 164.02 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 110.179 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.512 ' CE1' ' HG3' ' A' ' 22' ' ' GLU . 7.2 m-85 -104.34 157.85 16.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.419 -0.8 . . . . 0.0 108.858 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 19.6 mt-10 -127.07 118.59 24.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.961 . . . . 0.0 109.314 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.696 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -114.71 112.44 22.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.009 -1.057 . . . . 0.0 109.062 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 13.9 t0 -79.87 150.24 30.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 p -129.26 -174.5 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.318 -179.955 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.454 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 22.9 m120 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -88.82 -28.1 20.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.694 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.561 HD13 ' CE2' ' A' ' 18' ' ' TYR . 12.1 tp -78.39 -45.07 23.3 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.054 -1.029 . . . . 0.0 108.407 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.865 HG13 ' CB ' ' A' ' 74' ' ' LEU . 33.4 t -63.82 -54.62 29.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 70' ' ' TYR . 15.8 t80 -55.57 -32.55 63.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.177 -0.952 . . . . 0.0 109.533 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m -70.09 -38.08 75.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.851 . . . . 0.0 110.061 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.564 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 43.2 m-85 -104.35 10.32 35.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.015 -1.053 . . . . 0.0 110.142 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 4.1 tpp180 60.24 25.25 14.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.062 -1.024 . . . . 0.0 109.984 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.865 ' CB ' HG13 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -43.5 137.76 2.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.511 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.959 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -107.58 119.11 51.58 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.68 134.52 12.26 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.343 2.029 . . . . 0.0 110.104 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 179.82 5.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.088 -1.008 . . . . 0.0 109.742 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.97 132.09 37.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.494 -0.754 . . . . 0.0 109.146 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 30.5 p90 -124.81 161.54 26.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.682 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -89.43 150.32 22.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -53.27 -32.8 50.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.136 -0.978 . . . . 0.0 110.039 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -87.45 -25.74 23.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 110.138 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -71.11 -38.18 72.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.118 -0.988 . . . . 0.0 109.855 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.478 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 3.8 t80 -68.48 -35.38 77.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.562 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.761 ' O ' HG22 ' A' ' 88' ' ' ILE . 7.5 mtm -64.06 -56.03 17.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.9 p -58.87 -37.71 77.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -74.87 -19.5 60.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 85' ' ' MET . 0.2 OUTLIER -75.16 -31.96 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.866 . . . . 0.0 108.845 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 3.4 mttt -70.82 -53.97 13.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.462 -0.773 . . . . 0.0 109.345 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.16 -24.02 73.23 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -75.36 -36.84 60.91 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.153 -1.204 . . . . 0.0 108.235 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -48.36 66.17 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.549 -0.719 . . . . 0.0 109.148 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 89' ' ' LYS . 28.3 mmtm -55.2 -41.26 71.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.334 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.54 -42.58 71.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 109.137 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.883 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 28.3 mm -70.66 -26.6 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.319 -0.863 . . . . 0.0 109.26 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.46 -34.29 75.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.959 . . . . 0.0 108.684 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.27 -47.94 46.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.559 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -56.9 -32.94 66.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.989 . . . . 0.0 109.433 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.932 HD22 ' HB3' ' A' ' 106' ' ' ARG . 86.9 mt -73.0 -41.93 63.77 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.255 -0.903 . . . . 0.0 109.326 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -33.93 73.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.384 -0.823 . . . . 0.0 109.556 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -73.15 -39.25 65.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.557 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.6 p -90.97 -82.4 0.29 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.12 123.82 26.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.381 -0.824 . . . . 0.0 109.055 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.61 -26.45 11.73 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.401 2.067 . . . . 0.0 110.661 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.21 -7.11 39.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.614 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.932 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -92.29 1.74 57.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.618 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 14.3 t -69.83 -46.43 24.13 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 110.252 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.9 Cg_endo -78.26 -36.6 0.95 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.02 1.813 . . . . 0.0 110.673 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.69 -51.15 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.995 . . . . 0.0 109.592 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.883 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 6.5 t80 -65.31 -37.72 88.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.919 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.785 ' O ' HD12 ' A' ' 115' ' ' ILE . 1.2 mt-10 -64.56 -35.51 81.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 109.953 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -71.75 -41.02 68.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.497 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -69.52 -54.54 13.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.077 -1.014 . . . . 0.0 110.374 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.702 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -58.92 -27.17 65.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 109.972 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -60.17 -49.11 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.338 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 115' ' ' ILE . . . -67.26 -40.76 92.15 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.628 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -61.26 -30.76 70.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -1.128 . . . . 0.0 110.177 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 114' ' ' ALA . 69.4 t -67.14 -41.74 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 110.391 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -69.3 -44.13 72.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.047 -1.033 . . . . 0.0 110.027 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -57.04 -52.28 65.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.172 -0.955 . . . . 0.0 110.039 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.825 HG12 HD13 ' A' ' 144' ' ' LEU . 1.6 mp -58.18 -44.54 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.08 -1.012 . . . . 0.0 109.323 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.11 -30.42 64.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.25 -46.32 54.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.729 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 124' ' ' ASN . 2.4 p-10 -143.5 57.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 109.698 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 126' ' ' LYS . 21.9 p90 -51.79 -25.61 7.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 109.815 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.2 mmtt -61.96 -44.84 95.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 109.676 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -79.06 -23.01 44.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.618 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.595 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 2.8 m-85 -76.05 -20.32 57.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 109.751 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.8 OUTLIER 49.6 -177.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 110.029 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.491 ' CD2' HG11 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -142.91 121.38 12.42 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.479 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.799 ' O ' HG13 ' A' ' 142' ' ' VAL . 18.4 m-85 -108.9 176.93 4.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.03 -1.044 . . . . 0.0 110.869 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.959 HG22 ' O ' ' A' ' 75' ' ' SER . 1.6 tt -155.54 150.88 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.561 -0.712 . . . . 0.0 109.556 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.72 -176.68 43.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -18.85 63.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -1.205 . . . . 0.0 109.429 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 m -64.47 -37.06 86.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.259 -0.901 . . . . 0.0 109.461 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.447 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER 62.23 43.79 8.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.764 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -98.65 127.26 36.24 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.72 -1.55 11.5 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.291 1.994 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -115.03 10.95 16.34 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.344 -0.848 . . . . 0.0 109.003 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.515 ' HB1' HG12 ' A' ' 7' ' ' VAL . . . -100.95 -177.38 3.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.266 -0.896 . . . . 0.0 109.6 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -83.49 142.32 31.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.535 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 131' ' ' TYR . 41.1 t -108.45 141.48 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 0.0 109.65 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.461 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 21.8 t -92.04 122.97 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.313 -0.867 . . . . 0.0 108.932 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.825 HD13 HG12 ' A' ' 121' ' ' ILE . 1.1 mt -90.24 124.53 34.95 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.288 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.584 ' CE ' ' CE ' ' A' ' 156' ' ' MET . 53.5 ttm -104.93 128.47 53.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.595 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 52.6 t30 -147.01 165.24 30.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.54 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -84.47 157.78 21.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.405 ' HG3' ' CD1' ' A' ' 155' ' ' TYR . 2.8 mtt85 -87.77 176.12 7.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.187 -0.945 . . . . 0.0 109.214 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.18 -13.93 51.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.22 -0.925 . . . . 0.0 109.137 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.3 -60.8 3.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.326 -0.859 . . . . 0.0 109.096 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 131.61 -27.02 3.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -133.95 37.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -1.175 . . . . 0.0 109.421 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.2 m -129.03 100.58 20.48 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.368 -0.833 . . . . 0.0 109.358 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.74 127.16 6.2 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.534 2.156 . . . . 0.0 110.481 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.405 ' CD1' ' HG3' ' A' ' 148' ' ' ARG . 26.0 p90 -145.03 159.42 42.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.584 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -129.68 142.72 50.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.278 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.5 mt -102.4 148.45 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.579 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.657 ' CE2' HD13 ' A' ' 13' ' ' LEU . 54.9 m-85 -127.17 118.66 24.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 109.36 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.468 ' HA ' HG12 ' A' ' 27' ' ' VAL . 43.8 m-85 -53.51 119.52 4.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.653 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 26' ' ' ILE . 7.8 tptt -66.7 -38.06 85.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.74 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.438 ' OD1' ' HB3' ' A' ' 159' ' ' PHE . 1.4 p-10 -44.76 -48.81 10.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.642 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 6' ' ' ASP . . . -104.71 50.21 0.86 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 164' ' ' VAL . 6.9 tt -145.18 155.17 43.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -1.194 . . . . 0.0 109.3 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.809 ' N ' HD23 ' A' ' 163' ' ' LEU . 4.3 m -144.2 135.52 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.973 . . . . 0.0 109.818 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.0 m -99.02 137.96 36.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.079 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -127.12 139.09 53.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.782 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.508 ' HA ' HD22 ' A' ' 2' ' ' LEU . 5.5 ttmt -78.58 125.27 29.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 109.35 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.497 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.9 165.82 14.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.586 HD12 ' HA ' ' A' ' 168' ' ' PHE . 82.6 mt -120.99 135.31 55.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.62 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.586 ' CD2' HD21 ' A' ' 163' ' ' LEU . 68.6 m-85 -121.54 133.02 55.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.833 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -135.07 153.59 51.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.832 . . . . 0.0 109.366 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 41.9 t0 -61.78 148.11 44.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.506 ' CG2' HG13 ' A' ' 164' ' ' VAL . 18.5 t -91.2 53.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.898 . . . . 0.0 109.434 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.594 HG22 ' N ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -163.76 -54.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.084 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.594 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER 177.81 64.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.496 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.729 ' HA3' HD13 ' A' ' 13' ' ' LEU . . . -111.1 -18.74 8.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.5 OUTLIER 45.98 87.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -1.187 . . . . 0.0 109.234 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.402 ' HG3' ' C ' ' A' ' 11' ' ' ASP . 2.9 mt-10 58.18 102.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.121 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.729 HD13 ' HA3' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -117.25 -55.78 2.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.556 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.783 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 7.9 p -140.19 164.25 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 108.942 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.547 ' N ' HG22 ' A' ' 14' ' ' VAL . 53.9 p -153.24 172.12 17.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.54 2.32 29.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.484 -0.76 . . . . 0.0 109.759 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.78 -10.24 45.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.102 -0.999 . . . . 0.0 109.035 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.662 ' CD2' HD11 ' A' ' 68' ' ' LEU . 34.7 m-85 -123.42 19.47 9.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.366 -0.834 . . . . 0.0 109.157 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 0.6 OUTLIER 61.62 128.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.348 -0.845 . . . . 0.0 108.925 -179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 30' ' ' ALA . 65.3 mt -118.91 151.17 38.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.129 -0.982 . . . . 0.0 110.139 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -133.66 122.86 24.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 109.492 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.52 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -80.97 121.24 25.78 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.271 -0.893 . . . . 0.0 108.733 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 24' ' ' ASP . 6.6 t -77.38 154.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.716 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' VAL . 6.9 m-20 -42.77 -32.0 0.55 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.818 . . . . 0.0 109.542 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 26' ' ' ILE . 39.9 m-20 -70.6 -116.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -153.77 63.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.734 -1.229 . . . . 0.0 109.483 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 159' ' ' PHE . 16.6 m -152.36 144.21 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.127 -0.983 . . . . 0.0 109.757 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 3.7 m-85 -98.95 134.19 42.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 108.851 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -108.78 138.26 45.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.989 -1.069 . . . . 0.0 109.967 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.783 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -116.17 113.98 23.82 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -65.74 150.15 48.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 0.0 109.689 -179.578 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.6 t -102.94 146.82 27.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.147 -0.971 . . . . 0.0 109.642 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 32.8 m120 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.264 0.554 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 21.0 p30 -99.32 -21.77 15.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 109.333 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.662 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -82.86 -42.78 17.38 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 74' ' ' LEU . 87.8 t -72.37 -35.19 51.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.475 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 2.1 t80 -69.38 -58.25 4.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.906 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 t -56.93 -52.54 64.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.939 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 11.1 m-85 -83.17 -3.47 57.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 109.633 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.518 ' CA ' ' O ' ' A' ' 69' ' ' VAL . 11.4 tpt180 53.63 34.39 18.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 109.545 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.536 ' HB2' HG13 ' A' ' 69' ' ' VAL . 11.8 mt -42.77 142.36 0.89 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.84 . . . . 0.0 109.251 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.86 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -124.46 135.6 26.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.682 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.38 140.98 15.65 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.526 2.151 . . . . 0.0 110.187 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 p -122.34 175.62 6.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.664 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.2 m -144.7 151.2 38.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.068 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.629 ' CE2' ' CD2' ' A' ' 130' ' ' PHE . 6.6 p90 -172.05 -177.54 1.91 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 0.0 109.819 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.08 166.71 10.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.364 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -57.86 -52.16 66.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.733 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -26.21 67.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.788 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.3 t -71.93 -41.06 68.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.967 . . . . 0.0 109.946 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.551 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 24.8 t80 -60.34 -39.06 85.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.796 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.5 mtm -63.44 -43.45 97.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.059 -1.026 . . . . 0.0 109.847 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -40.31 95.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.17 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -67.43 -58.2 5.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.161 -0.962 . . . . 0.0 109.895 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 84' ' ' TYR . 6.3 tp -52.2 -23.79 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.843 . . . . 0.0 109.862 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -74.18 -42.26 60.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.067 -1.02 . . . . 0.0 109.655 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.12 -30.72 76.13 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.529 ' CE1' HD11 ' A' ' 95' ' ' ILE . 31.2 t80 -80.82 -35.96 32.25 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.046 -1.267 . . . . 0.0 108.846 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -43.54 96.65 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.405 -0.809 . . . . 0.0 109.221 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -40.69 82.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.338 -0.851 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.23 82.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 91' ' ' TYR . 39.7 mm -61.64 -44.3 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.159 -0.963 . . . . 0.0 109.555 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.518 ' CE ' HG13 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -47.02 -51.59 16.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.912 . . . . 0.0 109.194 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.84 80.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.539 ' HD3' HD23 ' A' ' 99' ' ' LEU . 1.2 tmt_? -57.46 -36.1 70.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 109.344 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.703 HD13 ' HD2' ' A' ' 106' ' ' ARG . 8.6 mt -72.59 -49.82 29.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -0.852 . . . . 0.0 109.601 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -23.99 52.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.719 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.48 -21.66 17.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 109.568 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 2.7 t -114.13 -89.0 0.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.56 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -120.74 99.64 47.14 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.382 -0.824 . . . . 0.0 109.535 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 107' ' ' VAL . 32.8 Cg_endo -74.37 -13.19 22.98 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.433 2.088 . . . . 0.0 110.392 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -7.14 16.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.127 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.703 ' HD2' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -118.76 21.48 12.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.032 -1.043 . . . . 0.0 109.772 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 16.4 t -72.42 -46.34 10.24 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.494 -0.754 . . . . 0.0 110.868 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.5 Cg_endo -77.0 -48.89 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 121.976 1.784 . . . . 0.0 110.814 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.578 HG22 ' HA ' ' A' ' 106' ' ' ARG . 30.1 m -57.04 -44.86 83.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.104 -0.997 . . . . 0.0 109.589 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.556 ' N ' HG23 ' A' ' 109' ' ' VAL . 29.0 t80 -67.0 -37.87 84.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.84 -54.28 47.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.1 -1.0 . . . . 0.0 110.308 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -60.63 -45.92 92.24 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.105 -0.997 . . . . 0.0 110.207 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -56.34 -40.42 74.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 109.909 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.23 -27.37 63.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.081 -1.012 . . . . 0.0 109.586 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.64 -48.53 71.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.221 -0.924 . . . . 0.0 109.138 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.66 -29.91 76.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -69.98 -42.65 72.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -1.217 . . . . 0.0 109.812 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 97.4 t -69.68 -32.54 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -71.67 -34.51 69.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.127 -0.983 . . . . 0.0 109.624 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.51 ' N ' ' HD3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -84.53 -16.91 40.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.135 -0.978 . . . . 0.0 109.843 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.474 HD11 HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -81.97 -42.96 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.123 -0.986 . . . . 0.0 109.337 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 119' ' ' LYS . 6.6 mt -54.42 -28.2 42.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 109.465 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.24 -49.19 64.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 109.542 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 127' ' ' ASP . 6.4 m-20 -130.53 63.21 1.57 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -0.849 . . . . 0.0 109.416 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.484 ' CE2' ' CD2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -62.02 -49.93 74.06 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.364 -0.835 . . . . 0.0 109.753 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -55.55 -29.02 58.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.585 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.527 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -81.2 -26.55 35.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 109.945 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 129' ' ' ASP . 11.8 m-85 -84.16 -21.25 31.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.932 . . . . 0.0 110.018 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 128' ' ' TYR . 38.6 m-20 54.79 168.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.045 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.629 ' CD2' ' CE2' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -128.01 121.14 29.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.136 -0.978 . . . . 0.0 108.963 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.54 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 17.2 m-85 -109.5 174.71 5.74 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.21 -0.931 . . . . 0.0 110.538 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.86 HG22 ' O ' ' A' ' 75' ' ' SER . 3.6 tt -149.16 162.22 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.553 -0.717 . . . . 0.0 109.365 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.44 -176.93 50.54 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -68.5 -27.01 65.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -1.109 . . . . 0.0 109.398 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 136' ' ' MET . 1.0 OUTLIER -61.1 -34.15 74.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 65.16 39.77 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.385 -0.822 . . . . 0.0 109.371 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.35 139.91 27.46 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 109.198 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -73.8 -17.34 22.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.355 2.037 . . . . 0.0 109.982 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.76 -12.95 62.06 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.77 149.46 21.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.337 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.501 ' HE1' ' HA ' ' A' ' 158' ' ' PHE . 0.2 OUTLIER -66.49 139.14 57.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.603 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.1 m -88.43 141.68 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.821 . . . . 0.0 109.469 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 1.057 HG13 ' O ' ' A' ' 157' ' ' ILE . 16.5 t -97.05 140.82 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.193 -0.942 . . . . 0.0 109.053 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.519 HD23 ' C ' ' A' ' 143' ' ' VAL . 12.4 mt -110.94 134.55 52.48 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.514 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.54 ' HE3' ' CZ ' ' A' ' 131' ' ' TYR . 1.4 mtm -104.74 128.88 52.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 109.109 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.504 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 28.5 t-20 -150.24 159.15 44.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.958 . . . . 0.0 109.685 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -89.05 128.47 35.73 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.292 -0.88 . . . . 0.0 109.013 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -166.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 109.64 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -30.38 70.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 109.723 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -53.68 -59.3 4.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.698 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 111.39 -22.63 19.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.722 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -116.51 8.67 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -1.123 . . . . 0.0 109.165 179.575 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.8 m -117.38 101.3 52.84 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.157 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.49 137.58 14.81 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.601 2.201 . . . . 0.0 110.378 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 14.9 p90 -145.25 139.64 27.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.162 -0.961 . . . . 0.0 109.733 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.521 ' HB2' ' CE1' ' A' ' 158' ' ' PHE . 3.3 mtt -101.89 165.06 11.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 1.057 ' O ' HG13 ' A' ' 143' ' ' VAL . 12.5 mt -125.8 141.07 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.984 -1.073 . . . . 0.0 110.23 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.652 ' HD2' HD23 ' A' ' 13' ' ' LEU . 11.3 m-85 -132.92 118.58 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.418 -0.801 . . . . 0.0 108.902 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.419 ' HA ' HG12 ' A' ' 27' ' ' VAL . 3.2 m-85 -48.59 138.4 10.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 109.722 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -65.98 -51.98 53.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.898 . . . . 0.0 109.156 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 110' ' ' PHE . 3.9 m-20 -47.04 -48.46 22.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.009 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -86.76 50.53 4.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 163' ' ' LEU . 2.1 tt -158.96 116.51 2.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.465 -1.021 . . . . 0.0 109.222 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.506 HG13 ' CG2' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -114.29 148.73 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 4.9 p -96.64 120.58 37.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.32 -0.862 . . . . 0.0 109.372 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -127.3 129.04 46.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.16 128.62 37.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.194 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.586 ' HA ' HD12 ' A' ' 3' ' ' LEU . 15.6 p90 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.74 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.818 ' C ' HD23 ' A' ' 2' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.818 HD23 ' C ' ' A' ' 1' ' ' MET . 4.7 mt -114.05 166.26 11.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.026 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.4 ' HA ' ' OG ' ' A' ' 15' ' ' SER . 11.1 mt -127.96 143.3 51.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 109.298 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.606 ' HB3' HD22 ' A' ' 163' ' ' LEU . 29.9 m-85 -121.59 112.35 18.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.885 . . . . 0.0 109.825 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.541 ' O ' HD23 ' A' ' 163' ' ' LEU . 9.6 mttt -112.9 150.41 31.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.328 -0.858 . . . . 0.0 109.402 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 141' ' ' MET . 0.4 OUTLIER -68.34 158.24 33.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.586 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 164' ' ' VAL . 40.8 t -94.92 -15.68 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.389 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.742 HG21 ' O ' ' A' ' 139' ' ' ASP . 0.8 OUTLIER -89.47 -25.05 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.256 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.5 -46.02 2.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.13 58.35 2.34 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 6.0 p-10 -134.24 179.96 5.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -1.144 . . . . 0.0 109.283 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -78.65 89.45 4.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.962 . . . . 0.0 109.703 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -82.24 -62.8 1.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 109.029 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' A' ' 30' ' ' ALA . 13.8 p -143.19 171.03 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.592 ' N ' HG22 ' A' ' 14' ' ' VAL . 4.9 m -156.49 178.32 10.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.151 . . . . 0.0 110.804 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -84.12 12.5 6.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.517 -0.739 . . . . 0.0 109.889 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . . . -66.32 -9.23 31.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.004 . . . . 0.0 109.02 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.585 ' CD1' HD11 ' A' ' 68' ' ' LEU . 4.6 m-85 -128.7 21.13 5.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.424 -0.797 . . . . 0.0 109.264 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER 62.91 126.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.062 -1.024 . . . . 0.0 108.309 -178.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.888 HD23 ' HA ' ' A' ' 30' ' ' ALA . 12.9 mt -120.35 147.17 45.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 110.584 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.9 mmtp -123.23 140.59 52.87 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -100.75 114.41 28.14 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.11 -0.994 . . . . 0.0 108.828 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 24' ' ' ASP . 3.2 t -68.63 158.37 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.371 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' VAL . 1.5 t70 -41.15 -47.19 3.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.426 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' ASP . 16.2 m-20 -62.12 -148.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 108.957 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.97 60.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.233 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 m -134.19 150.62 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.882 . . . . 0.0 109.784 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.04 155.77 21.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -0.82 . . . . 0.0 109.134 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 2.4 pt-20 -133.29 120.71 21.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.043 -1.036 . . . . 0.0 109.661 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.888 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -100.14 127.05 46.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.441 -0.787 . . . . 0.0 109.087 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 64.9 m-20 -68.0 145.69 54.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.932 . . . . 0.0 109.77 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -125.52 152.97 44.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.248 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.449 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.557 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 56.1 p30 -80.4 -18.02 50.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.585 HD11 ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.63 -35.41 22.7 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.21 -0.931 . . . . 0.0 108.976 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.705 HG13 ' HB2' ' A' ' 74' ' ' LEU . 73.6 t -72.84 -45.2 56.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.395 -0.815 . . . . 0.0 109.277 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -69.31 -36.25 76.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.106 -0.996 . . . . 0.0 110.109 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.1 m -70.51 -49.74 45.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.19 -0.944 . . . . 0.0 110.437 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' A' ' 14' ' ' VAL . 16.9 m-85 -92.24 -0.26 57.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.021 . . . . 0.0 110.132 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 57.27 64.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.956 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.705 ' HB2' HG13 ' A' ' 69' ' ' VAL . 12.0 mt -77.78 164.38 25.27 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.101 -1.0 . . . . 0.0 108.941 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.447 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -131.45 106.16 14.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.269 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.464 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 35.4 Cg_endo -76.8 120.9 5.66 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.359 2.039 . . . . 0.0 110.503 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.733 HG22 ' O ' ' A' ' 130' ' ' PHE . 10.0 t -88.95 157.55 18.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.9 . . . . 0.0 109.425 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.4 t -114.15 7.93 16.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.935 . . . . 0.0 109.509 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 6.9 p90 -136.35 142.72 43.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.632 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 1.0 OUTLIER 172.68 30.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.883 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -52.98 60.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.037 -1.039 . . . . 0.0 109.428 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -118.41 -31.24 4.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.82 . . . . 0.0 109.297 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.459 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 4.1 m -59.67 -30.44 68.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.201 -0.937 . . . . 0.0 108.911 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' A' ' 80' ' ' ASP . 5.0 t80 -66.61 -44.67 81.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 0.0 109.601 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.592 ' O ' HG22 ' A' ' 88' ' ' ILE . 7.6 mtt -60.93 -43.79 98.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.944 . . . . 0.0 109.92 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.1 m -66.87 -26.75 67.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.208 -0.932 . . . . 0.0 110.183 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CD2' ' O ' ' A' ' 83' ' ' SER . 12.4 m-85 -81.46 -29.34 33.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 109.945 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 85' ' ' MET . 3.0 tp -75.92 -28.16 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -49.2 16.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.374 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.01 -34.37 89.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -72.76 -36.2 67.62 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -61.0 -38.4 85.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.425 ' HD2' ' HE3' ' A' ' 96' ' ' LYS . 11.6 mmtm -67.26 -39.48 86.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.382 -0.824 . . . . 0.0 109.182 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.11 72.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.113 -0.992 . . . . 0.0 108.761 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.794 HG21 ' CE2' ' A' ' 110' ' ' PHE . 33.2 mm -62.92 -43.43 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.307 -0.87 . . . . 0.0 109.253 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HE3' ' HD2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -47.08 -37.42 9.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.261 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.1 -47.1 47.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.424 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.952 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -48.97 -46.29 43.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 109.545 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.952 HD23 ' HD3' ' A' ' 98' ' ' ARG . 6.1 mt -63.84 -46.46 84.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.204 -0.935 . . . . 0.0 109.17 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -23.74 7.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 108.881 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 98' ' ' ARG . 2.3 mt-10 -78.24 -48.15 16.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.441 -0.787 . . . . 0.0 109.223 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.0 -72.51 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.484 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.11 139.74 14.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.363 -0.836 . . . . 0.0 109.478 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.81 -13.97 21.74 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.662 2.241 . . . . 0.0 110.816 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 83.1 mt-10 -67.43 -23.52 65.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -0.972 . . . . 0.0 109.686 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.629 ' O ' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -87.81 5.71 38.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 109.565 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 108' ' ' PRO . 2.4 t -72.06 -50.02 9.49 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 109.532 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 107' ' ' VAL . 36.8 Cg_endo -79.56 -33.39 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.226 1.951 . . . . 0.0 110.435 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 49.8 t -67.47 -53.93 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.37 -0.831 . . . . 0.0 109.885 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.794 ' CE2' HG21 ' A' ' 95' ' ' ILE . 92.4 t80 -68.67 -37.53 79.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.895 . . . . 0.0 109.936 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -49.12 79.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.979 . . . . 0.0 110.229 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -70.88 -37.18 73.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.252 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.477 ' N ' ' HG3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -62.8 -35.07 78.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.879 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.769 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -71.42 -28.08 63.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 109.661 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -34.12 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.304 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.26 -44.95 84.41 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.509 ' HZ ' HD13 ' A' ' 157' ' ' ILE . 2.2 t80 -67.5 -44.59 78.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -1.148 . . . . 0.0 109.811 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 114' ' ' ALA . 85.1 t -53.56 -35.39 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.356 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -43.38 67.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 109.678 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -33.14 72.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.869 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.406 ' HA ' ' CE2' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -78.17 -35.15 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.106 -0.997 . . . . 0.0 109.377 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 122' ' ' LEU . 44.9 mt -60.52 -28.65 68.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.652 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.31 -36.68 78.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -143.13 59.55 1.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.19 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -59.16 -28.88 67.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.937 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 4.7 mmtp -72.24 -36.2 69.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 109.796 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -80.08 -23.67 41.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.809 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 129' ' ' ASP . 46.7 m-85 -85.7 -25.0 26.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.122 -0.987 . . . . 0.0 109.712 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 126' ' ' LYS . 8.8 m-20 53.33 175.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.367 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.733 ' O ' HG22 ' A' ' 77' ' ' THR . 0.3 OUTLIER -136.53 121.7 19.1 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.242 -0.911 . . . . 0.0 108.814 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.464 ' CE2' ' HB3' ' A' ' 76' ' ' PRO . 14.7 m-85 -101.7 166.91 10.43 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.201 -0.937 . . . . 0.0 110.308 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -156.42 142.97 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.528 -0.732 . . . . 0.0 109.497 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.45 179.57 1.86 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -67.74 -27.19 66.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -1.125 . . . . 0.0 109.248 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.544 ' O ' ' CG ' ' A' ' 136' ' ' MET . 1.0 OUTLIER -60.29 -35.07 74.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.301 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 79.92 20.01 0.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.501 -0.749 . . . . 0.0 109.471 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.47 123.62 35.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.029 -1.044 . . . . 0.0 109.798 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.443 ' HG3' ' CD1' ' A' ' 87' ' ' TYR . 32.3 Cg_endo -73.24 -13.5 25.67 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.145 1.897 . . . . 0.0 109.789 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.742 ' O ' HG21 ' A' ' 8' ' ' ILE . 2.8 m-20 -62.86 -21.21 65.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 141' ' ' MET . . . -76.78 -69.82 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.85 . . . . 0.0 109.089 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 5.8 tmm? 173.4 137.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 109.352 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.84 140.55 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 157' ' ' ILE . 3.4 t -112.14 138.05 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -106.18 143.67 33.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.411 ' HG3' ' HG2' ' A' ' 156' ' ' MET . 1.2 mtt -107.75 132.28 53.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.282 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 13.2 t30 -143.77 160.28 41.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 109.643 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.74 146.29 24.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.94 . . . . 0.0 109.444 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.411 HH11 HG21 ' A' ' 153' ' ' THR . 4.0 ttp180 -77.81 -172.83 2.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.563 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -21.64 63.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.51 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -58.02 5.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.85 -13.0 9.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.609 ' O ' HD12 ' A' ' 152' ' ' ILE . 2.4 pp -124.47 5.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.267 -1.137 . . . . 0.0 109.586 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.411 HG21 HH11 ' A' ' 148' ' ' ARG . 3.2 m -111.88 100.28 48.19 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.242 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 36.9 Cg_endo -81.59 132.27 7.73 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.622 2.215 . . . . 0.0 110.598 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 146' ' ' ASN . 38.4 p90 -133.78 142.59 47.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.106 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 9.6 mtt -100.79 161.15 13.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 110.207 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.796 ' O ' HG13 ' A' ' 143' ' ' VAL . 68.9 mt -124.46 145.78 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.215 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.73 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 4.2 m-85 -137.3 141.82 41.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 109.483 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -58.83 120.31 8.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 109.356 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -67.58 -45.61 75.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 109.513 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.61 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . 4.6 t0 -54.53 -25.84 28.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.345 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -103.8 39.2 2.89 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 4' ' ' TYR . 8.1 mt -149.75 140.19 22.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.388 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 7' ' ' VAL . 28.2 m -114.0 123.01 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.521 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.56 119.57 23.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.468 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -117.18 138.03 51.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.571 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.434 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -80.35 146.48 31.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.508 ' O ' ' CD1' ' A' ' 168' ' ' PHE . 5.1 t80 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.373 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.291 0.567 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.616 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 1.3 mm? -75.11 156.56 35.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.282 -0.886 . . . . 0.0 109.683 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 166' ' ' GLU . 2.9 mp -134.29 124.06 25.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.733 ' HB2' HG13 ' A' ' 14' ' ' VAL . 6.1 m-85 -96.12 109.58 21.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.429 -0.795 . . . . 0.0 109.81 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.637 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -110.03 152.45 25.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.348 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.482 ' HB2' HD23 ' A' ' 13' ' ' LEU . 20.2 t0 -68.11 134.57 50.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.523 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 8' ' ' ILE . 13.9 p -76.13 -36.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.433 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.729 HG22 ' OG ' ' A' ' 9' ' ' SER . 2.3 mp -66.47 -91.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.729 ' OG ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -135.11 80.84 1.86 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.38 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 6' ' ' ASP . . . -145.31 -62.99 0.02 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.6 t0 68.21 11.01 8.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -1.099 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.506 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER 173.1 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.693 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 12' ' ' GLU . 1.1 mm? -122.7 -61.37 1.46 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 109.285 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.909 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 10.5 p -136.76 166.35 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 108.979 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.4 p -145.47 164.34 31.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.009 -1.057 . . . . 0.0 110.543 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.512 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 1.5 t0 -82.96 8.1 13.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.461 -0.775 . . . . 0.0 109.745 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.23 -19.92 65.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 0.0 109.131 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.805 ' CD2' HD11 ' A' ' 68' ' ' LEU . 14.2 m-85 -110.87 21.26 16.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.272 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER 58.75 111.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 30' ' ' ALA . 16.2 mt -105.53 144.8 31.79 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.14 -0.975 . . . . 0.0 110.609 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.83 133.03 56.51 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.914 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER -97.13 120.94 38.42 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.298 -0.876 . . . . 0.0 108.703 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 24' ' ' ASP . 12.0 t -72.07 155.16 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' VAL . 22.2 t70 -43.4 -31.46 0.68 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.69 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.854 ' O ' HG23 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -70.15 -103.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.473 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -166.95 63.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.959 -1.088 . . . . 0.0 109.442 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 3.6 m -142.83 142.27 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.965 . . . . 0.0 109.735 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -100.59 132.36 46.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.429 -0.794 . . . . 0.0 109.144 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 18.6 mt-10 -107.99 124.7 50.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.93 . . . . 0.0 109.268 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.909 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -105.59 116.09 31.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 109.27 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.95 147.05 49.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.727 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.463 ' HB2' ' HG2' ' A' ' 154' ' ' PRO . 3.9 m -115.56 167.8 10.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -0.912 . . . . 0.0 109.378 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.162 -0.961 . . . . 0.0 109.625 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.316 0.579 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 71' ' ' SER . 31.9 t-20 -80.72 -21.65 40.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.551 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.805 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.22 -40.0 18.62 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.17 -0.956 . . . . 0.0 108.566 179.574 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.486 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 41.4 t -67.07 -44.36 88.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.543 -0.723 . . . . 0.0 109.343 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -70.18 -40.46 74.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.869 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 1.3 t -63.26 -34.29 77.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 110.119 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.744 ' HB2' HD23 ' A' ' 74' ' ' LEU . 59.4 m-85 -111.32 6.75 20.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.03 -1.043 . . . . 0.0 109.904 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER 54.04 32.63 15.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 109.913 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.744 HD23 ' HB2' ' A' ' 72' ' ' PHE . 1.3 mm? -43.13 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.269 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -127.92 141.69 41.96 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.149 -0.97 . . . . 0.0 109.48 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 36.3 Cg_endo -78.47 127.15 7.96 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.576 2.184 . . . . 0.0 110.456 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.452 HG21 ' HB ' ' A' ' 132' ' ' ILE . 1.0 OUTLIER -138.33 176.54 8.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.12 -0.988 . . . . 0.0 109.641 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.412 ' O ' ' CD2' ' A' ' 130' ' ' PHE . 13.1 m -120.66 -149.41 0.43 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.228 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.647 ' CG ' ' CE1' ' A' ' 125' ' ' PHE . 6.5 p90 -164.84 -178.75 5.41 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.173 -0.954 . . . . 0.0 109.405 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.543 ' CB ' ' CB ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -120.85 136.94 54.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.125 -0.984 . . . . 0.0 109.63 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.45 -38.18 88.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 109.851 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.82 -33.64 6.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 109.781 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.543 ' CB ' ' CB ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -71.08 -29.44 65.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.922 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.529 ' CE1' ' HB ' ' A' ' 88' ' ' ILE . 5.6 t80 -56.69 -35.95 69.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.006 -1.059 . . . . 0.0 109.812 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.8 mtm -53.66 -43.55 68.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.912 -1.118 . . . . 0.0 109.694 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 t -70.62 -41.07 72.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.064 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -56.67 -56.47 21.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 109.57 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.529 ' HB ' ' CE1' ' A' ' 84' ' ' TYR . 4.2 tp -59.33 -29.33 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.857 . . . . 0.0 109.459 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -57.45 11.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.136 -0.977 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.02 -19.91 70.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -70.64 -40.71 72.91 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.167 -1.196 . . . . 0.0 107.778 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.437 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -69.41 -41.78 75.93 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -40.07 63.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.425 -0.797 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.07 73.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.21 -0.932 . . . . 0.0 109.189 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.771 HG21 ' CE1' ' A' ' 110' ' ' PHE . 13.5 mm -63.02 -38.21 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.185 -0.947 . . . . 0.0 109.127 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.471 ' HD3' ' OE1' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -55.48 -35.1 65.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.068 . . . . 0.0 109.397 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.65 59.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.915 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -59.63 -31.74 69.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.015 . . . . 0.0 109.623 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.797 HD22 ' CD ' ' A' ' 106' ' ' ARG . 28.2 mt -72.56 -44.34 62.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.965 . . . . 0.0 109.6 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.471 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -58.56 -35.98 73.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.59 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -83.72 -18.29 38.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.442 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 1.5 t -115.83 -75.35 0.59 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.459 ' HB2' ' HG2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -126.69 95.82 36.82 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.436 -0.79 . . . . 0.0 109.174 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' A' ' 107' ' ' VAL . 33.8 Cg_endo -74.42 -22.14 16.51 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.461 2.107 . . . . 0.0 110.489 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 -20.13 62.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.567 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.797 ' CD ' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -99.64 20.81 13.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.419 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 19.9 t -68.73 -45.59 33.49 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 110.638 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.8 Cg_endo -77.24 -25.1 8.84 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.952 1.768 . . . . 0.0 110.614 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.84 -52.77 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.262 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.771 ' CE1' HG21 ' A' ' 95' ' ' ILE . 24.7 t80 -67.31 -37.61 83.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.72 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -61.04 -37.39 82.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.033 -1.042 . . . . 0.0 109.978 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -71.28 -38.48 71.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.936 . . . . 0.0 110.224 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.33 -51.18 55.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.113 -0.992 . . . . 0.0 110.24 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.822 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -57.89 -34.01 69.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.402 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -58.1 -46.76 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.119 -0.988 . . . . 0.0 109.513 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.437 ' N ' HG22 ' A' ' 115' ' ' ILE . . . -67.51 -43.71 85.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.1 -35.94 72.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.173 -1.192 . . . . 0.0 110.285 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 114' ' ' ALA . 39.6 t -63.15 -40.31 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.076 -1.015 . . . . 0.0 109.925 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.493 ' C ' ' CD ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -71.3 -28.78 64.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 109.202 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -56.33 10.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.885 . . . . 0.0 109.573 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.3 mp -59.82 -42.95 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 0.0 109.528 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 59.6 mt -48.46 -26.91 2.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.66 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.14 67.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -136.7 55.61 1.83 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 109.392 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.647 ' CE1' ' CG ' ' A' ' 79' ' ' PHE . 20.3 t80 -58.55 -33.77 70.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.653 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -39.33 80.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 109.763 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -78.67 -24.82 44.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.939 . . . . 0.0 109.686 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 129' ' ' ASP . 10.6 m-85 -77.6 -9.64 59.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.549 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.9 m-20 48.1 -175.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.352 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.837 ' CZ ' HG11 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -139.8 120.45 14.25 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.327 -0.858 . . . . 0.0 108.842 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.515 ' CE1' ' HB3' ' A' ' 145' ' ' MET . 15.2 m-85 -111.72 171.89 7.22 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.095 -1.003 . . . . 0.0 110.467 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.471 ' O ' HD13 ' A' ' 74' ' ' LEU . 6.4 tt -149.23 140.55 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.474 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.11 160.24 22.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.25 -21.82 66.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -1.086 . . . . 0.0 109.609 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 136' ' ' MET . 18.7 t -65.73 -34.84 79.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.469 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 135' ' ' SER . 3.2 ttm 74.86 59.78 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 0.0 109.464 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' A' ' 135' ' ' SER . 0.4 OUTLIER -129.45 109.63 17.63 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.356 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.13 -2.12 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.304 2.003 . . . . 0.0 110.32 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.651 ' O ' HG21 ' A' ' 8' ' ' ILE . 10.1 m-20 -104.41 -3.16 24.42 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.341 -0.85 . . . . 0.0 109.193 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 9' ' ' SER . . . -91.76 -72.89 0.57 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.161 -0.962 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.466 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 3.6 ttp -177.78 141.43 0.28 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.779 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.837 HG11 ' CZ ' ' A' ' 130' ' ' PHE . 74.6 t -102.76 141.53 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.114 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.468 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 3.3 t -102.3 143.55 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.102 -0.999 . . . . 0.0 109.559 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 144' ' ' LEU . 15.5 mt -106.63 134.58 49.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.326 -0.859 . . . . 0.0 109.195 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.515 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 12.1 ttm -113.28 124.49 52.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.337 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.575 ' O ' ' CD2' ' A' ' 155' ' ' TYR . 8.8 t30 -144.51 144.32 31.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -74.36 148.22 41.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -55.69 -172.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 109.586 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -79.99 -1.44 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.632 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.546 ' CB ' HD12 ' A' ' 152' ' ' ILE . 1.2 m-20 -104.22 -35.04 8.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.327 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.25 38.22 6.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.833 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -127.71 -26.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -1.164 . . . . 0.0 109.763 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 153' ' ' THR . 5.0 t -136.58 132.39 18.65 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 0.0 109.351 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 32' ' ' CYS . 36.6 Cg_endo -80.8 153.28 19.72 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.661 2.241 . . . . 0.0 110.602 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 146' ' ' ASN . 24.7 p90 -145.12 134.59 23.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 109.347 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.13 154.33 19.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.341 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 143' ' ' VAL . 6.4 mt -115.87 145.47 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.468 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 58.1 m-85 -136.93 129.17 29.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.439 ' HB2' ' SD ' ' A' ' 141' ' ' MET . 3.4 m-85 -60.79 127.78 33.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 109.632 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.07 -54.42 18.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.781 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . 12.7 t0 -43.62 -34.77 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.811 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -102.98 53.57 0.74 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.693 HD22 ' HB3' ' A' ' 4' ' ' TYR . 5.1 mt -161.96 130.23 4.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.482 HG23 ' HG3' ' A' ' 5' ' ' LYS . 5.4 m -114.1 139.15 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.3 p -83.24 142.71 30.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.61 ' O ' HD12 ' A' ' 3' ' ' LEU . 2.5 tp10 -133.79 123.16 24.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 109.523 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.37 110.95 23.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.365 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.123 -0.985 . . . . 0.0 109.476 -179.83 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 168' ' ' PHE . 17.8 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.514 HD22 ' HA ' ' A' ' 167' ' ' LYS . 14.7 mt -105.47 157.6 17.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 3' ' ' LEU . 8.4 mt -104.51 123.52 47.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 0.0 109.288 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 4.2 m-85 -107.35 118.48 36.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.677 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -139.8 156.31 46.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.271 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.01 155.89 29.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.647 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 p -97.58 -11.62 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.872 . . . . 0.0 109.418 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.412 HG21 ' O ' ' A' ' 139' ' ' ASP . 1.0 OUTLIER -91.76 -23.87 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.179 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.5 m -124.37 -10.77 7.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.744 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.87 58.18 9.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.449 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 10.0 m-20 -127.51 134.53 49.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -1.134 . . . . 0.0 109.487 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.415 ' C ' HD23 ' A' ' 13' ' ' LEU . 43.3 mt-10 -63.17 116.64 5.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.87 . . . . 0.0 109.569 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 4.0 mt -116.72 -48.04 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.874 . . . . 0.0 109.377 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.909 HG23 HD21 ' A' ' 68' ' ' LEU . 6.1 p -136.58 175.1 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.002 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.613 ' H ' HG22 ' A' ' 14' ' ' VAL . 3.1 p -159.57 173.22 16.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.87 -1.144 . . . . 0.0 110.594 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.468 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 10.9 t0 -84.1 2.86 37.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.529 -0.732 . . . . 0.0 109.7 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.74 -11.73 55.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.126 -0.984 . . . . 0.0 109.035 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.911 ' CE1' HD13 ' A' ' 68' ' ' LEU . 26.2 m-85 -120.62 21.08 11.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.453 -0.78 . . . . 0.0 109.267 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.31 133.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 30' ' ' ALA . 69.1 mt -129.31 143.57 50.9 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.277 -0.889 . . . . 0.0 109.765 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 29' ' ' GLU . 1.3 mttm -129.62 133.5 47.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 109.469 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -91.97 121.59 33.7 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.476 ' HB ' ' OD1' ' A' ' 25' ' ' ASP . 13.3 t -76.66 153.42 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -42.98 -36.93 1.71 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.579 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.6 ' OD1' HG22 ' A' ' 27' ' ' VAL . 6.1 p30 -63.73 -123.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.9 . . . . 0.0 109.311 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.519 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -146.14 63.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.746 -1.221 . . . . 0.0 109.35 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.6 HG22 ' OD1' ' A' ' 25' ' ' ASP . 13.3 m -151.94 163.47 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.746 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 4.8 m-85 -115.85 156.97 25.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.117 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 156' ' ' MET . 7.5 pt-20 -128.98 128.37 43.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.521 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.642 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -111.42 116.42 30.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.516 -0.74 . . . . 0.0 109.279 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 51.1 m-20 -63.32 142.55 58.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 109.581 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 58.6 m -133.45 152.66 51.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.902 . . . . 0.0 109.405 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.301 -0.874 . . . . 0.0 109.549 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -74.04 -24.28 59.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.729 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.911 HD13 ' CE1' ' A' ' 18' ' ' TYR . 27.7 tp -81.81 -45.03 16.14 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.083 -1.01 . . . . 0.0 108.552 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.975 HG13 ' CB ' ' A' ' 74' ' ' LEU . 55.8 t -65.03 -38.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.397 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -69.59 -36.21 76.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.132 -0.98 . . . . 0.0 109.902 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.6 -50.69 62.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.868 . . . . 0.0 110.129 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.672 ' HE2' HD11 ' A' ' 68' ' ' LEU . 34.9 m-85 -82.71 -3.66 56.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.997 . . . . 0.0 110.128 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER 73.49 18.39 3.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.498 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.975 ' CB ' HG13 ' A' ' 69' ' ' VAL . 1.8 mm? -39.29 138.69 0.61 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.463 -0.773 . . . . 0.0 109.976 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.816 ' O ' HG22 ' A' ' 132' ' ' ILE . 2.2 p -118.05 113.97 37.28 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.34 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.21 149.23 21.93 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.418 2.078 . . . . 0.0 110.468 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.5 p -113.78 -175.42 2.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.347 -0.846 . . . . 0.0 108.974 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.38 -44.66 0.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.809 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.502 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 6.6 p90 -78.57 132.11 37.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.586 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.556 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . 1.4 m-20 -175.97 27.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 109.825 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -45.0 95.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.069 -1.019 . . . . 0.0 109.354 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -122.49 -32.53 3.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.54 -32.4 72.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.293 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.573 ' CD2' ' CZ ' ' A' ' 125' ' ' PHE . 1.0 OUTLIER -58.71 -48.1 82.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.578 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.473 ' O ' HG22 ' A' ' 88' ' ' ILE . 2.2 mtt -60.3 -33.79 72.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.974 . . . . 0.0 109.818 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 t -67.61 -39.2 84.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.74 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -67.9 -47.18 69.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.806 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 85' ' ' MET . 6.2 tp -61.46 -26.73 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.505 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -43.35 57.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 109.595 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.29 -26.52 73.48 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' ' 141' ' ' MET . 17.9 m-85 -81.64 -36.65 28.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -1.152 . . . . 0.0 109.03 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -41.86 86.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.305 -0.872 . . . . 0.0 109.55 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.546 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -70.72 -42.96 69.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.059 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 93' ' ' LYS . . . -55.31 -49.47 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.04 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.732 HG21 ' CE2' ' A' ' 110' ' ' PHE . 34.1 mm -57.28 -43.19 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.344 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.55 -47.61 39.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.276 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.19 -34.56 77.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.324 -0.86 . . . . 0.0 109.298 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.446 ' O ' ' OG ' ' A' ' 102' ' ' SER . 3.6 tmt_? -63.36 -34.01 76.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.765 HD13 ' HD2' ' A' ' 106' ' ' ARG . 9.9 mt -71.83 -45.53 61.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.161 -0.962 . . . . 0.0 109.295 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -54.76 -35.36 63.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.588 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.39 -40.31 62.14 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.0 109.085 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -89.83 -77.55 0.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.524 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 103' ' ' ASN . 5.0 p30 -144.24 118.89 5.95 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.845 . . . . 0.0 109.398 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.55 ' HA ' HG23 ' A' ' 107' ' ' VAL . 33.1 Cg_endo -74.69 -13.56 22.12 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.487 2.125 . . . . 0.0 110.609 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.28 -19.79 65.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.868 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.765 ' HD2' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -100.89 15.52 28.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 109.603 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.604 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 15.6 t -72.27 -45.41 10.7 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 110.894 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 107' ' ' VAL . 34.0 Cg_endo -76.34 -49.29 0.12 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.953 1.769 . . . . 0.0 111.009 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 110' ' ' PHE . 29.5 m -58.31 -44.35 88.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.043 -1.036 . . . . 0.0 109.679 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.732 ' CE2' HG21 ' A' ' 95' ' ' ILE . 52.6 t80 -65.5 -38.51 89.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.243 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.981 ' O ' HD12 ' A' ' 115' ' ' ILE . 1.1 mt-10 -63.71 -44.33 93.92 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.133 -0.98 . . . . 0.0 110.332 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -33.81 76.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.155 -0.965 . . . . 0.0 110.122 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -69.57 -46.96 65.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.986 . . . . 0.0 109.864 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -64.66 -27.25 68.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 109.688 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.981 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -72.48 -44.93 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.7 -48.4 72.91 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.576 ' CE1' ' OD2' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -60.12 -41.33 92.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -1.19 . . . . 0.0 109.869 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 114' ' ' ALA . 56.9 t -64.32 -32.38 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.9 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -70.76 -33.28 70.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.029 . . . . 0.0 109.861 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -32.59 57.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.138 -0.976 . . . . 0.0 109.815 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.5 mp -72.04 -31.21 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.923 . . . . 0.0 109.319 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 95.6 mt -64.86 -26.79 68.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.048 -1.033 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.6 -29.18 69.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.975 . . . . 0.0 109.928 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.61 55.53 1.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.156 -0.965 . . . . 0.0 109.436 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 130' ' ' PHE . 4.0 t80 -63.34 -20.88 65.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.731 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 127' ' ' ASP . 6.0 ptmm? -74.4 -47.11 35.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.058 -1.026 . . . . 0.0 109.71 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.445 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 8.5 t70 -72.28 -23.72 61.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.616 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 1.1 m-85 -79.33 -24.28 42.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.112 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.531 ' C ' ' CD1' ' A' ' 130' ' ' PHE . 2.5 m-20 53.24 173.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 109.14 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.687 ' CE1' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -134.51 121.19 20.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 108.98 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 13.0 m-85 -105.66 164.63 11.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.102 -0.999 . . . . 0.0 110.661 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 75' ' ' SER . 0.8 OUTLIER -146.79 138.8 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.436 -0.79 . . . . 0.0 109.435 179.464 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.21 155.21 3.59 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -59.24 -23.9 62.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -1.143 . . . . 0.0 109.119 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 136' ' ' MET . 3.0 p -64.65 -35.22 80.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.408 -0.807 . . . . 0.0 109.285 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 72.67 40.82 0.59 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.293 -0.88 . . . . 0.0 109.365 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.84 134.14 32.63 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.867 . . . . 0.0 109.309 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.67 -5.74 16.83 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.385 2.057 . . . . 0.0 110.133 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.412 ' O ' HG21 ' A' ' 8' ' ' ILE . 46.1 m-20 -98.21 -4.32 35.66 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.287 -0.883 . . . . 0.0 109.208 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.05 134.99 39.68 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.547 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -64.49 152.17 42.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.6 m -88.64 141.89 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 109.369 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.67 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.6 t -92.23 130.01 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.236 -0.915 . . . . 0.0 108.967 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 129' ' ' ASP . 1.5 mt -103.42 135.43 45.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.535 ' CG ' ' HG2' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.54 142.73 38.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.573 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 1.8 t30 -145.97 166.37 26.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.717 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.72 125.93 35.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.566 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.491 ' HG3' ' CD2' ' A' ' 155' ' ' TYR . 0.9 OUTLIER -66.32 -169.31 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.24 -0.912 . . . . 0.0 109.404 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -16.09 60.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.465 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 148' ' ' ARG . 2.0 m-20 -57.89 -56.57 20.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 0.0 109.333 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 126.73 -23.19 5.68 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.838 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -140.45 37.07 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -1.127 . . . . 0.0 109.221 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.4 m -127.27 100.54 26.33 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.08 131.81 9.07 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.569 2.179 . . . . 0.0 109.814 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.491 ' CD2' ' HG3' ' A' ' 148' ' ' ARG . 40.3 p90 -135.96 142.64 44.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.097 -1.002 . . . . 0.0 109.718 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.91 ' SD ' HD23 ' A' ' 68' ' ' LEU . 6.5 mtp -99.02 149.16 23.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.208 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.624 ' O ' HG13 ' A' ' 143' ' ' VAL . 68.8 mt -117.15 141.38 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.67 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 5.7 m-85 -132.61 141.79 48.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 109.307 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.484 ' O ' ' HB2' ' A' ' 163' ' ' LEU . 72.6 m-85 -71.06 127.71 33.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 109.697 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.417 ' HE2' ' C ' ' A' ' 160' ' ' LYS . 0.7 OUTLIER -67.21 -40.83 86.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.343 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.426 ' HB3' HD12 ' A' ' 95' ' ' ILE . 2.3 m-20 -52.62 -33.28 45.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.409 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -112.65 50.05 0.8 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 159' ' ' PHE . 0.6 OUTLIER -153.26 129.24 10.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -1.121 . . . . 0.0 109.525 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 m -118.81 144.84 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 109.307 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -106.08 129.64 54.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 109.862 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -120.65 122.43 40.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.249 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.514 ' HA ' HD22 ' A' ' 2' ' ' LEU . 2.1 tttp -55.75 123.24 13.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.736 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.403 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.486 ' CG ' HD23 ' A' ' 2' ' ' LEU . 4.6 ptp . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.287 0.565 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.486 HD23 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -67.09 147.16 53.5 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 2' ' ' LEU . 57.9 mt -118.41 126.65 52.53 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.429 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 165' ' ' SER . 75.8 m-85 -114.15 121.58 44.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.725 ' HA ' HD23 ' A' ' 13' ' ' LEU . 10.0 ptmt -126.37 160.79 29.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.616 -0.678 . . . . 0.0 109.228 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.418 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 25.6 t0 -98.86 154.08 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.329 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.36 -17.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.0 mt -75.43 -44.65 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 164.56 43.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.24 -41.94 3.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 57.1 99.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -1.19 . . . . 0.0 109.478 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 44.73 81.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.415 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.068 HD11 HD12 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -86.15 -32.06 21.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.718 HG21 ' CB ' ' A' ' 30' ' ' ALA . 8.2 p -166.91 174.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.966 -1.083 . . . . 0.0 109.529 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.626 ' H ' HG22 ' A' ' 14' ' ' VAL . 28.2 t -146.17 168.34 21.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.987 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.51 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 20.4 t0 -93.11 -4.59 52.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 109.483 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.18 -20.71 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.151 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.631 ' CD2' HD11 ' A' ' 68' ' ' LEU . 13.5 m-85 -99.08 -55.67 2.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.401 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 18' ' ' TYR . 3.3 m-20 155.44 130.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 30' ' ' ALA . 76.7 mt -130.27 133.56 46.59 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.046 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -131.43 127.52 37.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 9.2 pt-20 -92.9 129.59 38.77 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.058 -1.026 . . . . 0.0 109.614 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' ASP . 4.1 t -78.32 152.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -43.79 -28.46 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.884 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.728 ' O ' HG23 ' A' ' 26' ' ' ILE . 3.0 m-20 -65.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -162.98 49.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.987 -1.071 . . . . 0.0 109.203 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 6.7 m -140.57 151.42 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.654 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -100.6 157.63 16.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.081 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.2 tt0 -128.61 116.87 20.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.105 . . . . 0.0 109.629 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.718 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -107.24 112.82 25.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 108.958 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -73.89 146.64 43.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.979 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.04 148.54 48.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.828 . . . . 0.0 109.072 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.11 165.98 12.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.494 ' CG ' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -101.1 134.79 43.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.453 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 64' ' ' THR . 1.4 m -131.65 149.07 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.444 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.26 125.25 41.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.274 -0.891 . . . . 0.0 109.385 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.78 160.76 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.875 . . . . 0.0 109.385 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -93.8 98.19 10.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -104.89 137.54 42.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.375 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.76 43.4 1.71 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.96 154.7 8.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 43' ' ' VAL . 8.4 t70 -144.88 -53.19 0.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -1.17 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 47' ' ' ALA . 95.8 t 43.77 81.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.487 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.17 -172.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.767 HG22 ' O ' ' A' ' 45' ' ' ILE . 2.5 mp -93.81 57.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.342 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.615 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . 121.52 118.81 2.58 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 46' ' ' GLY . . . 169.18 49.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -1.112 . . . . 0.0 109.585 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -146.51 141.96 16.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 109.482 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.49 -89.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.628 2.219 . . . . 0.0 110.424 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -134.17 141.53 47.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.394 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.97 178.01 8.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -121.78 -25.13 5.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.0 t0 63.87 37.36 9.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 109.487 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -109.8 -63.59 1.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.87 . . . . 0.0 109.356 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 10.4 mm-40 64.63 -91.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.598 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -123.57 172.91 8.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 109.706 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -113.81 18.07 17.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.326 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.33 17.19 7.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 179.56 123.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -72.52 -69.36 0.41 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.358 -0.839 . . . . 0.0 109.62 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 163.62 55.44 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.43 124.59 28.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -1.135 . . . . 0.0 109.391 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.55 129.82 43.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 109.501 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.494 ' OG1' ' CG ' ' A' ' 34' ' ' MET . 9.0 t -83.16 139.96 32.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.424 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.73 156.43 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -0.88 . . . . 0.0 109.48 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -60.68 152.41 26.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.305 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 71' ' ' SER . 19.7 p30 -85.45 -17.77 35.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.975 . . . . 0.0 109.57 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.631 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.09 -41.75 16.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 108.716 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.856 HG22 ' HB2' ' A' ' 74' ' ' LEU . 45.2 t -72.35 -36.69 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.411 -0.805 . . . . 0.0 109.286 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -69.61 -43.18 73.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -74.22 -27.94 61.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.936 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' C ' ' CD ' ' A' ' 73' ' ' ARG . 26.3 m-85 -114.39 16.66 17.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.458 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER 37.84 44.06 0.55 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.729 -0.607 . . . . 0.0 110.596 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.856 ' HB2' HG22 ' A' ' 69' ' ' VAL . 6.6 mt -49.44 142.85 7.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.997 -1.065 . . . . 0.0 108.566 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.693 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.4 p -128.96 107.7 18.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.992 -1.067 . . . . 0.0 109.463 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 131' ' ' TYR . 35.8 Cg_endo -78.21 134.04 12.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.454 2.103 . . . . 0.0 110.247 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -124.26 159.69 29.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.729 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.75 164.36 24.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -150.24 179.98 7.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.778 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.59 153.62 36.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.105 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.55 67.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.703 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.66 -31.32 65.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 109.529 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.5 m -66.15 -29.96 70.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 10.3 t80 -65.75 -36.87 84.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.703 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 3.1 mtt -64.66 -38.03 89.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 110.011 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -71.11 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.918 . . . . 0.0 110.496 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -77.27 -38.98 49.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.5 HG23 ' HE3' ' A' ' 89' ' ' LYS . 6.7 tp -76.34 -26.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.843 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.5 ' HE3' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -76.77 -56.38 4.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 109.673 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.18 -23.0 73.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 91' ' ' TYR . 30.1 t80 -81.34 -40.7 23.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.022 -1.281 . . . . 0.0 108.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -63.47 -40.54 97.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 89' ' ' LYS . 0.5 OUTLIER -65.24 -38.53 90.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.94 -46.59 78.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.025 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.515 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 29.2 mm -64.74 -40.39 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -51.61 -38.09 53.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.133 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.61 -39.13 64.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 0.0 109.68 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.547 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -59.9 -32.11 70.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.365 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 50.6 mt -73.08 -47.35 45.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -55.34 -36.89 66.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.751 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.59 -31.5 41.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.2 t -105.08 -78.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.723 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 9.9 t-20 -119.83 107.94 39.59 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.26 -19.78 19.42 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.385 2.057 . . . . 0.0 110.381 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -74.14 -11.43 60.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.214 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.544 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -94.1 0.71 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.489 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 53.6 t -71.95 -43.23 10.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 111.29 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.5 Cg_endo -76.45 -52.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.877 1.718 . . . . 0.0 111.085 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 2.3 m -59.72 -36.99 69.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.997 -1.064 . . . . 0.0 109.587 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 44.9 t80 -69.67 -37.34 76.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.276 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.784 ' O ' HD12 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -68.53 -48.78 63.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.868 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -49.47 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.057 . . . . 0.0 110.807 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 109' ' ' VAL . 2.5 m120 -64.49 -48.91 73.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.439 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -62.72 -32.09 73.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -68.27 -39.63 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.402 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.59 -47.82 73.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -42.09 97.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.988 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 114' ' ' ALA . 71.8 t -60.13 -35.53 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.847 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -68.18 -38.13 81.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.933 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -78.83 -17.56 55.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.94 . . . . 0.0 109.897 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.44 -37.87 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 109.678 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 15.7 mt -62.34 -31.63 72.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 109.659 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.1 -26.29 26.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.636 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -154.76 54.53 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 2.2 p90 -59.8 -22.13 61.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.639 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.444 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -76.58 -43.42 38.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -65.11 -26.39 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 4.9 m-85 -85.11 -12.24 53.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.338 -0.851 . . . . 0.0 109.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' O ' HD22 ' A' ' 144' ' ' LEU . 4.1 m-20 50.88 177.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.667 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.804 ' CE1' HG13 ' A' ' 142' ' ' VAL . 2.7 t80 -139.07 121.23 15.79 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.559 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 9.1 m-85 -103.36 170.69 7.8 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.056 -1.028 . . . . 0.0 110.669 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 75' ' ' SER . 2.0 tt -156.54 142.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.65 -178.94 51.87 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.421 ' OE1' ' HG2' ' A' ' 73' ' ' ARG . 3.6 mp0 -64.36 -19.45 65.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 136' ' ' MET . 82.6 p -56.01 -33.58 65.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 135' ' ' SER . 13.7 mmt 64.7 53.86 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.572 -0.705 . . . . 0.0 109.494 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.43 ' N ' HD11 ' A' ' 132' ' ' ILE . 6.4 t0 -128.96 120.12 20.2 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.323 -0.86 . . . . 0.0 109.176 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.98 2.67 6.37 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.286 1.99 . . . . 0.0 110.559 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.78 12.94 11.45 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.275 -0.891 . . . . 0.0 109.197 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.39 -156.87 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.452 ' HE3' ' HB2' ' A' ' 159' ' ' PHE . 0.0 OUTLIER -64.5 121.53 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.804 HG13 ' CE1' ' A' ' 130' ' ' PHE . 94.4 t -106.35 120.27 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.549 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.623 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 7.2 t -109.46 141.52 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.485 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 129' ' ' ASP . 53.1 mt -114.65 141.42 47.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.31 -0.869 . . . . 0.0 108.965 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.1 ttm -104.8 119.68 39.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.018 . . . . 0.0 109.522 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.586 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 44.6 t30 -138.09 146.72 43.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.541 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.9 OUTLIER -87.3 146.2 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.885 . . . . 0.0 109.541 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -58.75 -171.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.29 -17.46 64.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -53.49 4.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.541 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 114.89 -24.72 10.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 152' ' ' ILE . 1.3 tp -85.18 3.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.291 -1.123 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 m -123.67 101.18 36.94 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.6 122.82 5.13 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.509 2.14 . . . . 0.0 109.924 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 155' ' ' TYR . 5.9 p90 -141.03 148.66 40.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.28 158.6 26.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 109.022 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 143' ' ' VAL . 41.6 mt -116.64 141.93 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 110.02 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 4.5 m-85 -126.3 113.69 17.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.477 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 8.0 m-85 -42.93 119.31 1.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.06 -28.58 67.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.865 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 159' ' ' PHE . 3.3 p30 -57.63 -39.7 77.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.443 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -105.93 43.04 1.76 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.068 HD12 HD11 ' A' ' 13' ' ' LEU . 3.6 tt -142.47 125.76 16.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.44 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -112.77 157.42 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.552 ' HA ' ' CD1' ' A' ' 4' ' ' TYR . 1.7 m -101.49 139.21 37.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.08 123.17 33.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -90.57 139.32 30.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 167' ' ' LYS . 12.2 mt -99.02 154.07 18.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.644 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.4 mt -113.56 138.16 50.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.765 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.484 ' HB2' HG13 ' A' ' 14' ' ' VAL . 13.2 m-85 -116.5 108.45 16.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.104 -0.998 . . . . 0.0 109.585 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.526 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.6 OUTLIER -105.08 163.46 12.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.493 -0.754 . . . . 0.0 109.345 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.506 ' OD1' ' CE ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -81.01 157.12 25.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 109.303 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.475 ' CG2' HG13 ' A' ' 164' ' ' VAL . 68.5 t -106.52 -18.82 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.975 . . . . 0.0 109.601 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 mt -85.9 -25.06 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 109.267 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.84 -58.62 1.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.498 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.21 74.42 0.91 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -161.98 160.53 27.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -1.153 . . . . 0.0 109.51 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.7 129.24 36.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.718 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -118.05 -76.76 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.09 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 6.0 p -131.78 167.21 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.599 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.9 p -136.35 148.91 48.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.87 -1.144 . . . . 0.0 110.408 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.494 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 36.3 t70 -82.23 5.61 19.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.491 -0.756 . . . . 0.0 109.284 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.46 -24.09 67.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.893 . . . . 0.0 108.884 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.583 ' CE2' HD13 ' A' ' 68' ' ' LEU . 30.2 m-85 -100.13 21.19 13.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.548 -0.72 . . . . 0.0 109.604 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER 58.3 112.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 108.89 -179.328 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 30' ' ' ALA . 12.2 mt -103.48 147.1 27.56 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 110.343 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -129.75 122.85 29.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.803 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -80.86 128.64 33.89 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ASP . 2.5 t -86.79 92.36 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 0.0 110.116 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 23' ' ' VAL . 23.5 m-20 22.89 45.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 120.848 0.356 . . . . 0.0 111.673 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' VAL . 18.6 m-20 -161.25 -114.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.943 -1.098 . . . . 0.0 109.684 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 160' ' ' LYS . 1.0 OUTLIER -144.71 12.9 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.809 -1.182 . . . . 0.0 109.427 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 12.3 m -104.41 133.68 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 34.7 m-85 -98.51 151.23 20.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.314 -0.866 . . . . 0.0 109.077 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 mt-10 -117.41 117.44 29.48 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.514 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.82 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -96.75 112.62 24.3 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 4.7 m-20 -68.93 150.78 47.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 110.042 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.59 144.24 36.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.27 -0.894 . . . . 0.0 109.188 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 137.67 51.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 0.0 109.586 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.9 mmt -82.06 129.69 34.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.3 m -114.51 135.17 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.366 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.75 110.93 17.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.954 . . . . 0.0 109.525 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.0 132.68 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 38' ' ' LYS . 1.1 ptmm? -67.44 106.49 2.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.407 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -93.99 146.06 24.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.543 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.74 83.16 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.72 -125.34 5.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 58.41 45.05 17.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -1.172 . . . . 0.0 109.368 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 43' ' ' VAL . 12.0 p -112.49 6.02 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.662 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.9 t70 56.18 64.74 1.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.661 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 46' ' ' GLY . 17.0 mm -134.74 -85.08 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.602 ' N ' HG22 ' A' ' 45' ' ' ILE . . . -176.77 -114.88 0.4 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.96 141.09 35.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.182 -1.187 . . . . 0.0 109.481 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -54.18 144.83 38.01 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.425 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.4 95.31 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.57 2.18 . . . . 0.0 110.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t -75.84 -27.45 57.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.416 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.19 54.74 0.23 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -133.15 40.69 3.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.236 -0.915 . . . . 0.0 109.405 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -166.19 -40.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.861 . . . . 0.0 109.284 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.86 179.38 8.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.191 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -161.7 90.01 0.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.661 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 4.3 mt-10 61.47 60.93 1.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.903 . . . . 0.0 109.759 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -102.54 -31.89 10.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.235 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.74 146.31 52.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.252 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.18 38.32 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.497 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -136.61 7.17 3.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.534 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.8 64.43 0.43 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.7 p -108.88 -174.42 2.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 109.535 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -140.39 132.72 28.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 109.414 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -72.89 127.6 33.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.205 -0.934 . . . . 0.0 109.463 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 35' ' ' VAL . 35.4 m -142.66 136.06 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.456 ' CG ' ' HB ' ' A' ' 69' ' ' VAL . 1.5 p30 -56.7 151.92 13.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 108.954 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.524 ' OD1' ' CE1' ' A' ' 18' ' ' TYR . 30.9 p30 -98.14 -15.01 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.87 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.964 HD23 ' HE2' ' A' ' 156' ' ' MET . 48.9 tp -85.48 -41.57 15.23 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.148 -0.97 . . . . 0.0 108.989 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.685 HG13 ' HB2' ' A' ' 74' ' ' LEU . 66.6 t -72.77 -37.75 56.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.358 -0.839 . . . . 0.0 109.172 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -69.28 -48.89 60.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.453 -0.779 . . . . 0.0 110.295 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 t -69.4 -52.5 26.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.217 -0.927 . . . . 0.0 110.05 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.698 ' CD1' HD12 ' A' ' 68' ' ' LEU . 28.8 m-85 -75.19 -12.75 60.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.14 37.29 3.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.685 ' HB2' HG13 ' A' ' 69' ' ' VAL . 9.3 mt -50.28 107.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.981 -1.074 . . . . 0.0 108.742 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.047 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -89.96 126.73 56.36 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.864 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.52 129.32 8.36 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.502 2.135 . . . . 0.0 110.16 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.12 135.81 37.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.088 -1.008 . . . . 0.0 109.656 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.5 m -64.54 -172.4 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.193 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -158.43 -176.94 6.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.082 -1.011 . . . . 0.0 109.592 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.568 ' CB ' ' HB2' ' A' ' 83' ' ' SER . 0.1 OUTLIER -114.69 142.09 46.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.454 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -44.97 95.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 110.153 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.61 -40.27 14.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.991 . . . . 0.0 110.427 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.568 ' HB2' ' CB ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -59.1 -29.48 67.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 109.59 -179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -56.9 -48.39 78.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.782 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mtt -64.05 -46.43 84.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.198 -0.939 . . . . 0.0 110.021 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 m -54.9 -37.05 65.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 109.97 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.57 ' CZ ' ' O ' ' A' ' 138' ' ' PRO . 24.1 t80 -76.47 -33.97 58.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 109.735 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' MET . 3.6 mm -71.42 -15.6 18.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.125 -0.984 . . . . 0.0 109.308 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -57.1 3.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.34 72.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -77.86 -36.8 49.51 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.282 -1.128 . . . . 0.0 108.395 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.456 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -62.44 -51.94 65.5 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -57.14 -38.82 74.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.487 -0.758 . . . . 0.0 109.293 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.76 -50.42 72.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.917 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.771 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 30.3 mm -65.37 -28.97 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -44.78 93.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.192 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 100' ' ' GLN . . . -69.3 -25.89 64.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -0.844 . . . . 0.0 109.102 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -71.27 -41.1 70.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.613 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 106' ' ' ARG . 61.2 mt -72.79 -48.57 37.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.946 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -58.41 -31.77 68.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.741 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -79.24 -28.8 42.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.06 -1.025 . . . . 0.0 108.883 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.502 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 73.4 m -93.93 -79.02 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.4 -0.813 . . . . 0.0 109.015 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.95 140.36 26.64 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.832 . . . . 0.0 109.271 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -74.88 -17.25 20.03 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.654 2.236 . . . . 0.0 111.12 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -71.09 -8.95 56.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -0.967 . . . . 0.0 109.955 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.903 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -100.44 -5.06 27.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.117 -0.989 . . . . 0.0 109.793 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.588 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 3.1 t -69.18 -47.52 28.48 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.09 -1.006 . . . . 0.0 109.985 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 36.1 Cg_endo -78.54 -39.23 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.129 1.886 . . . . 0.0 110.876 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.09 -50.07 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.174 -0.953 . . . . 0.0 109.855 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.771 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 60.2 t80 -68.81 -39.67 79.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.29 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 1.2 mm-40 -61.4 -43.47 98.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.119 -0.988 . . . . 0.0 110.406 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -70.39 -45.51 65.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.063 -1.023 . . . . 0.0 110.182 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 117' ' ' PHE . 3.8 t-20 -57.95 -38.7 76.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.159 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.794 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -71.02 -31.76 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 110.156 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.474 ' O ' ' HD2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -70.36 -48.89 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.134 -0.979 . . . . 0.0 109.747 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 120' ' ' LYS . . . -66.92 -49.31 55.41 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -58.14 -42.88 86.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.108 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 114' ' ' ALA . 53.3 t -57.28 -37.04 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.989 . . . . 0.0 110.023 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -71.01 -45.49 63.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.018 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 0.1 OUTLIER -56.67 -54.21 48.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.702 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.66 -53.68 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 0.0 109.347 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 119' ' ' LYS . 42.9 mt -45.95 -48.05 16.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.729 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -46.88 -45.86 20.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.42 ' HB3' ' OD1' ' A' ' 127' ' ' ASP . 7.1 m120 -139.42 66.14 1.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.524 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.85 -49.6 75.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -52.53 -28.6 21.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 109.776 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 124' ' ' ASN . 3.6 m-20 -77.75 -37.86 48.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 109.722 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 129' ' ' ASP . 27.4 m-85 -77.95 -14.65 59.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.648 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.4 OUTLIER 50.82 177.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.648 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 131' ' ' TYR . 2.0 t80 -136.78 121.3 18.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.828 . . . . 0.0 108.837 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.575 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 19.3 m-85 -107.75 175.78 5.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 110.871 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 1.047 HG22 ' O ' ' A' ' 75' ' ' SER . 18.6 tt -147.33 159.7 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.534 -0.729 . . . . 0.0 109.399 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -88.13 171.9 41.12 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -24.07 64.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -1.153 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.3 OUTLIER -59.68 -34.98 73.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.494 ' CB ' ' O ' ' A' ' 135' ' ' SER . 3.2 tpt 75.75 37.17 0.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.24 125.28 26.99 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.273 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.57 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 33.9 Cg_endo -75.44 -0.25 9.88 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.295 1.997 . . . . 0.0 110.35 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -105.65 -0.73 25.35 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.31 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 141' ' ' MET . . . -94.98 44.34 1.1 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.905 . . . . 0.0 109.617 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.506 ' CE ' ' OD1' ' A' ' 6' ' ' ASP . 2.3 mtp 67.42 140.84 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 109.688 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.566 ' CG1' ' CE1' ' A' ' 130' ' ' PHE . 19.0 m -112.73 141.32 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.267 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.784 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.9 t -109.31 144.12 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 0.0 109.836 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.0 mt -113.62 147.92 37.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.197 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.432 ' SD ' ' SD ' ' A' ' 156' ' ' MET . 5.2 tpp -116.71 123.0 46.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.866 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.54 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 13.9 t-20 -141.63 151.25 42.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.383 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -76.48 154.97 34.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.655 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -100.64 -172.66 2.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -28.62 63.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.27 -47.94 65.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.539 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 106.71 -34.66 5.56 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.744 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -121.2 20.93 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -1.102 . . . . 0.0 109.191 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.3 m -117.01 101.5 53.34 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.339 -0.85 . . . . 0.0 109.361 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.68 129.06 8.99 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.5 2.133 . . . . 0.0 110.581 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 33.4 p90 -131.0 152.07 50.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 0.0 109.282 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.964 ' HE2' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -117.1 157.65 25.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.608 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.525 ' O ' HG13 ' A' ' 143' ' ' VAL . 20.4 mt -115.39 137.12 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 109.616 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.784 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 31.4 m-85 -129.22 141.71 51.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.087 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -75.24 117.57 17.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.896 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -68.44 -28.17 66.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 160' ' ' LYS . 0.8 OUTLIER -58.82 -18.92 36.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.748 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -125.72 39.88 1.96 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.526 HD23 ' O ' ' A' ' 5' ' ' LYS . 9.5 mt -137.57 149.5 46.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -1.221 . . . . 0.0 109.668 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.475 HG13 ' CG2' ' A' ' 7' ' ' VAL . 5.5 m -128.41 122.99 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.149 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.84 132.58 35.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.496 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -118.51 126.35 51.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.823 . . . . 0.0 109.221 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.454 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.9 OUTLIER -61.21 119.16 7.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.75 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.586 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 0.9 OUTLIER -68.82 149.44 48.96 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.23 -0.919 . . . . 0.0 109.852 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.843 HD23 ' HB3' ' A' ' 15' ' ' SER . 13.0 mt -126.17 123.8 39.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.511 -0.743 . . . . 0.0 109.128 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.869 ' HD2' HD11 ' A' ' 163' ' ' LEU . 30.3 m-85 -102.05 118.97 38.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 0.0 109.758 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 35.3 pttt -136.75 165.33 26.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.462 -0.774 . . . . 0.0 109.433 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 20.3 p30 -71.88 145.33 48.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 7' ' ' VAL . 14.9 p -107.81 43.22 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.474 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.441 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 1.1 tt -140.64 -38.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 27.1 t -104.89 -70.66 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.595 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 138.86 84.08 0.11 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 12' ' ' GLU . 19.2 t0 179.58 141.44 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -1.13 . . . . 0.0 109.336 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.562 ' HG3' ' CE2' ' A' ' 72' ' ' PHE . 1.2 pm0 -78.98 147.57 32.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.536 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 mt -130.9 -41.72 1.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.283 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.858 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 2.6 p -138.98 167.44 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.843 ' HB3' HD23 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -160.21 176.14 12.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.888 -1.132 . . . . 0.0 110.94 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 8.5 t70 -81.21 1.13 33.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.621 -0.674 . . . . 0.0 109.804 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.52 -16.26 63.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.075 -1.016 . . . . 0.0 108.758 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.845 ' CE2' HD13 ' A' ' 68' ' ' LEU . 27.2 m-85 -122.56 19.31 10.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.463 -0.773 . . . . 0.0 109.081 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 18' ' ' TYR . 1.2 m-20 61.79 134.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 108.835 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.601 HD21 ' CG2' ' A' ' 14' ' ' VAL . 12.2 mt -126.44 155.04 42.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.199 -0.938 . . . . 0.0 110.119 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.517 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 12.6 mmtt -132.26 120.97 22.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.445 -0.784 . . . . 0.0 109.118 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -87.24 126.14 34.64 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.187 -0.946 . . . . 0.0 108.804 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 24' ' ' ASP . 3.4 t -76.63 158.43 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.591 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' VAL . 1.3 t0 -42.9 -33.17 0.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.418 -0.801 . . . . 0.0 109.313 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.491 ' HB3' ' ND2' ' A' ' 113' ' ' ASN . 5.4 m-20 -69.85 -140.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.069 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.842 HD11 ' OD1' ' A' ' 113' ' ' ASN . 1.5 pp -129.18 61.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.9 -1.125 . . . . 0.0 109.435 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 m -146.12 147.61 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.773 . . . . 0.0 109.372 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 22' ' ' GLU . 44.3 m-85 -103.89 158.52 16.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.517 ' CG ' ' HB2' ' A' ' 21' ' ' LYS . 11.2 pt-20 -130.2 129.4 43.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 109.57 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.858 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -111.77 134.4 53.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -0.929 . . . . 0.0 109.429 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -98.19 134.87 40.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.418 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 68' ' ' LEU . 63.1 m -110.36 155.86 21.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 109.731 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.71 138.71 53.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -0.846 . . . . 0.0 109.462 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.44 118.7 21.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.137 -0.977 . . . . 0.0 109.386 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.3 m -123.48 167.53 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.948 . . . . 0.0 109.636 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.3 t -111.2 149.03 31.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.901 . . . . 0.0 109.547 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.59 147.47 26.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.192 -0.943 . . . . 0.0 109.632 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.5 97.76 6.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.52 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -98.63 115.83 29.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.83 68.48 1.59 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 42' ' ' ASP . . . -157.14 -91.43 0.08 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER 72.75 34.38 1.18 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -1.16 . . . . 0.0 109.656 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.5 67.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 109.349 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.46 170.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 109.6 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 45' ' ' ILE . 48.8 mm -122.48 9.71 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.06 137.89 6.23 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 48' ' ' ASN . . . -62.64 -163.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -1.154 . . . . 0.0 109.323 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 27.2 m-20 63.3 149.09 0.1 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.562 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 36.4 Cg_endo -78.99 95.52 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.587 2.191 . . . . 0.0 110.346 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.8 m -131.67 35.41 3.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.77 149.99 22.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' N ' ' OE1' ' A' ' 52' ' ' GLU . 17.9 mp0 -140.8 125.18 17.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.369 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.6 108.92 15.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.367 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 55' ' ' GLU . . . -48.53 -54.3 14.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.421 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.48 ' HG3' ' HG2' ' A' ' 56' ' ' GLU . 5.1 pt-20 176.37 -33.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.481 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.48 ' HG2' ' HG3' ' A' ' 55' ' ' GLU . 3.0 pt-20 -161.13 105.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -151.74 174.13 13.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.45 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.17 150.26 24.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -118.03 -62.34 1.56 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.322 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 87.2 mt-10 60.87 85.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.888 . . . . 0.0 109.637 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.553 ' C ' HG23 ' A' ' 62' ' ' THR . . . 140.82 87.71 0.12 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.553 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.2 p 61.87 141.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.324 -1.103 . . . . 0.0 109.579 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -151.85 147.8 27.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.367 -0.833 . . . . 0.0 109.523 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.36 136.31 39.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 109.371 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.03 160.44 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.606 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.464 ' CB ' ' HB ' ' A' ' 69' ' ' VAL . 0.5 OUTLIER -59.54 154.14 18.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -89.25 -39.74 13.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.883 . . . . 0.0 109.634 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.845 HD13 ' CE2' ' A' ' 18' ' ' TYR . 25.4 tp -80.79 -34.76 33.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.082 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.692 HG13 ' HB2' ' A' ' 74' ' ' LEU . 94.5 t -67.45 -39.84 83.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.45 -0.781 . . . . 0.0 109.333 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -69.63 -52.22 27.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -28.55 70.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 0.0 110.545 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.562 ' CE2' ' HG3' ' A' ' 12' ' ' GLU . 9.2 m-85 -102.97 -4.74 24.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.89 -1.131 . . . . 0.0 110.028 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.51 28.81 16.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.015 . . . . 0.0 109.852 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.692 ' HB2' HG13 ' A' ' 69' ' ' VAL . 2.3 mm? -49.24 140.24 10.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.093 -1.005 . . . . 0.0 109.285 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.4 t -123.39 139.62 32.26 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 109.486 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.79 132.74 10.95 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.537 2.158 . . . . 0.0 110.145 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 p -128.18 165.76 19.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.417 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.28 129.73 3.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.517 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 17.0 t80 -141.6 160.38 40.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 109.452 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.57 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 40.3 m-20 -39.36 129.64 1.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.479 -0.763 . . . . 0.0 109.673 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HG3' ' CE1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -61.63 -32.35 72.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.606 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -44.54 59.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 109.922 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 80' ' ' ASP . 10.8 t -62.91 -37.89 88.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.784 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.502 ' CE1' HG12 ' A' ' 88' ' ' ILE . 1.4 t80 -55.69 -35.83 66.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.235 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.754 ' O ' HG22 ' A' ' 88' ' ' ILE . 30.4 mtt -56.76 -48.26 78.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -0.954 . . . . 0.0 109.368 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.28 -45.38 91.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.18 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.438 ' O ' ' CD2' ' A' ' 91' ' ' TYR . 25.5 m-85 -68.04 -17.69 64.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.754 HG22 ' O ' ' A' ' 85' ' ' MET . 0.3 OUTLIER -76.57 -30.2 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -79.17 -35.33 42.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.384 -0.822 . . . . 0.0 109.032 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.82 -36.58 87.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 87' ' ' TYR . 20.0 m-85 -78.48 -36.93 44.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.118 -1.225 . . . . 0.0 108.942 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.9 OUTLIER -62.38 -39.91 94.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 108.791 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -69.09 -34.33 74.93 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.1 73.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 109.164 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 47.1 mm -66.76 -36.12 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 109.23 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HD3' HG13 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -60.22 -35.49 75.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.161 -0.962 . . . . 0.0 109.255 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.52 -55.13 6.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.947 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -52.28 -33.1 40.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 109.936 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.959 HD22 ' HB3' ' A' ' 106' ' ' ARG . 83.6 mt -72.82 -45.11 60.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -56.55 -38.45 71.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -32.99 63.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 m -98.35 -72.49 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.823 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -140.7 119.06 8.21 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.52 -17.64 20.69 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.458 2.105 . . . . 0.0 110.745 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -68.99 -9.6 53.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.679 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.959 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -101.34 -5.78 24.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 109.603 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.623 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 51.9 t -71.34 -42.99 12.13 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 111.04 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.2 Cg_endo -76.97 -52.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.894 1.729 . . . . 0.0 110.984 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.579 HG23 ' H ' ' A' ' 110' ' ' PHE . 15.6 m -55.87 -52.63 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.097 -1.002 . . . . 0.0 109.413 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.579 ' H ' HG23 ' A' ' 109' ' ' VAL . 46.1 t80 -62.79 -37.04 85.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.116 -0.99 . . . . 0.0 109.177 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -54.13 -48.08 71.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 110.304 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 109' ' ' VAL . 1.0 OUTLIER -67.65 -36.12 80.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.05 -1.031 . . . . 0.0 110.179 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.842 ' OD1' HD11 ' A' ' 26' ' ' ILE . 21.2 t-20 -67.5 -32.94 74.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.399 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.693 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -71.07 -29.82 65.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.157 -0.964 . . . . 0.0 109.889 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -71.32 -40.21 73.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.231 -0.918 . . . . 0.0 108.985 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -67.56 -46.45 69.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.484 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -68.18 -30.74 69.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -1.154 . . . . 0.0 110.065 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 114' ' ' ALA . 37.6 t -68.8 -50.59 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.095 -1.003 . . . . 0.0 109.509 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.455 ' C ' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -65.97 -28.69 69.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 0.0 109.653 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.66 -60.75 2.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.147 -0.971 . . . . 0.0 109.609 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.579 HG12 HD13 ' A' ' 144' ' ' LEU . 1.2 mp -55.41 -37.65 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.441 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 45.5 mt -53.03 -42.29 65.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 109.603 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.88 -39.68 40.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 109.268 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.523 ' HB3' ' CB ' ' A' ' 127' ' ' ASP . 8.6 m120 -130.04 64.08 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.0 109.247 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.577 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 6.9 t80 -60.55 -38.98 86.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 109.856 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -77.23 -30.76 54.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 110.012 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.523 ' CB ' ' HB3' ' A' ' 124' ' ' ASN . 1.2 t70 -75.13 -23.83 57.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.986 . . . . 0.0 109.953 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.793 ' HB3' HD22 ' A' ' 144' ' ' LEU . 41.5 m-85 -94.03 -33.0 13.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.716 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.887 ' O ' HD23 ' A' ' 144' ' ' LEU . 92.1 m-20 53.87 -177.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -141.41 122.39 14.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 108.796 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.41 ' HB3' HD12 ' A' ' 74' ' ' LEU . 10.6 m-85 -97.97 173.04 7.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.0 110.757 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 14.8 tt -156.59 138.21 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.651 -0.655 . . . . 0.0 109.268 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.06 170.88 8.04 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.29 -18.31 64.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -1.178 . . . . 0.0 109.355 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 136' ' ' MET . 4.8 t -60.54 -36.44 78.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 0.0 109.48 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.41 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 69.93 49.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.297 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.11 119.2 54.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.237 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.37 0.35 9.16 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.307 2.005 . . . . 0.0 110.239 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -100.55 -8.87 22.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.374 -0.829 . . . . 0.0 109.091 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.441 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -88.88 152.99 21.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -0.89 . . . . 0.0 109.286 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.507 ' CE ' ' HB2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -65.62 166.1 11.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.656 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.07 141.83 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.444 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.49 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 17.3 t -97.3 139.25 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.152 -0.968 . . . . 0.0 109.235 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 129' ' ' ASP . 17.6 mt -107.12 136.6 46.69 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.426 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.56 137.09 47.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.629 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.444 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 24.6 t-20 -152.16 164.34 37.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 109.534 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.42 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 2.6 m-85 -107.83 137.23 46.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.425 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.8 OUTLIER -65.56 167.06 9.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.284 -0.885 . . . . 0.0 109.387 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 148' ' ' ARG . 4.9 mt-10 -44.26 -28.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.444 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -50.43 70.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.516 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.42 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 101.18 -20.68 46.34 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.82 ' O ' HD12 ' A' ' 152' ' ' ILE . 2.0 pp -105.71 7.04 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -1.038 . . . . 0.0 109.366 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.2 m -114.08 101.34 53.92 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.236 -0.915 . . . . 0.0 109.26 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.2 119.24 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.443 2.095 . . . . 0.0 110.415 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 5.1 p90 -138.61 138.76 38.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.946 . . . . 0.0 109.465 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.508 ' SD ' ' N ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -116.92 149.59 39.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 109.174 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.492 ' C ' ' CD1' ' A' ' 158' ' ' PHE . 2.6 mt -105.89 149.12 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.617 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 6.0 m-85 -132.34 117.88 18.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 0.0 109.267 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 163' ' ' LEU . 36.6 m-85 -53.67 121.65 8.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 109.375 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 8.1 tttt -66.84 -26.7 67.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.681 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 159' ' ' PHE . 0.4 OUTLIER -56.49 -43.99 80.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.331 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -108.41 27.93 12.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.869 HD11 ' HD2' ' A' ' 4' ' ' TYR . 1.2 tm? -147.45 126.91 13.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.349 -1.089 . . . . 0.0 109.111 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.783 ' N ' HD22 ' A' ' 163' ' ' LEU . 10.8 m -135.72 155.95 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.57 ' OG ' ' CE1' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -88.85 150.45 22.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.449 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -142.57 122.59 13.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 109.313 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -90.46 146.03 24.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.39 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.73 HD21 ' HE3' ' A' ' 167' ' ' LYS . 12.7 mt -102.62 152.49 21.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 2' ' ' LEU . 12.8 mt -107.54 146.49 31.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.84 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.51 ' HD2' HD13 ' A' ' 163' ' ' LEU . 8.3 m-85 -121.7 111.66 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 0.0 109.173 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.679 ' O ' HD23 ' A' ' 163' ' ' LEU . 15.8 mttm -114.48 156.68 24.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.68 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.0 155.9 21.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.546 ' O ' HG22 ' A' ' 7' ' ' VAL . 13.3 p -92.07 -0.42 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.507 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.483 HG21 ' O ' ' A' ' 139' ' ' ASP . 47.6 mm -80.16 -58.68 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.686 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 10' ' ' GLY . 41.7 t -119.13 13.62 12.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' SER . . . 44.99 70.89 0.54 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.411 ' CG ' ' OG ' ' A' ' 135' ' ' SER . 15.0 t70 -137.85 138.35 39.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -1.07 . . . . 0.0 109.329 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.447 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -44.83 143.82 1.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.47 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.65 HD12 ' CE2' ' A' ' 158' ' ' PHE . 0.2 OUTLIER -134.32 -62.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.831 HG21 ' CB ' ' A' ' 30' ' ' ALA . 4.4 p -144.37 -178.85 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.91 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.729 ' H ' HG22 ' A' ' 14' ' ' VAL . 72.7 m -149.45 165.38 32.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.723 -1.236 . . . . 0.0 110.602 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.19 7.98 22.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.498 -0.751 . . . . 0.0 109.503 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.82 -10.6 49.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.116 -0.99 . . . . 0.0 108.923 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.783 ' CD2' HD11 ' A' ' 68' ' ' LEU . 24.3 m-85 -121.03 21.54 11.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 0.0 109.147 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER 64.21 132.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.825 HD23 ' HA ' ' A' ' 30' ' ' ALA . 21.9 mt -126.14 142.79 51.38 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.216 -0.927 . . . . 0.0 110.052 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.04 140.14 50.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.465 -0.772 . . . . 0.0 109.42 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.14 112.92 24.94 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.259 -0.901 . . . . 0.0 108.903 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.54 152.68 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.446 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -54.01 -19.6 5.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.668 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -75.46 -98.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.04 -1.038 . . . . 0.0 109.318 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -165.76 56.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.005 -1.06 . . . . 0.0 109.617 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.411 HG13 ' C ' ' A' ' 26' ' ' ILE . 11.1 m -152.05 158.16 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.077 -1.014 . . . . 0.0 109.76 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.413 ' C ' ' HG2' ' A' ' 29' ' ' GLU . 6.0 m-85 -103.58 162.2 13.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 0.0 109.026 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.6 mm-40 -130.99 117.41 19.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.831 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -103.97 112.76 25.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 108.956 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 2.3 m-20 -77.92 150.47 34.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.824 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.434 ' SG ' ' HG2' ' A' ' 154' ' ' PRO . 1.7 p -125.46 175.72 7.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.871 . . . . 0.0 109.315 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.33 164.65 27.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 0.0 109.459 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.5 126.19 48.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.465 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 65' ' ' VAL . 33.8 m -115.14 131.22 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.855 . . . . 0.0 109.544 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.77 112.65 24.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 0.0 109.311 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 m -129.28 133.29 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.621 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -76.15 92.94 3.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.243 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.455 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -119.65 131.88 55.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.537 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.47 -58.17 4.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 42' ' ' ASP . . . 104.1 -109.09 3.3 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' GLY . 46.4 m-20 44.13 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -1.154 . . . . 0.0 109.379 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 60' ' ' GLU . 9.0 p -81.5 -27.35 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.68 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 45' ' ' ILE . 23.0 t70 -126.7 -89.07 0.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.651 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.484 HG22 ' OD2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -165.02 -39.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 109.407 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -171.78 139.97 5.6 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 57.41 70.23 0.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.113 -1.227 . . . . 0.0 109.306 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' ND2' HG12 ' A' ' 43' ' ' VAL . 89.9 m-20 -60.62 126.51 85.14 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.164 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 50' ' ' SER . 36.3 Cg_endo -79.14 68.93 8.13 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.303 2.002 . . . . 0.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 49' ' ' PRO . 4.4 t 75.62 97.94 0.07 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.143 -0.973 . . . . 0.0 109.296 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 52' ' ' GLU . . . -56.38 -170.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' ALA . 3.9 mm-40 60.93 96.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 109.659 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 44.93 -97.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.699 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' GLU . . . 54.06 84.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 109.561 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 49.18 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.951 . . . . 0.0 109.514 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.55 117.95 22.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.85 . . . . 0.0 109.505 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -154.56 28.79 0.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.72 -167.15 1.47 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.368 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -75.37 164.73 26.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.406 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.617 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.1 mt-10 -87.69 -31.39 19.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.81 27.59 2.72 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.3 p -105.48 155.76 18.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.315 -1.109 . . . . 0.0 109.445 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.459 ' OE1' ' CG1' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -135.31 113.81 11.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 109.516 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.1 t -76.67 130.37 37.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.218 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 35' ' ' VAL . 33.4 m -128.42 125.6 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.907 . . . . 0.0 109.682 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -51.09 142.02 13.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.18 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 71' ' ' SER . 10.0 p30 -74.19 -21.48 59.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 109.739 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.783 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -81.47 -36.94 28.72 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.099 -1.001 . . . . 0.0 108.771 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 73' ' ' ARG . 41.7 t -71.33 -54.32 17.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.419 -0.801 . . . . 0.0 109.706 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -61.76 -41.31 97.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 0.0 110.142 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 5.0 t -68.4 -33.19 73.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.152 -0.968 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.485 ' HB2' HD23 ' A' ' 74' ' ' LEU . 22.9 m-85 -110.08 13.32 23.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.04 -1.037 . . . . 0.0 109.996 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 69' ' ' VAL . 55.0 mtt180 43.41 69.42 0.4 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.155 -0.966 . . . . 0.0 109.481 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 72' ' ' PHE . 1.7 mm? -89.81 137.96 31.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.399 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.539 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -100.03 117.83 62.63 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.152 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.71 123.59 5.37 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.551 2.168 . . . . 0.0 110.631 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.47 ' HG1' ' HD2' ' A' ' 79' ' ' PHE . 2.4 t -132.69 174.2 10.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 108.988 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -142.57 9.22 1.79 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.222 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 16.7 p90 -86.91 123.04 31.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.045 -1.035 . . . . 0.0 109.599 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -174.23 21.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.943 . . . . 0.0 110.54 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -63.58 -53.46 51.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.945 -1.097 . . . . 0.0 109.347 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.06 -24.67 4.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -29.89 67.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.118 -0.989 . . . . 0.0 109.165 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.558 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -58.84 -46.27 88.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 109.356 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.447 ' HA ' HG22 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -64.84 -30.04 71.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.262 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -71.16 -55.4 8.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.017 -1.052 . . . . 0.0 110.691 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.554 ' CD1' ' HG2' ' A' ' 138' ' ' PRO . 39.7 m-85 -63.91 -41.45 97.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.088 -1.007 . . . . 0.0 109.897 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -68.84 -22.33 26.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 109.469 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -55.2 5.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.344 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.12 -19.89 68.52 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -81.12 -39.02 26.26 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.157 -1.202 . . . . 0.0 108.326 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.65 -40.69 92.75 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.69 -43.99 95.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 0.0 109.125 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.56 -50.09 68.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 108.886 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.633 HG23 ' OD1' ' A' ' 161' ' ' ASP . 41.9 mm -60.02 -32.07 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.224 -0.923 . . . . 0.0 108.682 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -50.32 71.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 108.948 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.82 77.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.154 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HD3' HD23 ' A' ' 99' ' ' LEU . 3.8 tmt_? -58.63 -43.84 89.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.126 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.504 HD13 ' HG2' ' A' ' 106' ' ' ARG . 24.7 mt -64.67 -48.47 74.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.378 -0.826 . . . . 0.0 109.033 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -52.72 -25.26 10.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.198 -0.939 . . . . 0.0 108.827 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -76.32 -43.28 41.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 108.966 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.8 t -88.85 -71.77 0.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.191 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -148.04 137.25 11.95 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.04 -16.73 19.95 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.604 2.203 . . . . 0.0 111.066 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.52 -14.08 62.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.008 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.504 ' HG2' HD13 ' A' ' 99' ' ' LEU . 12.8 ttp-105 -93.09 -5.94 49.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.664 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 62.9 t -71.21 -43.09 12.55 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 111.344 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.4 Cg_endo -77.38 -54.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.883 1.722 . . . . 0.0 110.99 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.606 HG23 ' N ' ' A' ' 110' ' ' PHE . 35.7 m -56.52 -46.0 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.114 -0.992 . . . . 0.0 110.007 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.606 ' N ' HG23 ' A' ' 109' ' ' VAL . 62.5 t80 -65.06 -45.87 83.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.822 . . . . 0.0 110.696 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 115' ' ' ILE . 67.7 tt0 -57.28 -47.77 80.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.008 -1.057 . . . . 0.0 110.536 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -68.38 -31.69 71.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.058 -1.026 . . . . 0.0 110.345 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -66.36 -54.24 26.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 109.913 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -69.57 -26.55 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.988 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 111' ' ' GLU . 4.1 mm -62.29 -49.08 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.127 -0.983 . . . . 0.0 109.162 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.96 -41.04 99.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -35.2 75.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.25 -1.147 . . . . 0.0 109.602 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 114' ' ' ALA . 70.4 t -70.58 -38.06 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 109.561 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 115' ' ' ILE . 3.3 mmtt -64.34 -29.66 70.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 109.801 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -81.83 -46.9 13.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 109.893 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.2 OUTLIER -53.98 -37.86 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.16 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.02 -45.87 86.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.122 -0.986 . . . . 0.0 109.424 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -48.05 -39.66 20.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.868 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -136.43 45.65 2.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.146 -0.971 . . . . 0.0 109.735 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 10.1 p90 -63.02 -22.86 67.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.443 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.413 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -70.95 -47.02 61.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.547 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 2.0 m-20 -71.13 -23.57 62.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.342 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.559 ' HB3' HD22 ' A' ' 144' ' ' LEU . 6.3 m-85 -76.45 -10.72 59.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.513 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 50.94 -172.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.946 . . . . 0.0 109.451 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 77' ' ' THR . 0.3 OUTLIER -149.22 121.68 8.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -107.4 166.81 10.38 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.035 -1.041 . . . . 0.0 110.38 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 75' ' ' SER . 7.6 tt -146.79 130.51 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.405 -0.809 . . . . 0.0 109.477 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.56 179.16 3.87 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.08 -23.27 67.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -1.127 . . . . 0.0 109.453 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 136' ' ' MET . 7.2 m -58.71 -34.58 71.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.511 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 76.81 20.4 1.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.308 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -114.62 119.58 39.37 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.242 -0.911 . . . . 0.0 109.276 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 87' ' ' TYR . 33.4 Cg_endo -75.4 -5.51 16.7 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.262 1.974 . . . . 0.0 110.303 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.483 ' O ' HG21 ' A' ' 8' ' ' ILE . 2.4 p30 -95.38 -4.88 44.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 0.0 109.143 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' A' ' 141' ' ' MET . . . -98.45 47.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.53 ' CB ' ' O ' ' A' ' 140' ' ' ALA . 27.3 ttm 79.66 115.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.759 -0.588 . . . . 0.0 109.606 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.15 130.59 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.351 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 157' ' ' ILE . 3.0 t -99.84 138.82 23.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.271 -0.893 . . . . 0.0 109.069 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 128' ' ' TYR . 18.6 mt -115.0 146.49 41.19 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.229 -0.92 . . . . 0.0 109.622 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.428 ' HG2' ' HG2' ' A' ' 156' ' ' MET . 0.0 OUTLIER -109.3 124.79 51.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.329 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.542 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 24.3 t-20 -138.31 140.22 39.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.5 OUTLIER -77.8 147.04 35.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -0.845 . . . . 0.0 109.563 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -79.22 178.42 8.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.0 -25.36 8.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.45 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.447 ' OD2' HG13 ' A' ' 152' ' ' ILE . 31.9 t0 -72.17 -47.99 46.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 0.0 109.397 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 105.33 -28.61 13.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.798 ' O ' HD12 ' A' ' 152' ' ' ILE . 2.3 pp -99.78 11.51 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -1.153 . . . . 0.0 109.641 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.1 m -121.49 100.59 44.34 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.158 -0.964 . . . . 0.0 109.428 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.434 ' HG2' ' SG ' ' A' ' 32' ' ' CYS . 36.9 Cg_endo -81.22 131.02 7.49 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.554 2.169 . . . . 0.0 110.502 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 146' ' ' ASN . 32.9 p90 -135.18 144.49 47.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.377 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.5 ' HB3' ' CG1' ' A' ' 143' ' ' VAL . 2.0 mtt -107.93 163.91 12.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 109.888 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.638 ' O ' HG13 ' A' ' 143' ' ' VAL . 8.0 mt -124.15 139.36 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 109.384 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.65 ' CE2' HD12 ' A' ' 13' ' ' LEU . 52.7 m-85 -129.97 116.0 17.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.491 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 2.2 m-85 -43.15 116.81 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.263 -0.898 . . . . 0.0 109.746 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -68.65 -42.59 77.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.825 . . . . 0.0 109.979 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.633 ' OD1' HG23 ' A' ' 95' ' ' ILE . 3.5 t70 -47.22 -35.79 8.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.465 ' O ' ' HE2' ' A' ' 141' ' ' MET . . . -110.74 50.26 0.78 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 5' ' ' LYS . 3.8 mt -134.16 154.96 50.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.237 . . . . 0.0 109.68 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 5' ' ' LYS . 7.2 m -143.27 125.83 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 59.4 m -82.59 135.55 35.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -127.72 124.9 38.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.892 . . . . 0.0 109.574 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.73 ' HE3' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -68.5 117.17 9.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.445 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.494 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttm . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 167' ' ' LYS . 12.6 mt -112.5 151.5 29.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 109.641 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 3' ' ' LEU . 32.4 mt -105.92 122.93 47.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.667 ' HD2' HD11 ' A' ' 163' ' ' LEU . 3.6 m-85 -103.92 117.88 35.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.942 . . . . 0.0 109.185 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -129.63 143.27 50.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.644 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.861 ' OD1' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -74.35 156.77 36.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.529 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 7' ' ' VAL . 93.2 t -98.72 -6.45 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.356 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 3.1 mt -101.47 -61.31 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 109.651 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 8' ' ' ILE . 10.3 t -43.23 -47.39 6.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.57 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.96 -63.65 0.37 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.87 65.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -1.19 . . . . 0.0 109.52 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 179.37 141.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.861 HD22 ' OD1' ' A' ' 6' ' ' ASP . 23.9 tp -171.96 -75.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 0.0 109.62 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.843 HG21 ' CB ' ' A' ' 30' ' ' ALA . 3.2 p -153.18 -172.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 108.972 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.743 ' H ' HG22 ' A' ' 14' ' ' VAL . 51.5 p -162.57 174.27 12.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.843 -1.161 . . . . 0.0 110.168 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.42 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 37.5 t70 -82.95 10.98 6.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.399 -0.813 . . . . 0.0 109.988 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.08 -9.67 33.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 109.227 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 39.4 m-85 -126.77 21.56 6.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.243 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 14.9 m-20 67.96 130.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 30' ' ' ALA . 34.8 mt -126.31 147.89 49.64 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.178 -0.951 . . . . 0.0 110.371 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 136.8 44.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.504 -0.747 . . . . 0.0 109.381 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 1.1 tt0 -99.24 113.17 25.29 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.264 -0.898 . . . . 0.0 108.837 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ASP . 33.2 t -62.36 157.69 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.222 -0.924 . . . . 0.0 109.574 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -43.73 -28.37 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.247 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -75.24 -143.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 108.998 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.446 ' O ' ' HB3' ' A' ' 160' ' ' LYS . 1.0 OUTLIER -123.41 54.58 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.054 -1.029 . . . . 0.0 109.591 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.2 m -136.86 153.84 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 109.473 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 4.3 m-85 -107.27 163.16 13.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.308 -0.87 . . . . 0.0 109.222 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 47.6 mt-10 -128.98 119.91 25.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.843 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -114.86 112.52 22.88 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 11.1 m-20 -75.01 145.62 42.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 t -104.21 125.89 50.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.415 -0.803 . . . . 0.0 108.944 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -106.63 154.64 20.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.104 -0.998 . . . . 0.0 109.969 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.3 mmm -103.5 135.12 45.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 108.808 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.54 174.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.067 -1.021 . . . . 0.0 109.802 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.844 ' HB ' HG21 ' A' ' 62' ' ' THR . 1.5 p -93.84 118.35 31.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.378 -0.826 . . . . 0.0 109.278 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.5 m -123.71 125.95 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 99.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.341 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -81.75 115.95 21.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.915 . . . . 0.0 109.563 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.04 26.24 21.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.54 144.34 35.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -147.85 43.4 1.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -1.191 . . . . 0.0 109.496 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 43' ' ' VAL . 3.5 m -76.27 -17.14 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.729 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 45' ' ' ILE . 31.1 m-20 -80.67 -16.94 52.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 109.392 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.51 ' O ' HG23 ' A' ' 45' ' ' ILE . 3.1 tp 38.64 60.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.619 -0.676 . . . . 0.0 110.287 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.83 144.07 35.33 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.95 109.63 10.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -1.225 . . . . 0.0 109.475 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.41 147.13 34.72 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.447 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 -86.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.612 2.208 . . . . 0.0 110.238 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 26.2 t -105.64 -64.46 1.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 109.445 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 50' ' ' SER . . . 174.53 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.833 . . . . 0.0 109.457 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -102.34 61.71 0.85 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.158 -0.964 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.76 173.08 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.582 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . . . -78.96 154.81 29.28 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.905 . . . . 0.0 109.406 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 3.9 tt0 -50.02 -27.69 5.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.59 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.469 ' OE2' ' ND2' ' A' ' 57' ' ' ASN . 3.2 pt-20 179.52 177.35 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 109.689 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.469 ' ND2' ' OE2' ' A' ' 56' ' ' GLU . 70.8 m-80 43.73 79.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.866 . . . . 0.0 109.427 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . . . -158.07 -161.42 1.01 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.95 . . . . 0.0 109.635 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -44.53 153.44 0.16 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 109.701 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 56.34 66.41 1.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 109.673 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 62' ' ' THR . . . 149.14 57.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.844 HG21 ' HB ' ' A' ' 36' ' ' THR . 5.8 t -56.43 -163.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -1.142 . . . . 0.0 109.284 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.458 ' N ' HG23 ' A' ' 62' ' ' THR . 0.9 OUTLIER -146.56 140.78 26.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -0.955 . . . . 0.0 109.507 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.01 125.4 30.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.6 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.1 159.43 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 109.485 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.492 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 32.8 m120 -54.25 143.32 23.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.891 . . . . 0.0 109.525 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 32.3 t-20 -92.71 -26.18 17.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.707 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.615 HD11 HG23 ' A' ' 14' ' ' VAL . 49.7 tp -87.78 -47.79 8.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 108.749 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 74' ' ' LEU . 50.7 t -60.42 -47.88 90.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -69.29 -47.59 64.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 110.139 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 t -49.4 -52.25 29.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.561 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 68' ' ' LEU . 72.5 m-85 -102.12 8.48 40.71 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.046 -1.033 . . . . 0.0 110.178 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.481 ' O ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 57.24 95.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.023 . . . . 0.0 109.263 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.726 ' HB2' HG13 ' A' ' 69' ' ' VAL . 3.9 mm? -114.31 139.13 49.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.336 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.523 ' O ' HG22 ' A' ' 132' ' ' ILE . 4.4 t -125.92 124.06 24.68 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 109.397 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.85 157.81 27.59 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.398 2.065 . . . . 0.0 110.263 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -93.87 -174.27 3.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 109.391 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.1 4.42 2.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.702 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 14.1 t80 -160.34 124.26 3.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.501 ' HB2' ' CD2' ' A' ' 130' ' ' PHE . 0.3 OUTLIER -161.56 23.74 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.328 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -53.17 61.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -23.7 11.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.315 -0.866 . . . . 0.0 109.331 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.6 m -72.02 -31.45 66.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 80' ' ' ASP . 3.9 t80 -58.83 -36.65 74.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.604 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.738 ' O ' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -63.37 -53.04 58.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.73 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.3 m -61.62 -28.56 69.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.872 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 91' ' ' TYR . 10.9 m-85 -69.63 -46.3 66.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.092 -1.005 . . . . 0.0 109.749 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 85' ' ' MET . 5.9 tp -65.12 -24.58 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.279 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -46.85 38.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.766 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.94 -27.1 72.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 87' ' ' TYR . 21.1 m-85 -81.21 -36.75 29.67 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.083 -1.245 . . . . 0.0 109.307 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.511 ' O ' ' HE3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -63.76 -41.32 98.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.89 . . . . 0.0 109.863 -179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -73.45 -40.9 63.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.958 . . . . 0.0 109.723 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -44.47 73.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.613 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.676 HD12 ' OD1' ' A' ' 161' ' ' ASP . 49.2 mm -62.15 -37.41 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.491 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -50.68 61.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.87 . . . . 0.0 109.29 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.89 -27.89 68.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.385 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.578 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.41 -36.49 82.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.316 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 106' ' ' ARG . 33.3 mt -72.59 -50.45 25.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.127 -0.983 . . . . 0.0 109.616 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -51.51 -34.19 35.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.304 -0.872 . . . . 0.0 109.0 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.2 -37.09 72.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 109.056 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.5 m -96.95 -82.04 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.378 -0.826 . . . . 0.0 109.601 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.509 ' OD1' ' CG ' ' A' ' 105' ' ' GLU . 3.1 p30 -132.0 134.69 25.49 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.64 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.15 -19.01 17.95 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.503 2.135 . . . . 0.0 110.854 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.509 ' CG ' ' OD1' ' A' ' 103' ' ' ASN . 16.2 pt-20 -68.87 -8.76 46.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 0.0 109.861 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.729 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -93.92 -3.53 51.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.994 . . . . 0.0 109.782 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 25.8 t -72.4 -45.02 10.29 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 111.015 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.2 Cg_endo -77.41 -47.39 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.989 1.793 . . . . 0.0 111.156 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 110' ' ' PHE . 1.4 p -63.51 -44.68 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 109.598 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.532 ' N ' ' CG1' ' A' ' 109' ' ' VAL . 49.0 t80 -64.5 -41.0 96.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.501 -0.749 . . . . 0.0 110.34 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -40.37 94.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.015 -1.053 . . . . 0.0 110.338 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -48.98 45.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.045 -1.034 . . . . 0.0 110.783 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.41 -54.62 43.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.054 -1.029 . . . . 0.0 110.465 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.716 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -60.71 -26.71 67.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.001 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 115' ' ' ILE . 0.9 OUTLIER -65.12 -49.15 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.086 -1.009 . . . . 0.0 109.286 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.37 -33.59 82.57 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.507 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.1 OUTLIER -63.6 -45.46 90.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -1.13 . . . . 0.0 109.969 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 114' ' ' ALA . 60.6 t -53.78 -38.62 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.326 -0.859 . . . . 0.0 110.657 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -71.19 -49.29 45.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 110.562 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 117' ' ' PHE . 0.1 OUTLIER -73.0 -11.18 60.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.028 -1.045 . . . . 0.0 110.27 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -83.2 -44.57 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.06 -1.025 . . . . 0.0 109.665 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.402 ' N ' HG22 ' A' ' 121' ' ' ILE . 40.0 mt -53.64 -36.4 62.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 109.964 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 122' ' ' LEU . . . -45.1 -39.39 5.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 109.719 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.564 ' O ' ' CE1' ' A' ' 128' ' ' TYR . 35.2 m-80 -113.0 50.71 0.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 109.939 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.651 ' HA ' ' CE1' ' A' ' 128' ' ' TYR . 53.7 t80 -64.02 -54.13 39.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.175 -0.953 . . . . 0.0 109.991 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.48 -5.46 58.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -0.904 . . . . 0.0 109.086 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.515 ' HB2' ' CB ' ' A' ' 124' ' ' ASN . 15.8 m-20 -80.73 -41.53 23.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.84 . . . . 0.0 109.908 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.651 ' CE1' ' HA ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -102.03 10.78 39.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.086 . . . . 0.0 110.727 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 0.3 OUTLIER 43.86 -151.75 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.196 -0.94 . . . . 0.0 109.345 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.576 ' CE1' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -149.59 121.25 8.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 108.991 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.462 ' CE1' ' SD ' ' A' ' 145' ' ' MET . 13.2 m-85 -104.19 164.76 11.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.146 -0.971 . . . . 0.0 110.36 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 75' ' ' SER . 12.8 tt -157.11 135.87 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.421 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -48.24 156.14 1.19 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -17.71 16.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.152 . . . . 0.0 109.522 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.1 OUTLIER -57.68 -38.92 75.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.214 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.491 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.1 OUTLIER 74.72 27.16 1.3 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 0.0 109.603 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.24 114.27 51.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 136' ' ' MET . 33.8 Cg_endo -74.49 1.69 7.16 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.336 2.024 . . . . 0.0 110.392 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 139' ' ' ASP . 62.6 t0 -121.54 15.43 11.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.353 -0.842 . . . . 0.0 109.119 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -97.69 -94.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.867 . . . . 0.0 109.726 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 142' ' ' VAL . 9.1 tmm? -163.11 139.13 7.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 109.56 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.454 ' O ' ' SD ' ' A' ' 141' ' ' MET . 5.6 m -104.41 135.25 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 157' ' ' ILE . 4.3 t -103.55 130.01 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.167 -0.958 . . . . 0.0 109.469 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.592 HD22 ' CD1' ' A' ' 128' ' ' TYR . 47.0 mt -88.99 152.41 21.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.846 . . . . 0.0 109.324 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.462 ' SD ' ' CE1' ' A' ' 131' ' ' TYR . 1.4 ttt -111.92 115.48 29.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 109.539 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 155' ' ' TYR . 1.5 m-20 -121.0 165.88 14.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' A' ' 151' ' ' GLY . 0.1 OUTLIER -107.64 135.52 48.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.464 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 153' ' ' THR . 3.3 ttp180 -60.32 173.22 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 109.453 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.38 -31.27 65.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.336 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.46 -46.8 68.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.855 . . . . 0.0 109.348 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.56 ' O ' ' CE1' ' A' ' 147' ' ' TYR . . . 102.09 -28.49 15.7 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 152' ' ' ILE . 1.2 tp -87.45 -10.98 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -1.093 . . . . 0.0 109.24 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 148' ' ' ARG . 2.9 m -115.45 102.13 54.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.401 -0.812 . . . . 0.0 109.34 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.39 143.6 22.16 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.425 2.083 . . . . 0.0 110.3 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 146' ' ' ASN . 6.4 p90 -143.43 144.98 32.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 mtm -110.21 166.96 10.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.346 -0.846 . . . . 0.0 109.177 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 143' ' ' VAL . 3.6 mt -131.55 139.37 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 29.9 m-85 -123.09 153.81 39.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.336 -0.853 . . . . 0.0 109.302 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -75.76 113.93 13.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 26' ' ' ILE . 1.7 tttt -60.35 -44.43 95.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 109.369 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.676 ' OD1' HD12 ' A' ' 95' ' ' ILE . 3.3 p30 -49.38 -38.89 30.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.188 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -104.64 47.55 1.06 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.667 HD11 ' HD2' ' A' ' 4' ' ' TYR . 4.9 tt -151.68 126.77 9.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.437 -1.037 . . . . 0.0 109.31 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.502 HG13 ' CG2' ' A' ' 7' ' ' VAL . 13.4 m -112.27 140.55 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.915 . . . . 0.0 109.575 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.99 134.38 47.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.464 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.83 126.78 53.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.893 . . . . 0.0 109.416 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.459 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -67.09 123.12 19.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.413 -0.804 . . . . 0.0 109.416 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.484 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 2' ' ' LEU . 6.8 mt -111.36 152.89 26.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.694 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.1 mt -114.98 143.44 45.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.493 -0.754 . . . . 0.0 109.078 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.673 ' HD2' HD21 ' A' ' 163' ' ' LEU . 53.0 m-85 -120.47 112.87 19.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.511 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 164' ' ' VAL . 10.5 ttpt -117.6 157.48 26.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.582 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.524 ' OD2' ' CE ' ' A' ' 141' ' ' MET . 2.0 t70 -92.67 155.27 17.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.343 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 8' ' ' ILE . 12.1 m -97.44 -38.87 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.481 ' N ' HG23 ' A' ' 7' ' ' VAL . 4.7 mt -46.65 -79.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.867 . . . . 0.0 109.301 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.24 31.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.919 . . . . 0.0 109.523 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.86 68.13 0.28 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 12' ' ' GLU . 10.1 p30 -52.3 143.81 14.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -1.166 . . . . 0.0 109.429 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 11' ' ' ASP . 44.0 mm-40 58.87 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.82 -74.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.303 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.033 HG23 HD21 ' A' ' 68' ' ' LEU . 7.9 p -149.66 175.4 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 108.95 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.628 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.2 p -138.21 165.83 25.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.862 -1.148 . . . . 0.0 110.754 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.503 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -85.2 8.88 16.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 0.0 109.77 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.94 -25.14 66.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.027 . . . . 0.0 108.961 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.755 ' CE2' HD13 ' A' ' 68' ' ' LEU . 47.2 m-85 -102.47 21.94 14.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.116 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER 60.31 122.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.5 -0.75 . . . . 0.0 109.161 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.813 HD23 ' HA ' ' A' ' 30' ' ' ALA . 22.9 mt -116.04 152.12 34.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.34 -0.85 . . . . 0.0 109.878 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' ' OE2' ' A' ' 29' ' ' GLU . 1.7 mptp? -131.19 148.93 52.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -0.863 . . . . 0.0 109.746 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.38 125.36 36.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.834 . . . . 0.0 109.201 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' ASP . 15.8 t -78.09 148.48 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.729 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' VAL . 76.0 m-20 -44.13 -31.84 1.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.397 -0.815 . . . . 0.0 109.752 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.773 ' O ' HG23 ' A' ' 26' ' ' ILE . 6.5 m-20 -73.47 -101.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.773 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -164.66 59.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.041 -1.037 . . . . 0.0 109.382 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.507 HG21 HG21 ' A' ' 157' ' ' ILE . 18.7 m -145.46 167.78 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.635 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -111.42 144.81 40.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.854 . . . . 0.0 109.353 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.7 pt-20 -117.06 125.11 50.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.014 -1.054 . . . . 0.0 109.317 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.913 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -113.6 112.73 24.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.441 -0.787 . . . . 0.0 108.944 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 31.5 m-20 -67.18 149.62 50.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.35 -0.844 . . . . 0.0 109.893 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.9 p -142.92 174.52 10.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.408 -0.808 . . . . 0.0 109.293 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -115.56 163.32 15.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.74 120.56 38.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.319 -0.863 . . . . 0.0 109.291 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.66 138.33 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.361 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.459 ' HA ' HG22 ' A' ' 64' ' ' THR . 0.0 OUTLIER -88.43 134.72 33.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 m -137.31 155.59 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.341 -0.849 . . . . 0.0 109.28 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -115.48 109.93 18.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 109.518 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 40' ' ' GLY . 20.8 mt-30 -99.13 160.55 14.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.39 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 39' ' ' GLN . . . -44.22 -67.65 1.04 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.33 -81.49 0.13 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.05 99.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -1.153 . . . . 0.0 109.469 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -71.82 -33.98 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.589 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -89.74 102.14 14.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.737 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.558 HD13 ' OE2' ' A' ' 55' ' ' GLU . 19.5 tt -137.27 23.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 109.388 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.59 178.43 0.27 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 48' ' ' ASN . . . 59.48 -175.72 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -1.149 . . . . 0.0 109.474 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 4.4 m-20 64.31 146.54 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.433 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.18 173.65 13.59 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.573 2.182 . . . . 0.0 110.482 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.89 178.93 4.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.92 . . . . 0.0 109.396 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.44 179.91 7.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.22 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.8 -37.96 64.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -106.06 117.31 33.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 56.85 -179.91 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.875 . . . . 0.0 109.263 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.558 ' OE2' HD13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -85.87 -59.72 2.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.58 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.55 -171.54 2.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 1.1 m-20 -79.86 -171.38 2.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.456 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 57' ' ' ASN . . . 66.75 86.17 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.64 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.72 122.66 3.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.192 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -126.71 59.33 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.16 -0.963 . . . . 0.0 109.838 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.49 -105.3 2.22 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.1 p -69.5 167.51 16.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -1.184 . . . . 0.0 109.087 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 63' ' ' GLU . 1.6 pm0 -147.73 139.38 23.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.131 -0.98 . . . . 0.0 109.737 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 36' ' ' THR . 0.9 OUTLIER -93.09 144.36 25.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 109.414 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 65' ' ' VAL . 32.7 m -126.25 131.7 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.504 ' ND2' ' SD ' ' A' ' 145' ' ' MET . 11.9 m120 -71.42 131.61 43.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.489 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -46.88 -24.47 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.694 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.033 HD21 HG23 ' A' ' 14' ' ' VAL . 31.4 tp -82.25 -42.73 18.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.039 -1.038 . . . . 0.0 108.49 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.578 HG13 ' HB2' ' A' ' 74' ' ' LEU . 3.1 t -54.96 -56.1 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.473 -0.767 . . . . 0.0 108.954 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 70' ' ' TYR . 4.2 t80 -61.38 -41.34 96.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 109.92 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.94 -45.47 64.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.044 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -111.74 19.83 17.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 109.882 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.63 82.58 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.938 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.578 ' HB2' HG13 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -95.22 169.76 9.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 108.824 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.61 ' O ' HG22 ' A' ' 132' ' ' ILE . 1.8 m -128.18 102.96 20.88 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.975 -1.078 . . . . 0.0 110.044 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.433 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 36.3 Cg_endo -80.0 118.37 3.71 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.489 2.126 . . . . 0.0 110.135 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 130' ' ' PHE . 6.0 t -87.93 161.33 17.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.304 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 t -125.95 4.86 7.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 109.81 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.55 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 6.5 t80 -138.62 128.35 24.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 109.711 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.529 ' OD2' ' CE1' ' A' ' 130' ' ' PHE . 4.4 p-10 169.96 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.766 . . . . 0.0 109.454 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -62.36 -42.97 99.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 109.237 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -113.76 -28.65 7.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.492 -0.755 . . . . 0.0 109.09 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -29.09 67.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.324 -0.86 . . . . 0.0 109.317 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.485 ' HB2' ' HB2' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -55.11 -48.96 72.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.488 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.474 ' HA ' HG22 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -64.26 -29.86 70.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 109.993 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -55.24 18.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 88' ' ' ILE . 21.6 m-85 -70.7 -58.25 3.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 109.845 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -42.74 -37.9 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 109.573 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 15.2 mmtp -63.07 -52.69 61.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.356 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.65 -20.26 56.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.602 ' CE2' ' CB ' ' A' ' 141' ' ' MET . 2.8 t80 -77.88 -36.45 49.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.212 -1.17 . . . . 0.0 108.484 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.448 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -64.99 -42.14 94.79 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 4.5 mptt -67.1 -32.02 72.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.588 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.38 89.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.026 -1.046 . . . . 0.0 109.702 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.775 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 34.8 mm -57.57 -45.44 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.172 -0.955 . . . . 0.0 109.749 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -48.09 -33.47 8.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 109.09 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.529 ' N ' ' HG3' ' A' ' 96' ' ' LYS . . . -73.04 -46.82 49.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 108.998 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.881 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -50.54 -38.05 42.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.143 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.881 HD23 ' HD3' ' A' ' 98' ' ' ARG . 1.4 mt -69.92 -44.9 68.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.406 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -51.88 -30.27 23.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.331 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 97' ' ' ALA . 6.9 mt-10 -78.71 -39.26 37.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.156 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.54 -82.51 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.274 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -135.93 135.88 22.27 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -74.84 -14.84 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.593 2.195 . . . . 0.0 110.748 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.74 -13.54 61.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.854 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.782 ' HB3' HD13 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -89.56 -11.42 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.119 -0.988 . . . . 0.0 109.764 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.704 ' HA ' HD12 ' A' ' 99' ' ' LEU . 7.9 t -65.12 -44.39 70.02 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 111.203 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.4 Cg_endo -76.55 -58.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.933 1.756 . . . . 0.0 110.984 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 110' ' ' PHE . 15.8 m -55.9 -43.93 76.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.067 -1.02 . . . . 0.0 109.592 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.775 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 43.7 t80 -58.64 -49.63 76.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.734 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -57.25 -29.91 64.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.115 -0.991 . . . . 0.0 110.175 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -49.16 40.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.152 -0.968 . . . . 0.0 111.569 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.596 ' ND2' ' HA ' ' A' ' 110' ' ' PHE . 10.8 p30 -72.19 -46.73 55.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.847 -1.158 . . . . 0.0 110.733 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -54.93 -46.82 74.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.066 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -53.36 -44.09 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.874 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.46 -41.21 96.47 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.561 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.72 -37.29 78.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -1.179 . . . . 0.0 110.028 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 47.8 t -63.89 -45.21 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.356 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.505 ' C ' ' CD ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -66.13 -28.87 69.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.984 . . . . 0.0 109.611 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -67.55 -49.13 64.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.983 . . . . 0.0 110.0 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.07 HG12 HD13 ' A' ' 144' ' ' LEU . 1.6 mp -70.18 -32.01 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 109.699 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 122' ' ' LEU . 43.5 mt -57.16 -30.47 64.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.696 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.51 -48.32 62.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 109.773 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 127' ' ' ASP . 1.5 m-80 -139.57 69.56 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -63.15 -21.59 66.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -62.93 -63.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.845 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 128' ' ' TYR . 18.7 p30 -65.63 -22.68 66.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.246 -0.909 . . . . 0.0 109.959 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 2.9 m-85 -76.08 -16.92 59.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 109.903 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.489 ' C ' ' CG ' ' A' ' 130' ' ' PHE . 3.0 m-20 44.8 -168.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.166 -0.959 . . . . 0.0 109.264 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.811 ' HB3' HG11 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -154.06 121.14 5.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 108.681 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.967 ' O ' HG13 ' A' ' 142' ' ' VAL . 14.6 m-85 -105.16 164.42 11.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.178 -0.951 . . . . 0.0 110.692 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 75' ' ' SER . 1.1 tt -155.94 139.77 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.403 -0.81 . . . . 0.0 109.488 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.37 164.25 1.09 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 135' ' ' SER . 2.6 pt-20 -67.13 -21.07 65.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -1.177 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.2 OUTLIER -62.34 -35.3 78.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 77.48 50.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.869 . . . . 0.0 109.612 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.33 107.77 60.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.123 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.34 0.23 8.81 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.26 1.973 . . . . 0.0 110.486 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.77 -14.68 23.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.884 . . . . 0.0 109.115 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 141' ' ' MET . . . -79.7 -91.77 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.445 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.602 ' CB ' ' CE2' ' A' ' 91' ' ' TYR . 1.9 ptp 179.42 149.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 131' ' ' TYR . 70.3 t -97.76 138.15 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.183 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.639 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 3.6 t -93.25 111.35 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.134 -0.979 . . . . 0.0 109.043 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 1.07 HD13 HG12 ' A' ' 121' ' ' ILE . 2.5 mt -79.26 149.13 31.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.778 ' HE3' ' CE2' ' A' ' 131' ' ' TYR . 12.4 ttm -124.58 131.21 53.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.624 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.545 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 25.8 t-20 -142.34 168.79 18.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 109.108 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.468 ' HB3' ' HA2' ' A' ' 151' ' ' GLY . 4.5 m-85 -77.06 159.39 29.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.058 -1.026 . . . . 0.0 109.385 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.59 ' HB2' ' CD1' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -151.59 -173.62 4.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 110.011 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 56.05 -97.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 109.655 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -106.94 -25.72 11.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.019 -1.051 . . . . 0.0 109.152 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 147' ' ' TYR . . . 123.17 17.43 3.31 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.65 -21.37 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.281 -1.129 . . . . 0.0 108.903 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 153' ' ' THR . 2.9 t -105.0 128.21 27.16 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.111 -0.993 . . . . 0.0 109.566 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -82.87 146.92 13.24 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.754 2.303 . . . . 0.0 110.696 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.59 ' CD1' ' HB2' ' A' ' 148' ' ' ARG . 7.2 p90 -145.18 155.33 43.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 108.851 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.461 ' SD ' ' N ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -126.73 162.2 26.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 109.795 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.507 HG21 HG21 ' A' ' 27' ' ' VAL . 4.4 mt -124.26 145.3 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 109.507 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.639 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 9.7 m-85 -129.31 128.52 43.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.312 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -51.23 127.27 18.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -62.49 -53.69 51.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.405 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -47.52 -44.72 25.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -90.17 44.19 2.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.806 ' O ' HD23 ' A' ' 163' ' ' LEU . 2.2 tt -158.5 123.54 4.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.431 -1.041 . . . . 0.0 109.212 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 5' ' ' LYS . 30.1 m -116.69 153.61 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.456 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.8 p -90.86 146.92 23.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.953 . . . . 0.0 109.639 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.53 120.64 15.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.471 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 168' ' ' PHE . 0.0 OUTLIER -70.21 108.27 4.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.404 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 168' ' ' PHE . 13.9 t80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.545 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.52 ' HG2' HD21 ' A' ' 3' ' ' LEU . 7.6 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.616 HD13 ' O ' ' A' ' 166' ' ' GLU . 0.8 OUTLIER -68.48 146.74 52.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 110.126 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.914 HD11 ' CG ' ' A' ' 168' ' ' PHE . 6.8 mt -121.85 139.57 53.46 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.633 ' HB2' HG13 ' A' ' 14' ' ' VAL . 91.5 m-85 -121.43 108.89 14.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.977 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 1.8 mtmm -108.82 167.29 10.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.454 -0.778 . . . . 0.0 109.272 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -83.86 151.23 25.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.97 . . . . 0.0 109.362 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.543 HG21 HG13 ' A' ' 164' ' ' VAL . 5.3 t -108.31 35.6 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 109.486 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.927 HG21 ' O ' ' A' ' 139' ' ' ASP . 24.0 mm -117.07 -52.4 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.417 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.96 -34.96 2.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.5 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 106.62 2.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -176.28 136.54 0.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -1.145 . . . . 0.0 109.496 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' OE1' ' CG ' ' A' ' 72' ' ' PHE . 7.8 pt-20 -48.51 147.36 2.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.642 HD22 ' HD2' ' A' ' 158' ' ' PHE . 3.7 mt -132.6 -80.58 0.49 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.154 -0.966 . . . . 0.0 109.532 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.862 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 2.6 p -132.37 166.77 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.853 . . . . 0.0 109.104 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.596 ' N ' HG22 ' A' ' 14' ' ' VAL . 3.9 p -142.0 161.93 36.75 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.017 -1.052 . . . . 0.0 110.098 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -83.02 1.27 40.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.381 -0.824 . . . . 0.0 109.598 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.86 -9.39 37.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.378 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.673 ' CE2' HD13 ' A' ' 68' ' ' LEU . 35.7 m-85 -119.52 20.69 12.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 65.38 130.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 109.006 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.734 HD23 ' HA ' ' A' ' 30' ' ' ALA . 49.4 mt -125.68 146.08 49.89 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -0.95 . . . . 0.0 110.015 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -123.43 134.26 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -0.807 . . . . 0.0 109.35 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.438 ' CD ' ' HA ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -90.93 122.4 33.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.181 -0.949 . . . . 0.0 108.789 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 2.3 t -114.55 120.44 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 4.0 t70 74.4 5.97 4.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 109.802 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 20.3 t0 59.12 68.89 0.77 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 109.513 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.656 HG23 HG13 ' A' ' 27' ' ' VAL . 5.8 tt 174.54 -29.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.129 -0.982 . . . . 0.0 109.905 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.656 HG13 HG23 ' A' ' 26' ' ' ILE . 23.1 m -120.93 140.13 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.957 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -105.44 148.92 26.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.193 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -120.97 121.06 37.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.405 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.862 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -106.22 112.88 26.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.193 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -68.38 149.57 49.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 66' ' ' ASN . 34.7 m -100.26 151.17 21.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 0.0 109.259 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.16 134.35 51.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.748 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.414 ' CE ' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -80.06 135.95 36.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -0.876 . . . . 0.0 109.059 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 35' ' ' VAL . 17.1 m -142.58 125.05 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.206 -0.934 . . . . 0.0 109.436 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 36' ' ' THR . 1.4 t -86.07 142.72 28.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.47 HG22 ' HG2' ' A' ' 63' ' ' GLU . 2.9 m -129.01 137.25 57.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.226 -0.922 . . . . 0.0 109.601 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -90.77 102.7 15.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -108.28 131.12 55.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.512 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.59 2.72 53.25 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 -162.27 27.77 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -174.88 64.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -1.122 . . . . 0.0 109.697 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 3.2 t -114.49 -73.37 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.567 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.536 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 1.3 p30 170.22 -37.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.354 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER 40.52 30.95 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.523 -0.736 . . . . 0.0 109.729 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' ASP . . . 104.53 -131.19 10.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.22 64.79 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -1.183 . . . . 0.0 109.526 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 0.8 OUTLIER -47.71 111.8 1.86 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.225 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 50' ' ' SER . 35.4 Cg_endo -77.47 6.29 4.53 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.469 2.113 . . . . 0.0 110.8 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 48.9 m 60.23 -89.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 109.518 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.498 ' C ' ' CG ' ' A' ' 52' ' ' GLU . . . -154.99 169.1 24.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.599 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.498 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 1.0 OUTLIER 39.63 -96.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 0.0 109.884 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 51' ' ' ALA . 17.1 p-10 -154.29 147.57 24.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -99.92 117.32 33.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.569 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -119.93 -16.67 8.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -96.31 175.7 6.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 109.37 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -133.97 38.92 3.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.579 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.78 76.16 1.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.441 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.69 128.02 55.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.435 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 60' ' ' GLU . 5.4 pt-20 -166.75 91.4 0.42 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.546 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.58 97.92 0.26 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p 49.65 -174.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -1.108 . . . . 0.0 109.716 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.47 ' HG2' HG22 ' A' ' 37' ' ' VAL . 2.2 pt-20 -155.31 146.11 22.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.682 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 138.07 32.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.865 . . . . 0.0 109.31 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.4 m -148.48 140.55 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.485 ' OD1' ' HB3' ' A' ' 32' ' ' CYS . 1.5 m-20 -56.6 154.2 9.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.36 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 71' ' ' SER . 33.7 t30 -89.7 -27.09 20.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.739 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.673 HD13 ' CE2' ' A' ' 18' ' ' TYR . 13.3 tp -83.48 -37.63 22.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 108.982 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.573 HG13 ' HB2' ' A' ' 74' ' ' LEU . 53.3 t -72.61 -48.28 47.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.723 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -69.29 -36.04 76.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 110.93 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 70.3 m -79.49 -52.85 7.51 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.966 -1.084 . . . . 0.0 110.506 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CG ' ' OE1' ' A' ' 12' ' ' GLU . 7.2 m-30 -79.82 -3.6 48.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.128 -0.982 . . . . 0.0 109.968 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.81 88.04 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 109.571 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.573 ' HB2' HG13 ' A' ' 69' ' ' VAL . 1.4 mm? -111.85 139.05 47.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 108.719 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.67 122.99 18.1 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.066 -1.021 . . . . 0.0 109.871 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.14 126.28 7.7 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.374 2.049 . . . . 0.0 110.097 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 t -123.92 117.02 23.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -0.966 . . . . 0.0 109.645 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -59.34 151.46 23.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.242 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 17.9 t80 -151.93 155.3 37.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 109.703 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.637 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 1.4 m-20 -86.42 124.27 32.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -0.879 . . . . 0.0 109.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -34.61 68.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.147 -0.971 . . . . 0.0 110.033 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -56.25 -64.91 0.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.617 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 79' ' ' PHE . 7.4 t -59.8 -28.74 67.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.788 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.32 -35.48 67.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.495 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.4 mtt -57.04 -49.42 75.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.141 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -48.81 79.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.489 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -62.7 -19.19 63.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.256 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 92' ' ' MET . 0.6 OUTLIER -79.22 -28.92 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -39.55 58.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.426 -0.796 . . . . 0.0 109.115 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.13 -38.79 88.48 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.568 ' CZ ' ' O ' ' A' ' 138' ' ' PRO . 14.7 m-30 -74.52 -36.5 63.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.101 -1.234 . . . . 0.0 108.816 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.536 ' CE ' ' O ' ' A' ' 92' ' ' MET . 0.0 OUTLIER -65.21 -38.99 92.15 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.624 0.726 . . . . 0.0 109.293 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.506 ' C ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.15 -36.91 82.86 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.571 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.58 -50.77 67.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.994 -1.066 . . . . 0.0 109.244 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.837 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 29.5 mm -59.93 -43.0 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.235 -0.915 . . . . 0.0 108.969 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -47.38 -51.61 19.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.875 . . . . 0.0 109.364 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 100' ' ' GLN . . . -58.19 -36.53 73.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.015 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 101' ' ' GLU . 1.8 tmt_? -64.15 -32.85 74.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -0.916 . . . . 0.0 109.683 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.526 HD23 ' HD3' ' A' ' 98' ' ' ARG . 22.4 mt -73.78 -50.21 21.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 110.213 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.539 ' HG3' ' N ' ' A' ' 101' ' ' GLU . 2.6 pt20 -55.83 -34.98 65.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.679 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 7.4 pt-20 -72.79 -35.52 67.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.103 -0.998 . . . . 0.0 109.191 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.52 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 10.2 t -88.28 -80.31 0.28 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.277 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.74 137.78 26.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 109.325 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.92 -25.97 11.53 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.547 2.165 . . . . 0.0 110.637 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -70.46 -6.83 38.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.676 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.516 ' O ' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -97.92 -4.8 35.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 109.819 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.607 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 32.7 t -70.18 -44.62 20.49 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.989 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.6 Cg_endo -77.7 -41.05 0.34 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.018 1.812 . . . . 0.0 111.096 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.34 -43.37 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 0.0 109.938 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.837 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 87.1 t80 -69.72 -37.11 76.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 0.0 110.408 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -63.25 -53.78 47.64 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.09 -1.006 . . . . 0.0 110.719 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -47.19 61.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.016 -1.053 . . . . 0.0 110.675 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -55.73 -54.26 46.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.138 -0.976 . . . . 0.0 110.124 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.77 69.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 109.968 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -59.22 -35.51 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.126 -0.983 . . . . 0.0 109.559 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.48 -45.85 95.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.623 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -68.14 -30.72 69.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -1.2 . . . . 0.0 110.081 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 54.4 t -68.02 -42.35 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.888 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 115' ' ' ILE . 40.2 mmtt -69.06 -42.05 76.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.075 -1.015 . . . . 0.0 109.78 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.499 ' HA ' ' CE ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -59.54 -60.5 3.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.797 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 117' ' ' PHE . 1.3 mt -53.98 -47.69 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 122' ' ' LEU . 25.6 mt -47.3 -49.6 23.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 109.762 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.78 -41.85 45.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.966 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.73 52.02 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.885 . . . . 0.0 109.435 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 8.9 p90 -63.43 -27.53 69.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.578 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.427 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 5.5 mttp -64.82 -39.77 94.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.404 -0.81 . . . . 0.0 109.704 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.67 -23.76 42.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 110.01 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 129' ' ' ASP . 7.1 m-85 -81.7 -25.92 35.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.874 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.521 ' C ' ' CD1' ' A' ' 130' ' ' PHE . 14.0 m-20 51.29 179.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.59 ' HB3' HG11 ' A' ' 142' ' ' VAL . 36.3 m-85 -142.3 121.61 13.11 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.352 -0.843 . . . . 0.0 109.052 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.987 ' O ' HG13 ' A' ' 142' ' ' VAL . 10.9 m-85 -99.31 166.24 11.3 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.189 -0.944 . . . . 0.0 110.538 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 7.8 tp -156.58 146.84 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.702 . . . . 0.0 109.278 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.03 162.38 52.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -58.24 -23.63 56.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -1.107 . . . . 0.0 109.427 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 136' ' ' MET . 11.4 p -68.59 -34.76 76.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 109.359 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.486 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 0.0 OUTLIER 70.6 63.63 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.521 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.37 105.73 38.2 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.341 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.568 ' O ' ' CZ ' ' A' ' 91' ' ' TYR . 34.0 Cg_endo -74.5 -20.85 17.7 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.274 1.982 . . . . 0.0 109.961 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.927 ' O ' HG21 ' A' ' 8' ' ' ILE . 7.7 t70 -75.43 -6.26 49.18 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.364 -0.835 . . . . 0.0 108.962 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.15 -175.71 2.88 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.266 -0.896 . . . . 0.0 109.35 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.2 ptm -92.31 167.47 11.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 109.475 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.987 HG13 ' O ' ' A' ' 131' ' ' TYR . 58.7 t -113.35 142.03 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 109.185 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 157' ' ' ILE . 13.0 t -90.01 130.04 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.174 -0.954 . . . . 0.0 108.838 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.558 HD13 HG12 ' A' ' 121' ' ' ILE . 18.0 mt -92.55 134.4 35.02 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.492 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.471 ' HB2' ' CE1' ' A' ' 131' ' ' TYR . 4.8 ttt -107.63 126.28 52.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.571 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 2.2 t30 -139.34 169.11 18.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 1.6 m-85 -110.23 144.81 38.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.65 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.445 ' CZ ' HG21 ' A' ' 153' ' ' THR . 0.5 OUTLIER -67.48 170.67 7.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 109.608 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -47.67 -35.8 10.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 109.577 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -77.35 -44.63 28.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.298 -0.876 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.569 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 100.46 -30.2 10.71 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.6 tp -68.2 -6.57 5.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.47 -1.018 . . . . 0.0 109.661 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 153' ' ' THR . 1.7 m -122.81 101.73 39.08 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 109.665 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.14 121.8 5.02 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.57 2.18 . . . . 0.0 109.98 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 146' ' ' ASN . 31.7 p90 -126.37 148.35 49.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -0.983 . . . . 0.0 109.88 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.461 ' HG2' ' HG3' ' A' ' 145' ' ' MET . 0.2 OUTLIER -116.14 167.17 11.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.35 -0.844 . . . . 0.0 109.135 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.772 ' O ' HG13 ' A' ' 143' ' ' VAL . 11.6 mt -128.46 148.63 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 0.0 109.783 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.642 ' HD2' HD22 ' A' ' 13' ' ' LEU . 12.4 m-85 -136.55 125.73 24.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.471 ' HB3' ' OD1' ' A' ' 161' ' ' ASP . 2.5 m-85 -60.03 132.41 53.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 110.25 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 77.3 tttt -68.23 -41.85 80.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.487 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.471 ' OD1' ' HB3' ' A' ' 159' ' ' PHE . 5.2 p-10 -50.56 -45.01 56.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.012 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -97.93 45.94 1.65 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.845 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -161.34 129.23 4.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.464 -1.021 . . . . 0.0 108.919 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.543 HG13 HG21 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -115.46 149.16 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.624 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.89 121.64 38.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.616 ' O ' HD13 ' A' ' 2' ' ' LEU . 1.8 tp10 -118.42 142.98 47.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.671 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.49 113.6 25.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.914 ' CG ' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.489 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mt -100.8 158.4 15.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 3' ' ' LEU . 25.7 mt -112.41 134.47 53.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.479 -0.763 . . . . 0.0 109.427 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.599 ' CD2' HD21 ' A' ' 163' ' ' LEU . 10.5 m-85 -117.4 112.24 20.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.68 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 12' ' ' GLU . 1.5 mtmt -123.15 162.39 22.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.415 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -97.04 158.21 15.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.416 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.86 54.32 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -0.984 . . . . 0.0 109.663 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -140.7 -50.1 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.034 -1.041 . . . . 0.0 109.595 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.587 ' O ' ' HB2' ' A' ' 140' ' ' ALA . 1.5 t 176.47 45.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -141.87 -43.93 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 6.8 t0 74.96 -137.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -1.112 . . . . 0.0 109.275 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.447 ' HA ' ' HG2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -42.33 121.37 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.047 -1.033 . . . . 0.0 109.677 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.476 ' HA ' HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -125.1 -62.08 1.25 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.138 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.826 HG21 ' CB ' ' A' ' 30' ' ' ALA . 6.5 p -143.46 175.81 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.365 -0.834 . . . . 0.0 108.855 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.652 ' H ' HG22 ' A' ' 14' ' ' VAL . 22.6 t -147.49 169.59 19.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.846 -1.159 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.545 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 31.4 t70 -87.54 12.73 11.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.479 -0.763 . . . . 0.0 109.447 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.39 -15.28 63.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 108.996 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CE1' ' ND2' ' A' ' 67' ' ' ASN . 44.5 m-85 -115.92 21.38 13.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.471 -0.768 . . . . 0.0 109.207 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.2 t0 65.32 129.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 108.511 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 30' ' ' ALA . 13.0 mt -124.28 143.2 50.69 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.144 -0.973 . . . . 0.0 110.252 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.32 136.7 52.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.34 117.74 34.45 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.252 -0.905 . . . . 0.0 108.767 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 t -68.46 147.81 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 109.49 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -46.31 -25.4 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 109.751 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.467 ' O ' HG23 ' A' ' 26' ' ' ILE . 2.2 m-20 -77.96 -110.39 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -154.82 64.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.811 -1.181 . . . . 0.0 109.305 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.3 m -147.18 141.27 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 109.674 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.409 ' CE2' ' HE2' ' A' ' 4' ' ' TYR . 4.9 m-85 -98.65 148.39 23.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.152 -0.968 . . . . 0.0 109.066 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 19.4 mt-10 -125.15 121.11 33.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.116 -0.99 . . . . 0.0 110.12 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.89 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -106.39 112.71 25.83 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -71.52 146.48 48.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 110.509 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 28.3 p -126.74 115.18 19.01 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.425 ' HG2' ' ND2' ' A' ' 67' ' ' ASN . 14.6 pt20 -92.69 157.22 16.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 110.056 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.5 mmm -92.25 133.28 35.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -0.815 . . . . 0.0 109.207 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.3 m -117.35 144.71 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.59 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -100.07 117.36 34.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.268 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.558 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.3 m -85.18 123.01 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.893 . . . . 0.0 109.429 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -92.69 105.48 17.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.0 109.585 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -96.06 157.6 15.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.462 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.34 -44.63 65.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.55 -166.47 24.78 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.66 -38.8 1.87 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -1.107 . . . . 0.0 109.443 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 44' ' ' ASP . 75.9 t -124.26 -92.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.315 -0.866 . . . . 0.0 109.322 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.508 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER 66.25 -88.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.739 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 46' ' ' GLY . 4.3 tt -135.38 -42.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.572 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 152.36 155.26 6.98 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.23 74.25 1.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.386 -1.067 . . . . 0.0 109.58 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.48 146.24 0.11 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 109.734 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.57 -176.92 3.52 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.59 2.193 . . . . 0.0 110.335 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m 59.34 37.46 23.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 109.578 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 47.15 -168.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.491 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.462 ' N ' ' OE1' ' A' ' 52' ' ' GLU . 13.5 mp0 -119.09 -71.62 0.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.528 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 6.4 t70 179.39 160.35 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.535 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.33 177.68 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.321 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 -87.22 -172.31 3.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 6.0 pt-20 -125.99 134.0 51.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.496 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER 177.77 60.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.543 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' C ' ' HG3' ' A' ' 59' ' ' GLU . . . -141.77 122.53 14.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.442 ' HG3' ' C ' ' A' ' 58' ' ' ALA . 42.0 mt-10 -149.67 -159.25 1.01 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.37 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER 68.96 8.66 6.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.923 . . . . 0.0 109.619 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' C ' HG23 ' A' ' 62' ' ' THR . . . 67.6 99.07 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.469 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.3 p 57.97 159.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -1.145 . . . . 0.0 109.319 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -123.91 144.77 49.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 109.624 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.56 133.03 41.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.275 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.2 137.86 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 0.0 109.616 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -60.37 141.38 56.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.427 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.462 ' ND2' ' CE1' ' A' ' 18' ' ' TYR . 38.5 p-10 -86.12 -19.57 29.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.671 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 18.1 tp -86.38 -47.56 9.23 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 108.957 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.773 HG13 ' HB2' ' A' ' 74' ' ' LEU . 55.6 t -68.24 -37.33 77.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.322 -0.862 . . . . 0.0 109.171 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -69.84 -44.57 69.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 109.668 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 t -63.24 -36.93 85.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.315 -0.866 . . . . 0.0 110.121 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.692 ' HB2' HD23 ' A' ' 74' ' ' LEU . 25.9 m-85 -103.26 2.9 34.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 109.891 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER 56.82 29.66 16.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.154 -0.966 . . . . 0.0 109.789 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.773 ' HB2' HG13 ' A' ' 69' ' ' VAL . 2.0 mm? -41.72 149.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.411 -0.806 . . . . 0.0 109.345 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.434 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -131.06 127.38 21.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.384 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.16 122.17 5.61 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.496 2.131 . . . . 0.0 110.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.4 127.26 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.37 -178.68 3.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.29 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 50.5 t80 -164.91 163.0 21.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.605 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 35.6 m-20 -77.38 120.48 22.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.458 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 2.1 tmtt? -59.14 -53.25 60.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.88 -45.33 86.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.76 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.505 ' CB ' ' HB2' ' A' ' 80' ' ' ASP . 1.3 t -61.75 -29.06 69.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.344 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 81' ' ' LYS . 41.6 t80 -58.41 -34.99 71.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.779 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -57.34 12.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.96 . . . . 0.0 109.778 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -59.87 -38.02 81.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.003 . . . . 0.0 109.273 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.509 ' CE2' ' CZ ' ' A' ' 91' ' ' TYR . 6.5 t80 -66.44 -23.1 66.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.385 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -78.72 -31.48 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 108.952 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -72.02 -47.28 52.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.41 -29.86 74.61 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.509 ' CZ ' ' CE2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -75.38 -35.79 61.02 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.129 -1.218 . . . . 0.0 108.41 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -54.42 26.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.598 -0.689 . . . . 0.0 109.745 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -38.47 75.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.346 -0.846 . . . . 0.0 109.868 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.54 -45.34 73.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.113 -0.992 . . . . 0.0 109.297 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.473 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 34.8 mm -69.82 -36.67 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -47.19 63.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 109.202 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.72 81.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.127 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.4 OUTLIER -52.95 -44.29 66.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.456 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.827 HD13 ' HB3' ' A' ' 106' ' ' ARG . 2.0 mt -71.93 -44.06 64.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.295 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -25.16 9.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.199 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -86.98 -34.44 19.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 t -96.09 -89.02 0.26 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.326 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.439 ' OD1' ' NH2' ' A' ' 106' ' ' ARG . 27.8 p-10 -125.62 132.38 24.3 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.271 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.9 -19.44 18.09 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.641 2.227 . . . . 0.0 110.884 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.9 -6.82 29.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.202 -0.936 . . . . 0.0 109.905 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.827 ' HB3' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -95.81 -5.94 40.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.084 -1.01 . . . . 0.0 109.811 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.625 ' HA ' HD12 ' A' ' 99' ' ' LEU . 96.0 t -72.18 -43.25 9.99 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.137 -0.977 . . . . 0.0 111.229 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.6 Cg_endo -75.98 -56.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.762 1.641 . . . . 0.0 110.862 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 110' ' ' PHE . 12.8 m -55.84 -40.95 64.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.036 -1.04 . . . . 0.0 109.471 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.511 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 68.9 t80 -65.82 -37.1 85.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.817 . . . . 0.0 110.253 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.775 ' O ' HD13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -66.42 -49.87 65.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.964 -1.085 . . . . 0.0 110.562 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -66.14 -49.45 67.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.887 -1.133 . . . . 0.0 110.544 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -58.2 -46.42 85.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.985 . . . . 0.0 109.813 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -65.44 -27.56 68.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.373 -0.829 . . . . 0.0 109.751 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.775 HD13 ' O ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -67.13 -47.41 81.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.251 -0.905 . . . . 0.0 109.446 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.27 -50.51 44.53 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.475 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.78 -38.95 76.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.081 -1.247 . . . . 0.0 109.803 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 114' ' ' ALA . 53.1 t -68.4 -39.16 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -32.34 69.64 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.157 -0.964 . . . . 0.0 109.295 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -96.92 -10.07 27.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.661 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.2 -53.68 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.629 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.537 ' N ' HG22 ' A' ' 121' ' ' ILE . 10.1 mt -48.77 -44.23 38.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.016 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.79 76.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 110.033 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.542 ' O ' ' CE2' ' A' ' 128' ' ' TYR . 19.6 m-20 -101.44 38.84 1.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.14 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.651 ' HA ' ' CE1' ' A' ' 128' ' ' TYR . 13.4 t80 -63.41 -53.69 48.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.082 -1.011 . . . . 0.0 109.061 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -78.9 -8.43 58.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 108.988 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 124' ' ' ASN . 0.8 OUTLIER -80.17 -39.53 29.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.341 -0.85 . . . . 0.0 109.937 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.651 ' CE1' ' HA ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -108.55 -10.43 15.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.969 -1.082 . . . . 0.0 110.041 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.8 m-20 52.27 173.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.726 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -114.71 122.23 45.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.599 ' HB3' HD12 ' A' ' 74' ' ' LEU . 11.2 m-85 -103.27 177.63 4.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 110.558 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.671 ' O ' HD13 ' A' ' 74' ' ' LEU . 3.9 tp -143.02 149.03 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.541 -0.725 . . . . 0.0 109.545 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 132' ' ' ILE . . . -73.01 -178.77 35.41 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -18.06 63.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -1.187 . . . . 0.0 109.539 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -60.95 -41.69 96.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.217 -0.927 . . . . 0.0 109.39 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 75.56 48.88 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.672 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.53 ' O ' HD11 ' A' ' 132' ' ' ILE . 72.4 m-20 -118.84 134.02 23.6 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 109.373 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.409 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 34.1 Cg_endo -75.59 -5.48 16.58 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.317 2.011 . . . . 0.0 110.157 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.425 ' HB3' ' CB ' ' A' ' 9' ' ' SER . 11.4 t70 -101.48 -3.31 28.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 109.304 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 9' ' ' SER . . . -85.17 137.87 32.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 109.378 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.471 ' SD ' ' HB2' ' A' ' 159' ' ' PHE . 1.4 ttp -43.42 152.99 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.742 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.9 m -100.67 141.44 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.365 -0.835 . . . . 0.0 109.279 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.611 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.1 t -102.27 139.04 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.236 -0.915 . . . . 0.0 109.42 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.515 ' HB3' ' CG ' ' A' ' 128' ' ' TYR . 4.9 mt -107.13 146.16 31.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.31 -0.869 . . . . 0.0 109.206 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 128' ' ' TYR . 1.8 ttm -111.98 125.78 54.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.674 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.41 ' HB3' ' OH ' ' A' ' 155' ' ' TYR . 2.4 t-20 -139.13 169.08 18.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 4.9 m-85 -102.66 145.91 28.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.597 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.574 ' HB2' ' CE2' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -142.85 -170.84 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.345 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' ARG . 0.8 OUTLIER 62.07 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.571 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.68 -22.17 11.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.586 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.591 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 124.27 -18.37 7.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 152' ' ' ILE . 2.4 tp -96.26 7.23 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.299 -1.118 . . . . 0.0 109.394 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.6 m -110.64 101.8 50.13 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.298 -0.876 . . . . 0.0 109.633 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.59 139.39 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.521 2.147 . . . . 0.0 110.18 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 148' ' ' ARG . 52.0 p90 -145.14 158.64 43.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 109.655 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 158' ' ' PHE . 7.1 mtm -107.44 156.14 19.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.301 -0.874 . . . . 0.0 109.295 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.497 ' O ' HG13 ' A' ' 143' ' ' VAL . 42.3 mt -122.6 132.61 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.08 -1.012 . . . . 0.0 110.011 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.611 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 7.8 m-85 -126.22 115.11 19.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.481 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 3.8 m-85 -50.41 126.28 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.397 -0.814 . . . . 0.0 109.774 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 161' ' ' ASP . 4.9 tttm -68.49 -38.14 80.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.772 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 1.8 p30 -43.26 -41.45 3.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . -110.0 54.29 0.55 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.608 ' C ' HD23 ' A' ' 163' ' ' LEU . 8.7 tt -157.66 142.37 16.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -1.099 . . . . 0.0 109.556 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.475 ' N ' HD23 ' A' ' 163' ' ' LEU . 19.8 m -127.65 152.65 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.4 m -104.31 121.34 43.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.099 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -115.93 127.56 55.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.616 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 146.53 25.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.875 . . . . 0.0 109.564 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' C ' HD23 ' A' ' 2' ' ' LEU . 2.4 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 167' ' ' LYS . 2.9 mt -105.44 165.04 11.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.897 . . . . 0.0 109.421 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 3' ' ' LEU . 79.6 mt -127.27 129.63 48.08 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.432 -0.792 . . . . 0.0 109.584 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HB3' HD22 ' A' ' 163' ' ' LEU . 64.2 m-85 -111.59 108.79 18.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.255 -0.903 . . . . 0.0 109.312 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.669 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -117.24 163.91 15.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.773 ' HB2' HD12 ' A' ' 13' ' ' LEU . 4.3 t0 -76.23 152.41 36.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.889 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.572 ' CG2' HG13 ' A' ' 164' ' ' VAL . 2.7 t -102.32 -5.97 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.81 . . . . 0.0 109.344 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.603 HG21 ' O ' ' A' ' 139' ' ' ASP . 4.7 mt -97.54 -79.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.415 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -144.47 67.37 1.26 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 0.0 109.554 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -130.81 -65.83 0.1 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER 73.52 13.18 4.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.315 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 1.4 pt-20 170.67 107.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.039 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.773 HD12 ' HB2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -129.4 -64.98 0.87 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.834 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.894 HG23 HD21 ' A' ' 68' ' ' LEU . 11.3 p -157.31 170.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.299 -0.876 . . . . 0.0 108.968 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.68 ' C ' HD11 ' A' ' 20' ' ' LEU . 3.7 p -155.06 -176.23 5.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.667 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.23 10.71 6.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.545 -0.722 . . . . 0.0 110.165 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.493 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . . . -66.05 -10.25 38.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.056 -1.027 . . . . 0.0 109.19 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.614 ' CG ' HD11 ' A' ' 68' ' ' LEU . 8.1 m-85 -127.41 21.69 6.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.174 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.19 130.56 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.768 HD23 ' HA ' ' A' ' 30' ' ' ALA . 19.3 mt -126.86 148.46 49.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 110.484 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.96 133.14 53.77 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.7 122.47 38.5 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.179 -0.951 . . . . 0.0 108.839 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.39 158.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.095 -1.003 . . . . 0.0 109.168 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -64.1 -10.53 23.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.086 -1.009 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.76 ' C ' HG23 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -76.87 1.45 17.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.779 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.76 HG23 ' C ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 75.22 25.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.428 ' HB ' HG22 ' A' ' 157' ' ' ILE . 20.2 m -119.3 156.57 21.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 110.186 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -107.64 157.01 18.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 0.0 109.07 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.5 mt-10 -130.47 117.63 19.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.946 -1.096 . . . . 0.0 109.342 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.768 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -110.25 114.15 27.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -57.46 143.13 41.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -102.84 174.1 6.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.244 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 3.0 tt0 -138.48 150.85 46.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.912 . . . . 0.0 109.588 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.46 ' SD ' ' HG3' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -114.52 130.88 56.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.9 130.43 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.454 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.88 111.99 13.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.621 HG23 ' HG3' ' A' ' 39' ' ' GLN . 33.5 m -127.14 162.99 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.425 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -83.5 92.73 7.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.578 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.621 ' HG3' HG23 ' A' ' 37' ' ' VAL . 12.0 mt-30 -123.31 154.78 38.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.374 -0.829 . . . . 0.0 109.413 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.22 80.33 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.08 -33.24 0.42 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.45 14.76 5.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.13 -1.217 . . . . 0.0 109.642 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 44' ' ' ASP . 13.0 t -94.15 -17.76 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.94 . . . . 0.0 109.448 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER 43.9 79.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.654 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 45' ' ' ILE . 0.7 OUTLIER -172.93 66.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.185 -0.947 . . . . 0.0 109.612 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -46.25 130.47 11.0 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.5 -18.48 19.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -1.126 . . . . 0.0 109.556 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -139.25 92.54 10.57 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.32 153.94 31.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.692 2.261 . . . . 0.0 110.509 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t 58.12 31.68 21.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.845 . . . . 0.0 109.319 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.17 61.65 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 109.129 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.485 ' HB2' ' OD1' ' A' ' 57' ' ' ASN . 4.3 pt-20 -143.81 157.59 44.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 109.538 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 17.1 t0 -149.15 92.12 1.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.306 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . 70.24 -168.66 0.16 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.263 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.48 -175.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.056 -1.027 . . . . 0.0 109.364 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.44 2.86 52.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 109.584 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.485 ' OD1' ' HB2' ' A' ' 52' ' ' GLU . 0.1 OUTLIER 60.18 -170.41 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 109.393 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 57' ' ' ASN . . . 63.68 109.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.851 . . . . 0.0 109.52 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -138.9 64.52 1.48 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 0.0 109.504 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.02 59.1 0.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.596 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 62' ' ' THR . . . -168.56 -69.19 0.03 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 61' ' ' GLY . 3.5 p 59.8 145.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -1.111 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -146.93 145.15 29.7 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.27 136.4 56.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.087 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.1 m -125.68 147.98 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 0.0 109.566 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 3.6 m-20 -69.88 152.92 43.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 52.7 t-20 -90.98 -26.62 19.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.622 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.894 HD21 HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -77.31 -42.5 36.56 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.771 HG13 ' HB2' ' A' ' 74' ' ' LEU . 44.6 t -73.19 -34.73 45.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.454 -0.779 . . . . 0.0 109.301 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 15.3 t80 -63.33 -48.79 76.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 110.384 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.54 -40.39 61.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.18 -0.95 . . . . 0.0 110.32 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CB ' HD23 ' A' ' 74' ' ' LEU . 62.8 m-85 -86.2 4.31 39.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 109.992 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.468 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 4.8 mtt85 52.82 35.66 19.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.569 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.771 ' HB2' HG13 ' A' ' 69' ' ' VAL . 1.8 mm? -57.59 167.58 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.879 -1.138 . . . . 0.0 108.715 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.568 ' HB3' HG23 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -130.23 117.03 17.8 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.996 -1.065 . . . . 0.0 109.73 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.86 123.29 5.71 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.488 2.125 . . . . 0.0 110.506 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.863 HG22 ' O ' ' A' ' 130' ' ' PHE . 14.8 t -105.91 128.35 53.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.354 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -100.46 2.08 41.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 109.847 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 12.3 t80 -120.87 124.75 45.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.068 -1.02 . . . . 0.0 109.529 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 178.3 31.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.71 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -62.61 -46.78 86.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 109.349 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.13 -23.1 9.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.366 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 m -72.0 -32.65 67.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 0.0 109.656 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 2.2 t80 -60.14 -43.92 95.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.942 . . . . 0.0 109.808 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtt -60.18 -50.79 72.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.333 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -60.03 -36.54 77.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.042 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.632 ' CD1' ' CB ' ' A' ' 138' ' ' PRO . 8.9 m-85 -74.96 -23.84 58.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.102 -0.999 . . . . 0.0 109.686 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.3 -29.03 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.021 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.57 -36.91 25.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.233 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.98 -31.19 74.84 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.604 ' CZ ' ' HG3' ' A' ' 141' ' ' MET . 2.2 t80 -81.18 -39.32 25.66 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.16 -1.2 . . . . 0.0 109.077 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -47.46 84.4 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.113 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -39.34 93.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.312 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.52 -47.31 73.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.221 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.537 HD11 ' HE1' ' A' ' 91' ' ' TYR . 47.5 mm -66.33 -32.08 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.33 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -36.06 71.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.889 -1.132 . . . . 0.0 108.577 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.72 -49.8 23.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.404 -0.81 . . . . 0.0 109.952 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -54.19 -34.69 61.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.064 -1.023 . . . . 0.0 109.708 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.535 ' HB2' HG22 ' A' ' 107' ' ' VAL . 61.3 mt -73.93 -35.52 64.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.102 -0.999 . . . . 0.0 109.12 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -22.23 65.05 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.147 -0.971 . . . . 0.0 109.287 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.01 -41.42 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 110.119 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 t -145.4 47.34 1.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.937 -1.102 . . . . 0.0 110.292 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 1.9 m-20 174.65 72.98 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.38 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.56 -43.31 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.7 2.267 . . . . 0.0 110.682 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.408 ' O ' HG22 ' A' ' 109' ' ' VAL . 4.9 mt-10 -72.27 -12.89 61.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.849 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.501 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -93.21 -7.57 44.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.139 -0.976 . . . . 0.0 109.799 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 71.0 t -67.16 -44.14 47.79 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 111.14 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.9 Cg_endo -76.54 -54.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.866 1.71 . . . . 0.0 110.979 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 0.8 OUTLIER -59.78 -34.21 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.076 -1.015 . . . . 0.0 109.68 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.475 ' CB ' ' O ' ' A' ' 106' ' ' ARG . 93.4 t80 -68.95 -43.44 75.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.955 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -31.17 71.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 109.814 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -71.82 -49.37 39.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.553 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -68.92 -51.36 40.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.17 -0.956 . . . . 0.0 110.391 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.921 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -54.4 -26.95 33.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.881 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.11 -39.0 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.454 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.74 -49.96 51.52 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.413 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.44 -30.68 68.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -1.108 . . . . 0.0 109.582 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 114' ' ' ALA . 78.5 t -63.69 -41.1 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.64 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.84 -37.23 79.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.118 -0.989 . . . . 0.0 109.798 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -61.79 -60.12 4.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.829 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 117' ' ' PHE . 1.9 mp -56.38 -48.32 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 109.766 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 52.8 mt -46.91 -35.17 6.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.129 -0.982 . . . . 0.0 109.695 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -45.74 -48.94 15.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.802 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.6 57.35 1.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 109.664 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 1.9 p90 -55.63 -20.53 14.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.628 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.438 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -71.35 -45.61 62.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.759 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -73.41 -26.34 60.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -78.03 -25.13 47.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.421 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 60.04 170.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.541 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.863 ' O ' HG22 ' A' ' 77' ' ' THR . 2.1 m-85 -133.16 122.02 23.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 108.872 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.63 ' O ' HG13 ' A' ' 142' ' ' VAL . 14.7 m-85 -101.25 166.92 10.52 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.146 -0.971 . . . . 0.0 110.391 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.568 HG23 ' HB3' ' A' ' 75' ' ' SER . 3.6 tt -152.06 135.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.636 -0.665 . . . . 0.0 109.516 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.1 173.61 0.36 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -66.18 -23.98 66.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -1.113 . . . . 0.0 109.499 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.2 OUTLIER -59.27 -35.2 73.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.177 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.464 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER 71.68 53.05 0.22 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 109.61 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.531 ' N ' HD11 ' A' ' 132' ' ' ILE . 1.9 t70 -130.6 134.01 25.52 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.363 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.632 ' CB ' ' CD1' ' A' ' 87' ' ' TYR . 34.4 Cg_endo -75.1 -0.21 9.73 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.345 2.03 . . . . 0.0 110.374 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.603 ' O ' HG21 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -103.11 7.86 38.75 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 109.008 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 141' ' ' MET . . . -106.14 17.74 23.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.914 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.604 ' HG3' ' CZ ' ' A' ' 91' ' ' TYR . 7.9 ttm 74.45 148.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.037 -1.039 . . . . 0.0 110.274 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 131' ' ' TYR . 16.5 t -114.38 139.3 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 109.226 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.71 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.7 t -105.73 125.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.062 -1.024 . . . . 0.0 109.602 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -106.21 149.4 26.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.921 . . . . 0.0 109.069 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.502 ' HB3' ' HB3' ' A' ' 156' ' ' MET . 12.9 ptp -146.1 147.34 31.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.0 . . . . 0.0 109.744 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -156.18 161.64 40.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.911 . . . . 0.0 109.424 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.4 139.29 58.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.947 . . . . 0.0 109.374 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.441 ' CD ' HG22 ' A' ' 153' ' ' THR . 15.4 ptm180 -70.38 -170.28 0.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 109.616 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -27.82 68.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.923 . . . . 0.0 109.672 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 152' ' ' ILE . 1.2 m-20 -75.79 -14.9 60.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 56.36 22.68 38.56 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.804 HD12 ' HB ' ' A' ' 153' ' ' THR . 2.7 pp -110.0 -29.26 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -1.136 . . . . 0.0 109.795 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.804 ' HB ' HD12 ' A' ' 152' ' ' ILE . 5.9 t -138.22 134.68 17.85 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.014 . . . . 0.0 109.812 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.46 ' HG3' ' SD ' ' A' ' 34' ' ' MET . 36.7 Cg_endo -81.07 151.89 18.44 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.664 2.242 . . . . 0.0 110.332 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -145.17 133.66 21.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.448 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.617 ' HG3' ' CE1' ' A' ' 158' ' ' PHE . 0.0 OUTLIER -105.8 155.41 19.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.296 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.428 HG22 ' HB ' ' A' ' 27' ' ' VAL . 2.5 mt -118.16 154.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.771 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.71 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 49.9 m-85 -133.12 164.16 27.64 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.483 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 97.6 m-85 -107.88 121.12 44.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 0.0 109.426 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -59.19 -32.76 70.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 110.036 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 5.2 p30 -44.42 -28.26 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 109.683 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . -130.89 58.17 0.71 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 5' ' ' LYS . 4.4 mt -153.92 138.14 16.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -1.198 . . . . 0.0 109.506 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.572 HG13 ' CG2' ' A' ' 7' ' ' VAL . 2.0 m -119.03 130.94 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 109.791 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.8 p -85.74 125.85 33.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.253 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.77 142.11 45.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.868 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.441 ' HA ' HD22 ' A' ' 2' ' ' LEU . 4.6 tppt? -102.41 126.45 49.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 109.062 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 167' ' ' LYS . 7.4 p90 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.686 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 166' ' ' GLU . 0.3 OUTLIER -68.49 143.64 54.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.222 -0.924 . . . . 0.0 110.069 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 2' ' ' LEU . 21.8 mt -115.43 128.21 55.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.632 -0.668 . . . . 0.0 109.482 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.742 ' CD2' HD21 ' A' ' 163' ' ' LEU . 4.4 m-85 -104.27 132.08 50.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.325 -0.859 . . . . 0.0 109.419 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 9.6 pttt -146.89 164.63 32.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.735 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 162' ' ' GLY . 44.1 t0 -87.65 146.66 25.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.298 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.71 -12.38 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.586 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.871 HG21 ' HA ' ' A' ' 140' ' ' ALA . 29.4 mm -54.59 -69.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.507 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -99.37 -51.76 3.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.392 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 95.46 1.68 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 4.5 p30 -170.53 153.85 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.178 -1.19 . . . . 0.0 109.526 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 3.7 mm-40 -71.29 118.57 14.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.252 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.84 -41.88 3.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 109.496 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.839 HG21 ' HB2' ' A' ' 30' ' ' ALA . 2.3 p -153.18 169.26 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.603 ' N ' HG22 ' A' ' 14' ' ' VAL . 51.8 p -153.64 177.7 10.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.975 -1.078 . . . . 0.0 110.419 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.1 6.77 17.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.419 -0.801 . . . . 0.0 109.783 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.04 -8.4 44.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.145 -0.972 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 19' ' ' ASP . 52.6 m-85 -126.54 19.14 7.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.432 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER 61.46 120.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 37.3 mt -111.82 138.73 48.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.168 -0.957 . . . . 0.0 110.45 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -119.58 136.61 54.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.602 -0.687 . . . . 0.0 109.462 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 1.4 tt0 -99.81 115.98 30.84 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.247 -0.908 . . . . 0.0 108.881 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.519 HG22 ' OE2' ' A' ' 29' ' ' GLU . 6.4 t -70.82 158.92 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 109.48 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' VAL . 21.9 t0 -39.22 -39.97 0.68 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.507 -0.745 . . . . 0.0 109.568 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.88 -143.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 108.834 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.564 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -125.98 62.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.031 -1.043 . . . . 0.0 109.244 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.535 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 16.4 m -138.49 150.97 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.543 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -104.7 157.07 17.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.519 ' OE2' HG22 ' A' ' 23' ' ' VAL . 80.4 mt-10 -122.86 117.47 25.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.422 -0.799 . . . . 0.0 109.079 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.839 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -113.54 115.45 28.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.48 150.09 45.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.9 p -143.55 158.37 43.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.394 -0.816 . . . . 0.0 109.207 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.43 157.78 17.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.484 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.7 mtp -108.06 121.97 45.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.332 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.2 m -119.46 160.67 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 0.0 109.573 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.6 138.53 39.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.92 . . . . 0.0 109.677 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 m -125.18 141.67 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.62 106.64 17.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.427 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -71.53 160.52 32.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.402 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 41' ' ' GLY . . . -122.27 74.21 0.37 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 40' ' ' GLY . . . -49.37 179.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.97 -12.65 54.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -1.161 . . . . 0.0 109.587 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -117.75 -66.56 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.942 . . . . 0.0 109.562 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 18.4 m-20 60.43 -100.39 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.431 -0.793 . . . . 0.0 109.616 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 45' ' ' ILE . 3.8 tp 177.95 43.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 0.0 109.415 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 45' ' ' ILE . . . -50.83 -99.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.27 -90.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -1.147 . . . . 0.0 109.392 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 46' ' ' GLY . 10.4 p30 -110.48 146.85 35.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.363 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.38 -2.69 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.623 2.215 . . . . 0.0 110.459 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -129.57 -161.89 1.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.542 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 62.96 -136.93 0.41 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.0 109.295 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 51' ' ' ALA . 12.3 mt-10 -41.92 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.085 -1.01 . . . . 0.0 109.883 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 51' ' ' ALA . 18.0 t0 -119.49 -26.55 5.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.302 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.562 ' O ' ' CB ' ' A' ' 55' ' ' GLU . . . 51.53 -90.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 109.619 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 83.89 -50.25 0.13 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.788 -0.57 . . . . 0.0 109.703 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -110.23 -177.97 3.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -0.945 . . . . 0.0 109.578 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 m120 62.0 104.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 109.724 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.25 129.19 17.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.203 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.81 29.52 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.512 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.4 -89.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.5 32.44 2.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 p -85.29 122.55 29.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.015 -1.285 . . . . 0.0 109.332 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.01 151.98 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.501 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.33 131.76 34.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.885 . . . . 0.0 109.726 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 m -117.03 134.74 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.9 . . . . 0.0 109.571 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.545 ' HB2' HG23 ' A' ' 69' ' ' VAL . 34.9 m120 -69.86 134.81 48.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 28.9 p-10 -56.18 -24.41 41.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.825 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' A' ' 72' ' ' PHE . 58.4 tp -82.06 -34.85 29.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 108.953 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.847 HG13 ' CB ' ' A' ' 74' ' ' LEU . 53.5 t -66.36 -55.33 19.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.487 -0.758 . . . . 0.0 109.751 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -66.46 -42.88 86.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 0.0 110.224 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.1 m -55.94 -46.03 78.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.044 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.565 ' CE2' HD11 ' A' ' 68' ' ' LEU . 16.4 m-30 -100.43 18.82 18.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.483 ' O ' HD22 ' A' ' 74' ' ' LEU . 18.9 ttm105 49.3 89.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 109.479 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.847 ' CB ' HG13 ' A' ' 69' ' ' VAL . 1.9 mm? -117.4 143.06 46.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.326 -0.859 . . . . 0.0 109.049 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.728 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -121.43 143.36 37.52 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 109.741 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 36.7 Cg_endo -79.89 139.91 14.09 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.677 2.252 . . . . 0.0 110.467 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.0 t -122.05 135.39 54.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.231 -0.918 . . . . 0.0 109.257 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 t -114.45 145.58 41.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.925 . . . . 0.0 109.717 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CZ ' ' CD2' ' A' ' 130' ' ' PHE . 5.1 p90 -172.29 -177.6 1.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 82' ' ' LYS . 21.2 p-10 -101.07 169.13 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.023 . . . . 0.0 109.606 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -53.69 -47.78 70.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.0 109.913 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.464 ' HB2' ' OD2' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -50.37 -35.69 29.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.778 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.461 ' HB2' ' OD1' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -71.9 -36.94 70.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.772 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 1.6 t80 -63.51 -47.41 81.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.827 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -40.97 91.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.936 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.03 -28.57 66.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.977 . . . . 0.0 109.911 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 138' ' ' PRO . 3.2 m-85 -70.12 -47.25 62.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 109.625 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 92' ' ' MET . 6.3 tp -74.17 -15.98 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.398 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.17 -59.77 2.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.2 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.61 -26.57 72.92 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.598 ' CE1' HD11 ' A' ' 95' ' ' ILE . 4.5 t80 -72.46 -36.1 68.4 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -63.44 -43.33 97.72 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -58.14 -45.36 87.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.36 -0.838 . . . . 0.0 109.001 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.52 71.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 108.768 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.697 HG21 ' CE2' ' A' ' 110' ' ' PHE . 27.0 mm -56.04 -30.44 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 0.0 109.026 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.584 ' HD2' HG13 ' A' ' 107' ' ' VAL . 0.3 OUTLIER -54.18 -47.29 72.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.57 -30.82 64.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.757 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.515 ' CZ ' ' O ' ' A' ' 161' ' ' ASP . 3.8 tmt_? -60.7 -44.92 95.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 109.898 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 106' ' ' ARG . 14.2 mt -72.33 -49.75 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.158 -0.964 . . . . 0.0 109.784 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.4 -26.17 40.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.955 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -79.76 -45.11 19.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 0.0 109.199 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p -95.86 -70.37 0.72 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.447 ' HB3' ' NH2' ' A' ' 106' ' ' ARG . 12.9 t-20 -123.38 118.13 27.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.452 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.8 -29.03 9.02 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.403 2.069 . . . . 0.0 110.675 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.448 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 3.0 mt-10 -70.28 -6.64 36.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.64 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HB3' HD13 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -88.71 -3.34 58.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 0.0 109.878 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 59.1 t -72.34 -43.79 9.85 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 111.171 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.4 Cg_endo -77.86 -50.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.824 1.683 . . . . 0.0 110.902 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 110' ' ' PHE . 3.9 p -60.59 -46.84 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.72 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.697 ' CE2' HG21 ' A' ' 95' ' ' ILE . 73.3 t80 -67.66 -37.4 82.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -0.783 . . . . 0.0 110.401 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 6.2 tm-20 -59.47 -49.66 76.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.06 -1.025 . . . . 0.0 110.451 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -64.82 -44.05 91.12 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.11 -0.994 . . . . 0.0 110.281 -179.273 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -61.2 -32.5 72.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.937 -1.102 . . . . 0.0 110.007 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.75 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -64.22 -51.0 65.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 111.367 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.88 HD12 ' N ' ' A' ' 116' ' ' GLY . 1.7 pp -62.94 -45.79 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.769 -1.207 . . . . 0.0 110.576 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.88 ' N ' HD12 ' A' ' 115' ' ' ILE . . . -59.06 -40.14 95.21 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.487 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -73.03 -30.24 63.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -1.16 . . . . 0.0 109.871 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 114' ' ' ALA . 69.2 t -65.65 -43.95 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.896 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.517 ' C ' ' CD ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -71.84 -32.06 67.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.627 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -28.65 61.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 109.999 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 117' ' ' PHE . 1.2 mp -79.55 -30.68 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.998 -1.064 . . . . 0.0 108.977 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 122' ' ' LEU . 23.2 mt -58.93 -26.19 64.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.897 . . . . 0.0 109.621 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 122' ' ' LEU . . . -43.89 -39.61 4.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.843 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 128' ' ' TYR . 2.6 m-20 -143.82 58.67 1.37 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 109.804 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 4.6 p90 -62.59 -35.03 78.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.417 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.495 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -76.36 -26.37 55.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.71 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 2.8 t70 -77.52 -27.69 51.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 109.516 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 128' ' ' TYR . 1.6 m-30 -100.04 -1.57 36.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.07 -159.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 109.465 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 79' ' ' PHE . 68.5 m-85 -147.97 121.71 9.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 69' ' ' VAL . 11.9 m-85 -98.6 168.15 10.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.961 . . . . 0.0 110.296 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.815 ' O ' HD13 ' A' ' 74' ' ' LEU . 2.1 tt -150.7 146.54 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.408 -0.807 . . . . 0.0 109.437 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.75 168.44 46.65 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 135' ' ' SER . 0.2 OUTLIER -57.45 -21.21 35.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -1.159 . . . . 0.0 109.368 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 136' ' ' MET . 49.9 m -62.58 -41.71 99.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 75.41 41.81 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 109.691 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.25 129.39 24.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.148 -0.97 . . . . 0.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 87' ' ' TYR . 33.3 Cg_endo -75.13 -13.35 21.17 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.322 2.015 . . . . 0.0 110.306 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -97.25 8.29 44.85 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 108.953 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.871 ' HA ' HG21 ' A' ' 8' ' ' ILE . . . -92.26 -161.81 0.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.347 -0.846 . . . . 0.0 109.489 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.444 ' SD ' ' O ' ' A' ' 162' ' ' GLY . 2.6 ttp -88.82 145.68 25.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.676 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.96 141.05 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.285 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.535 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.1 t -109.79 136.46 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.87 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 128' ' ' TYR . 53.0 mt -107.7 151.24 25.94 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.813 . . . . 0.0 108.976 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.82 134.98 50.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.632 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -155.03 143.3 20.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.38 -0.825 . . . . 0.0 109.292 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.433 ' CD1' ' HA2' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -65.41 160.41 22.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.313 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 153' ' ' THR . 0.0 OUTLIER -58.49 173.58 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.15 -17.28 39.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -107.36 -47.35 3.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -0.978 . . . . 0.0 109.364 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.433 ' HA2' ' CD1' ' A' ' 147' ' ' TYR . . . 120.28 29.17 1.66 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.76 -38.87 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -1.075 . . . . 0.0 109.279 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 148' ' ' ARG . 14.8 t -137.43 142.11 36.18 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.069 -1.019 . . . . 0.0 109.713 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 153' ' ' THR . 36.5 Cg_endo -79.35 146.71 19.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.665 2.244 . . . . 0.0 110.447 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -145.13 160.24 41.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.387 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.501 ' HB2' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -122.17 159.06 28.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.336 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 27' ' ' VAL . 36.8 mt -113.29 136.26 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.672 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.535 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 48.1 m-85 -123.74 118.22 26.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.03 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -50.07 119.5 3.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.096 -1.002 . . . . 0.0 109.565 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 161' ' ' ASP . 18.8 tptp -67.34 -42.09 84.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.341 -0.849 . . . . 0.0 109.526 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.562 ' OD2' HD21 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -44.11 -38.85 3.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.22 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.446 ' O ' ' OD1' ' A' ' 6' ' ' ASP . . . -108.8 52.73 0.63 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.742 HD21 ' CD2' ' A' ' 4' ' ' TYR . 7.9 tt -151.17 149.44 29.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -1.123 . . . . 0.0 109.405 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 165' ' ' SER . 0.6 OUTLIER -138.0 157.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.901 . . . . 0.0 109.61 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' A' ' 164' ' ' VAL . 0.7 OUTLIER -111.02 120.88 43.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.675 . . . . 0.0 109.458 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.579 ' O ' HD13 ' A' ' 2' ' ' LEU . 2.9 tt0 -108.11 147.2 31.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.428 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.07 116.02 28.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 0.0 109.329 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.447 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' O ' HD23 ' A' ' 2' ' ' LEU . 6.2 ptt? . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 167' ' ' LYS . 11.9 mt -121.27 149.07 43.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.631 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 3' ' ' LEU . 23.4 mt -101.4 122.91 44.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.555 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.585 ' CB ' HG13 ' A' ' 14' ' ' VAL . 6.2 m-85 -106.42 118.8 37.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.866 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 0.7 OUTLIER -129.67 141.13 50.97 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.8 ' OD1' HD11 ' A' ' 13' ' ' LEU . 12.2 p-10 -167.36 110.14 0.66 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.074 -1.016 . . . . 0.0 110.183 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.515 HG12 ' HB1' ' A' ' 140' ' ' ALA . 20.9 t -147.77 48.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER 62.12 15.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.9 t -163.96 -34.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.571 -0.706 . . . . 0.0 109.596 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.46 100.29 2.61 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 12' ' ' GLU . 51.8 t0 -130.08 -78.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.763 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.546 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER 161.61 113.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 109.408 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.978 HD12 ' N ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -146.51 -31.31 0.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.136 -0.977 . . . . 0.0 110.817 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.978 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.3 p -134.97 174.12 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.723 -1.235 . . . . 0.0 109.06 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.624 ' C ' HD11 ' A' ' 20' ' ' LEU . 36.2 m -164.49 -174.73 3.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.021 . . . . 0.0 110.404 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.05 12.89 6.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.568 -0.708 . . . . 0.0 109.711 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.04 -17.03 64.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.955 . . . . 0.0 109.053 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.561 ' CE2' HD13 ' A' ' 68' ' ' LEU . 56.7 m-85 -118.37 19.49 13.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.462 -0.774 . . . . 0.0 109.169 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 18' ' ' TYR . 8.6 t0 63.33 120.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 30' ' ' ALA . 10.0 mt -113.71 153.11 29.53 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.2 -0.938 . . . . 0.0 110.359 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -129.41 141.21 51.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.496 -0.752 . . . . 0.0 109.177 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.512 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 1.5 mt-10 -93.97 128.55 40.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.938 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 t -80.07 153.44 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.841 . . . . 0.0 109.589 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.01 -17.14 6.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.761 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 26' ' ' ILE . 8.5 m-20 -81.61 -100.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.619 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -164.53 60.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 0.0 109.41 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 159' ' ' PHE . 14.7 m -152.28 164.02 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 110.179 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.512 ' CE1' ' HG3' ' A' ' 22' ' ' GLU . 7.2 m-85 -104.34 157.85 16.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.419 -0.8 . . . . 0.0 108.858 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 19.6 mt-10 -127.07 118.59 24.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.961 . . . . 0.0 109.314 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.696 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -114.71 112.44 22.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.009 -1.057 . . . . 0.0 109.062 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 13.9 t0 -79.87 150.24 30.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 p -129.26 -174.5 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -141.15 141.71 34.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.318 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.466 ' CG ' ' O ' ' A' ' 34' ' ' MET . 7.6 ptm -91.22 123.94 35.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.535 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.3 m -121.57 160.13 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.442 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.34 121.78 34.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.405 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.5 m -121.13 138.47 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.587 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -71.19 93.5 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -119.14 139.21 52.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.313 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.69 -54.35 0.05 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.77 -119.03 6.1 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -117.13 -9.37 11.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.219 -1.165 . . . . 0.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 44' ' ' ASP . 68.7 t -119.11 -92.98 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.488 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.597 ' N ' HG12 ' A' ' 43' ' ' VAL . 3.3 t70 44.75 52.78 7.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 109.282 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 45' ' ' ILE . 6.8 tp -123.2 14.11 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.691 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.56 52.54 0.17 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' A' ' 48' ' ' ASN . . . -132.02 151.39 51.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -1.151 . . . . 0.0 109.325 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.452 ' C ' ' O ' ' A' ' 47' ' ' ALA . 1.4 p-10 40.84 78.55 0.37 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.447 -0.783 . . . . 0.0 109.469 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.62 -7.75 15.79 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.744 2.296 . . . . 0.0 110.711 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 56.27 -167.05 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.537 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.525 ' HB1' ' OE2' ' A' ' 52' ' ' GLU . . . -134.0 -73.15 0.49 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.883 . . . . 0.0 109.421 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.525 ' OE2' ' HB1' ' A' ' 51' ' ' ALA . 3.8 mp0 -109.79 18.61 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.341 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 t70 55.97 -177.44 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.344 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 55' ' ' GLU . . . -115.89 -8.16 11.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.463 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 14.5 tt0 72.03 48.14 0.28 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.298 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -147.7 -80.73 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.242 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -97.27 128.64 44.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.32 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.71 -98.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.312 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.48 ' C ' ' CG ' ' A' ' 60' ' ' GLU . 5.3 tp10 -172.62 -74.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 109.447 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' CG ' ' C ' ' A' ' 59' ' ' GLU . 1.4 pt-20 39.18 43.11 0.83 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.457 -0.777 . . . . 0.0 109.851 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.81 69.38 1.4 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 59' ' ' GLU . 20.5 p -142.65 126.99 17.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -1.096 . . . . 0.0 109.46 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -126.16 142.92 51.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.364 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.54 135.45 36.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.963 . . . . 0.0 109.451 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASN . 17.7 m -132.95 131.64 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.454 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 22.9 m120 -45.2 153.74 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.473 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -88.82 -28.1 20.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.694 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.561 HD13 ' CE2' ' A' ' 18' ' ' TYR . 12.1 tp -78.39 -45.07 23.3 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.054 -1.029 . . . . 0.0 108.407 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.865 HG13 ' CB ' ' A' ' 74' ' ' LEU . 33.4 t -63.82 -54.62 29.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 70' ' ' TYR . 15.8 t80 -55.57 -32.55 63.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.177 -0.952 . . . . 0.0 109.533 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m -70.09 -38.08 75.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.851 . . . . 0.0 110.061 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.564 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 43.2 m-85 -104.35 10.32 35.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.015 -1.053 . . . . 0.0 110.142 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 4.1 tpp180 60.24 25.25 14.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.062 -1.024 . . . . 0.0 109.984 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.865 ' CB ' HG13 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -43.5 137.76 2.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.511 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.959 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -107.58 119.11 51.58 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.68 134.52 12.26 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.343 2.029 . . . . 0.0 110.104 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 179.82 5.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.088 -1.008 . . . . 0.0 109.742 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.97 132.09 37.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.494 -0.754 . . . . 0.0 109.146 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 30.5 p90 -124.81 161.54 26.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.682 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -89.43 150.32 22.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -53.27 -32.8 50.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.136 -0.978 . . . . 0.0 110.039 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -87.45 -25.74 23.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 110.138 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -71.11 -38.18 72.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.118 -0.988 . . . . 0.0 109.855 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.478 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 3.8 t80 -68.48 -35.38 77.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.562 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.761 ' O ' HG22 ' A' ' 88' ' ' ILE . 7.5 mtm -64.06 -56.03 17.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.9 p -58.87 -37.71 77.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -74.87 -19.5 60.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 85' ' ' MET . 0.2 OUTLIER -75.16 -31.96 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.866 . . . . 0.0 108.845 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 3.4 mttt -70.82 -53.97 13.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.462 -0.773 . . . . 0.0 109.345 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.16 -24.02 73.23 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -75.36 -36.84 60.91 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.153 -1.204 . . . . 0.0 108.235 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -48.36 66.17 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.549 -0.719 . . . . 0.0 109.148 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 89' ' ' LYS . 28.3 mmtm -55.2 -41.26 71.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.334 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.54 -42.58 71.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 109.137 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.883 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 28.3 mm -70.66 -26.6 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.319 -0.863 . . . . 0.0 109.26 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.46 -34.29 75.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.959 . . . . 0.0 108.684 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.27 -47.94 46.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.559 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -56.9 -32.94 66.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.989 . . . . 0.0 109.433 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.932 HD22 ' HB3' ' A' ' 106' ' ' ARG . 86.9 mt -73.0 -41.93 63.77 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.255 -0.903 . . . . 0.0 109.326 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -33.93 73.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.384 -0.823 . . . . 0.0 109.556 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -73.15 -39.25 65.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.557 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.6 p -90.97 -82.4 0.29 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.12 123.82 26.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.381 -0.824 . . . . 0.0 109.055 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.61 -26.45 11.73 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.401 2.067 . . . . 0.0 110.661 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.21 -7.11 39.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.614 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.932 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -92.29 1.74 57.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.618 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 14.3 t -69.83 -46.43 24.13 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 110.252 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.9 Cg_endo -78.26 -36.6 0.95 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.02 1.813 . . . . 0.0 110.673 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.69 -51.15 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.995 . . . . 0.0 109.592 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.883 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 6.5 t80 -65.31 -37.72 88.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.919 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.785 ' O ' HD12 ' A' ' 115' ' ' ILE . 1.2 mt-10 -64.56 -35.51 81.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 109.953 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -71.75 -41.02 68.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.497 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -69.52 -54.54 13.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.077 -1.014 . . . . 0.0 110.374 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.702 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -58.92 -27.17 65.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 109.972 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -60.17 -49.11 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.338 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 115' ' ' ILE . . . -67.26 -40.76 92.15 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.628 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -61.26 -30.76 70.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -1.128 . . . . 0.0 110.177 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 114' ' ' ALA . 69.4 t -67.14 -41.74 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 110.391 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -69.3 -44.13 72.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.047 -1.033 . . . . 0.0 110.027 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -57.04 -52.28 65.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.172 -0.955 . . . . 0.0 110.039 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.825 HG12 HD13 ' A' ' 144' ' ' LEU . 1.6 mp -58.18 -44.54 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.08 -1.012 . . . . 0.0 109.323 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.11 -30.42 64.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.25 -46.32 54.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.729 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 124' ' ' ASN . 2.4 p-10 -143.5 57.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 109.698 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 126' ' ' LYS . 21.9 p90 -51.79 -25.61 7.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 109.815 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.2 mmtt -61.96 -44.84 95.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 109.676 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -79.06 -23.01 44.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.618 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.595 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 2.8 m-85 -76.05 -20.32 57.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 109.751 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.8 OUTLIER 49.6 -177.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 110.029 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.491 ' CD2' HG11 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -142.91 121.38 12.42 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.479 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.799 ' O ' HG13 ' A' ' 142' ' ' VAL . 18.4 m-85 -108.9 176.93 4.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.03 -1.044 . . . . 0.0 110.869 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.959 HG22 ' O ' ' A' ' 75' ' ' SER . 1.6 tt -155.54 150.88 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.561 -0.712 . . . . 0.0 109.556 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.72 -176.68 43.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -18.85 63.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -1.205 . . . . 0.0 109.429 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 m -64.47 -37.06 86.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.259 -0.901 . . . . 0.0 109.461 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.447 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER 62.23 43.79 8.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.764 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -98.65 127.26 36.24 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.72 -1.55 11.5 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.291 1.994 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -115.03 10.95 16.34 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.344 -0.848 . . . . 0.0 109.003 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.515 ' HB1' HG12 ' A' ' 7' ' ' VAL . . . -100.95 -177.38 3.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.266 -0.896 . . . . 0.0 109.6 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -83.49 142.32 31.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.535 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 131' ' ' TYR . 41.1 t -108.45 141.48 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 0.0 109.65 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.461 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 21.8 t -92.04 122.97 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.313 -0.867 . . . . 0.0 108.932 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.825 HD13 HG12 ' A' ' 121' ' ' ILE . 1.1 mt -90.24 124.53 34.95 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.288 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.584 ' CE ' ' CE ' ' A' ' 156' ' ' MET . 53.5 ttm -104.93 128.47 53.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.595 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 52.6 t30 -147.01 165.24 30.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.54 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -84.47 157.78 21.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.405 ' HG3' ' CD1' ' A' ' 155' ' ' TYR . 2.8 mtt85 -87.77 176.12 7.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.187 -0.945 . . . . 0.0 109.214 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.18 -13.93 51.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.22 -0.925 . . . . 0.0 109.137 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.3 -60.8 3.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.326 -0.859 . . . . 0.0 109.096 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 131.61 -27.02 3.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -133.95 37.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -1.175 . . . . 0.0 109.421 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.2 m -129.03 100.58 20.48 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.368 -0.833 . . . . 0.0 109.358 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.74 127.16 6.2 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.534 2.156 . . . . 0.0 110.481 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.405 ' CD1' ' HG3' ' A' ' 148' ' ' ARG . 26.0 p90 -145.03 159.42 42.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.584 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -129.68 142.72 50.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.278 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.5 mt -102.4 148.45 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.579 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.657 ' CE2' HD13 ' A' ' 13' ' ' LEU . 54.9 m-85 -127.17 118.66 24.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 109.36 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.468 ' HA ' HG12 ' A' ' 27' ' ' VAL . 43.8 m-85 -53.51 119.52 4.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.653 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 26' ' ' ILE . 7.8 tptt -66.7 -38.06 85.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.74 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.438 ' OD1' ' HB3' ' A' ' 159' ' ' PHE . 1.4 p-10 -44.76 -48.81 10.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.642 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 6' ' ' ASP . . . -104.71 50.21 0.86 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 164' ' ' VAL . 6.9 tt -145.18 155.17 43.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -1.194 . . . . 0.0 109.3 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.809 ' N ' HD23 ' A' ' 163' ' ' LEU . 4.3 m -144.2 135.52 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.973 . . . . 0.0 109.818 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.0 m -99.02 137.96 36.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.079 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -127.12 139.09 53.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.782 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.508 ' HA ' HD22 ' A' ' 2' ' ' LEU . 5.5 ttmt -78.58 125.27 29.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 109.35 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.497 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.9 165.82 14.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.586 HD12 ' HA ' ' A' ' 168' ' ' PHE . 82.6 mt -120.99 135.31 55.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.62 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.586 ' CD2' HD21 ' A' ' 163' ' ' LEU . 68.6 m-85 -121.54 133.02 55.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.833 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -135.07 153.59 51.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.832 . . . . 0.0 109.366 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 41.9 t0 -61.78 148.11 44.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.506 ' CG2' HG13 ' A' ' 164' ' ' VAL . 18.5 t -91.2 53.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.898 . . . . 0.0 109.434 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.594 HG22 ' N ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -163.76 -54.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.084 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.594 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER 177.81 64.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.496 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.729 ' HA3' HD13 ' A' ' 13' ' ' LEU . . . -111.1 -18.74 8.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.5 OUTLIER 45.98 87.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -1.187 . . . . 0.0 109.234 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.402 ' HG3' ' C ' ' A' ' 11' ' ' ASP . 2.9 mt-10 58.18 102.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.121 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.729 HD13 ' HA3' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -117.25 -55.78 2.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.556 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.783 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 7.9 p -140.19 164.25 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 108.942 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.547 ' N ' HG22 ' A' ' 14' ' ' VAL . 53.9 p -153.24 172.12 17.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.54 2.32 29.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.484 -0.76 . . . . 0.0 109.759 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.78 -10.24 45.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.102 -0.999 . . . . 0.0 109.035 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.662 ' CD2' HD11 ' A' ' 68' ' ' LEU . 34.7 m-85 -123.42 19.47 9.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.366 -0.834 . . . . 0.0 109.157 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 0.6 OUTLIER 61.62 128.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.348 -0.845 . . . . 0.0 108.925 -179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 30' ' ' ALA . 65.3 mt -118.91 151.17 38.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.129 -0.982 . . . . 0.0 110.139 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -133.66 122.86 24.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 109.492 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.52 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -80.97 121.24 25.78 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.271 -0.893 . . . . 0.0 108.733 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 24' ' ' ASP . 6.6 t -77.38 154.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.716 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' VAL . 6.9 m-20 -42.77 -32.0 0.55 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.818 . . . . 0.0 109.542 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 26' ' ' ILE . 39.9 m-20 -70.6 -116.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -153.77 63.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.734 -1.229 . . . . 0.0 109.483 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 159' ' ' PHE . 16.6 m -152.36 144.21 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.127 -0.983 . . . . 0.0 109.757 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 3.7 m-85 -98.95 134.19 42.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 108.851 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -108.78 138.26 45.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.989 -1.069 . . . . 0.0 109.967 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.783 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -116.17 113.98 23.82 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -65.74 150.15 48.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 0.0 109.689 -179.578 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.6 t -102.94 146.82 27.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.0 150.75 50.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.147 -0.971 . . . . 0.0 109.642 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.527 ' HG2' ' CG2' ' A' ' 64' ' ' THR . 0.0 OUTLIER -89.52 133.09 34.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 m -128.08 120.81 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.287 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 t -76.74 151.16 36.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.94 . . . . 0.0 109.586 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.9 m -137.03 131.65 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.312 -0.867 . . . . 0.0 109.44 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.585 ' HA ' HG22 ' A' ' 62' ' ' THR . 31.0 mttt -77.47 128.92 35.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.648 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -102.06 150.45 23.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 109.331 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.22 15.96 61.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.85 57.23 4.65 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -161.87 71.84 0.37 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -1.154 . . . . 0.0 109.459 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -51.88 -72.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.214 -0.929 . . . . 0.0 109.377 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -100.52 118.38 36.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.452 -0.78 . . . . 0.0 109.577 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.659 ' O ' HG23 ' A' ' 45' ' ' ILE . 6.9 tp -146.93 72.19 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.82 142.52 16.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 57' ' ' ASN . . . -160.29 127.23 4.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -1.167 . . . . 0.0 109.51 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.518 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 1.4 m-80 43.28 62.42 8.87 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 48' ' ' ASN . 35.8 Cg_endo -78.03 75.85 4.64 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.786 2.324 . . . . 0.0 110.424 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.8 42.02 1.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.482 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 59.65 52.14 5.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 53' ' ' ASP . 12.5 mt-10 -97.91 18.84 14.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.511 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 52' ' ' GLU . 11.5 t70 61.13 134.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 0.0 109.65 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.37 -170.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 109.82 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 1.6 pp20? -114.04 170.07 8.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.62 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 2.1 mt-10 164.66 166.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.548 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 8.9 t30 62.18 130.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.333 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.571 ' HB1' HD11 ' A' ' 45' ' ' ILE . . . -171.59 -78.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -151.38 -60.77 0.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.506 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -77.36 -80.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 62' ' ' THR . . . 106.62 77.21 1.06 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 38' ' ' LYS . 17.8 p 43.73 -167.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.113 . . . . 0.0 109.683 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HG2' ' C ' ' A' ' 62' ' ' THR . 65.3 mm-40 -145.56 146.22 31.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.527 ' CG2' ' HG2' ' A' ' 34' ' ' MET . 0.0 OUTLIER -99.89 134.26 43.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 109.446 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.54 146.62 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.406 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 77.5 m-20 -54.46 148.56 11.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.57 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 21.0 p30 -99.32 -21.77 15.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 109.333 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.662 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -82.86 -42.78 17.38 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 74' ' ' LEU . 87.8 t -72.37 -35.19 51.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.475 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 2.1 t80 -69.38 -58.25 4.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.906 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 t -56.93 -52.54 64.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.939 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 11.1 m-85 -83.17 -3.47 57.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 109.633 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.518 ' CA ' ' O ' ' A' ' 69' ' ' VAL . 11.4 tpt180 53.63 34.39 18.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 109.545 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.536 ' HB2' HG13 ' A' ' 69' ' ' VAL . 11.8 mt -42.77 142.36 0.89 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.84 . . . . 0.0 109.251 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.86 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -124.46 135.6 26.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.682 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.38 140.98 15.65 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.526 2.151 . . . . 0.0 110.187 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 p -122.34 175.62 6.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.664 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.2 m -144.7 151.2 38.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.068 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.629 ' CE2' ' CD2' ' A' ' 130' ' ' PHE . 6.6 p90 -172.05 -177.54 1.91 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 0.0 109.819 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.08 166.71 10.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.364 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -57.86 -52.16 66.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.733 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -26.21 67.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.788 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.3 t -71.93 -41.06 68.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.967 . . . . 0.0 109.946 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.551 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 24.8 t80 -60.34 -39.06 85.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.796 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.5 mtm -63.44 -43.45 97.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.059 -1.026 . . . . 0.0 109.847 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -40.31 95.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.17 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -67.43 -58.2 5.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.161 -0.962 . . . . 0.0 109.895 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 84' ' ' TYR . 6.3 tp -52.2 -23.79 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.843 . . . . 0.0 109.862 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -74.18 -42.26 60.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.067 -1.02 . . . . 0.0 109.655 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.12 -30.72 76.13 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.529 ' CE1' HD11 ' A' ' 95' ' ' ILE . 31.2 t80 -80.82 -35.96 32.25 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.046 -1.267 . . . . 0.0 108.846 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -43.54 96.65 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.405 -0.809 . . . . 0.0 109.221 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -40.69 82.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.338 -0.851 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.23 82.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 91' ' ' TYR . 39.7 mm -61.64 -44.3 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.159 -0.963 . . . . 0.0 109.555 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.518 ' CE ' HG13 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -47.02 -51.59 16.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.912 . . . . 0.0 109.194 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.84 80.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.539 ' HD3' HD23 ' A' ' 99' ' ' LEU . 1.2 tmt_? -57.46 -36.1 70.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 109.344 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.703 HD13 ' HD2' ' A' ' 106' ' ' ARG . 8.6 mt -72.59 -49.82 29.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -0.852 . . . . 0.0 109.601 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -23.99 52.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.719 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.48 -21.66 17.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 109.568 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 2.7 t -114.13 -89.0 0.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.56 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -120.74 99.64 47.14 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.382 -0.824 . . . . 0.0 109.535 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 107' ' ' VAL . 32.8 Cg_endo -74.37 -13.19 22.98 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.433 2.088 . . . . 0.0 110.392 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -7.14 16.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.127 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.703 ' HD2' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -118.76 21.48 12.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.032 -1.043 . . . . 0.0 109.772 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 16.4 t -72.42 -46.34 10.24 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.494 -0.754 . . . . 0.0 110.868 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.5 Cg_endo -77.0 -48.89 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 121.976 1.784 . . . . 0.0 110.814 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.578 HG22 ' HA ' ' A' ' 106' ' ' ARG . 30.1 m -57.04 -44.86 83.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.104 -0.997 . . . . 0.0 109.589 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.556 ' N ' HG23 ' A' ' 109' ' ' VAL . 29.0 t80 -67.0 -37.87 84.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.84 -54.28 47.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.1 -1.0 . . . . 0.0 110.308 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -60.63 -45.92 92.24 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.105 -0.997 . . . . 0.0 110.207 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -56.34 -40.42 74.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 109.909 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.23 -27.37 63.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.081 -1.012 . . . . 0.0 109.586 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.64 -48.53 71.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.221 -0.924 . . . . 0.0 109.138 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.66 -29.91 76.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -69.98 -42.65 72.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -1.217 . . . . 0.0 109.812 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 97.4 t -69.68 -32.54 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -71.67 -34.51 69.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.127 -0.983 . . . . 0.0 109.624 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.51 ' N ' ' HD3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -84.53 -16.91 40.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.135 -0.978 . . . . 0.0 109.843 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.474 HD11 HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -81.97 -42.96 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.123 -0.986 . . . . 0.0 109.337 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 119' ' ' LYS . 6.6 mt -54.42 -28.2 42.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 109.465 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.24 -49.19 64.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 109.542 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 127' ' ' ASP . 6.4 m-20 -130.53 63.21 1.57 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -0.849 . . . . 0.0 109.416 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.484 ' CE2' ' CD2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -62.02 -49.93 74.06 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.364 -0.835 . . . . 0.0 109.753 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -55.55 -29.02 58.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.585 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.527 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -81.2 -26.55 35.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 109.945 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 129' ' ' ASP . 11.8 m-85 -84.16 -21.25 31.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.932 . . . . 0.0 110.018 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 128' ' ' TYR . 38.6 m-20 54.79 168.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.045 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.629 ' CD2' ' CE2' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -128.01 121.14 29.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.136 -0.978 . . . . 0.0 108.963 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 17.2 m-85 -109.5 174.71 5.74 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.21 -0.931 . . . . 0.0 110.538 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.86 HG22 ' O ' ' A' ' 75' ' ' SER . 3.6 tt -149.16 162.22 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.553 -0.717 . . . . 0.0 109.365 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.44 -176.93 50.54 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -68.5 -27.01 65.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -1.109 . . . . 0.0 109.398 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 136' ' ' MET . 1.0 OUTLIER -61.1 -34.15 74.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 65.16 39.77 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.385 -0.822 . . . . 0.0 109.371 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.35 139.91 27.46 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 109.198 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -73.8 -17.34 22.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.355 2.037 . . . . 0.0 109.982 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.76 -12.95 62.06 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.77 149.46 21.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.337 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.501 ' HE1' ' HA ' ' A' ' 158' ' ' PHE . 0.2 OUTLIER -66.49 139.14 57.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.603 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.1 m -88.43 141.68 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.821 . . . . 0.0 109.469 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 1.057 HG13 ' O ' ' A' ' 157' ' ' ILE . 16.5 t -97.05 140.82 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.193 -0.942 . . . . 0.0 109.053 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.519 HD23 ' C ' ' A' ' 143' ' ' VAL . 12.4 mt -110.94 134.55 52.48 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.514 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.485 ' HG2' ' HG2' ' A' ' 156' ' ' MET . 1.4 mtm -104.74 128.88 52.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 109.109 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.504 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 28.5 t-20 -150.24 159.15 44.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.958 . . . . 0.0 109.685 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -89.05 128.47 35.73 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.292 -0.88 . . . . 0.0 109.013 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -166.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 109.64 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -30.38 70.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 109.723 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -53.68 -59.3 4.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.698 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 111.39 -22.63 19.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.722 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -116.51 8.67 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -1.123 . . . . 0.0 109.165 179.575 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.8 m -117.38 101.3 52.84 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.157 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.49 137.58 14.81 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.601 2.201 . . . . 0.0 110.378 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 14.9 p90 -145.25 139.64 27.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.162 -0.961 . . . . 0.0 109.733 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.521 ' HB2' ' CE1' ' A' ' 158' ' ' PHE . 3.3 mtt -101.89 165.06 11.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 1.057 ' O ' HG13 ' A' ' 143' ' ' VAL . 12.5 mt -125.8 141.07 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.984 -1.073 . . . . 0.0 110.23 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.652 ' HD2' HD23 ' A' ' 13' ' ' LEU . 11.3 m-85 -132.92 118.58 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.418 -0.801 . . . . 0.0 108.902 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.419 ' HA ' HG12 ' A' ' 27' ' ' VAL . 3.2 m-85 -48.59 138.4 10.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 109.722 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -65.98 -51.98 53.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.898 . . . . 0.0 109.156 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 110' ' ' PHE . 3.9 m-20 -47.04 -48.46 22.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.009 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -86.76 50.53 4.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 163' ' ' LEU . 2.1 tt -158.96 116.51 2.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.465 -1.021 . . . . 0.0 109.222 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.506 HG13 ' CG2' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -114.29 148.73 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 4.9 p -96.64 120.58 37.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.32 -0.862 . . . . 0.0 109.372 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -127.3 129.04 46.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.16 128.62 37.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.194 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.586 ' HA ' HD12 ' A' ' 3' ' ' LEU . 15.6 p90 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.74 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.818 ' C ' HD23 ' A' ' 2' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.818 HD23 ' C ' ' A' ' 1' ' ' MET . 4.7 mt -114.05 166.26 11.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.026 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.4 ' HA ' ' OG ' ' A' ' 15' ' ' SER . 11.1 mt -127.96 143.3 51.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 109.298 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.606 ' HB3' HD22 ' A' ' 163' ' ' LEU . 29.9 m-85 -121.59 112.35 18.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.885 . . . . 0.0 109.825 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.541 ' O ' HD23 ' A' ' 163' ' ' LEU . 9.6 mttt -112.9 150.41 31.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.328 -0.858 . . . . 0.0 109.402 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 141' ' ' MET . 0.4 OUTLIER -68.34 158.24 33.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.586 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 164' ' ' VAL . 40.8 t -94.92 -15.68 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.389 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.742 HG21 ' O ' ' A' ' 139' ' ' ASP . 0.8 OUTLIER -89.47 -25.05 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.256 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.5 -46.02 2.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.13 58.35 2.34 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 6.0 p-10 -134.24 179.96 5.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -1.144 . . . . 0.0 109.283 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -78.65 89.45 4.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.962 . . . . 0.0 109.703 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -82.24 -62.8 1.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 109.029 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' A' ' 30' ' ' ALA . 13.8 p -143.19 171.03 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.592 ' N ' HG22 ' A' ' 14' ' ' VAL . 4.9 m -156.49 178.32 10.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.151 . . . . 0.0 110.804 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -84.12 12.5 6.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.517 -0.739 . . . . 0.0 109.889 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . . . -66.32 -9.23 31.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.004 . . . . 0.0 109.02 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.585 ' CD1' HD11 ' A' ' 68' ' ' LEU . 4.6 m-85 -128.7 21.13 5.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.424 -0.797 . . . . 0.0 109.264 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER 62.91 126.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.062 -1.024 . . . . 0.0 108.309 -178.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.888 HD23 ' HA ' ' A' ' 30' ' ' ALA . 12.9 mt -120.35 147.17 45.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 110.584 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.9 mmtp -123.23 140.59 52.87 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -100.75 114.41 28.14 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.11 -0.994 . . . . 0.0 108.828 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 24' ' ' ASP . 3.2 t -68.63 158.37 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.371 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' VAL . 1.5 t70 -41.15 -47.19 3.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.426 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' ASP . 16.2 m-20 -62.12 -148.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 108.957 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.97 60.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.233 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 m -134.19 150.62 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.882 . . . . 0.0 109.784 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.04 155.77 21.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -0.82 . . . . 0.0 109.134 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 2.4 pt-20 -133.29 120.71 21.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.043 -1.036 . . . . 0.0 109.661 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.888 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -100.14 127.05 46.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.441 -0.787 . . . . 0.0 109.087 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 64.9 m-20 -68.0 145.69 54.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.932 . . . . 0.0 109.77 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -125.52 152.97 44.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.248 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.449 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -122.45 152.07 40.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.557 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.446 ' CG ' ' HB ' ' A' ' 64' ' ' THR . 2.9 ttm -96.53 135.63 38.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.41 -0.807 . . . . 0.0 109.401 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -123.5 174.15 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.182 -0.949 . . . . 0.0 109.637 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.29 120.58 41.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.92 162.89 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.355 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.808 ' HE3' HG21 ' A' ' 62' ' ' THR . 1.0 OUTLIER -123.19 112.49 17.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.396 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 40' ' ' GLY . 19.7 mt-30 -117.4 147.4 42.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.484 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 39' ' ' GLN . . . -45.19 -61.75 3.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.48 -58.19 0.55 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.44 46.48 2.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -1.153 . . . . 0.0 109.536 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.7 t -54.57 -29.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.6 170.61 11.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.514 ' CG1' ' O ' ' A' ' 45' ' ' ILE . 2.4 tt -164.91 26.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 109.588 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.0 12.08 77.59 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.81 132.29 54.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -1.168 . . . . 0.0 109.382 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 t30 58.22 86.93 0.15 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.407 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.17 117.24 4.07 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.64 2.227 . . . . 0.0 110.578 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.37 10.58 2.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.336 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -167.5 -66.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.915 . . . . 0.0 109.468 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 48.25 85.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 9.0 p-10 -118.99 45.32 2.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 109.297 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . 64.62 114.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.551 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -83.0 127.96 34.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.182 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -147.7 81.13 1.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.625 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -113.75 -169.27 1.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.316 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 60' ' ' GLU . . . -178.96 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.713 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 47.17 -92.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.633 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 58' ' ' ALA . 1.5 mt-10 49.12 23.16 0.71 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.533 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' ' OG1' ' A' ' 62' ' ' THR . . . 65.03 91.6 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.808 HG21 ' HE3' ' A' ' 38' ' ' LYS . 4.8 p 57.26 -162.45 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.384 -1.068 . . . . 0.0 109.437 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.69 145.36 24.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.471 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 34' ' ' MET . 1.2 p -88.45 147.01 24.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 109.405 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.7 m -135.89 147.99 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.563 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -70.71 154.06 42.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.291 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 56.1 p30 -80.4 -18.02 50.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.585 HD11 ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.63 -35.41 22.7 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.21 -0.931 . . . . 0.0 108.976 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.705 HG13 ' HB2' ' A' ' 74' ' ' LEU . 73.6 t -72.84 -45.2 56.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.395 -0.815 . . . . 0.0 109.277 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -69.31 -36.25 76.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.106 -0.996 . . . . 0.0 110.109 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.1 m -70.51 -49.74 45.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.19 -0.944 . . . . 0.0 110.437 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' A' ' 14' ' ' VAL . 16.9 m-85 -92.24 -0.26 57.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.021 . . . . 0.0 110.132 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 57.27 64.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.956 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.705 ' HB2' HG13 ' A' ' 69' ' ' VAL . 12.0 mt -77.78 164.38 25.27 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.101 -1.0 . . . . 0.0 108.941 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.447 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -131.45 106.16 14.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.269 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.464 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 35.4 Cg_endo -76.8 120.9 5.66 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.359 2.039 . . . . 0.0 110.503 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.733 HG22 ' O ' ' A' ' 130' ' ' PHE . 10.0 t -88.95 157.55 18.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.9 . . . . 0.0 109.425 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.4 t -114.15 7.93 16.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.935 . . . . 0.0 109.509 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 6.9 p90 -136.35 142.72 43.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.632 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 1.0 OUTLIER 172.68 30.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.883 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -52.98 60.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.037 -1.039 . . . . 0.0 109.428 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -118.41 -31.24 4.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.82 . . . . 0.0 109.297 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.459 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 4.1 m -59.67 -30.44 68.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.201 -0.937 . . . . 0.0 108.911 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' A' ' 80' ' ' ASP . 5.0 t80 -66.61 -44.67 81.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 0.0 109.601 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.592 ' O ' HG22 ' A' ' 88' ' ' ILE . 7.6 mtt -60.93 -43.79 98.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.944 . . . . 0.0 109.92 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.1 m -66.87 -26.75 67.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.208 -0.932 . . . . 0.0 110.183 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CD2' ' O ' ' A' ' 83' ' ' SER . 12.4 m-85 -81.46 -29.34 33.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 109.945 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 85' ' ' MET . 3.0 tp -75.92 -28.16 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -49.2 16.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.374 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.01 -34.37 89.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -72.76 -36.2 67.62 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -61.0 -38.4 85.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.425 ' HD2' ' HE3' ' A' ' 96' ' ' LYS . 11.6 mmtm -67.26 -39.48 86.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.382 -0.824 . . . . 0.0 109.182 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.11 72.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.113 -0.992 . . . . 0.0 108.761 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.794 HG21 ' CE2' ' A' ' 110' ' ' PHE . 33.2 mm -62.92 -43.43 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.307 -0.87 . . . . 0.0 109.253 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HE3' ' HD2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -47.08 -37.42 9.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.261 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.1 -47.1 47.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.424 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.952 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -48.97 -46.29 43.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 109.545 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.952 HD23 ' HD3' ' A' ' 98' ' ' ARG . 6.1 mt -63.84 -46.46 84.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.204 -0.935 . . . . 0.0 109.17 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -23.74 7.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 108.881 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 98' ' ' ARG . 2.3 mt-10 -78.24 -48.15 16.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.441 -0.787 . . . . 0.0 109.223 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.0 -72.51 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.484 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.11 139.74 14.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.363 -0.836 . . . . 0.0 109.478 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.81 -13.97 21.74 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.662 2.241 . . . . 0.0 110.816 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 83.1 mt-10 -67.43 -23.52 65.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -0.972 . . . . 0.0 109.686 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.629 ' O ' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -87.81 5.71 38.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 109.565 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 108' ' ' PRO . 2.4 t -72.06 -50.02 9.49 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 109.532 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 107' ' ' VAL . 36.8 Cg_endo -79.56 -33.39 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.226 1.951 . . . . 0.0 110.435 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 49.8 t -67.47 -53.93 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.37 -0.831 . . . . 0.0 109.885 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.794 ' CE2' HG21 ' A' ' 95' ' ' ILE . 92.4 t80 -68.67 -37.53 79.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.895 . . . . 0.0 109.936 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -49.12 79.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.979 . . . . 0.0 110.229 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -70.88 -37.18 73.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.252 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.477 ' N ' ' HG3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -62.8 -35.07 78.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.879 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.769 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -71.42 -28.08 63.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 109.661 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -34.12 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.304 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.26 -44.95 84.41 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.509 ' HZ ' HD13 ' A' ' 157' ' ' ILE . 2.2 t80 -67.5 -44.59 78.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -1.148 . . . . 0.0 109.811 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 114' ' ' ALA . 85.1 t -53.56 -35.39 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.356 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -43.38 67.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 109.678 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -33.14 72.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.869 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.406 ' HA ' ' CE2' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -78.17 -35.15 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.106 -0.997 . . . . 0.0 109.377 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 122' ' ' LEU . 44.9 mt -60.52 -28.65 68.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.652 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.31 -36.68 78.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -143.13 59.55 1.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.19 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -59.16 -28.88 67.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.937 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 4.7 mmtp -72.24 -36.2 69.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 109.796 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -80.08 -23.67 41.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.809 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 129' ' ' ASP . 46.7 m-85 -85.7 -25.0 26.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.122 -0.987 . . . . 0.0 109.712 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 126' ' ' LYS . 8.8 m-20 53.33 175.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.367 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.733 ' O ' HG22 ' A' ' 77' ' ' THR . 0.3 OUTLIER -136.53 121.7 19.1 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.242 -0.911 . . . . 0.0 108.814 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.464 ' CE2' ' HB3' ' A' ' 76' ' ' PRO . 14.7 m-85 -101.7 166.91 10.43 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.201 -0.937 . . . . 0.0 110.308 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -156.42 142.97 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.528 -0.732 . . . . 0.0 109.497 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.45 179.57 1.86 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -67.74 -27.19 66.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -1.125 . . . . 0.0 109.248 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.544 ' O ' ' CG ' ' A' ' 136' ' ' MET . 1.0 OUTLIER -60.29 -35.07 74.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.301 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 79.92 20.01 0.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.501 -0.749 . . . . 0.0 109.471 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.47 123.62 35.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.029 -1.044 . . . . 0.0 109.798 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.443 ' HG3' ' CD1' ' A' ' 87' ' ' TYR . 32.3 Cg_endo -73.24 -13.5 25.67 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.145 1.897 . . . . 0.0 109.789 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.742 ' O ' HG21 ' A' ' 8' ' ' ILE . 2.8 m-20 -62.86 -21.21 65.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 141' ' ' MET . . . -76.78 -69.82 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.85 . . . . 0.0 109.089 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 5.8 tmm? 173.4 137.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 109.352 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.84 140.55 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 157' ' ' ILE . 3.4 t -112.14 138.05 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -106.18 143.67 33.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.411 ' HG3' ' HG2' ' A' ' 156' ' ' MET . 1.2 mtt -107.75 132.28 53.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.282 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 13.2 t30 -143.77 160.28 41.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 109.643 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.74 146.29 24.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.94 . . . . 0.0 109.444 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.411 HH11 HG21 ' A' ' 153' ' ' THR . 4.0 ttp180 -77.81 -172.83 2.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.563 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -21.64 63.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.51 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -58.02 5.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.85 -13.0 9.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.609 ' O ' HD12 ' A' ' 152' ' ' ILE . 2.4 pp -124.47 5.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.267 -1.137 . . . . 0.0 109.586 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.411 HG21 HH11 ' A' ' 148' ' ' ARG . 3.2 m -111.88 100.28 48.19 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.242 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 36.9 Cg_endo -81.59 132.27 7.73 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.622 2.215 . . . . 0.0 110.598 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 146' ' ' ASN . 38.4 p90 -133.78 142.59 47.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.106 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 9.6 mtt -100.79 161.15 13.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 110.207 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.796 ' O ' HG13 ' A' ' 143' ' ' VAL . 68.9 mt -124.46 145.78 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.215 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.73 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 4.2 m-85 -137.3 141.82 41.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 109.483 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -58.83 120.31 8.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 109.356 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -67.58 -45.61 75.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 109.513 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.61 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . 4.6 t0 -54.53 -25.84 28.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.345 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -103.8 39.2 2.89 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 4' ' ' TYR . 8.1 mt -149.75 140.19 22.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.388 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 7' ' ' VAL . 28.2 m -114.0 123.01 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.521 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.56 119.57 23.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.468 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -117.18 138.03 51.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.571 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.434 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -80.35 146.48 31.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.508 ' O ' ' CD1' ' A' ' 168' ' ' PHE . 5.1 t80 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.373 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.291 0.567 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.616 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 1.3 mm? -75.11 156.56 35.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.282 -0.886 . . . . 0.0 109.683 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 166' ' ' GLU . 2.9 mp -134.29 124.06 25.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.733 ' HB2' HG13 ' A' ' 14' ' ' VAL . 6.1 m-85 -96.12 109.58 21.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.429 -0.795 . . . . 0.0 109.81 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.637 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -110.03 152.45 25.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.348 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.482 ' HB2' HD23 ' A' ' 13' ' ' LEU . 20.2 t0 -68.11 134.57 50.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.523 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 8' ' ' ILE . 13.9 p -76.13 -36.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.433 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.729 HG22 ' OG ' ' A' ' 9' ' ' SER . 2.3 mp -66.47 -91.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.729 ' OG ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -135.11 80.84 1.86 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.38 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 6' ' ' ASP . . . -145.31 -62.99 0.02 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.6 t0 68.21 11.01 8.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -1.099 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.506 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER 173.1 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.693 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 12' ' ' GLU . 1.1 mm? -122.7 -61.37 1.46 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 109.285 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.909 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 10.5 p -136.76 166.35 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 108.979 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.4 p -145.47 164.34 31.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.009 -1.057 . . . . 0.0 110.543 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.512 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 1.5 t0 -82.96 8.1 13.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.461 -0.775 . . . . 0.0 109.745 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.23 -19.92 65.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 0.0 109.131 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.805 ' CD2' HD11 ' A' ' 68' ' ' LEU . 14.2 m-85 -110.87 21.26 16.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.272 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER 58.75 111.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 30' ' ' ALA . 16.2 mt -105.53 144.8 31.79 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.14 -0.975 . . . . 0.0 110.609 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.83 133.03 56.51 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.914 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER -97.13 120.94 38.42 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.298 -0.876 . . . . 0.0 108.703 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 24' ' ' ASP . 12.0 t -72.07 155.16 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' VAL . 22.2 t70 -43.4 -31.46 0.68 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.69 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.854 ' O ' HG23 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -70.15 -103.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.473 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -166.95 63.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.959 -1.088 . . . . 0.0 109.442 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 3.6 m -142.83 142.27 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.965 . . . . 0.0 109.735 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -100.59 132.36 46.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.429 -0.794 . . . . 0.0 109.144 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 18.6 mt-10 -107.99 124.7 50.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.93 . . . . 0.0 109.268 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.909 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -105.59 116.09 31.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 109.27 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.95 147.05 49.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.727 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.463 ' HB2' ' HG2' ' A' ' 154' ' ' PRO . 3.9 m -115.56 167.8 10.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -0.912 . . . . 0.0 109.378 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.409 ' HG2' ' N ' ' A' ' 34' ' ' MET . 18.5 tt0 -131.84 148.6 52.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.162 -0.961 . . . . 0.0 109.625 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.453 ' CG ' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -99.08 121.06 40.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 109.635 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 m -119.83 144.79 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 0.0 109.353 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 p -78.74 128.91 34.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.01 134.22 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.25 -0.906 . . . . 0.0 109.437 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 104.16 16.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.673 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.57 151.18 33.84 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -0.897 . . . . 0.0 109.453 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.48 -61.31 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.65 ' O ' HG23 ' A' ' 43' ' ' VAL . . . 170.0 -69.43 0.14 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER 39.33 34.24 0.12 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.52 -0.988 . . . . 0.0 109.761 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 41' ' ' GLY . 56.5 t -139.23 -38.29 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 43' ' ' VAL . 2.2 m-20 44.68 92.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 45' ' ' ILE . 12.8 mt -68.15 -63.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.502 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.83 143.12 14.33 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.26 121.01 9.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -1.13 . . . . 0.0 109.533 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 179.02 90.49 0.17 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.54 103.76 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.725 2.283 . . . . 0.0 110.304 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 78.3 p -146.1 60.08 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 109.707 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 50' ' ' SER . . . 173.81 148.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 0.0 109.756 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 54.26 52.05 13.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.598 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.77 -38.12 82.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.169 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.56 126.89 29.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.232 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -52.14 108.6 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.828 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 9.2 tt0 73.49 130.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.972 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.05 -158.9 0.68 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.57 -59.25 1.75 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.149 -0.969 . . . . 0.0 109.454 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.17 162.17 0.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.676 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -112.73 -21.29 11.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.29 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.05 1.46 61.29 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.1 p -57.68 136.61 56.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -1.167 . . . . 0.0 109.481 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.29 142.86 28.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.453 ' HB ' ' CG ' ' A' ' 34' ' ' MET . 0.1 OUTLIER -86.19 147.57 26.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.69 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.02 139.15 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.852 . . . . 0.0 109.281 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -62.71 152.26 36.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.771 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 71' ' ' SER . 31.9 t-20 -80.72 -21.65 40.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.551 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.805 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.22 -40.0 18.62 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.17 -0.956 . . . . 0.0 108.566 179.574 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.486 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 41.4 t -67.07 -44.36 88.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.543 -0.723 . . . . 0.0 109.343 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -70.18 -40.46 74.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.869 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 1.3 t -63.26 -34.29 77.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 110.119 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.744 ' HB2' HD23 ' A' ' 74' ' ' LEU . 59.4 m-85 -111.32 6.75 20.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.03 -1.043 . . . . 0.0 109.904 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER 54.04 32.63 15.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 109.913 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.744 HD23 ' HB2' ' A' ' 72' ' ' PHE . 1.3 mm? -43.13 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.269 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -127.92 141.69 41.96 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.149 -0.97 . . . . 0.0 109.48 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 36.3 Cg_endo -78.47 127.15 7.96 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.576 2.184 . . . . 0.0 110.456 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.452 HG21 ' HB ' ' A' ' 132' ' ' ILE . 1.0 OUTLIER -138.33 176.54 8.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.12 -0.988 . . . . 0.0 109.641 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.412 ' O ' ' CD2' ' A' ' 130' ' ' PHE . 13.1 m -120.66 -149.41 0.43 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.228 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.647 ' CG ' ' CE1' ' A' ' 125' ' ' PHE . 6.5 p90 -164.84 -178.75 5.41 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.173 -0.954 . . . . 0.0 109.405 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.543 ' CB ' ' CB ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -120.85 136.94 54.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.125 -0.984 . . . . 0.0 109.63 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.45 -38.18 88.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 109.851 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.82 -33.64 6.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 109.781 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.543 ' CB ' ' CB ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -71.08 -29.44 65.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.922 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.529 ' CE1' ' HB ' ' A' ' 88' ' ' ILE . 5.6 t80 -56.69 -35.95 69.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.006 -1.059 . . . . 0.0 109.812 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.8 mtm -53.66 -43.55 68.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.912 -1.118 . . . . 0.0 109.694 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 t -70.62 -41.07 72.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.064 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -56.67 -56.47 21.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 109.57 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.529 ' HB ' ' CE1' ' A' ' 84' ' ' TYR . 4.2 tp -59.33 -29.33 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.857 . . . . 0.0 109.459 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -57.45 11.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.136 -0.977 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.02 -19.91 70.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -70.64 -40.71 72.91 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.167 -1.196 . . . . 0.0 107.778 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.437 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -69.41 -41.78 75.93 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -40.07 63.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.425 -0.797 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.07 73.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.21 -0.932 . . . . 0.0 109.189 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.771 HG21 ' CE1' ' A' ' 110' ' ' PHE . 13.5 mm -63.02 -38.21 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.185 -0.947 . . . . 0.0 109.127 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.471 ' HD3' ' OE1' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -55.48 -35.1 65.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.068 . . . . 0.0 109.397 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.65 59.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.915 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -59.63 -31.74 69.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.015 . . . . 0.0 109.623 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.797 HD22 ' CD ' ' A' ' 106' ' ' ARG . 28.2 mt -72.56 -44.34 62.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.965 . . . . 0.0 109.6 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.471 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -58.56 -35.98 73.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.59 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -83.72 -18.29 38.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.442 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 1.5 t -115.83 -75.35 0.59 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.459 ' HB2' ' HG2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -126.69 95.82 36.82 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.436 -0.79 . . . . 0.0 109.174 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' A' ' 107' ' ' VAL . 33.8 Cg_endo -74.42 -22.14 16.51 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.461 2.107 . . . . 0.0 110.489 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 -20.13 62.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.567 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.797 ' CD ' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -99.64 20.81 13.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.419 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 19.9 t -68.73 -45.59 33.49 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 110.638 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.8 Cg_endo -77.24 -25.1 8.84 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.952 1.768 . . . . 0.0 110.614 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.84 -52.77 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.262 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.771 ' CE1' HG21 ' A' ' 95' ' ' ILE . 24.7 t80 -67.31 -37.61 83.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.72 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -61.04 -37.39 82.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.033 -1.042 . . . . 0.0 109.978 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -71.28 -38.48 71.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.936 . . . . 0.0 110.224 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.33 -51.18 55.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.113 -0.992 . . . . 0.0 110.24 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.822 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -57.89 -34.01 69.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.402 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -58.1 -46.76 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.119 -0.988 . . . . 0.0 109.513 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.437 ' N ' HG22 ' A' ' 115' ' ' ILE . . . -67.51 -43.71 85.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.1 -35.94 72.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.173 -1.192 . . . . 0.0 110.285 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 114' ' ' ALA . 39.6 t -63.15 -40.31 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.076 -1.015 . . . . 0.0 109.925 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.493 ' C ' ' CD ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -71.3 -28.78 64.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 109.202 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -56.33 10.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.885 . . . . 0.0 109.573 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.3 mp -59.82 -42.95 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 0.0 109.528 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 59.6 mt -48.46 -26.91 2.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.66 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.14 67.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -136.7 55.61 1.83 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 109.392 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.647 ' CE1' ' CG ' ' A' ' 79' ' ' PHE . 20.3 t80 -58.55 -33.77 70.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.653 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -39.33 80.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 109.763 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -78.67 -24.82 44.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.939 . . . . 0.0 109.686 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 129' ' ' ASP . 10.6 m-85 -77.6 -9.64 59.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.549 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.9 m-20 48.1 -175.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.352 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.837 ' CZ ' HG11 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -139.8 120.45 14.25 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.327 -0.858 . . . . 0.0 108.842 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.515 ' CE1' ' HB3' ' A' ' 145' ' ' MET . 15.2 m-85 -111.72 171.89 7.22 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.095 -1.003 . . . . 0.0 110.467 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.471 ' O ' HD13 ' A' ' 74' ' ' LEU . 6.4 tt -149.23 140.55 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.474 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.11 160.24 22.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.25 -21.82 66.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -1.086 . . . . 0.0 109.609 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 136' ' ' MET . 18.7 t -65.73 -34.84 79.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.469 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 135' ' ' SER . 3.2 ttm 74.86 59.78 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 0.0 109.464 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' A' ' 135' ' ' SER . 0.4 OUTLIER -129.45 109.63 17.63 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.356 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.13 -2.12 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.304 2.003 . . . . 0.0 110.32 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.651 ' O ' HG21 ' A' ' 8' ' ' ILE . 10.1 m-20 -104.41 -3.16 24.42 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.341 -0.85 . . . . 0.0 109.193 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 9' ' ' SER . . . -91.76 -72.89 0.57 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.161 -0.962 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.466 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 3.6 ttp -177.78 141.43 0.28 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.779 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.837 HG11 ' CZ ' ' A' ' 130' ' ' PHE . 74.6 t -102.76 141.53 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.114 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.468 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 3.3 t -102.3 143.55 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.102 -0.999 . . . . 0.0 109.559 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 144' ' ' LEU . 15.5 mt -106.63 134.58 49.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.326 -0.859 . . . . 0.0 109.195 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.515 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 12.1 ttm -113.28 124.49 52.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.337 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.575 ' O ' ' CD2' ' A' ' 155' ' ' TYR . 8.8 t30 -144.51 144.32 31.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -74.36 148.22 41.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -55.69 -172.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 109.586 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -79.99 -1.44 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.632 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.546 ' CB ' HD12 ' A' ' 152' ' ' ILE . 1.2 m-20 -104.22 -35.04 8.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.327 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.25 38.22 6.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.833 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -127.71 -26.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -1.164 . . . . 0.0 109.763 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 153' ' ' THR . 5.0 t -136.58 132.39 18.65 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 0.0 109.351 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 32' ' ' CYS . 36.6 Cg_endo -80.8 153.28 19.72 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.661 2.241 . . . . 0.0 110.602 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 146' ' ' ASN . 24.7 p90 -145.12 134.59 23.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 109.347 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.13 154.33 19.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.341 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 143' ' ' VAL . 6.4 mt -115.87 145.47 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.468 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 58.1 m-85 -136.93 129.17 29.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.439 ' HB2' ' SD ' ' A' ' 141' ' ' MET . 3.4 m-85 -60.79 127.78 33.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 109.632 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.07 -54.42 18.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.781 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . 12.7 t0 -43.62 -34.77 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.811 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -102.98 53.57 0.74 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.693 HD22 ' HB3' ' A' ' 4' ' ' TYR . 5.1 mt -161.96 130.23 4.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.482 HG23 ' HG3' ' A' ' 5' ' ' LYS . 5.4 m -114.1 139.15 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.3 p -83.24 142.71 30.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.61 ' O ' HD12 ' A' ' 3' ' ' LEU . 2.5 tp10 -133.79 123.16 24.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 109.523 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.37 110.95 23.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.365 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.123 -0.985 . . . . 0.0 109.476 -179.83 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 168' ' ' PHE . 17.8 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.514 HD22 ' HA ' ' A' ' 167' ' ' LYS . 14.7 mt -105.47 157.6 17.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 3' ' ' LEU . 8.4 mt -104.51 123.52 47.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 0.0 109.288 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 4.2 m-85 -107.35 118.48 36.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.677 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -139.8 156.31 46.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.271 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.01 155.89 29.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.647 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 p -97.58 -11.62 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.872 . . . . 0.0 109.418 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.412 HG21 ' O ' ' A' ' 139' ' ' ASP . 1.0 OUTLIER -91.76 -23.87 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.179 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.5 m -124.37 -10.77 7.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.744 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.87 58.18 9.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.449 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 10.0 m-20 -127.51 134.53 49.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -1.134 . . . . 0.0 109.487 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.415 ' C ' HD23 ' A' ' 13' ' ' LEU . 43.3 mt-10 -63.17 116.64 5.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.87 . . . . 0.0 109.569 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 4.0 mt -116.72 -48.04 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.874 . . . . 0.0 109.377 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.909 HG23 HD21 ' A' ' 68' ' ' LEU . 6.1 p -136.58 175.1 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.002 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.613 ' H ' HG22 ' A' ' 14' ' ' VAL . 3.1 p -159.57 173.22 16.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.87 -1.144 . . . . 0.0 110.594 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.468 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 10.9 t0 -84.1 2.86 37.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.529 -0.732 . . . . 0.0 109.7 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.74 -11.73 55.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.126 -0.984 . . . . 0.0 109.035 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.911 ' CE1' HD13 ' A' ' 68' ' ' LEU . 26.2 m-85 -120.62 21.08 11.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.453 -0.78 . . . . 0.0 109.267 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.31 133.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 30' ' ' ALA . 69.1 mt -129.31 143.57 50.9 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.277 -0.889 . . . . 0.0 109.765 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 29' ' ' GLU . 1.3 mttm -129.62 133.5 47.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 109.469 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -91.97 121.59 33.7 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.476 ' HB ' ' OD1' ' A' ' 25' ' ' ASP . 13.3 t -76.66 153.42 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -42.98 -36.93 1.71 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.579 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.6 ' OD1' HG22 ' A' ' 27' ' ' VAL . 6.1 p30 -63.73 -123.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.9 . . . . 0.0 109.311 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.519 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -146.14 63.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.746 -1.221 . . . . 0.0 109.35 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.6 HG22 ' OD1' ' A' ' 25' ' ' ASP . 13.3 m -151.94 163.47 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.746 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 4.8 m-85 -115.85 156.97 25.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.117 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 156' ' ' MET . 7.5 pt-20 -128.98 128.37 43.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.521 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.642 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -111.42 116.42 30.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.516 -0.74 . . . . 0.0 109.279 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 51.1 m-20 -63.32 142.55 58.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 109.581 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 58.6 m -133.45 152.66 51.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.902 . . . . 0.0 109.405 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -103.41 161.52 13.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.301 -0.874 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.7 mtt -105.0 131.71 52.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.468 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -136.84 128.02 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.898 . . . . 0.0 109.389 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.6 t -76.5 135.88 39.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 109.569 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.57 152.52 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 0.0 109.634 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.63 97.74 11.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.72 139.19 39.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.66 -106.11 2.79 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.04 150.56 19.6 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -128.82 -59.74 1.12 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -1.12 . . . . 0.0 109.361 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 43' ' ' VAL . 5.7 p -139.02 69.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.936 . . . . 0.0 109.347 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.7 -172.82 4.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 109.581 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.4 mm -67.55 -23.39 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.494 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.33 54.7 0.12 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.592 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -115.11 -88.06 0.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -1.135 . . . . 0.0 109.596 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.577 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -48.83 -51.59 53.1 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.992 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 48' ' ' ASN . 35.6 Cg_endo -78.72 -16.06 13.22 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.489 2.126 . . . . 0.0 110.906 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -143.72 57.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.064 -1.022 . . . . 0.0 109.717 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . 179.22 -66.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.94 . . . . 0.0 109.668 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 48' ' ' ASN . 7.8 pt-20 -143.81 178.38 7.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -111.1 31.62 5.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.328 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.495 ' O ' ' ND2' ' A' ' 48' ' ' ASN . . . -77.08 115.44 16.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 109.662 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -73.53 96.6 2.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.312 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.79 83.55 3.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.976 . . . . 0.0 109.698 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -124.92 -165.15 1.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -0.89 . . . . 0.0 109.451 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -176.51 45.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.313 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 67.18 23.17 9.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.347 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.29 13.53 8.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.873 . . . . 0.0 109.493 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.02 -27.78 11.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.7 p -65.64 123.37 19.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -1.142 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -133.75 148.75 51.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.57 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.94 117.87 23.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 109.272 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.94 143.6 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -74.02 154.38 39.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -74.04 -24.28 59.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.729 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.911 HD13 ' CE1' ' A' ' 18' ' ' TYR . 27.7 tp -81.81 -45.03 16.14 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.083 -1.01 . . . . 0.0 108.552 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.975 HG13 ' CB ' ' A' ' 74' ' ' LEU . 55.8 t -65.03 -38.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.397 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -69.59 -36.21 76.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.132 -0.98 . . . . 0.0 109.902 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.6 -50.69 62.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.868 . . . . 0.0 110.129 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.672 ' HE2' HD11 ' A' ' 68' ' ' LEU . 34.9 m-85 -82.71 -3.66 56.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.997 . . . . 0.0 110.128 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER 73.49 18.39 3.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.498 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.975 ' CB ' HG13 ' A' ' 69' ' ' VAL . 1.8 mm? -39.29 138.69 0.61 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.463 -0.773 . . . . 0.0 109.976 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.816 ' O ' HG22 ' A' ' 132' ' ' ILE . 2.2 p -118.05 113.97 37.28 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.34 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.21 149.23 21.93 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.418 2.078 . . . . 0.0 110.468 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.5 p -113.78 -175.42 2.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.347 -0.846 . . . . 0.0 108.974 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.38 -44.66 0.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.809 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.502 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 6.6 p90 -78.57 132.11 37.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.586 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.556 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . 1.4 m-20 -175.97 27.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 109.825 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -45.0 95.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.069 -1.019 . . . . 0.0 109.354 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -122.49 -32.53 3.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.54 -32.4 72.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.293 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.573 ' CD2' ' CZ ' ' A' ' 125' ' ' PHE . 1.0 OUTLIER -58.71 -48.1 82.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.578 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.473 ' O ' HG22 ' A' ' 88' ' ' ILE . 2.2 mtt -60.3 -33.79 72.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.974 . . . . 0.0 109.818 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 t -67.61 -39.2 84.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.74 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -67.9 -47.18 69.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.806 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 85' ' ' MET . 6.2 tp -61.46 -26.73 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.505 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -43.35 57.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 109.595 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.29 -26.52 73.48 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' ' 141' ' ' MET . 17.9 m-85 -81.64 -36.65 28.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -1.152 . . . . 0.0 109.03 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -41.86 86.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.305 -0.872 . . . . 0.0 109.55 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.546 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -70.72 -42.96 69.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.059 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 93' ' ' LYS . . . -55.31 -49.47 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.04 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.732 HG21 ' CE2' ' A' ' 110' ' ' PHE . 34.1 mm -57.28 -43.19 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.344 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.55 -47.61 39.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.276 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.19 -34.56 77.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.324 -0.86 . . . . 0.0 109.298 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.446 ' O ' ' OG ' ' A' ' 102' ' ' SER . 3.6 tmt_? -63.36 -34.01 76.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.765 HD13 ' HD2' ' A' ' 106' ' ' ARG . 9.9 mt -71.83 -45.53 61.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.161 -0.962 . . . . 0.0 109.295 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -54.76 -35.36 63.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.588 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.39 -40.31 62.14 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.0 109.085 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -89.83 -77.55 0.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.524 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 103' ' ' ASN . 5.0 p30 -144.24 118.89 5.95 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.845 . . . . 0.0 109.398 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.55 ' HA ' HG23 ' A' ' 107' ' ' VAL . 33.1 Cg_endo -74.69 -13.56 22.12 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.487 2.125 . . . . 0.0 110.609 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.28 -19.79 65.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.868 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.765 ' HD2' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -100.89 15.52 28.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 109.603 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.604 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 15.6 t -72.27 -45.41 10.7 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 110.894 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 107' ' ' VAL . 34.0 Cg_endo -76.34 -49.29 0.12 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.953 1.769 . . . . 0.0 111.009 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 110' ' ' PHE . 29.5 m -58.31 -44.35 88.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.043 -1.036 . . . . 0.0 109.679 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.732 ' CE2' HG21 ' A' ' 95' ' ' ILE . 52.6 t80 -65.5 -38.51 89.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.243 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.981 ' O ' HD12 ' A' ' 115' ' ' ILE . 1.1 mt-10 -63.71 -44.33 93.92 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.133 -0.98 . . . . 0.0 110.332 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -33.81 76.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.155 -0.965 . . . . 0.0 110.122 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -69.57 -46.96 65.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.986 . . . . 0.0 109.864 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -64.66 -27.25 68.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 109.688 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.981 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -72.48 -44.93 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.7 -48.4 72.91 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.576 ' CE1' ' OD2' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -60.12 -41.33 92.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -1.19 . . . . 0.0 109.869 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 114' ' ' ALA . 56.9 t -64.32 -32.38 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.9 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -70.76 -33.28 70.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.029 . . . . 0.0 109.861 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -32.59 57.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.138 -0.976 . . . . 0.0 109.815 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.5 mp -72.04 -31.21 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.923 . . . . 0.0 109.319 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 95.6 mt -64.86 -26.79 68.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.048 -1.033 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.6 -29.18 69.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.975 . . . . 0.0 109.928 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.61 55.53 1.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.156 -0.965 . . . . 0.0 109.436 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 130' ' ' PHE . 4.0 t80 -63.34 -20.88 65.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.731 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 127' ' ' ASP . 6.0 ptmm? -74.4 -47.11 35.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.058 -1.026 . . . . 0.0 109.71 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.445 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 8.5 t70 -72.28 -23.72 61.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.616 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 1.1 m-85 -79.33 -24.28 42.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.112 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.531 ' C ' ' CD1' ' A' ' 130' ' ' PHE . 2.5 m-20 53.24 173.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 109.14 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.687 ' CE1' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -134.51 121.19 20.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 108.98 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 13.0 m-85 -105.66 164.63 11.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.102 -0.999 . . . . 0.0 110.661 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 75' ' ' SER . 0.8 OUTLIER -146.79 138.8 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.436 -0.79 . . . . 0.0 109.435 179.464 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.21 155.21 3.59 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -59.24 -23.9 62.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -1.143 . . . . 0.0 109.119 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 136' ' ' MET . 3.0 p -64.65 -35.22 80.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.408 -0.807 . . . . 0.0 109.285 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 72.67 40.82 0.59 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.293 -0.88 . . . . 0.0 109.365 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.84 134.14 32.63 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.867 . . . . 0.0 109.309 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.67 -5.74 16.83 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.385 2.057 . . . . 0.0 110.133 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.412 ' O ' HG21 ' A' ' 8' ' ' ILE . 46.1 m-20 -98.21 -4.32 35.66 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.287 -0.883 . . . . 0.0 109.208 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.05 134.99 39.68 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.547 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -64.49 152.17 42.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.6 m -88.64 141.89 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 109.369 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.67 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.6 t -92.23 130.01 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.236 -0.915 . . . . 0.0 108.967 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 129' ' ' ASP . 1.5 mt -103.42 135.43 45.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.535 ' CG ' ' HG2' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.54 142.73 38.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.573 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 1.8 t30 -145.97 166.37 26.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.717 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.72 125.93 35.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.566 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.491 ' HG3' ' CD2' ' A' ' 155' ' ' TYR . 0.9 OUTLIER -66.32 -169.31 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.24 -0.912 . . . . 0.0 109.404 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -16.09 60.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.465 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 148' ' ' ARG . 2.0 m-20 -57.89 -56.57 20.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 0.0 109.333 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 126.73 -23.19 5.68 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.838 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -140.45 37.07 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -1.127 . . . . 0.0 109.221 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.4 m -127.27 100.54 26.33 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.08 131.81 9.07 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.569 2.179 . . . . 0.0 109.814 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.491 ' CD2' ' HG3' ' A' ' 148' ' ' ARG . 40.3 p90 -135.96 142.64 44.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.097 -1.002 . . . . 0.0 109.718 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.91 ' SD ' HD23 ' A' ' 68' ' ' LEU . 6.5 mtp -99.02 149.16 23.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.208 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.624 ' O ' HG13 ' A' ' 143' ' ' VAL . 68.8 mt -117.15 141.38 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.67 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 5.7 m-85 -132.61 141.79 48.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 109.307 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.484 ' O ' ' HB2' ' A' ' 163' ' ' LEU . 72.6 m-85 -71.06 127.71 33.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 109.697 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.417 ' HE2' ' C ' ' A' ' 160' ' ' LYS . 0.7 OUTLIER -67.21 -40.83 86.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.343 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.426 ' HB3' HD12 ' A' ' 95' ' ' ILE . 2.3 m-20 -52.62 -33.28 45.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.409 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -112.65 50.05 0.8 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 159' ' ' PHE . 0.6 OUTLIER -153.26 129.24 10.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -1.121 . . . . 0.0 109.525 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 m -118.81 144.84 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 109.307 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -106.08 129.64 54.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 109.862 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -120.65 122.43 40.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.249 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.514 ' HA ' HD22 ' A' ' 2' ' ' LEU . 2.1 tttp -55.75 123.24 13.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.736 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.403 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.486 ' CG ' HD23 ' A' ' 2' ' ' LEU . 4.6 ptp . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.287 0.565 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.486 HD23 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -67.09 147.16 53.5 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 2' ' ' LEU . 57.9 mt -118.41 126.65 52.53 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.429 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 165' ' ' SER . 75.8 m-85 -114.15 121.58 44.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.725 ' HA ' HD23 ' A' ' 13' ' ' LEU . 10.0 ptmt -126.37 160.79 29.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.616 -0.678 . . . . 0.0 109.228 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.418 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 25.6 t0 -98.86 154.08 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.329 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.36 -17.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.0 mt -75.43 -44.65 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 164.56 43.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.24 -41.94 3.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 57.1 99.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -1.19 . . . . 0.0 109.478 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 44.73 81.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.415 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.068 HD11 HD12 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -86.15 -32.06 21.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.718 HG21 ' CB ' ' A' ' 30' ' ' ALA . 8.2 p -166.91 174.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.966 -1.083 . . . . 0.0 109.529 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.626 ' H ' HG22 ' A' ' 14' ' ' VAL . 28.2 t -146.17 168.34 21.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.987 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.51 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 20.4 t0 -93.11 -4.59 52.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 109.483 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.18 -20.71 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.151 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.631 ' CD2' HD11 ' A' ' 68' ' ' LEU . 13.5 m-85 -99.08 -55.67 2.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.401 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 18' ' ' TYR . 3.3 m-20 155.44 130.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 30' ' ' ALA . 76.7 mt -130.27 133.56 46.59 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.046 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -131.43 127.52 37.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 9.2 pt-20 -92.9 129.59 38.77 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.058 -1.026 . . . . 0.0 109.614 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' ASP . 4.1 t -78.32 152.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -43.79 -28.46 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.884 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.728 ' O ' HG23 ' A' ' 26' ' ' ILE . 3.0 m-20 -65.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -162.98 49.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.987 -1.071 . . . . 0.0 109.203 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 6.7 m -140.57 151.42 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.654 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -100.6 157.63 16.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.081 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.2 tt0 -128.61 116.87 20.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.105 . . . . 0.0 109.629 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.718 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -107.24 112.82 25.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 108.958 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -73.89 146.64 43.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.979 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.04 148.54 48.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.828 . . . . 0.0 109.072 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.8 m120 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 71' ' ' SER . 19.7 p30 -85.45 -17.77 35.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.975 . . . . 0.0 109.57 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.631 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.09 -41.75 16.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 108.716 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.856 HG22 ' HB2' ' A' ' 74' ' ' LEU . 45.2 t -72.35 -36.69 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.411 -0.805 . . . . 0.0 109.286 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -69.61 -43.18 73.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -74.22 -27.94 61.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.936 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.489 ' C ' ' CD ' ' A' ' 73' ' ' ARG . 26.3 m-85 -114.39 16.66 17.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.458 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER 37.84 44.06 0.55 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.729 -0.607 . . . . 0.0 110.596 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.856 ' HB2' HG22 ' A' ' 69' ' ' VAL . 6.6 mt -49.44 142.85 7.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.997 -1.065 . . . . 0.0 108.566 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.693 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.4 p -128.96 107.7 18.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.992 -1.067 . . . . 0.0 109.463 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 131' ' ' TYR . 35.8 Cg_endo -78.21 134.04 12.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.454 2.103 . . . . 0.0 110.247 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -124.26 159.69 29.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.729 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.75 164.36 24.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -150.24 179.98 7.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.778 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.59 153.62 36.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.105 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.55 67.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.703 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.66 -31.32 65.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 109.529 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.5 m -66.15 -29.96 70.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 10.3 t80 -65.75 -36.87 84.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.703 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 3.1 mtt -64.66 -38.03 89.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 110.011 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -71.11 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.918 . . . . 0.0 110.496 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -77.27 -38.98 49.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.5 HG23 ' HE3' ' A' ' 89' ' ' LYS . 6.7 tp -76.34 -26.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.843 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.5 ' HE3' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -76.77 -56.38 4.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 109.673 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.18 -23.0 73.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 91' ' ' TYR . 30.1 t80 -81.34 -40.7 23.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.022 -1.281 . . . . 0.0 108.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -63.47 -40.54 97.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 89' ' ' LYS . 0.5 OUTLIER -65.24 -38.53 90.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.94 -46.59 78.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.025 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.515 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 29.2 mm -64.74 -40.39 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -51.61 -38.09 53.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.133 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.61 -39.13 64.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 0.0 109.68 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.547 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -59.9 -32.11 70.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.365 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.547 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 50.6 mt -73.08 -47.35 45.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -55.34 -36.89 66.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.751 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.59 -31.5 41.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.2 t -105.08 -78.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.723 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 59.3 t30 -119.83 107.94 39.59 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.26 -19.78 19.42 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.385 2.057 . . . . 0.0 110.381 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -74.14 -11.43 60.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.214 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.544 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -94.1 0.71 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.489 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 53.6 t -71.95 -43.23 10.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 111.29 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.5 Cg_endo -76.45 -52.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.877 1.718 . . . . 0.0 111.085 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 2.3 m -59.72 -36.99 69.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.997 -1.064 . . . . 0.0 109.587 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 44.9 t80 -69.67 -37.34 76.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.276 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.784 ' O ' HD12 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -68.53 -48.78 63.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.868 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -49.47 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.057 . . . . 0.0 110.807 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 109' ' ' VAL . 2.5 m120 -64.49 -48.91 73.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.439 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -62.72 -32.09 73.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -68.27 -39.63 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.402 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.59 -47.82 73.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -42.09 97.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.988 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 114' ' ' ALA . 71.8 t -60.13 -35.53 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.847 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -68.18 -38.13 81.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.933 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -78.83 -17.56 55.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.94 . . . . 0.0 109.897 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.44 -37.87 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 109.678 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 15.7 mt -62.34 -31.63 72.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 109.659 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.487 ' O ' ' ND2' ' A' ' 124' ' ' ASN . . . -54.1 -26.29 26.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.636 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 123' ' ' ALA . 12.4 m-80 -154.76 54.53 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 2.2 p90 -59.8 -22.13 61.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.639 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.444 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -76.58 -43.42 38.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -65.11 -26.39 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 4.9 m-85 -85.11 -12.24 53.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.338 -0.851 . . . . 0.0 109.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.486 ' O ' HD22 ' A' ' 144' ' ' LEU . 4.1 m-20 50.88 177.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.667 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.804 ' CE1' HG13 ' A' ' 142' ' ' VAL . 2.7 t80 -139.07 121.23 15.79 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.559 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 9.1 m-85 -103.36 170.69 7.8 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.056 -1.028 . . . . 0.0 110.669 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 75' ' ' SER . 2.0 tt -156.54 142.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.65 -178.94 51.87 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.421 ' OE1' ' HG2' ' A' ' 73' ' ' ARG . 3.6 mp0 -64.36 -19.45 65.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 136' ' ' MET . 82.6 p -56.01 -33.58 65.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 135' ' ' SER . 13.7 mmt 64.7 53.86 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.572 -0.705 . . . . 0.0 109.494 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.43 ' N ' HD11 ' A' ' 132' ' ' ILE . 6.4 t0 -128.96 120.12 20.2 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.323 -0.86 . . . . 0.0 109.176 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.98 2.67 6.37 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.286 1.99 . . . . 0.0 110.559 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.78 12.94 11.45 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.275 -0.891 . . . . 0.0 109.197 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.39 -156.87 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.452 ' HE3' ' HB2' ' A' ' 159' ' ' PHE . 0.0 OUTLIER -64.5 121.53 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.804 HG13 ' CE1' ' A' ' 130' ' ' PHE . 94.4 t -106.35 120.27 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.549 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.623 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 7.2 t -109.46 141.52 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.485 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 129' ' ' ASP . 53.1 mt -114.65 141.42 47.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.31 -0.869 . . . . 0.0 108.965 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.1 ttm -104.8 119.68 39.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.018 . . . . 0.0 109.522 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.586 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 44.6 t30 -138.09 146.72 43.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.541 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.9 OUTLIER -87.3 146.2 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.885 . . . . 0.0 109.541 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -58.75 -171.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.29 -17.46 64.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -53.49 4.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.541 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 114.89 -24.72 10.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 152' ' ' ILE . 1.3 tp -85.18 3.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.291 -1.123 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 m -123.67 101.18 36.94 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.6 122.82 5.13 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.509 2.14 . . . . 0.0 109.924 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 155' ' ' TYR . 5.9 p90 -141.03 148.66 40.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.28 158.6 26.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 109.022 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 143' ' ' VAL . 41.6 mt -116.64 141.93 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 110.02 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 4.5 m-85 -126.3 113.69 17.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.477 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 8.0 m-85 -42.93 119.31 1.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.06 -28.58 67.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.865 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 159' ' ' PHE . 3.3 p30 -57.63 -39.7 77.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.443 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -105.93 43.04 1.76 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 1.068 HD12 HD11 ' A' ' 13' ' ' LEU . 3.6 tt -142.47 125.76 16.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.44 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -112.77 157.42 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.552 ' HA ' ' CD1' ' A' ' 4' ' ' TYR . 1.7 m -101.49 139.21 37.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.08 123.17 33.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -90.57 139.32 30.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 167' ' ' LYS . 12.2 mt -99.02 154.07 18.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.644 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.4 mt -113.56 138.16 50.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.765 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.484 ' HB2' HG13 ' A' ' 14' ' ' VAL . 13.2 m-85 -116.5 108.45 16.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.104 -0.998 . . . . 0.0 109.585 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.526 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.6 OUTLIER -105.08 163.46 12.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.493 -0.754 . . . . 0.0 109.345 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.506 ' OD1' ' CE ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -81.01 157.12 25.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 109.303 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.475 ' CG2' HG13 ' A' ' 164' ' ' VAL . 68.5 t -106.52 -18.82 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.975 . . . . 0.0 109.601 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 mt -85.9 -25.06 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 109.267 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.84 -58.62 1.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.498 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.21 74.42 0.91 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -161.98 160.53 27.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -1.153 . . . . 0.0 109.51 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.7 129.24 36.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.718 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -118.05 -76.76 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.09 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 6.0 p -131.78 167.21 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.599 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.9 p -136.35 148.91 48.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.87 -1.144 . . . . 0.0 110.408 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.494 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 36.3 t70 -82.23 5.61 19.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.491 -0.756 . . . . 0.0 109.284 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.46 -24.09 67.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.893 . . . . 0.0 108.884 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.583 ' CE2' HD13 ' A' ' 68' ' ' LEU . 30.2 m-85 -100.13 21.19 13.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.548 -0.72 . . . . 0.0 109.604 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER 58.3 112.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 108.89 -179.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 30' ' ' ALA . 12.2 mt -103.48 147.1 27.56 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 110.343 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -129.75 122.85 29.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.803 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -80.86 128.64 33.89 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ASP . 2.5 t -86.79 92.36 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 0.0 110.116 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 23' ' ' VAL . 23.5 m-20 22.89 45.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 120.848 0.356 . . . . 0.0 111.673 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' VAL . 18.6 m-20 -161.25 -114.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.943 -1.098 . . . . 0.0 109.684 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 160' ' ' LYS . 1.0 OUTLIER -144.71 12.9 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.809 -1.182 . . . . 0.0 109.427 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 12.3 m -104.41 133.68 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 34.7 m-85 -98.51 151.23 20.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.314 -0.866 . . . . 0.0 109.077 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 mt-10 -117.41 117.44 29.48 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.514 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.82 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -96.75 112.62 24.3 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 4.7 m-20 -68.93 150.78 47.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 110.042 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.59 144.24 36.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.27 -0.894 . . . . 0.0 109.188 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 0.0 109.586 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.456 ' CG ' ' HB ' ' A' ' 69' ' ' VAL . 1.5 p30 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.524 ' OD1' ' CE1' ' A' ' 18' ' ' TYR . 30.9 p30 -98.14 -15.01 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.87 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.964 HD23 ' HE2' ' A' ' 156' ' ' MET . 48.9 tp -85.48 -41.57 15.23 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.148 -0.97 . . . . 0.0 108.989 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.685 HG13 ' HB2' ' A' ' 74' ' ' LEU . 66.6 t -72.77 -37.75 56.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.358 -0.839 . . . . 0.0 109.172 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -69.28 -48.89 60.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.453 -0.779 . . . . 0.0 110.295 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 t -69.4 -52.5 26.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.217 -0.927 . . . . 0.0 110.05 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.698 ' CD1' HD12 ' A' ' 68' ' ' LEU . 28.8 m-85 -75.19 -12.75 60.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.14 37.29 3.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.685 ' HB2' HG13 ' A' ' 69' ' ' VAL . 9.3 mt -50.28 107.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.981 -1.074 . . . . 0.0 108.742 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.047 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -89.96 126.73 56.36 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.864 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.52 129.32 8.36 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.502 2.135 . . . . 0.0 110.16 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.12 135.81 37.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.088 -1.008 . . . . 0.0 109.656 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.5 m -64.54 -172.4 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.193 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -158.43 -176.94 6.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.082 -1.011 . . . . 0.0 109.592 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.568 ' CB ' ' HB2' ' A' ' 83' ' ' SER . 0.1 OUTLIER -114.69 142.09 46.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.454 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -44.97 95.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 110.153 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.61 -40.27 14.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.991 . . . . 0.0 110.427 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.568 ' HB2' ' CB ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -59.1 -29.48 67.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 109.59 -179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -56.9 -48.39 78.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.782 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mtt -64.05 -46.43 84.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.198 -0.939 . . . . 0.0 110.021 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 m -54.9 -37.05 65.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 109.97 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.57 ' CZ ' ' O ' ' A' ' 138' ' ' PRO . 24.1 t80 -76.47 -33.97 58.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 109.735 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' MET . 3.6 mm -71.42 -15.6 18.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.125 -0.984 . . . . 0.0 109.308 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -57.1 3.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.34 72.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -77.86 -36.8 49.51 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.282 -1.128 . . . . 0.0 108.395 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.456 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -62.44 -51.94 65.5 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -57.14 -38.82 74.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.487 -0.758 . . . . 0.0 109.293 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.76 -50.42 72.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.917 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.771 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 30.3 mm -65.37 -28.97 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -44.78 93.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.192 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 100' ' ' GLN . . . -69.3 -25.89 64.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -0.844 . . . . 0.0 109.102 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -71.27 -41.1 70.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.613 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 106' ' ' ARG . 61.2 mt -72.79 -48.57 37.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.946 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -58.41 -31.77 68.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.741 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -79.24 -28.8 42.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.06 -1.025 . . . . 0.0 108.883 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.502 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 73.4 m -93.93 -79.02 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.4 -0.813 . . . . 0.0 109.015 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.95 140.36 26.64 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.832 . . . . 0.0 109.271 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -74.88 -17.25 20.03 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.654 2.236 . . . . 0.0 111.12 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -71.09 -8.95 56.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -0.967 . . . . 0.0 109.955 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.903 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -100.44 -5.06 27.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.117 -0.989 . . . . 0.0 109.793 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.588 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 3.1 t -69.18 -47.52 28.48 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.09 -1.006 . . . . 0.0 109.985 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 36.1 Cg_endo -78.54 -39.23 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.129 1.886 . . . . 0.0 110.876 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.09 -50.07 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.174 -0.953 . . . . 0.0 109.855 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.771 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 60.2 t80 -68.81 -39.67 79.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.29 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 1.2 mm-40 -61.4 -43.47 98.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.119 -0.988 . . . . 0.0 110.406 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -70.39 -45.51 65.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.063 -1.023 . . . . 0.0 110.182 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 117' ' ' PHE . 3.8 t-20 -57.95 -38.7 76.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.159 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.794 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -71.02 -31.76 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 110.156 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.474 ' O ' ' HD2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -70.36 -48.89 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.134 -0.979 . . . . 0.0 109.747 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 120' ' ' LYS . . . -66.92 -49.31 55.41 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -58.14 -42.88 86.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.108 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 114' ' ' ALA . 53.3 t -57.28 -37.04 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.989 . . . . 0.0 110.023 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -71.01 -45.49 63.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.018 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 0.1 OUTLIER -56.67 -54.21 48.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.702 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.66 -53.68 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 0.0 109.347 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 119' ' ' LYS . 42.9 mt -45.95 -48.05 16.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.729 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -46.88 -45.86 20.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.42 ' HB3' ' OD1' ' A' ' 127' ' ' ASP . 7.1 m120 -139.42 66.14 1.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.524 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.85 -49.6 75.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -52.53 -28.6 21.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 109.776 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 124' ' ' ASN . 3.6 m-20 -77.75 -37.86 48.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 109.722 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 129' ' ' ASP . 27.4 m-85 -77.95 -14.65 59.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.648 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.4 OUTLIER 50.82 177.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.648 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 131' ' ' TYR . 2.0 t80 -136.78 121.3 18.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.828 . . . . 0.0 108.837 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.575 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 19.3 m-85 -107.75 175.78 5.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 110.871 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 1.047 HG22 ' O ' ' A' ' 75' ' ' SER . 18.6 tt -147.33 159.7 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.534 -0.729 . . . . 0.0 109.399 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -88.13 171.9 41.12 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -24.07 64.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -1.153 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.3 OUTLIER -59.68 -34.98 73.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.494 ' CB ' ' O ' ' A' ' 135' ' ' SER . 3.2 tpt 75.75 37.17 0.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.24 125.28 26.99 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.273 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.57 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 33.9 Cg_endo -75.44 -0.25 9.88 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.295 1.997 . . . . 0.0 110.35 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -105.65 -0.73 25.35 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.31 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 141' ' ' MET . . . -94.98 44.34 1.1 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.905 . . . . 0.0 109.617 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.506 ' CE ' ' OD1' ' A' ' 6' ' ' ASP . 2.3 mtp 67.42 140.84 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 109.688 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.566 ' CG1' ' CE1' ' A' ' 130' ' ' PHE . 19.0 m -112.73 141.32 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.267 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.784 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.9 t -109.31 144.12 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 0.0 109.836 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.0 mt -113.62 147.92 37.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.197 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.432 ' SD ' ' SD ' ' A' ' 156' ' ' MET . 5.2 tpp -116.71 123.0 46.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.866 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.54 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 13.9 t-20 -141.63 151.25 42.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.383 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -76.48 154.97 34.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.655 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -100.64 -172.66 2.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -28.62 63.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.27 -47.94 65.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.539 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 106.71 -34.66 5.56 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.744 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -121.2 20.93 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -1.102 . . . . 0.0 109.191 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.3 m -117.01 101.5 53.34 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.339 -0.85 . . . . 0.0 109.361 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.68 129.06 8.99 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.5 2.133 . . . . 0.0 110.581 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 33.4 p90 -131.0 152.07 50.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 0.0 109.282 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.964 ' HE2' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -117.1 157.65 25.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.608 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.525 ' O ' HG13 ' A' ' 143' ' ' VAL . 20.4 mt -115.39 137.12 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 109.616 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.784 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 31.4 m-85 -129.22 141.71 51.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.087 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -75.24 117.57 17.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.896 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -68.44 -28.17 66.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 160' ' ' LYS . 0.8 OUTLIER -58.82 -18.92 36.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.748 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -125.72 39.88 1.96 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.526 HD23 ' O ' ' A' ' 5' ' ' LYS . 9.5 mt -137.57 149.5 46.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -1.221 . . . . 0.0 109.668 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.475 HG13 ' CG2' ' A' ' 7' ' ' VAL . 5.5 m -128.41 122.99 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.149 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.84 132.58 35.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.496 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -118.51 126.35 51.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.823 . . . . 0.0 109.221 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.454 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.9 OUTLIER -61.21 119.16 7.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.75 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.586 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 0.9 OUTLIER -68.82 149.44 48.96 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.23 -0.919 . . . . 0.0 109.852 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.843 HD23 ' HB3' ' A' ' 15' ' ' SER . 13.0 mt -126.17 123.8 39.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.511 -0.743 . . . . 0.0 109.128 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.869 ' HD2' HD11 ' A' ' 163' ' ' LEU . 30.3 m-85 -102.05 118.97 38.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 0.0 109.758 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 35.3 pttt -136.75 165.33 26.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.462 -0.774 . . . . 0.0 109.433 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 20.3 p30 -71.88 145.33 48.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 7' ' ' VAL . 14.9 p -107.81 43.22 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.474 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.441 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 1.1 tt -140.64 -38.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 27.1 t -104.89 -70.66 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.595 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 138.86 84.08 0.11 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 12' ' ' GLU . 19.2 t0 179.58 141.44 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -1.13 . . . . 0.0 109.336 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.562 ' HG3' ' CE2' ' A' ' 72' ' ' PHE . 1.2 pm0 -78.98 147.57 32.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.536 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 mt -130.9 -41.72 1.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.283 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.858 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 2.6 p -138.98 167.44 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.843 ' HB3' HD23 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -160.21 176.14 12.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.888 -1.132 . . . . 0.0 110.94 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 8.5 t70 -81.21 1.13 33.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.621 -0.674 . . . . 0.0 109.804 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.52 -16.26 63.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.075 -1.016 . . . . 0.0 108.758 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.845 ' CE2' HD13 ' A' ' 68' ' ' LEU . 27.2 m-85 -122.56 19.31 10.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.463 -0.773 . . . . 0.0 109.081 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 18' ' ' TYR . 1.2 m-20 61.79 134.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 108.835 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.601 HD21 ' CG2' ' A' ' 14' ' ' VAL . 12.2 mt -126.44 155.04 42.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.199 -0.938 . . . . 0.0 110.119 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.517 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 12.6 mmtt -132.26 120.97 22.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.445 -0.784 . . . . 0.0 109.118 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -87.24 126.14 34.64 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.187 -0.946 . . . . 0.0 108.804 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 24' ' ' ASP . 3.4 t -76.63 158.43 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.591 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' VAL . 1.3 t0 -42.9 -33.17 0.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.418 -0.801 . . . . 0.0 109.313 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.491 ' HB3' ' ND2' ' A' ' 113' ' ' ASN . 5.4 m-20 -69.85 -140.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.069 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.842 HD11 ' OD1' ' A' ' 113' ' ' ASN . 1.5 pp -129.18 61.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.9 -1.125 . . . . 0.0 109.435 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 m -146.12 147.61 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.773 . . . . 0.0 109.372 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 22' ' ' GLU . 44.3 m-85 -103.89 158.52 16.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.517 ' CG ' ' HB2' ' A' ' 21' ' ' LYS . 11.2 pt-20 -130.2 129.4 43.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 109.57 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.858 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -111.77 134.4 53.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -0.929 . . . . 0.0 109.429 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -98.19 134.87 40.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.418 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 68' ' ' LEU . 63.1 m -110.36 155.86 21.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 109.731 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.346 -0.846 . . . . 0.0 109.462 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.464 ' CB ' ' HB ' ' A' ' 69' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.3 0.571 . . . . 0.0 109.578 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -89.25 -39.74 13.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.883 . . . . 0.0 109.634 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.845 HD13 ' CE2' ' A' ' 18' ' ' TYR . 25.4 tp -80.79 -34.76 33.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.082 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.692 HG13 ' HB2' ' A' ' 74' ' ' LEU . 94.5 t -67.45 -39.84 83.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.45 -0.781 . . . . 0.0 109.333 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -69.63 -52.22 27.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -28.55 70.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 0.0 110.545 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.562 ' CE2' ' HG3' ' A' ' 12' ' ' GLU . 9.2 m-85 -102.97 -4.74 24.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.89 -1.131 . . . . 0.0 110.028 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.51 28.81 16.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.015 . . . . 0.0 109.852 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.692 ' HB2' HG13 ' A' ' 69' ' ' VAL . 2.3 mm? -49.24 140.24 10.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.093 -1.005 . . . . 0.0 109.285 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.4 t -123.39 139.62 32.26 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 109.486 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.79 132.74 10.95 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.537 2.158 . . . . 0.0 110.145 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 p -128.18 165.76 19.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.417 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.28 129.73 3.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.517 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 17.0 t80 -141.6 160.38 40.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 109.452 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.57 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 40.3 m-20 -39.36 129.64 1.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.479 -0.763 . . . . 0.0 109.673 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HG3' ' CE1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -61.63 -32.35 72.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.606 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -44.54 59.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 109.922 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 80' ' ' ASP . 10.8 t -62.91 -37.89 88.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.784 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.502 ' CE1' HG12 ' A' ' 88' ' ' ILE . 1.4 t80 -55.69 -35.83 66.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.235 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.754 ' O ' HG22 ' A' ' 88' ' ' ILE . 30.4 mtt -56.76 -48.26 78.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -0.954 . . . . 0.0 109.368 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.28 -45.38 91.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.18 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.438 ' O ' ' CD2' ' A' ' 91' ' ' TYR . 25.5 m-85 -68.04 -17.69 64.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.754 HG22 ' O ' ' A' ' 85' ' ' MET . 0.3 OUTLIER -76.57 -30.2 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -79.17 -35.33 42.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.384 -0.822 . . . . 0.0 109.032 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.82 -36.58 87.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 87' ' ' TYR . 20.0 m-85 -78.48 -36.93 44.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.118 -1.225 . . . . 0.0 108.942 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.9 OUTLIER -62.38 -39.91 94.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 108.791 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -69.09 -34.33 74.93 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.1 73.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 109.164 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 47.1 mm -66.76 -36.12 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 109.23 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HD3' HG13 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -60.22 -35.49 75.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.161 -0.962 . . . . 0.0 109.255 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.52 -55.13 6.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.947 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -52.28 -33.1 40.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 109.936 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.959 HD22 ' HB3' ' A' ' 106' ' ' ARG . 83.6 mt -72.82 -45.11 60.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -56.55 -38.45 71.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -32.99 63.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 m -98.35 -72.49 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.823 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -140.7 119.06 8.21 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.52 -17.64 20.69 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.458 2.105 . . . . 0.0 110.745 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -68.99 -9.6 53.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.679 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.959 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -101.34 -5.78 24.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 109.603 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.623 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 51.9 t -71.34 -42.99 12.13 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 111.04 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.2 Cg_endo -76.97 -52.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.894 1.729 . . . . 0.0 110.984 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.579 HG23 ' H ' ' A' ' 110' ' ' PHE . 15.6 m -55.87 -52.63 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.097 -1.002 . . . . 0.0 109.413 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.579 ' H ' HG23 ' A' ' 109' ' ' VAL . 46.1 t80 -62.79 -37.04 85.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.116 -0.99 . . . . 0.0 109.177 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -54.13 -48.08 71.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 110.304 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 109' ' ' VAL . 1.0 OUTLIER -67.65 -36.12 80.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.05 -1.031 . . . . 0.0 110.179 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.842 ' OD1' HD11 ' A' ' 26' ' ' ILE . 21.2 t-20 -67.5 -32.94 74.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.399 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.693 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -71.07 -29.82 65.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.157 -0.964 . . . . 0.0 109.889 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -71.32 -40.21 73.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.231 -0.918 . . . . 0.0 108.985 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -67.56 -46.45 69.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.484 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -68.18 -30.74 69.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -1.154 . . . . 0.0 110.065 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 114' ' ' ALA . 37.6 t -68.8 -50.59 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.095 -1.003 . . . . 0.0 109.509 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.455 ' C ' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -65.97 -28.69 69.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 0.0 109.653 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.66 -60.75 2.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.147 -0.971 . . . . 0.0 109.609 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.579 HG12 HD13 ' A' ' 144' ' ' LEU . 1.2 mp -55.41 -37.65 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.441 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 45.5 mt -53.03 -42.29 65.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 109.603 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.88 -39.68 40.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 109.268 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.523 ' HB3' ' CB ' ' A' ' 127' ' ' ASP . 8.6 m120 -130.04 64.08 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.0 109.247 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.577 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 6.9 t80 -60.55 -38.98 86.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 109.856 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -77.23 -30.76 54.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 110.012 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.523 ' CB ' ' HB3' ' A' ' 124' ' ' ASN . 1.2 t70 -75.13 -23.83 57.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.986 . . . . 0.0 109.953 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.793 ' HB3' HD22 ' A' ' 144' ' ' LEU . 41.5 m-85 -94.03 -33.0 13.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.716 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.887 ' O ' HD23 ' A' ' 144' ' ' LEU . 92.1 m-20 53.87 -177.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -141.41 122.39 14.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 108.796 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.41 ' HB3' HD12 ' A' ' 74' ' ' LEU . 10.6 m-85 -97.97 173.04 7.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.0 110.757 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 14.8 tt -156.59 138.21 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.651 -0.655 . . . . 0.0 109.268 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.06 170.88 8.04 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.29 -18.31 64.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -1.178 . . . . 0.0 109.355 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 136' ' ' MET . 4.8 t -60.54 -36.44 78.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 0.0 109.48 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.41 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 69.93 49.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.297 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.11 119.2 54.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.237 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.37 0.35 9.16 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.307 2.005 . . . . 0.0 110.239 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -100.55 -8.87 22.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.374 -0.829 . . . . 0.0 109.091 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.441 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -88.88 152.99 21.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -0.89 . . . . 0.0 109.286 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.507 ' CE ' ' HB2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -65.62 166.1 11.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.656 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.07 141.83 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.444 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.49 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 17.3 t -97.3 139.25 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.152 -0.968 . . . . 0.0 109.235 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 129' ' ' ASP . 17.6 mt -107.12 136.6 46.69 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.426 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.56 137.09 47.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.629 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.444 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 24.6 t-20 -152.16 164.34 37.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 109.534 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.42 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 2.6 m-85 -107.83 137.23 46.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.425 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.8 OUTLIER -65.56 167.06 9.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.284 -0.885 . . . . 0.0 109.387 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 148' ' ' ARG . 4.9 mt-10 -44.26 -28.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.444 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -50.43 70.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.516 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.42 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 101.18 -20.68 46.34 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.82 ' O ' HD12 ' A' ' 152' ' ' ILE . 2.0 pp -105.71 7.04 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -1.038 . . . . 0.0 109.366 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.2 m -114.08 101.34 53.92 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.236 -0.915 . . . . 0.0 109.26 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.2 119.24 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.443 2.095 . . . . 0.0 110.415 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 5.1 p90 -138.61 138.76 38.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.946 . . . . 0.0 109.465 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.508 ' SD ' ' N ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -116.92 149.59 39.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 109.174 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.492 ' C ' ' CD1' ' A' ' 158' ' ' PHE . 2.6 mt -105.89 149.12 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.617 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 6.0 m-85 -132.34 117.88 18.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 0.0 109.267 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 163' ' ' LEU . 36.6 m-85 -53.67 121.65 8.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 109.375 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 8.1 tttt -66.84 -26.7 67.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.681 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 159' ' ' PHE . 0.4 OUTLIER -56.49 -43.99 80.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.331 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -108.41 27.93 12.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.869 HD11 ' HD2' ' A' ' 4' ' ' TYR . 1.2 tm? -147.45 126.91 13.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.349 -1.089 . . . . 0.0 109.111 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.783 ' N ' HD22 ' A' ' 163' ' ' LEU . 10.8 m -135.72 155.95 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.57 ' OG ' ' CE1' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -88.85 150.45 22.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.449 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -142.57 122.59 13.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 109.313 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -90.46 146.03 24.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.39 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.73 HD21 ' HE3' ' A' ' 167' ' ' LYS . 12.7 mt -102.62 152.49 21.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 2' ' ' LEU . 12.8 mt -107.54 146.49 31.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.84 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.51 ' HD2' HD13 ' A' ' 163' ' ' LEU . 8.3 m-85 -121.7 111.66 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 0.0 109.173 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.679 ' O ' HD23 ' A' ' 163' ' ' LEU . 15.8 mttm -114.48 156.68 24.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.68 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.0 155.9 21.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.546 ' O ' HG22 ' A' ' 7' ' ' VAL . 13.3 p -92.07 -0.42 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.507 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.483 HG21 ' O ' ' A' ' 139' ' ' ASP . 47.6 mm -80.16 -58.68 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.686 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 10' ' ' GLY . 41.7 t -119.13 13.62 12.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' SER . . . 44.99 70.89 0.54 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.411 ' CG ' ' OG ' ' A' ' 135' ' ' SER . 15.0 t70 -137.85 138.35 39.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -1.07 . . . . 0.0 109.329 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.447 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -44.83 143.82 1.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.47 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.65 HD12 ' CE2' ' A' ' 158' ' ' PHE . 0.2 OUTLIER -134.32 -62.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.831 HG21 ' CB ' ' A' ' 30' ' ' ALA . 4.4 p -144.37 -178.85 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.91 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.729 ' H ' HG22 ' A' ' 14' ' ' VAL . 72.7 m -149.45 165.38 32.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.723 -1.236 . . . . 0.0 110.602 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.19 7.98 22.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.498 -0.751 . . . . 0.0 109.503 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.82 -10.6 49.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.116 -0.99 . . . . 0.0 108.923 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.783 ' CD2' HD11 ' A' ' 68' ' ' LEU . 24.3 m-85 -121.03 21.54 11.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 0.0 109.147 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER 64.21 132.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD23 ' HA ' ' A' ' 30' ' ' ALA . 21.9 mt -126.14 142.79 51.38 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.216 -0.927 . . . . 0.0 110.052 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.04 140.14 50.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.465 -0.772 . . . . 0.0 109.42 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.14 112.92 24.94 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.259 -0.901 . . . . 0.0 108.903 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.54 152.68 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.446 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -54.01 -19.6 5.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.668 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -75.46 -98.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.04 -1.038 . . . . 0.0 109.318 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -165.76 56.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.005 -1.06 . . . . 0.0 109.617 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.411 HG13 ' C ' ' A' ' 26' ' ' ILE . 11.1 m -152.05 158.16 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.077 -1.014 . . . . 0.0 109.76 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.413 ' C ' ' HG2' ' A' ' 29' ' ' GLU . 6.0 m-85 -103.58 162.2 13.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 0.0 109.026 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.6 mm-40 -130.99 117.41 19.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.831 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -103.97 112.76 25.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 108.956 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 2.3 m-20 -77.92 150.47 34.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.824 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.434 ' SG ' ' HG2' ' A' ' 154' ' ' PRO . 1.7 p -125.46 175.72 7.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.871 . . . . 0.0 109.315 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 0.0 109.459 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 m120 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 71' ' ' SER . 10.0 p30 -74.19 -21.48 59.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 109.739 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.783 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -81.47 -36.94 28.72 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.099 -1.001 . . . . 0.0 108.771 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 73' ' ' ARG . 41.7 t -71.33 -54.32 17.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.419 -0.801 . . . . 0.0 109.706 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -61.76 -41.31 97.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 0.0 110.142 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 5.0 t -68.4 -33.19 73.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.152 -0.968 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.485 ' HB2' HD23 ' A' ' 74' ' ' LEU . 22.9 m-85 -110.08 13.32 23.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.04 -1.037 . . . . 0.0 109.996 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 69' ' ' VAL . 55.0 mtt180 43.41 69.42 0.4 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.155 -0.966 . . . . 0.0 109.481 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 72' ' ' PHE . 1.7 mm? -89.81 137.96 31.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.399 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.539 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -100.03 117.83 62.63 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.152 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.71 123.59 5.37 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.551 2.168 . . . . 0.0 110.631 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.47 ' HG1' ' HD2' ' A' ' 79' ' ' PHE . 2.4 t -132.69 174.2 10.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 108.988 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -142.57 9.22 1.79 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.222 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 16.7 p90 -86.91 123.04 31.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.045 -1.035 . . . . 0.0 109.599 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -174.23 21.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.943 . . . . 0.0 110.54 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -63.58 -53.46 51.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.945 -1.097 . . . . 0.0 109.347 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.06 -24.67 4.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -29.89 67.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.118 -0.989 . . . . 0.0 109.165 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.558 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -58.84 -46.27 88.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 109.356 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.447 ' HA ' HG22 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -64.84 -30.04 71.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.262 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -71.16 -55.4 8.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.017 -1.052 . . . . 0.0 110.691 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.554 ' CD1' ' HG2' ' A' ' 138' ' ' PRO . 39.7 m-85 -63.91 -41.45 97.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.088 -1.007 . . . . 0.0 109.897 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -68.84 -22.33 26.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 109.469 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -55.2 5.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.344 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.12 -19.89 68.52 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -81.12 -39.02 26.26 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.157 -1.202 . . . . 0.0 108.326 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.65 -40.69 92.75 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.69 -43.99 95.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 0.0 109.125 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.56 -50.09 68.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 108.886 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.633 HG23 ' OD1' ' A' ' 161' ' ' ASP . 41.9 mm -60.02 -32.07 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.224 -0.923 . . . . 0.0 108.682 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -50.32 71.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 108.948 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.82 77.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.154 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HD3' HD23 ' A' ' 99' ' ' LEU . 3.8 tmt_? -58.63 -43.84 89.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.126 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.504 HD13 ' HG2' ' A' ' 106' ' ' ARG . 24.7 mt -64.67 -48.47 74.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.378 -0.826 . . . . 0.0 109.033 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -52.72 -25.26 10.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.198 -0.939 . . . . 0.0 108.827 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -76.32 -43.28 41.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 108.966 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.8 t -88.85 -71.77 0.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.191 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -148.04 137.25 11.95 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.04 -16.73 19.95 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.604 2.203 . . . . 0.0 111.066 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.52 -14.08 62.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.008 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.504 ' HG2' HD13 ' A' ' 99' ' ' LEU . 12.8 ttp-105 -93.09 -5.94 49.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.664 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 62.9 t -71.21 -43.09 12.55 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 111.344 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.4 Cg_endo -77.38 -54.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.883 1.722 . . . . 0.0 110.99 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.606 HG23 ' N ' ' A' ' 110' ' ' PHE . 35.7 m -56.52 -46.0 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.114 -0.992 . . . . 0.0 110.007 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.606 ' N ' HG23 ' A' ' 109' ' ' VAL . 62.5 t80 -65.06 -45.87 83.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.822 . . . . 0.0 110.696 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 115' ' ' ILE . 67.7 tt0 -57.28 -47.77 80.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.008 -1.057 . . . . 0.0 110.536 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -68.38 -31.69 71.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.058 -1.026 . . . . 0.0 110.345 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -66.36 -54.24 26.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 109.913 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -69.57 -26.55 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.988 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 111' ' ' GLU . 4.1 mm -62.29 -49.08 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.127 -0.983 . . . . 0.0 109.162 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.96 -41.04 99.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -35.2 75.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.25 -1.147 . . . . 0.0 109.602 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 114' ' ' ALA . 70.4 t -70.58 -38.06 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 109.561 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 115' ' ' ILE . 3.3 mmtt -64.34 -29.66 70.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 109.801 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -81.83 -46.9 13.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 109.893 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.2 OUTLIER -53.98 -37.86 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.16 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.02 -45.87 86.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.122 -0.986 . . . . 0.0 109.424 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -48.05 -39.66 20.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.868 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -136.43 45.65 2.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.146 -0.971 . . . . 0.0 109.735 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 10.1 p90 -63.02 -22.86 67.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.443 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.413 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -70.95 -47.02 61.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.547 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 2.0 m-20 -71.13 -23.57 62.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.342 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.559 ' HB3' HD22 ' A' ' 144' ' ' LEU . 6.3 m-85 -76.45 -10.72 59.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.513 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 50.94 -172.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.946 . . . . 0.0 109.451 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 77' ' ' THR . 0.3 OUTLIER -149.22 121.68 8.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -107.4 166.81 10.38 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.035 -1.041 . . . . 0.0 110.38 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 75' ' ' SER . 7.6 tt -146.79 130.51 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.405 -0.809 . . . . 0.0 109.477 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.56 179.16 3.87 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.08 -23.27 67.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -1.127 . . . . 0.0 109.453 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 136' ' ' MET . 7.2 m -58.71 -34.58 71.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.511 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 76.81 20.4 1.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.308 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -114.62 119.58 39.37 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.242 -0.911 . . . . 0.0 109.276 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 87' ' ' TYR . 33.4 Cg_endo -75.4 -5.51 16.7 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.262 1.974 . . . . 0.0 110.303 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.483 ' O ' HG21 ' A' ' 8' ' ' ILE . 2.4 p30 -95.38 -4.88 44.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 0.0 109.143 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' A' ' 141' ' ' MET . . . -98.45 47.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.53 ' CB ' ' O ' ' A' ' 140' ' ' ALA . 27.3 ttm 79.66 115.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.759 -0.588 . . . . 0.0 109.606 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.15 130.59 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.351 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 157' ' ' ILE . 3.0 t -99.84 138.82 23.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.271 -0.893 . . . . 0.0 109.069 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 128' ' ' TYR . 18.6 mt -115.0 146.49 41.19 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.229 -0.92 . . . . 0.0 109.622 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.428 ' HG2' ' HG2' ' A' ' 156' ' ' MET . 0.0 OUTLIER -109.3 124.79 51.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.329 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.542 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 24.3 t-20 -138.31 140.22 39.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.5 OUTLIER -77.8 147.04 35.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -0.845 . . . . 0.0 109.563 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -79.22 178.42 8.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.0 -25.36 8.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.45 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.447 ' OD2' HG13 ' A' ' 152' ' ' ILE . 31.9 t0 -72.17 -47.99 46.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 0.0 109.397 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 105.33 -28.61 13.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.798 ' O ' HD12 ' A' ' 152' ' ' ILE . 2.3 pp -99.78 11.51 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -1.153 . . . . 0.0 109.641 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.1 m -121.49 100.59 44.34 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.158 -0.964 . . . . 0.0 109.428 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.434 ' HG2' ' SG ' ' A' ' 32' ' ' CYS . 36.9 Cg_endo -81.22 131.02 7.49 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.554 2.169 . . . . 0.0 110.502 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 146' ' ' ASN . 32.9 p90 -135.18 144.49 47.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.377 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.5 ' HB3' ' CG1' ' A' ' 143' ' ' VAL . 2.0 mtt -107.93 163.91 12.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 109.888 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.638 ' O ' HG13 ' A' ' 143' ' ' VAL . 8.0 mt -124.15 139.36 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 109.384 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.65 ' CE2' HD12 ' A' ' 13' ' ' LEU . 52.7 m-85 -129.97 116.0 17.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.491 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 2.2 m-85 -43.15 116.81 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.263 -0.898 . . . . 0.0 109.746 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -68.65 -42.59 77.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.825 . . . . 0.0 109.979 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.633 ' OD1' HG23 ' A' ' 95' ' ' ILE . 3.5 t70 -47.22 -35.79 8.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.465 ' O ' ' HE2' ' A' ' 141' ' ' MET . . . -110.74 50.26 0.78 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 5' ' ' LYS . 3.8 mt -134.16 154.96 50.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.237 . . . . 0.0 109.68 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 5' ' ' LYS . 7.2 m -143.27 125.83 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 59.4 m -82.59 135.55 35.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -127.72 124.9 38.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.892 . . . . 0.0 109.574 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.73 ' HE3' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -68.5 117.17 9.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.445 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.494 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttm . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 167' ' ' LYS . 12.6 mt -112.5 151.5 29.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 109.641 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 3' ' ' LEU . 32.4 mt -105.92 122.93 47.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.667 ' HD2' HD11 ' A' ' 163' ' ' LEU . 3.6 m-85 -103.92 117.88 35.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.942 . . . . 0.0 109.185 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -129.63 143.27 50.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.644 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.861 ' OD1' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -74.35 156.77 36.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.529 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 7' ' ' VAL . 93.2 t -98.72 -6.45 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.356 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 3.1 mt -101.47 -61.31 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 109.651 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 8' ' ' ILE . 10.3 t -43.23 -47.39 6.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.57 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.96 -63.65 0.37 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.87 65.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -1.19 . . . . 0.0 109.52 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 179.37 141.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.861 HD22 ' OD1' ' A' ' 6' ' ' ASP . 23.9 tp -171.96 -75.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 0.0 109.62 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.843 HG21 ' CB ' ' A' ' 30' ' ' ALA . 3.2 p -153.18 -172.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 108.972 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.743 ' H ' HG22 ' A' ' 14' ' ' VAL . 51.5 p -162.57 174.27 12.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.843 -1.161 . . . . 0.0 110.168 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.42 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 37.5 t70 -82.95 10.98 6.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.399 -0.813 . . . . 0.0 109.988 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.08 -9.67 33.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 109.227 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 39.4 m-85 -126.77 21.56 6.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.243 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 14.9 m-20 67.96 130.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 30' ' ' ALA . 34.8 mt -126.31 147.89 49.64 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.178 -0.951 . . . . 0.0 110.371 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 136.8 44.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.504 -0.747 . . . . 0.0 109.381 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 1.1 tt0 -99.24 113.17 25.29 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.264 -0.898 . . . . 0.0 108.837 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ASP . 33.2 t -62.36 157.69 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.222 -0.924 . . . . 0.0 109.574 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -43.73 -28.37 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.247 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -75.24 -143.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 108.998 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.446 ' O ' ' HB3' ' A' ' 160' ' ' LYS . 1.0 OUTLIER -123.41 54.58 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.054 -1.029 . . . . 0.0 109.591 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.2 m -136.86 153.84 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 109.473 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 4.3 m-85 -107.27 163.16 13.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.308 -0.87 . . . . 0.0 109.222 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 47.6 mt-10 -128.98 119.91 25.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.843 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -114.86 112.52 22.88 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 11.1 m-20 -75.01 145.62 42.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 t -104.21 125.89 50.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.415 -0.803 . . . . 0.0 108.944 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.104 -0.998 . . . . 0.0 109.969 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.492 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 32.8 m120 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.338 0.589 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 32.3 t-20 -92.71 -26.18 17.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.707 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.615 HD11 HG23 ' A' ' 14' ' ' VAL . 49.7 tp -87.78 -47.79 8.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 108.749 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 74' ' ' LEU . 50.7 t -60.42 -47.88 90.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -69.29 -47.59 64.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 110.139 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 t -49.4 -52.25 29.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.561 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 68' ' ' LEU . 72.5 m-85 -102.12 8.48 40.71 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.046 -1.033 . . . . 0.0 110.178 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.481 ' O ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 57.24 95.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.023 . . . . 0.0 109.263 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.726 ' HB2' HG13 ' A' ' 69' ' ' VAL . 3.9 mm? -114.31 139.13 49.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.336 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.523 ' O ' HG22 ' A' ' 132' ' ' ILE . 4.4 t -125.92 124.06 24.68 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 109.397 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.85 157.81 27.59 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.398 2.065 . . . . 0.0 110.263 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -93.87 -174.27 3.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 109.391 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.1 4.42 2.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.702 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 14.1 t80 -160.34 124.26 3.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.501 ' HB2' ' CD2' ' A' ' 130' ' ' PHE . 0.3 OUTLIER -161.56 23.74 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.328 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -53.17 61.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -23.7 11.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.315 -0.866 . . . . 0.0 109.331 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.6 m -72.02 -31.45 66.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 80' ' ' ASP . 3.9 t80 -58.83 -36.65 74.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.604 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.738 ' O ' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -63.37 -53.04 58.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.73 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.3 m -61.62 -28.56 69.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.872 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 91' ' ' TYR . 10.9 m-85 -69.63 -46.3 66.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.092 -1.005 . . . . 0.0 109.749 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 85' ' ' MET . 5.9 tp -65.12 -24.58 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.279 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -46.85 38.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.766 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.94 -27.1 72.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 87' ' ' TYR . 21.1 m-85 -81.21 -36.75 29.67 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.083 -1.245 . . . . 0.0 109.307 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.511 ' O ' ' HE3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -63.76 -41.32 98.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.89 . . . . 0.0 109.863 -179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -73.45 -40.9 63.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.958 . . . . 0.0 109.723 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -44.47 73.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.613 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.676 HD12 ' OD1' ' A' ' 161' ' ' ASP . 49.2 mm -62.15 -37.41 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.491 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -50.68 61.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.87 . . . . 0.0 109.29 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.89 -27.89 68.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.385 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.578 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.41 -36.49 82.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.316 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 106' ' ' ARG . 33.3 mt -72.59 -50.45 25.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.127 -0.983 . . . . 0.0 109.616 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -51.51 -34.19 35.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.304 -0.872 . . . . 0.0 109.0 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.2 -37.09 72.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 109.056 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.5 m -96.95 -82.04 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.378 -0.826 . . . . 0.0 109.601 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.509 ' OD1' ' CG ' ' A' ' 105' ' ' GLU . 3.1 p30 -132.0 134.69 25.49 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.64 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.15 -19.01 17.95 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.503 2.135 . . . . 0.0 110.854 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.509 ' CG ' ' OD1' ' A' ' 103' ' ' ASN . 16.2 pt-20 -68.87 -8.76 46.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 0.0 109.861 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.729 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -93.92 -3.53 51.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.994 . . . . 0.0 109.782 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 25.8 t -72.4 -45.02 10.29 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 111.015 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.2 Cg_endo -77.41 -47.39 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.989 1.793 . . . . 0.0 111.156 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 110' ' ' PHE . 1.4 p -63.51 -44.68 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 109.598 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.532 ' N ' ' CG1' ' A' ' 109' ' ' VAL . 49.0 t80 -64.5 -41.0 96.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.501 -0.749 . . . . 0.0 110.34 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -40.37 94.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.015 -1.053 . . . . 0.0 110.338 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -48.98 45.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.045 -1.034 . . . . 0.0 110.783 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.41 -54.62 43.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.054 -1.029 . . . . 0.0 110.465 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.716 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -60.71 -26.71 67.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.001 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 115' ' ' ILE . 0.9 OUTLIER -65.12 -49.15 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.086 -1.009 . . . . 0.0 109.286 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.37 -33.59 82.57 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.507 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.1 OUTLIER -63.6 -45.46 90.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -1.13 . . . . 0.0 109.969 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 114' ' ' ALA . 60.6 t -53.78 -38.62 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.326 -0.859 . . . . 0.0 110.657 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -71.19 -49.29 45.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 110.562 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 117' ' ' PHE . 0.1 OUTLIER -73.0 -11.18 60.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.028 -1.045 . . . . 0.0 110.27 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -83.2 -44.57 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.06 -1.025 . . . . 0.0 109.665 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.402 ' N ' HG22 ' A' ' 121' ' ' ILE . 40.0 mt -53.64 -36.4 62.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 109.964 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 122' ' ' LEU . . . -45.1 -39.39 5.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 109.719 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.564 ' O ' ' CE1' ' A' ' 128' ' ' TYR . 35.2 m-80 -113.0 50.71 0.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 109.939 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.651 ' HA ' ' CE1' ' A' ' 128' ' ' TYR . 53.7 t80 -64.02 -54.13 39.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.175 -0.953 . . . . 0.0 109.991 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.48 -5.46 58.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -0.904 . . . . 0.0 109.086 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.515 ' HB2' ' CB ' ' A' ' 124' ' ' ASN . 15.8 m-20 -80.73 -41.53 23.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.84 . . . . 0.0 109.908 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.651 ' CE1' ' HA ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -102.03 10.78 39.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.086 . . . . 0.0 110.727 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 0.3 OUTLIER 43.86 -151.75 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.196 -0.94 . . . . 0.0 109.345 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.576 ' CE1' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -149.59 121.25 8.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 108.991 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.462 ' CE1' ' SD ' ' A' ' 145' ' ' MET . 13.2 m-85 -104.19 164.76 11.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.146 -0.971 . . . . 0.0 110.36 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 75' ' ' SER . 12.8 tt -157.11 135.87 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.421 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -48.24 156.14 1.19 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -17.71 16.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.152 . . . . 0.0 109.522 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.1 OUTLIER -57.68 -38.92 75.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.214 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.491 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.1 OUTLIER 74.72 27.16 1.3 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 0.0 109.603 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.24 114.27 51.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 136' ' ' MET . 33.8 Cg_endo -74.49 1.69 7.16 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.336 2.024 . . . . 0.0 110.392 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 139' ' ' ASP . 62.6 t0 -121.54 15.43 11.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.353 -0.842 . . . . 0.0 109.119 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -97.69 -94.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.867 . . . . 0.0 109.726 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 142' ' ' VAL . 9.1 tmm? -163.11 139.13 7.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 109.56 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.454 ' O ' ' SD ' ' A' ' 141' ' ' MET . 5.6 m -104.41 135.25 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 157' ' ' ILE . 4.3 t -103.55 130.01 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.167 -0.958 . . . . 0.0 109.469 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.592 HD22 ' CD1' ' A' ' 128' ' ' TYR . 47.0 mt -88.99 152.41 21.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.846 . . . . 0.0 109.324 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.462 ' SD ' ' CE1' ' A' ' 131' ' ' TYR . 1.4 ttt -111.92 115.48 29.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 109.539 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 155' ' ' TYR . 1.5 m-20 -121.0 165.88 14.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' A' ' 151' ' ' GLY . 0.1 OUTLIER -107.64 135.52 48.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.464 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 153' ' ' THR . 3.3 ttp180 -60.32 173.22 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 109.453 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.38 -31.27 65.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.336 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.46 -46.8 68.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.855 . . . . 0.0 109.348 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.56 ' O ' ' CE1' ' A' ' 147' ' ' TYR . . . 102.09 -28.49 15.7 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 152' ' ' ILE . 1.2 tp -87.45 -10.98 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -1.093 . . . . 0.0 109.24 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 148' ' ' ARG . 2.9 m -115.45 102.13 54.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.401 -0.812 . . . . 0.0 109.34 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.39 143.6 22.16 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.425 2.083 . . . . 0.0 110.3 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 146' ' ' ASN . 6.4 p90 -143.43 144.98 32.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 mtm -110.21 166.96 10.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.346 -0.846 . . . . 0.0 109.177 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 143' ' ' VAL . 3.6 mt -131.55 139.37 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 29.9 m-85 -123.09 153.81 39.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.336 -0.853 . . . . 0.0 109.302 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -75.76 113.93 13.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 26' ' ' ILE . 1.7 tttt -60.35 -44.43 95.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 109.369 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.676 ' OD1' HD12 ' A' ' 95' ' ' ILE . 3.3 p30 -49.38 -38.89 30.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.188 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -104.64 47.55 1.06 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.667 HD11 ' HD2' ' A' ' 4' ' ' TYR . 4.9 tt -151.68 126.77 9.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.437 -1.037 . . . . 0.0 109.31 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.502 HG13 ' CG2' ' A' ' 7' ' ' VAL . 13.4 m -112.27 140.55 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.915 . . . . 0.0 109.575 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.99 134.38 47.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.464 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.83 126.78 53.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.893 . . . . 0.0 109.416 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.459 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -67.09 123.12 19.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.413 -0.804 . . . . 0.0 109.416 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.484 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 2' ' ' LEU . 6.8 mt -111.36 152.89 26.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.694 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.1 mt -114.98 143.44 45.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.493 -0.754 . . . . 0.0 109.078 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.673 ' HD2' HD21 ' A' ' 163' ' ' LEU . 53.0 m-85 -120.47 112.87 19.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.511 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 164' ' ' VAL . 10.5 ttpt -117.6 157.48 26.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.582 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.524 ' OD2' ' CE ' ' A' ' 141' ' ' MET . 2.0 t70 -92.67 155.27 17.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.343 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 8' ' ' ILE . 12.1 m -97.44 -38.87 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.481 ' N ' HG23 ' A' ' 7' ' ' VAL . 4.7 mt -46.65 -79.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.867 . . . . 0.0 109.301 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.24 31.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.919 . . . . 0.0 109.523 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.86 68.13 0.28 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 12' ' ' GLU . 10.1 p30 -52.3 143.81 14.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -1.166 . . . . 0.0 109.429 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 11' ' ' ASP . 44.0 mm-40 58.87 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.82 -74.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.303 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.033 HG23 HD21 ' A' ' 68' ' ' LEU . 7.9 p -149.66 175.4 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 108.95 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.628 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.2 p -138.21 165.83 25.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.862 -1.148 . . . . 0.0 110.754 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.503 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -85.2 8.88 16.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 0.0 109.77 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.94 -25.14 66.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.027 . . . . 0.0 108.961 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.755 ' CE2' HD13 ' A' ' 68' ' ' LEU . 47.2 m-85 -102.47 21.94 14.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.116 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER 60.31 122.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.5 -0.75 . . . . 0.0 109.161 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.813 HD23 ' HA ' ' A' ' 30' ' ' ALA . 22.9 mt -116.04 152.12 34.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.34 -0.85 . . . . 0.0 109.878 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' ' OE2' ' A' ' 29' ' ' GLU . 1.7 mptp? -131.19 148.93 52.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -0.863 . . . . 0.0 109.746 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.38 125.36 36.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.834 . . . . 0.0 109.201 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' ASP . 15.8 t -78.09 148.48 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.729 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' VAL . 76.0 m-20 -44.13 -31.84 1.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.397 -0.815 . . . . 0.0 109.752 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.773 ' O ' HG23 ' A' ' 26' ' ' ILE . 6.5 m-20 -73.47 -101.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.773 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -164.66 59.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.041 -1.037 . . . . 0.0 109.382 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.507 HG21 HG21 ' A' ' 157' ' ' ILE . 18.7 m -145.46 167.78 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.635 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -111.42 144.81 40.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.854 . . . . 0.0 109.353 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.7 pt-20 -117.06 125.11 50.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.014 -1.054 . . . . 0.0 109.317 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.913 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -113.6 112.73 24.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.441 -0.787 . . . . 0.0 108.944 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 31.5 m-20 -67.18 149.62 50.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.35 -0.844 . . . . 0.0 109.893 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.9 p -142.92 174.52 10.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.408 -0.808 . . . . 0.0 109.293 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.395 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.504 ' ND2' ' SD ' ' A' ' 145' ' ' MET . 11.9 m120 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -46.88 -24.47 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.694 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.033 HD21 HG23 ' A' ' 14' ' ' VAL . 31.4 tp -82.25 -42.73 18.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.039 -1.038 . . . . 0.0 108.49 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.578 HG13 ' HB2' ' A' ' 74' ' ' LEU . 3.1 t -54.96 -56.1 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.473 -0.767 . . . . 0.0 108.954 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 70' ' ' TYR . 4.2 t80 -61.38 -41.34 96.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 109.92 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.94 -45.47 64.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.044 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -111.74 19.83 17.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 109.882 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.63 82.58 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.938 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.578 ' HB2' HG13 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -95.22 169.76 9.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 108.824 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.61 ' O ' HG22 ' A' ' 132' ' ' ILE . 1.8 m -128.18 102.96 20.88 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.975 -1.078 . . . . 0.0 110.044 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.433 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 36.3 Cg_endo -80.0 118.37 3.71 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.489 2.126 . . . . 0.0 110.135 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 130' ' ' PHE . 6.0 t -87.93 161.33 17.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.304 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 t -125.95 4.86 7.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 109.81 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.55 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 6.5 t80 -138.62 128.35 24.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 109.711 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.529 ' OD2' ' CE1' ' A' ' 130' ' ' PHE . 4.4 p-10 169.96 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.766 . . . . 0.0 109.454 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -62.36 -42.97 99.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 109.237 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -113.76 -28.65 7.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.492 -0.755 . . . . 0.0 109.09 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -29.09 67.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.324 -0.86 . . . . 0.0 109.317 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.485 ' HB2' ' HB2' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -55.11 -48.96 72.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.488 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.474 ' HA ' HG22 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -64.26 -29.86 70.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 109.993 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -55.24 18.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 88' ' ' ILE . 21.6 m-85 -70.7 -58.25 3.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 109.845 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -42.74 -37.9 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 109.573 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 15.2 mmtp -63.07 -52.69 61.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.356 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.65 -20.26 56.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.602 ' CE2' ' CB ' ' A' ' 141' ' ' MET . 2.8 t80 -77.88 -36.45 49.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.212 -1.17 . . . . 0.0 108.484 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.448 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -64.99 -42.14 94.79 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 4.5 mptt -67.1 -32.02 72.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.588 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.38 89.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.026 -1.046 . . . . 0.0 109.702 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.775 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 34.8 mm -57.57 -45.44 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.172 -0.955 . . . . 0.0 109.749 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -48.09 -33.47 8.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 109.09 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.529 ' N ' ' HG3' ' A' ' 96' ' ' LYS . . . -73.04 -46.82 49.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 108.998 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.881 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -50.54 -38.05 42.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.143 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.881 HD23 ' HD3' ' A' ' 98' ' ' ARG . 1.4 mt -69.92 -44.9 68.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.406 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -51.88 -30.27 23.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.331 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 97' ' ' ALA . 6.9 mt-10 -78.71 -39.26 37.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.156 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.54 -82.51 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.274 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -135.93 135.88 22.27 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -74.84 -14.84 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.593 2.195 . . . . 0.0 110.748 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.74 -13.54 61.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.854 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.782 ' HB3' HD13 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -89.56 -11.42 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.119 -0.988 . . . . 0.0 109.764 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.704 ' HA ' HD12 ' A' ' 99' ' ' LEU . 7.9 t -65.12 -44.39 70.02 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 111.203 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.4 Cg_endo -76.55 -58.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.933 1.756 . . . . 0.0 110.984 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 110' ' ' PHE . 15.8 m -55.9 -43.93 76.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.067 -1.02 . . . . 0.0 109.592 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.775 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 43.7 t80 -58.64 -49.63 76.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.734 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -57.25 -29.91 64.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.115 -0.991 . . . . 0.0 110.175 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -49.16 40.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.152 -0.968 . . . . 0.0 111.569 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.537 ' ND2' ' N ' ' A' ' 114' ' ' ALA . 1.7 p-10 -72.19 -46.73 55.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.847 -1.158 . . . . 0.0 110.733 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.537 ' N ' ' ND2' ' A' ' 113' ' ' ASN . . . -54.93 -46.82 74.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.066 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -53.36 -44.09 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.874 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.46 -41.21 96.47 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.561 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.72 -37.29 78.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -1.179 . . . . 0.0 110.028 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 47.8 t -63.89 -45.21 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.356 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.505 ' C ' ' CD ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -66.13 -28.87 69.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.984 . . . . 0.0 109.611 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -67.55 -49.13 64.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.983 . . . . 0.0 110.0 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.07 HG12 HD13 ' A' ' 144' ' ' LEU . 1.6 mp -70.18 -32.01 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 109.699 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 122' ' ' LEU . 43.5 mt -57.16 -30.47 64.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.696 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.51 -48.32 62.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 109.773 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 127' ' ' ASP . 1.5 m-80 -139.57 69.56 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -63.15 -21.59 66.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -62.93 -63.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.845 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 128' ' ' TYR . 18.7 p30 -65.63 -22.68 66.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.246 -0.909 . . . . 0.0 109.959 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 2.9 m-85 -76.08 -16.92 59.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 109.903 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.489 ' C ' ' CG ' ' A' ' 130' ' ' PHE . 3.0 m-20 44.8 -168.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.166 -0.959 . . . . 0.0 109.264 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.811 ' HB3' HG11 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -154.06 121.14 5.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 108.681 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.967 ' O ' HG13 ' A' ' 142' ' ' VAL . 14.6 m-85 -105.16 164.42 11.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.178 -0.951 . . . . 0.0 110.692 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 75' ' ' SER . 1.1 tt -155.94 139.77 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.403 -0.81 . . . . 0.0 109.488 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.37 164.25 1.09 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 135' ' ' SER . 2.6 pt-20 -67.13 -21.07 65.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -1.177 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.2 OUTLIER -62.34 -35.3 78.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 77.48 50.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.869 . . . . 0.0 109.612 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.33 107.77 60.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.123 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.34 0.23 8.81 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.26 1.973 . . . . 0.0 110.486 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.77 -14.68 23.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.884 . . . . 0.0 109.115 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 141' ' ' MET . . . -79.7 -91.77 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.445 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.602 ' CB ' ' CE2' ' A' ' 91' ' ' TYR . 1.9 ptp 179.42 149.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 131' ' ' TYR . 70.3 t -97.76 138.15 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.183 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.639 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 3.6 t -93.25 111.35 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.134 -0.979 . . . . 0.0 109.043 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 1.07 HD13 HG12 ' A' ' 121' ' ' ILE . 2.5 mt -79.26 149.13 31.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.778 ' HE3' ' CE2' ' A' ' 131' ' ' TYR . 12.4 ttm -124.58 131.21 53.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.624 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.545 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 19.7 t30 -142.34 168.79 18.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 109.108 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.468 ' HB3' ' HA2' ' A' ' 151' ' ' GLY . 4.5 m-85 -77.06 159.39 29.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.058 -1.026 . . . . 0.0 109.385 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.59 ' HB2' ' CD1' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -151.59 -173.62 4.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 110.011 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 56.05 -97.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 109.655 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -106.94 -25.72 11.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.019 -1.051 . . . . 0.0 109.152 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 147' ' ' TYR . . . 123.17 17.43 3.31 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.65 -21.37 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.281 -1.129 . . . . 0.0 108.903 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 153' ' ' THR . 2.9 t -105.0 128.21 27.16 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.111 -0.993 . . . . 0.0 109.566 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -82.87 146.92 13.24 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.754 2.303 . . . . 0.0 110.696 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.59 ' CD1' ' HB2' ' A' ' 148' ' ' ARG . 7.2 p90 -145.18 155.33 43.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 108.851 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.461 ' SD ' ' N ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -126.73 162.2 26.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 109.795 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.507 HG21 HG21 ' A' ' 27' ' ' VAL . 4.4 mt -124.26 145.3 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 109.507 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.639 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 9.7 m-85 -129.31 128.52 43.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.312 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -51.23 127.27 18.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -62.49 -53.69 51.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.405 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -47.52 -44.72 25.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -90.17 44.19 2.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.806 ' O ' HD23 ' A' ' 163' ' ' LEU . 2.2 tt -158.5 123.54 4.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.431 -1.041 . . . . 0.0 109.212 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 5' ' ' LYS . 30.1 m -116.69 153.61 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.456 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.8 p -90.86 146.92 23.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.953 . . . . 0.0 109.639 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.53 120.64 15.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.471 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 168' ' ' PHE . 0.0 OUTLIER -70.21 108.27 4.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.404 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 168' ' ' PHE . 13.9 t80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.545 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.52 ' HG2' HD21 ' A' ' 3' ' ' LEU . 7.6 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.616 HD13 ' O ' ' A' ' 166' ' ' GLU . 0.8 OUTLIER -68.48 146.74 52.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 110.126 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.914 HD11 ' CG ' ' A' ' 168' ' ' PHE . 6.8 mt -121.85 139.57 53.46 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.633 ' HB2' HG13 ' A' ' 14' ' ' VAL . 91.5 m-85 -121.43 108.89 14.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.977 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 1.8 mtmm -108.82 167.29 10.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.454 -0.778 . . . . 0.0 109.272 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -83.86 151.23 25.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.97 . . . . 0.0 109.362 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.543 HG21 HG13 ' A' ' 164' ' ' VAL . 5.3 t -108.31 35.6 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 109.486 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.927 HG21 ' O ' ' A' ' 139' ' ' ASP . 24.0 mm -117.07 -52.4 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.417 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.96 -34.96 2.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.5 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 106.62 2.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -176.28 136.54 0.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -1.145 . . . . 0.0 109.496 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.476 ' OE1' ' CG ' ' A' ' 72' ' ' PHE . 7.8 pt-20 -48.51 147.36 2.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.642 HD22 ' HD2' ' A' ' 158' ' ' PHE . 3.7 mt -132.6 -80.58 0.49 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.154 -0.966 . . . . 0.0 109.532 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.862 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 2.6 p -132.37 166.77 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.853 . . . . 0.0 109.104 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.596 ' N ' HG22 ' A' ' 14' ' ' VAL . 3.9 p -142.0 161.93 36.75 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.017 -1.052 . . . . 0.0 110.098 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -83.02 1.27 40.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.381 -0.824 . . . . 0.0 109.598 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.86 -9.39 37.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.378 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.673 ' CE2' HD13 ' A' ' 68' ' ' LEU . 35.7 m-85 -119.52 20.69 12.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 65.38 130.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 109.006 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.734 HD23 ' HA ' ' A' ' 30' ' ' ALA . 49.4 mt -125.68 146.08 49.89 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -0.95 . . . . 0.0 110.015 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -123.43 134.26 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -0.807 . . . . 0.0 109.35 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.438 ' CD ' ' HA ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -90.93 122.4 33.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.181 -0.949 . . . . 0.0 108.789 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 2.3 t -114.55 120.44 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 4.0 t70 74.4 5.97 4.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 109.802 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 20.3 t0 59.12 68.89 0.77 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 109.513 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.656 HG23 HG13 ' A' ' 27' ' ' VAL . 5.8 tt 174.54 -29.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.129 -0.982 . . . . 0.0 109.905 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.656 HG13 HG23 ' A' ' 26' ' ' ILE . 23.1 m -120.93 140.13 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.957 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -105.44 148.92 26.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.193 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -120.97 121.06 37.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.405 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.862 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -106.22 112.88 26.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.193 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -68.38 149.57 49.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 66' ' ' ASN . 34.7 m -100.26 151.17 21.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 0.0 109.259 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.748 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.485 ' OD1' ' HB3' ' A' ' 32' ' ' CYS . 1.5 m-20 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 71' ' ' SER . 33.7 t30 -89.7 -27.09 20.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.739 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.673 HD13 ' CE2' ' A' ' 18' ' ' TYR . 13.3 tp -83.48 -37.63 22.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 108.982 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.573 HG13 ' HB2' ' A' ' 74' ' ' LEU . 53.3 t -72.61 -48.28 47.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.723 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -69.29 -36.04 76.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 110.93 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 70.3 m -79.49 -52.85 7.51 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.966 -1.084 . . . . 0.0 110.506 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CG ' ' OE1' ' A' ' 12' ' ' GLU . 7.2 m-30 -79.82 -3.6 48.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.128 -0.982 . . . . 0.0 109.968 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.81 88.04 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 109.571 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.573 ' HB2' HG13 ' A' ' 69' ' ' VAL . 1.4 mm? -111.85 139.05 47.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 108.719 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.67 122.99 18.1 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.066 -1.021 . . . . 0.0 109.871 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.14 126.28 7.7 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.374 2.049 . . . . 0.0 110.097 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 t -123.92 117.02 23.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -0.966 . . . . 0.0 109.645 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -59.34 151.46 23.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.242 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 17.9 t80 -151.93 155.3 37.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 109.703 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.637 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 1.4 m-20 -86.42 124.27 32.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -0.879 . . . . 0.0 109.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -34.61 68.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.147 -0.971 . . . . 0.0 110.033 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -56.25 -64.91 0.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.617 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 79' ' ' PHE . 7.4 t -59.8 -28.74 67.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.788 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.32 -35.48 67.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.495 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.4 mtt -57.04 -49.42 75.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.141 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -48.81 79.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.489 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -62.7 -19.19 63.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.256 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 92' ' ' MET . 0.6 OUTLIER -79.22 -28.92 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -39.55 58.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.426 -0.796 . . . . 0.0 109.115 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.13 -38.79 88.48 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.568 ' CZ ' ' O ' ' A' ' 138' ' ' PRO . 14.7 m-30 -74.52 -36.5 63.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.101 -1.234 . . . . 0.0 108.816 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.536 ' CE ' ' O ' ' A' ' 92' ' ' MET . 0.0 OUTLIER -65.21 -38.99 92.15 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.624 0.726 . . . . 0.0 109.293 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.506 ' C ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.15 -36.91 82.86 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.571 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.58 -50.77 67.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.994 -1.066 . . . . 0.0 109.244 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.837 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 29.5 mm -59.93 -43.0 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.235 -0.915 . . . . 0.0 108.969 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -47.38 -51.61 19.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.875 . . . . 0.0 109.364 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 100' ' ' GLN . . . -58.19 -36.53 73.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.015 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 101' ' ' GLU . 1.8 tmt_? -64.15 -32.85 74.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -0.916 . . . . 0.0 109.683 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.526 HD23 ' HD3' ' A' ' 98' ' ' ARG . 22.4 mt -73.78 -50.21 21.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 110.213 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.539 ' HG3' ' N ' ' A' ' 101' ' ' GLU . 2.6 pt20 -55.83 -34.98 65.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.679 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 7.4 pt-20 -72.79 -35.52 67.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.103 -0.998 . . . . 0.0 109.191 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.52 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 10.2 t -88.28 -80.31 0.28 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.277 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -135.74 137.78 26.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 109.325 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.92 -25.97 11.53 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.547 2.165 . . . . 0.0 110.637 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -70.46 -6.83 38.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.676 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.516 ' O ' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -97.92 -4.8 35.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 109.819 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.607 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 32.7 t -70.18 -44.62 20.49 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.989 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.6 Cg_endo -77.7 -41.05 0.34 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.018 1.812 . . . . 0.0 111.096 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.34 -43.37 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 0.0 109.938 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.837 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 87.1 t80 -69.72 -37.11 76.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 0.0 110.408 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -63.25 -53.78 47.64 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.09 -1.006 . . . . 0.0 110.719 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -47.19 61.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.016 -1.053 . . . . 0.0 110.675 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -55.73 -54.26 46.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.138 -0.976 . . . . 0.0 110.124 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.77 69.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 109.968 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -59.22 -35.51 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.126 -0.983 . . . . 0.0 109.559 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.48 -45.85 95.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.623 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -68.14 -30.72 69.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -1.2 . . . . 0.0 110.081 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 54.4 t -68.02 -42.35 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.888 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 115' ' ' ILE . 40.2 mmtt -69.06 -42.05 76.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.075 -1.015 . . . . 0.0 109.78 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.499 ' HA ' ' CE ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -59.54 -60.5 3.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.797 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 117' ' ' PHE . 1.3 mt -53.98 -47.69 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 122' ' ' LEU . 25.6 mt -47.3 -49.6 23.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 109.762 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.78 -41.85 45.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.966 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.73 52.02 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.885 . . . . 0.0 109.435 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 8.9 p90 -63.43 -27.53 69.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.578 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.427 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 5.5 mttp -64.82 -39.77 94.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.404 -0.81 . . . . 0.0 109.704 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.67 -23.76 42.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 110.01 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 129' ' ' ASP . 7.1 m-85 -81.7 -25.92 35.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.874 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.521 ' C ' ' CD1' ' A' ' 130' ' ' PHE . 14.0 m-20 51.29 179.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.59 ' HB3' HG11 ' A' ' 142' ' ' VAL . 36.3 m-85 -142.3 121.61 13.11 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.352 -0.843 . . . . 0.0 109.052 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.987 ' O ' HG13 ' A' ' 142' ' ' VAL . 10.9 m-85 -99.31 166.24 11.3 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.189 -0.944 . . . . 0.0 110.538 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 7.8 tp -156.58 146.84 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.702 . . . . 0.0 109.278 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.03 162.38 52.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -58.24 -23.63 56.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -1.107 . . . . 0.0 109.427 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 136' ' ' MET . 11.4 p -68.59 -34.76 76.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 109.359 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.486 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 0.0 OUTLIER 70.6 63.63 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.521 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.37 105.73 38.2 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.341 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.568 ' O ' ' CZ ' ' A' ' 91' ' ' TYR . 34.0 Cg_endo -74.5 -20.85 17.7 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.274 1.982 . . . . 0.0 109.961 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.927 ' O ' HG21 ' A' ' 8' ' ' ILE . 7.7 t70 -75.43 -6.26 49.18 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.364 -0.835 . . . . 0.0 108.962 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.15 -175.71 2.88 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.266 -0.896 . . . . 0.0 109.35 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.2 ptm -92.31 167.47 11.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 109.475 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.987 HG13 ' O ' ' A' ' 131' ' ' TYR . 58.7 t -113.35 142.03 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 109.185 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 157' ' ' ILE . 13.0 t -90.01 130.04 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.174 -0.954 . . . . 0.0 108.838 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.558 HD13 HG12 ' A' ' 121' ' ' ILE . 18.0 mt -92.55 134.4 35.02 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.492 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.471 ' HB2' ' CE1' ' A' ' 131' ' ' TYR . 4.8 ttt -107.63 126.28 52.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.571 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 2.2 t30 -139.34 169.11 18.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 1.6 m-85 -110.23 144.81 38.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.65 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.445 ' CZ ' HG21 ' A' ' 153' ' ' THR . 0.5 OUTLIER -67.48 170.67 7.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 109.608 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -47.67 -35.8 10.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 109.577 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -77.35 -44.63 28.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.298 -0.876 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.569 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 100.46 -30.2 10.71 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.6 tp -68.2 -6.57 5.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.47 -1.018 . . . . 0.0 109.661 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 153' ' ' THR . 1.7 m -122.81 101.73 39.08 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 109.665 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.14 121.8 5.02 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.57 2.18 . . . . 0.0 109.98 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 146' ' ' ASN . 31.7 p90 -126.37 148.35 49.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -0.983 . . . . 0.0 109.88 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.461 ' HG2' ' HG3' ' A' ' 145' ' ' MET . 0.2 OUTLIER -116.14 167.17 11.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.35 -0.844 . . . . 0.0 109.135 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.772 ' O ' HG13 ' A' ' 143' ' ' VAL . 11.6 mt -128.46 148.63 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 0.0 109.783 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.642 ' HD2' HD22 ' A' ' 13' ' ' LEU . 12.4 m-85 -136.55 125.73 24.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.471 ' HB3' ' OD1' ' A' ' 161' ' ' ASP . 2.5 m-85 -60.03 132.41 53.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 110.25 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 77.3 tttt -68.23 -41.85 80.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.487 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.471 ' OD1' ' HB3' ' A' ' 159' ' ' PHE . 5.2 p-10 -50.56 -45.01 56.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.012 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -97.93 45.94 1.65 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.845 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -161.34 129.23 4.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.464 -1.021 . . . . 0.0 108.919 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.543 HG13 HG21 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -115.46 149.16 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.624 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.89 121.64 38.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.616 ' O ' HD13 ' A' ' 2' ' ' LEU . 1.8 tp10 -118.42 142.98 47.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.671 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.49 113.6 25.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.914 ' CG ' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.489 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mt -100.8 158.4 15.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 3' ' ' LEU . 25.7 mt -112.41 134.47 53.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.479 -0.763 . . . . 0.0 109.427 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.599 ' CD2' HD21 ' A' ' 163' ' ' LEU . 10.5 m-85 -117.4 112.24 20.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.68 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 12' ' ' GLU . 1.5 mtmt -123.15 162.39 22.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.415 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -97.04 158.21 15.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.416 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.86 54.32 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -0.984 . . . . 0.0 109.663 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -140.7 -50.1 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.034 -1.041 . . . . 0.0 109.595 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.587 ' O ' ' HB2' ' A' ' 140' ' ' ALA . 1.5 t 176.47 45.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -141.87 -43.93 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 6.8 t0 74.96 -137.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -1.112 . . . . 0.0 109.275 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.447 ' HA ' ' HG2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -42.33 121.37 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.047 -1.033 . . . . 0.0 109.677 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.476 ' HA ' HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -125.1 -62.08 1.25 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.138 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.826 HG21 ' CB ' ' A' ' 30' ' ' ALA . 6.5 p -143.46 175.81 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.365 -0.834 . . . . 0.0 108.855 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.652 ' H ' HG22 ' A' ' 14' ' ' VAL . 22.6 t -147.49 169.59 19.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.846 -1.159 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.545 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 31.4 t70 -87.54 12.73 11.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.479 -0.763 . . . . 0.0 109.447 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.39 -15.28 63.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 108.996 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CE1' ' ND2' ' A' ' 67' ' ' ASN . 44.5 m-85 -115.92 21.38 13.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.471 -0.768 . . . . 0.0 109.207 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.2 t0 65.32 129.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 108.511 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 30' ' ' ALA . 13.0 mt -124.28 143.2 50.69 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.144 -0.973 . . . . 0.0 110.252 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.32 136.7 52.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.34 117.74 34.45 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.252 -0.905 . . . . 0.0 108.767 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 t -68.46 147.81 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 109.49 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -46.31 -25.4 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 109.751 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.467 ' O ' HG23 ' A' ' 26' ' ' ILE . 2.2 m-20 -77.96 -110.39 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -154.82 64.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.811 -1.181 . . . . 0.0 109.305 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.3 m -147.18 141.27 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 109.674 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.409 ' CE2' ' HE2' ' A' ' 4' ' ' TYR . 4.9 m-85 -98.65 148.39 23.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.152 -0.968 . . . . 0.0 109.066 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 19.4 mt-10 -125.15 121.11 33.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.116 -0.99 . . . . 0.0 110.12 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.89 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -106.39 112.71 25.83 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -71.52 146.48 48.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 110.509 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 28.3 p -126.74 115.18 19.01 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.425 ' HG2' ' ND2' ' A' ' 67' ' ' ASN . 14.6 pt20 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 110.056 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.462 ' ND2' ' CE1' ' A' ' 18' ' ' TYR . 38.5 p-10 -86.12 -19.57 29.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.671 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 18.1 tp -86.38 -47.56 9.23 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 108.957 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.773 HG13 ' HB2' ' A' ' 74' ' ' LEU . 55.6 t -68.24 -37.33 77.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.322 -0.862 . . . . 0.0 109.171 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -69.84 -44.57 69.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 109.668 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 t -63.24 -36.93 85.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.315 -0.866 . . . . 0.0 110.121 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.692 ' HB2' HD23 ' A' ' 74' ' ' LEU . 25.9 m-85 -103.26 2.9 34.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 109.891 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER 56.82 29.66 16.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.154 -0.966 . . . . 0.0 109.789 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.773 ' HB2' HG13 ' A' ' 69' ' ' VAL . 2.0 mm? -41.72 149.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.411 -0.806 . . . . 0.0 109.345 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.434 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -131.06 127.38 21.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.384 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.16 122.17 5.61 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.496 2.131 . . . . 0.0 110.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.4 127.26 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.37 -178.68 3.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.29 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 50.5 t80 -164.91 163.0 21.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.605 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 35.6 m-20 -77.38 120.48 22.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.458 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 2.1 tmtt? -59.14 -53.25 60.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.88 -45.33 86.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.76 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.505 ' CB ' ' HB2' ' A' ' 80' ' ' ASP . 1.3 t -61.75 -29.06 69.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.344 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 81' ' ' LYS . 41.6 t80 -58.41 -34.99 71.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.779 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -57.34 12.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.96 . . . . 0.0 109.778 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -59.87 -38.02 81.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.003 . . . . 0.0 109.273 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.509 ' CE2' ' CZ ' ' A' ' 91' ' ' TYR . 6.5 t80 -66.44 -23.1 66.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.385 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -78.72 -31.48 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 108.952 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -72.02 -47.28 52.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.41 -29.86 74.61 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.509 ' CZ ' ' CE2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -75.38 -35.79 61.02 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.129 -1.218 . . . . 0.0 108.41 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -54.42 26.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.598 -0.689 . . . . 0.0 109.745 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -38.47 75.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.346 -0.846 . . . . 0.0 109.868 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.54 -45.34 73.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.113 -0.992 . . . . 0.0 109.297 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.473 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 34.8 mm -69.82 -36.67 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -47.19 63.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 109.202 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.72 81.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.127 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.4 OUTLIER -52.95 -44.29 66.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.456 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.827 HD13 ' HB3' ' A' ' 106' ' ' ARG . 2.0 mt -71.93 -44.06 64.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.295 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -25.16 9.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.199 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -86.98 -34.44 19.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 t -96.09 -89.02 0.26 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.326 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.439 ' OD1' ' NH2' ' A' ' 106' ' ' ARG . 27.8 p-10 -125.62 132.38 24.3 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.271 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.9 -19.44 18.09 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.641 2.227 . . . . 0.0 110.884 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.9 -6.82 29.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.202 -0.936 . . . . 0.0 109.905 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.827 ' HB3' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -95.81 -5.94 40.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.084 -1.01 . . . . 0.0 109.811 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.625 ' HA ' HD12 ' A' ' 99' ' ' LEU . 96.0 t -72.18 -43.25 9.99 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.137 -0.977 . . . . 0.0 111.229 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.6 Cg_endo -75.98 -56.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.762 1.641 . . . . 0.0 110.862 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 110' ' ' PHE . 12.8 m -55.84 -40.95 64.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.036 -1.04 . . . . 0.0 109.471 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.511 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 68.9 t80 -65.82 -37.1 85.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.817 . . . . 0.0 110.253 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.775 ' O ' HD13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -66.42 -49.87 65.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.964 -1.085 . . . . 0.0 110.562 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -66.14 -49.45 67.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.887 -1.133 . . . . 0.0 110.544 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -58.2 -46.42 85.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.985 . . . . 0.0 109.813 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -65.44 -27.56 68.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.373 -0.829 . . . . 0.0 109.751 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.775 HD13 ' O ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -67.13 -47.41 81.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.251 -0.905 . . . . 0.0 109.446 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.27 -50.51 44.53 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.475 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.78 -38.95 76.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.081 -1.247 . . . . 0.0 109.803 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 114' ' ' ALA . 53.1 t -68.4 -39.16 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -32.34 69.64 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.157 -0.964 . . . . 0.0 109.295 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -96.92 -10.07 27.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.661 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.2 -53.68 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.629 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.537 ' N ' HG22 ' A' ' 121' ' ' ILE . 10.1 mt -48.77 -44.23 38.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.016 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.79 76.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 110.033 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.542 ' O ' ' CE2' ' A' ' 128' ' ' TYR . 19.6 m-20 -101.44 38.84 1.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.14 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.651 ' HA ' ' CE1' ' A' ' 128' ' ' TYR . 13.4 t80 -63.41 -53.69 48.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.082 -1.011 . . . . 0.0 109.061 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -78.9 -8.43 58.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 108.988 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 124' ' ' ASN . 0.8 OUTLIER -80.17 -39.53 29.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.341 -0.85 . . . . 0.0 109.937 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.651 ' CE1' ' HA ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -108.55 -10.43 15.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.969 -1.082 . . . . 0.0 110.041 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.8 m-20 52.27 173.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.726 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -114.71 122.23 45.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.599 ' HB3' HD12 ' A' ' 74' ' ' LEU . 11.2 m-85 -103.27 177.63 4.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 110.558 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.671 ' O ' HD13 ' A' ' 74' ' ' LEU . 3.9 tp -143.02 149.03 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.541 -0.725 . . . . 0.0 109.545 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 132' ' ' ILE . . . -73.01 -178.77 35.41 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -18.06 63.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -1.187 . . . . 0.0 109.539 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -60.95 -41.69 96.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.217 -0.927 . . . . 0.0 109.39 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 75.56 48.88 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.672 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.53 ' O ' HD11 ' A' ' 132' ' ' ILE . 72.4 m-20 -118.84 134.02 23.6 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 109.373 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.409 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 34.1 Cg_endo -75.59 -5.48 16.58 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.317 2.011 . . . . 0.0 110.157 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.425 ' HB3' ' CB ' ' A' ' 9' ' ' SER . 11.4 t70 -101.48 -3.31 28.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 109.304 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 9' ' ' SER . . . -85.17 137.87 32.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 109.378 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.471 ' SD ' ' HB2' ' A' ' 159' ' ' PHE . 1.4 ttp -43.42 152.99 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.742 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.9 m -100.67 141.44 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.365 -0.835 . . . . 0.0 109.279 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.611 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.1 t -102.27 139.04 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.236 -0.915 . . . . 0.0 109.42 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.515 ' HB3' ' CG ' ' A' ' 128' ' ' TYR . 4.9 mt -107.13 146.16 31.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.31 -0.869 . . . . 0.0 109.206 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 128' ' ' TYR . 1.8 ttm -111.98 125.78 54.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.674 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.41 ' HB3' ' OH ' ' A' ' 155' ' ' TYR . 2.4 t-20 -139.13 169.08 18.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 4.9 m-85 -102.66 145.91 28.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.597 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.574 ' HB2' ' CE2' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -142.85 -170.84 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.345 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' ARG . 0.8 OUTLIER 62.07 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.571 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.68 -22.17 11.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.586 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.591 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 124.27 -18.37 7.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 152' ' ' ILE . 2.4 tp -96.26 7.23 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.299 -1.118 . . . . 0.0 109.394 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.6 m -110.64 101.8 50.13 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.298 -0.876 . . . . 0.0 109.633 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.59 139.39 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.521 2.147 . . . . 0.0 110.18 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 148' ' ' ARG . 52.0 p90 -145.14 158.64 43.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 109.655 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 158' ' ' PHE . 7.1 mtm -107.44 156.14 19.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.301 -0.874 . . . . 0.0 109.295 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.497 ' O ' HG13 ' A' ' 143' ' ' VAL . 42.3 mt -122.6 132.61 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.08 -1.012 . . . . 0.0 110.011 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.611 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 7.8 m-85 -126.22 115.11 19.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.481 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 3.8 m-85 -50.41 126.28 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.397 -0.814 . . . . 0.0 109.774 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 161' ' ' ASP . 4.9 tttm -68.49 -38.14 80.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.772 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 1.8 p30 -43.26 -41.45 3.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . -110.0 54.29 0.55 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.608 ' C ' HD23 ' A' ' 163' ' ' LEU . 8.7 tt -157.66 142.37 16.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -1.099 . . . . 0.0 109.556 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.475 ' N ' HD23 ' A' ' 163' ' ' LEU . 19.8 m -127.65 152.65 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.4 m -104.31 121.34 43.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.099 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -115.93 127.56 55.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.616 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 146.53 25.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.875 . . . . 0.0 109.564 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.433 ' C ' HD23 ' A' ' 2' ' ' LEU . 2.4 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 167' ' ' LYS . 2.9 mt -105.44 165.04 11.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.897 . . . . 0.0 109.421 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 3' ' ' LEU . 79.6 mt -127.27 129.63 48.08 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.432 -0.792 . . . . 0.0 109.584 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HB3' HD22 ' A' ' 163' ' ' LEU . 64.2 m-85 -111.59 108.79 18.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.255 -0.903 . . . . 0.0 109.312 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.669 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -117.24 163.91 15.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.773 ' HB2' HD12 ' A' ' 13' ' ' LEU . 4.3 t0 -76.23 152.41 36.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.889 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.572 ' CG2' HG13 ' A' ' 164' ' ' VAL . 2.7 t -102.32 -5.97 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.81 . . . . 0.0 109.344 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.603 HG21 ' O ' ' A' ' 139' ' ' ASP . 4.7 mt -97.54 -79.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.415 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -144.47 67.37 1.26 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 0.0 109.554 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -130.81 -65.83 0.1 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER 73.52 13.18 4.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.315 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 1.4 pt-20 170.67 107.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.039 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.773 HD12 ' HB2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -129.4 -64.98 0.87 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.834 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.894 HG23 HD21 ' A' ' 68' ' ' LEU . 11.3 p -157.31 170.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.299 -0.876 . . . . 0.0 108.968 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.68 ' C ' HD11 ' A' ' 20' ' ' LEU . 3.7 p -155.06 -176.23 5.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.667 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.23 10.71 6.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.545 -0.722 . . . . 0.0 110.165 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.493 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . . . -66.05 -10.25 38.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.056 -1.027 . . . . 0.0 109.19 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.614 ' CG ' HD11 ' A' ' 68' ' ' LEU . 8.1 m-85 -127.41 21.69 6.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.174 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.19 130.56 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.768 HD23 ' HA ' ' A' ' 30' ' ' ALA . 19.3 mt -126.86 148.46 49.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 110.484 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.96 133.14 53.77 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.7 122.47 38.5 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.179 -0.951 . . . . 0.0 108.839 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.39 158.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.095 -1.003 . . . . 0.0 109.168 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -64.1 -10.53 23.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.086 -1.009 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.76 ' C ' HG23 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -76.87 1.45 17.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.779 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.76 HG23 ' C ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 75.22 25.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.428 ' HB ' HG22 ' A' ' 157' ' ' ILE . 20.2 m -119.3 156.57 21.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 110.186 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -107.64 157.01 18.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 0.0 109.07 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.5 mt-10 -130.47 117.63 19.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.946 -1.096 . . . . 0.0 109.342 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.768 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -110.25 114.15 27.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -57.46 143.13 41.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -102.84 174.1 6.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.244 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 3.0 tt0 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.912 . . . . 0.0 109.588 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 3.6 m-20 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 52.7 t-20 -90.98 -26.62 19.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.622 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.894 HD21 HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -77.31 -42.5 36.56 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.771 HG13 ' HB2' ' A' ' 74' ' ' LEU . 44.6 t -73.19 -34.73 45.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.454 -0.779 . . . . 0.0 109.301 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 15.3 t80 -63.33 -48.79 76.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 110.384 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.54 -40.39 61.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.18 -0.95 . . . . 0.0 110.32 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CB ' HD23 ' A' ' 74' ' ' LEU . 62.8 m-85 -86.2 4.31 39.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 109.992 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.468 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 4.8 mtt85 52.82 35.66 19.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.569 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.771 ' HB2' HG13 ' A' ' 69' ' ' VAL . 1.8 mm? -57.59 167.58 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.879 -1.138 . . . . 0.0 108.715 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.568 ' HB3' HG23 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -130.23 117.03 17.8 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.996 -1.065 . . . . 0.0 109.73 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.86 123.29 5.71 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.488 2.125 . . . . 0.0 110.506 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.863 HG22 ' O ' ' A' ' 130' ' ' PHE . 14.8 t -105.91 128.35 53.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.354 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -100.46 2.08 41.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 109.847 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 12.3 t80 -120.87 124.75 45.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.068 -1.02 . . . . 0.0 109.529 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 178.3 31.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.71 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -62.61 -46.78 86.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 109.349 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.13 -23.1 9.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.366 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 m -72.0 -32.65 67.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 0.0 109.656 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 2.2 t80 -60.14 -43.92 95.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.942 . . . . 0.0 109.808 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtt -60.18 -50.79 72.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.333 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -60.03 -36.54 77.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.042 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.632 ' CD1' ' CB ' ' A' ' 138' ' ' PRO . 8.9 m-85 -74.96 -23.84 58.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.102 -0.999 . . . . 0.0 109.686 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.3 -29.03 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.021 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.57 -36.91 25.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.233 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.98 -31.19 74.84 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.604 ' CZ ' ' HG3' ' A' ' 141' ' ' MET . 2.2 t80 -81.18 -39.32 25.66 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.16 -1.2 . . . . 0.0 109.077 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -47.46 84.4 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.113 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -39.34 93.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.312 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.52 -47.31 73.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.221 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.537 HD11 ' HE1' ' A' ' 91' ' ' TYR . 47.5 mm -66.33 -32.08 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.33 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -36.06 71.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.889 -1.132 . . . . 0.0 108.577 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.72 -49.8 23.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.404 -0.81 . . . . 0.0 109.952 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -54.19 -34.69 61.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.064 -1.023 . . . . 0.0 109.708 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.535 ' HB2' HG22 ' A' ' 107' ' ' VAL . 61.3 mt -73.93 -35.52 64.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.102 -0.999 . . . . 0.0 109.12 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -22.23 65.05 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.147 -0.971 . . . . 0.0 109.287 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.01 -41.42 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 110.119 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 t -145.4 47.34 1.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.937 -1.102 . . . . 0.0 110.292 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 1.9 m-20 174.65 72.98 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.38 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.56 -43.31 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.7 2.267 . . . . 0.0 110.682 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.408 ' O ' HG22 ' A' ' 109' ' ' VAL . 4.9 mt-10 -72.27 -12.89 61.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.849 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.501 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -93.21 -7.57 44.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.139 -0.976 . . . . 0.0 109.799 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 71.0 t -67.16 -44.14 47.79 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 111.14 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.9 Cg_endo -76.54 -54.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.866 1.71 . . . . 0.0 110.979 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 0.8 OUTLIER -59.78 -34.21 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.076 -1.015 . . . . 0.0 109.68 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.475 ' CB ' ' O ' ' A' ' 106' ' ' ARG . 93.4 t80 -68.95 -43.44 75.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.955 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -31.17 71.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 109.814 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -71.82 -49.37 39.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.553 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -68.92 -51.36 40.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.17 -0.956 . . . . 0.0 110.391 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.921 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -54.4 -26.95 33.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.881 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.11 -39.0 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.454 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.74 -49.96 51.52 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.413 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.44 -30.68 68.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -1.108 . . . . 0.0 109.582 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 114' ' ' ALA . 78.5 t -63.69 -41.1 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.64 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.84 -37.23 79.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.118 -0.989 . . . . 0.0 109.798 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -61.79 -60.12 4.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.829 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 117' ' ' PHE . 1.9 mp -56.38 -48.32 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 109.766 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 52.8 mt -46.91 -35.17 6.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.129 -0.982 . . . . 0.0 109.695 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -45.74 -48.94 15.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.802 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.6 57.35 1.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 109.664 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 1.9 p90 -55.63 -20.53 14.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.628 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.438 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -71.35 -45.61 62.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.759 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -73.41 -26.34 60.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -78.03 -25.13 47.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.421 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 60.04 170.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.541 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.863 ' O ' HG22 ' A' ' 77' ' ' THR . 2.1 m-85 -133.16 122.02 23.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 108.872 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.63 ' O ' HG13 ' A' ' 142' ' ' VAL . 14.7 m-85 -101.25 166.92 10.52 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.146 -0.971 . . . . 0.0 110.391 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.568 HG23 ' HB3' ' A' ' 75' ' ' SER . 3.6 tt -152.06 135.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.636 -0.665 . . . . 0.0 109.516 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.1 173.61 0.36 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -66.18 -23.98 66.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -1.113 . . . . 0.0 109.499 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.2 OUTLIER -59.27 -35.2 73.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.177 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.464 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER 71.68 53.05 0.22 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 109.61 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.531 ' N ' HD11 ' A' ' 132' ' ' ILE . 1.9 t70 -130.6 134.01 25.52 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.363 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.632 ' CB ' ' CD1' ' A' ' 87' ' ' TYR . 34.4 Cg_endo -75.1 -0.21 9.73 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.345 2.03 . . . . 0.0 110.374 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.603 ' O ' HG21 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -103.11 7.86 38.75 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 109.008 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 141' ' ' MET . . . -106.14 17.74 23.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.914 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.604 ' HG3' ' CZ ' ' A' ' 91' ' ' TYR . 7.9 ttm 74.45 148.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.037 -1.039 . . . . 0.0 110.274 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 131' ' ' TYR . 16.5 t -114.38 139.3 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 109.226 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.71 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.7 t -105.73 125.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.062 -1.024 . . . . 0.0 109.602 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -106.21 149.4 26.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.921 . . . . 0.0 109.069 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.502 ' HB3' ' HB3' ' A' ' 156' ' ' MET . 12.9 ptp -146.1 147.34 31.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.0 . . . . 0.0 109.744 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -156.18 161.64 40.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.911 . . . . 0.0 109.424 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.4 139.29 58.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.947 . . . . 0.0 109.374 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.441 ' CD ' HG22 ' A' ' 153' ' ' THR . 15.4 ptm180 -70.38 -170.28 0.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 109.616 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -27.82 68.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.923 . . . . 0.0 109.672 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 152' ' ' ILE . 1.2 m-20 -75.79 -14.9 60.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 56.36 22.68 38.56 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.804 HD12 ' HB ' ' A' ' 153' ' ' THR . 2.7 pp -110.0 -29.26 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -1.136 . . . . 0.0 109.795 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.804 ' HB ' HD12 ' A' ' 152' ' ' ILE . 5.9 t -138.22 134.68 17.85 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.014 . . . . 0.0 109.812 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 153' ' ' THR . 36.7 Cg_endo -81.07 151.89 18.44 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.664 2.242 . . . . 0.0 110.332 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -145.17 133.66 21.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.448 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.617 ' HG3' ' CE1' ' A' ' 158' ' ' PHE . 0.0 OUTLIER -105.8 155.41 19.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.296 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.428 HG22 ' HB ' ' A' ' 27' ' ' VAL . 2.5 mt -118.16 154.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.771 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.71 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 49.9 m-85 -133.12 164.16 27.64 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.483 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 97.6 m-85 -107.88 121.12 44.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 0.0 109.426 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -59.19 -32.76 70.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 110.036 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 5.2 p30 -44.42 -28.26 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 109.683 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . -130.89 58.17 0.71 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 5' ' ' LYS . 4.4 mt -153.92 138.14 16.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -1.198 . . . . 0.0 109.506 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.572 HG13 ' CG2' ' A' ' 7' ' ' VAL . 2.0 m -119.03 130.94 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 109.791 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.8 p -85.74 125.85 33.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.253 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.77 142.11 45.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.868 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.441 ' HA ' HD22 ' A' ' 2' ' ' LEU . 4.6 tppt? -102.41 126.45 49.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 109.062 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 167' ' ' LYS . 7.4 p90 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.686 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 166' ' ' GLU . 0.3 OUTLIER -68.49 143.64 54.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.222 -0.924 . . . . 0.0 110.069 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 2' ' ' LEU . 21.8 mt -115.43 128.21 55.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.632 -0.668 . . . . 0.0 109.482 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.742 ' CD2' HD21 ' A' ' 163' ' ' LEU . 4.4 m-85 -104.27 132.08 50.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.325 -0.859 . . . . 0.0 109.419 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 9.6 pttt -146.89 164.63 32.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.735 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 162' ' ' GLY . 44.1 t0 -87.65 146.66 25.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.298 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.71 -12.38 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.586 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.871 HG21 ' HA ' ' A' ' 140' ' ' ALA . 29.4 mm -54.59 -69.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.507 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -99.37 -51.76 3.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.392 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 95.46 1.68 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 4.5 p30 -170.53 153.85 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.178 -1.19 . . . . 0.0 109.526 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 3.7 mm-40 -71.29 118.57 14.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.252 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.84 -41.88 3.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 109.496 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.839 HG21 ' HB2' ' A' ' 30' ' ' ALA . 2.3 p -153.18 169.26 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.603 ' N ' HG22 ' A' ' 14' ' ' VAL . 51.8 p -153.64 177.7 10.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.975 -1.078 . . . . 0.0 110.419 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.1 6.77 17.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.419 -0.801 . . . . 0.0 109.783 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.04 -8.4 44.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.145 -0.972 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 19' ' ' ASP . 52.6 m-85 -126.54 19.14 7.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.432 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER 61.46 120.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 37.3 mt -111.82 138.73 48.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.168 -0.957 . . . . 0.0 110.45 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -119.58 136.61 54.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.602 -0.687 . . . . 0.0 109.462 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 1.4 tt0 -99.81 115.98 30.84 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.247 -0.908 . . . . 0.0 108.881 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.519 HG22 ' OE2' ' A' ' 29' ' ' GLU . 6.4 t -70.82 158.92 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 109.48 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' VAL . 21.9 t0 -39.22 -39.97 0.68 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.507 -0.745 . . . . 0.0 109.568 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.88 -143.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 108.834 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.564 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -125.98 62.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.031 -1.043 . . . . 0.0 109.244 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.535 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 16.4 m -138.49 150.97 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.543 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -104.7 157.07 17.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.519 ' OE2' HG22 ' A' ' 23' ' ' VAL . 80.4 mt-10 -122.86 117.47 25.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.422 -0.799 . . . . 0.0 109.079 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.839 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -113.54 115.45 28.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.48 150.09 45.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.9 p -143.55 158.37 43.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.394 -0.816 . . . . 0.0 109.207 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.545 ' HB2' HG23 ' A' ' 69' ' ' VAL . 34.9 m120 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 28.9 p-10 -56.18 -24.41 41.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.825 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' A' ' 72' ' ' PHE . 58.4 tp -82.06 -34.85 29.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 108.953 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.847 HG13 ' CB ' ' A' ' 74' ' ' LEU . 53.5 t -66.36 -55.33 19.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.487 -0.758 . . . . 0.0 109.751 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -66.46 -42.88 86.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 0.0 110.224 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.1 m -55.94 -46.03 78.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.044 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.565 ' CE2' HD11 ' A' ' 68' ' ' LEU . 16.4 m-30 -100.43 18.82 18.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.483 ' O ' HD22 ' A' ' 74' ' ' LEU . 18.9 ttm105 49.3 89.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 109.479 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.847 ' CB ' HG13 ' A' ' 69' ' ' VAL . 1.9 mm? -117.4 143.06 46.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.326 -0.859 . . . . 0.0 109.049 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.728 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -121.43 143.36 37.52 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 109.741 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 36.7 Cg_endo -79.89 139.91 14.09 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.677 2.252 . . . . 0.0 110.467 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.0 t -122.05 135.39 54.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.231 -0.918 . . . . 0.0 109.257 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 t -114.45 145.58 41.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.925 . . . . 0.0 109.717 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CZ ' ' CD2' ' A' ' 130' ' ' PHE . 5.1 p90 -172.29 -177.6 1.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 82' ' ' LYS . 21.2 p-10 -101.07 169.13 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.023 . . . . 0.0 109.606 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -53.69 -47.78 70.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.0 109.913 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.464 ' HB2' ' OD2' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -50.37 -35.69 29.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.778 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.461 ' HB2' ' OD1' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -71.9 -36.94 70.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.772 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 1.6 t80 -63.51 -47.41 81.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.827 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -40.97 91.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.936 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.03 -28.57 66.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.977 . . . . 0.0 109.911 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 138' ' ' PRO . 3.2 m-85 -70.12 -47.25 62.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 109.625 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 92' ' ' MET . 6.3 tp -74.17 -15.98 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.398 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.17 -59.77 2.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.2 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.61 -26.57 72.92 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.598 ' CE1' HD11 ' A' ' 95' ' ' ILE . 4.5 t80 -72.46 -36.1 68.4 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -63.44 -43.33 97.72 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -58.14 -45.36 87.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.36 -0.838 . . . . 0.0 109.001 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.52 71.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 108.768 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.697 HG21 ' CE2' ' A' ' 110' ' ' PHE . 27.0 mm -56.04 -30.44 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 0.0 109.026 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.584 ' HD2' HG13 ' A' ' 107' ' ' VAL . 0.3 OUTLIER -54.18 -47.29 72.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.57 -30.82 64.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.757 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.515 ' CZ ' ' O ' ' A' ' 161' ' ' ASP . 3.8 tmt_? -60.7 -44.92 95.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 109.898 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 106' ' ' ARG . 14.2 mt -72.33 -49.75 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.158 -0.964 . . . . 0.0 109.784 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.4 -26.17 40.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.955 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -79.76 -45.11 19.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 0.0 109.199 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p -95.86 -70.37 0.72 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.447 ' HB3' ' NH2' ' A' ' 106' ' ' ARG . 10.8 t30 -123.38 118.13 27.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.452 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.8 -29.03 9.02 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.403 2.069 . . . . 0.0 110.675 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.448 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 3.0 mt-10 -70.28 -6.64 36.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.64 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HB3' HD13 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -88.71 -3.34 58.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 0.0 109.878 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 59.1 t -72.34 -43.79 9.85 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 111.171 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.4 Cg_endo -77.86 -50.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.824 1.683 . . . . 0.0 110.902 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 110' ' ' PHE . 3.9 p -60.59 -46.84 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.72 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.697 ' CE2' HG21 ' A' ' 95' ' ' ILE . 73.3 t80 -67.66 -37.4 82.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -0.783 . . . . 0.0 110.401 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 6.2 tm-20 -59.47 -49.66 76.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.06 -1.025 . . . . 0.0 110.451 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -64.82 -44.05 91.12 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.11 -0.994 . . . . 0.0 110.281 -179.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -61.2 -32.5 72.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.937 -1.102 . . . . 0.0 110.007 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.75 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -64.22 -51.0 65.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 111.367 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.88 HD12 ' N ' ' A' ' 116' ' ' GLY . 1.7 pp -62.94 -45.79 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.769 -1.207 . . . . 0.0 110.576 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.88 ' N ' HD12 ' A' ' 115' ' ' ILE . . . -59.06 -40.14 95.21 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.487 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -73.03 -30.24 63.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -1.16 . . . . 0.0 109.871 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 114' ' ' ALA . 69.2 t -65.65 -43.95 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.896 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.517 ' C ' ' CD ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -71.84 -32.06 67.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.627 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -28.65 61.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 109.999 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 117' ' ' PHE . 1.2 mp -79.55 -30.68 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.998 -1.064 . . . . 0.0 108.977 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 122' ' ' LEU . 23.2 mt -58.93 -26.19 64.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.897 . . . . 0.0 109.621 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 122' ' ' LEU . . . -43.89 -39.61 4.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.843 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 128' ' ' TYR . 2.6 m-20 -143.82 58.67 1.37 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 109.804 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 4.6 p90 -62.59 -35.03 78.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.417 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.495 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -76.36 -26.37 55.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.71 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 2.8 t70 -77.52 -27.69 51.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 109.516 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 128' ' ' TYR . 1.6 m-30 -100.04 -1.57 36.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.07 -159.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 109.465 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 79' ' ' PHE . 68.5 m-85 -147.97 121.71 9.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 69' ' ' VAL . 11.9 m-85 -98.6 168.15 10.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.961 . . . . 0.0 110.296 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.815 ' O ' HD13 ' A' ' 74' ' ' LEU . 2.1 tt -150.7 146.54 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.408 -0.807 . . . . 0.0 109.437 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.75 168.44 46.65 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 135' ' ' SER . 0.2 OUTLIER -57.45 -21.21 35.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -1.159 . . . . 0.0 109.368 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 136' ' ' MET . 49.9 m -62.58 -41.71 99.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 75.41 41.81 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 109.691 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.25 129.39 24.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.148 -0.97 . . . . 0.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 87' ' ' TYR . 33.3 Cg_endo -75.13 -13.35 21.17 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.322 2.015 . . . . 0.0 110.306 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -97.25 8.29 44.85 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 108.953 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.871 ' HA ' HG21 ' A' ' 8' ' ' ILE . . . -92.26 -161.81 0.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.347 -0.846 . . . . 0.0 109.489 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.444 ' SD ' ' O ' ' A' ' 162' ' ' GLY . 2.6 ttp -88.82 145.68 25.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.676 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.96 141.05 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.285 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.535 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.1 t -109.79 136.46 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.87 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 128' ' ' TYR . 53.0 mt -107.7 151.24 25.94 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.813 . . . . 0.0 108.976 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.82 134.98 50.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.632 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -155.03 143.3 20.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.38 -0.825 . . . . 0.0 109.292 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.433 ' CD1' ' HA2' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -65.41 160.41 22.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.313 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 153' ' ' THR . 0.0 OUTLIER -58.49 173.58 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.15 -17.28 39.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -107.36 -47.35 3.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -0.978 . . . . 0.0 109.364 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.433 ' HA2' ' CD1' ' A' ' 147' ' ' TYR . . . 120.28 29.17 1.66 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.76 -38.87 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -1.075 . . . . 0.0 109.279 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 148' ' ' ARG . 14.8 t -137.43 142.11 36.18 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.069 -1.019 . . . . 0.0 109.713 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 153' ' ' THR . 36.5 Cg_endo -79.35 146.71 19.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.665 2.244 . . . . 0.0 110.447 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -145.13 160.24 41.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.387 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.501 ' HB2' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -122.17 159.06 28.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.336 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 27' ' ' VAL . 36.8 mt -113.29 136.26 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.672 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.535 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 48.1 m-85 -123.74 118.22 26.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.03 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -50.07 119.5 3.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.096 -1.002 . . . . 0.0 109.565 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 161' ' ' ASP . 18.8 tptp -67.34 -42.09 84.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.341 -0.849 . . . . 0.0 109.526 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.562 ' OD2' HD21 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -44.11 -38.85 3.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.22 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.446 ' O ' ' OD1' ' A' ' 6' ' ' ASP . . . -108.8 52.73 0.63 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.742 HD21 ' CD2' ' A' ' 4' ' ' TYR . 7.9 tt -151.17 149.44 29.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -1.123 . . . . 0.0 109.405 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 165' ' ' SER . 0.6 OUTLIER -138.0 157.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.901 . . . . 0.0 109.61 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' A' ' 164' ' ' VAL . 0.7 OUTLIER -111.02 120.88 43.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.675 . . . . 0.0 109.458 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.579 ' O ' HD13 ' A' ' 2' ' ' LEU . 2.9 tt0 -108.11 147.2 31.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.428 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.07 116.02 28.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 0.0 109.329 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.447 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.488 ' O ' HD23 ' A' ' 2' ' ' LEU . 6.2 ptt? . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 167' ' ' LYS . 11.9 mt -121.27 149.07 43.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.631 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 3' ' ' LEU . 23.4 mt -101.4 122.91 44.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.555 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.585 ' CB ' HG13 ' A' ' 14' ' ' VAL . 6.2 m-85 -106.42 118.8 37.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.866 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 0.7 OUTLIER -129.67 141.13 50.97 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.8 ' OD1' HD11 ' A' ' 13' ' ' LEU . 12.2 p-10 -167.36 110.14 0.66 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.074 -1.016 . . . . 0.0 110.183 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.515 HG12 ' HB1' ' A' ' 140' ' ' ALA . 20.9 t -147.77 48.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER 62.12 15.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.9 t -163.96 -34.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.571 -0.706 . . . . 0.0 109.596 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.46 100.29 2.61 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 12' ' ' GLU . 51.8 t0 -130.08 -78.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.763 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.546 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER 161.61 113.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 109.408 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.978 HD12 ' N ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -146.51 -31.31 0.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.136 -0.977 . . . . 0.0 110.817 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.978 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.3 p -134.97 174.12 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.723 -1.235 . . . . 0.0 109.06 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.624 ' C ' HD11 ' A' ' 20' ' ' LEU . 36.2 m -164.49 -174.73 3.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.021 . . . . 0.0 110.404 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.05 12.89 6.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.568 -0.708 . . . . 0.0 109.711 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.04 -17.03 64.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.955 . . . . 0.0 109.053 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.561 ' CE2' HD13 ' A' ' 68' ' ' LEU . 56.7 m-85 -118.37 19.49 13.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.462 -0.774 . . . . 0.0 109.169 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 18' ' ' TYR . 8.6 t0 63.33 120.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 30' ' ' ALA . 10.0 mt -113.71 153.11 29.53 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.2 -0.938 . . . . 0.0 110.359 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -129.41 141.21 51.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.496 -0.752 . . . . 0.0 109.177 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.512 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 1.5 mt-10 -93.97 128.55 40.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.938 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 t -80.07 153.44 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.841 . . . . 0.0 109.589 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.01 -17.14 6.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.761 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 26' ' ' ILE . 8.5 m-20 -81.61 -100.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.619 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -164.53 60.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 0.0 109.41 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 159' ' ' PHE . 14.7 m -152.28 164.02 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 110.179 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.512 ' CE1' ' HG3' ' A' ' 22' ' ' GLU . 7.2 m-85 -104.34 157.85 16.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.419 -0.8 . . . . 0.0 108.858 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 19.6 mt-10 -127.07 118.59 24.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.961 . . . . 0.0 109.314 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.696 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -114.71 112.44 22.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.009 -1.057 . . . . 0.0 109.062 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 13.9 t0 -79.87 150.24 30.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 p -129.26 -174.5 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.318 -179.955 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.454 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 22.9 m120 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -88.82 -28.1 20.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.694 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.561 HD13 ' CE2' ' A' ' 18' ' ' TYR . 12.1 tp -78.39 -45.07 23.3 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.054 -1.029 . . . . 0.0 108.407 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.865 HG13 ' CB ' ' A' ' 74' ' ' LEU . 33.4 t -63.82 -54.62 29.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 70' ' ' TYR . 15.8 t80 -55.57 -32.55 63.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.177 -0.952 . . . . 0.0 109.533 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m -70.09 -38.08 75.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.851 . . . . 0.0 110.061 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.564 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 43.2 m-85 -104.35 10.32 35.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.015 -1.053 . . . . 0.0 110.142 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 4.1 tpp180 60.24 25.25 14.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.062 -1.024 . . . . 0.0 109.984 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.865 ' CB ' HG13 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -43.5 137.76 2.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.511 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.959 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -107.58 119.11 51.58 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.68 134.52 12.26 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.343 2.029 . . . . 0.0 110.104 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 179.82 5.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.088 -1.008 . . . . 0.0 109.742 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.97 132.09 37.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.494 -0.754 . . . . 0.0 109.146 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 30.5 p90 -124.81 161.54 26.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.682 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -89.43 150.32 22.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -53.27 -32.8 50.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.136 -0.978 . . . . 0.0 110.039 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -87.45 -25.74 23.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 110.138 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -71.11 -38.18 72.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.118 -0.988 . . . . 0.0 109.855 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.478 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 3.8 t80 -68.48 -35.38 77.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.562 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.761 ' O ' HG22 ' A' ' 88' ' ' ILE . 7.5 mtm -64.06 -56.03 17.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.9 p -58.87 -37.71 77.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -74.87 -19.5 60.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 85' ' ' MET . 0.2 OUTLIER -75.16 -31.96 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.866 . . . . 0.0 108.845 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 3.4 mttt -70.82 -53.97 13.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.462 -0.773 . . . . 0.0 109.345 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.16 -24.02 73.23 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -75.36 -36.84 60.91 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.153 -1.204 . . . . 0.0 108.235 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -48.36 66.17 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.549 -0.719 . . . . 0.0 109.148 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 89' ' ' LYS . 28.3 mmtm -55.2 -41.26 71.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.334 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.54 -42.58 71.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 109.137 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.883 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 28.3 mm -70.66 -26.6 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.319 -0.863 . . . . 0.0 109.26 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.46 -34.29 75.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.959 . . . . 0.0 108.684 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.27 -47.94 46.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.559 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -56.9 -32.94 66.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.989 . . . . 0.0 109.433 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.932 HD22 ' HB3' ' A' ' 106' ' ' ARG . 86.9 mt -73.0 -41.93 63.77 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.255 -0.903 . . . . 0.0 109.326 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -33.93 73.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.384 -0.823 . . . . 0.0 109.556 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -73.15 -39.25 65.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.557 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.6 p -90.97 -82.4 0.29 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.12 123.82 26.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.381 -0.824 . . . . 0.0 109.055 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.61 -26.45 11.73 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.401 2.067 . . . . 0.0 110.661 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.21 -7.11 39.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.614 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.932 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -92.29 1.74 57.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.618 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 14.3 t -69.83 -46.43 24.13 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 110.252 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.9 Cg_endo -78.26 -36.6 0.95 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.02 1.813 . . . . 0.0 110.673 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.69 -51.15 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.995 . . . . 0.0 109.592 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.883 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 6.5 t80 -65.31 -37.72 88.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.919 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.785 ' O ' HD12 ' A' ' 115' ' ' ILE . 1.2 mt-10 -64.56 -35.51 81.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 109.953 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -71.75 -41.02 68.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.497 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -69.52 -54.54 13.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.077 -1.014 . . . . 0.0 110.374 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.702 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -58.92 -27.17 65.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 109.972 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -60.17 -49.11 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.338 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 115' ' ' ILE . . . -67.26 -40.76 92.15 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.628 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -61.26 -30.76 70.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -1.128 . . . . 0.0 110.177 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 114' ' ' ALA . 69.4 t -67.14 -41.74 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 110.391 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -69.3 -44.13 72.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.047 -1.033 . . . . 0.0 110.027 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -57.04 -52.28 65.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.172 -0.955 . . . . 0.0 110.039 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.825 HG12 HD13 ' A' ' 144' ' ' LEU . 1.6 mp -58.18 -44.54 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.08 -1.012 . . . . 0.0 109.323 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.11 -30.42 64.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.25 -46.32 54.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.729 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 124' ' ' ASN . 2.4 p-10 -143.5 57.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 109.698 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 126' ' ' LYS . 21.9 p90 -51.79 -25.61 7.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 109.815 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.2 mmtt -61.96 -44.84 95.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 109.676 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -79.06 -23.01 44.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.618 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.595 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 2.8 m-85 -76.05 -20.32 57.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 109.751 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.8 OUTLIER 49.6 -177.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 110.029 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.491 ' CD2' HG11 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -142.91 121.38 12.42 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.799 ' O ' HG13 ' A' ' 142' ' ' VAL . 18.4 m-85 -108.9 176.93 4.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.03 -1.044 . . . . 0.0 110.869 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.959 HG22 ' O ' ' A' ' 75' ' ' SER . 1.6 tt -155.54 150.88 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.561 -0.712 . . . . 0.0 109.556 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.72 -176.68 43.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -18.85 63.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -1.205 . . . . 0.0 109.429 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 m -64.47 -37.06 86.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.259 -0.901 . . . . 0.0 109.461 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.447 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER 62.23 43.79 8.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.764 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -98.65 127.26 36.24 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.72 -1.55 11.5 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.291 1.994 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -115.03 10.95 16.34 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.344 -0.848 . . . . 0.0 109.003 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.515 ' HB1' HG12 ' A' ' 7' ' ' VAL . . . -100.95 -177.38 3.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.266 -0.896 . . . . 0.0 109.6 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -83.49 142.32 31.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.535 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 131' ' ' TYR . 41.1 t -108.45 141.48 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 0.0 109.65 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.461 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 21.8 t -92.04 122.97 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.313 -0.867 . . . . 0.0 108.932 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.825 HD13 HG12 ' A' ' 121' ' ' ILE . 1.1 mt -90.24 124.53 34.95 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.288 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.584 ' CE ' ' CE ' ' A' ' 156' ' ' MET . 53.5 ttm -104.93 128.47 53.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.595 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 14.4 t-20 -147.01 165.24 30.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.54 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -84.47 157.78 21.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.405 ' HG3' ' CD1' ' A' ' 155' ' ' TYR . 2.8 mtt85 -87.77 176.12 7.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.187 -0.945 . . . . 0.0 109.214 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.18 -13.93 51.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.22 -0.925 . . . . 0.0 109.137 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.3 -60.8 3.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.326 -0.859 . . . . 0.0 109.096 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 131.61 -27.02 3.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -133.95 37.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -1.175 . . . . 0.0 109.421 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.2 m -129.03 100.58 20.48 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.368 -0.833 . . . . 0.0 109.358 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.74 127.16 6.2 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.534 2.156 . . . . 0.0 110.481 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.405 ' CD1' ' HG3' ' A' ' 148' ' ' ARG . 26.0 p90 -145.03 159.42 42.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.584 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -129.68 142.72 50.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.278 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.5 mt -102.4 148.45 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.579 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.657 ' CE2' HD13 ' A' ' 13' ' ' LEU . 54.9 m-85 -127.17 118.66 24.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 109.36 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.468 ' HA ' HG12 ' A' ' 27' ' ' VAL . 43.8 m-85 -53.51 119.52 4.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.653 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 26' ' ' ILE . 7.8 tptt -66.7 -38.06 85.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.74 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.438 ' OD1' ' HB3' ' A' ' 159' ' ' PHE . 1.4 p-10 -44.76 -48.81 10.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.642 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 6' ' ' ASP . . . -104.71 50.21 0.86 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 164' ' ' VAL . 6.9 tt -145.18 155.17 43.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -1.194 . . . . 0.0 109.3 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.809 ' N ' HD23 ' A' ' 163' ' ' LEU . 4.3 m -144.2 135.52 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.973 . . . . 0.0 109.818 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.0 m -99.02 137.96 36.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.079 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -127.12 139.09 53.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.782 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.508 ' HA ' HD22 ' A' ' 2' ' ' LEU . 5.5 ttmt -78.58 125.27 29.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 109.35 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.497 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.9 165.82 14.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.586 HD12 ' HA ' ' A' ' 168' ' ' PHE . 82.6 mt -120.99 135.31 55.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.62 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.586 ' CD2' HD21 ' A' ' 163' ' ' LEU . 68.6 m-85 -121.54 133.02 55.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.833 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -135.07 153.59 51.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.832 . . . . 0.0 109.366 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 41.9 t0 -61.78 148.11 44.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.506 ' CG2' HG13 ' A' ' 164' ' ' VAL . 18.5 t -91.2 53.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.898 . . . . 0.0 109.434 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.594 HG22 ' N ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -163.76 -54.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.084 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.594 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER 177.81 64.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.496 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.729 ' HA3' HD13 ' A' ' 13' ' ' LEU . . . -111.1 -18.74 8.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.5 OUTLIER 45.98 87.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -1.187 . . . . 0.0 109.234 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.402 ' HG3' ' C ' ' A' ' 11' ' ' ASP . 2.9 mt-10 58.18 102.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.121 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.729 HD13 ' HA3' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -117.25 -55.78 2.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.556 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.783 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 7.9 p -140.19 164.25 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 108.942 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.547 ' N ' HG22 ' A' ' 14' ' ' VAL . 53.9 p -153.24 172.12 17.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.54 2.32 29.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.484 -0.76 . . . . 0.0 109.759 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.78 -10.24 45.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.102 -0.999 . . . . 0.0 109.035 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.662 ' CD2' HD11 ' A' ' 68' ' ' LEU . 34.7 m-85 -123.42 19.47 9.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.366 -0.834 . . . . 0.0 109.157 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 0.6 OUTLIER 61.62 128.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.348 -0.845 . . . . 0.0 108.925 -179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 30' ' ' ALA . 65.3 mt -118.91 151.17 38.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.129 -0.982 . . . . 0.0 110.139 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -133.66 122.86 24.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 109.492 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.52 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -80.97 121.24 25.78 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.271 -0.893 . . . . 0.0 108.733 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 24' ' ' ASP . 6.6 t -77.38 154.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.716 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' VAL . 6.9 m-20 -42.77 -32.0 0.55 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.818 . . . . 0.0 109.542 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 26' ' ' ILE . 39.9 m-20 -70.6 -116.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -153.77 63.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.734 -1.229 . . . . 0.0 109.483 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 159' ' ' PHE . 16.6 m -152.36 144.21 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.127 -0.983 . . . . 0.0 109.757 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 3.7 m-85 -98.95 134.19 42.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 108.851 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -108.78 138.26 45.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.989 -1.069 . . . . 0.0 109.967 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.783 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -116.17 113.98 23.82 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -65.74 150.15 48.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 0.0 109.689 -179.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.6 t -102.94 146.82 27.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.147 -0.971 . . . . 0.0 109.642 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 32.8 m120 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.264 0.554 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 21.0 p30 -99.32 -21.77 15.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 109.333 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.662 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -82.86 -42.78 17.38 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 74' ' ' LEU . 87.8 t -72.37 -35.19 51.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.475 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 2.1 t80 -69.38 -58.25 4.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.906 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 t -56.93 -52.54 64.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.939 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 11.1 m-85 -83.17 -3.47 57.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 109.633 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.518 ' CA ' ' O ' ' A' ' 69' ' ' VAL . 11.4 tpt180 53.63 34.39 18.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 109.545 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.536 ' HB2' HG13 ' A' ' 69' ' ' VAL . 11.8 mt -42.77 142.36 0.89 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.84 . . . . 0.0 109.251 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.86 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -124.46 135.6 26.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.682 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.38 140.98 15.65 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.526 2.151 . . . . 0.0 110.187 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 p -122.34 175.62 6.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.664 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.2 m -144.7 151.2 38.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.068 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.629 ' CE2' ' CD2' ' A' ' 130' ' ' PHE . 6.6 p90 -172.05 -177.54 1.91 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 0.0 109.819 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.08 166.71 10.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.364 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -57.86 -52.16 66.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.733 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -26.21 67.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.788 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.3 t -71.93 -41.06 68.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.967 . . . . 0.0 109.946 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.551 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 24.8 t80 -60.34 -39.06 85.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.796 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.5 mtm -63.44 -43.45 97.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.059 -1.026 . . . . 0.0 109.847 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -40.31 95.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.17 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -67.43 -58.2 5.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.161 -0.962 . . . . 0.0 109.895 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 84' ' ' TYR . 6.3 tp -52.2 -23.79 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.843 . . . . 0.0 109.862 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -74.18 -42.26 60.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.067 -1.02 . . . . 0.0 109.655 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.12 -30.72 76.13 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.529 ' CE1' HD11 ' A' ' 95' ' ' ILE . 31.2 t80 -80.82 -35.96 32.25 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.046 -1.267 . . . . 0.0 108.846 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -43.54 96.65 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.405 -0.809 . . . . 0.0 109.221 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -40.69 82.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.338 -0.851 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.23 82.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 91' ' ' TYR . 39.7 mm -61.64 -44.3 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.159 -0.963 . . . . 0.0 109.555 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.518 ' CE ' HG13 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -47.02 -51.59 16.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.912 . . . . 0.0 109.194 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.84 80.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.539 ' HD3' HD23 ' A' ' 99' ' ' LEU . 1.2 tmt_? -57.46 -36.1 70.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 109.344 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.703 HD13 ' HD2' ' A' ' 106' ' ' ARG . 8.6 mt -72.59 -49.82 29.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -0.852 . . . . 0.0 109.601 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -23.99 52.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.719 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.48 -21.66 17.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 109.568 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 2.7 t -114.13 -89.0 0.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.56 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -120.74 99.64 47.14 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.382 -0.824 . . . . 0.0 109.535 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 107' ' ' VAL . 32.8 Cg_endo -74.37 -13.19 22.98 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.433 2.088 . . . . 0.0 110.392 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -7.14 16.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.127 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.703 ' HD2' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -118.76 21.48 12.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.032 -1.043 . . . . 0.0 109.772 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 16.4 t -72.42 -46.34 10.24 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.494 -0.754 . . . . 0.0 110.868 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.5 Cg_endo -77.0 -48.89 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 121.976 1.784 . . . . 0.0 110.814 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.578 HG22 ' HA ' ' A' ' 106' ' ' ARG . 30.1 m -57.04 -44.86 83.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.104 -0.997 . . . . 0.0 109.589 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.556 ' N ' HG23 ' A' ' 109' ' ' VAL . 29.0 t80 -67.0 -37.87 84.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.84 -54.28 47.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.1 -1.0 . . . . 0.0 110.308 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -60.63 -45.92 92.24 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.105 -0.997 . . . . 0.0 110.207 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -56.34 -40.42 74.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 109.909 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.23 -27.37 63.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.081 -1.012 . . . . 0.0 109.586 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.64 -48.53 71.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.221 -0.924 . . . . 0.0 109.138 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.66 -29.91 76.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -69.98 -42.65 72.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -1.217 . . . . 0.0 109.812 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 97.4 t -69.68 -32.54 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -71.67 -34.51 69.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.127 -0.983 . . . . 0.0 109.624 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.51 ' N ' ' HD3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -84.53 -16.91 40.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.135 -0.978 . . . . 0.0 109.843 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.474 HD11 HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -81.97 -42.96 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.123 -0.986 . . . . 0.0 109.337 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 119' ' ' LYS . 6.6 mt -54.42 -28.2 42.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 109.465 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.24 -49.19 64.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 109.542 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 127' ' ' ASP . 6.4 m-20 -130.53 63.21 1.57 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -0.849 . . . . 0.0 109.416 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.484 ' CE2' ' CD2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -62.02 -49.93 74.06 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.364 -0.835 . . . . 0.0 109.753 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -55.55 -29.02 58.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.585 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.527 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -81.2 -26.55 35.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 109.945 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 129' ' ' ASP . 11.8 m-85 -84.16 -21.25 31.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.932 . . . . 0.0 110.018 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 128' ' ' TYR . 38.6 m-20 54.79 168.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.045 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.629 ' CD2' ' CE2' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -128.01 121.14 29.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.136 -0.978 . . . . 0.0 108.963 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.54 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 17.2 m-85 -109.5 174.71 5.74 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.21 -0.931 . . . . 0.0 110.538 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.86 HG22 ' O ' ' A' ' 75' ' ' SER . 3.6 tt -149.16 162.22 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.553 -0.717 . . . . 0.0 109.365 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.44 -176.93 50.54 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -68.5 -27.01 65.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -1.109 . . . . 0.0 109.398 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 136' ' ' MET . 1.0 OUTLIER -61.1 -34.15 74.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 65.16 39.77 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.385 -0.822 . . . . 0.0 109.371 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.35 139.91 27.46 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 109.198 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -73.8 -17.34 22.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.355 2.037 . . . . 0.0 109.982 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.76 -12.95 62.06 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.77 149.46 21.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.337 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.501 ' HE1' ' HA ' ' A' ' 158' ' ' PHE . 0.2 OUTLIER -66.49 139.14 57.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.603 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.1 m -88.43 141.68 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.821 . . . . 0.0 109.469 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 1.057 HG13 ' O ' ' A' ' 157' ' ' ILE . 16.5 t -97.05 140.82 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.193 -0.942 . . . . 0.0 109.053 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.519 HD23 ' C ' ' A' ' 143' ' ' VAL . 12.4 mt -110.94 134.55 52.48 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.514 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.54 ' HE3' ' CZ ' ' A' ' 131' ' ' TYR . 1.4 mtm -104.74 128.88 52.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 109.109 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.504 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 28.5 t-20 -150.24 159.15 44.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.958 . . . . 0.0 109.685 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -89.05 128.47 35.73 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.292 -0.88 . . . . 0.0 109.013 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -166.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 109.64 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -30.38 70.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 109.723 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -53.68 -59.3 4.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.698 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 111.39 -22.63 19.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.722 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -116.51 8.67 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -1.123 . . . . 0.0 109.165 179.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.8 m -117.38 101.3 52.84 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.157 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.49 137.58 14.81 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.601 2.201 . . . . 0.0 110.378 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 14.9 p90 -145.25 139.64 27.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.162 -0.961 . . . . 0.0 109.733 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.521 ' HB2' ' CE1' ' A' ' 158' ' ' PHE . 3.3 mtt -101.89 165.06 11.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 1.057 ' O ' HG13 ' A' ' 143' ' ' VAL . 12.5 mt -125.8 141.07 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.984 -1.073 . . . . 0.0 110.23 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.652 ' HD2' HD23 ' A' ' 13' ' ' LEU . 11.3 m-85 -132.92 118.58 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.418 -0.801 . . . . 0.0 108.902 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.419 ' HA ' HG12 ' A' ' 27' ' ' VAL . 3.2 m-85 -48.59 138.4 10.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 109.722 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -65.98 -51.98 53.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.898 . . . . 0.0 109.156 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 110' ' ' PHE . 3.9 m-20 -47.04 -48.46 22.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.009 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -86.76 50.53 4.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 163' ' ' LEU . 2.1 tt -158.96 116.51 2.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.465 -1.021 . . . . 0.0 109.222 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.506 HG13 ' CG2' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -114.29 148.73 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 4.9 p -96.64 120.58 37.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.32 -0.862 . . . . 0.0 109.372 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -127.3 129.04 46.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.16 128.62 37.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.194 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.586 ' HA ' HD12 ' A' ' 3' ' ' LEU . 15.6 p90 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.74 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.818 ' C ' HD23 ' A' ' 2' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.818 HD23 ' C ' ' A' ' 1' ' ' MET . 4.7 mt -114.05 166.26 11.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.026 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.4 ' HA ' ' OG ' ' A' ' 15' ' ' SER . 11.1 mt -127.96 143.3 51.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 109.298 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.606 ' HB3' HD22 ' A' ' 163' ' ' LEU . 29.9 m-85 -121.59 112.35 18.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.885 . . . . 0.0 109.825 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.541 ' O ' HD23 ' A' ' 163' ' ' LEU . 9.6 mttt -112.9 150.41 31.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.328 -0.858 . . . . 0.0 109.402 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 141' ' ' MET . 0.4 OUTLIER -68.34 158.24 33.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.586 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 164' ' ' VAL . 40.8 t -94.92 -15.68 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.389 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.742 HG21 ' O ' ' A' ' 139' ' ' ASP . 0.8 OUTLIER -89.47 -25.05 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.256 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.5 -46.02 2.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.13 58.35 2.34 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 6.0 p-10 -134.24 179.96 5.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -1.144 . . . . 0.0 109.283 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -78.65 89.45 4.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.962 . . . . 0.0 109.703 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -82.24 -62.8 1.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 109.029 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' A' ' 30' ' ' ALA . 13.8 p -143.19 171.03 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.592 ' N ' HG22 ' A' ' 14' ' ' VAL . 4.9 m -156.49 178.32 10.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.151 . . . . 0.0 110.804 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -84.12 12.5 6.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.517 -0.739 . . . . 0.0 109.889 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . . . -66.32 -9.23 31.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.004 . . . . 0.0 109.02 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.585 ' CD1' HD11 ' A' ' 68' ' ' LEU . 4.6 m-85 -128.7 21.13 5.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.424 -0.797 . . . . 0.0 109.264 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER 62.91 126.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.062 -1.024 . . . . 0.0 108.309 -178.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.888 HD23 ' HA ' ' A' ' 30' ' ' ALA . 12.9 mt -120.35 147.17 45.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 110.584 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.9 mmtp -123.23 140.59 52.87 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -100.75 114.41 28.14 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.11 -0.994 . . . . 0.0 108.828 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 24' ' ' ASP . 3.2 t -68.63 158.37 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.371 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' VAL . 1.5 t70 -41.15 -47.19 3.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.426 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' ASP . 16.2 m-20 -62.12 -148.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 108.957 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.97 60.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.233 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 m -134.19 150.62 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.882 . . . . 0.0 109.784 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.04 155.77 21.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -0.82 . . . . 0.0 109.134 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 2.4 pt-20 -133.29 120.71 21.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.043 -1.036 . . . . 0.0 109.661 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.888 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -100.14 127.05 46.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.441 -0.787 . . . . 0.0 109.087 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 64.9 m-20 -68.0 145.69 54.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.932 . . . . 0.0 109.77 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -125.52 152.97 44.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.248 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.449 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.557 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 56.1 p30 -80.4 -18.02 50.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.585 HD11 ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.63 -35.41 22.7 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.21 -0.931 . . . . 0.0 108.976 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.705 HG13 ' HB2' ' A' ' 74' ' ' LEU . 73.6 t -72.84 -45.2 56.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.395 -0.815 . . . . 0.0 109.277 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -69.31 -36.25 76.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.106 -0.996 . . . . 0.0 110.109 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.1 m -70.51 -49.74 45.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.19 -0.944 . . . . 0.0 110.437 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' A' ' 14' ' ' VAL . 16.9 m-85 -92.24 -0.26 57.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.021 . . . . 0.0 110.132 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 57.27 64.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.956 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.705 ' HB2' HG13 ' A' ' 69' ' ' VAL . 12.0 mt -77.78 164.38 25.27 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.101 -1.0 . . . . 0.0 108.941 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.447 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -131.45 106.16 14.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.269 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.464 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 35.4 Cg_endo -76.8 120.9 5.66 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.359 2.039 . . . . 0.0 110.503 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.733 HG22 ' O ' ' A' ' 130' ' ' PHE . 10.0 t -88.95 157.55 18.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.9 . . . . 0.0 109.425 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.4 t -114.15 7.93 16.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.935 . . . . 0.0 109.509 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 6.9 p90 -136.35 142.72 43.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.632 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 1.0 OUTLIER 172.68 30.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.883 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -52.98 60.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.037 -1.039 . . . . 0.0 109.428 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -118.41 -31.24 4.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.82 . . . . 0.0 109.297 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.459 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 4.1 m -59.67 -30.44 68.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.201 -0.937 . . . . 0.0 108.911 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' A' ' 80' ' ' ASP . 5.0 t80 -66.61 -44.67 81.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 0.0 109.601 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.592 ' O ' HG22 ' A' ' 88' ' ' ILE . 7.6 mtt -60.93 -43.79 98.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.944 . . . . 0.0 109.92 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.1 m -66.87 -26.75 67.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.208 -0.932 . . . . 0.0 110.183 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CD2' ' O ' ' A' ' 83' ' ' SER . 12.4 m-85 -81.46 -29.34 33.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 109.945 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 85' ' ' MET . 3.0 tp -75.92 -28.16 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -49.2 16.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.374 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.01 -34.37 89.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -72.76 -36.2 67.62 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -61.0 -38.4 85.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.425 ' HD2' ' HE3' ' A' ' 96' ' ' LYS . 11.6 mmtm -67.26 -39.48 86.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.382 -0.824 . . . . 0.0 109.182 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.11 72.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.113 -0.992 . . . . 0.0 108.761 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.794 HG21 ' CE2' ' A' ' 110' ' ' PHE . 33.2 mm -62.92 -43.43 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.307 -0.87 . . . . 0.0 109.253 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HE3' ' HD2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -47.08 -37.42 9.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.261 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.1 -47.1 47.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.424 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.952 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -48.97 -46.29 43.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 109.545 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.952 HD23 ' HD3' ' A' ' 98' ' ' ARG . 6.1 mt -63.84 -46.46 84.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.204 -0.935 . . . . 0.0 109.17 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -23.74 7.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 108.881 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 98' ' ' ARG . 2.3 mt-10 -78.24 -48.15 16.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.441 -0.787 . . . . 0.0 109.223 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.0 -72.51 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.484 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.11 139.74 14.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.363 -0.836 . . . . 0.0 109.478 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.81 -13.97 21.74 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.662 2.241 . . . . 0.0 110.816 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 83.1 mt-10 -67.43 -23.52 65.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -0.972 . . . . 0.0 109.686 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.629 ' O ' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -87.81 5.71 38.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 109.565 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 108' ' ' PRO . 2.4 t -72.06 -50.02 9.49 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 109.532 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 107' ' ' VAL . 36.8 Cg_endo -79.56 -33.39 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.226 1.951 . . . . 0.0 110.435 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 49.8 t -67.47 -53.93 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.37 -0.831 . . . . 0.0 109.885 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.794 ' CE2' HG21 ' A' ' 95' ' ' ILE . 92.4 t80 -68.67 -37.53 79.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.895 . . . . 0.0 109.936 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -49.12 79.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.979 . . . . 0.0 110.229 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -70.88 -37.18 73.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.477 ' N ' ' HG3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -62.8 -35.07 78.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.879 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.769 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -71.42 -28.08 63.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 109.661 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -34.12 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.304 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.26 -44.95 84.41 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.509 ' HZ ' HD13 ' A' ' 157' ' ' ILE . 2.2 t80 -67.5 -44.59 78.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -1.148 . . . . 0.0 109.811 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 114' ' ' ALA . 85.1 t -53.56 -35.39 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.356 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -43.38 67.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 109.678 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -33.14 72.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.869 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.406 ' HA ' ' CE2' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -78.17 -35.15 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.106 -0.997 . . . . 0.0 109.377 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 122' ' ' LEU . 44.9 mt -60.52 -28.65 68.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.652 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.31 -36.68 78.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -143.13 59.55 1.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.19 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -59.16 -28.88 67.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.937 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 4.7 mmtp -72.24 -36.2 69.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 109.796 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -80.08 -23.67 41.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.809 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 129' ' ' ASP . 46.7 m-85 -85.7 -25.0 26.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.122 -0.987 . . . . 0.0 109.712 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 126' ' ' LYS . 8.8 m-20 53.33 175.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.367 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.733 ' O ' HG22 ' A' ' 77' ' ' THR . 0.3 OUTLIER -136.53 121.7 19.1 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.242 -0.911 . . . . 0.0 108.814 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.464 ' CE2' ' HB3' ' A' ' 76' ' ' PRO . 14.7 m-85 -101.7 166.91 10.43 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.201 -0.937 . . . . 0.0 110.308 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -156.42 142.97 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.528 -0.732 . . . . 0.0 109.497 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.45 179.57 1.86 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -67.74 -27.19 66.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -1.125 . . . . 0.0 109.248 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.544 ' O ' ' CG ' ' A' ' 136' ' ' MET . 1.0 OUTLIER -60.29 -35.07 74.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.301 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 79.92 20.01 0.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.501 -0.749 . . . . 0.0 109.471 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.47 123.62 35.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.029 -1.044 . . . . 0.0 109.798 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.443 ' HG3' ' CD1' ' A' ' 87' ' ' TYR . 32.3 Cg_endo -73.24 -13.5 25.67 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.145 1.897 . . . . 0.0 109.789 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.742 ' O ' HG21 ' A' ' 8' ' ' ILE . 2.8 m-20 -62.86 -21.21 65.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 141' ' ' MET . . . -76.78 -69.82 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.85 . . . . 0.0 109.089 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 5.8 tmm? 173.4 137.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 109.352 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.84 140.55 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 157' ' ' ILE . 3.4 t -112.14 138.05 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -106.18 143.67 33.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.411 ' HG3' ' HG2' ' A' ' 156' ' ' MET . 1.2 mtt -107.75 132.28 53.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.282 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 13.2 t30 -143.77 160.28 41.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 109.643 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.74 146.29 24.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.94 . . . . 0.0 109.444 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.411 HH11 HG21 ' A' ' 153' ' ' THR . 4.0 ttp180 -77.81 -172.83 2.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.563 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -21.64 63.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.51 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -58.02 5.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.85 -13.0 9.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.609 ' O ' HD12 ' A' ' 152' ' ' ILE . 2.4 pp -124.47 5.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.267 -1.137 . . . . 0.0 109.586 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.411 HG21 HH11 ' A' ' 148' ' ' ARG . 3.2 m -111.88 100.28 48.19 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.242 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 36.9 Cg_endo -81.59 132.27 7.73 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.622 2.215 . . . . 0.0 110.598 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 146' ' ' ASN . 38.4 p90 -133.78 142.59 47.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.106 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 9.6 mtt -100.79 161.15 13.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 110.207 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.796 ' O ' HG13 ' A' ' 143' ' ' VAL . 68.9 mt -124.46 145.78 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.215 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.73 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 4.2 m-85 -137.3 141.82 41.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 109.483 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -58.83 120.31 8.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 109.356 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -67.58 -45.61 75.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 109.513 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.61 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . 4.6 t0 -54.53 -25.84 28.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.345 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -103.8 39.2 2.89 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 4' ' ' TYR . 8.1 mt -149.75 140.19 22.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.388 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 7' ' ' VAL . 28.2 m -114.0 123.01 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.521 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.56 119.57 23.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.468 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -117.18 138.03 51.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.571 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.434 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -80.35 146.48 31.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.508 ' O ' ' CD1' ' A' ' 168' ' ' PHE . 5.1 t80 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.373 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.291 0.567 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.616 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 1.3 mm? -75.11 156.56 35.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.282 -0.886 . . . . 0.0 109.683 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 166' ' ' GLU . 2.9 mp -134.29 124.06 25.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.733 ' HB2' HG13 ' A' ' 14' ' ' VAL . 6.1 m-85 -96.12 109.58 21.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.429 -0.795 . . . . 0.0 109.81 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.637 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -110.03 152.45 25.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.348 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.482 ' HB2' HD23 ' A' ' 13' ' ' LEU . 20.2 t0 -68.11 134.57 50.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.523 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 8' ' ' ILE . 13.9 p -76.13 -36.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.433 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.729 HG22 ' OG ' ' A' ' 9' ' ' SER . 2.3 mp -66.47 -91.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.729 ' OG ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -135.11 80.84 1.86 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.38 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 6' ' ' ASP . . . -145.31 -62.99 0.02 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.6 t0 68.21 11.01 8.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -1.099 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.506 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER 173.1 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.693 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 12' ' ' GLU . 1.1 mm? -122.7 -61.37 1.46 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 109.285 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.909 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 10.5 p -136.76 166.35 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 108.979 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.4 p -145.47 164.34 31.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.009 -1.057 . . . . 0.0 110.543 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.512 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 1.5 t0 -82.96 8.1 13.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.461 -0.775 . . . . 0.0 109.745 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.23 -19.92 65.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 0.0 109.131 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.805 ' CD2' HD11 ' A' ' 68' ' ' LEU . 14.2 m-85 -110.87 21.26 16.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.272 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER 58.75 111.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 30' ' ' ALA . 16.2 mt -105.53 144.8 31.79 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.14 -0.975 . . . . 0.0 110.609 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.83 133.03 56.51 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.914 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER -97.13 120.94 38.42 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.298 -0.876 . . . . 0.0 108.703 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 24' ' ' ASP . 12.0 t -72.07 155.16 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' VAL . 22.2 t70 -43.4 -31.46 0.68 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.69 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.854 ' O ' HG23 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -70.15 -103.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.473 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -166.95 63.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.959 -1.088 . . . . 0.0 109.442 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 3.6 m -142.83 142.27 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.965 . . . . 0.0 109.735 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -100.59 132.36 46.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.429 -0.794 . . . . 0.0 109.144 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 18.6 mt-10 -107.99 124.7 50.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.93 . . . . 0.0 109.268 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.909 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -105.59 116.09 31.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 109.27 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.95 147.05 49.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.727 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.463 ' HB2' ' HG2' ' A' ' 154' ' ' PRO . 3.9 m -115.56 167.8 10.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -0.912 . . . . 0.0 109.378 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.162 -0.961 . . . . 0.0 109.625 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.316 0.579 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 71' ' ' SER . 31.9 t-20 -80.72 -21.65 40.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.551 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.805 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.22 -40.0 18.62 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.17 -0.956 . . . . 0.0 108.566 179.574 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.486 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 41.4 t -67.07 -44.36 88.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.543 -0.723 . . . . 0.0 109.343 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -70.18 -40.46 74.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.869 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 1.3 t -63.26 -34.29 77.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 110.119 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.744 ' HB2' HD23 ' A' ' 74' ' ' LEU . 59.4 m-85 -111.32 6.75 20.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.03 -1.043 . . . . 0.0 109.904 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER 54.04 32.63 15.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 109.913 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.744 HD23 ' HB2' ' A' ' 72' ' ' PHE . 1.3 mm? -43.13 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.269 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -127.92 141.69 41.96 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.149 -0.97 . . . . 0.0 109.48 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 36.3 Cg_endo -78.47 127.15 7.96 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.576 2.184 . . . . 0.0 110.456 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.452 HG21 ' HB ' ' A' ' 132' ' ' ILE . 1.0 OUTLIER -138.33 176.54 8.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.12 -0.988 . . . . 0.0 109.641 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.412 ' O ' ' CD2' ' A' ' 130' ' ' PHE . 13.1 m -120.66 -149.41 0.43 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.228 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.647 ' CG ' ' CE1' ' A' ' 125' ' ' PHE . 6.5 p90 -164.84 -178.75 5.41 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.173 -0.954 . . . . 0.0 109.405 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.543 ' CB ' ' CB ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -120.85 136.94 54.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.125 -0.984 . . . . 0.0 109.63 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.45 -38.18 88.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 109.851 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.82 -33.64 6.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 109.781 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.543 ' CB ' ' CB ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -71.08 -29.44 65.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.922 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.529 ' CE1' ' HB ' ' A' ' 88' ' ' ILE . 5.6 t80 -56.69 -35.95 69.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.006 -1.059 . . . . 0.0 109.812 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.8 mtm -53.66 -43.55 68.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.912 -1.118 . . . . 0.0 109.694 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 t -70.62 -41.07 72.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.064 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -56.67 -56.47 21.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 109.57 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.529 ' HB ' ' CE1' ' A' ' 84' ' ' TYR . 4.2 tp -59.33 -29.33 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.857 . . . . 0.0 109.459 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -57.45 11.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.136 -0.977 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.02 -19.91 70.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -70.64 -40.71 72.91 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.167 -1.196 . . . . 0.0 107.778 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.437 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -69.41 -41.78 75.93 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -40.07 63.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.425 -0.797 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.07 73.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.21 -0.932 . . . . 0.0 109.189 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.771 HG21 ' CE1' ' A' ' 110' ' ' PHE . 13.5 mm -63.02 -38.21 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.185 -0.947 . . . . 0.0 109.127 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.471 ' HD3' ' OE1' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -55.48 -35.1 65.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.068 . . . . 0.0 109.397 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.65 59.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.915 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -59.63 -31.74 69.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.015 . . . . 0.0 109.623 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.797 HD22 ' CD ' ' A' ' 106' ' ' ARG . 28.2 mt -72.56 -44.34 62.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.965 . . . . 0.0 109.6 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.471 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -58.56 -35.98 73.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.59 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -83.72 -18.29 38.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.442 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 1.5 t -115.83 -75.35 0.59 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.459 ' HB2' ' HG2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -126.69 95.82 36.82 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.436 -0.79 . . . . 0.0 109.174 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' A' ' 107' ' ' VAL . 33.8 Cg_endo -74.42 -22.14 16.51 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.461 2.107 . . . . 0.0 110.489 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 -20.13 62.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.567 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.797 ' CD ' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -99.64 20.81 13.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.419 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 19.9 t -68.73 -45.59 33.49 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 110.638 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.8 Cg_endo -77.24 -25.1 8.84 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.952 1.768 . . . . 0.0 110.614 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.84 -52.77 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.262 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.771 ' CE1' HG21 ' A' ' 95' ' ' ILE . 24.7 t80 -67.31 -37.61 83.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.72 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -61.04 -37.39 82.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.033 -1.042 . . . . 0.0 109.978 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -71.28 -38.48 71.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.936 . . . . 0.0 110.224 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -67.33 -51.18 55.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.113 -0.992 . . . . 0.0 110.24 -179.323 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.822 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -57.89 -34.01 69.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.402 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -58.1 -46.76 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.119 -0.988 . . . . 0.0 109.513 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.437 ' N ' HG22 ' A' ' 115' ' ' ILE . . . -67.51 -43.71 85.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.1 -35.94 72.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.173 -1.192 . . . . 0.0 110.285 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 114' ' ' ALA . 39.6 t -63.15 -40.31 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.076 -1.015 . . . . 0.0 109.925 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.493 ' C ' ' CD ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -71.3 -28.78 64.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 109.202 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -56.33 10.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.885 . . . . 0.0 109.573 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.3 mp -59.82 -42.95 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 0.0 109.528 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 59.6 mt -48.46 -26.91 2.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.66 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.14 67.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -136.7 55.61 1.83 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 109.392 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.647 ' CE1' ' CG ' ' A' ' 79' ' ' PHE . 20.3 t80 -58.55 -33.77 70.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.653 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -39.33 80.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 109.763 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -78.67 -24.82 44.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.939 . . . . 0.0 109.686 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 129' ' ' ASP . 10.6 m-85 -77.6 -9.64 59.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.549 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.9 m-20 48.1 -175.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.352 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.837 ' CZ ' HG11 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -139.8 120.45 14.25 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.327 -0.858 . . . . 0.0 108.842 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.515 ' CE1' ' HB3' ' A' ' 145' ' ' MET . 15.2 m-85 -111.72 171.89 7.22 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.095 -1.003 . . . . 0.0 110.467 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.471 ' O ' HD13 ' A' ' 74' ' ' LEU . 6.4 tt -149.23 140.55 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.474 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.11 160.24 22.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.25 -21.82 66.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -1.086 . . . . 0.0 109.609 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 136' ' ' MET . 18.7 t -65.73 -34.84 79.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.469 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 135' ' ' SER . 3.2 ttm 74.86 59.78 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 0.0 109.464 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' A' ' 135' ' ' SER . 0.4 OUTLIER -129.45 109.63 17.63 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.356 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.13 -2.12 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.304 2.003 . . . . 0.0 110.32 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.651 ' O ' HG21 ' A' ' 8' ' ' ILE . 10.1 m-20 -104.41 -3.16 24.42 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.341 -0.85 . . . . 0.0 109.193 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 9' ' ' SER . . . -91.76 -72.89 0.57 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.161 -0.962 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.466 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 3.6 ttp -177.78 141.43 0.28 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.779 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.837 HG11 ' CZ ' ' A' ' 130' ' ' PHE . 74.6 t -102.76 141.53 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.114 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.468 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 3.3 t -102.3 143.55 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.102 -0.999 . . . . 0.0 109.559 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 144' ' ' LEU . 15.5 mt -106.63 134.58 49.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.326 -0.859 . . . . 0.0 109.195 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.515 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 12.1 ttm -113.28 124.49 52.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.337 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.575 ' O ' ' CD2' ' A' ' 155' ' ' TYR . 8.8 t30 -144.51 144.32 31.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -74.36 148.22 41.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -55.69 -172.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 109.586 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -79.99 -1.44 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.632 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.546 ' CB ' HD12 ' A' ' 152' ' ' ILE . 1.2 m-20 -104.22 -35.04 8.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.327 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.25 38.22 6.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.833 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -127.71 -26.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -1.164 . . . . 0.0 109.763 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 153' ' ' THR . 5.0 t -136.58 132.39 18.65 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 0.0 109.351 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 32' ' ' CYS . 36.6 Cg_endo -80.8 153.28 19.72 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.661 2.241 . . . . 0.0 110.602 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 146' ' ' ASN . 24.7 p90 -145.12 134.59 23.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 109.347 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.13 154.33 19.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.341 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 143' ' ' VAL . 6.4 mt -115.87 145.47 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.468 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 58.1 m-85 -136.93 129.17 29.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.439 ' HB2' ' SD ' ' A' ' 141' ' ' MET . 3.4 m-85 -60.79 127.78 33.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 109.632 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.07 -54.42 18.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.781 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . 12.7 t0 -43.62 -34.77 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.811 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -102.98 53.57 0.74 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.693 HD22 ' HB3' ' A' ' 4' ' ' TYR . 5.1 mt -161.96 130.23 4.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.482 HG23 ' HG3' ' A' ' 5' ' ' LYS . 5.4 m -114.1 139.15 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.3 p -83.24 142.71 30.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.61 ' O ' HD12 ' A' ' 3' ' ' LEU . 2.5 tp10 -133.79 123.16 24.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 109.523 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.37 110.95 23.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.365 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.123 -0.985 . . . . 0.0 109.476 -179.83 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 168' ' ' PHE . 17.8 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.514 HD22 ' HA ' ' A' ' 167' ' ' LYS . 14.7 mt -105.47 157.6 17.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 3' ' ' LEU . 8.4 mt -104.51 123.52 47.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 0.0 109.288 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 4.2 m-85 -107.35 118.48 36.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.677 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -139.8 156.31 46.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.271 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.01 155.89 29.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.647 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 p -97.58 -11.62 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.872 . . . . 0.0 109.418 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.412 HG21 ' O ' ' A' ' 139' ' ' ASP . 1.0 OUTLIER -91.76 -23.87 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.179 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.5 m -124.37 -10.77 7.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.744 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.87 58.18 9.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.449 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 10.0 m-20 -127.51 134.53 49.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -1.134 . . . . 0.0 109.487 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.415 ' C ' HD23 ' A' ' 13' ' ' LEU . 43.3 mt-10 -63.17 116.64 5.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.87 . . . . 0.0 109.569 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 4.0 mt -116.72 -48.04 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.874 . . . . 0.0 109.377 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.909 HG23 HD21 ' A' ' 68' ' ' LEU . 6.1 p -136.58 175.1 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.002 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.613 ' H ' HG22 ' A' ' 14' ' ' VAL . 3.1 p -159.57 173.22 16.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.87 -1.144 . . . . 0.0 110.594 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.468 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 10.9 t0 -84.1 2.86 37.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.529 -0.732 . . . . 0.0 109.7 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.74 -11.73 55.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.126 -0.984 . . . . 0.0 109.035 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.911 ' CE1' HD13 ' A' ' 68' ' ' LEU . 26.2 m-85 -120.62 21.08 11.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.453 -0.78 . . . . 0.0 109.267 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.31 133.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 30' ' ' ALA . 69.1 mt -129.31 143.57 50.9 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.277 -0.889 . . . . 0.0 109.765 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 29' ' ' GLU . 1.3 mttm -129.62 133.5 47.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 109.469 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -91.97 121.59 33.7 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.476 ' HB ' ' OD1' ' A' ' 25' ' ' ASP . 13.3 t -76.66 153.42 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -42.98 -36.93 1.71 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.579 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.6 ' OD1' HG22 ' A' ' 27' ' ' VAL . 6.1 p30 -63.73 -123.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.9 . . . . 0.0 109.311 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.519 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -146.14 63.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.746 -1.221 . . . . 0.0 109.35 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.6 HG22 ' OD1' ' A' ' 25' ' ' ASP . 13.3 m -151.94 163.47 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.746 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 4.8 m-85 -115.85 156.97 25.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.117 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 156' ' ' MET . 7.5 pt-20 -128.98 128.37 43.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.521 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.642 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -111.42 116.42 30.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.516 -0.74 . . . . 0.0 109.279 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 51.1 m-20 -63.32 142.55 58.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 109.581 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 58.6 m -133.45 152.66 51.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.902 . . . . 0.0 109.405 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.301 -0.874 . . . . 0.0 109.549 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -74.04 -24.28 59.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.729 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.911 HD13 ' CE1' ' A' ' 18' ' ' TYR . 27.7 tp -81.81 -45.03 16.14 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.083 -1.01 . . . . 0.0 108.552 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.975 HG13 ' CB ' ' A' ' 74' ' ' LEU . 55.8 t -65.03 -38.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.397 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -69.59 -36.21 76.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.132 -0.98 . . . . 0.0 109.902 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.6 -50.69 62.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.868 . . . . 0.0 110.129 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.672 ' HE2' HD11 ' A' ' 68' ' ' LEU . 34.9 m-85 -82.71 -3.66 56.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.997 . . . . 0.0 110.128 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER 73.49 18.39 3.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.498 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.975 ' CB ' HG13 ' A' ' 69' ' ' VAL . 1.8 mm? -39.29 138.69 0.61 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.463 -0.773 . . . . 0.0 109.976 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.816 ' O ' HG22 ' A' ' 132' ' ' ILE . 2.2 p -118.05 113.97 37.28 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.34 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.21 149.23 21.93 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.418 2.078 . . . . 0.0 110.468 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.5 p -113.78 -175.42 2.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.347 -0.846 . . . . 0.0 108.974 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.38 -44.66 0.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.809 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.502 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 6.6 p90 -78.57 132.11 37.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.586 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.556 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . 1.4 m-20 -175.97 27.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 109.825 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -45.0 95.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.069 -1.019 . . . . 0.0 109.354 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -122.49 -32.53 3.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.54 -32.4 72.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.293 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.573 ' CD2' ' CZ ' ' A' ' 125' ' ' PHE . 1.0 OUTLIER -58.71 -48.1 82.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.578 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.473 ' O ' HG22 ' A' ' 88' ' ' ILE . 2.2 mtt -60.3 -33.79 72.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.974 . . . . 0.0 109.818 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 t -67.61 -39.2 84.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.74 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -67.9 -47.18 69.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.806 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 85' ' ' MET . 6.2 tp -61.46 -26.73 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.505 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -43.35 57.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 109.595 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.29 -26.52 73.48 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' ' 141' ' ' MET . 17.9 m-85 -81.64 -36.65 28.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -1.152 . . . . 0.0 109.03 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -41.86 86.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.305 -0.872 . . . . 0.0 109.55 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.546 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -70.72 -42.96 69.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.059 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 93' ' ' LYS . . . -55.31 -49.47 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.04 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.732 HG21 ' CE2' ' A' ' 110' ' ' PHE . 34.1 mm -57.28 -43.19 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.344 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.55 -47.61 39.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.276 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.19 -34.56 77.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.324 -0.86 . . . . 0.0 109.298 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.446 ' O ' ' OG ' ' A' ' 102' ' ' SER . 3.6 tmt_? -63.36 -34.01 76.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.765 HD13 ' HD2' ' A' ' 106' ' ' ARG . 9.9 mt -71.83 -45.53 61.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.161 -0.962 . . . . 0.0 109.295 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -54.76 -35.36 63.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.588 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.39 -40.31 62.14 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.0 109.085 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -89.83 -77.55 0.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.524 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 103' ' ' ASN . 5.0 p30 -144.24 118.89 5.95 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.845 . . . . 0.0 109.398 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.55 ' HA ' HG23 ' A' ' 107' ' ' VAL . 33.1 Cg_endo -74.69 -13.56 22.12 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.487 2.125 . . . . 0.0 110.609 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.28 -19.79 65.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.868 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.765 ' HD2' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -100.89 15.52 28.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 109.603 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.604 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 15.6 t -72.27 -45.41 10.7 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 110.894 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 107' ' ' VAL . 34.0 Cg_endo -76.34 -49.29 0.12 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.953 1.769 . . . . 0.0 111.009 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 110' ' ' PHE . 29.5 m -58.31 -44.35 88.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.043 -1.036 . . . . 0.0 109.679 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.732 ' CE2' HG21 ' A' ' 95' ' ' ILE . 52.6 t80 -65.5 -38.51 89.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.243 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.981 ' O ' HD12 ' A' ' 115' ' ' ILE . 1.1 mt-10 -63.71 -44.33 93.92 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.133 -0.98 . . . . 0.0 110.332 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -33.81 76.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.155 -0.965 . . . . 0.0 110.122 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -69.57 -46.96 65.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.986 . . . . 0.0 109.864 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -64.66 -27.25 68.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 109.688 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.981 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -72.48 -44.93 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.7 -48.4 72.91 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.576 ' CE1' ' OD2' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -60.12 -41.33 92.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -1.19 . . . . 0.0 109.869 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 114' ' ' ALA . 56.9 t -64.32 -32.38 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.9 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -70.76 -33.28 70.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.029 . . . . 0.0 109.861 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -32.59 57.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.138 -0.976 . . . . 0.0 109.815 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.5 mp -72.04 -31.21 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.923 . . . . 0.0 109.319 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 95.6 mt -64.86 -26.79 68.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.048 -1.033 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.6 -29.18 69.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.975 . . . . 0.0 109.928 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.61 55.53 1.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.156 -0.965 . . . . 0.0 109.436 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 130' ' ' PHE . 4.0 t80 -63.34 -20.88 65.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.731 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 127' ' ' ASP . 6.0 ptmm? -74.4 -47.11 35.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.058 -1.026 . . . . 0.0 109.71 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.445 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 8.5 t70 -72.28 -23.72 61.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.616 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 1.1 m-85 -79.33 -24.28 42.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.112 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.531 ' C ' ' CD1' ' A' ' 130' ' ' PHE . 2.5 m-20 53.24 173.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 109.14 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.687 ' CE1' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -134.51 121.19 20.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 108.98 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 13.0 m-85 -105.66 164.63 11.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.102 -0.999 . . . . 0.0 110.661 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 75' ' ' SER . 0.8 OUTLIER -146.79 138.8 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.436 -0.79 . . . . 0.0 109.435 179.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.21 155.21 3.59 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -59.24 -23.9 62.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -1.143 . . . . 0.0 109.119 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 136' ' ' MET . 3.0 p -64.65 -35.22 80.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.408 -0.807 . . . . 0.0 109.285 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 72.67 40.82 0.59 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.293 -0.88 . . . . 0.0 109.365 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.84 134.14 32.63 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.867 . . . . 0.0 109.309 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.67 -5.74 16.83 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.385 2.057 . . . . 0.0 110.133 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.412 ' O ' HG21 ' A' ' 8' ' ' ILE . 46.1 m-20 -98.21 -4.32 35.66 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.287 -0.883 . . . . 0.0 109.208 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.05 134.99 39.68 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.547 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -64.49 152.17 42.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.6 m -88.64 141.89 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 109.369 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.67 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.6 t -92.23 130.01 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.236 -0.915 . . . . 0.0 108.967 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 129' ' ' ASP . 1.5 mt -103.42 135.43 45.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.535 ' CG ' ' HG2' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.54 142.73 38.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.573 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 1.8 t30 -145.97 166.37 26.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.717 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.72 125.93 35.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.566 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.491 ' HG3' ' CD2' ' A' ' 155' ' ' TYR . 0.9 OUTLIER -66.32 -169.31 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.24 -0.912 . . . . 0.0 109.404 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -16.09 60.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.465 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 148' ' ' ARG . 2.0 m-20 -57.89 -56.57 20.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 0.0 109.333 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 126.73 -23.19 5.68 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.838 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -140.45 37.07 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -1.127 . . . . 0.0 109.221 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.4 m -127.27 100.54 26.33 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.08 131.81 9.07 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.569 2.179 . . . . 0.0 109.814 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.491 ' CD2' ' HG3' ' A' ' 148' ' ' ARG . 40.3 p90 -135.96 142.64 44.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.097 -1.002 . . . . 0.0 109.718 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.91 ' SD ' HD23 ' A' ' 68' ' ' LEU . 6.5 mtp -99.02 149.16 23.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.208 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.624 ' O ' HG13 ' A' ' 143' ' ' VAL . 68.8 mt -117.15 141.38 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.67 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 5.7 m-85 -132.61 141.79 48.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 109.307 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.484 ' O ' ' HB2' ' A' ' 163' ' ' LEU . 72.6 m-85 -71.06 127.71 33.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 109.697 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.417 ' HE2' ' C ' ' A' ' 160' ' ' LYS . 0.7 OUTLIER -67.21 -40.83 86.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.343 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.426 ' HB3' HD12 ' A' ' 95' ' ' ILE . 2.3 m-20 -52.62 -33.28 45.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.409 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -112.65 50.05 0.8 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 159' ' ' PHE . 0.6 OUTLIER -153.26 129.24 10.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -1.121 . . . . 0.0 109.525 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 m -118.81 144.84 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 109.307 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -106.08 129.64 54.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 109.862 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -120.65 122.43 40.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.249 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.514 ' HA ' HD22 ' A' ' 2' ' ' LEU . 2.1 tttp -55.75 123.24 13.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.736 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.403 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.486 ' CG ' HD23 ' A' ' 2' ' ' LEU . 4.6 ptp . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.287 0.565 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.486 HD23 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -67.09 147.16 53.5 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 2' ' ' LEU . 57.9 mt -118.41 126.65 52.53 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.429 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 165' ' ' SER . 75.8 m-85 -114.15 121.58 44.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.725 ' HA ' HD23 ' A' ' 13' ' ' LEU . 10.0 ptmt -126.37 160.79 29.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.616 -0.678 . . . . 0.0 109.228 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.418 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 25.6 t0 -98.86 154.08 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.329 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.36 -17.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.0 mt -75.43 -44.65 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 164.56 43.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.24 -41.94 3.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 57.1 99.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -1.19 . . . . 0.0 109.478 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 44.73 81.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.415 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.068 HD11 HD12 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -86.15 -32.06 21.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.718 HG21 ' CB ' ' A' ' 30' ' ' ALA . 8.2 p -166.91 174.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.966 -1.083 . . . . 0.0 109.529 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.626 ' H ' HG22 ' A' ' 14' ' ' VAL . 28.2 t -146.17 168.34 21.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.987 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.51 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 20.4 t0 -93.11 -4.59 52.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 109.483 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.18 -20.71 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.151 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.631 ' CD2' HD11 ' A' ' 68' ' ' LEU . 13.5 m-85 -99.08 -55.67 2.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.401 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 18' ' ' TYR . 3.3 m-20 155.44 130.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 30' ' ' ALA . 76.7 mt -130.27 133.56 46.59 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.046 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -131.43 127.52 37.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 9.2 pt-20 -92.9 129.59 38.77 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.058 -1.026 . . . . 0.0 109.614 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' ASP . 4.1 t -78.32 152.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -43.79 -28.46 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.884 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.728 ' O ' HG23 ' A' ' 26' ' ' ILE . 3.0 m-20 -65.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -162.98 49.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.987 -1.071 . . . . 0.0 109.203 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 6.7 m -140.57 151.42 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.654 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -100.6 157.63 16.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.081 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.2 tt0 -128.61 116.87 20.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.105 . . . . 0.0 109.629 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.718 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -107.24 112.82 25.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 108.958 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -73.89 146.64 43.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.979 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.04 148.54 48.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.828 . . . . 0.0 109.072 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.11 165.98 12.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.494 ' CG ' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -101.1 134.79 43.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.453 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 64' ' ' THR . 1.4 m -131.65 149.07 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.444 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.26 125.25 41.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.274 -0.891 . . . . 0.0 109.385 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.78 160.76 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.875 . . . . 0.0 109.385 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -93.8 98.19 10.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -104.89 137.54 42.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.375 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.76 43.4 1.71 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.96 154.7 8.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 43' ' ' VAL . 8.4 t70 -144.88 -53.19 0.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -1.17 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 47' ' ' ALA . 95.8 t 43.77 81.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.487 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.17 -172.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.767 HG22 ' O ' ' A' ' 45' ' ' ILE . 2.5 mp -93.81 57.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.342 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.615 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . 121.52 118.81 2.58 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 46' ' ' GLY . . . 169.18 49.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -1.112 . . . . 0.0 109.585 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -146.51 141.96 16.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 109.482 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.49 -89.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.628 2.219 . . . . 0.0 110.424 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -134.17 141.53 47.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.394 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.97 178.01 8.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -121.78 -25.13 5.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.0 t0 63.87 37.36 9.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 109.487 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -109.8 -63.59 1.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.87 . . . . 0.0 109.356 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 10.4 mm-40 64.63 -91.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.598 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -123.57 172.91 8.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 109.706 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -113.81 18.07 17.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.326 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.33 17.19 7.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 179.56 123.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -72.52 -69.36 0.41 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.358 -0.839 . . . . 0.0 109.62 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 163.62 55.44 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.43 124.59 28.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -1.135 . . . . 0.0 109.391 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.55 129.82 43.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 109.501 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.494 ' OG1' ' CG ' ' A' ' 34' ' ' MET . 9.0 t -83.16 139.96 32.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.424 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.73 156.43 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -0.88 . . . . 0.0 109.48 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -60.68 152.41 26.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.305 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 71' ' ' SER . 19.7 p30 -85.45 -17.77 35.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.975 . . . . 0.0 109.57 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.631 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.09 -41.75 16.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 108.716 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.856 HG22 ' HB2' ' A' ' 74' ' ' LEU . 45.2 t -72.35 -36.69 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.411 -0.805 . . . . 0.0 109.286 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -69.61 -43.18 73.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -74.22 -27.94 61.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.936 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' C ' ' CD ' ' A' ' 73' ' ' ARG . 26.3 m-85 -114.39 16.66 17.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.458 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER 37.84 44.06 0.55 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.729 -0.607 . . . . 0.0 110.596 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.856 ' HB2' HG22 ' A' ' 69' ' ' VAL . 6.6 mt -49.44 142.85 7.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.997 -1.065 . . . . 0.0 108.566 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.693 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.4 p -128.96 107.7 18.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.992 -1.067 . . . . 0.0 109.463 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 131' ' ' TYR . 35.8 Cg_endo -78.21 134.04 12.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.454 2.103 . . . . 0.0 110.247 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -124.26 159.69 29.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.729 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.75 164.36 24.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -150.24 179.98 7.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.778 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.59 153.62 36.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.105 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.55 67.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.703 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.66 -31.32 65.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 109.529 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.5 m -66.15 -29.96 70.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 10.3 t80 -65.75 -36.87 84.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.703 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 3.1 mtt -64.66 -38.03 89.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 110.011 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -71.11 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.918 . . . . 0.0 110.496 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -77.27 -38.98 49.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.5 HG23 ' HE3' ' A' ' 89' ' ' LYS . 6.7 tp -76.34 -26.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.843 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.5 ' HE3' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -76.77 -56.38 4.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 109.673 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.18 -23.0 73.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 91' ' ' TYR . 30.1 t80 -81.34 -40.7 23.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.022 -1.281 . . . . 0.0 108.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -63.47 -40.54 97.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 89' ' ' LYS . 0.5 OUTLIER -65.24 -38.53 90.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.94 -46.59 78.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.025 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.515 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 29.2 mm -64.74 -40.39 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -51.61 -38.09 53.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.133 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.61 -39.13 64.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 0.0 109.68 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.547 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -59.9 -32.11 70.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.365 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 50.6 mt -73.08 -47.35 45.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -55.34 -36.89 66.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.751 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.59 -31.5 41.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.2 t -105.08 -78.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.723 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 59.3 t30 -119.83 107.94 39.59 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.26 -19.78 19.42 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.385 2.057 . . . . 0.0 110.381 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -74.14 -11.43 60.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.214 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.544 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -94.1 0.71 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.489 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 53.6 t -71.95 -43.23 10.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 111.29 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.5 Cg_endo -76.45 -52.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.877 1.718 . . . . 0.0 111.085 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 2.3 m -59.72 -36.99 69.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.997 -1.064 . . . . 0.0 109.587 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 44.9 t80 -69.67 -37.34 76.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.276 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.784 ' O ' HD12 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -68.53 -48.78 63.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.868 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -49.47 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.057 . . . . 0.0 110.807 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 109' ' ' VAL . 2.5 m120 -64.49 -48.91 73.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.439 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -62.72 -32.09 73.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -68.27 -39.63 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.402 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.59 -47.82 73.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -42.09 97.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.988 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 114' ' ' ALA . 71.8 t -60.13 -35.53 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.847 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -68.18 -38.13 81.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.933 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -78.83 -17.56 55.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.94 . . . . 0.0 109.897 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.44 -37.87 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 109.678 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 15.7 mt -62.34 -31.63 72.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 109.659 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.487 ' O ' ' ND2' ' A' ' 124' ' ' ASN . . . -54.1 -26.29 26.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.636 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 123' ' ' ALA . 12.4 m-80 -154.76 54.53 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 2.2 p90 -59.8 -22.13 61.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.639 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.444 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -76.58 -43.42 38.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -65.11 -26.39 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 4.9 m-85 -85.11 -12.24 53.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.338 -0.851 . . . . 0.0 109.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' O ' HD22 ' A' ' 144' ' ' LEU . 4.1 m-20 50.88 177.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.667 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.804 ' CE1' HG13 ' A' ' 142' ' ' VAL . 2.7 t80 -139.07 121.23 15.79 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.559 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 9.1 m-85 -103.36 170.69 7.8 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.056 -1.028 . . . . 0.0 110.669 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 75' ' ' SER . 2.0 tt -156.54 142.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.65 -178.94 51.87 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.421 ' OE1' ' HG2' ' A' ' 73' ' ' ARG . 3.6 mp0 -64.36 -19.45 65.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 136' ' ' MET . 82.6 p -56.01 -33.58 65.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 135' ' ' SER . 13.7 mmt 64.7 53.86 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.572 -0.705 . . . . 0.0 109.494 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.43 ' N ' HD11 ' A' ' 132' ' ' ILE . 6.4 t0 -128.96 120.12 20.2 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.323 -0.86 . . . . 0.0 109.176 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.98 2.67 6.37 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.286 1.99 . . . . 0.0 110.559 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.78 12.94 11.45 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.275 -0.891 . . . . 0.0 109.197 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.39 -156.87 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.452 ' HE3' ' HB2' ' A' ' 159' ' ' PHE . 0.0 OUTLIER -64.5 121.53 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.804 HG13 ' CE1' ' A' ' 130' ' ' PHE . 94.4 t -106.35 120.27 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.549 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.623 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 7.2 t -109.46 141.52 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.485 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 129' ' ' ASP . 53.1 mt -114.65 141.42 47.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.31 -0.869 . . . . 0.0 108.965 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.1 ttm -104.8 119.68 39.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.018 . . . . 0.0 109.522 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.586 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 44.6 t30 -138.09 146.72 43.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.541 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.9 OUTLIER -87.3 146.2 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.885 . . . . 0.0 109.541 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -58.75 -171.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.29 -17.46 64.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -53.49 4.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.541 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 114.89 -24.72 10.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 152' ' ' ILE . 1.3 tp -85.18 3.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.291 -1.123 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 m -123.67 101.18 36.94 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.6 122.82 5.13 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.509 2.14 . . . . 0.0 109.924 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 155' ' ' TYR . 5.9 p90 -141.03 148.66 40.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.28 158.6 26.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 109.022 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 143' ' ' VAL . 41.6 mt -116.64 141.93 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 110.02 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 4.5 m-85 -126.3 113.69 17.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.477 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 8.0 m-85 -42.93 119.31 1.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.06 -28.58 67.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.865 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 159' ' ' PHE . 3.3 p30 -57.63 -39.7 77.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.443 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -105.93 43.04 1.76 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.068 HD12 HD11 ' A' ' 13' ' ' LEU . 3.6 tt -142.47 125.76 16.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.44 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -112.77 157.42 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.552 ' HA ' ' CD1' ' A' ' 4' ' ' TYR . 1.7 m -101.49 139.21 37.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.08 123.17 33.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -90.57 139.32 30.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 167' ' ' LYS . 12.2 mt -99.02 154.07 18.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.644 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.4 mt -113.56 138.16 50.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.765 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.484 ' HB2' HG13 ' A' ' 14' ' ' VAL . 13.2 m-85 -116.5 108.45 16.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.104 -0.998 . . . . 0.0 109.585 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.526 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.6 OUTLIER -105.08 163.46 12.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.493 -0.754 . . . . 0.0 109.345 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.506 ' OD1' ' CE ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -81.01 157.12 25.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 109.303 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.475 ' CG2' HG13 ' A' ' 164' ' ' VAL . 68.5 t -106.52 -18.82 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.975 . . . . 0.0 109.601 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 mt -85.9 -25.06 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 109.267 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.84 -58.62 1.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.498 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.21 74.42 0.91 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -161.98 160.53 27.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -1.153 . . . . 0.0 109.51 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.7 129.24 36.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.718 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -118.05 -76.76 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.09 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 6.0 p -131.78 167.21 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.599 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.9 p -136.35 148.91 48.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.87 -1.144 . . . . 0.0 110.408 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.494 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 36.3 t70 -82.23 5.61 19.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.491 -0.756 . . . . 0.0 109.284 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.46 -24.09 67.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.893 . . . . 0.0 108.884 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.583 ' CE2' HD13 ' A' ' 68' ' ' LEU . 30.2 m-85 -100.13 21.19 13.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.548 -0.72 . . . . 0.0 109.604 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER 58.3 112.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 108.89 -179.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 30' ' ' ALA . 12.2 mt -103.48 147.1 27.56 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 110.343 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -129.75 122.85 29.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.803 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -80.86 128.64 33.89 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ASP . 2.5 t -86.79 92.36 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 0.0 110.116 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 23' ' ' VAL . 23.5 m-20 22.89 45.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 120.848 0.356 . . . . 0.0 111.673 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' VAL . 18.6 m-20 -161.25 -114.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.943 -1.098 . . . . 0.0 109.684 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 160' ' ' LYS . 1.0 OUTLIER -144.71 12.9 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.809 -1.182 . . . . 0.0 109.427 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 12.3 m -104.41 133.68 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 34.7 m-85 -98.51 151.23 20.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.314 -0.866 . . . . 0.0 109.077 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 mt-10 -117.41 117.44 29.48 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.514 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.82 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -96.75 112.62 24.3 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 4.7 m-20 -68.93 150.78 47.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 110.042 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.59 144.24 36.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.27 -0.894 . . . . 0.0 109.188 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 137.67 51.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 0.0 109.586 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.9 mmt -82.06 129.69 34.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.3 m -114.51 135.17 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.366 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.75 110.93 17.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.954 . . . . 0.0 109.525 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.0 132.68 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 38' ' ' LYS . 1.1 ptmm? -67.44 106.49 2.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.407 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -93.99 146.06 24.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.543 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.74 83.16 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.72 -125.34 5.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 58.41 45.05 17.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -1.172 . . . . 0.0 109.368 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 43' ' ' VAL . 12.0 p -112.49 6.02 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.662 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.9 t70 56.18 64.74 1.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.661 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 46' ' ' GLY . 17.0 mm -134.74 -85.08 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.602 ' N ' HG22 ' A' ' 45' ' ' ILE . . . -176.77 -114.88 0.4 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.96 141.09 35.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.182 -1.187 . . . . 0.0 109.481 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -54.18 144.83 38.01 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.425 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.4 95.31 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.57 2.18 . . . . 0.0 110.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t -75.84 -27.45 57.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.416 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.19 54.74 0.23 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -133.15 40.69 3.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.236 -0.915 . . . . 0.0 109.405 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -166.19 -40.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.861 . . . . 0.0 109.284 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.86 179.38 8.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.191 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -161.7 90.01 0.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.661 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 4.3 mt-10 61.47 60.93 1.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.903 . . . . 0.0 109.759 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -102.54 -31.89 10.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.235 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.74 146.31 52.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.252 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.18 38.32 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.497 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -136.61 7.17 3.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.534 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.8 64.43 0.43 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.7 p -108.88 -174.42 2.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 109.535 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -140.39 132.72 28.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 109.414 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -72.89 127.6 33.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.205 -0.934 . . . . 0.0 109.463 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 35' ' ' VAL . 35.4 m -142.66 136.06 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.456 ' CG ' ' HB ' ' A' ' 69' ' ' VAL . 1.5 p30 -56.7 151.92 13.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 108.954 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.524 ' OD1' ' CE1' ' A' ' 18' ' ' TYR . 30.9 p30 -98.14 -15.01 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.87 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.964 HD23 ' HE2' ' A' ' 156' ' ' MET . 48.9 tp -85.48 -41.57 15.23 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.148 -0.97 . . . . 0.0 108.989 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.685 HG13 ' HB2' ' A' ' 74' ' ' LEU . 66.6 t -72.77 -37.75 56.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.358 -0.839 . . . . 0.0 109.172 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -69.28 -48.89 60.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.453 -0.779 . . . . 0.0 110.295 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 t -69.4 -52.5 26.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.217 -0.927 . . . . 0.0 110.05 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.698 ' CD1' HD12 ' A' ' 68' ' ' LEU . 28.8 m-85 -75.19 -12.75 60.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.14 37.29 3.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.685 ' HB2' HG13 ' A' ' 69' ' ' VAL . 9.3 mt -50.28 107.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.981 -1.074 . . . . 0.0 108.742 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.047 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -89.96 126.73 56.36 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.864 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.52 129.32 8.36 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.502 2.135 . . . . 0.0 110.16 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.12 135.81 37.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.088 -1.008 . . . . 0.0 109.656 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.5 m -64.54 -172.4 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.193 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -158.43 -176.94 6.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.082 -1.011 . . . . 0.0 109.592 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.568 ' CB ' ' HB2' ' A' ' 83' ' ' SER . 0.1 OUTLIER -114.69 142.09 46.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.454 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -44.97 95.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 110.153 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.61 -40.27 14.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.991 . . . . 0.0 110.427 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.568 ' HB2' ' CB ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -59.1 -29.48 67.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 109.59 -179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -56.9 -48.39 78.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.782 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mtt -64.05 -46.43 84.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.198 -0.939 . . . . 0.0 110.021 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 m -54.9 -37.05 65.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 109.97 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.57 ' CZ ' ' O ' ' A' ' 138' ' ' PRO . 24.1 t80 -76.47 -33.97 58.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 109.735 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' MET . 3.6 mm -71.42 -15.6 18.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.125 -0.984 . . . . 0.0 109.308 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -57.1 3.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.34 72.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -77.86 -36.8 49.51 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.282 -1.128 . . . . 0.0 108.395 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.456 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -62.44 -51.94 65.5 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -57.14 -38.82 74.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.487 -0.758 . . . . 0.0 109.293 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.76 -50.42 72.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.917 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.771 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 30.3 mm -65.37 -28.97 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -44.78 93.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.192 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 100' ' ' GLN . . . -69.3 -25.89 64.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -0.844 . . . . 0.0 109.102 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -71.27 -41.1 70.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.613 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 106' ' ' ARG . 61.2 mt -72.79 -48.57 37.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.946 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -58.41 -31.77 68.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.741 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -79.24 -28.8 42.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.06 -1.025 . . . . 0.0 108.883 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.502 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 73.4 m -93.93 -79.02 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.4 -0.813 . . . . 0.0 109.015 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.95 140.36 26.64 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.832 . . . . 0.0 109.271 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -74.88 -17.25 20.03 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.654 2.236 . . . . 0.0 111.12 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -71.09 -8.95 56.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -0.967 . . . . 0.0 109.955 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.903 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -100.44 -5.06 27.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.117 -0.989 . . . . 0.0 109.793 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.588 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 3.1 t -69.18 -47.52 28.48 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.09 -1.006 . . . . 0.0 109.985 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 36.1 Cg_endo -78.54 -39.23 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.129 1.886 . . . . 0.0 110.876 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.09 -50.07 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.174 -0.953 . . . . 0.0 109.855 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.771 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 60.2 t80 -68.81 -39.67 79.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.29 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 1.2 mm-40 -61.4 -43.47 98.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.119 -0.988 . . . . 0.0 110.406 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -70.39 -45.51 65.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.063 -1.023 . . . . 0.0 110.182 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 117' ' ' PHE . 3.8 t-20 -57.95 -38.7 76.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.159 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.794 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -71.02 -31.76 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 110.156 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.474 ' O ' ' HD2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -70.36 -48.89 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.134 -0.979 . . . . 0.0 109.747 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 120' ' ' LYS . . . -66.92 -49.31 55.41 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -58.14 -42.88 86.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.108 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 114' ' ' ALA . 53.3 t -57.28 -37.04 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.989 . . . . 0.0 110.023 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -71.01 -45.49 63.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.018 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 0.1 OUTLIER -56.67 -54.21 48.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.702 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.66 -53.68 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 0.0 109.347 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 119' ' ' LYS . 42.9 mt -45.95 -48.05 16.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.729 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -46.88 -45.86 20.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.42 ' HB3' ' OD1' ' A' ' 127' ' ' ASP . 7.1 m120 -139.42 66.14 1.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.524 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.85 -49.6 75.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -52.53 -28.6 21.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 109.776 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 124' ' ' ASN . 3.6 m-20 -77.75 -37.86 48.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 109.722 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 129' ' ' ASP . 27.4 m-85 -77.95 -14.65 59.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.648 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.4 OUTLIER 50.82 177.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.648 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 131' ' ' TYR . 2.0 t80 -136.78 121.3 18.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.828 . . . . 0.0 108.837 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.575 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 19.3 m-85 -107.75 175.78 5.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 110.871 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 1.047 HG22 ' O ' ' A' ' 75' ' ' SER . 18.6 tt -147.33 159.7 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.534 -0.729 . . . . 0.0 109.399 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -88.13 171.9 41.12 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -24.07 64.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -1.153 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.3 OUTLIER -59.68 -34.98 73.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.494 ' CB ' ' O ' ' A' ' 135' ' ' SER . 3.2 tpt 75.75 37.17 0.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.24 125.28 26.99 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.273 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.57 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 33.9 Cg_endo -75.44 -0.25 9.88 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.295 1.997 . . . . 0.0 110.35 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -105.65 -0.73 25.35 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.31 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 141' ' ' MET . . . -94.98 44.34 1.1 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.905 . . . . 0.0 109.617 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.506 ' CE ' ' OD1' ' A' ' 6' ' ' ASP . 2.3 mtp 67.42 140.84 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 109.688 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.566 ' CG1' ' CE1' ' A' ' 130' ' ' PHE . 19.0 m -112.73 141.32 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.267 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.784 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.9 t -109.31 144.12 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 0.0 109.836 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.0 mt -113.62 147.92 37.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.197 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.432 ' SD ' ' SD ' ' A' ' 156' ' ' MET . 5.2 tpp -116.71 123.0 46.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.866 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.54 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 13.9 t-20 -141.63 151.25 42.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.383 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -76.48 154.97 34.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.655 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -100.64 -172.66 2.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -28.62 63.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.27 -47.94 65.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.539 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 106.71 -34.66 5.56 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.744 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -121.2 20.93 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -1.102 . . . . 0.0 109.191 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.3 m -117.01 101.5 53.34 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.339 -0.85 . . . . 0.0 109.361 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.68 129.06 8.99 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.5 2.133 . . . . 0.0 110.581 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 33.4 p90 -131.0 152.07 50.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 0.0 109.282 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.964 ' HE2' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -117.1 157.65 25.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.608 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.525 ' O ' HG13 ' A' ' 143' ' ' VAL . 20.4 mt -115.39 137.12 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 109.616 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.784 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 31.4 m-85 -129.22 141.71 51.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.087 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -75.24 117.57 17.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.896 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -68.44 -28.17 66.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 160' ' ' LYS . 0.8 OUTLIER -58.82 -18.92 36.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.748 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -125.72 39.88 1.96 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.526 HD23 ' O ' ' A' ' 5' ' ' LYS . 9.5 mt -137.57 149.5 46.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -1.221 . . . . 0.0 109.668 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.475 HG13 ' CG2' ' A' ' 7' ' ' VAL . 5.5 m -128.41 122.99 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.149 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.84 132.58 35.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.496 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -118.51 126.35 51.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.823 . . . . 0.0 109.221 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.454 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.9 OUTLIER -61.21 119.16 7.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.75 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.586 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 0.9 OUTLIER -68.82 149.44 48.96 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.23 -0.919 . . . . 0.0 109.852 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.843 HD23 ' HB3' ' A' ' 15' ' ' SER . 13.0 mt -126.17 123.8 39.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.511 -0.743 . . . . 0.0 109.128 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.869 ' HD2' HD11 ' A' ' 163' ' ' LEU . 30.3 m-85 -102.05 118.97 38.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 0.0 109.758 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 35.3 pttt -136.75 165.33 26.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.462 -0.774 . . . . 0.0 109.433 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 20.3 p30 -71.88 145.33 48.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 7' ' ' VAL . 14.9 p -107.81 43.22 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.474 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.441 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 1.1 tt -140.64 -38.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 27.1 t -104.89 -70.66 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.595 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 138.86 84.08 0.11 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 12' ' ' GLU . 19.2 t0 179.58 141.44 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -1.13 . . . . 0.0 109.336 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.562 ' HG3' ' CE2' ' A' ' 72' ' ' PHE . 1.2 pm0 -78.98 147.57 32.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.536 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 mt -130.9 -41.72 1.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.283 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.858 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 2.6 p -138.98 167.44 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.843 ' HB3' HD23 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -160.21 176.14 12.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.888 -1.132 . . . . 0.0 110.94 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 8.5 t70 -81.21 1.13 33.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.621 -0.674 . . . . 0.0 109.804 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.52 -16.26 63.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.075 -1.016 . . . . 0.0 108.758 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.845 ' CE2' HD13 ' A' ' 68' ' ' LEU . 27.2 m-85 -122.56 19.31 10.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.463 -0.773 . . . . 0.0 109.081 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 18' ' ' TYR . 1.2 m-20 61.79 134.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 108.835 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.601 HD21 ' CG2' ' A' ' 14' ' ' VAL . 12.2 mt -126.44 155.04 42.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.199 -0.938 . . . . 0.0 110.119 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.517 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 12.6 mmtt -132.26 120.97 22.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.445 -0.784 . . . . 0.0 109.118 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -87.24 126.14 34.64 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.187 -0.946 . . . . 0.0 108.804 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 24' ' ' ASP . 3.4 t -76.63 158.43 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.591 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' VAL . 1.3 t0 -42.9 -33.17 0.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.418 -0.801 . . . . 0.0 109.313 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.491 ' HB3' ' ND2' ' A' ' 113' ' ' ASN . 5.4 m-20 -69.85 -140.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.069 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.842 HD11 ' OD1' ' A' ' 113' ' ' ASN . 1.5 pp -129.18 61.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.9 -1.125 . . . . 0.0 109.435 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 m -146.12 147.61 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.773 . . . . 0.0 109.372 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 22' ' ' GLU . 44.3 m-85 -103.89 158.52 16.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.517 ' CG ' ' HB2' ' A' ' 21' ' ' LYS . 11.2 pt-20 -130.2 129.4 43.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 109.57 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.858 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -111.77 134.4 53.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -0.929 . . . . 0.0 109.429 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -98.19 134.87 40.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.418 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 68' ' ' LEU . 63.1 m -110.36 155.86 21.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 109.731 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.71 138.71 53.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -0.846 . . . . 0.0 109.462 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.44 118.7 21.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.137 -0.977 . . . . 0.0 109.386 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.3 m -123.48 167.53 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.948 . . . . 0.0 109.636 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.3 t -111.2 149.03 31.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.901 . . . . 0.0 109.547 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.59 147.47 26.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.192 -0.943 . . . . 0.0 109.632 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.5 97.76 6.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.52 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -98.63 115.83 29.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.83 68.48 1.59 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 42' ' ' ASP . . . -157.14 -91.43 0.08 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER 72.75 34.38 1.18 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -1.16 . . . . 0.0 109.656 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.5 67.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 109.349 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.46 170.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 109.6 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 45' ' ' ILE . 48.8 mm -122.48 9.71 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.06 137.89 6.23 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 48' ' ' ASN . . . -62.64 -163.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -1.154 . . . . 0.0 109.323 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 27.2 m-20 63.3 149.09 0.1 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.562 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 36.4 Cg_endo -78.99 95.52 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.587 2.191 . . . . 0.0 110.346 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.8 m -131.67 35.41 3.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.77 149.99 22.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' N ' ' OE1' ' A' ' 52' ' ' GLU . 17.9 mp0 -140.8 125.18 17.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.369 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.6 108.92 15.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.367 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 55' ' ' GLU . . . -48.53 -54.3 14.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.421 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.48 ' HG3' ' HG2' ' A' ' 56' ' ' GLU . 5.1 pt-20 176.37 -33.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.481 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.48 ' HG2' ' HG3' ' A' ' 55' ' ' GLU . 3.0 pt-20 -161.13 105.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -151.74 174.13 13.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.45 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.17 150.26 24.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -118.03 -62.34 1.56 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.322 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 87.2 mt-10 60.87 85.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.888 . . . . 0.0 109.637 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.553 ' C ' HG23 ' A' ' 62' ' ' THR . . . 140.82 87.71 0.12 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.553 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.2 p 61.87 141.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.324 -1.103 . . . . 0.0 109.579 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -151.85 147.8 27.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.367 -0.833 . . . . 0.0 109.523 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.36 136.31 39.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 109.371 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.03 160.44 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.606 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.464 ' CB ' ' HB ' ' A' ' 69' ' ' VAL . 0.8 OUTLIER -59.54 154.14 18.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -89.25 -39.74 13.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.883 . . . . 0.0 109.634 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.845 HD13 ' CE2' ' A' ' 18' ' ' TYR . 25.4 tp -80.79 -34.76 33.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.082 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.692 HG13 ' HB2' ' A' ' 74' ' ' LEU . 94.5 t -67.45 -39.84 83.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.45 -0.781 . . . . 0.0 109.333 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -69.63 -52.22 27.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -28.55 70.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 0.0 110.545 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.562 ' CE2' ' HG3' ' A' ' 12' ' ' GLU . 9.2 m-85 -102.97 -4.74 24.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.89 -1.131 . . . . 0.0 110.028 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.51 28.81 16.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.015 . . . . 0.0 109.852 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.692 ' HB2' HG13 ' A' ' 69' ' ' VAL . 2.3 mm? -49.24 140.24 10.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.093 -1.005 . . . . 0.0 109.285 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.4 t -123.39 139.62 32.26 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 109.486 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.79 132.74 10.95 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.537 2.158 . . . . 0.0 110.145 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 p -128.18 165.76 19.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.417 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.28 129.73 3.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.517 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 17.0 t80 -141.6 160.38 40.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 109.452 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.57 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 40.3 m-20 -39.36 129.64 1.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.479 -0.763 . . . . 0.0 109.673 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HG3' ' CE1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -61.63 -32.35 72.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.606 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -44.54 59.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 109.922 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 80' ' ' ASP . 10.8 t -62.91 -37.89 88.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.784 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.502 ' CE1' HG12 ' A' ' 88' ' ' ILE . 1.4 t80 -55.69 -35.83 66.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.235 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.754 ' O ' HG22 ' A' ' 88' ' ' ILE . 30.4 mtt -56.76 -48.26 78.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -0.954 . . . . 0.0 109.368 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.28 -45.38 91.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.18 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.438 ' O ' ' CD2' ' A' ' 91' ' ' TYR . 25.5 m-85 -68.04 -17.69 64.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.754 HG22 ' O ' ' A' ' 85' ' ' MET . 0.3 OUTLIER -76.57 -30.2 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -79.17 -35.33 42.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.384 -0.822 . . . . 0.0 109.032 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.82 -36.58 87.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 87' ' ' TYR . 20.0 m-85 -78.48 -36.93 44.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.118 -1.225 . . . . 0.0 108.942 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.9 OUTLIER -62.38 -39.91 94.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 108.791 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -69.09 -34.33 74.93 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.1 73.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 109.164 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 47.1 mm -66.76 -36.12 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 109.23 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HD3' HG13 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -60.22 -35.49 75.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.161 -0.962 . . . . 0.0 109.255 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.52 -55.13 6.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.947 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -52.28 -33.1 40.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 109.936 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.959 HD22 ' HB3' ' A' ' 106' ' ' ARG . 83.6 mt -72.82 -45.11 60.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -56.55 -38.45 71.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -32.99 63.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 m -98.35 -72.49 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.823 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -140.7 119.06 8.21 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.52 -17.64 20.69 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.458 2.105 . . . . 0.0 110.745 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -68.99 -9.6 53.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.679 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.959 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -101.34 -5.78 24.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 109.603 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.623 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 51.9 t -71.34 -42.99 12.13 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 111.04 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.2 Cg_endo -76.97 -52.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.894 1.729 . . . . 0.0 110.984 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.579 HG23 ' H ' ' A' ' 110' ' ' PHE . 15.6 m -55.87 -52.63 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.097 -1.002 . . . . 0.0 109.413 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.579 ' H ' HG23 ' A' ' 109' ' ' VAL . 46.1 t80 -62.79 -37.04 85.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.116 -0.99 . . . . 0.0 109.177 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -54.13 -48.08 71.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 110.304 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 109' ' ' VAL . 1.0 OUTLIER -67.65 -36.12 80.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.05 -1.031 . . . . 0.0 110.179 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.842 ' OD1' HD11 ' A' ' 26' ' ' ILE . 21.2 t-20 -67.5 -32.94 74.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.399 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.693 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -71.07 -29.82 65.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.157 -0.964 . . . . 0.0 109.889 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -71.32 -40.21 73.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.231 -0.918 . . . . 0.0 108.985 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -67.56 -46.45 69.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.484 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -68.18 -30.74 69.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -1.154 . . . . 0.0 110.065 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 114' ' ' ALA . 37.6 t -68.8 -50.59 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.095 -1.003 . . . . 0.0 109.509 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.455 ' C ' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -65.97 -28.69 69.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 0.0 109.653 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.66 -60.75 2.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.147 -0.971 . . . . 0.0 109.609 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.579 HG12 HD13 ' A' ' 144' ' ' LEU . 1.2 mp -55.41 -37.65 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.441 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 45.5 mt -53.03 -42.29 65.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 109.603 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.88 -39.68 40.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 109.268 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.523 ' HB3' ' CB ' ' A' ' 127' ' ' ASP . 8.6 m120 -130.04 64.08 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.0 109.247 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.577 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 6.9 t80 -60.55 -38.98 86.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 109.856 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -77.23 -30.76 54.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 110.012 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.523 ' CB ' ' HB3' ' A' ' 124' ' ' ASN . 1.2 t70 -75.13 -23.83 57.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.986 . . . . 0.0 109.953 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.793 ' HB3' HD22 ' A' ' 144' ' ' LEU . 41.5 m-85 -94.03 -33.0 13.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.716 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.887 ' O ' HD23 ' A' ' 144' ' ' LEU . 92.1 m-20 53.87 -177.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -141.41 122.39 14.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 108.796 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.41 ' HB3' HD12 ' A' ' 74' ' ' LEU . 10.6 m-85 -97.97 173.04 7.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.0 110.757 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 14.8 tt -156.59 138.21 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.651 -0.655 . . . . 0.0 109.268 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.06 170.88 8.04 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.29 -18.31 64.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -1.178 . . . . 0.0 109.355 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 136' ' ' MET . 4.8 t -60.54 -36.44 78.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 0.0 109.48 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.41 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 69.93 49.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.297 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.11 119.2 54.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.237 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.37 0.35 9.16 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.307 2.005 . . . . 0.0 110.239 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -100.55 -8.87 22.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.374 -0.829 . . . . 0.0 109.091 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.441 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -88.88 152.99 21.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -0.89 . . . . 0.0 109.286 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.507 ' CE ' ' HB2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -65.62 166.1 11.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.656 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.07 141.83 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.444 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.49 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 17.3 t -97.3 139.25 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.152 -0.968 . . . . 0.0 109.235 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 129' ' ' ASP . 17.6 mt -107.12 136.6 46.69 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.426 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.56 137.09 47.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.629 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.444 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 24.6 t-20 -152.16 164.34 37.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 109.534 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.42 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 2.6 m-85 -107.83 137.23 46.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.425 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.8 OUTLIER -65.56 167.06 9.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.284 -0.885 . . . . 0.0 109.387 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 148' ' ' ARG . 4.9 mt-10 -44.26 -28.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.444 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -50.43 70.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.516 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.42 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 101.18 -20.68 46.34 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.82 ' O ' HD12 ' A' ' 152' ' ' ILE . 2.0 pp -105.71 7.04 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -1.038 . . . . 0.0 109.366 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.2 m -114.08 101.34 53.92 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.236 -0.915 . . . . 0.0 109.26 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.2 119.24 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.443 2.095 . . . . 0.0 110.415 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 5.1 p90 -138.61 138.76 38.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.946 . . . . 0.0 109.465 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.508 ' SD ' ' N ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -116.92 149.59 39.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 109.174 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.492 ' C ' ' CD1' ' A' ' 158' ' ' PHE . 2.6 mt -105.89 149.12 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.617 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 6.0 m-85 -132.34 117.88 18.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 0.0 109.267 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 163' ' ' LEU . 36.6 m-85 -53.67 121.65 8.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 109.375 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 8.1 tttt -66.84 -26.7 67.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.681 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 159' ' ' PHE . 0.4 OUTLIER -56.49 -43.99 80.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.331 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -108.41 27.93 12.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.869 HD11 ' HD2' ' A' ' 4' ' ' TYR . 1.2 tm? -147.45 126.91 13.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.349 -1.089 . . . . 0.0 109.111 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.783 ' N ' HD22 ' A' ' 163' ' ' LEU . 10.8 m -135.72 155.95 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.57 ' OG ' ' CE1' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -88.85 150.45 22.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.449 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -142.57 122.59 13.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 109.313 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -90.46 146.03 24.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.39 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.73 HD21 ' HE3' ' A' ' 167' ' ' LYS . 12.7 mt -102.62 152.49 21.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 2' ' ' LEU . 12.8 mt -107.54 146.49 31.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.84 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.51 ' HD2' HD13 ' A' ' 163' ' ' LEU . 8.3 m-85 -121.7 111.66 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 0.0 109.173 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.679 ' O ' HD23 ' A' ' 163' ' ' LEU . 15.8 mttm -114.48 156.68 24.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.68 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.0 155.9 21.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.546 ' O ' HG22 ' A' ' 7' ' ' VAL . 13.3 p -92.07 -0.42 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.507 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.483 HG21 ' O ' ' A' ' 139' ' ' ASP . 47.6 mm -80.16 -58.68 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.686 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 10' ' ' GLY . 41.7 t -119.13 13.62 12.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' SER . . . 44.99 70.89 0.54 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.411 ' CG ' ' OG ' ' A' ' 135' ' ' SER . 15.0 t70 -137.85 138.35 39.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -1.07 . . . . 0.0 109.329 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.447 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -44.83 143.82 1.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.47 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.65 HD12 ' CE2' ' A' ' 158' ' ' PHE . 0.2 OUTLIER -134.32 -62.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.831 HG21 ' CB ' ' A' ' 30' ' ' ALA . 4.4 p -144.37 -178.85 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.91 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.729 ' H ' HG22 ' A' ' 14' ' ' VAL . 72.7 m -149.45 165.38 32.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.723 -1.236 . . . . 0.0 110.602 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.19 7.98 22.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.498 -0.751 . . . . 0.0 109.503 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.82 -10.6 49.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.116 -0.99 . . . . 0.0 108.923 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.783 ' CD2' HD11 ' A' ' 68' ' ' LEU . 24.3 m-85 -121.03 21.54 11.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 0.0 109.147 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER 64.21 132.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.825 HD23 ' HA ' ' A' ' 30' ' ' ALA . 21.9 mt -126.14 142.79 51.38 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.216 -0.927 . . . . 0.0 110.052 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.04 140.14 50.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.465 -0.772 . . . . 0.0 109.42 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.14 112.92 24.94 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.259 -0.901 . . . . 0.0 108.903 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.54 152.68 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.446 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -54.01 -19.6 5.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.668 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -75.46 -98.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.04 -1.038 . . . . 0.0 109.318 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -165.76 56.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.005 -1.06 . . . . 0.0 109.617 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.411 HG13 ' C ' ' A' ' 26' ' ' ILE . 11.1 m -152.05 158.16 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.077 -1.014 . . . . 0.0 109.76 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.413 ' C ' ' HG2' ' A' ' 29' ' ' GLU . 6.0 m-85 -103.58 162.2 13.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 0.0 109.026 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.6 mm-40 -130.99 117.41 19.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.831 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -103.97 112.76 25.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 108.956 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 2.3 m-20 -77.92 150.47 34.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.824 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.434 ' SG ' ' HG2' ' A' ' 154' ' ' PRO . 1.7 p -125.46 175.72 7.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.871 . . . . 0.0 109.315 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.33 164.65 27.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 0.0 109.459 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.5 126.19 48.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.465 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 65' ' ' VAL . 33.8 m -115.14 131.22 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.855 . . . . 0.0 109.544 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.77 112.65 24.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 0.0 109.311 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 m -129.28 133.29 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.621 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -76.15 92.94 3.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.243 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.455 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -119.65 131.88 55.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.537 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.47 -58.17 4.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 42' ' ' ASP . . . 104.1 -109.09 3.3 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' GLY . 46.4 m-20 44.13 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -1.154 . . . . 0.0 109.379 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 60' ' ' GLU . 9.0 p -81.5 -27.35 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.68 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 45' ' ' ILE . 23.0 t70 -126.7 -89.07 0.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.651 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.484 HG22 ' OD2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -165.02 -39.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 109.407 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -171.78 139.97 5.6 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 57.41 70.23 0.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.113 -1.227 . . . . 0.0 109.306 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' ND2' HG12 ' A' ' 43' ' ' VAL . 89.9 m-20 -60.62 126.51 85.14 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.164 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 50' ' ' SER . 36.3 Cg_endo -79.14 68.93 8.13 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.303 2.002 . . . . 0.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 49' ' ' PRO . 4.4 t 75.62 97.94 0.07 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.143 -0.973 . . . . 0.0 109.296 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 52' ' ' GLU . . . -56.38 -170.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' ALA . 3.9 mm-40 60.93 96.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 109.659 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 44.93 -97.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.699 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' GLU . . . 54.06 84.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 109.561 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 49.18 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.951 . . . . 0.0 109.514 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.55 117.95 22.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.85 . . . . 0.0 109.505 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -154.56 28.79 0.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.72 -167.15 1.47 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.368 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -75.37 164.73 26.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.406 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.617 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.1 mt-10 -87.69 -31.39 19.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.81 27.59 2.72 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.3 p -105.48 155.76 18.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.315 -1.109 . . . . 0.0 109.445 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.459 ' OE1' ' CG1' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -135.31 113.81 11.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 109.516 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.1 t -76.67 130.37 37.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.218 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 35' ' ' VAL . 33.4 m -128.42 125.6 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.907 . . . . 0.0 109.682 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -51.09 142.02 13.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.18 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 71' ' ' SER . 10.0 p30 -74.19 -21.48 59.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 109.739 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.783 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -81.47 -36.94 28.72 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.099 -1.001 . . . . 0.0 108.771 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 73' ' ' ARG . 41.7 t -71.33 -54.32 17.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.419 -0.801 . . . . 0.0 109.706 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -61.76 -41.31 97.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 0.0 110.142 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 5.0 t -68.4 -33.19 73.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.152 -0.968 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.485 ' HB2' HD23 ' A' ' 74' ' ' LEU . 22.9 m-85 -110.08 13.32 23.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.04 -1.037 . . . . 0.0 109.996 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 69' ' ' VAL . 55.0 mtt180 43.41 69.42 0.4 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.155 -0.966 . . . . 0.0 109.481 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 72' ' ' PHE . 1.7 mm? -89.81 137.96 31.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.399 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.539 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -100.03 117.83 62.63 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.152 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.71 123.59 5.37 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.551 2.168 . . . . 0.0 110.631 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.47 ' HG1' ' HD2' ' A' ' 79' ' ' PHE . 2.4 t -132.69 174.2 10.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 108.988 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -142.57 9.22 1.79 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.222 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 16.7 p90 -86.91 123.04 31.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.045 -1.035 . . . . 0.0 109.599 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -174.23 21.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.943 . . . . 0.0 110.54 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -63.58 -53.46 51.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.945 -1.097 . . . . 0.0 109.347 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.06 -24.67 4.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -29.89 67.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.118 -0.989 . . . . 0.0 109.165 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.558 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -58.84 -46.27 88.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 109.356 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.447 ' HA ' HG22 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -64.84 -30.04 71.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.262 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -71.16 -55.4 8.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.017 -1.052 . . . . 0.0 110.691 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.554 ' CD1' ' HG2' ' A' ' 138' ' ' PRO . 39.7 m-85 -63.91 -41.45 97.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.088 -1.007 . . . . 0.0 109.897 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -68.84 -22.33 26.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 109.469 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -55.2 5.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.344 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.12 -19.89 68.52 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -81.12 -39.02 26.26 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.157 -1.202 . . . . 0.0 108.326 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.65 -40.69 92.75 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.69 -43.99 95.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 0.0 109.125 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.56 -50.09 68.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 108.886 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.633 HG23 ' OD1' ' A' ' 161' ' ' ASP . 41.9 mm -60.02 -32.07 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.224 -0.923 . . . . 0.0 108.682 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -50.32 71.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 108.948 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.82 77.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.154 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HD3' HD23 ' A' ' 99' ' ' LEU . 3.8 tmt_? -58.63 -43.84 89.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.126 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.504 HD13 ' HG2' ' A' ' 106' ' ' ARG . 24.7 mt -64.67 -48.47 74.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.378 -0.826 . . . . 0.0 109.033 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -52.72 -25.26 10.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.198 -0.939 . . . . 0.0 108.827 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -76.32 -43.28 41.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 108.966 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.8 t -88.85 -71.77 0.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.191 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -148.04 137.25 11.95 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.04 -16.73 19.95 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.604 2.203 . . . . 0.0 111.066 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.52 -14.08 62.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.008 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.504 ' HG2' HD13 ' A' ' 99' ' ' LEU . 12.8 ttp-105 -93.09 -5.94 49.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.664 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 62.9 t -71.21 -43.09 12.55 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 111.344 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.4 Cg_endo -77.38 -54.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.883 1.722 . . . . 0.0 110.99 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.606 HG23 ' N ' ' A' ' 110' ' ' PHE . 35.7 m -56.52 -46.0 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.114 -0.992 . . . . 0.0 110.007 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.606 ' N ' HG23 ' A' ' 109' ' ' VAL . 62.5 t80 -65.06 -45.87 83.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.822 . . . . 0.0 110.696 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 115' ' ' ILE . 67.7 tt0 -57.28 -47.77 80.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.008 -1.057 . . . . 0.0 110.536 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -68.38 -31.69 71.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.058 -1.026 . . . . 0.0 110.345 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -66.36 -54.24 26.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 109.913 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -69.57 -26.55 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.988 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 111' ' ' GLU . 4.1 mm -62.29 -49.08 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.127 -0.983 . . . . 0.0 109.162 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.96 -41.04 99.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -35.2 75.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.25 -1.147 . . . . 0.0 109.602 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 114' ' ' ALA . 70.4 t -70.58 -38.06 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 109.561 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 115' ' ' ILE . 3.3 mmtt -64.34 -29.66 70.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 109.801 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -81.83 -46.9 13.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 109.893 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.2 OUTLIER -53.98 -37.86 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.16 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.02 -45.87 86.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.122 -0.986 . . . . 0.0 109.424 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -48.05 -39.66 20.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.868 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -136.43 45.65 2.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.146 -0.971 . . . . 0.0 109.735 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 10.1 p90 -63.02 -22.86 67.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.443 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.413 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -70.95 -47.02 61.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.547 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 2.0 m-20 -71.13 -23.57 62.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.342 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.559 ' HB3' HD22 ' A' ' 144' ' ' LEU . 6.3 m-85 -76.45 -10.72 59.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.513 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 50.94 -172.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.946 . . . . 0.0 109.451 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 77' ' ' THR . 0.3 OUTLIER -149.22 121.68 8.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -107.4 166.81 10.38 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.035 -1.041 . . . . 0.0 110.38 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 75' ' ' SER . 7.6 tt -146.79 130.51 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.405 -0.809 . . . . 0.0 109.477 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.56 179.16 3.87 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.08 -23.27 67.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -1.127 . . . . 0.0 109.453 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 136' ' ' MET . 7.2 m -58.71 -34.58 71.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.511 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 76.81 20.4 1.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.308 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -114.62 119.58 39.37 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.242 -0.911 . . . . 0.0 109.276 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 87' ' ' TYR . 33.4 Cg_endo -75.4 -5.51 16.7 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.262 1.974 . . . . 0.0 110.303 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.483 ' O ' HG21 ' A' ' 8' ' ' ILE . 2.4 p30 -95.38 -4.88 44.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 0.0 109.143 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' A' ' 141' ' ' MET . . . -98.45 47.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.53 ' CB ' ' O ' ' A' ' 140' ' ' ALA . 27.3 ttm 79.66 115.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.759 -0.588 . . . . 0.0 109.606 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.15 130.59 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.351 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 157' ' ' ILE . 3.0 t -99.84 138.82 23.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.271 -0.893 . . . . 0.0 109.069 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 128' ' ' TYR . 18.6 mt -115.0 146.49 41.19 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.229 -0.92 . . . . 0.0 109.622 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.428 ' HG2' ' HG2' ' A' ' 156' ' ' MET . 0.0 OUTLIER -109.3 124.79 51.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.329 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.542 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 24.3 t-20 -138.31 140.22 39.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.5 OUTLIER -77.8 147.04 35.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -0.845 . . . . 0.0 109.563 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -79.22 178.42 8.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.0 -25.36 8.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.45 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.447 ' OD2' HG13 ' A' ' 152' ' ' ILE . 31.9 t0 -72.17 -47.99 46.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 0.0 109.397 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 105.33 -28.61 13.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.798 ' O ' HD12 ' A' ' 152' ' ' ILE . 2.3 pp -99.78 11.51 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -1.153 . . . . 0.0 109.641 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.1 m -121.49 100.59 44.34 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.158 -0.964 . . . . 0.0 109.428 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.434 ' HG2' ' SG ' ' A' ' 32' ' ' CYS . 36.9 Cg_endo -81.22 131.02 7.49 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.554 2.169 . . . . 0.0 110.502 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 146' ' ' ASN . 32.9 p90 -135.18 144.49 47.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.377 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.5 ' HB3' ' CG1' ' A' ' 143' ' ' VAL . 2.0 mtt -107.93 163.91 12.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 109.888 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.638 ' O ' HG13 ' A' ' 143' ' ' VAL . 8.0 mt -124.15 139.36 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 109.384 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.65 ' CE2' HD12 ' A' ' 13' ' ' LEU . 52.7 m-85 -129.97 116.0 17.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.491 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 2.2 m-85 -43.15 116.81 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.263 -0.898 . . . . 0.0 109.746 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -68.65 -42.59 77.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.825 . . . . 0.0 109.979 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.633 ' OD1' HG23 ' A' ' 95' ' ' ILE . 3.5 t70 -47.22 -35.79 8.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.465 ' O ' ' HE2' ' A' ' 141' ' ' MET . . . -110.74 50.26 0.78 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 5' ' ' LYS . 3.8 mt -134.16 154.96 50.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.237 . . . . 0.0 109.68 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 5' ' ' LYS . 7.2 m -143.27 125.83 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 59.4 m -82.59 135.55 35.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -127.72 124.9 38.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.892 . . . . 0.0 109.574 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.73 ' HE3' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -68.5 117.17 9.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.445 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.494 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttm . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 167' ' ' LYS . 12.6 mt -112.5 151.5 29.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 109.641 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 3' ' ' LEU . 32.4 mt -105.92 122.93 47.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.667 ' HD2' HD11 ' A' ' 163' ' ' LEU . 3.6 m-85 -103.92 117.88 35.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.942 . . . . 0.0 109.185 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -129.63 143.27 50.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.644 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.861 ' OD1' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -74.35 156.77 36.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.529 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 7' ' ' VAL . 93.2 t -98.72 -6.45 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.356 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 140' ' ' ALA . 3.1 mt -101.47 -61.31 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 109.651 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 8' ' ' ILE . 10.3 t -43.23 -47.39 6.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.57 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.96 -63.65 0.37 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.87 65.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -1.19 . . . . 0.0 109.52 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 179.37 141.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.861 HD22 ' OD1' ' A' ' 6' ' ' ASP . 23.9 tp -171.96 -75.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 0.0 109.62 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.843 HG21 ' CB ' ' A' ' 30' ' ' ALA . 3.2 p -153.18 -172.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 108.972 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.743 ' H ' HG22 ' A' ' 14' ' ' VAL . 51.5 p -162.57 174.27 12.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.843 -1.161 . . . . 0.0 110.168 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.42 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 37.5 t70 -82.95 10.98 6.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.399 -0.813 . . . . 0.0 109.988 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.08 -9.67 33.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 109.227 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 39.4 m-85 -126.77 21.56 6.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.243 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 14.9 m-20 67.96 130.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 30' ' ' ALA . 34.8 mt -126.31 147.89 49.64 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.178 -0.951 . . . . 0.0 110.371 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 136.8 44.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.504 -0.747 . . . . 0.0 109.381 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 1.1 tt0 -99.24 113.17 25.29 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.264 -0.898 . . . . 0.0 108.837 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ASP . 33.2 t -62.36 157.69 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.222 -0.924 . . . . 0.0 109.574 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -43.73 -28.37 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.247 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -75.24 -143.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 108.998 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.446 ' O ' ' HB3' ' A' ' 160' ' ' LYS . 1.0 OUTLIER -123.41 54.58 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.054 -1.029 . . . . 0.0 109.591 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.2 m -136.86 153.84 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 109.473 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 4.3 m-85 -107.27 163.16 13.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.308 -0.87 . . . . 0.0 109.222 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 47.6 mt-10 -128.98 119.91 25.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.843 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -114.86 112.52 22.88 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 11.1 m-20 -75.01 145.62 42.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 t -104.21 125.89 50.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.415 -0.803 . . . . 0.0 108.944 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -106.63 154.64 20.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.104 -0.998 . . . . 0.0 109.969 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.3 mmm -103.5 135.12 45.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 108.808 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.54 174.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.067 -1.021 . . . . 0.0 109.802 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.844 ' HB ' HG21 ' A' ' 62' ' ' THR . 1.5 p -93.84 118.35 31.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.378 -0.826 . . . . 0.0 109.278 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.5 m -123.71 125.95 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 99.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.341 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -81.75 115.95 21.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.915 . . . . 0.0 109.563 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.04 26.24 21.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.54 144.34 35.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -147.85 43.4 1.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -1.191 . . . . 0.0 109.496 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 43' ' ' VAL . 3.5 m -76.27 -17.14 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.729 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 45' ' ' ILE . 31.1 m-20 -80.67 -16.94 52.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 109.392 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.51 ' O ' HG23 ' A' ' 45' ' ' ILE . 3.1 tp 38.64 60.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.619 -0.676 . . . . 0.0 110.287 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.83 144.07 35.33 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.95 109.63 10.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -1.225 . . . . 0.0 109.475 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.41 147.13 34.72 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.447 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 -86.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.612 2.208 . . . . 0.0 110.238 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 26.2 t -105.64 -64.46 1.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 109.445 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 50' ' ' SER . . . 174.53 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.833 . . . . 0.0 109.457 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -102.34 61.71 0.85 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.158 -0.964 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.76 173.08 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.582 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . . . -78.96 154.81 29.28 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.905 . . . . 0.0 109.406 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 3.9 tt0 -50.02 -27.69 5.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.59 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.2 pt-20 179.52 177.35 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 109.689 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' GLU . 29.3 m120 43.73 79.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.866 . . . . 0.0 109.427 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . . . -158.07 -161.42 1.01 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.95 . . . . 0.0 109.635 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -44.53 153.44 0.16 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 109.701 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 56.34 66.41 1.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 109.673 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 62' ' ' THR . . . 149.14 57.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.844 HG21 ' HB ' ' A' ' 36' ' ' THR . 5.8 t -56.43 -163.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -1.142 . . . . 0.0 109.284 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.458 ' N ' HG23 ' A' ' 62' ' ' THR . 0.9 OUTLIER -146.56 140.78 26.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -0.955 . . . . 0.0 109.507 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.01 125.4 30.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.6 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.1 159.43 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 109.485 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.492 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 32.8 m120 -54.25 143.32 23.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.891 . . . . 0.0 109.525 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 32.3 t-20 -92.71 -26.18 17.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.707 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.615 HD11 HG23 ' A' ' 14' ' ' VAL . 49.7 tp -87.78 -47.79 8.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 108.749 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 74' ' ' LEU . 50.7 t -60.42 -47.88 90.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -69.29 -47.59 64.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 110.139 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 t -49.4 -52.25 29.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.561 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 68' ' ' LEU . 72.5 m-85 -102.12 8.48 40.71 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.046 -1.033 . . . . 0.0 110.178 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.481 ' O ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 57.24 95.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.023 . . . . 0.0 109.263 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.726 ' HB2' HG13 ' A' ' 69' ' ' VAL . 3.9 mm? -114.31 139.13 49.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.336 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.523 ' O ' HG22 ' A' ' 132' ' ' ILE . 4.4 t -125.92 124.06 24.68 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 109.397 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.85 157.81 27.59 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.398 2.065 . . . . 0.0 110.263 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -93.87 -174.27 3.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 109.391 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.1 4.42 2.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.702 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 14.1 t80 -160.34 124.26 3.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.501 ' HB2' ' CD2' ' A' ' 130' ' ' PHE . 0.3 OUTLIER -161.56 23.74 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.328 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -53.17 61.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -23.7 11.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.315 -0.866 . . . . 0.0 109.331 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.6 m -72.02 -31.45 66.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 80' ' ' ASP . 3.9 t80 -58.83 -36.65 74.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.604 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.738 ' O ' HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -63.37 -53.04 58.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.73 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.3 m -61.62 -28.56 69.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.872 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 91' ' ' TYR . 10.9 m-85 -69.63 -46.3 66.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.092 -1.005 . . . . 0.0 109.749 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 85' ' ' MET . 5.9 tp -65.12 -24.58 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.279 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -46.85 38.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.766 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.94 -27.1 72.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 87' ' ' TYR . 21.1 m-85 -81.21 -36.75 29.67 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.083 -1.245 . . . . 0.0 109.307 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.511 ' O ' ' HE3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -63.76 -41.32 98.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.89 . . . . 0.0 109.863 -179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -73.45 -40.9 63.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.958 . . . . 0.0 109.723 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -44.47 73.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.613 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.676 HD12 ' OD1' ' A' ' 161' ' ' ASP . 49.2 mm -62.15 -37.41 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.491 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -50.68 61.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.87 . . . . 0.0 109.29 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.89 -27.89 68.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.385 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.578 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.41 -36.49 82.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.316 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 106' ' ' ARG . 33.3 mt -72.59 -50.45 25.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.127 -0.983 . . . . 0.0 109.616 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -51.51 -34.19 35.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.304 -0.872 . . . . 0.0 109.0 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.2 -37.09 72.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 109.056 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.5 m -96.95 -82.04 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.378 -0.826 . . . . 0.0 109.601 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.509 ' OD1' ' CG ' ' A' ' 105' ' ' GLU . 3.1 p30 -132.0 134.69 25.49 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.64 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.15 -19.01 17.95 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.503 2.135 . . . . 0.0 110.854 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.509 ' CG ' ' OD1' ' A' ' 103' ' ' ASN . 16.2 pt-20 -68.87 -8.76 46.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 0.0 109.861 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.729 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -93.92 -3.53 51.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.994 . . . . 0.0 109.782 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 25.8 t -72.4 -45.02 10.29 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 111.015 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.2 Cg_endo -77.41 -47.39 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.989 1.793 . . . . 0.0 111.156 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 110' ' ' PHE . 1.4 p -63.51 -44.68 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 109.598 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.532 ' N ' ' CG1' ' A' ' 109' ' ' VAL . 49.0 t80 -64.5 -41.0 96.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.501 -0.749 . . . . 0.0 110.34 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -40.37 94.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.015 -1.053 . . . . 0.0 110.338 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -48.98 45.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.045 -1.034 . . . . 0.0 110.783 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.41 -54.62 43.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.054 -1.029 . . . . 0.0 110.465 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.716 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -60.71 -26.71 67.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.001 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 115' ' ' ILE . 0.9 OUTLIER -65.12 -49.15 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.086 -1.009 . . . . 0.0 109.286 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.37 -33.59 82.57 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.507 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.1 OUTLIER -63.6 -45.46 90.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -1.13 . . . . 0.0 109.969 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 114' ' ' ALA . 60.6 t -53.78 -38.62 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.326 -0.859 . . . . 0.0 110.657 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -71.19 -49.29 45.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 110.562 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 117' ' ' PHE . 0.1 OUTLIER -73.0 -11.18 60.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.028 -1.045 . . . . 0.0 110.27 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -83.2 -44.57 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.06 -1.025 . . . . 0.0 109.665 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.402 ' N ' HG22 ' A' ' 121' ' ' ILE . 40.0 mt -53.64 -36.4 62.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 109.964 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 122' ' ' LEU . . . -45.1 -39.39 5.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 109.719 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.564 ' O ' ' CE1' ' A' ' 128' ' ' TYR . 35.2 m-80 -113.0 50.71 0.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 109.939 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.651 ' HA ' ' CE1' ' A' ' 128' ' ' TYR . 53.7 t80 -64.02 -54.13 39.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.175 -0.953 . . . . 0.0 109.991 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.48 -5.46 58.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -0.904 . . . . 0.0 109.086 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.515 ' HB2' ' CB ' ' A' ' 124' ' ' ASN . 15.8 m-20 -80.73 -41.53 23.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.84 . . . . 0.0 109.908 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.651 ' CE1' ' HA ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -102.03 10.78 39.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.086 . . . . 0.0 110.727 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 0.3 OUTLIER 43.86 -151.75 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.196 -0.94 . . . . 0.0 109.345 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.576 ' CE1' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -149.59 121.25 8.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 108.991 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.462 ' CE1' ' SD ' ' A' ' 145' ' ' MET . 13.2 m-85 -104.19 164.76 11.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.146 -0.971 . . . . 0.0 110.36 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 75' ' ' SER . 12.8 tt -157.11 135.87 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.421 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -48.24 156.14 1.19 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -17.71 16.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.152 . . . . 0.0 109.522 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.1 OUTLIER -57.68 -38.92 75.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.214 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.491 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.1 OUTLIER 74.72 27.16 1.3 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 0.0 109.603 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.24 114.27 51.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 136' ' ' MET . 33.8 Cg_endo -74.49 1.69 7.16 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.336 2.024 . . . . 0.0 110.392 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 139' ' ' ASP . 62.6 t0 -121.54 15.43 11.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.353 -0.842 . . . . 0.0 109.119 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . . . -97.69 -94.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.867 . . . . 0.0 109.726 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 142' ' ' VAL . 9.1 tmm? -163.11 139.13 7.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 109.56 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.454 ' O ' ' SD ' ' A' ' 141' ' ' MET . 5.6 m -104.41 135.25 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 157' ' ' ILE . 4.3 t -103.55 130.01 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.167 -0.958 . . . . 0.0 109.469 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.592 HD22 ' CD1' ' A' ' 128' ' ' TYR . 47.0 mt -88.99 152.41 21.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.846 . . . . 0.0 109.324 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.462 ' SD ' ' CE1' ' A' ' 131' ' ' TYR . 1.4 ttt -111.92 115.48 29.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 109.539 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 155' ' ' TYR . 1.5 m-20 -121.0 165.88 14.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' A' ' 151' ' ' GLY . 0.1 OUTLIER -107.64 135.52 48.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.464 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 153' ' ' THR . 3.3 ttp180 -60.32 173.22 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 109.453 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.38 -31.27 65.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.336 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.46 -46.8 68.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.855 . . . . 0.0 109.348 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.56 ' O ' ' CE1' ' A' ' 147' ' ' TYR . . . 102.09 -28.49 15.7 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 152' ' ' ILE . 1.2 tp -87.45 -10.98 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -1.093 . . . . 0.0 109.24 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 148' ' ' ARG . 2.9 m -115.45 102.13 54.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.401 -0.812 . . . . 0.0 109.34 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.39 143.6 22.16 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.425 2.083 . . . . 0.0 110.3 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 146' ' ' ASN . 6.4 p90 -143.43 144.98 32.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 mtm -110.21 166.96 10.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.346 -0.846 . . . . 0.0 109.177 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 143' ' ' VAL . 3.6 mt -131.55 139.37 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 29.9 m-85 -123.09 153.81 39.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.336 -0.853 . . . . 0.0 109.302 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -75.76 113.93 13.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 26' ' ' ILE . 1.7 tttt -60.35 -44.43 95.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 109.369 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.676 ' OD1' HD12 ' A' ' 95' ' ' ILE . 3.3 p30 -49.38 -38.89 30.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.188 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -104.64 47.55 1.06 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.667 HD11 ' HD2' ' A' ' 4' ' ' TYR . 4.9 tt -151.68 126.77 9.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.437 -1.037 . . . . 0.0 109.31 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.502 HG13 ' CG2' ' A' ' 7' ' ' VAL . 13.4 m -112.27 140.55 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.915 . . . . 0.0 109.575 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.99 134.38 47.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.464 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.83 126.78 53.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.893 . . . . 0.0 109.416 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.459 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -67.09 123.12 19.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.413 -0.804 . . . . 0.0 109.416 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.484 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 2' ' ' LEU . 6.8 mt -111.36 152.89 26.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.694 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.1 mt -114.98 143.44 45.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.493 -0.754 . . . . 0.0 109.078 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.673 ' HD2' HD21 ' A' ' 163' ' ' LEU . 53.0 m-85 -120.47 112.87 19.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.511 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 164' ' ' VAL . 10.5 ttpt -117.6 157.48 26.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.582 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.524 ' OD2' ' CE ' ' A' ' 141' ' ' MET . 2.0 t70 -92.67 155.27 17.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.343 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 8' ' ' ILE . 12.1 m -97.44 -38.87 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.481 ' N ' HG23 ' A' ' 7' ' ' VAL . 4.7 mt -46.65 -79.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.867 . . . . 0.0 109.301 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.24 31.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.919 . . . . 0.0 109.523 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.86 68.13 0.28 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 12' ' ' GLU . 10.1 p30 -52.3 143.81 14.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -1.166 . . . . 0.0 109.429 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 11' ' ' ASP . 44.0 mm-40 58.87 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.82 -74.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.303 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.033 HG23 HD21 ' A' ' 68' ' ' LEU . 7.9 p -149.66 175.4 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 108.95 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.628 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.2 p -138.21 165.83 25.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.862 -1.148 . . . . 0.0 110.754 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.503 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -85.2 8.88 16.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 0.0 109.77 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.94 -25.14 66.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.027 . . . . 0.0 108.961 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.755 ' CE2' HD13 ' A' ' 68' ' ' LEU . 47.2 m-85 -102.47 21.94 14.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.116 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER 60.31 122.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.5 -0.75 . . . . 0.0 109.161 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.813 HD23 ' HA ' ' A' ' 30' ' ' ALA . 22.9 mt -116.04 152.12 34.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.34 -0.85 . . . . 0.0 109.878 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' ' OE2' ' A' ' 29' ' ' GLU . 1.7 mptp? -131.19 148.93 52.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -0.863 . . . . 0.0 109.746 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.38 125.36 36.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.834 . . . . 0.0 109.201 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' ASP . 15.8 t -78.09 148.48 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.729 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' VAL . 76.0 m-20 -44.13 -31.84 1.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.397 -0.815 . . . . 0.0 109.752 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.773 ' O ' HG23 ' A' ' 26' ' ' ILE . 6.5 m-20 -73.47 -101.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.773 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -164.66 59.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.041 -1.037 . . . . 0.0 109.382 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.507 HG21 HG21 ' A' ' 157' ' ' ILE . 18.7 m -145.46 167.78 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.635 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -111.42 144.81 40.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.854 . . . . 0.0 109.353 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.7 pt-20 -117.06 125.11 50.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.014 -1.054 . . . . 0.0 109.317 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.913 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -113.6 112.73 24.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.441 -0.787 . . . . 0.0 108.944 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 31.5 m-20 -67.18 149.62 50.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.35 -0.844 . . . . 0.0 109.893 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.9 p -142.92 174.52 10.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.408 -0.808 . . . . 0.0 109.293 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -115.56 163.32 15.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.74 120.56 38.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.319 -0.863 . . . . 0.0 109.291 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.66 138.33 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.361 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.459 ' HA ' HG22 ' A' ' 64' ' ' THR . 0.0 OUTLIER -88.43 134.72 33.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 m -137.31 155.59 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.341 -0.849 . . . . 0.0 109.28 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -115.48 109.93 18.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 109.518 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 40' ' ' GLY . 20.8 mt-30 -99.13 160.55 14.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.39 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 39' ' ' GLN . . . -44.22 -67.65 1.04 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.33 -81.49 0.13 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.05 99.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -1.153 . . . . 0.0 109.469 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -71.82 -33.98 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.589 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -89.74 102.14 14.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.737 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.558 HD13 ' OE2' ' A' ' 55' ' ' GLU . 19.5 tt -137.27 23.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 109.388 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.59 178.43 0.27 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 48' ' ' ASN . . . 59.48 -175.72 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -1.149 . . . . 0.0 109.474 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 4.4 m-20 64.31 146.54 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.433 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.18 173.65 13.59 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.573 2.182 . . . . 0.0 110.482 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.89 178.93 4.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.92 . . . . 0.0 109.396 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.44 179.91 7.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.22 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.8 -37.96 64.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -106.06 117.31 33.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 56.85 -179.91 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.875 . . . . 0.0 109.263 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.558 ' OE2' HD13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -85.87 -59.72 2.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.58 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.55 -171.54 2.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -79.86 -171.38 2.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.456 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 57' ' ' ASN . . . 66.75 86.17 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.64 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.72 122.66 3.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.192 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -126.71 59.33 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.16 -0.963 . . . . 0.0 109.838 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.49 -105.3 2.22 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.1 p -69.5 167.51 16.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -1.184 . . . . 0.0 109.087 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 63' ' ' GLU . 1.6 pm0 -147.73 139.38 23.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.131 -0.98 . . . . 0.0 109.737 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 36' ' ' THR . 0.9 OUTLIER -93.09 144.36 25.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 109.414 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 65' ' ' VAL . 32.7 m -126.25 131.7 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.504 ' ND2' ' SD ' ' A' ' 145' ' ' MET . 11.9 m120 -71.42 131.61 43.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.489 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -46.88 -24.47 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.694 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.033 HD21 HG23 ' A' ' 14' ' ' VAL . 31.4 tp -82.25 -42.73 18.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.039 -1.038 . . . . 0.0 108.49 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.578 HG13 ' HB2' ' A' ' 74' ' ' LEU . 3.1 t -54.96 -56.1 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.473 -0.767 . . . . 0.0 108.954 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 70' ' ' TYR . 4.2 t80 -61.38 -41.34 96.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 109.92 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.94 -45.47 64.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.044 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -111.74 19.83 17.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 109.882 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.63 82.58 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.938 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.578 ' HB2' HG13 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -95.22 169.76 9.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 108.824 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.61 ' O ' HG22 ' A' ' 132' ' ' ILE . 1.8 m -128.18 102.96 20.88 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.975 -1.078 . . . . 0.0 110.044 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.433 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 36.3 Cg_endo -80.0 118.37 3.71 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.489 2.126 . . . . 0.0 110.135 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 130' ' ' PHE . 6.0 t -87.93 161.33 17.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.304 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 t -125.95 4.86 7.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 109.81 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.55 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 6.5 t80 -138.62 128.35 24.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 109.711 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.529 ' OD2' ' CE1' ' A' ' 130' ' ' PHE . 4.4 p-10 169.96 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.766 . . . . 0.0 109.454 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -62.36 -42.97 99.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 109.237 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -113.76 -28.65 7.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.492 -0.755 . . . . 0.0 109.09 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -29.09 67.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.324 -0.86 . . . . 0.0 109.317 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.485 ' HB2' ' HB2' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -55.11 -48.96 72.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.488 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.474 ' HA ' HG22 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -64.26 -29.86 70.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 109.993 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -55.24 18.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 88' ' ' ILE . 21.6 m-85 -70.7 -58.25 3.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 109.845 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -42.74 -37.9 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 109.573 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 15.2 mmtp -63.07 -52.69 61.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.356 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.65 -20.26 56.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.602 ' CE2' ' CB ' ' A' ' 141' ' ' MET . 2.8 t80 -77.88 -36.45 49.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.212 -1.17 . . . . 0.0 108.484 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.448 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -64.99 -42.14 94.79 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 4.5 mptt -67.1 -32.02 72.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.588 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.38 89.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.026 -1.046 . . . . 0.0 109.702 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.775 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 34.8 mm -57.57 -45.44 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.172 -0.955 . . . . 0.0 109.749 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -48.09 -33.47 8.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 109.09 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.529 ' N ' ' HG3' ' A' ' 96' ' ' LYS . . . -73.04 -46.82 49.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 108.998 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.881 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -50.54 -38.05 42.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.143 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.881 HD23 ' HD3' ' A' ' 98' ' ' ARG . 1.4 mt -69.92 -44.9 68.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.406 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -51.88 -30.27 23.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.331 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 97' ' ' ALA . 6.9 mt-10 -78.71 -39.26 37.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.156 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.54 -82.51 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.274 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -135.93 135.88 22.27 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -74.84 -14.84 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.593 2.195 . . . . 0.0 110.748 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.74 -13.54 61.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.854 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.782 ' HB3' HD13 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -89.56 -11.42 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.119 -0.988 . . . . 0.0 109.764 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.704 ' HA ' HD12 ' A' ' 99' ' ' LEU . 7.9 t -65.12 -44.39 70.02 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 111.203 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.4 Cg_endo -76.55 -58.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.933 1.756 . . . . 0.0 110.984 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 110' ' ' PHE . 15.8 m -55.9 -43.93 76.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.067 -1.02 . . . . 0.0 109.592 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.775 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 43.7 t80 -58.64 -49.63 76.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.734 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -57.25 -29.91 64.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.115 -0.991 . . . . 0.0 110.175 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -49.16 40.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.152 -0.968 . . . . 0.0 111.569 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.537 ' ND2' ' N ' ' A' ' 114' ' ' ALA . 1.7 p-10 -72.19 -46.73 55.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.847 -1.158 . . . . 0.0 110.733 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.537 ' N ' ' ND2' ' A' ' 113' ' ' ASN . . . -54.93 -46.82 74.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.066 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -53.36 -44.09 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.874 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.46 -41.21 96.47 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.561 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.72 -37.29 78.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -1.179 . . . . 0.0 110.028 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 47.8 t -63.89 -45.21 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.356 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.505 ' C ' ' CD ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -66.13 -28.87 69.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.984 . . . . 0.0 109.611 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -67.55 -49.13 64.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.983 . . . . 0.0 110.0 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.07 HG12 HD13 ' A' ' 144' ' ' LEU . 1.6 mp -70.18 -32.01 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 109.699 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 122' ' ' LEU . 43.5 mt -57.16 -30.47 64.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.696 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.51 -48.32 62.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 109.773 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 127' ' ' ASP . 1.5 m-80 -139.57 69.56 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -63.15 -21.59 66.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -62.93 -63.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.845 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 128' ' ' TYR . 18.7 p30 -65.63 -22.68 66.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.246 -0.909 . . . . 0.0 109.959 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 2.9 m-85 -76.08 -16.92 59.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 109.903 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.489 ' C ' ' CG ' ' A' ' 130' ' ' PHE . 3.0 m-20 44.8 -168.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.166 -0.959 . . . . 0.0 109.264 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.811 ' HB3' HG11 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -154.06 121.14 5.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 108.681 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.967 ' O ' HG13 ' A' ' 142' ' ' VAL . 14.6 m-85 -105.16 164.42 11.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.178 -0.951 . . . . 0.0 110.692 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 75' ' ' SER . 1.1 tt -155.94 139.77 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.403 -0.81 . . . . 0.0 109.488 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.37 164.25 1.09 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 135' ' ' SER . 2.6 pt-20 -67.13 -21.07 65.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -1.177 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.2 OUTLIER -62.34 -35.3 78.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 77.48 50.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.869 . . . . 0.0 109.612 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.33 107.77 60.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.123 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.34 0.23 8.81 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.26 1.973 . . . . 0.0 110.486 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.77 -14.68 23.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.884 . . . . 0.0 109.115 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 141' ' ' MET . . . -79.7 -91.77 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.445 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.602 ' CB ' ' CE2' ' A' ' 91' ' ' TYR . 1.9 ptp 179.42 149.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 131' ' ' TYR . 70.3 t -97.76 138.15 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.183 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.639 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 3.6 t -93.25 111.35 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.134 -0.979 . . . . 0.0 109.043 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 1.07 HD13 HG12 ' A' ' 121' ' ' ILE . 2.5 mt -79.26 149.13 31.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.778 ' HE3' ' CE2' ' A' ' 131' ' ' TYR . 12.4 ttm -124.58 131.21 53.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.624 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.545 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 19.7 t30 -142.34 168.79 18.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 109.108 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.468 ' HB3' ' HA2' ' A' ' 151' ' ' GLY . 4.5 m-85 -77.06 159.39 29.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.058 -1.026 . . . . 0.0 109.385 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.59 ' HB2' ' CD1' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -151.59 -173.62 4.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 110.011 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 56.05 -97.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 109.655 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -106.94 -25.72 11.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.019 -1.051 . . . . 0.0 109.152 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 147' ' ' TYR . . . 123.17 17.43 3.31 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.65 -21.37 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.281 -1.129 . . . . 0.0 108.903 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 153' ' ' THR . 2.9 t -105.0 128.21 27.16 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.111 -0.993 . . . . 0.0 109.566 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -82.87 146.92 13.24 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.754 2.303 . . . . 0.0 110.696 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.59 ' CD1' ' HB2' ' A' ' 148' ' ' ARG . 7.2 p90 -145.18 155.33 43.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 108.851 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.461 ' SD ' ' N ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -126.73 162.2 26.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 109.795 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.507 HG21 HG21 ' A' ' 27' ' ' VAL . 4.4 mt -124.26 145.3 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 109.507 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.639 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 9.7 m-85 -129.31 128.52 43.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.312 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -51.23 127.27 18.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -62.49 -53.69 51.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.405 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -47.52 -44.72 25.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -90.17 44.19 2.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.806 ' O ' HD23 ' A' ' 163' ' ' LEU . 2.2 tt -158.5 123.54 4.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.431 -1.041 . . . . 0.0 109.212 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 5' ' ' LYS . 30.1 m -116.69 153.61 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.456 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.8 p -90.86 146.92 23.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.953 . . . . 0.0 109.639 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.53 120.64 15.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.471 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 168' ' ' PHE . 0.0 OUTLIER -70.21 108.27 4.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.404 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 168' ' ' PHE . 13.9 t80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.545 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.52 ' HG2' HD21 ' A' ' 3' ' ' LEU . 7.6 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.616 HD13 ' O ' ' A' ' 166' ' ' GLU . 0.8 OUTLIER -68.48 146.74 52.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 110.126 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.914 HD11 ' CG ' ' A' ' 168' ' ' PHE . 6.8 mt -121.85 139.57 53.46 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.633 ' HB2' HG13 ' A' ' 14' ' ' VAL . 91.5 m-85 -121.43 108.89 14.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.977 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 1.8 mtmm -108.82 167.29 10.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.454 -0.778 . . . . 0.0 109.272 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -83.86 151.23 25.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.97 . . . . 0.0 109.362 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.543 HG21 HG13 ' A' ' 164' ' ' VAL . 5.3 t -108.31 35.6 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 109.486 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.927 HG21 ' O ' ' A' ' 139' ' ' ASP . 24.0 mm -117.07 -52.4 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.417 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.96 -34.96 2.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.5 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 106.62 2.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -176.28 136.54 0.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -1.145 . . . . 0.0 109.496 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' OE1' ' CG ' ' A' ' 72' ' ' PHE . 7.8 pt-20 -48.51 147.36 2.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.642 HD22 ' HD2' ' A' ' 158' ' ' PHE . 3.7 mt -132.6 -80.58 0.49 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.154 -0.966 . . . . 0.0 109.532 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.862 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 2.6 p -132.37 166.77 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.853 . . . . 0.0 109.104 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.596 ' N ' HG22 ' A' ' 14' ' ' VAL . 3.9 p -142.0 161.93 36.75 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.017 -1.052 . . . . 0.0 110.098 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -83.02 1.27 40.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.381 -0.824 . . . . 0.0 109.598 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.86 -9.39 37.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.378 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.673 ' CE2' HD13 ' A' ' 68' ' ' LEU . 35.7 m-85 -119.52 20.69 12.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 65.38 130.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 109.006 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.734 HD23 ' HA ' ' A' ' 30' ' ' ALA . 49.4 mt -125.68 146.08 49.89 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -0.95 . . . . 0.0 110.015 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -123.43 134.26 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -0.807 . . . . 0.0 109.35 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.438 ' CD ' ' HA ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -90.93 122.4 33.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.181 -0.949 . . . . 0.0 108.789 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 2.3 t -114.55 120.44 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 4.0 t70 74.4 5.97 4.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 109.802 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 20.3 t0 59.12 68.89 0.77 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 109.513 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.656 HG23 HG13 ' A' ' 27' ' ' VAL . 5.8 tt 174.54 -29.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.129 -0.982 . . . . 0.0 109.905 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.656 HG13 HG23 ' A' ' 26' ' ' ILE . 23.1 m -120.93 140.13 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.957 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -105.44 148.92 26.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.193 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -120.97 121.06 37.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.405 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.862 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -106.22 112.88 26.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.193 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -68.38 149.57 49.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 66' ' ' ASN . 34.7 m -100.26 151.17 21.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 0.0 109.259 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.16 134.35 51.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.748 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.414 ' CE ' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -80.06 135.95 36.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -0.876 . . . . 0.0 109.059 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 35' ' ' VAL . 17.1 m -142.58 125.05 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.206 -0.934 . . . . 0.0 109.436 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 36' ' ' THR . 1.4 t -86.07 142.72 28.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.47 HG22 ' HG2' ' A' ' 63' ' ' GLU . 2.9 m -129.01 137.25 57.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.226 -0.922 . . . . 0.0 109.601 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -90.77 102.7 15.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -108.28 131.12 55.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.512 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.59 2.72 53.25 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 -162.27 27.77 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -174.88 64.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -1.122 . . . . 0.0 109.697 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 44' ' ' ASP . 3.2 t -114.49 -73.37 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.567 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.536 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 1.3 p30 170.22 -37.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.354 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER 40.52 30.95 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.523 -0.736 . . . . 0.0 109.729 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' ASP . . . 104.53 -131.19 10.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.22 64.79 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -1.183 . . . . 0.0 109.526 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -47.71 111.8 1.86 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.225 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 50' ' ' SER . 35.4 Cg_endo -77.47 6.29 4.53 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.469 2.113 . . . . 0.0 110.8 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 48.9 m 60.23 -89.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 109.518 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.498 ' C ' ' CG ' ' A' ' 52' ' ' GLU . . . -154.99 169.1 24.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.599 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.498 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 1.0 OUTLIER 39.63 -96.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 0.0 109.884 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 51' ' ' ALA . 17.1 p-10 -154.29 147.57 24.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -99.92 117.32 33.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.569 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -119.93 -16.67 8.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -96.31 175.7 6.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 109.37 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -133.97 38.92 3.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.579 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.78 76.16 1.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.441 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.69 128.02 55.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.435 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 60' ' ' GLU . 5.4 pt-20 -166.75 91.4 0.42 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.546 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.58 97.92 0.26 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p 49.65 -174.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -1.108 . . . . 0.0 109.716 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.47 ' HG2' HG22 ' A' ' 37' ' ' VAL . 2.2 pt-20 -155.31 146.11 22.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.682 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 138.07 32.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.865 . . . . 0.0 109.31 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.4 m -148.48 140.55 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.485 ' OD1' ' HB3' ' A' ' 32' ' ' CYS . 1.5 m-20 -56.6 154.2 9.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.36 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 71' ' ' SER . 33.7 t30 -89.7 -27.09 20.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.739 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.673 HD13 ' CE2' ' A' ' 18' ' ' TYR . 13.3 tp -83.48 -37.63 22.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 108.982 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.573 HG13 ' HB2' ' A' ' 74' ' ' LEU . 53.3 t -72.61 -48.28 47.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.723 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -69.29 -36.04 76.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 110.93 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 70.3 m -79.49 -52.85 7.51 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.966 -1.084 . . . . 0.0 110.506 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CG ' ' OE1' ' A' ' 12' ' ' GLU . 7.2 m-30 -79.82 -3.6 48.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.128 -0.982 . . . . 0.0 109.968 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.81 88.04 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 109.571 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.573 ' HB2' HG13 ' A' ' 69' ' ' VAL . 1.4 mm? -111.85 139.05 47.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 108.719 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.67 122.99 18.1 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.066 -1.021 . . . . 0.0 109.871 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.14 126.28 7.7 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.374 2.049 . . . . 0.0 110.097 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 t -123.92 117.02 23.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -0.966 . . . . 0.0 109.645 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -59.34 151.46 23.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.242 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 17.9 t80 -151.93 155.3 37.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 109.703 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.637 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 1.4 m-20 -86.42 124.27 32.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -0.879 . . . . 0.0 109.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -34.61 68.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.147 -0.971 . . . . 0.0 110.033 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -56.25 -64.91 0.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.617 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 79' ' ' PHE . 7.4 t -59.8 -28.74 67.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.788 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.32 -35.48 67.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.495 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.4 mtt -57.04 -49.42 75.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.141 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -48.81 79.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.489 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -62.7 -19.19 63.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.256 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 92' ' ' MET . 0.6 OUTLIER -79.22 -28.92 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -39.55 58.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.426 -0.796 . . . . 0.0 109.115 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.13 -38.79 88.48 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.568 ' CZ ' ' O ' ' A' ' 138' ' ' PRO . 14.7 m-30 -74.52 -36.5 63.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.101 -1.234 . . . . 0.0 108.816 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.536 ' CE ' ' O ' ' A' ' 92' ' ' MET . 0.0 OUTLIER -65.21 -38.99 92.15 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.624 0.726 . . . . 0.0 109.293 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.506 ' C ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.15 -36.91 82.86 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.571 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.58 -50.77 67.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.994 -1.066 . . . . 0.0 109.244 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.837 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 29.5 mm -59.93 -43.0 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.235 -0.915 . . . . 0.0 108.969 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -47.38 -51.61 19.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.875 . . . . 0.0 109.364 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 100' ' ' GLN . . . -58.19 -36.53 73.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.015 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 101' ' ' GLU . 1.8 tmt_? -64.15 -32.85 74.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -0.916 . . . . 0.0 109.683 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.526 HD23 ' HD3' ' A' ' 98' ' ' ARG . 22.4 mt -73.78 -50.21 21.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 110.213 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.539 ' HG3' ' N ' ' A' ' 101' ' ' GLU . 2.6 pt20 -55.83 -34.98 65.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.679 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 7.4 pt-20 -72.79 -35.52 67.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.103 -0.998 . . . . 0.0 109.191 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.52 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 10.2 t -88.28 -80.31 0.28 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.277 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -135.74 137.78 26.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 109.325 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.92 -25.97 11.53 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.547 2.165 . . . . 0.0 110.637 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -70.46 -6.83 38.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.676 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.516 ' O ' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -97.92 -4.8 35.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 109.819 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.607 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 32.7 t -70.18 -44.62 20.49 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.989 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.6 Cg_endo -77.7 -41.05 0.34 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.018 1.812 . . . . 0.0 111.096 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.34 -43.37 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 0.0 109.938 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.837 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 87.1 t80 -69.72 -37.11 76.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 0.0 110.408 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -63.25 -53.78 47.64 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.09 -1.006 . . . . 0.0 110.719 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -47.19 61.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.016 -1.053 . . . . 0.0 110.675 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -55.73 -54.26 46.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.138 -0.976 . . . . 0.0 110.124 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.77 69.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 109.968 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -59.22 -35.51 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.126 -0.983 . . . . 0.0 109.559 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.48 -45.85 95.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.623 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -68.14 -30.72 69.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -1.2 . . . . 0.0 110.081 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 54.4 t -68.02 -42.35 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.888 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 115' ' ' ILE . 40.2 mmtt -69.06 -42.05 76.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.075 -1.015 . . . . 0.0 109.78 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.499 ' HA ' ' CE ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -59.54 -60.5 3.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.797 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 117' ' ' PHE . 1.3 mt -53.98 -47.69 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 122' ' ' LEU . 25.6 mt -47.3 -49.6 23.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 109.762 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.78 -41.85 45.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.966 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.73 52.02 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.885 . . . . 0.0 109.435 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 8.9 p90 -63.43 -27.53 69.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.578 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.427 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 5.5 mttp -64.82 -39.77 94.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.404 -0.81 . . . . 0.0 109.704 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.67 -23.76 42.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 110.01 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 129' ' ' ASP . 7.1 m-85 -81.7 -25.92 35.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.874 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.521 ' C ' ' CD1' ' A' ' 130' ' ' PHE . 14.0 m-20 51.29 179.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.59 ' HB3' HG11 ' A' ' 142' ' ' VAL . 36.3 m-85 -142.3 121.61 13.11 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.352 -0.843 . . . . 0.0 109.052 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.987 ' O ' HG13 ' A' ' 142' ' ' VAL . 10.9 m-85 -99.31 166.24 11.3 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.189 -0.944 . . . . 0.0 110.538 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 7.8 tp -156.58 146.84 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.702 . . . . 0.0 109.278 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.03 162.38 52.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -58.24 -23.63 56.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -1.107 . . . . 0.0 109.427 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 136' ' ' MET . 11.4 p -68.59 -34.76 76.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 109.359 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.486 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 0.0 OUTLIER 70.6 63.63 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.521 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.37 105.73 38.2 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.341 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.568 ' O ' ' CZ ' ' A' ' 91' ' ' TYR . 34.0 Cg_endo -74.5 -20.85 17.7 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.274 1.982 . . . . 0.0 109.961 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.927 ' O ' HG21 ' A' ' 8' ' ' ILE . 7.7 t70 -75.43 -6.26 49.18 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.364 -0.835 . . . . 0.0 108.962 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.15 -175.71 2.88 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.266 -0.896 . . . . 0.0 109.35 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.2 ptm -92.31 167.47 11.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 109.475 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.987 HG13 ' O ' ' A' ' 131' ' ' TYR . 58.7 t -113.35 142.03 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 109.185 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 157' ' ' ILE . 13.0 t -90.01 130.04 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.174 -0.954 . . . . 0.0 108.838 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.558 HD13 HG12 ' A' ' 121' ' ' ILE . 18.0 mt -92.55 134.4 35.02 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.492 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.471 ' HB2' ' CE1' ' A' ' 131' ' ' TYR . 4.8 ttt -107.63 126.28 52.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.571 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 2.2 t30 -139.34 169.11 18.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 1.6 m-85 -110.23 144.81 38.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.65 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.445 ' CZ ' HG21 ' A' ' 153' ' ' THR . 0.5 OUTLIER -67.48 170.67 7.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 109.608 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -47.67 -35.8 10.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 109.577 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -77.35 -44.63 28.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.298 -0.876 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.569 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 100.46 -30.2 10.71 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.6 tp -68.2 -6.57 5.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.47 -1.018 . . . . 0.0 109.661 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 153' ' ' THR . 1.7 m -122.81 101.73 39.08 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 109.665 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.14 121.8 5.02 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.57 2.18 . . . . 0.0 109.98 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 146' ' ' ASN . 31.7 p90 -126.37 148.35 49.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -0.983 . . . . 0.0 109.88 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.461 ' HG2' ' HG3' ' A' ' 145' ' ' MET . 0.2 OUTLIER -116.14 167.17 11.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.35 -0.844 . . . . 0.0 109.135 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.772 ' O ' HG13 ' A' ' 143' ' ' VAL . 11.6 mt -128.46 148.63 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 0.0 109.783 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.642 ' HD2' HD22 ' A' ' 13' ' ' LEU . 12.4 m-85 -136.55 125.73 24.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.471 ' HB3' ' OD1' ' A' ' 161' ' ' ASP . 2.5 m-85 -60.03 132.41 53.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 110.25 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 77.3 tttt -68.23 -41.85 80.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.487 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.471 ' OD1' ' HB3' ' A' ' 159' ' ' PHE . 5.2 p-10 -50.56 -45.01 56.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.012 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -97.93 45.94 1.65 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.845 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -161.34 129.23 4.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.464 -1.021 . . . . 0.0 108.919 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.543 HG13 HG21 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -115.46 149.16 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.624 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.89 121.64 38.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.616 ' O ' HD13 ' A' ' 2' ' ' LEU . 1.8 tp10 -118.42 142.98 47.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.671 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.49 113.6 25.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.914 ' CG ' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.489 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mt -100.8 158.4 15.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 3' ' ' LEU . 25.7 mt -112.41 134.47 53.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.479 -0.763 . . . . 0.0 109.427 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.599 ' CD2' HD21 ' A' ' 163' ' ' LEU . 10.5 m-85 -117.4 112.24 20.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.68 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 12' ' ' GLU . 1.5 mtmt -123.15 162.39 22.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.415 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -97.04 158.21 15.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.416 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.86 54.32 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -0.984 . . . . 0.0 109.663 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -140.7 -50.1 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.034 -1.041 . . . . 0.0 109.595 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.587 ' O ' ' HB2' ' A' ' 140' ' ' ALA . 1.5 t 176.47 45.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -141.87 -43.93 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 6.8 t0 74.96 -137.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -1.112 . . . . 0.0 109.275 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.447 ' HA ' ' HG2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -42.33 121.37 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.047 -1.033 . . . . 0.0 109.677 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.476 ' HA ' HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -125.1 -62.08 1.25 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.138 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.826 HG21 ' CB ' ' A' ' 30' ' ' ALA . 6.5 p -143.46 175.81 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.365 -0.834 . . . . 0.0 108.855 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.652 ' H ' HG22 ' A' ' 14' ' ' VAL . 22.6 t -147.49 169.59 19.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.846 -1.159 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.545 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 31.4 t70 -87.54 12.73 11.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.479 -0.763 . . . . 0.0 109.447 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.39 -15.28 63.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 108.996 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CE1' ' ND2' ' A' ' 67' ' ' ASN . 44.5 m-85 -115.92 21.38 13.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.471 -0.768 . . . . 0.0 109.207 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.2 t0 65.32 129.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 108.511 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 30' ' ' ALA . 13.0 mt -124.28 143.2 50.69 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.144 -0.973 . . . . 0.0 110.252 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.32 136.7 52.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.34 117.74 34.45 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.252 -0.905 . . . . 0.0 108.767 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 t -68.46 147.81 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 109.49 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -46.31 -25.4 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 109.751 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.467 ' O ' HG23 ' A' ' 26' ' ' ILE . 2.2 m-20 -77.96 -110.39 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -154.82 64.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.811 -1.181 . . . . 0.0 109.305 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.3 m -147.18 141.27 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 109.674 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.409 ' CE2' ' HE2' ' A' ' 4' ' ' TYR . 4.9 m-85 -98.65 148.39 23.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.152 -0.968 . . . . 0.0 109.066 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 19.4 mt-10 -125.15 121.11 33.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.116 -0.99 . . . . 0.0 110.12 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.89 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -106.39 112.71 25.83 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -71.52 146.48 48.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 110.509 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 28.3 p -126.74 115.18 19.01 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.425 ' HG2' ' ND2' ' A' ' 67' ' ' ASN . 14.6 pt20 -92.69 157.22 16.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 110.056 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.5 mmm -92.25 133.28 35.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -0.815 . . . . 0.0 109.207 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.3 m -117.35 144.71 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.59 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -100.07 117.36 34.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.268 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.558 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.3 m -85.18 123.01 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.893 . . . . 0.0 109.429 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -92.69 105.48 17.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.0 109.585 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -96.06 157.6 15.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.462 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.34 -44.63 65.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.55 -166.47 24.78 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.66 -38.8 1.87 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -1.107 . . . . 0.0 109.443 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 44' ' ' ASP . 75.9 t -124.26 -92.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.315 -0.866 . . . . 0.0 109.322 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.508 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER 66.25 -88.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.739 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 46' ' ' GLY . 4.3 tt -135.38 -42.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.572 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 152.36 155.26 6.98 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.23 74.25 1.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.386 -1.067 . . . . 0.0 109.58 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.48 146.24 0.11 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 109.734 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.57 -176.92 3.52 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.59 2.193 . . . . 0.0 110.335 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m 59.34 37.46 23.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 109.578 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 47.15 -168.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.491 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.462 ' N ' ' OE1' ' A' ' 52' ' ' GLU . 13.5 mp0 -119.09 -71.62 0.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.528 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 6.4 t70 179.39 160.35 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.535 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.33 177.68 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.321 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 -87.22 -172.31 3.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 6.0 pt-20 -125.99 134.0 51.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.496 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER 177.77 60.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.543 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' C ' ' HG3' ' A' ' 59' ' ' GLU . . . -141.77 122.53 14.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.442 ' HG3' ' C ' ' A' ' 58' ' ' ALA . 42.0 mt-10 -149.67 -159.25 1.01 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.37 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER 68.96 8.66 6.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.923 . . . . 0.0 109.619 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' C ' HG23 ' A' ' 62' ' ' THR . . . 67.6 99.07 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.469 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.3 p 57.97 159.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -1.145 . . . . 0.0 109.319 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -123.91 144.77 49.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 109.624 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.56 133.03 41.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.275 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.2 137.86 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 0.0 109.616 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -60.37 141.38 56.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.427 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.462 ' ND2' ' CE1' ' A' ' 18' ' ' TYR . 38.5 p-10 -86.12 -19.57 29.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.671 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 18.1 tp -86.38 -47.56 9.23 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 108.957 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.773 HG13 ' HB2' ' A' ' 74' ' ' LEU . 55.6 t -68.24 -37.33 77.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.322 -0.862 . . . . 0.0 109.171 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -69.84 -44.57 69.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 109.668 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 t -63.24 -36.93 85.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.315 -0.866 . . . . 0.0 110.121 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.692 ' HB2' HD23 ' A' ' 74' ' ' LEU . 25.9 m-85 -103.26 2.9 34.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 109.891 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER 56.82 29.66 16.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.154 -0.966 . . . . 0.0 109.789 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.773 ' HB2' HG13 ' A' ' 69' ' ' VAL . 2.0 mm? -41.72 149.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.411 -0.806 . . . . 0.0 109.345 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.434 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -131.06 127.38 21.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.384 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.16 122.17 5.61 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.496 2.131 . . . . 0.0 110.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.4 127.26 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.37 -178.68 3.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.29 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' A' ' 80' ' ' ASP . 50.5 t80 -164.91 163.0 21.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.605 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 35.6 m-20 -77.38 120.48 22.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.458 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 2.1 tmtt? -59.14 -53.25 60.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.88 -45.33 86.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.76 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.505 ' CB ' ' HB2' ' A' ' 80' ' ' ASP . 1.3 t -61.75 -29.06 69.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.344 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 81' ' ' LYS . 41.6 t80 -58.41 -34.99 71.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.779 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -57.34 12.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.96 . . . . 0.0 109.778 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -59.87 -38.02 81.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.003 . . . . 0.0 109.273 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.509 ' CE2' ' CZ ' ' A' ' 91' ' ' TYR . 6.5 t80 -66.44 -23.1 66.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.385 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -78.72 -31.48 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 108.952 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -72.02 -47.28 52.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.41 -29.86 74.61 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.509 ' CZ ' ' CE2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -75.38 -35.79 61.02 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.129 -1.218 . . . . 0.0 108.41 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -54.42 26.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.598 -0.689 . . . . 0.0 109.745 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -38.47 75.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.346 -0.846 . . . . 0.0 109.868 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.54 -45.34 73.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.113 -0.992 . . . . 0.0 109.297 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.473 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 34.8 mm -69.82 -36.67 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -47.19 63.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 109.202 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.72 81.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.127 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.4 OUTLIER -52.95 -44.29 66.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.456 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.827 HD13 ' HB3' ' A' ' 106' ' ' ARG . 2.0 mt -71.93 -44.06 64.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.295 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -25.16 9.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.199 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -86.98 -34.44 19.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 t -96.09 -89.02 0.26 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.326 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.439 ' OD1' ' NH2' ' A' ' 106' ' ' ARG . 27.8 p-10 -125.62 132.38 24.3 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.271 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.9 -19.44 18.09 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.641 2.227 . . . . 0.0 110.884 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.9 -6.82 29.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.202 -0.936 . . . . 0.0 109.905 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.827 ' HB3' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -95.81 -5.94 40.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.084 -1.01 . . . . 0.0 109.811 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.625 ' HA ' HD12 ' A' ' 99' ' ' LEU . 96.0 t -72.18 -43.25 9.99 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.137 -0.977 . . . . 0.0 111.229 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.6 Cg_endo -75.98 -56.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.762 1.641 . . . . 0.0 110.862 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 110' ' ' PHE . 12.8 m -55.84 -40.95 64.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.036 -1.04 . . . . 0.0 109.471 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.511 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 68.9 t80 -65.82 -37.1 85.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.817 . . . . 0.0 110.253 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.775 ' O ' HD13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -66.42 -49.87 65.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.964 -1.085 . . . . 0.0 110.562 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -66.14 -49.45 67.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.887 -1.133 . . . . 0.0 110.544 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -58.2 -46.42 85.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.985 . . . . 0.0 109.813 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -65.44 -27.56 68.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.373 -0.829 . . . . 0.0 109.751 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.775 HD13 ' O ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -67.13 -47.41 81.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.251 -0.905 . . . . 0.0 109.446 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.27 -50.51 44.53 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.475 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.78 -38.95 76.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.081 -1.247 . . . . 0.0 109.803 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 114' ' ' ALA . 53.1 t -68.4 -39.16 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -32.34 69.64 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.157 -0.964 . . . . 0.0 109.295 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -96.92 -10.07 27.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.661 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.2 -53.68 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.629 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.537 ' N ' HG22 ' A' ' 121' ' ' ILE . 10.1 mt -48.77 -44.23 38.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.016 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.79 76.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 110.033 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.542 ' O ' ' CE2' ' A' ' 128' ' ' TYR . 19.6 m-20 -101.44 38.84 1.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.14 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.651 ' HA ' ' CE1' ' A' ' 128' ' ' TYR . 13.4 t80 -63.41 -53.69 48.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.082 -1.011 . . . . 0.0 109.061 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -78.9 -8.43 58.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 108.988 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 124' ' ' ASN . 0.8 OUTLIER -80.17 -39.53 29.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.341 -0.85 . . . . 0.0 109.937 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.651 ' CE1' ' HA ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -108.55 -10.43 15.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.969 -1.082 . . . . 0.0 110.041 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.8 m-20 52.27 173.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.726 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -114.71 122.23 45.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.599 ' HB3' HD12 ' A' ' 74' ' ' LEU . 11.2 m-85 -103.27 177.63 4.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 110.558 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.671 ' O ' HD13 ' A' ' 74' ' ' LEU . 3.9 tp -143.02 149.03 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.541 -0.725 . . . . 0.0 109.545 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 132' ' ' ILE . . . -73.01 -178.77 35.41 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -18.06 63.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -1.187 . . . . 0.0 109.539 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -60.95 -41.69 96.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.217 -0.927 . . . . 0.0 109.39 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 75.56 48.88 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.672 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.53 ' O ' HD11 ' A' ' 132' ' ' ILE . 72.4 m-20 -118.84 134.02 23.6 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 109.373 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.409 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 34.1 Cg_endo -75.59 -5.48 16.58 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.317 2.011 . . . . 0.0 110.157 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.425 ' HB3' ' CB ' ' A' ' 9' ' ' SER . 11.4 t70 -101.48 -3.31 28.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 109.304 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 9' ' ' SER . . . -85.17 137.87 32.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 109.378 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.471 ' SD ' ' HB2' ' A' ' 159' ' ' PHE . 1.4 ttp -43.42 152.99 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.742 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.9 m -100.67 141.44 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.365 -0.835 . . . . 0.0 109.279 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.611 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.1 t -102.27 139.04 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.236 -0.915 . . . . 0.0 109.42 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.515 ' HB3' ' CG ' ' A' ' 128' ' ' TYR . 4.9 mt -107.13 146.16 31.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.31 -0.869 . . . . 0.0 109.206 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 128' ' ' TYR . 1.8 ttm -111.98 125.78 54.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.674 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.41 ' HB3' ' OH ' ' A' ' 155' ' ' TYR . 2.4 t-20 -139.13 169.08 18.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 4.9 m-85 -102.66 145.91 28.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.597 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.574 ' HB2' ' CE2' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -142.85 -170.84 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.345 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' ARG . 0.8 OUTLIER 62.07 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.571 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.68 -22.17 11.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.586 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.591 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 124.27 -18.37 7.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 152' ' ' ILE . 2.4 tp -96.26 7.23 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.299 -1.118 . . . . 0.0 109.394 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.6 m -110.64 101.8 50.13 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.298 -0.876 . . . . 0.0 109.633 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.59 139.39 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.521 2.147 . . . . 0.0 110.18 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 148' ' ' ARG . 52.0 p90 -145.14 158.64 43.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 109.655 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 158' ' ' PHE . 7.1 mtm -107.44 156.14 19.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.301 -0.874 . . . . 0.0 109.295 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.497 ' O ' HG13 ' A' ' 143' ' ' VAL . 42.3 mt -122.6 132.61 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.08 -1.012 . . . . 0.0 110.011 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.611 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 7.8 m-85 -126.22 115.11 19.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.481 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 3.8 m-85 -50.41 126.28 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.397 -0.814 . . . . 0.0 109.774 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 161' ' ' ASP . 4.9 tttm -68.49 -38.14 80.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.772 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 1.8 p30 -43.26 -41.45 3.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . -110.0 54.29 0.55 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.608 ' C ' HD23 ' A' ' 163' ' ' LEU . 8.7 tt -157.66 142.37 16.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -1.099 . . . . 0.0 109.556 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.475 ' N ' HD23 ' A' ' 163' ' ' LEU . 19.8 m -127.65 152.65 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.4 m -104.31 121.34 43.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.099 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -115.93 127.56 55.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.616 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 146.53 25.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.875 . . . . 0.0 109.564 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' C ' HD23 ' A' ' 2' ' ' LEU . 2.4 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 167' ' ' LYS . 2.9 mt -105.44 165.04 11.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.897 . . . . 0.0 109.421 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 3' ' ' LEU . 79.6 mt -127.27 129.63 48.08 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.432 -0.792 . . . . 0.0 109.584 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HB3' HD22 ' A' ' 163' ' ' LEU . 64.2 m-85 -111.59 108.79 18.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.255 -0.903 . . . . 0.0 109.312 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.669 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -117.24 163.91 15.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.773 ' HB2' HD12 ' A' ' 13' ' ' LEU . 4.3 t0 -76.23 152.41 36.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.889 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.572 ' CG2' HG13 ' A' ' 164' ' ' VAL . 2.7 t -102.32 -5.97 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.81 . . . . 0.0 109.344 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.603 HG21 ' O ' ' A' ' 139' ' ' ASP . 4.7 mt -97.54 -79.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.415 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -144.47 67.37 1.26 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 0.0 109.554 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -130.81 -65.83 0.1 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER 73.52 13.18 4.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.315 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 1.4 pt-20 170.67 107.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.039 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.773 HD12 ' HB2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -129.4 -64.98 0.87 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.834 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.894 HG23 HD21 ' A' ' 68' ' ' LEU . 11.3 p -157.31 170.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.299 -0.876 . . . . 0.0 108.968 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.68 ' C ' HD11 ' A' ' 20' ' ' LEU . 3.7 p -155.06 -176.23 5.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.667 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.23 10.71 6.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.545 -0.722 . . . . 0.0 110.165 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.493 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . . . -66.05 -10.25 38.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.056 -1.027 . . . . 0.0 109.19 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.614 ' CG ' HD11 ' A' ' 68' ' ' LEU . 8.1 m-85 -127.41 21.69 6.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.174 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.19 130.56 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.768 HD23 ' HA ' ' A' ' 30' ' ' ALA . 19.3 mt -126.86 148.46 49.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 110.484 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.96 133.14 53.77 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.7 122.47 38.5 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.179 -0.951 . . . . 0.0 108.839 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.39 158.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.095 -1.003 . . . . 0.0 109.168 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -64.1 -10.53 23.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.086 -1.009 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.76 ' C ' HG23 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -76.87 1.45 17.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.779 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.76 HG23 ' C ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 75.22 25.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.428 ' HB ' HG22 ' A' ' 157' ' ' ILE . 20.2 m -119.3 156.57 21.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 110.186 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -107.64 157.01 18.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 0.0 109.07 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.5 mt-10 -130.47 117.63 19.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.946 -1.096 . . . . 0.0 109.342 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.768 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -110.25 114.15 27.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -57.46 143.13 41.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -102.84 174.1 6.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.244 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 3.0 tt0 -138.48 150.85 46.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.912 . . . . 0.0 109.588 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.46 ' SD ' ' HG3' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -114.52 130.88 56.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.9 130.43 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.454 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.88 111.99 13.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.621 HG23 ' HG3' ' A' ' 39' ' ' GLN . 33.5 m -127.14 162.99 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.425 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -83.5 92.73 7.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.578 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.621 ' HG3' HG23 ' A' ' 37' ' ' VAL . 12.0 mt-30 -123.31 154.78 38.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.374 -0.829 . . . . 0.0 109.413 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.22 80.33 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.08 -33.24 0.42 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.45 14.76 5.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.13 -1.217 . . . . 0.0 109.642 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 44' ' ' ASP . 13.0 t -94.15 -17.76 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.94 . . . . 0.0 109.448 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER 43.9 79.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.654 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 45' ' ' ILE . 0.7 OUTLIER -172.93 66.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.185 -0.947 . . . . 0.0 109.612 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -46.25 130.47 11.0 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.5 -18.48 19.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -1.126 . . . . 0.0 109.556 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 4.5 p30 -139.25 92.54 10.57 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.32 153.94 31.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.692 2.261 . . . . 0.0 110.509 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t 58.12 31.68 21.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.845 . . . . 0.0 109.319 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.17 61.65 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 109.129 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.485 ' HB2' ' OD1' ' A' ' 57' ' ' ASN . 4.3 pt-20 -143.81 157.59 44.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 109.538 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 17.1 t0 -149.15 92.12 1.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.306 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . 70.24 -168.66 0.16 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.263 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.48 -175.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.056 -1.027 . . . . 0.0 109.364 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.44 2.86 52.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 109.584 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.485 ' OD1' ' HB2' ' A' ' 52' ' ' GLU . 0.1 OUTLIER 60.18 -170.41 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 109.393 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 57' ' ' ASN . . . 63.68 109.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.851 . . . . 0.0 109.52 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -138.9 64.52 1.48 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 0.0 109.504 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.02 59.1 0.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.596 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 62' ' ' THR . . . -168.56 -69.19 0.03 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 61' ' ' GLY . 3.5 p 59.8 145.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -1.111 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -146.93 145.15 29.7 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.27 136.4 56.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.087 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.1 m -125.68 147.98 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 0.0 109.566 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 3.6 m-20 -69.88 152.92 43.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 52.7 t-20 -90.98 -26.62 19.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.622 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.894 HD21 HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -77.31 -42.5 36.56 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.771 HG13 ' HB2' ' A' ' 74' ' ' LEU . 44.6 t -73.19 -34.73 45.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.454 -0.779 . . . . 0.0 109.301 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 15.3 t80 -63.33 -48.79 76.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 110.384 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.54 -40.39 61.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.18 -0.95 . . . . 0.0 110.32 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CB ' HD23 ' A' ' 74' ' ' LEU . 62.8 m-85 -86.2 4.31 39.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 109.992 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.468 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 4.8 mtt85 52.82 35.66 19.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.569 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.771 ' HB2' HG13 ' A' ' 69' ' ' VAL . 1.8 mm? -57.59 167.58 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.879 -1.138 . . . . 0.0 108.715 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.568 ' HB3' HG23 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -130.23 117.03 17.8 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.996 -1.065 . . . . 0.0 109.73 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.86 123.29 5.71 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.488 2.125 . . . . 0.0 110.506 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.863 HG22 ' O ' ' A' ' 130' ' ' PHE . 14.8 t -105.91 128.35 53.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.354 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -100.46 2.08 41.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 109.847 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 12.3 t80 -120.87 124.75 45.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.068 -1.02 . . . . 0.0 109.529 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 178.3 31.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.71 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -62.61 -46.78 86.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 109.349 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.13 -23.1 9.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.366 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 m -72.0 -32.65 67.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 0.0 109.656 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 2.2 t80 -60.14 -43.92 95.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.942 . . . . 0.0 109.808 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtt -60.18 -50.79 72.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.333 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -60.03 -36.54 77.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.042 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.632 ' CD1' ' CB ' ' A' ' 138' ' ' PRO . 8.9 m-85 -74.96 -23.84 58.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.102 -0.999 . . . . 0.0 109.686 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.3 -29.03 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.021 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.57 -36.91 25.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.233 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.98 -31.19 74.84 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.604 ' CZ ' ' HG3' ' A' ' 141' ' ' MET . 2.2 t80 -81.18 -39.32 25.66 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.16 -1.2 . . . . 0.0 109.077 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -47.46 84.4 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.113 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -39.34 93.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.312 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.52 -47.31 73.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.221 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.537 HD11 ' HE1' ' A' ' 91' ' ' TYR . 47.5 mm -66.33 -32.08 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.33 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -36.06 71.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.889 -1.132 . . . . 0.0 108.577 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.72 -49.8 23.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.404 -0.81 . . . . 0.0 109.952 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -54.19 -34.69 61.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.064 -1.023 . . . . 0.0 109.708 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.535 ' HB2' HG22 ' A' ' 107' ' ' VAL . 61.3 mt -73.93 -35.52 64.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.102 -0.999 . . . . 0.0 109.12 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -22.23 65.05 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.147 -0.971 . . . . 0.0 109.287 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.01 -41.42 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 110.119 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 t -145.4 47.34 1.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.937 -1.102 . . . . 0.0 110.292 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 1.9 m-20 174.65 72.98 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.38 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.56 -43.31 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.7 2.267 . . . . 0.0 110.682 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.408 ' O ' HG22 ' A' ' 109' ' ' VAL . 4.9 mt-10 -72.27 -12.89 61.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.849 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.501 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -93.21 -7.57 44.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.139 -0.976 . . . . 0.0 109.799 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 71.0 t -67.16 -44.14 47.79 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 111.14 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.9 Cg_endo -76.54 -54.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.866 1.71 . . . . 0.0 110.979 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 0.8 OUTLIER -59.78 -34.21 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.076 -1.015 . . . . 0.0 109.68 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.475 ' CB ' ' O ' ' A' ' 106' ' ' ARG . 93.4 t80 -68.95 -43.44 75.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.955 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -31.17 71.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 109.814 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -71.82 -49.37 39.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.553 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -68.92 -51.36 40.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.17 -0.956 . . . . 0.0 110.391 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.921 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -54.4 -26.95 33.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.881 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.11 -39.0 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.454 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.74 -49.96 51.52 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.413 ' O ' HD12 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.44 -30.68 68.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -1.108 . . . . 0.0 109.582 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 114' ' ' ALA . 78.5 t -63.69 -41.1 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.64 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.84 -37.23 79.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.118 -0.989 . . . . 0.0 109.798 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -61.79 -60.12 4.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.829 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 117' ' ' PHE . 1.9 mp -56.38 -48.32 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 109.766 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 52.8 mt -46.91 -35.17 6.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.129 -0.982 . . . . 0.0 109.695 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -45.74 -48.94 15.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.802 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.6 57.35 1.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 109.664 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 1.9 p90 -55.63 -20.53 14.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.628 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.438 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -71.35 -45.61 62.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.759 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -73.41 -26.34 60.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -78.03 -25.13 47.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.421 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 60.04 170.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.541 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.863 ' O ' HG22 ' A' ' 77' ' ' THR . 2.1 m-85 -133.16 122.02 23.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 108.872 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.63 ' O ' HG13 ' A' ' 142' ' ' VAL . 14.7 m-85 -101.25 166.92 10.52 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.146 -0.971 . . . . 0.0 110.391 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.568 HG23 ' HB3' ' A' ' 75' ' ' SER . 3.6 tt -152.06 135.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.636 -0.665 . . . . 0.0 109.516 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.1 173.61 0.36 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -66.18 -23.98 66.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -1.113 . . . . 0.0 109.499 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 136' ' ' MET . 0.2 OUTLIER -59.27 -35.2 73.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.177 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.464 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER 71.68 53.05 0.22 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 109.61 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.531 ' N ' HD11 ' A' ' 132' ' ' ILE . 1.9 t70 -130.6 134.01 25.52 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.363 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.632 ' CB ' ' CD1' ' A' ' 87' ' ' TYR . 34.4 Cg_endo -75.1 -0.21 9.73 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.345 2.03 . . . . 0.0 110.374 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.603 ' O ' HG21 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -103.11 7.86 38.75 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 109.008 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 141' ' ' MET . . . -106.14 17.74 23.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.914 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.604 ' HG3' ' CZ ' ' A' ' 91' ' ' TYR . 7.9 ttm 74.45 148.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.037 -1.039 . . . . 0.0 110.274 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 131' ' ' TYR . 16.5 t -114.38 139.3 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 109.226 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.71 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.7 t -105.73 125.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.062 -1.024 . . . . 0.0 109.602 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -106.21 149.4 26.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.921 . . . . 0.0 109.069 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.502 ' HB3' ' HB3' ' A' ' 156' ' ' MET . 12.9 ptp -146.1 147.34 31.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.0 . . . . 0.0 109.744 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -156.18 161.64 40.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.911 . . . . 0.0 109.424 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.4 139.29 58.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.947 . . . . 0.0 109.374 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.441 ' CD ' HG22 ' A' ' 153' ' ' THR . 15.4 ptm180 -70.38 -170.28 0.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 109.616 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -27.82 68.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.923 . . . . 0.0 109.672 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 152' ' ' ILE . 1.2 m-20 -75.79 -14.9 60.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 56.36 22.68 38.56 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.804 HD12 ' HB ' ' A' ' 153' ' ' THR . 2.7 pp -110.0 -29.26 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -1.136 . . . . 0.0 109.795 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.804 ' HB ' HD12 ' A' ' 152' ' ' ILE . 5.9 t -138.22 134.68 17.85 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.014 . . . . 0.0 109.812 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.46 ' HG3' ' SD ' ' A' ' 34' ' ' MET . 36.7 Cg_endo -81.07 151.89 18.44 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.664 2.242 . . . . 0.0 110.332 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -145.17 133.66 21.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.448 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.617 ' HG3' ' CE1' ' A' ' 158' ' ' PHE . 0.0 OUTLIER -105.8 155.41 19.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.296 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.428 HG22 ' HB ' ' A' ' 27' ' ' VAL . 2.5 mt -118.16 154.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.771 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.71 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 49.9 m-85 -133.12 164.16 27.64 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.483 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 97.6 m-85 -107.88 121.12 44.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 0.0 109.426 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -59.19 -32.76 70.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 110.036 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 5.2 p30 -44.42 -28.26 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 109.683 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . -130.89 58.17 0.71 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 5' ' ' LYS . 4.4 mt -153.92 138.14 16.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -1.198 . . . . 0.0 109.506 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.572 HG13 ' CG2' ' A' ' 7' ' ' VAL . 2.0 m -119.03 130.94 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 109.791 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.8 p -85.74 125.85 33.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.253 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.77 142.11 45.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.868 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.441 ' HA ' HD22 ' A' ' 2' ' ' LEU . 4.6 tppt? -102.41 126.45 49.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 109.062 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 167' ' ' LYS . 7.4 p90 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.686 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 166' ' ' GLU . 0.3 OUTLIER -68.49 143.64 54.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.222 -0.924 . . . . 0.0 110.069 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 2' ' ' LEU . 21.8 mt -115.43 128.21 55.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.632 -0.668 . . . . 0.0 109.482 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.742 ' CD2' HD21 ' A' ' 163' ' ' LEU . 4.4 m-85 -104.27 132.08 50.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.325 -0.859 . . . . 0.0 109.419 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 9.6 pttt -146.89 164.63 32.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.735 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 162' ' ' GLY . 44.1 t0 -87.65 146.66 25.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.298 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.71 -12.38 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.586 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.871 HG21 ' HA ' ' A' ' 140' ' ' ALA . 29.4 mm -54.59 -69.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.507 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -99.37 -51.76 3.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.392 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 95.46 1.68 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 4.5 p30 -170.53 153.85 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.178 -1.19 . . . . 0.0 109.526 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 3.7 mm-40 -71.29 118.57 14.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.252 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.84 -41.88 3.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 109.496 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.839 HG21 ' HB2' ' A' ' 30' ' ' ALA . 2.3 p -153.18 169.26 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.603 ' N ' HG22 ' A' ' 14' ' ' VAL . 51.8 p -153.64 177.7 10.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.975 -1.078 . . . . 0.0 110.419 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.1 6.77 17.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.419 -0.801 . . . . 0.0 109.783 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.04 -8.4 44.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.145 -0.972 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 19' ' ' ASP . 52.6 m-85 -126.54 19.14 7.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.432 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER 61.46 120.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 37.3 mt -111.82 138.73 48.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.168 -0.957 . . . . 0.0 110.45 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -119.58 136.61 54.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.602 -0.687 . . . . 0.0 109.462 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 1.4 tt0 -99.81 115.98 30.84 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.247 -0.908 . . . . 0.0 108.881 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.519 HG22 ' OE2' ' A' ' 29' ' ' GLU . 6.4 t -70.82 158.92 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 109.48 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' VAL . 21.9 t0 -39.22 -39.97 0.68 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.507 -0.745 . . . . 0.0 109.568 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.88 -143.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 108.834 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.564 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -125.98 62.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.031 -1.043 . . . . 0.0 109.244 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.535 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 16.4 m -138.49 150.97 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.543 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -104.7 157.07 17.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.519 ' OE2' HG22 ' A' ' 23' ' ' VAL . 80.4 mt-10 -122.86 117.47 25.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.422 -0.799 . . . . 0.0 109.079 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.839 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -113.54 115.45 28.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.48 150.09 45.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.9 p -143.55 158.37 43.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.394 -0.816 . . . . 0.0 109.207 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.43 157.78 17.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.484 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.7 mtp -108.06 121.97 45.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.332 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.2 m -119.46 160.67 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 0.0 109.573 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.6 138.53 39.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.92 . . . . 0.0 109.677 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 m -125.18 141.67 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.62 106.64 17.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.427 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -71.53 160.52 32.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.402 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 41' ' ' GLY . . . -122.27 74.21 0.37 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 40' ' ' GLY . . . -49.37 179.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.97 -12.65 54.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -1.161 . . . . 0.0 109.587 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -117.75 -66.56 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.942 . . . . 0.0 109.562 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 18.4 m-20 60.43 -100.39 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.431 -0.793 . . . . 0.0 109.616 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 45' ' ' ILE . 3.8 tp 177.95 43.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 0.0 109.415 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 45' ' ' ILE . . . -50.83 -99.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.27 -90.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -1.147 . . . . 0.0 109.392 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 46' ' ' GLY . 10.4 p30 -110.48 146.85 35.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.363 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.38 -2.69 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.623 2.215 . . . . 0.0 110.459 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -129.57 -161.89 1.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.542 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 62.96 -136.93 0.41 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.0 109.295 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 51' ' ' ALA . 12.3 mt-10 -41.92 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.085 -1.01 . . . . 0.0 109.883 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 51' ' ' ALA . 18.0 t0 -119.49 -26.55 5.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.302 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.562 ' O ' ' CB ' ' A' ' 55' ' ' GLU . . . 51.53 -90.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 109.619 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 83.89 -50.25 0.13 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.788 -0.57 . . . . 0.0 109.703 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -110.23 -177.97 3.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -0.945 . . . . 0.0 109.578 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 m120 62.0 104.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 109.724 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.25 129.19 17.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.203 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.81 29.52 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.512 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.4 -89.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.5 32.44 2.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 p -85.29 122.55 29.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.015 -1.285 . . . . 0.0 109.332 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.01 151.98 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.501 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.33 131.76 34.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.885 . . . . 0.0 109.726 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 m -117.03 134.74 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.9 . . . . 0.0 109.571 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.545 ' HB2' HG23 ' A' ' 69' ' ' VAL . 34.9 m120 -69.86 134.81 48.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 28.9 p-10 -56.18 -24.41 41.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.825 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' A' ' 72' ' ' PHE . 58.4 tp -82.06 -34.85 29.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 108.953 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.847 HG13 ' CB ' ' A' ' 74' ' ' LEU . 53.5 t -66.36 -55.33 19.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.487 -0.758 . . . . 0.0 109.751 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -66.46 -42.88 86.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 0.0 110.224 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.1 m -55.94 -46.03 78.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.044 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.565 ' CE2' HD11 ' A' ' 68' ' ' LEU . 16.4 m-30 -100.43 18.82 18.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.483 ' O ' HD22 ' A' ' 74' ' ' LEU . 18.9 ttm105 49.3 89.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 109.479 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.847 ' CB ' HG13 ' A' ' 69' ' ' VAL . 1.9 mm? -117.4 143.06 46.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.326 -0.859 . . . . 0.0 109.049 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.728 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.9 OUTLIER -121.43 143.36 37.52 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 109.741 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 36.7 Cg_endo -79.89 139.91 14.09 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.677 2.252 . . . . 0.0 110.467 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.0 t -122.05 135.39 54.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.231 -0.918 . . . . 0.0 109.257 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 t -114.45 145.58 41.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.925 . . . . 0.0 109.717 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CZ ' ' CD2' ' A' ' 130' ' ' PHE . 5.1 p90 -172.29 -177.6 1.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 82' ' ' LYS . 21.2 p-10 -101.07 169.13 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.023 . . . . 0.0 109.606 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -53.69 -47.78 70.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.0 109.913 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.464 ' HB2' ' OD2' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -50.37 -35.69 29.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.778 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.461 ' HB2' ' OD1' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -71.9 -36.94 70.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.772 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 1.6 t80 -63.51 -47.41 81.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.827 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -40.97 91.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.936 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.03 -28.57 66.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.977 . . . . 0.0 109.911 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 138' ' ' PRO . 3.2 m-85 -70.12 -47.25 62.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 109.625 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 92' ' ' MET . 6.3 tp -74.17 -15.98 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.398 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.17 -59.77 2.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.2 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.61 -26.57 72.92 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.598 ' CE1' HD11 ' A' ' 95' ' ' ILE . 4.5 t80 -72.46 -36.1 68.4 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -63.44 -43.33 97.72 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -58.14 -45.36 87.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.36 -0.838 . . . . 0.0 109.001 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.52 71.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 108.768 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.697 HG21 ' CE2' ' A' ' 110' ' ' PHE . 27.0 mm -56.04 -30.44 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 0.0 109.026 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.584 ' HD2' HG13 ' A' ' 107' ' ' VAL . 0.3 OUTLIER -54.18 -47.29 72.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.57 -30.82 64.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.757 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.515 ' CZ ' ' O ' ' A' ' 161' ' ' ASP . 3.8 tmt_? -60.7 -44.92 95.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 109.898 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 106' ' ' ARG . 14.2 mt -72.33 -49.75 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.158 -0.964 . . . . 0.0 109.784 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.4 -26.17 40.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.955 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -79.76 -45.11 19.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 0.0 109.199 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p -95.86 -70.37 0.72 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.447 ' HB3' ' NH2' ' A' ' 106' ' ' ARG . 10.8 t30 -123.38 118.13 27.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.452 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.8 -29.03 9.02 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.403 2.069 . . . . 0.0 110.675 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.448 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 3.0 mt-10 -70.28 -6.64 36.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.64 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HB3' HD13 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -88.71 -3.34 58.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 0.0 109.878 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 59.1 t -72.34 -43.79 9.85 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 111.171 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.4 Cg_endo -77.86 -50.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.824 1.683 . . . . 0.0 110.902 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 110' ' ' PHE . 3.9 p -60.59 -46.84 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.72 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.697 ' CE2' HG21 ' A' ' 95' ' ' ILE . 73.3 t80 -67.66 -37.4 82.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -0.783 . . . . 0.0 110.401 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 6.2 tm-20 -59.47 -49.66 76.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.06 -1.025 . . . . 0.0 110.451 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -64.82 -44.05 91.12 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.11 -0.994 . . . . 0.0 110.281 -179.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -61.2 -32.5 72.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.937 -1.102 . . . . 0.0 110.007 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.75 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -64.22 -51.0 65.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 111.367 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.88 HD12 ' N ' ' A' ' 116' ' ' GLY . 1.7 pp -62.94 -45.79 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.769 -1.207 . . . . 0.0 110.576 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.88 ' N ' HD12 ' A' ' 115' ' ' ILE . . . -59.06 -40.14 95.21 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.487 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -73.03 -30.24 63.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -1.16 . . . . 0.0 109.871 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 114' ' ' ALA . 69.2 t -65.65 -43.95 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.896 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.517 ' C ' ' CD ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -71.84 -32.06 67.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.627 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -28.65 61.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 109.999 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 117' ' ' PHE . 1.2 mp -79.55 -30.68 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.998 -1.064 . . . . 0.0 108.977 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 122' ' ' LEU . 23.2 mt -58.93 -26.19 64.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.897 . . . . 0.0 109.621 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 122' ' ' LEU . . . -43.89 -39.61 4.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.843 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 128' ' ' TYR . 2.6 m-20 -143.82 58.67 1.37 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 109.804 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 125' ' ' PHE . 4.6 p90 -62.59 -35.03 78.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.417 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.495 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -76.36 -26.37 55.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.71 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 2.8 t70 -77.52 -27.69 51.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 109.516 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 128' ' ' TYR . 1.6 m-30 -100.04 -1.57 36.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.07 -159.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 109.465 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 79' ' ' PHE . 68.5 m-85 -147.97 121.71 9.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 69' ' ' VAL . 11.9 m-85 -98.6 168.15 10.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.961 . . . . 0.0 110.296 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.815 ' O ' HD13 ' A' ' 74' ' ' LEU . 2.1 tt -150.7 146.54 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.408 -0.807 . . . . 0.0 109.437 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.75 168.44 46.65 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 135' ' ' SER . 0.2 OUTLIER -57.45 -21.21 35.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -1.159 . . . . 0.0 109.368 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 136' ' ' MET . 49.9 m -62.58 -41.71 99.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 75.41 41.81 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 109.691 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.25 129.39 24.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.148 -0.97 . . . . 0.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 87' ' ' TYR . 33.3 Cg_endo -75.13 -13.35 21.17 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.322 2.015 . . . . 0.0 110.306 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -97.25 8.29 44.85 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 108.953 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.871 ' HA ' HG21 ' A' ' 8' ' ' ILE . . . -92.26 -161.81 0.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.347 -0.846 . . . . 0.0 109.489 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.444 ' SD ' ' O ' ' A' ' 162' ' ' GLY . 2.6 ttp -88.82 145.68 25.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.676 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.96 141.05 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.285 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.535 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.1 t -109.79 136.46 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.87 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 128' ' ' TYR . 53.0 mt -107.7 151.24 25.94 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.813 . . . . 0.0 108.976 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.82 134.98 50.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.632 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -155.03 143.3 20.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.38 -0.825 . . . . 0.0 109.292 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.433 ' CD1' ' HA2' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -65.41 160.41 22.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.313 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 153' ' ' THR . 0.0 OUTLIER -58.49 173.58 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.15 -17.28 39.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -107.36 -47.35 3.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -0.978 . . . . 0.0 109.364 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.433 ' HA2' ' CD1' ' A' ' 147' ' ' TYR . . . 120.28 29.17 1.66 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -100.76 -38.87 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -1.075 . . . . 0.0 109.279 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 148' ' ' ARG . 14.8 t -137.43 142.11 36.18 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.069 -1.019 . . . . 0.0 109.713 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 153' ' ' THR . 36.5 Cg_endo -79.35 146.71 19.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.665 2.244 . . . . 0.0 110.447 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -145.13 160.24 41.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.387 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.501 ' HB2' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -122.17 159.06 28.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.336 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 27' ' ' VAL . 36.8 mt -113.29 136.26 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.672 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.535 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 48.1 m-85 -123.74 118.22 26.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.03 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -50.07 119.5 3.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.096 -1.002 . . . . 0.0 109.565 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 161' ' ' ASP . 18.8 tptp -67.34 -42.09 84.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.341 -0.849 . . . . 0.0 109.526 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.562 ' OD2' HD21 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -44.11 -38.85 3.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.22 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.446 ' O ' ' OD1' ' A' ' 6' ' ' ASP . . . -108.8 52.73 0.63 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.742 HD21 ' CD2' ' A' ' 4' ' ' TYR . 7.9 tt -151.17 149.44 29.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -1.123 . . . . 0.0 109.405 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 165' ' ' SER . 0.6 OUTLIER -138.0 157.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.901 . . . . 0.0 109.61 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' A' ' 164' ' ' VAL . 0.7 OUTLIER -111.02 120.88 43.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.675 . . . . 0.0 109.458 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.579 ' O ' HD13 ' A' ' 2' ' ' LEU . 2.9 tt0 -108.11 147.2 31.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.428 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.07 116.02 28.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 0.0 109.329 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.447 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' O ' HD23 ' A' ' 2' ' ' LEU . 6.2 ptt? . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 167' ' ' LYS . 11.9 mt -121.27 149.07 43.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.631 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 3' ' ' LEU . 23.4 mt -101.4 122.91 44.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.555 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.585 ' CB ' HG13 ' A' ' 14' ' ' VAL . 6.2 m-85 -106.42 118.8 37.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.866 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 0.7 OUTLIER -129.67 141.13 50.97 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.8 ' OD1' HD11 ' A' ' 13' ' ' LEU . 12.2 p-10 -167.36 110.14 0.66 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.074 -1.016 . . . . 0.0 110.183 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.515 HG12 ' HB1' ' A' ' 140' ' ' ALA . 20.9 t -147.77 48.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER 62.12 15.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.9 t -163.96 -34.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.571 -0.706 . . . . 0.0 109.596 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.46 100.29 2.61 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 12' ' ' GLU . 51.8 t0 -130.08 -78.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.763 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.546 ' HA ' ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER 161.61 113.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 109.408 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.978 HD12 ' N ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -146.51 -31.31 0.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.136 -0.977 . . . . 0.0 110.817 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.978 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.3 p -134.97 174.12 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.723 -1.235 . . . . 0.0 109.06 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.624 ' C ' HD11 ' A' ' 20' ' ' LEU . 36.2 m -164.49 -174.73 3.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.021 . . . . 0.0 110.404 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.05 12.89 6.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.568 -0.708 . . . . 0.0 109.711 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.04 -17.03 64.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.955 . . . . 0.0 109.053 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.561 ' CE2' HD13 ' A' ' 68' ' ' LEU . 56.7 m-85 -118.37 19.49 13.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.462 -0.774 . . . . 0.0 109.169 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 18' ' ' TYR . 8.6 t0 63.33 120.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 30' ' ' ALA . 10.0 mt -113.71 153.11 29.53 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.2 -0.938 . . . . 0.0 110.359 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -129.41 141.21 51.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.496 -0.752 . . . . 0.0 109.177 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.512 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 1.5 mt-10 -93.97 128.55 40.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.938 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 t -80.07 153.44 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.841 . . . . 0.0 109.589 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.01 -17.14 6.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.761 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 26' ' ' ILE . 8.5 m-20 -81.61 -100.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.619 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -164.53 60.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 0.0 109.41 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 159' ' ' PHE . 14.7 m -152.28 164.02 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 110.179 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.512 ' CE1' ' HG3' ' A' ' 22' ' ' GLU . 7.2 m-85 -104.34 157.85 16.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.419 -0.8 . . . . 0.0 108.858 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 19.6 mt-10 -127.07 118.59 24.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.961 . . . . 0.0 109.314 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.696 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -114.71 112.44 22.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.009 -1.057 . . . . 0.0 109.062 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 13.9 t0 -79.87 150.24 30.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 p -129.26 -174.5 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -141.15 141.71 34.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.318 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.466 ' CG ' ' O ' ' A' ' 34' ' ' MET . 7.6 ptm -91.22 123.94 35.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.535 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.3 m -121.57 160.13 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.442 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.34 121.78 34.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.405 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.5 m -121.13 138.47 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.587 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -71.19 93.5 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -119.14 139.21 52.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.313 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.69 -54.35 0.05 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.77 -119.03 6.1 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -117.13 -9.37 11.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.219 -1.165 . . . . 0.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 44' ' ' ASP . 68.7 t -119.11 -92.98 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.488 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.597 ' N ' HG12 ' A' ' 43' ' ' VAL . 3.3 t70 44.75 52.78 7.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 109.282 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 45' ' ' ILE . 6.8 tp -123.2 14.11 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.691 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.56 52.54 0.17 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' A' ' 48' ' ' ASN . . . -132.02 151.39 51.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -1.151 . . . . 0.0 109.325 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.452 ' C ' ' O ' ' A' ' 47' ' ' ALA . 1.4 p-10 40.84 78.55 0.37 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.447 -0.783 . . . . 0.0 109.469 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.62 -7.75 15.79 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.744 2.296 . . . . 0.0 110.711 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 56.27 -167.05 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.537 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.525 ' HB1' ' OE2' ' A' ' 52' ' ' GLU . . . -134.0 -73.15 0.49 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.883 . . . . 0.0 109.421 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.525 ' OE2' ' HB1' ' A' ' 51' ' ' ALA . 3.8 mp0 -109.79 18.61 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.341 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 t70 55.97 -177.44 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.344 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 55' ' ' GLU . . . -115.89 -8.16 11.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.463 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 14.5 tt0 72.03 48.14 0.28 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.298 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -147.7 -80.73 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.242 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -97.27 128.64 44.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.32 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.71 -98.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.312 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.48 ' C ' ' CG ' ' A' ' 60' ' ' GLU . 5.3 tp10 -172.62 -74.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 109.447 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' CG ' ' C ' ' A' ' 59' ' ' GLU . 1.4 pt-20 39.18 43.11 0.83 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.457 -0.777 . . . . 0.0 109.851 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.81 69.38 1.4 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 59' ' ' GLU . 20.5 p -142.65 126.99 17.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -1.096 . . . . 0.0 109.46 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -126.16 142.92 51.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.364 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.54 135.45 36.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.963 . . . . 0.0 109.451 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASN . 17.7 m -132.95 131.64 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.454 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 22.9 m120 -45.2 153.74 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.473 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -88.82 -28.1 20.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.694 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.561 HD13 ' CE2' ' A' ' 18' ' ' TYR . 12.1 tp -78.39 -45.07 23.3 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.054 -1.029 . . . . 0.0 108.407 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.865 HG13 ' CB ' ' A' ' 74' ' ' LEU . 33.4 t -63.82 -54.62 29.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 70' ' ' TYR . 15.8 t80 -55.57 -32.55 63.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.177 -0.952 . . . . 0.0 109.533 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m -70.09 -38.08 75.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.851 . . . . 0.0 110.061 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.564 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 43.2 m-85 -104.35 10.32 35.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.015 -1.053 . . . . 0.0 110.142 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 4.1 tpp180 60.24 25.25 14.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.062 -1.024 . . . . 0.0 109.984 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.865 ' CB ' HG13 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -43.5 137.76 2.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.511 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.959 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -107.58 119.11 51.58 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.68 134.52 12.26 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.343 2.029 . . . . 0.0 110.104 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 179.82 5.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.088 -1.008 . . . . 0.0 109.742 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.97 132.09 37.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.494 -0.754 . . . . 0.0 109.146 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 30.5 p90 -124.81 161.54 26.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.682 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -89.43 150.32 22.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -53.27 -32.8 50.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.136 -0.978 . . . . 0.0 110.039 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -87.45 -25.74 23.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 110.138 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -71.11 -38.18 72.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.118 -0.988 . . . . 0.0 109.855 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.478 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 3.8 t80 -68.48 -35.38 77.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.562 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.761 ' O ' HG22 ' A' ' 88' ' ' ILE . 7.5 mtm -64.06 -56.03 17.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.9 p -58.87 -37.71 77.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -74.87 -19.5 60.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 85' ' ' MET . 0.2 OUTLIER -75.16 -31.96 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.866 . . . . 0.0 108.845 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 3.4 mttt -70.82 -53.97 13.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.462 -0.773 . . . . 0.0 109.345 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.16 -24.02 73.23 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -75.36 -36.84 60.91 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.153 -1.204 . . . . 0.0 108.235 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -48.36 66.17 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.549 -0.719 . . . . 0.0 109.148 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 89' ' ' LYS . 28.3 mmtm -55.2 -41.26 71.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.334 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.54 -42.58 71.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 109.137 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.883 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 28.3 mm -70.66 -26.6 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.319 -0.863 . . . . 0.0 109.26 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.46 -34.29 75.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.959 . . . . 0.0 108.684 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.27 -47.94 46.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.559 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -56.9 -32.94 66.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.989 . . . . 0.0 109.433 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.932 HD22 ' HB3' ' A' ' 106' ' ' ARG . 86.9 mt -73.0 -41.93 63.77 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.255 -0.903 . . . . 0.0 109.326 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -33.93 73.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.384 -0.823 . . . . 0.0 109.556 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -73.15 -39.25 65.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.557 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.6 p -90.97 -82.4 0.29 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.12 123.82 26.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.381 -0.824 . . . . 0.0 109.055 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.61 -26.45 11.73 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.401 2.067 . . . . 0.0 110.661 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.21 -7.11 39.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.614 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.932 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -92.29 1.74 57.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.618 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 14.3 t -69.83 -46.43 24.13 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 110.252 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 35.9 Cg_endo -78.26 -36.6 0.95 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.02 1.813 . . . . 0.0 110.673 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.69 -51.15 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.995 . . . . 0.0 109.592 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.883 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 6.5 t80 -65.31 -37.72 88.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.919 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.785 ' O ' HD12 ' A' ' 115' ' ' ILE . 1.2 mt-10 -64.56 -35.51 81.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 109.953 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -71.75 -41.02 68.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.497 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -69.52 -54.54 13.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.077 -1.014 . . . . 0.0 110.374 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.702 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -58.92 -27.17 65.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 109.972 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -60.17 -49.11 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.338 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 115' ' ' ILE . . . -67.26 -40.76 92.15 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.628 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -61.26 -30.76 70.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -1.128 . . . . 0.0 110.177 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 114' ' ' ALA . 69.4 t -67.14 -41.74 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 110.391 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -69.3 -44.13 72.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.047 -1.033 . . . . 0.0 110.027 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -57.04 -52.28 65.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.172 -0.955 . . . . 0.0 110.039 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.825 HG12 HD13 ' A' ' 144' ' ' LEU . 1.6 mp -58.18 -44.54 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.08 -1.012 . . . . 0.0 109.323 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.11 -30.42 64.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.25 -46.32 54.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.729 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 124' ' ' ASN . 2.4 p-10 -143.5 57.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 109.698 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 126' ' ' LYS . 21.9 p90 -51.79 -25.61 7.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 109.815 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.2 mmtt -61.96 -44.84 95.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 109.676 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -79.06 -23.01 44.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.618 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.595 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 2.8 m-85 -76.05 -20.32 57.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 109.751 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.8 OUTLIER 49.6 -177.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 110.029 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.491 ' CD2' HG11 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -142.91 121.38 12.42 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.799 ' O ' HG13 ' A' ' 142' ' ' VAL . 18.4 m-85 -108.9 176.93 4.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.03 -1.044 . . . . 0.0 110.869 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.959 HG22 ' O ' ' A' ' 75' ' ' SER . 1.6 tt -155.54 150.88 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.561 -0.712 . . . . 0.0 109.556 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.72 -176.68 43.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -18.85 63.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -1.205 . . . . 0.0 109.429 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 m -64.47 -37.06 86.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.259 -0.901 . . . . 0.0 109.461 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.447 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER 62.23 43.79 8.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.764 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -98.65 127.26 36.24 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.72 -1.55 11.5 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.291 1.994 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -115.03 10.95 16.34 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.344 -0.848 . . . . 0.0 109.003 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.515 ' HB1' HG12 ' A' ' 7' ' ' VAL . . . -100.95 -177.38 3.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.266 -0.896 . . . . 0.0 109.6 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -83.49 142.32 31.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.535 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 131' ' ' TYR . 41.1 t -108.45 141.48 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 0.0 109.65 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.461 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 21.8 t -92.04 122.97 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.313 -0.867 . . . . 0.0 108.932 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.825 HD13 HG12 ' A' ' 121' ' ' ILE . 1.1 mt -90.24 124.53 34.95 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.288 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.584 ' CE ' ' CE ' ' A' ' 156' ' ' MET . 53.5 ttm -104.93 128.47 53.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.595 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 14.4 t-20 -147.01 165.24 30.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.54 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -84.47 157.78 21.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.405 ' HG3' ' CD1' ' A' ' 155' ' ' TYR . 2.8 mtt85 -87.77 176.12 7.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.187 -0.945 . . . . 0.0 109.214 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.18 -13.93 51.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.22 -0.925 . . . . 0.0 109.137 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.3 -60.8 3.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.326 -0.859 . . . . 0.0 109.096 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 131.61 -27.02 3.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -133.95 37.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -1.175 . . . . 0.0 109.421 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.2 m -129.03 100.58 20.48 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.368 -0.833 . . . . 0.0 109.358 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.74 127.16 6.2 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.534 2.156 . . . . 0.0 110.481 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.405 ' CD1' ' HG3' ' A' ' 148' ' ' ARG . 26.0 p90 -145.03 159.42 42.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.584 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -129.68 142.72 50.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.278 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.5 mt -102.4 148.45 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.579 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.657 ' CE2' HD13 ' A' ' 13' ' ' LEU . 54.9 m-85 -127.17 118.66 24.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 109.36 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.468 ' HA ' HG12 ' A' ' 27' ' ' VAL . 43.8 m-85 -53.51 119.52 4.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.653 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 26' ' ' ILE . 7.8 tptt -66.7 -38.06 85.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.74 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.438 ' OD1' ' HB3' ' A' ' 159' ' ' PHE . 1.4 p-10 -44.76 -48.81 10.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.642 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 6' ' ' ASP . . . -104.71 50.21 0.86 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 164' ' ' VAL . 6.9 tt -145.18 155.17 43.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -1.194 . . . . 0.0 109.3 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.809 ' N ' HD23 ' A' ' 163' ' ' LEU . 4.3 m -144.2 135.52 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.973 . . . . 0.0 109.818 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.0 m -99.02 137.96 36.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.079 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -127.12 139.09 53.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.782 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.508 ' HA ' HD22 ' A' ' 2' ' ' LEU . 5.5 ttmt -78.58 125.27 29.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 109.35 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.497 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.9 165.82 14.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.586 HD12 ' HA ' ' A' ' 168' ' ' PHE . 82.6 mt -120.99 135.31 55.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.62 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.586 ' CD2' HD21 ' A' ' 163' ' ' LEU . 68.6 m-85 -121.54 133.02 55.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.833 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -135.07 153.59 51.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.832 . . . . 0.0 109.366 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 41.9 t0 -61.78 148.11 44.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.506 ' CG2' HG13 ' A' ' 164' ' ' VAL . 18.5 t -91.2 53.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.898 . . . . 0.0 109.434 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.594 HG22 ' N ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -163.76 -54.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.084 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.594 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER 177.81 64.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.496 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.729 ' HA3' HD13 ' A' ' 13' ' ' LEU . . . -111.1 -18.74 8.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.5 OUTLIER 45.98 87.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -1.187 . . . . 0.0 109.234 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.402 ' HG3' ' C ' ' A' ' 11' ' ' ASP . 2.9 mt-10 58.18 102.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.121 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.729 HD13 ' HA3' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -117.25 -55.78 2.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.556 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.783 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 7.9 p -140.19 164.25 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 108.942 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.547 ' N ' HG22 ' A' ' 14' ' ' VAL . 53.9 p -153.24 172.12 17.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.54 2.32 29.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.484 -0.76 . . . . 0.0 109.759 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.78 -10.24 45.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.102 -0.999 . . . . 0.0 109.035 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.662 ' CD2' HD11 ' A' ' 68' ' ' LEU . 34.7 m-85 -123.42 19.47 9.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.366 -0.834 . . . . 0.0 109.157 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 0.6 OUTLIER 61.62 128.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.348 -0.845 . . . . 0.0 108.925 -179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 30' ' ' ALA . 65.3 mt -118.91 151.17 38.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.129 -0.982 . . . . 0.0 110.139 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -133.66 122.86 24.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 109.492 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.52 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -80.97 121.24 25.78 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.271 -0.893 . . . . 0.0 108.733 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 24' ' ' ASP . 6.6 t -77.38 154.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.716 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' VAL . 6.9 m-20 -42.77 -32.0 0.55 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.818 . . . . 0.0 109.542 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 26' ' ' ILE . 39.9 m-20 -70.6 -116.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -153.77 63.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.734 -1.229 . . . . 0.0 109.483 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 159' ' ' PHE . 16.6 m -152.36 144.21 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.127 -0.983 . . . . 0.0 109.757 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 3.7 m-85 -98.95 134.19 42.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 108.851 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -108.78 138.26 45.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.989 -1.069 . . . . 0.0 109.967 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.783 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -116.17 113.98 23.82 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -65.74 150.15 48.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 0.0 109.689 -179.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.6 t -102.94 146.82 27.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.0 150.75 50.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.147 -0.971 . . . . 0.0 109.642 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.527 ' HG2' ' CG2' ' A' ' 64' ' ' THR . 0.0 OUTLIER -89.52 133.09 34.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 m -128.08 120.81 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.287 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 t -76.74 151.16 36.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.94 . . . . 0.0 109.586 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.9 m -137.03 131.65 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.312 -0.867 . . . . 0.0 109.44 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.585 ' HA ' HG22 ' A' ' 62' ' ' THR . 31.0 mttt -77.47 128.92 35.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.648 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -102.06 150.45 23.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 109.331 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.22 15.96 61.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.85 57.23 4.65 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -161.87 71.84 0.37 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -1.154 . . . . 0.0 109.459 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -51.88 -72.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.214 -0.929 . . . . 0.0 109.377 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -100.52 118.38 36.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.452 -0.78 . . . . 0.0 109.577 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.659 ' O ' HG23 ' A' ' 45' ' ' ILE . 6.9 tp -146.93 72.19 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.82 142.52 16.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 57' ' ' ASN . . . -160.29 127.23 4.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -1.167 . . . . 0.0 109.51 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.518 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 1.4 m-80 43.28 62.42 8.87 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 48' ' ' ASN . 35.8 Cg_endo -78.03 75.85 4.64 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.786 2.324 . . . . 0.0 110.424 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.8 42.02 1.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.482 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 59.65 52.14 5.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 53' ' ' ASP . 12.5 mt-10 -97.91 18.84 14.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.511 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 52' ' ' GLU . 11.5 t70 61.13 134.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 0.0 109.65 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.37 -170.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 109.82 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 1.6 pp20? -114.04 170.07 8.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.62 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 2.1 mt-10 164.66 166.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.548 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 8.9 t30 62.18 130.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.333 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.571 ' HB1' HD11 ' A' ' 45' ' ' ILE . . . -171.59 -78.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -151.38 -60.77 0.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.506 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -77.36 -80.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 62' ' ' THR . . . 106.62 77.21 1.06 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 38' ' ' LYS . 17.8 p 43.73 -167.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.113 . . . . 0.0 109.683 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HG2' ' C ' ' A' ' 62' ' ' THR . 65.3 mm-40 -145.56 146.22 31.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.527 ' CG2' ' HG2' ' A' ' 34' ' ' MET . 0.0 OUTLIER -99.89 134.26 43.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 109.446 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.54 146.62 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.406 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 32.8 m120 -54.46 148.56 11.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.57 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 21.0 p30 -99.32 -21.77 15.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 109.333 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.662 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -82.86 -42.78 17.38 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 74' ' ' LEU . 87.8 t -72.37 -35.19 51.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.526 -0.734 . . . . 0.0 109.475 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 2.1 t80 -69.38 -58.25 4.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.906 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 t -56.93 -52.54 64.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.939 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 13' ' ' LEU . 11.1 m-85 -83.17 -3.47 57.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 109.633 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.518 ' CA ' ' O ' ' A' ' 69' ' ' VAL . 11.4 tpt180 53.63 34.39 18.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 109.545 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.536 ' HB2' HG13 ' A' ' 69' ' ' VAL . 11.8 mt -42.77 142.36 0.89 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.84 . . . . 0.0 109.251 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.86 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -124.46 135.6 26.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.682 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.38 140.98 15.65 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.526 2.151 . . . . 0.0 110.187 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 p -122.34 175.62 6.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.664 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.2 m -144.7 151.2 38.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.068 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.629 ' CE2' ' CD2' ' A' ' 130' ' ' PHE . 6.6 p90 -172.05 -177.54 1.91 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 0.0 109.819 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.08 166.71 10.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.364 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -57.86 -52.16 66.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.733 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -26.21 67.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.788 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.3 t -71.93 -41.06 68.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.967 . . . . 0.0 109.946 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.551 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 24.8 t80 -60.34 -39.06 85.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.796 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.5 mtm -63.44 -43.45 97.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.059 -1.026 . . . . 0.0 109.847 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -40.31 95.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.17 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -67.43 -58.2 5.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.161 -0.962 . . . . 0.0 109.895 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 84' ' ' TYR . 6.3 tp -52.2 -23.79 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.843 . . . . 0.0 109.862 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -74.18 -42.26 60.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.067 -1.02 . . . . 0.0 109.655 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.12 -30.72 76.13 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.529 ' CE1' HD11 ' A' ' 95' ' ' ILE . 31.2 t80 -80.82 -35.96 32.25 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.046 -1.267 . . . . 0.0 108.846 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -43.54 96.65 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.405 -0.809 . . . . 0.0 109.221 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -40.69 82.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.338 -0.851 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.23 82.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 91' ' ' TYR . 39.7 mm -61.64 -44.3 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.159 -0.963 . . . . 0.0 109.555 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.518 ' CE ' HG13 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -47.02 -51.59 16.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.912 . . . . 0.0 109.194 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.84 80.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.539 ' HD3' HD23 ' A' ' 99' ' ' LEU . 1.2 tmt_? -57.46 -36.1 70.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.874 . . . . 0.0 109.344 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.703 HD13 ' HD2' ' A' ' 106' ' ' ARG . 8.6 mt -72.59 -49.82 29.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -0.852 . . . . 0.0 109.601 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -23.99 52.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.719 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.48 -21.66 17.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 109.568 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 2.7 t -114.13 -89.0 0.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.56 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -120.74 99.64 47.14 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.382 -0.824 . . . . 0.0 109.535 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 107' ' ' VAL . 32.8 Cg_endo -74.37 -13.19 22.98 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.433 2.088 . . . . 0.0 110.392 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -7.14 16.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.127 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.703 ' HD2' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -118.76 21.48 12.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.032 -1.043 . . . . 0.0 109.772 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 16.4 t -72.42 -46.34 10.24 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.494 -0.754 . . . . 0.0 110.868 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.5 Cg_endo -77.0 -48.89 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 121.976 1.784 . . . . 0.0 110.814 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.578 HG22 ' HA ' ' A' ' 106' ' ' ARG . 30.1 m -57.04 -44.86 83.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.104 -0.997 . . . . 0.0 109.589 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.556 ' N ' HG23 ' A' ' 109' ' ' VAL . 29.0 t80 -67.0 -37.87 84.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.84 -54.28 47.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.1 -1.0 . . . . 0.0 110.308 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -60.63 -45.92 92.24 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.105 -0.997 . . . . 0.0 110.207 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -56.34 -40.42 74.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 109.909 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.23 -27.37 63.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.081 -1.012 . . . . 0.0 109.586 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.64 -48.53 71.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.221 -0.924 . . . . 0.0 109.138 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.66 -29.91 76.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -69.98 -42.65 72.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -1.217 . . . . 0.0 109.812 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 97.4 t -69.68 -32.54 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -71.67 -34.51 69.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.127 -0.983 . . . . 0.0 109.624 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.51 ' N ' ' HD3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -84.53 -16.91 40.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.135 -0.978 . . . . 0.0 109.843 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.474 HD11 HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -81.97 -42.96 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.123 -0.986 . . . . 0.0 109.337 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 119' ' ' LYS . 6.6 mt -54.42 -28.2 42.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 109.465 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.24 -49.19 64.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 109.542 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 127' ' ' ASP . 6.4 m-20 -130.53 63.21 1.57 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -0.849 . . . . 0.0 109.416 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.484 ' CE2' ' CD2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -62.02 -49.93 74.06 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.364 -0.835 . . . . 0.0 109.753 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -55.55 -29.02 58.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.585 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.527 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -81.2 -26.55 35.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 109.945 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 129' ' ' ASP . 11.8 m-85 -84.16 -21.25 31.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.932 . . . . 0.0 110.018 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 128' ' ' TYR . 38.6 m-20 54.79 168.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.045 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.629 ' CD2' ' CE2' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -128.01 121.14 29.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.136 -0.978 . . . . 0.0 108.963 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 17.2 m-85 -109.5 174.71 5.74 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.21 -0.931 . . . . 0.0 110.538 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.86 HG22 ' O ' ' A' ' 75' ' ' SER . 3.6 tt -149.16 162.22 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.553 -0.717 . . . . 0.0 109.365 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.44 -176.93 50.54 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -68.5 -27.01 65.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -1.109 . . . . 0.0 109.398 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 136' ' ' MET . 1.0 OUTLIER -61.1 -34.15 74.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 65.16 39.77 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.385 -0.822 . . . . 0.0 109.371 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.35 139.91 27.46 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 109.198 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -73.8 -17.34 22.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.355 2.037 . . . . 0.0 109.982 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.76 -12.95 62.06 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.77 149.46 21.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.337 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.501 ' HE1' ' HA ' ' A' ' 158' ' ' PHE . 0.2 OUTLIER -66.49 139.14 57.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.603 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.1 m -88.43 141.68 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.821 . . . . 0.0 109.469 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 1.057 HG13 ' O ' ' A' ' 157' ' ' ILE . 16.5 t -97.05 140.82 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.193 -0.942 . . . . 0.0 109.053 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.519 HD23 ' C ' ' A' ' 143' ' ' VAL . 12.4 mt -110.94 134.55 52.48 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.514 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.485 ' HG2' ' HG2' ' A' ' 156' ' ' MET . 1.4 mtm -104.74 128.88 52.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 109.109 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.504 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 28.5 t-20 -150.24 159.15 44.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.958 . . . . 0.0 109.685 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -89.05 128.47 35.73 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.292 -0.88 . . . . 0.0 109.013 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -166.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 109.64 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -30.38 70.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 109.723 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -53.68 -59.3 4.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.698 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 111.39 -22.63 19.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.722 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -116.51 8.67 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -1.123 . . . . 0.0 109.165 179.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.8 m -117.38 101.3 52.84 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.157 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.49 137.58 14.81 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.601 2.201 . . . . 0.0 110.378 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 146' ' ' ASN . 14.9 p90 -145.25 139.64 27.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.162 -0.961 . . . . 0.0 109.733 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.521 ' HB2' ' CE1' ' A' ' 158' ' ' PHE . 3.3 mtt -101.89 165.06 11.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 1.057 ' O ' HG13 ' A' ' 143' ' ' VAL . 12.5 mt -125.8 141.07 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.984 -1.073 . . . . 0.0 110.23 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.652 ' HD2' HD23 ' A' ' 13' ' ' LEU . 11.3 m-85 -132.92 118.58 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.418 -0.801 . . . . 0.0 108.902 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.419 ' HA ' HG12 ' A' ' 27' ' ' VAL . 3.2 m-85 -48.59 138.4 10.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 109.722 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -65.98 -51.98 53.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.898 . . . . 0.0 109.156 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 110' ' ' PHE . 3.9 m-20 -47.04 -48.46 22.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.009 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -86.76 50.53 4.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 163' ' ' LEU . 2.1 tt -158.96 116.51 2.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.465 -1.021 . . . . 0.0 109.222 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.506 HG13 ' CG2' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -114.29 148.73 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 4.9 p -96.64 120.58 37.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.32 -0.862 . . . . 0.0 109.372 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -127.3 129.04 46.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.16 128.62 37.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.194 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.586 ' HA ' HD12 ' A' ' 3' ' ' LEU . 15.6 p90 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.74 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.818 ' C ' HD23 ' A' ' 2' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.818 HD23 ' C ' ' A' ' 1' ' ' MET . 4.7 mt -114.05 166.26 11.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.026 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.4 ' HA ' ' OG ' ' A' ' 15' ' ' SER . 11.1 mt -127.96 143.3 51.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 109.298 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.606 ' HB3' HD22 ' A' ' 163' ' ' LEU . 29.9 m-85 -121.59 112.35 18.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.885 . . . . 0.0 109.825 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.541 ' O ' HD23 ' A' ' 163' ' ' LEU . 9.6 mttt -112.9 150.41 31.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.328 -0.858 . . . . 0.0 109.402 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 141' ' ' MET . 0.4 OUTLIER -68.34 158.24 33.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.586 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 164' ' ' VAL . 40.8 t -94.92 -15.68 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.389 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.742 HG21 ' O ' ' A' ' 139' ' ' ASP . 0.8 OUTLIER -89.47 -25.05 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.256 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.5 -46.02 2.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.13 58.35 2.34 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 6.0 p-10 -134.24 179.96 5.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -1.144 . . . . 0.0 109.283 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -78.65 89.45 4.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.962 . . . . 0.0 109.703 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -82.24 -62.8 1.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 109.029 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' A' ' 30' ' ' ALA . 13.8 p -143.19 171.03 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.592 ' N ' HG22 ' A' ' 14' ' ' VAL . 4.9 m -156.49 178.32 10.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.151 . . . . 0.0 110.804 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -84.12 12.5 6.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.517 -0.739 . . . . 0.0 109.889 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . . . -66.32 -9.23 31.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.004 . . . . 0.0 109.02 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.585 ' CD1' HD11 ' A' ' 68' ' ' LEU . 4.6 m-85 -128.7 21.13 5.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.424 -0.797 . . . . 0.0 109.264 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER 62.91 126.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.062 -1.024 . . . . 0.0 108.309 -178.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.888 HD23 ' HA ' ' A' ' 30' ' ' ALA . 12.9 mt -120.35 147.17 45.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 110.584 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.9 mmtp -123.23 140.59 52.87 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -100.75 114.41 28.14 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.11 -0.994 . . . . 0.0 108.828 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 24' ' ' ASP . 3.2 t -68.63 158.37 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.371 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' VAL . 1.5 t70 -41.15 -47.19 3.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.426 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' ASP . 16.2 m-20 -62.12 -148.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 108.957 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.97 60.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.233 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 m -134.19 150.62 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.882 . . . . 0.0 109.784 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.04 155.77 21.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -0.82 . . . . 0.0 109.134 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 2.4 pt-20 -133.29 120.71 21.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.043 -1.036 . . . . 0.0 109.661 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.888 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -100.14 127.05 46.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.441 -0.787 . . . . 0.0 109.087 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 64.9 m-20 -68.0 145.69 54.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.932 . . . . 0.0 109.77 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -125.52 152.97 44.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.248 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.449 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -122.45 152.07 40.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.557 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.446 ' CG ' ' HB ' ' A' ' 64' ' ' THR . 2.9 ttm -96.53 135.63 38.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.41 -0.807 . . . . 0.0 109.401 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -123.5 174.15 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.182 -0.949 . . . . 0.0 109.637 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.29 120.58 41.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.92 162.89 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.355 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.808 ' HE3' HG21 ' A' ' 62' ' ' THR . 1.0 OUTLIER -123.19 112.49 17.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.396 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 40' ' ' GLY . 19.7 mt-30 -117.4 147.4 42.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.484 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 39' ' ' GLN . . . -45.19 -61.75 3.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.48 -58.19 0.55 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.44 46.48 2.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -1.153 . . . . 0.0 109.536 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.7 t -54.57 -29.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.6 170.61 11.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.514 ' CG1' ' O ' ' A' ' 45' ' ' ILE . 2.4 tt -164.91 26.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 109.588 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.0 12.08 77.59 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.81 132.29 54.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -1.168 . . . . 0.0 109.382 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 t30 58.22 86.93 0.15 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.407 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.17 117.24 4.07 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.64 2.227 . . . . 0.0 110.578 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.37 10.58 2.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.336 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -167.5 -66.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.915 . . . . 0.0 109.468 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 48.25 85.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 9.0 p-10 -118.99 45.32 2.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 109.297 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . 64.62 114.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.551 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -83.0 127.96 34.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.182 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -147.7 81.13 1.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.625 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -113.75 -169.27 1.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.316 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 60' ' ' GLU . . . -178.96 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.713 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 47.17 -92.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.633 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 58' ' ' ALA . 1.5 mt-10 49.12 23.16 0.71 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.533 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' ' OG1' ' A' ' 62' ' ' THR . . . 65.03 91.6 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.808 HG21 ' HE3' ' A' ' 38' ' ' LYS . 4.8 p 57.26 -162.45 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.384 -1.068 . . . . 0.0 109.437 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.69 145.36 24.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.471 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 34' ' ' MET . 1.2 p -88.45 147.01 24.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 109.405 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.7 m -135.89 147.99 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.563 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -70.71 154.06 42.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.291 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 56.1 p30 -80.4 -18.02 50.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.585 HD11 ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.63 -35.41 22.7 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.21 -0.931 . . . . 0.0 108.976 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.705 HG13 ' HB2' ' A' ' 74' ' ' LEU . 73.6 t -72.84 -45.2 56.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.395 -0.815 . . . . 0.0 109.277 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -69.31 -36.25 76.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.106 -0.996 . . . . 0.0 110.109 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.1 m -70.51 -49.74 45.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.19 -0.944 . . . . 0.0 110.437 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' A' ' 14' ' ' VAL . 16.9 m-85 -92.24 -0.26 57.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.021 . . . . 0.0 110.132 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 57.27 64.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.956 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.705 ' HB2' HG13 ' A' ' 69' ' ' VAL . 12.0 mt -77.78 164.38 25.27 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.101 -1.0 . . . . 0.0 108.941 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.447 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.6 OUTLIER -131.45 106.16 14.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.269 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.464 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 35.4 Cg_endo -76.8 120.9 5.66 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.359 2.039 . . . . 0.0 110.503 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.733 HG22 ' O ' ' A' ' 130' ' ' PHE . 10.0 t -88.95 157.55 18.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.9 . . . . 0.0 109.425 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.4 t -114.15 7.93 16.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.935 . . . . 0.0 109.509 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 79' ' ' PHE . 6.9 p90 -136.35 142.72 43.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.632 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 1.0 OUTLIER 172.68 30.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.883 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -52.98 60.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.037 -1.039 . . . . 0.0 109.428 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -118.41 -31.24 4.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.82 . . . . 0.0 109.297 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.459 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 4.1 m -59.67 -30.44 68.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.201 -0.937 . . . . 0.0 108.911 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' A' ' 80' ' ' ASP . 5.0 t80 -66.61 -44.67 81.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 0.0 109.601 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.592 ' O ' HG22 ' A' ' 88' ' ' ILE . 7.6 mtt -60.93 -43.79 98.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.944 . . . . 0.0 109.92 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.1 m -66.87 -26.75 67.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.208 -0.932 . . . . 0.0 110.183 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CD2' ' O ' ' A' ' 83' ' ' SER . 12.4 m-85 -81.46 -29.34 33.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 109.945 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 85' ' ' MET . 3.0 tp -75.92 -28.16 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -49.2 16.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.374 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.01 -34.37 89.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -72.76 -36.2 67.62 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -61.0 -38.4 85.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.425 ' HD2' ' HE3' ' A' ' 96' ' ' LYS . 11.6 mmtm -67.26 -39.48 86.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.382 -0.824 . . . . 0.0 109.182 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.11 72.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.113 -0.992 . . . . 0.0 108.761 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.794 HG21 ' CE2' ' A' ' 110' ' ' PHE . 33.2 mm -62.92 -43.43 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.307 -0.87 . . . . 0.0 109.253 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HE3' ' HD2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -47.08 -37.42 9.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.261 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.1 -47.1 47.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.424 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.952 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -48.97 -46.29 43.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 109.545 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.952 HD23 ' HD3' ' A' ' 98' ' ' ARG . 6.1 mt -63.84 -46.46 84.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.204 -0.935 . . . . 0.0 109.17 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -23.74 7.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 108.881 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 98' ' ' ARG . 2.3 mt-10 -78.24 -48.15 16.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.441 -0.787 . . . . 0.0 109.223 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.0 -72.51 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.484 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.11 139.74 14.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.363 -0.836 . . . . 0.0 109.478 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.81 -13.97 21.74 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.662 2.241 . . . . 0.0 110.816 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 83.1 mt-10 -67.43 -23.52 65.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -0.972 . . . . 0.0 109.686 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.629 ' O ' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -87.81 5.71 38.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 109.565 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 108' ' ' PRO . 2.4 t -72.06 -50.02 9.49 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 109.532 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 107' ' ' VAL . 36.8 Cg_endo -79.56 -33.39 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.226 1.951 . . . . 0.0 110.435 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 49.8 t -67.47 -53.93 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.37 -0.831 . . . . 0.0 109.885 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.794 ' CE2' HG21 ' A' ' 95' ' ' ILE . 92.4 t80 -68.67 -37.53 79.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.895 . . . . 0.0 109.936 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -49.12 79.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.979 . . . . 0.0 110.229 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -70.88 -37.18 73.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.477 ' N ' ' HG3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -62.8 -35.07 78.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.879 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.769 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -71.42 -28.08 63.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 109.661 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -34.12 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.304 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.26 -44.95 84.41 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.509 ' HZ ' HD13 ' A' ' 157' ' ' ILE . 2.2 t80 -67.5 -44.59 78.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -1.148 . . . . 0.0 109.811 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 114' ' ' ALA . 85.1 t -53.56 -35.39 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.356 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -43.38 67.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 109.678 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -33.14 72.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.869 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.406 ' HA ' ' CE2' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -78.17 -35.15 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.106 -0.997 . . . . 0.0 109.377 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 122' ' ' LEU . 44.9 mt -60.52 -28.65 68.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.652 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.31 -36.68 78.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -143.13 59.55 1.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.19 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -59.16 -28.88 67.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.937 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 4.7 mmtp -72.24 -36.2 69.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 109.796 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -80.08 -23.67 41.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.809 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 129' ' ' ASP . 46.7 m-85 -85.7 -25.0 26.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.122 -0.987 . . . . 0.0 109.712 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 126' ' ' LYS . 8.8 m-20 53.33 175.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.367 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.733 ' O ' HG22 ' A' ' 77' ' ' THR . 0.3 OUTLIER -136.53 121.7 19.1 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.242 -0.911 . . . . 0.0 108.814 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.464 ' CE2' ' HB3' ' A' ' 76' ' ' PRO . 14.7 m-85 -101.7 166.91 10.43 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.201 -0.937 . . . . 0.0 110.308 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 136' ' ' MET . 0.5 OUTLIER -156.42 142.97 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.528 -0.732 . . . . 0.0 109.497 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.45 179.57 1.86 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -67.74 -27.19 66.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -1.125 . . . . 0.0 109.248 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.544 ' O ' ' CG ' ' A' ' 136' ' ' MET . 1.0 OUTLIER -60.29 -35.07 74.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.301 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 79.92 20.01 0.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.501 -0.749 . . . . 0.0 109.471 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.47 123.62 35.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.029 -1.044 . . . . 0.0 109.798 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.443 ' HG3' ' CD1' ' A' ' 87' ' ' TYR . 32.3 Cg_endo -73.24 -13.5 25.67 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.145 1.897 . . . . 0.0 109.789 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.742 ' O ' HG21 ' A' ' 8' ' ' ILE . 2.8 m-20 -62.86 -21.21 65.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 141' ' ' MET . . . -76.78 -69.82 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.85 . . . . 0.0 109.089 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 5.8 tmm? 173.4 137.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 109.352 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.84 140.55 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 157' ' ' ILE . 3.4 t -112.14 138.05 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -106.18 143.67 33.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.411 ' HG3' ' HG2' ' A' ' 156' ' ' MET . 1.2 mtt -107.75 132.28 53.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.282 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 13.2 t30 -143.77 160.28 41.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 109.643 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.74 146.29 24.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.94 . . . . 0.0 109.444 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.411 HH11 HG21 ' A' ' 153' ' ' THR . 4.0 ttp180 -77.81 -172.83 2.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.563 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -21.64 63.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.51 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -58.02 5.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.85 -13.0 9.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.609 ' O ' HD12 ' A' ' 152' ' ' ILE . 2.4 pp -124.47 5.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.267 -1.137 . . . . 0.0 109.586 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.411 HG21 HH11 ' A' ' 148' ' ' ARG . 3.2 m -111.88 100.28 48.19 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.242 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 36.9 Cg_endo -81.59 132.27 7.73 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.622 2.215 . . . . 0.0 110.598 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 146' ' ' ASN . 38.4 p90 -133.78 142.59 47.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.106 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 9.6 mtt -100.79 161.15 13.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 110.207 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.796 ' O ' HG13 ' A' ' 143' ' ' VAL . 68.9 mt -124.46 145.78 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.215 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.73 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 4.2 m-85 -137.3 141.82 41.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 109.483 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -58.83 120.31 8.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 109.356 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -67.58 -45.61 75.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 109.513 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.61 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . 4.6 t0 -54.53 -25.84 28.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.345 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -103.8 39.2 2.89 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 4' ' ' TYR . 8.1 mt -149.75 140.19 22.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.388 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 7' ' ' VAL . 28.2 m -114.0 123.01 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.521 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.56 119.57 23.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.468 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -117.18 138.03 51.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.571 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.434 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -80.35 146.48 31.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.508 ' O ' ' CD1' ' A' ' 168' ' ' PHE . 5.1 t80 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.373 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.291 0.567 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.616 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 1.3 mm? -75.11 156.56 35.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.282 -0.886 . . . . 0.0 109.683 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 166' ' ' GLU . 2.9 mp -134.29 124.06 25.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.733 ' HB2' HG13 ' A' ' 14' ' ' VAL . 6.1 m-85 -96.12 109.58 21.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.429 -0.795 . . . . 0.0 109.81 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.637 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -110.03 152.45 25.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.348 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.482 ' HB2' HD23 ' A' ' 13' ' ' LEU . 20.2 t0 -68.11 134.57 50.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.523 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 8' ' ' ILE . 13.9 p -76.13 -36.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.433 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.729 HG22 ' OG ' ' A' ' 9' ' ' SER . 2.3 mp -66.47 -91.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.729 ' OG ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -135.11 80.84 1.86 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.38 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 6' ' ' ASP . . . -145.31 -62.99 0.02 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.6 t0 68.21 11.01 8.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -1.099 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.506 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER 173.1 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.693 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 12' ' ' GLU . 1.1 mm? -122.7 -61.37 1.46 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 109.285 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.909 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 10.5 p -136.76 166.35 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 108.979 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.4 p -145.47 164.34 31.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.009 -1.057 . . . . 0.0 110.543 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.512 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 1.5 t0 -82.96 8.1 13.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.461 -0.775 . . . . 0.0 109.745 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.23 -19.92 65.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 0.0 109.131 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.805 ' CD2' HD11 ' A' ' 68' ' ' LEU . 14.2 m-85 -110.87 21.26 16.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.272 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER 58.75 111.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 30' ' ' ALA . 16.2 mt -105.53 144.8 31.79 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.14 -0.975 . . . . 0.0 110.609 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.83 133.03 56.51 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.914 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER -97.13 120.94 38.42 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.298 -0.876 . . . . 0.0 108.703 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 24' ' ' ASP . 12.0 t -72.07 155.16 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' VAL . 22.2 t70 -43.4 -31.46 0.68 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.69 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.854 ' O ' HG23 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -70.15 -103.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.473 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -166.95 63.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.959 -1.088 . . . . 0.0 109.442 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 3.6 m -142.83 142.27 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.965 . . . . 0.0 109.735 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -100.59 132.36 46.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.429 -0.794 . . . . 0.0 109.144 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 18.6 mt-10 -107.99 124.7 50.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.93 . . . . 0.0 109.268 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.909 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -105.59 116.09 31.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 109.27 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.95 147.05 49.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.727 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.463 ' HB2' ' HG2' ' A' ' 154' ' ' PRO . 3.9 m -115.56 167.8 10.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -0.912 . . . . 0.0 109.378 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.409 ' HG2' ' N ' ' A' ' 34' ' ' MET . 18.5 tt0 -131.84 148.6 52.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.162 -0.961 . . . . 0.0 109.625 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.453 ' CG ' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -99.08 121.06 40.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 109.635 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 m -119.83 144.79 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 0.0 109.353 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 p -78.74 128.91 34.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.01 134.22 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.25 -0.906 . . . . 0.0 109.437 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 104.16 16.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.673 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.57 151.18 33.84 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -0.897 . . . . 0.0 109.453 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.48 -61.31 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.65 ' O ' HG23 ' A' ' 43' ' ' VAL . . . 170.0 -69.43 0.14 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER 39.33 34.24 0.12 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.52 -0.988 . . . . 0.0 109.761 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 41' ' ' GLY . 56.5 t -139.23 -38.29 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 43' ' ' VAL . 2.2 m-20 44.68 92.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 45' ' ' ILE . 12.8 mt -68.15 -63.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.502 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.83 143.12 14.33 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.26 121.01 9.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -1.13 . . . . 0.0 109.533 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 179.02 90.49 0.17 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.54 103.76 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.725 2.283 . . . . 0.0 110.304 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 78.3 p -146.1 60.08 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 109.707 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 50' ' ' SER . . . 173.81 148.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 0.0 109.756 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 54.26 52.05 13.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.598 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.77 -38.12 82.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.169 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.56 126.89 29.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.232 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -52.14 108.6 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.828 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 9.2 tt0 73.49 130.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.972 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.05 -158.9 0.68 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.57 -59.25 1.75 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.149 -0.969 . . . . 0.0 109.454 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.17 162.17 0.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.676 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -112.73 -21.29 11.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.29 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.05 1.46 61.29 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.1 p -57.68 136.61 56.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -1.167 . . . . 0.0 109.481 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.29 142.86 28.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.453 ' HB ' ' CG ' ' A' ' 34' ' ' MET . 0.1 OUTLIER -86.19 147.57 26.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.69 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.02 139.15 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.852 . . . . 0.0 109.281 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -62.71 152.26 36.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.771 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 71' ' ' SER . 31.9 t-20 -80.72 -21.65 40.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.551 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.805 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.22 -40.0 18.62 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.17 -0.956 . . . . 0.0 108.566 179.574 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.486 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 41.4 t -67.07 -44.36 88.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.543 -0.723 . . . . 0.0 109.343 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -70.18 -40.46 74.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.869 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 67' ' ' ASN . 1.3 t -63.26 -34.29 77.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 110.119 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.744 ' HB2' HD23 ' A' ' 74' ' ' LEU . 59.4 m-85 -111.32 6.75 20.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.03 -1.043 . . . . 0.0 109.904 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER 54.04 32.63 15.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 109.913 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.744 HD23 ' HB2' ' A' ' 72' ' ' PHE . 1.3 mm? -43.13 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.269 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -127.92 141.69 41.96 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.149 -0.97 . . . . 0.0 109.48 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 36.3 Cg_endo -78.47 127.15 7.96 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.576 2.184 . . . . 0.0 110.456 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.452 HG21 ' HB ' ' A' ' 132' ' ' ILE . 1.0 OUTLIER -138.33 176.54 8.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.12 -0.988 . . . . 0.0 109.641 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.412 ' O ' ' CD2' ' A' ' 130' ' ' PHE . 13.1 m -120.66 -149.41 0.43 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.228 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.647 ' CG ' ' CE1' ' A' ' 125' ' ' PHE . 6.5 p90 -164.84 -178.75 5.41 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.173 -0.954 . . . . 0.0 109.405 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.543 ' CB ' ' CB ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -120.85 136.94 54.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.125 -0.984 . . . . 0.0 109.63 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.45 -38.18 88.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 109.851 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.82 -33.64 6.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 109.781 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.543 ' CB ' ' CB ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -71.08 -29.44 65.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.922 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.529 ' CE1' ' HB ' ' A' ' 88' ' ' ILE . 5.6 t80 -56.69 -35.95 69.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.006 -1.059 . . . . 0.0 109.812 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.8 mtm -53.66 -43.55 68.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.912 -1.118 . . . . 0.0 109.694 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 t -70.62 -41.07 72.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.064 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -56.67 -56.47 21.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 109.57 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.529 ' HB ' ' CE1' ' A' ' 84' ' ' TYR . 4.2 tp -59.33 -29.33 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.857 . . . . 0.0 109.459 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -57.45 11.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.136 -0.977 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.02 -19.91 70.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -70.64 -40.71 72.91 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.167 -1.196 . . . . 0.0 107.778 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.437 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -69.41 -41.78 75.93 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -40.07 63.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.425 -0.797 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.07 73.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.21 -0.932 . . . . 0.0 109.189 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.771 HG21 ' CE1' ' A' ' 110' ' ' PHE . 13.5 mm -63.02 -38.21 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.185 -0.947 . . . . 0.0 109.127 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.471 ' HD3' ' OE1' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -55.48 -35.1 65.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.068 . . . . 0.0 109.397 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.65 59.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.915 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -59.63 -31.74 69.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.015 . . . . 0.0 109.623 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.797 HD22 ' CD ' ' A' ' 106' ' ' ARG . 28.2 mt -72.56 -44.34 62.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.965 . . . . 0.0 109.6 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.471 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -58.56 -35.98 73.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.59 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -83.72 -18.29 38.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.442 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 1.5 t -115.83 -75.35 0.59 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.459 ' HB2' ' HG2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -126.69 95.82 36.82 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.436 -0.79 . . . . 0.0 109.174 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' A' ' 107' ' ' VAL . 33.8 Cg_endo -74.42 -22.14 16.51 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.461 2.107 . . . . 0.0 110.489 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 -20.13 62.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.567 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.797 ' CD ' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -99.64 20.81 13.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.419 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 19.9 t -68.73 -45.59 33.49 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 110.638 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 34.8 Cg_endo -77.24 -25.1 8.84 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.952 1.768 . . . . 0.0 110.614 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.84 -52.77 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.262 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.771 ' CE1' HG21 ' A' ' 95' ' ' ILE . 24.7 t80 -67.31 -37.61 83.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.72 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -61.04 -37.39 82.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.033 -1.042 . . . . 0.0 109.978 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -71.28 -38.48 71.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.936 . . . . 0.0 110.224 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -67.33 -51.18 55.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.113 -0.992 . . . . 0.0 110.24 -179.323 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.822 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -57.89 -34.01 69.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.402 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -58.1 -46.76 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.119 -0.988 . . . . 0.0 109.513 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.437 ' N ' HG22 ' A' ' 115' ' ' ILE . . . -67.51 -43.71 85.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.1 -35.94 72.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.173 -1.192 . . . . 0.0 110.285 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 114' ' ' ALA . 39.6 t -63.15 -40.31 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.076 -1.015 . . . . 0.0 109.925 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.493 ' C ' ' CD ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -71.3 -28.78 64.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 109.202 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -56.33 10.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.885 . . . . 0.0 109.573 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.3 mp -59.82 -42.95 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 0.0 109.528 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 59.6 mt -48.46 -26.91 2.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.66 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.14 67.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -136.7 55.61 1.83 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 109.392 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.647 ' CE1' ' CG ' ' A' ' 79' ' ' PHE . 20.3 t80 -58.55 -33.77 70.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.653 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -39.33 80.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 109.763 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -78.67 -24.82 44.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.939 . . . . 0.0 109.686 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 129' ' ' ASP . 10.6 m-85 -77.6 -9.64 59.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.549 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.9 m-20 48.1 -175.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.352 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.837 ' CZ ' HG11 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -139.8 120.45 14.25 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.327 -0.858 . . . . 0.0 108.842 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.515 ' CE1' ' HB3' ' A' ' 145' ' ' MET . 15.2 m-85 -111.72 171.89 7.22 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.095 -1.003 . . . . 0.0 110.467 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.471 ' O ' HD13 ' A' ' 74' ' ' LEU . 6.4 tt -149.23 140.55 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.474 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.11 160.24 22.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.25 -21.82 66.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -1.086 . . . . 0.0 109.609 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 136' ' ' MET . 18.7 t -65.73 -34.84 79.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.469 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 135' ' ' SER . 3.2 ttm 74.86 59.78 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 0.0 109.464 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' A' ' 135' ' ' SER . 0.4 OUTLIER -129.45 109.63 17.63 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.356 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.13 -2.12 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.304 2.003 . . . . 0.0 110.32 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.651 ' O ' HG21 ' A' ' 8' ' ' ILE . 10.1 m-20 -104.41 -3.16 24.42 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.341 -0.85 . . . . 0.0 109.193 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 9' ' ' SER . . . -91.76 -72.89 0.57 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.161 -0.962 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.466 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 3.6 ttp -177.78 141.43 0.28 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.779 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.837 HG11 ' CZ ' ' A' ' 130' ' ' PHE . 74.6 t -102.76 141.53 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.114 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.468 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 3.3 t -102.3 143.55 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.102 -0.999 . . . . 0.0 109.559 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 144' ' ' LEU . 15.5 mt -106.63 134.58 49.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.326 -0.859 . . . . 0.0 109.195 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.515 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 12.1 ttm -113.28 124.49 52.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.337 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.575 ' O ' ' CD2' ' A' ' 155' ' ' TYR . 8.8 t30 -144.51 144.32 31.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -74.36 148.22 41.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -55.69 -172.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 109.586 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -79.99 -1.44 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.632 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.546 ' CB ' HD12 ' A' ' 152' ' ' ILE . 1.2 m-20 -104.22 -35.04 8.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.327 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.25 38.22 6.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.833 ' H ' HD13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -127.71 -26.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -1.164 . . . . 0.0 109.763 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 153' ' ' THR . 5.0 t -136.58 132.39 18.65 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 0.0 109.351 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 32' ' ' CYS . 36.6 Cg_endo -80.8 153.28 19.72 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.661 2.241 . . . . 0.0 110.602 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 146' ' ' ASN . 24.7 p90 -145.12 134.59 23.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 109.347 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.13 154.33 19.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.341 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 143' ' ' VAL . 6.4 mt -115.87 145.47 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.468 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 58.1 m-85 -136.93 129.17 29.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.439 ' HB2' ' SD ' ' A' ' 141' ' ' MET . 3.4 m-85 -60.79 127.78 33.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 109.632 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.07 -54.42 18.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.781 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . 12.7 t0 -43.62 -34.77 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.811 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -102.98 53.57 0.74 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.693 HD22 ' HB3' ' A' ' 4' ' ' TYR . 5.1 mt -161.96 130.23 4.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.482 HG23 ' HG3' ' A' ' 5' ' ' LYS . 5.4 m -114.1 139.15 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.3 p -83.24 142.71 30.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.61 ' O ' HD12 ' A' ' 3' ' ' LEU . 2.5 tp10 -133.79 123.16 24.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 109.523 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.37 110.95 23.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.365 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.123 -0.985 . . . . 0.0 109.476 -179.83 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 168' ' ' PHE . 17.8 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.514 HD22 ' HA ' ' A' ' 167' ' ' LYS . 14.7 mt -105.47 157.6 17.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 3' ' ' LEU . 8.4 mt -104.51 123.52 47.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 0.0 109.288 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 4.2 m-85 -107.35 118.48 36.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.677 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -139.8 156.31 46.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.271 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.01 155.89 29.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.647 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 p -97.58 -11.62 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.872 . . . . 0.0 109.418 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.412 HG21 ' O ' ' A' ' 139' ' ' ASP . 1.0 OUTLIER -91.76 -23.87 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.179 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.5 m -124.37 -10.77 7.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.744 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.87 58.18 9.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.449 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 10.0 m-20 -127.51 134.53 49.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -1.134 . . . . 0.0 109.487 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.415 ' C ' HD23 ' A' ' 13' ' ' LEU . 43.3 mt-10 -63.17 116.64 5.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.87 . . . . 0.0 109.569 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 4.0 mt -116.72 -48.04 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.874 . . . . 0.0 109.377 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.909 HG23 HD21 ' A' ' 68' ' ' LEU . 6.1 p -136.58 175.1 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.002 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.613 ' H ' HG22 ' A' ' 14' ' ' VAL . 3.1 p -159.57 173.22 16.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.87 -1.144 . . . . 0.0 110.594 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.468 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 10.9 t0 -84.1 2.86 37.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.529 -0.732 . . . . 0.0 109.7 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.74 -11.73 55.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.126 -0.984 . . . . 0.0 109.035 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.911 ' CE1' HD13 ' A' ' 68' ' ' LEU . 26.2 m-85 -120.62 21.08 11.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.453 -0.78 . . . . 0.0 109.267 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.31 133.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 30' ' ' ALA . 69.1 mt -129.31 143.57 50.9 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.277 -0.889 . . . . 0.0 109.765 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 29' ' ' GLU . 1.3 mttm -129.62 133.5 47.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 109.469 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -91.97 121.59 33.7 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.476 ' HB ' ' OD1' ' A' ' 25' ' ' ASP . 13.3 t -76.66 153.42 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -42.98 -36.93 1.71 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.579 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.6 ' OD1' HG22 ' A' ' 27' ' ' VAL . 6.1 p30 -63.73 -123.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.9 . . . . 0.0 109.311 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.519 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -146.14 63.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.746 -1.221 . . . . 0.0 109.35 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.6 HG22 ' OD1' ' A' ' 25' ' ' ASP . 13.3 m -151.94 163.47 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.746 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 22' ' ' GLU . 4.8 m-85 -115.85 156.97 25.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.117 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 156' ' ' MET . 7.5 pt-20 -128.98 128.37 43.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.521 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.642 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -111.42 116.42 30.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.516 -0.74 . . . . 0.0 109.279 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 51.1 m-20 -63.32 142.55 58.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 109.581 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 58.6 m -133.45 152.66 51.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.902 . . . . 0.0 109.405 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -103.41 161.52 13.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.301 -0.874 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.7 mtt -105.0 131.71 52.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.468 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -136.84 128.02 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.898 . . . . 0.0 109.389 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.6 t -76.5 135.88 39.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 109.569 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.57 152.52 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 0.0 109.634 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.63 97.74 11.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.72 139.19 39.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.66 -106.11 2.79 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.04 150.56 19.6 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -128.82 -59.74 1.12 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -1.12 . . . . 0.0 109.361 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 43' ' ' VAL . 5.7 p -139.02 69.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.936 . . . . 0.0 109.347 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.7 -172.82 4.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 109.581 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.4 mm -67.55 -23.39 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.494 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.33 54.7 0.12 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.592 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -115.11 -88.06 0.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -1.135 . . . . 0.0 109.596 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.577 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -48.83 -51.59 53.1 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.992 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 48' ' ' ASN . 35.6 Cg_endo -78.72 -16.06 13.22 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.489 2.126 . . . . 0.0 110.906 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -143.72 57.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.064 -1.022 . . . . 0.0 109.717 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . 179.22 -66.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.94 . . . . 0.0 109.668 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 48' ' ' ASN . 7.8 pt-20 -143.81 178.38 7.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -111.1 31.62 5.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.328 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' A' ' 48' ' ' ASN . . . -77.08 115.44 16.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 109.662 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -73.53 96.6 2.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.312 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.79 83.55 3.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.976 . . . . 0.0 109.698 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -124.92 -165.15 1.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -0.89 . . . . 0.0 109.451 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -176.51 45.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.313 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 67.18 23.17 9.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.347 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.29 13.53 8.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.873 . . . . 0.0 109.493 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.02 -27.78 11.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.7 p -65.64 123.37 19.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -1.142 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -133.75 148.75 51.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.57 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.94 117.87 23.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 109.272 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.94 143.6 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -74.02 154.38 39.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -74.04 -24.28 59.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.729 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.911 HD13 ' CE1' ' A' ' 18' ' ' TYR . 27.7 tp -81.81 -45.03 16.14 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.083 -1.01 . . . . 0.0 108.552 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.975 HG13 ' CB ' ' A' ' 74' ' ' LEU . 55.8 t -65.03 -38.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.397 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -69.59 -36.21 76.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.132 -0.98 . . . . 0.0 109.902 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.6 -50.69 62.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.868 . . . . 0.0 110.129 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.672 ' HE2' HD11 ' A' ' 68' ' ' LEU . 34.9 m-85 -82.71 -3.66 56.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.997 . . . . 0.0 110.128 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER 73.49 18.39 3.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.498 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.975 ' CB ' HG13 ' A' ' 69' ' ' VAL . 1.8 mm? -39.29 138.69 0.61 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.463 -0.773 . . . . 0.0 109.976 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.816 ' O ' HG22 ' A' ' 132' ' ' ILE . 2.2 p -118.05 113.97 37.28 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.34 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.21 149.23 21.93 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.418 2.078 . . . . 0.0 110.468 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.5 p -113.78 -175.42 2.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.347 -0.846 . . . . 0.0 108.974 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.38 -44.66 0.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.809 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.502 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 6.6 p90 -78.57 132.11 37.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.586 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.556 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . 1.4 m-20 -175.97 27.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 109.825 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -45.0 95.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.069 -1.019 . . . . 0.0 109.354 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -122.49 -32.53 3.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.54 -32.4 72.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.293 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.573 ' CD2' ' CZ ' ' A' ' 125' ' ' PHE . 1.0 OUTLIER -58.71 -48.1 82.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.578 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.473 ' O ' HG22 ' A' ' 88' ' ' ILE . 2.2 mtt -60.3 -33.79 72.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.974 . . . . 0.0 109.818 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 t -67.61 -39.2 84.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.74 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -67.9 -47.18 69.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.806 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 85' ' ' MET . 6.2 tp -61.46 -26.73 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.505 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -43.35 57.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 109.595 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.29 -26.52 73.48 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' ' 141' ' ' MET . 17.9 m-85 -81.64 -36.65 28.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -1.152 . . . . 0.0 109.03 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -41.86 86.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.305 -0.872 . . . . 0.0 109.55 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.546 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -70.72 -42.96 69.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.059 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 93' ' ' LYS . . . -55.31 -49.47 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.04 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.732 HG21 ' CE2' ' A' ' 110' ' ' PHE . 34.1 mm -57.28 -43.19 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.344 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.55 -47.61 39.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.276 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.19 -34.56 77.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.324 -0.86 . . . . 0.0 109.298 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.446 ' O ' ' OG ' ' A' ' 102' ' ' SER . 3.6 tmt_? -63.36 -34.01 76.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.765 HD13 ' HD2' ' A' ' 106' ' ' ARG . 9.9 mt -71.83 -45.53 61.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.161 -0.962 . . . . 0.0 109.295 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -54.76 -35.36 63.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.588 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.39 -40.31 62.14 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.0 109.085 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -89.83 -77.55 0.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.524 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 103' ' ' ASN . 5.0 p30 -144.24 118.89 5.95 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.845 . . . . 0.0 109.398 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.55 ' HA ' HG23 ' A' ' 107' ' ' VAL . 33.1 Cg_endo -74.69 -13.56 22.12 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.487 2.125 . . . . 0.0 110.609 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.28 -19.79 65.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.868 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.765 ' HD2' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -100.89 15.52 28.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 109.603 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.604 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 15.6 t -72.27 -45.41 10.7 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 110.894 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 107' ' ' VAL . 34.0 Cg_endo -76.34 -49.29 0.12 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.953 1.769 . . . . 0.0 111.009 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 110' ' ' PHE . 29.5 m -58.31 -44.35 88.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.043 -1.036 . . . . 0.0 109.679 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.732 ' CE2' HG21 ' A' ' 95' ' ' ILE . 52.6 t80 -65.5 -38.51 89.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.243 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.981 ' O ' HD12 ' A' ' 115' ' ' ILE . 1.1 mt-10 -63.71 -44.33 93.92 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.133 -0.98 . . . . 0.0 110.332 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -33.81 76.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.155 -0.965 . . . . 0.0 110.122 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -69.57 -46.96 65.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.986 . . . . 0.0 109.864 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -64.66 -27.25 68.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 109.688 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.981 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -72.48 -44.93 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.7 -48.4 72.91 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.576 ' CE1' ' OD2' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -60.12 -41.33 92.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -1.19 . . . . 0.0 109.869 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 114' ' ' ALA . 56.9 t -64.32 -32.38 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.9 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -70.76 -33.28 70.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.029 . . . . 0.0 109.861 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -32.59 57.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.138 -0.976 . . . . 0.0 109.815 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.5 mp -72.04 -31.21 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.923 . . . . 0.0 109.319 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 95.6 mt -64.86 -26.79 68.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.048 -1.033 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.6 -29.18 69.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.975 . . . . 0.0 109.928 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.61 55.53 1.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.156 -0.965 . . . . 0.0 109.436 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 130' ' ' PHE . 4.0 t80 -63.34 -20.88 65.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.731 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 127' ' ' ASP . 6.0 ptmm? -74.4 -47.11 35.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.058 -1.026 . . . . 0.0 109.71 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.445 ' N ' ' HG3' ' A' ' 126' ' ' LYS . 8.5 t70 -72.28 -23.72 61.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.616 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 146' ' ' ASN . 1.1 m-85 -79.33 -24.28 42.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.112 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.531 ' C ' ' CD1' ' A' ' 130' ' ' PHE . 2.5 m-20 53.24 173.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 109.14 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.687 ' CE1' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -134.51 121.19 20.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 108.98 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 13.0 m-85 -105.66 164.63 11.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.102 -0.999 . . . . 0.0 110.661 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 75' ' ' SER . 0.8 OUTLIER -146.79 138.8 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.436 -0.79 . . . . 0.0 109.435 179.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.21 155.21 3.59 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -59.24 -23.9 62.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -1.143 . . . . 0.0 109.119 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 136' ' ' MET . 3.0 p -64.65 -35.22 80.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.408 -0.807 . . . . 0.0 109.285 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER 72.67 40.82 0.59 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.293 -0.88 . . . . 0.0 109.365 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.84 134.14 32.63 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.867 . . . . 0.0 109.309 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.67 -5.74 16.83 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.385 2.057 . . . . 0.0 110.133 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.412 ' O ' HG21 ' A' ' 8' ' ' ILE . 46.1 m-20 -98.21 -4.32 35.66 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.287 -0.883 . . . . 0.0 109.208 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.05 134.99 39.68 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.547 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -64.49 152.17 42.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.6 m -88.64 141.89 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 109.369 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.67 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 2.6 t -92.23 130.01 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.236 -0.915 . . . . 0.0 108.967 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 129' ' ' ASP . 1.5 mt -103.42 135.43 45.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.535 ' CG ' ' HG2' ' A' ' 156' ' ' MET . 0.0 OUTLIER -108.54 142.73 38.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.573 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . 1.8 t30 -145.97 166.37 26.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.717 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.72 125.93 35.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.566 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.491 ' HG3' ' CD2' ' A' ' 155' ' ' TYR . 0.9 OUTLIER -66.32 -169.31 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.24 -0.912 . . . . 0.0 109.404 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -16.09 60.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.465 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 148' ' ' ARG . 2.0 m-20 -57.89 -56.57 20.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 0.0 109.333 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 126.73 -23.19 5.68 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.838 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -140.45 37.07 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -1.127 . . . . 0.0 109.221 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.4 m -127.27 100.54 26.33 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.08 131.81 9.07 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.569 2.179 . . . . 0.0 109.814 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.491 ' CD2' ' HG3' ' A' ' 148' ' ' ARG . 40.3 p90 -135.96 142.64 44.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.097 -1.002 . . . . 0.0 109.718 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.91 ' SD ' HD23 ' A' ' 68' ' ' LEU . 6.5 mtp -99.02 149.16 23.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.208 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.624 ' O ' HG13 ' A' ' 143' ' ' VAL . 68.8 mt -117.15 141.38 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.67 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 5.7 m-85 -132.61 141.79 48.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 109.307 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.484 ' O ' ' HB2' ' A' ' 163' ' ' LEU . 72.6 m-85 -71.06 127.71 33.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 109.697 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.417 ' HE2' ' C ' ' A' ' 160' ' ' LYS . 0.7 OUTLIER -67.21 -40.83 86.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.343 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.426 ' HB3' HD12 ' A' ' 95' ' ' ILE . 2.3 m-20 -52.62 -33.28 45.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.409 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -112.65 50.05 0.8 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 159' ' ' PHE . 0.6 OUTLIER -153.26 129.24 10.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -1.121 . . . . 0.0 109.525 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 m -118.81 144.84 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 109.307 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -106.08 129.64 54.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 109.862 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -120.65 122.43 40.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.249 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.514 ' HA ' HD22 ' A' ' 2' ' ' LEU . 2.1 tttp -55.75 123.24 13.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.736 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.403 179.831 . . . . . . . . 2 2 . 1 stop_ save_